data_1fhs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fhs _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.252 60.9 Cg_endo . . . . . 0 N--CA 1.452 -0.912 0 N-CA-C 110.883 -0.468 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -135.22 60.68 1.69 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 -15.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CE1' ' CA ' ' A' ' 12' ' ' GLY . 50.9 t80 -90.58 124.0 34.68 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 110.928 -2.851 . . . . 0.0 112.379 -155.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.7 m-85 -127.78 92.01 3.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 112.105 -2.316 . . . . 0.0 107.862 167.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.517 ' CA ' ' CE1' ' A' ' 10' ' ' PHE . . . -54.91 116.33 6.6 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.958 -170.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' CD ' ' OE2' ' A' ' 38' ' ' GLU . 25.4 pttm 31.1 42.28 0.01 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 111.685 -2.257 . . . . 0.0 111.109 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.521 ' CG1' ' HD2' ' A' ' 18' ' ' LYS . 10.3 tp -62.79 129.2 92.85 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 112.971 -1.922 . . . . 0.0 108.843 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.4 Cg_exo -45.86 123.29 5.92 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.834 1.689 . . . . 0.0 113.194 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 15' ' ' PRO . 41.5 ttm180 -37.06 -41.86 0.38 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.707 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -56.32 -81.19 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.246 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.604 ' CE ' ' SD ' ' A' ' 22' ' ' MET . 8.1 tmtm? -31.48 -42.66 0.05 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 112.646 -2.07 . . . . 0.0 111.029 -176.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -58.05 -69.55 0.17 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.717 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' SER . 53.5 mt-10 -48.03 -52.9 18.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.592 -2.095 . . . . 0.0 110.255 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 24' ' ' SER . 77.4 mm-40 -40.4 -87.46 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.753 -2.021 . . . . 0.0 110.621 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.604 ' SD ' ' CE ' ' A' ' 18' ' ' LYS . 16.9 ptm -50.77 -53.08 34.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.088 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.52 HD12 ' CD1' ' A' ' 100' ' ' ILE . 48.3 tp -48.38 -21.93 0.62 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 117.223 -1.791 . . . . 0.0 112.681 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' GLU . 37.0 t -83.18 -35.97 25.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.78 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HD3' ' CA ' ' A' ' 22' ' ' MET . 5.2 pttp -42.75 -25.18 0.08 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.028 172.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' HG3' ' CB ' ' A' ' 31' ' ' ALA . 38.6 mm-40 -53.9 141.96 25.9 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.481 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -81.71 -69.49 0.61 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 111.936 -2.393 . . . . 0.0 110.455 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -76.1 -156.97 0.07 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.749 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -122.5 130.38 52.99 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 112.75 -2.023 . . . . 0.0 110.068 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.37 34.47 1.01 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 118.236 -1.935 . . . . 0.0 111.901 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.481 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -99.9 131.93 45.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 118.114 -1.434 . . . . 0.0 108.101 173.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 40.2 p90 -143.08 157.55 44.42 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 115.231 -2.588 . . . . 0.0 111.835 -173.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -148.43 151.83 35.9 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 112.003 -2.362 . . . . 0.0 109.451 171.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.85 110.71 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 112.492 -2.14 . . . . 0.0 108.976 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.676 ' HE ' ' HG ' ' A' ' 45' ' ' SER . 34.4 ptt180 -96.7 128.11 43.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.373 -2.194 . . . . 0.0 110.051 -174.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.439 ' O ' ' CA ' ' A' ' 13' ' ' LYS . 45.1 tt0 -79.05 126.06 30.21 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.062 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.669 ' HG ' ' CB ' ' A' ' 43' ' ' ASP . 49.9 m -58.57 138.58 56.74 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 112.781 -2.009 . . . . 0.0 109.955 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' OE2' ' CD ' ' A' ' 13' ' ' LYS . 9.7 tp10 -38.6 -90.65 0.0 OUTLIER 'General case' 0 C--N 1.345 0.375 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.624 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 40' ' ' ALA . 49.0 m -89.9 -36.55 14.97 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 113.601 -1.636 . . . . 0.0 111.259 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 37' ' ' SER . . . -42.58 150.23 0.43 Allowed Pre-proline 0 C--N 1.348 0.508 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.158 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.67 -116.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.995 2.463 . . . . 0.0 110.784 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.02 57.83 4.83 Favored Glycine 0 C--N 1.346 1.089 0 C-N-CA 118.145 -1.979 . . . . 0.0 110.869 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.669 ' CB ' ' HG ' ' A' ' 37' ' ' SER . 3.4 m-20 -102.9 117.1 33.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 117.903 -1.519 . . . . 0.0 109.32 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.401 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 95.3 m-85 -134.24 130.28 36.92 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 112.904 -1.953 . . . . 0.0 109.839 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.676 ' HG ' ' HE ' ' A' ' 35' ' ' ARG . 77.7 p -119.0 126.38 51.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.48 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.0 tt -93.51 115.07 27.57 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.354 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.413 ' OG ' ' HG ' ' A' ' 33' ' ' LEU . 90.3 p -94.04 144.64 25.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.789 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 60.7 t -146.44 137.4 18.51 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.726 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -73.36 93.66 1.95 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 116.83 -1.948 . . . . 0.0 108.824 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.477 ' O ' ' O ' ' A' ' 51' ' ' GLY . 4.6 t80 -92.6 40.6 1.06 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.615 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.59 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . 58.6 145.37 0.01 OUTLIER Glycine 0 C--N 1.346 1.131 0 C-N-CA 118.148 -1.977 . . . . 0.0 110.54 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 8.1 t-20 72.07 -35.04 0.32 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 112.475 -1.863 . . . . 0.0 110.854 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.59 ' H ' ' C ' ' A' ' 51' ' ' GLY . 56.2 p30 -171.45 -163.63 0.29 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 117.264 -1.775 . . . . 0.0 110.295 176.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' CG1' HD21 ' A' ' 23' ' ' LEU . 88.4 t -108.76 123.87 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 112.369 -2.196 . . . . 0.0 110.009 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -100.44 157.97 16.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.716 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -136.61 133.85 36.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 112.515 -2.129 . . . . 0.0 110.304 -176.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.488 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 92.6 m-85 -113.19 111.12 21.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.927 -1.942 . . . . 0.0 109.897 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 29.6 mmmt -72.25 100.36 2.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.089 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 98.9 t -72.09 88.47 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 113.041 -1.891 . . . . 0.0 108.553 173.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 82.0 mt -74.04 160.41 31.32 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.733 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 . . . . . 0 N--CA 1.447 -0.586 0 CA-C-N 112.032 -2.349 . . . . 0.0 108.628 177.19 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.496 ' HA ' ' HZ3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 122.291 1.044 . . . . 0.0 110.579 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 17.3 m-85 -86.82 142.37 28.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.244 -2.253 . . . . 0.0 109.503 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -160.22 124.71 3.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.989 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.488 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 1.7 mt -61.59 -83.49 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.155 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -110.16 -42.76 4.09 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.222 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.0 t -137.93 -82.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.599 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.402 HG13 ' OH ' ' A' ' 83' ' ' TYR . 24.4 m -47.03 134.2 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 112.649 -2.069 . . . . 0.0 110.544 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.56 165.98 12.26 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.563 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -170.04 140.13 1.94 Allowed 'General case' 0 C--N 1.343 0.31 0 CA-C-N 111.505 -2.589 . . . . 0.0 109.631 -175.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -91.88 -13.43 31.31 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 111.692 -2.504 . . . . 0.0 112.558 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 79' ' ' GLU . 41.1 t -140.56 129.93 23.85 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 117.573 -1.651 . . . . 0.0 109.908 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 80' ' ' LEU . 99.3 mt -47.12 -39.81 14.18 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.455 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -52.0 -45.43 64.53 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.149 -1.82 . . . . 0.0 109.594 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 76' ' ' SER . 47.4 tp10 -57.0 -32.68 66.37 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 113.16 -1.836 . . . . 0.0 111.284 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 74' ' ' PHE . 7.1 tt -72.1 -70.83 0.31 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.333 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.6 t -37.98 -35.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 112.685 -2.052 . . . . 0.0 111.187 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -80.3 -42.07 23.72 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.563 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 80' ' ' LEU . 65.5 t80 -58.72 -43.08 90.05 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.2 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.421 ' NE2' ' CD1' ' A' ' 69' ' ' LEU . 87.7 m-70 -89.5 39.13 0.93 Allowed 'General case' 0 C--N 1.345 0.406 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.689 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.628 HH12 HH21 ' A' ' 98' ' ' ARG . 60.7 ttm-85 -107.33 -40.63 5.33 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.368 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -89.97 -40.89 12.07 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.476 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 88' ' ' SER . 23.6 m -110.97 41.29 1.85 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 117.831 -1.547 . . . . 0.0 110.903 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.56 ' HB3' ' H ' ' A' ' 95' ' ' ILE . 41.8 m 43.14 -153.59 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.527 169.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 89' ' ' VAL . 15.0 p -153.99 44.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-N 113.058 -1.883 . . . . 0.0 109.788 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 95' ' ' ILE . 43.0 t . . . . . 0 C--N 1.347 0.482 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.731 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 122.103 0.954 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.56 ' H ' ' HB3' ' A' ' 88' ' ' SER . 64.2 mt -115.96 151.63 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 112.622 -2.081 . . . . 0.0 109.433 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -143.71 138.78 29.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.35 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.4 mt -89.92 118.54 29.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.995 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.628 HH21 HH12 ' A' ' 85' ' ' ARG . 2.0 mmp_? -126.17 149.36 49.05 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.521 -2.127 . . . . 0.0 109.875 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.589 ' C ' ' H ' ' A' ' 101' ' ' GLU . 7.1 m-20 -54.01 124.19 14.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 112.163 -2.29 . . . . 0.0 109.83 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.525 ' CD1' HD21 ' A' ' 33' ' ' LEU . 10.6 tt -71.95 31.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 112.533 -2.121 . . . . 0.0 111.578 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.589 ' H ' ' C ' ' A' ' 99' ' ' ASP . 47.3 mm-40 . . . . . 0 N--CA 1.448 -0.569 0 C-N-CA 118.001 -1.479 . . . . 0.0 109.651 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' O ' ' CD2' ' A' ' 9' ' ' TRP . 75.2 Cg_exo . . . . . 0 N--CA 1.459 -0.538 0 N-CA-C 116.93 1.858 . . . . 0.0 116.93 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.458 ' CD2' ' O ' ' A' ' 8' ' ' PRO . 32.5 p-90 49.25 16.65 0.16 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 111.872 -2.422 . . . . 0.0 113.502 170.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -97.77 119.13 35.82 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 116.229 -2.188 . . . . 0.0 109.653 175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 8.6 m-85 -121.92 109.14 14.26 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 113.076 -1.875 . . . . 0.0 109.164 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -69.22 129.18 23.04 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 112.56 -2.109 . . . . 0.0 111.557 -174.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HZ1' ' CD ' ' A' ' 38' ' ' GLU . 83.7 tttt 25.89 47.66 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 111.713 -2.243 . . . . 0.0 111.899 176.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.434 HG21 ' CB ' ' A' ' 35' ' ' ARG . 8.7 tp -75.21 134.0 74.45 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 117.268 -1.773 . . . . 0.0 108.8 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' ARG . 20.8 Cg_endo -65.67 124.54 12.93 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.178 1.919 . . . . 0.0 111.332 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' CZ ' ' NH2' ' A' ' 35' ' ' ARG . 94.9 mtt-85 -34.22 -41.6 0.11 Allowed 'General case' 0 C--N 1.349 0.558 0 CA-C-N 112.779 -2.009 . . . . 0.0 110.983 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -54.72 -72.13 0.07 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.243 -1.798 . . . . 0.0 109.537 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 22' ' ' MET . 4.8 tppp? -41.74 -49.52 4.3 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.492 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -47.36 -58.53 4.04 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.479 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.462 ' O ' ' OG ' ' A' ' 24' ' ' SER . 89.4 mt-10 -49.96 -52.06 36.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.733 -2.03 . . . . 0.0 109.989 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 70.9 mt-10 -55.53 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.891 -1.958 . . . . 0.0 110.852 -173.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 3.0 ptm -45.46 -39.99 7.81 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.773 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.51 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 45.7 tp -68.56 -32.03 71.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 117.644 -1.623 . . . . 0.0 111.755 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 26' ' ' GLN . 59.3 m -68.58 -35.9 78.0 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 117.503 -1.679 . . . . 0.0 111.044 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -72.07 33.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.241 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.587 ' H ' ' C ' ' A' ' 24' ' ' SER . 13.6 mm-40 -101.69 132.37 47.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 117.818 -1.553 . . . . 0.0 110.022 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -81.26 -41.93 21.45 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 111.707 -2.497 . . . . 0.0 110.599 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.42 ' HD1' ' N ' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -92.49 106.88 18.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.583 -178.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 50' ' ' PHE . 70.9 m-20 -53.74 123.94 13.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.705 -2.043 . . . . 0.0 109.419 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 136.55 -31.77 2.54 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 117.585 -2.245 . . . . 0.0 112.037 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.572 ' HB3' HE21 ' A' ' 26' ' ' GLN . . . -46.32 136.61 7.04 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 118.078 -1.449 . . . . 0.0 109.358 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 47' ' ' SER . 28.2 p90 -145.3 162.76 36.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 116.384 -2.126 . . . . 0.0 110.982 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 33' ' ' LEU . 4.5 pp -147.95 150.17 33.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.343 -2.208 . . . . 0.0 109.577 172.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.7 mt -116.92 111.98 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 112.666 -2.061 . . . . 0.0 108.662 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.436 ' NH2' ' CZ ' ' A' ' 16' ' ' ARG . 40.7 ptt85 -95.59 129.09 42.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 112.634 -2.076 . . . . 0.0 110.259 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -96.96 128.36 43.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 112.45 -2.159 . . . . 0.0 109.869 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.433 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 43.2 t -60.54 155.63 18.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.845 -1.979 . . . . 0.0 109.613 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.509 ' CD ' ' HZ1' ' A' ' 13' ' ' LYS . 45.3 tt0 -41.08 -91.52 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 112.563 -2.108 . . . . 0.0 110.252 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.411 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 50.5 m -90.0 -44.25 9.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.1 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -41.44 102.58 0.27 Allowed Pre-proline 0 C--N 1.347 0.488 0 CA-C-N 113.218 -1.81 . . . . 0.0 110.059 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 39' ' ' SER . 58.2 Cg_endo -77.62 -4.45 14.6 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.88 1.72 . . . . 0.0 115.079 -177.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.45 39.63 2.69 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 118.422 -1.846 . . . . 0.0 111.108 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 54.9 m-20 -130.32 112.17 13.05 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 117.736 -1.586 . . . . 0.0 109.933 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 96.9 m-85 -147.64 117.54 7.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.867 -1.969 . . . . 0.0 109.389 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 79.0 p -122.98 128.04 49.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.486 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.519 ' CD2' HG21 ' A' ' 48' ' ' VAL . 6.2 tt -93.59 119.7 32.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.81 -1.995 . . . . 0.0 109.673 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.51 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 50.1 m -99.44 145.02 27.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.534 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.519 HG21 ' CD2' ' A' ' 46' ' ' LEU . 88.6 t -145.36 138.67 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 113.378 -1.737 . . . . 0.0 110.452 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.559 ' HZ3' ' C ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -80.35 106.56 12.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 112.869 -1.969 . . . . 0.0 108.721 173.046 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 72.8 t80 -79.76 -104.33 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 116.847 -1.941 . . . . 0.0 108.928 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.91 -69.08 1.35 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 118.718 -1.706 . . . . 0.0 109.633 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -130.4 -24.31 2.55 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 111.978 -2.111 . . . . 0.0 112.088 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.559 ' C ' ' HZ3' ' A' ' 49' ' ' LYS . 45.7 p-10 -99.9 157.37 16.57 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 118.661 -1.216 . . . . 0.0 110.473 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG2' ' OG ' ' A' ' 24' ' ' SER . 88.6 t -85.25 114.59 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.693 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.415 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 9.8 tt0 -90.27 158.74 17.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.933 -1.94 . . . . 0.0 109.399 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -130.66 131.62 44.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.779 -2.01 . . . . 0.0 110.746 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.415 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 96.3 m-85 -123.81 133.34 53.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.432 -2.167 . . . . 0.0 109.137 175.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.724 ' HB2' ' HZ3' ' A' ' 58' ' ' LYS . 10.6 mtmp? -104.06 107.97 19.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.321 -1.752 . . . . 0.0 110.242 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 72.1 t -76.57 85.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 112.683 -2.053 . . . . 0.0 108.565 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 71.9 mt -70.33 161.0 31.22 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 112.68 -2.055 . . . . 0.0 110.679 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? . . . . . 0 N--CA 1.449 -0.501 0 CA-C-N 112.392 -2.186 . . . . 0.0 109.884 -179.331 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.717 ' HZ1' ' HA ' ' A' ' 75' ' ' ASN . 7.6 mtpm? . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.129 0.49 . . . . 0.0 110.004 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 55.0 m-85 -88.05 129.53 35.25 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 115.848 -2.341 . . . . 0.0 109.899 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 74' ' ' PHE . 53.0 p90 -159.27 134.57 8.36 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 112.344 -2.207 . . . . 0.0 109.171 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.584 ' H ' HD13 ' A' ' 69' ' ' LEU . 4.2 mp -68.77 -52.95 24.9 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 116.682 -2.007 . . . . 0.0 109.247 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 18.2 m0 -135.53 -41.41 0.7 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.53 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.5 t -138.33 -83.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.546 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -47.19 133.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 112.552 -2.113 . . . . 0.0 110.782 -171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.692 ' HZ3' ' HB2' ' A' ' 73' ' ' LYS . 9.7 mtmp? -94.21 158.38 15.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.491 -2.141 . . . . 0.0 110.592 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 80' ' ' LEU . 6.6 p90 -159.13 140.14 12.78 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 111.156 -2.747 . . . . 0.0 109.213 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.717 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 6.0 m120 -81.41 -16.91 50.7 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 111.247 -2.706 . . . . 0.0 112.352 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 79' ' ' GLU . 40.3 t -147.28 134.89 20.99 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 117.681 -1.608 . . . . 0.0 109.97 -175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 80' ' ' LEU . 82.6 mt -46.61 -42.89 16.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 112.724 -2.035 . . . . 0.0 110.288 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 38.5 m-80 -49.53 -46.82 49.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.545 -1.661 . . . . 0.0 109.572 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 76' ' ' SER . 41.9 tt0 -57.92 -34.72 70.16 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 112.922 -1.944 . . . . 0.0 111.098 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 74' ' ' PHE . 5.4 tt -61.93 -65.54 0.67 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.783 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.5 t -43.83 -35.8 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 112.07 -2.332 . . . . 0.0 111.076 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 72.6 m-20 -59.87 -38.57 82.54 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.833 -178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.456 ' C ' ' H ' ' A' ' 85' ' ' ARG . 23.0 m-85 -66.24 -51.96 52.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.836 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.05 36.59 0.51 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.971 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 83' ' ' TYR . 6.1 tpm_? -101.12 7.7 43.13 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.389 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 79.4 p -89.93 -78.2 0.37 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 118.656 -1.218 . . . . 0.0 109.896 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.453 ' OG1' ' CZ ' ' A' ' 96' ' ' PHE . 9.2 t -170.02 39.48 0.02 OUTLIER 'General case' 0 C--N 1.346 0.451 0 C-N-CA 116.7 -2.0 . . . . 0.0 110.997 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 87' ' ' THR . 77.6 p -177.22 140.98 0.31 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 116.887 -1.925 . . . . 0.0 110.537 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.3 -38.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 111.985 -2.371 . . . . 0.0 110.778 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 C--N 1.346 0.446 0 C-N-CA 117.989 -1.484 . . . . 0.0 110.127 -175.372 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 25.0 mt -149.29 121.39 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 117.314 -1.754 . . . . 0.0 109.963 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.582 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 67.3 m-85 -120.62 140.6 51.32 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.76 -2.018 . . . . 0.0 109.499 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.97 106.67 18.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 117.311 -1.756 . . . . 0.0 108.825 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -121.5 152.81 38.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.4 -173.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -45.08 126.82 6.31 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 112.441 -2.163 . . . . 0.0 109.52 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.556 HG13 HE21 ' A' ' 26' ' ' GLN . 15.4 tt -84.63 2.64 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 112.766 -2.016 . . . . 0.0 113.656 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 . . . . . 0 N--CA 1.447 -0.61 0 C-N-CA 117.774 -1.571 . . . . 0.0 110.303 -176.539 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.453 -0.853 0 CA-C-O 122.076 0.782 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.467 ' CB ' ' CE2' ' A' ' 32' ' ' PHE . 59.2 p-90 38.57 47.37 1.1 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-N 112.538 -2.119 . . . . 0.0 110.545 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -142.67 108.4 5.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.438 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 12' ' ' GLY . 9.8 m-85 -125.03 97.23 5.17 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.195 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -27.79 -105.7 0.0 OUTLIER Glycine 0 C--N 1.347 1.167 0 CA-C-N 112.184 -2.28 . . . . 0.0 112.77 -174.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.677 ' HZ1' ' HB2' ' A' ' 38' ' ' GLU . 63.9 tttp -110.19 53.52 0.69 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 112.77 -1.715 . . . . 0.0 109.035 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.441 HG21 ' CB ' ' A' ' 35' ' ' ARG . 8.5 tp -71.08 133.74 85.68 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.977 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' ARG . 23.1 Cg_endo -66.24 124.05 12.02 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.184 1.923 . . . . 0.0 111.268 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 15' ' ' PRO . 68.1 ttt180 -33.74 -39.38 0.06 Allowed 'General case' 0 C--N 1.347 0.495 0 CA-C-N 112.766 -2.016 . . . . 0.0 111.124 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -53.55 -81.17 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.049 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 17' ' ' ALA . 16.8 tppt? -36.45 -36.54 0.1 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 112.977 -1.919 . . . . 0.0 111.374 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.549 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -59.23 -72.29 0.1 Allowed 'General case' 0 C--N 1.347 0.487 0 C-N-CA 117.375 -1.73 . . . . 0.0 109.061 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 24' ' ' SER . 94.3 mt-10 -43.97 -56.13 4.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 112.541 -2.118 . . . . 0.0 109.801 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 20' ' ' GLU . 11.9 mm-40 -37.05 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.317 -2.22 . . . . 0.0 110.887 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.41 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 17.7 ptm -56.84 -40.69 76.56 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 117.536 -1.666 . . . . 0.0 110.79 -172.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 39.5 tp -50.82 -32.78 21.17 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 116.922 -1.911 . . . . 0.0 111.433 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.597 ' C ' ' H ' ' A' ' 26' ' ' GLN . 41.6 t -75.51 -39.78 57.96 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.201 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -71.55 36.19 0.06 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.305 -1.77 . . . . 0.0 110.923 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.597 ' H ' ' C ' ' A' ' 24' ' ' SER . 12.9 mm100 -102.28 -172.96 2.23 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 117.926 -1.509 . . . . 0.0 109.697 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.439 ' O ' ' C ' ' A' ' 28' ' ' HIS . 3.0 mpt_? -75.63 37.34 0.14 Allowed 'General case' 0 C--N 1.346 0.428 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.947 -176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.607 ' CD2' ' HZ2' ' A' ' 49' ' ' LYS . 78.9 m80 38.09 36.25 0.11 Allowed 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.258 176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 74.8 m-20 -141.49 76.33 1.54 Allowed 'General case' 0 C--N 1.347 0.498 0 C-N-CA 116.748 -1.981 . . . . 0.0 110.975 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.517 ' HA2' ' CG1' ' A' ' 48' ' ' VAL . . . 46.72 20.89 0.72 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 113.013 -1.903 . . . . 0.0 113.373 170.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . -52.29 135.81 31.94 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 116.765 -1.974 . . . . 0.0 108.043 172.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.467 ' CE2' ' CB ' ' A' ' 9' ' ' TRP . 30.5 p90 -139.48 148.62 42.95 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 115.656 -2.418 . . . . 0.0 111.926 -169.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -139.58 150.89 45.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 112.082 -2.326 . . . . 0.0 109.333 171.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.5 mt -117.69 107.93 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.622 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.515 ' NH2' ' HG ' ' A' ' 45' ' ' SER . 31.4 ptt-85 -98.38 140.21 32.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 112.904 -1.953 . . . . 0.0 110.556 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' GLY . 23.9 pt-20 -105.36 137.46 43.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.307 -2.224 . . . . 0.0 109.451 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 36' ' ' GLU . 49.9 m -57.88 -153.87 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.692 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.677 ' HB2' ' HZ1' ' A' ' 13' ' ' LYS . 59.2 tt0 -71.63 -95.35 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.558 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 40' ' ' ALA . 87.1 p -89.99 -41.9 11.47 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.223 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -38.83 100.68 0.21 Allowed Pre-proline 0 C--N 1.348 0.519 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.248 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' SER . 57.9 Cg_endo -77.37 -4.36 14.63 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.855 1.703 . . . . 0.0 115.034 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.49 37.37 3.63 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 118.579 -1.772 . . . . 0.0 111.378 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 49.9 m-20 -129.74 100.83 5.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 117.732 -1.587 . . . . 0.0 109.647 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 21.6 m-85 -132.32 121.33 23.37 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.662 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.515 ' HG ' ' NH2' ' A' ' 35' ' ' ARG . 78.8 p -119.04 126.56 51.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.096 -1.866 . . . . 0.0 109.37 178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.455 ' CD1' HD23 ' A' ' 80' ' ' LEU . 5.3 tt -90.36 114.34 26.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.765 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.51 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 33.8 m -97.34 149.51 22.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.314 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.517 ' CG1' ' HA2' ' A' ' 30' ' ' GLY . 75.5 t -140.64 141.56 32.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 113.397 -1.729 . . . . 0.0 110.29 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.607 ' HZ2' ' CD2' ' A' ' 28' ' ' HIS . 22.2 tptp -73.78 97.29 2.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.792 -2.004 . . . . 0.0 108.847 173.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.479 ' O ' ' O ' ' A' ' 53' ' ' ASP . 5.7 t80 -116.46 110.43 18.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.031 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 50' ' ' PHE . . . -30.97 143.8 0.01 OUTLIER Glycine 0 C--N 1.347 1.193 0 CA-C-N 112.734 -2.03 . . . . 0.0 111.826 -176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 14.0 t30 82.99 -28.69 0.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 111.848 -2.176 . . . . 0.0 111.39 -175.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.602 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 30.7 t0 -172.53 -148.01 0.04 OUTLIER 'General case' 0 C--N 1.35 0.62 0 C-N-CA 116.33 -2.148 . . . . 0.0 110.381 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.602 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 93.3 t -129.22 119.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.506 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.501 HE22 ' HB2' ' A' ' 90' ' ' SER . 10.2 tt0 -90.01 159.95 16.61 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.052 -1.885 . . . . 0.0 109.655 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.534 ' HD1' ' H ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -146.73 145.17 29.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.66 -175.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.41 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 41.0 m-85 -134.02 110.48 9.68 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.304 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 56.1 mtmt -65.83 115.28 5.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 116.299 -2.16 . . . . 0.0 109.415 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 46.7 t -78.81 102.01 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 113.244 -1.798 . . . . 0.0 108.426 174.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 78.7 mt -93.96 -167.93 1.78 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.183 -169.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 66' ' ' LYS . 34.9 tpt85 . . . . . 0 CA--C 1.539 0.528 0 CA-C-N 111.954 -2.385 . . . . 0.0 110.387 172.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.509 ' O ' ' CG ' ' A' ' 61' ' ' ARG . 5.3 mtpm? . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 121.318 0.58 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.514 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 28.1 m-85 -94.93 139.03 31.9 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 117.512 -1.675 . . . . 0.0 110.617 -168.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CB ' ' HA ' ' A' ' 73' ' ' LYS . 4.0 p90 -141.22 152.38 44.54 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 116.251 -2.18 . . . . 0.0 110.366 172.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD12 ' CG ' ' A' ' 80' ' ' LEU . 15.3 mt -90.49 -85.82 0.21 Allowed 'General case' 0 C--N 1.346 0.447 0 CA-C-N 112.744 -2.025 . . . . 0.0 109.633 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -91.13 -44.8 9.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.887 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.7 t -145.34 -87.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 113.196 -1.82 . . . . 0.0 109.85 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.0 m -53.58 132.37 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.838 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 23.2 pttp -82.42 -162.37 0.56 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 112.818 -1.992 . . . . 0.0 109.988 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -154.8 137.38 15.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.73 -2.032 . . . . 0.0 108.726 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.495 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 54.4 p30 -65.45 -0.91 2.14 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 112.981 -1.918 . . . . 0.0 113.042 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 79' ' ' GLU . 80.3 p 178.21 146.57 0.14 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.15 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' A' ' 80' ' ' LEU . 92.6 mt -47.28 -40.29 16.44 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 116.897 -1.921 . . . . 0.0 110.176 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.437 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 25.8 m-80 -55.59 -38.15 69.03 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.809 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 76' ' ' SER . 36.5 tt0 -70.18 -23.91 63.05 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 117.49 -1.684 . . . . 0.0 111.868 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.455 HD23 ' CD1' ' A' ' 46' ' ' LEU . 9.0 tt -71.95 -49.33 38.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.046 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.79 -37.11 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 112.434 -2.166 . . . . 0.0 110.827 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 66.1 m-20 -74.66 -37.82 62.63 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 113.943 -1.481 . . . . 0.0 111.01 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.41 ' O ' HG21 ' A' ' 87' ' ' THR . 44.8 t80 -64.45 -52.34 58.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.743 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -86.27 40.55 0.88 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.564 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 83' ' ' TYR . 61.8 ttt180 -73.28 -36.84 66.4 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.806 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.593 ' C ' ' H ' ' A' ' 88' ' ' SER . 46.3 m -136.87 -27.0 1.02 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 118.16 -1.416 . . . . 0.0 112.079 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' SER . 10.3 t -70.51 26.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 118.099 -1.44 . . . . 0.0 112.23 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.593 ' H ' ' C ' ' A' ' 86' ' ' SER . 80.2 p 43.21 -166.66 0.01 OUTLIER 'General case' 0 C--N 1.348 0.521 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.235 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 89' ' ' VAL . 13.8 p -178.58 43.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 112.59 -2.096 . . . . 0.0 109.794 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.501 ' HB2' HE22 ' A' ' 55' ' ' GLN . 33.0 t . . . . . 0 N--CA 1.449 -0.476 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.406 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.466 ' O ' ' OE1' ' A' ' 94' ' ' GLN . 5.9 tm0? . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.842 0.83 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 88' ' ' SER . 12.7 mm -149.38 120.93 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.139 173.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.411 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 76.3 m-85 -138.8 139.45 38.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 113.118 -1.855 . . . . 0.0 108.879 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 86.2 mt -89.66 94.05 9.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.04 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.413 ' HD3' ' CB ' ' A' ' 29' ' ' ASP . 68.7 mtp85 -92.79 137.32 32.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 111.749 -2.478 . . . . 0.0 109.913 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.603 ' C ' ' H ' ' A' ' 101' ' ' GLU . 16.1 m-20 -48.58 118.75 2.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 112.412 -2.176 . . . . 0.0 109.377 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.538 HG13 HE21 ' A' ' 26' ' ' GLN . 11.0 tt -71.22 27.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 112.76 -2.018 . . . . 0.0 112.193 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.603 ' H ' ' C ' ' A' ' 99' ' ' ASP . 55.2 mm-40 . . . . . 0 N--CA 1.446 -0.642 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.083 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 CA--C 1.543 0.946 0 N-CA-C 114.163 0.793 . . . . 0.0 114.163 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.69 35.04 3.15 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.265 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -110.97 109.14 19.14 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.894 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 15.7 m-85 -105.82 99.18 8.79 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 117.709 -1.596 . . . . 0.0 109.332 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -66.27 124.59 25.43 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 112.102 -2.317 . . . . 0.0 111.485 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' CA ' ' O ' ' A' ' 36' ' ' GLU . 26.0 pttm 32.39 40.31 0.02 OUTLIER 'General case' 0 C--N 1.344 0.341 0 CA-C-N 111.857 -2.171 . . . . 0.0 111.145 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.502 ' CG1' ' HD2' ' A' ' 18' ' ' LYS . 10.8 tp -68.5 127.31 93.24 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.6 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' ARG . 53.5 Cg_exo -44.98 121.89 3.88 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.753 1.635 . . . . 0.0 113.103 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 15' ' ' PRO . 43.8 ttp180 -36.68 -37.53 0.14 Allowed 'General case' 0 C--N 1.345 0.4 0 CA-C-N 112.811 -1.995 . . . . 0.0 111.178 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' GLU . . . -70.43 -59.06 3.08 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.748 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.545 ' HE3' ' SD ' ' A' ' 22' ' ' MET . 7.2 tmtm? -44.69 -49.76 10.27 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.863 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -41.58 -54.3 3.24 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.835 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' SER . 66.0 mt-10 -60.35 -34.69 74.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.214 -2.267 . . . . 0.0 111.548 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' O ' ' OG ' ' A' ' 24' ' ' SER . 61.7 mt-10 -64.41 -70.76 0.21 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 117.182 -1.807 . . . . 0.0 111.05 -171.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.545 ' SD ' ' HE3' ' A' ' 18' ' ' LYS . 26.6 ptm -61.44 -39.17 89.84 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 116.836 -1.945 . . . . 0.0 110.644 -175.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.425 HD21 ' CG1' ' A' ' 54' ' ' VAL . 32.1 tp -61.28 -41.4 96.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 117.805 -1.558 . . . . 0.0 110.5 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 26' ' ' GLN . 75.6 p -64.87 -37.77 88.76 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.593 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 53.9 mttt -70.98 35.9 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.001 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.589 ' H ' ' C ' ' A' ' 24' ' ' SER . 43.0 mm-40 -108.96 135.77 49.6 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 117.981 -1.488 . . . . 0.0 110.003 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' A' ' 28' ' ' HIS . 10.0 mpt_? -91.21 89.96 7.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 111.813 -2.449 . . . . 0.0 109.407 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.496 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER 117.38 121.51 0.0 OUTLIER 'General case' 0 C--N 1.349 0.547 0 CA-C-N 111.561 -2.563 . . . . 0.0 109.277 177.392 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 49' ' ' LYS . 66.7 m-20 -61.01 132.03 52.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.686 -2.052 . . . . 0.0 109.876 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 146.45 -35.14 1.34 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 118.091 -2.004 . . . . 0.0 111.732 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.447 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -43.08 150.85 0.16 Allowed 'General case' 0 C--N 1.349 0.56 0 C-N-CA 118.581 -1.248 . . . . 0.0 109.717 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.424 ' CB ' ' O ' ' A' ' 47' ' ' SER . 44.0 p90 -154.8 160.45 41.28 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 115.157 -2.617 . . . . 0.0 111.84 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.471 HD21 ' CD1' ' A' ' 100' ' ' ILE . 0.4 OUTLIER -116.91 -174.42 2.58 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.534 169.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.6 mt -147.36 103.33 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 111.103 -2.772 . . . . 0.0 107.382 153.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 50.1 ptt85 -97.47 149.34 22.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.054 -169.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 37' ' ' SER . 39.4 tt0 -114.45 142.96 45.7 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 112.021 -2.354 . . . . 0.0 110.024 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' GLU . 35.8 t -53.84 -167.52 0.0 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.783 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' ' OG ' ' A' ' 37' ' ' SER . 39.9 tt0 -98.58 -70.04 0.74 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.109 -1.859 . . . . 0.0 110.37 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.404 ' O ' ' HB1' ' A' ' 40' ' ' ALA . 89.3 p -89.97 30.67 1.04 Allowed 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.948 -173.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 39' ' ' SER . . . -179.46 136.44 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.637 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.611 ' C ' ' H ' ' A' ' 43' ' ' ASP . 57.0 Cg_endo -72.29 -143.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.981 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 172.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 -31.76 0.39 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 118.438 -1.839 . . . . 0.0 112.517 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 41' ' ' PRO . 17.5 t70 -90.05 108.74 19.91 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.945 -175.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 23.8 m-85 -133.41 123.08 24.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.544 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' A' ' 59' ' ' VAL . 79.6 p -133.82 128.67 35.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 112.952 -1.931 . . . . 0.0 109.348 177.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.49 HD21 ' CG2' ' A' ' 48' ' ' VAL . 5.5 tt -84.14 116.21 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.693 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 50.8 m -93.2 143.17 26.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.965 -1.925 . . . . 0.0 108.932 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.49 ' CG2' HD21 ' A' ' 46' ' ' LEU . 58.2 t -135.05 141.54 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 117.041 -1.864 . . . . 0.0 110.43 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.725 ' HZ3' ' N ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -82.55 97.33 8.4 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.439 -2.164 . . . . 0.0 109.086 176.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.725 ' N ' ' HZ3' ' A' ' 49' ' ' LYS . 9.3 t80 -110.07 139.92 44.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 117.527 -1.669 . . . . 0.0 109.145 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . -46.33 143.01 4.77 Favored Glycine 0 C--N 1.343 0.958 0 C-N-CA 117.322 -2.37 . . . . 0.0 110.399 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 57.0 t30 77.65 -31.17 0.17 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 111.859 -2.17 . . . . 0.0 111.365 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 50' ' ' PHE . 2.8 p30 -174.93 154.31 1.84 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 115.346 -2.542 . . . . 0.0 111.829 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.425 ' CG1' HD21 ' A' ' 23' ' ' LEU . 92.2 t -72.92 125.84 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.459 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.0 tt0 -90.04 163.13 15.02 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.775 -177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -133.37 123.61 25.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 112.622 -2.081 . . . . 0.0 110.6 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.41 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 22.9 m-85 -123.19 144.99 49.0 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 112.816 -1.993 . . . . 0.0 109.403 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -105.89 116.62 32.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.232 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.518 HG21 ' CD1' ' A' ' 80' ' ' LEU . 33.4 t -89.36 101.21 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 112.667 -2.061 . . . . 0.0 108.171 173.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' ARG . 69.4 mt -82.61 152.58 25.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 112.933 -1.94 . . . . 0.0 111.743 -166.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.499 HH12 ' HZ ' ' A' ' 68' ' ' PHE . 22.6 ptt-85 . . . . . 0 CA--C 1.538 0.484 0 CA-C-N 110.272 -3.149 . . . . 0.0 113.298 -172.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.717 ' HZ3' ' HB2' ' A' ' 66' ' ' LYS . 10.3 mtmp? . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.454 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 76.5 m-85 -97.2 127.49 43.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 117.509 -1.676 . . . . 0.0 108.987 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.499 ' HZ ' HH12 ' A' ' 61' ' ' ARG . 31.1 p90 -157.87 153.6 26.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 116.124 -2.23 . . . . 0.0 110.366 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 mp -95.07 -43.02 8.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.215 -1.812 . . . . 0.0 110.031 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -138.73 -78.12 0.35 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.163 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.9 t -105.46 -85.25 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.584 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.31 131.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 112.823 -1.99 . . . . 0.0 109.874 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.585 ' HB2' ' HZ2' ' A' ' 66' ' ' LYS . 64.0 mttm -102.79 179.91 4.15 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.853 -1.976 . . . . 0.0 110.304 -176.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 67' ' ' TYR . 14.1 m-85 -150.17 133.42 16.35 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 112.693 -2.049 . . . . 0.0 109.28 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.567 ' N ' HD21 ' A' ' 75' ' ' ASN . 0.1 OUTLIER -69.44 -5.46 23.94 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.119 -1.855 . . . . 0.0 113.449 -178.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 49.4 m -167.93 149.21 5.26 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 117.724 -1.591 . . . . 0.0 109.784 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.513 ' CD2' HG13 ' A' ' 59' ' ' VAL . 87.2 mt -45.71 -45.68 14.45 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.202 -1.817 . . . . 0.0 109.831 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -54.07 -41.59 68.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 112.821 -1.991 . . . . 0.0 110.512 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.462 ' HB2' HD22 ' A' ' 75' ' ' ASN . 48.5 tp10 -63.86 -31.87 73.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 116.627 -2.029 . . . . 0.0 110.941 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.575 ' CD2' ' HD1' ' A' ' 84' ' ' HIS . 5.9 tt -63.16 -50.88 68.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 118.522 -1.271 . . . . 0.0 108.4 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 82' ' ' ASP . 87.4 t -54.72 -75.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.673 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.474 ' HA ' ' CD ' ' A' ' 85' ' ' ARG . 33.2 t0 -34.22 -47.49 0.29 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.617 -2.083 . . . . 0.0 111.273 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -71.7 -32.62 68.01 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.863 -172.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.575 ' HD1' ' CD2' ' A' ' 80' ' ' LEU . 35.8 m170 -98.68 -6.73 29.1 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 117.688 -1.605 . . . . 0.0 113.18 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.474 ' CD ' ' HA ' ' A' ' 82' ' ' ASP . 9.0 ptm180 -82.42 39.11 0.58 Allowed 'General case' 0 C--N 1.348 0.533 0 C-N-CA 116.889 -1.924 . . . . 0.0 110.557 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 84' ' ' HIS . 79.9 p -150.0 -73.81 0.17 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.741 -1.572 . . . . 0.0 109.566 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.408 ' N ' ' OG ' ' A' ' 86' ' ' SER . 60.0 p -84.08 38.31 0.65 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 112.966 -1.925 . . . . 0.0 110.961 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.728 ' HG ' ' H ' ' A' ' 95' ' ' ILE . 48.4 t 48.54 -168.97 0.02 OUTLIER 'General case' 0 C--N 1.346 0.425 0 C-N-CA 117.919 -1.512 . . . . 0.0 109.888 177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.505 ' H ' ' HB ' ' A' ' 95' ' ' ILE . 13.6 p -152.51 43.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.439 0 CA-C-N 113.199 -1.818 . . . . 0.0 110.201 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.458 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 19.2 t . . . . . 0 N--CA 1.45 -0.426 0 CA-C-N 113.145 -1.843 . . . . 0.0 108.793 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' OE1' ' CZ ' ' A' ' 50' ' ' PHE . 42.8 tt0 . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 111.644 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.728 ' H ' ' HG ' ' A' ' 88' ' ' SER . 13.0 mm -102.04 147.49 8.72 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 C-N-CA 117.367 -1.733 . . . . 0.0 110.499 -175.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.577 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 90.5 m-85 -149.99 135.55 18.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.631 -2.077 . . . . 0.0 109.101 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.3 mt -89.89 118.55 29.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 116.958 -1.897 . . . . 0.0 109.553 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 17.4 tpt180 -121.33 147.85 45.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.71 -2.041 . . . . 0.0 110.258 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.594 ' C ' ' H ' ' A' ' 101' ' ' GLU . 67.6 m-20 -61.0 116.21 4.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.431 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.471 ' CD1' HD21 ' A' ' 33' ' ' LEU . 12.0 tt -72.19 32.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.644 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.594 ' H ' ' C ' ' A' ' 99' ' ' ASP . 17.8 mm-40 . . . . . 0 N--CA 1.447 -0.598 0 C-N-CA 117.884 -1.526 . . . . 0.0 109.787 -174.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 CA--C 1.54 0.821 0 N-CA-C 113.872 0.682 . . . . 0.0 113.872 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.15 32.94 3.67 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.473 -177.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -89.63 121.09 31.49 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 117.594 -1.642 . . . . 0.0 109.961 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.9 m-85 -105.28 92.38 4.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 112.962 -1.926 . . . . 0.0 108.598 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -55.82 120.46 19.03 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 112.447 -2.161 . . . . 0.0 111.584 -172.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.481 ' CA ' ' O ' ' A' ' 36' ' ' GLU . 17.4 ptpt 28.77 44.71 0.01 OUTLIER 'General case' 0 C--N 1.346 0.433 0 CA-C-N 111.591 -2.305 . . . . 0.0 111.384 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.8 tp -63.17 131.23 94.68 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.611 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.5 Cg_exo -45.25 121.43 3.75 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.719 1.612 . . . . 0.0 112.886 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.496 ' CB ' ' NH1' ' A' ' 16' ' ' ARG . 22.4 ttm105 -38.78 -40.53 0.63 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.818 -177.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -59.92 3.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 113.47 -1.695 . . . . 0.0 109.627 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 22' ' ' MET . 24.4 tptm -44.65 -51.09 9.46 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 112.917 -1.947 . . . . 0.0 110.182 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -45.49 -47.02 14.11 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 113.456 -1.702 . . . . 0.0 109.842 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' O ' ' OG ' ' A' ' 24' ' ' SER . 88.8 mt-10 -62.65 -46.38 88.47 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.116 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 24' ' ' SER . 40.5 mt-10 -60.82 -77.93 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.693 -2.049 . . . . 0.0 110.644 -173.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 21' ' ' GLU . 2.9 ptm -43.87 -38.78 3.53 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.884 -176.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.456 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 28.4 tp -71.55 -33.17 68.89 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.62 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 26' ' ' GLN . 53.5 m -70.41 -28.01 64.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 117.888 -1.525 . . . . 0.0 111.897 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.72 ' HB3' ' HZ2' ' A' ' 25' ' ' LYS . 5.2 mtpm? -76.98 42.36 0.31 Allowed 'General case' 0 C--N 1.349 0.55 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.314 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.567 HE21 HG13 ' A' ' 100' ' ' ILE . 22.6 mm-40 -112.28 136.11 52.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.224 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.463 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 74.9 mtp85 -38.64 -85.26 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 111.646 -2.525 . . . . 0.0 110.37 -177.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 1.2 m-70 163.27 117.33 0.0 OUTLIER 'General case' 0 C--N 1.348 0.505 0 CA-C-N 112.506 -2.134 . . . . 0.0 107.995 -175.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -166.75 135.68 2.87 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.956 1.703 . . . . 0.0 108.462 -0.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 138.71 -9.98 3.41 Favored Glycine 0 CA--C 1.544 1.896 0 C-N-CA 117.301 -2.38 . . . . 0.0 113.41 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -46.19 144.58 1.93 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 118.372 -1.331 . . . . 0.0 109.142 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' SER . 53.4 p90 -147.76 160.13 43.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 115.868 -2.333 . . . . 0.0 111.424 -174.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.4 pp -149.07 153.07 37.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.001 -2.363 . . . . 0.0 109.29 173.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 45' ' ' SER . 23.0 mt -115.91 112.52 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.785 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.602 ' NH2' ' HG ' ' A' ' 45' ' ' SER . 30.4 ptt-85 -96.71 128.52 43.74 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 112.153 -2.294 . . . . 0.0 110.394 -172.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' O ' ' CA ' ' A' ' 13' ' ' LYS . 2.9 mp0 -79.05 112.32 16.13 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.281 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.472 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 50.5 m -58.52 144.61 41.91 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 112.921 -1.945 . . . . 0.0 110.413 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.8 tp10 -46.28 -96.76 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 112.359 -2.2 . . . . 0.0 110.024 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.1 t -113.58 43.1 1.84 Allowed 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.403 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HB2' ' CB ' ' A' ' 37' ' ' SER . . . -99.05 154.65 37.21 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 113.134 -1.848 . . . . 0.0 108.983 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' ALA . 74.7 Cg_exo -34.82 -110.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.917 2.411 . . . . 0.0 114.54 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -47.7 -59.78 5.82 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 117.333 -2.365 . . . . 0.0 108.352 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -111.47 107.27 16.41 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 113.772 -1.214 . . . . 0.0 108.103 -45.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -90.36 137.36 32.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.128 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.602 ' HG ' ' NH2' ' A' ' 35' ' ' ARG . 27.4 t -133.39 132.35 41.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.621 -2.081 . . . . 0.0 109.335 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tt -103.05 115.93 31.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.953 -1.931 . . . . 0.0 109.319 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 49.8 m -97.41 149.17 22.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.948 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 85.6 t -143.51 140.95 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 113.048 -1.887 . . . . 0.0 109.731 176.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 66.3 tttp -73.06 102.59 3.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 116.64 -2.024 . . . . 0.0 108.931 173.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 50' ' ' PHE . 62.7 t80 -88.29 -8.99 54.31 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.256 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.602 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . 88.54 134.74 4.96 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 118.875 -1.631 . . . . 0.0 109.431 -174.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 7.3 t30 71.91 -33.36 0.27 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 112.307 -1.947 . . . . 0.0 110.826 -174.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.602 ' H ' ' C ' ' A' ' 51' ' ' GLY . 18.5 t70 -159.13 -175.57 5.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 117.416 -1.714 . . . . 0.0 109.436 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.575 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 85.5 t -114.42 121.8 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.701 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.451 ' OE1' ' CZ ' ' A' ' 57' ' ' PHE . 7.3 tt0 -90.69 159.29 16.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.769 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -141.76 143.7 33.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.024 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.522 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 83.5 m-85 -122.3 105.08 9.89 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.697 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.685 ' HZ3' ' HB3' ' A' ' 58' ' ' LYS . 3.1 mmmp? -65.58 105.0 1.11 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.942 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 64.9 t -75.05 96.92 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.274 172.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 88.7 mt -79.41 -161.52 0.33 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.165 -170.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.71 ' CZ ' ' H ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 111.799 -2.455 . . . . 0.0 108.378 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.71 ' H ' ' CZ ' ' A' ' 61' ' ' ARG . 3.4 mtpm? . . . . . 0 CA--C 1.543 0.7 0 CA-C-O 121.927 0.87 . . . . 0.0 113.29 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 94.0 m-85 -144.02 140.76 29.75 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.539 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -163.75 134.95 4.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 114.768 -2.773 . . . . 0.0 111.884 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.522 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -124.81 162.97 23.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 112.204 -2.271 . . . . 0.0 107.713 163.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.42 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 38.5 m0 64.86 -84.66 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 111.986 -2.37 . . . . 0.0 110.188 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 69' ' ' LEU . 51.6 t -139.16 -92.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 116.902 -1.919 . . . . 0.0 110.428 -173.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -55.28 141.29 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.677 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.419 ' C ' ' CG ' ' A' ' 74' ' ' PHE . 67.7 mttm -76.98 -165.88 0.62 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 112.821 -1.991 . . . . 0.0 109.438 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.419 ' CG ' ' C ' ' A' ' 73' ' ' LYS . 15.3 m-85 -157.06 136.45 12.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.059 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.518 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 2.6 p-10 -65.48 -5.14 7.02 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.076 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 79' ' ' GLU . 80.2 p 178.22 153.72 0.33 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.988 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.443 ' CD2' HG13 ' A' ' 59' ' ' VAL . 94.1 mt -45.35 -42.52 10.08 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 117.386 -1.726 . . . . 0.0 110.21 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 14.0 t-20 -58.4 -40.49 82.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.239 -1.8 . . . . 0.0 110.816 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 76' ' ' SER . 43.1 tp10 -63.18 -30.11 71.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 116.644 -2.022 . . . . 0.0 111.237 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.453 HD12 ' CG ' ' A' ' 69' ' ' LEU . 5.8 tt -71.42 -59.96 2.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.531 176.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 97.5 t -46.15 -31.99 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 112.618 -2.083 . . . . 0.0 111.501 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 90.2 m-20 -80.06 -42.08 24.41 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.362 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -59.63 -41.08 89.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.591 -1.641 . . . . 0.0 110.449 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.416 ' HD1' ' CD2' ' A' ' 80' ' ' LEU . 33.1 m170 -90.41 39.69 0.98 Allowed 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.54 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 85' ' ' ARG . 62.0 ttt180 -124.45 0.8 8.3 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.876 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -89.91 -45.84 8.95 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.795 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' SER . 9.3 t -170.05 119.21 0.6 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 117.02 -1.872 . . . . 0.0 110.597 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.502 ' HA ' ' H ' ' A' ' 95' ' ' ILE . 43.0 t 66.14 143.89 0.03 OUTLIER 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.689 -2.05 . . . . 0.0 110.963 172.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 90' ' ' SER . 14.0 p -147.74 42.98 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.879 172.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.498 ' CB ' HD11 ' A' ' 95' ' ' ILE . 48.1 t . . . . . 0 C--N 1.347 0.469 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.39 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.412 ' HA ' ' OG ' ' A' ' 88' ' ' SER . 26.6 mt-30 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.93 0.871 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.502 ' H ' ' HA ' ' A' ' 88' ' ' SER . 40.6 mt -143.13 140.88 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.811 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.414 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 16.8 m-30 -111.67 146.45 37.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.524 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.6 mt -90.04 118.93 29.97 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 117.079 -1.848 . . . . 0.0 109.284 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 90.0 mtt-85 -122.23 146.79 46.94 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.905 -1.952 . . . . 0.0 109.97 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 100' ' ' ILE . 33.5 m-20 -57.12 122.63 12.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.759 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.59 HG12 ' H ' ' A' ' 101' ' ' GLU . 14.9 tt -59.74 -136.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 112.739 -2.028 . . . . 0.0 109.391 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.59 ' H ' HG12 ' A' ' 100' ' ' ILE . 81.0 mt-10 . . . . . 0 N--CA 1.447 -0.593 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.777 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 CA--C 1.543 0.946 0 N-CA-C 114.166 0.794 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.438 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 4.6 p-90 -161.34 31.19 0.14 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.653 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.438 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 96.5 m-85 -103.11 120.23 40.31 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.013 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 12' ' ' GLY . 8.1 m-85 -108.51 108.58 19.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.746 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -16.7 -111.57 0.0 OUTLIER Glycine 0 C--N 1.349 1.259 0 CA-C-N 111.67 -2.514 . . . . 0.0 113.016 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -116.12 43.07 2.23 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 112.978 -1.611 . . . . 0.0 109.88 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.521 HD12 ' CD ' ' A' ' 18' ' ' LYS . 10.9 tp -53.12 114.46 6.01 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.315 -178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' ARG . 47.2 Cg_exo -50.15 125.84 15.83 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.581 1.52 . . . . 0.0 111.869 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.714 ' HB3' HH12 ' A' ' 35' ' ' ARG . 18.3 ptp180 -34.7 -38.14 0.07 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.481 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -69.52 -62.44 1.38 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.455 -1.702 . . . . 0.0 109.74 178.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.649 ' HZ2' ' H ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -38.22 -44.43 0.86 Allowed 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.219 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -54.38 -59.88 4.09 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 112.735 -2.029 . . . . 0.0 109.459 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' OG ' ' A' ' 24' ' ' SER . 89.3 mt-10 -43.26 -43.65 4.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 112.795 -2.002 . . . . 0.0 110.263 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 24' ' ' SER . 38.5 mt-10 -60.6 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.443 -175.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.649 ' H ' ' HZ2' ' A' ' 18' ' ' LYS . 17.3 ptm -43.28 -40.31 3.44 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.794 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.602 ' C ' ' H ' ' A' ' 25' ' ' LYS . 31.8 tp -64.71 -36.74 85.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.132 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.51 ' OG ' ' CG2' ' A' ' 54' ' ' VAL . 63.2 m -73.23 28.71 0.06 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 117.368 -1.733 . . . . 0.0 111.656 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.602 ' H ' ' C ' ' A' ' 23' ' ' LEU . 53.1 mtpt -135.03 46.21 2.45 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.198 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.548 HE21 HG13 ' A' ' 100' ' ' ILE . 17.6 mm-40 -119.77 117.56 28.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 112.877 -1.965 . . . . 0.0 109.926 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 31.8 tpt85 -98.56 30.95 3.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 111.453 -2.612 . . . . 0.0 112.327 -169.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 29' ' ' ASP . 73.4 m80 -149.39 11.84 0.8 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 116.019 -2.273 . . . . 0.0 113.593 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' HIS . 7.6 t70 58.77 141.9 0.01 OUTLIER 'General case' 0 C--N 1.347 0.474 0 CA-C-O 122.155 0.979 . . . . 0.0 110.79 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.25 -21.82 43.76 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 117.749 -2.167 . . . . 0.0 112.932 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.517 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -42.58 117.46 1.03 Allowed 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.774 -1.17 . . . . 0.0 109.748 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.461 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 29.6 p90 -130.9 158.87 39.06 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 116.399 -2.121 . . . . 0.0 111.632 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -151.87 153.53 34.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 112.618 -2.083 . . . . 0.0 109.753 172.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.536 HD12 ' CD1' ' A' ' 77' ' ' LEU . 15.6 mt -121.46 113.39 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.639 -2.073 . . . . 0.0 108.793 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.714 HH12 ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -84.57 131.16 34.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 115.423 -2.511 . . . . 0.0 110.156 -175.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.9 tp10 -72.27 69.53 0.8 Allowed 'General case' 0 C--N 1.346 0.42 0 CA-C-N 112.744 -2.025 . . . . 0.0 109.401 176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.585 ' HG ' ' HA ' ' A' ' 41' ' ' PRO . 60.0 p 24.7 -147.61 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 112.158 -2.292 . . . . 0.0 111.791 -177.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -130.58 -70.56 0.61 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 112.999 -1.909 . . . . 0.0 109.021 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.1 t -134.87 43.85 2.68 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 112.435 -2.166 . . . . 0.0 109.677 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.444 ' HB1' ' CA ' ' A' ' 41' ' ' PRO . . . -80.18 -65.14 0.29 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.471 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.585 ' HA ' ' HG ' ' A' ' 37' ' ' SER . 84.2 Cg_endo -93.02 -2.11 49.82 Favored 'Cis proline' 0 C--N 1.357 0.978 0 N-CA-C 114.903 1.078 . . . . 0.0 114.903 -4.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.5 55.35 4.41 Favored Glycine 0 C--N 1.346 1.111 0 C-N-CA 119.052 -1.546 . . . . 0.0 111.493 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 49.3 m-20 -130.35 94.63 3.71 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 117.675 -1.61 . . . . 0.0 109.676 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -110.64 127.29 55.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 112.931 -1.94 . . . . 0.0 109.698 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.669 ' HG ' ' CD ' ' A' ' 35' ' ' ARG . 20.4 p -125.17 132.34 53.06 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.25 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.411 HD22 ' O ' ' A' ' 47' ' ' SER . 5.4 tt -91.68 113.95 26.35 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.099 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.9 m -95.33 153.0 17.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.159 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.4 t -153.12 135.92 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 117.167 -1.813 . . . . 0.0 110.11 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.494 ' HZ1' ' H ' ' A' ' 26' ' ' GLN . 89.0 tttt -83.32 106.94 15.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 112.946 -1.933 . . . . 0.0 108.645 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -75.22 -79.44 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.57 -176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.3 -75.94 0.44 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-N 111.796 -2.456 . . . . 0.0 109.871 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.64 -24.35 9.26 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 112.107 -2.046 . . . . 0.0 111.99 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -111.6 156.78 21.26 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 118.464 -1.294 . . . . 0.0 110.115 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' CG2' ' OG ' ' A' ' 24' ' ' SER . 99.1 t -83.44 105.27 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 112.683 -2.053 . . . . 0.0 109.952 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 56' ' ' HIS . 1.0 OUTLIER -96.98 145.71 25.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.081 176.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.471 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 44.4 p-80 -134.0 168.62 18.47 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.044 -171.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.455 ' CZ ' ' OE1' ' A' ' 55' ' ' GLN . 85.3 m-85 -139.02 112.13 7.99 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 112.142 -2.299 . . . . 0.0 109.208 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 37.4 mtmm -77.74 108.93 11.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 116.203 -2.199 . . . . 0.0 109.771 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.518 HG23 ' CD1' ' A' ' 77' ' ' LEU . 89.6 t -74.68 89.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.71 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 55.2 mt -81.39 152.35 27.5 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 112.61 -2.086 . . . . 0.0 109.664 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' LYS . 10.7 ttt180 . . . . . 0 N--CA 1.445 -0.69 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.76 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HZ1' ' HA ' ' A' ' 75' ' ' ASN . 4.6 mtpm? . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.236 0.541 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 87.8 m-85 -106.33 134.23 49.79 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.335 -177.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -151.79 172.04 16.77 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 116.616 -2.034 . . . . 0.0 110.983 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.479 ' CD1' HD12 ' A' ' 80' ' ' LEU . 5.0 mp -112.17 -91.67 0.48 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 111.833 -2.44 . . . . 0.0 109.498 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -90.15 -40.59 12.13 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.789 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 82.4 t -149.44 -85.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 117.428 -1.709 . . . . 0.0 110.203 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.6 m -49.42 132.45 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.367 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -87.5 151.0 23.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 112.238 -2.255 . . . . 0.0 109.963 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -125.71 141.72 51.87 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 112.557 -2.11 . . . . 0.0 108.603 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.71 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 1.7 p-10 -56.78 -33.64 66.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 116.856 -1.937 . . . . 0.0 111.126 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 69.0 m -170.67 170.47 6.67 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 118.465 -1.294 . . . . 0.0 109.451 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.536 ' CD1' HD12 ' A' ' 34' ' ' ILE . 3.7 mm? -39.8 -46.93 2.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.355 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 76' ' ' SER . 6.0 p-10 -52.35 -50.55 62.13 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 114.798 -2.761 . . . . 0.0 110.284 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 6.6 tp10 -64.08 -15.85 60.47 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 116.502 -2.079 . . . . 0.0 112.392 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.479 HD12 ' CD1' ' A' ' 69' ' ' LEU . 5.0 tt -83.04 -70.55 0.55 Allowed 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.42 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.0 t -35.87 -37.7 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 112.051 -2.34 . . . . 0.0 111.146 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 84' ' ' HIS . 25.1 t0 -70.81 -50.83 31.31 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.898 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 84' ' ' HIS . 16.3 m-30 -78.32 42.07 0.41 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.602 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.601 ' C ' ' H ' ' A' ' 86' ' ' SER . 58.8 m80 -152.44 -21.26 0.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.275 -1.784 . . . . 0.0 112.362 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 85' ' ' ARG . 11.7 ptp85 -75.08 38.84 0.13 Allowed 'General case' 0 C--N 1.348 0.543 0 C-N-CA 117.232 -1.787 . . . . 0.0 110.701 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.601 ' H ' ' C ' ' A' ' 84' ' ' HIS . 50.4 m -110.84 -45.73 3.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.566 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' SER . 8.9 t -169.95 105.9 0.34 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.173 -1.83 . . . . 0.0 109.991 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.524 ' HA ' ' H ' ' A' ' 95' ' ' ILE . 39.2 t 54.28 164.33 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.749 -2.023 . . . . 0.0 110.491 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 89' ' ' VAL . 14.7 p -143.93 42.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.381 0 CA-C-N 112.607 -2.088 . . . . 0.0 110.039 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 37.4 t . . . . . 0 C--N 1.348 0.504 0 CA-C-N 113.607 -1.633 . . . . 0.0 109.979 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 121.952 0.882 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.524 ' H ' ' HA ' ' A' ' 88' ' ' SER . 58.5 mt -132.75 125.81 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 112.896 -1.956 . . . . 0.0 109.717 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.81 145.84 47.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.844 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 98' ' ' ARG . 89.9 mt -89.95 106.7 18.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.488 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.604 ' HG2' ' H ' ' A' ' 99' ' ' ASP . 47.6 ttt180 -177.16 -159.63 0.05 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.413 -2.176 . . . . 0.0 107.567 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.604 ' H ' ' HG2' ' A' ' 98' ' ' ARG . 53.4 t0 80.35 -34.23 0.13 Allowed 'General case' 0 C--N 1.346 0.424 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.638 161.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.548 HG13 HE21 ' A' ' 26' ' ' GLN . 9.4 tt -69.84 20.61 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 115.886 -2.325 . . . . 0.0 112.92 -171.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 99' ' ' ASP . 75.5 tt0 . . . . . 0 N--CA 1.444 -0.768 0 C-N-CA 117.712 -1.595 . . . . 0.0 109.592 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo . . . . . 0 CA--C 1.543 0.927 0 N-CA-C 114.708 1.003 . . . . 0.0 114.708 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.1 36.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.731 -175.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -101.34 125.33 47.96 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.279 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 6.2 m-85 -120.91 114.67 21.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 113.199 -1.818 . . . . 0.0 108.577 175.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -75.91 124.54 7.46 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 112.447 -2.16 . . . . 0.0 111.554 -174.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.508 ' CG ' ' HA ' ' A' ' 38' ' ' GLU . 43.6 mtmt 32.3 45.42 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 111.739 -2.23 . . . . 0.0 111.243 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.45 130.84 81.23 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 113.319 -1.764 . . . . 0.0 108.836 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' ARG . 50.9 Cg_exo -46.04 121.26 4.21 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.618 1.545 . . . . 0.0 112.717 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 15' ' ' PRO . 53.3 ttp180 -40.59 -41.01 1.38 Allowed 'General case' 0 C--N 1.345 0.393 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.627 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -61.46 -68.65 0.3 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.61 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 17' ' ' ALA . 17.1 tppt? -38.5 -47.05 1.24 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.735 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.709 ' HB1' HH21 ' A' ' 35' ' ' ARG . . . -50.41 -65.97 0.47 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.226 -1.806 . . . . 0.0 109.072 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 47.4 mt-10 -42.65 -43.97 4.07 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.492 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 24' ' ' SER . 44.9 mt-10 -64.66 -82.3 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.602 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.412 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 27.0 ptm -47.19 -35.93 8.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.224 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.584 ' O ' ' CG ' ' A' ' 26' ' ' GLN . 49.3 tp -67.92 -32.25 72.57 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.571 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 26' ' ' GLN . 38.7 t -74.46 -34.18 63.08 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 117.915 -1.514 . . . . 0.0 111.219 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.7 ' HB3' ' HZ2' ' A' ' 25' ' ' LYS . 5.1 mtpm? -77.86 43.89 0.44 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.928 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.584 ' CG ' ' O ' ' A' ' 23' ' ' LEU . 23.1 mm-40 -114.35 -4.25 13.01 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.266 -1.788 . . . . 0.0 114.068 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 26' ' ' GLN . 10.6 tpp180 34.33 38.74 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.564 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.462 ' C ' ' HD1' ' A' ' 28' ' ' HIS . 1.7 t-80 -158.43 107.45 1.99 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.657 -1.611 . . . . 0.0 109.856 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.6 114.58 3.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.199 -1.818 . . . . 0.0 109.683 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 137.2 -31.96 2.47 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 117.611 -2.233 . . . . 0.0 112.101 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 30' ' ' GLY . . . -40.94 127.85 2.66 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.265 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.5 ' CD1' ' CD2' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -136.36 136.53 39.72 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.931 -1.94 . . . . 0.0 110.097 -177.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.593 ' HG ' ' HG ' ' A' ' 47' ' ' SER . 4.2 pp -128.03 147.97 50.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 111.289 -2.687 . . . . 0.0 108.195 160.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -107.7 104.46 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 113.568 -1.651 . . . . 0.0 108.708 178.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.709 HH21 ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -84.35 127.26 33.88 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.849 -175.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 39.6 tt0 -90.37 130.41 36.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 112.577 -2.101 . . . . 0.0 109.781 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 40' ' ' ALA . 1.6 p -39.95 122.11 1.41 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.414 -1.721 . . . . 0.0 110.257 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HA ' ' CG ' ' A' ' 13' ' ' LYS . 61.1 tt0 -49.55 -54.45 18.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.401 -2.181 . . . . 0.0 110.56 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 p -90.03 -94.59 0.11 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.065 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' O ' ' OG ' ' A' ' 37' ' ' SER . . . -53.76 139.64 50.85 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.04 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 43' ' ' ASP . 66.5 Cg_endo -77.44 -146.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 N-CA-C 106.879 -2.008 . . . . 0.0 106.879 171.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.76 -18.45 0.09 OUTLIER Glycine 0 CA--C 1.542 1.726 0 O-C-N 124.84 1.338 . . . . 0.0 113.794 172.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.595 ' H ' ' C ' ' A' ' 41' ' ' PRO . 70.2 m-20 -126.62 135.16 50.84 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 117.746 -1.582 . . . . 0.0 110.643 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.73 -169.82 2.37 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.285 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' A' ' 59' ' ' VAL . 74.7 p -170.05 137.86 1.63 Allowed 'General case' 0 C--N 1.345 0.408 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.465 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.509 HD23 ' CG2' ' A' ' 48' ' ' VAL . 2.6 tt -98.22 113.91 25.99 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 112.936 -1.938 . . . . 0.0 110.413 -172.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.593 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 88.8 p -95.24 133.48 39.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.385 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.509 ' CG2' HD23 ' A' ' 46' ' ' LEU . 46.9 t -135.28 147.93 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 117.496 -1.682 . . . . 0.0 109.299 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -83.79 100.69 11.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 115.914 -2.314 . . . . 0.0 108.955 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 53' ' ' ASP . 6.6 t80 -119.46 103.07 9.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.79 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -26.56 141.3 0.01 OUTLIER Glycine 0 C--N 1.348 1.227 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.942 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.576 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 87.6 m-20 104.68 -52.89 0.0 OUTLIER 'General case' 0 C--N 1.345 0.403 0 CA-C-N 111.356 -2.422 . . . . 0.0 108.111 -165.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.599 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 16.9 t70 -177.75 -173.23 0.39 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 111.584 -2.553 . . . . 0.0 109.799 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.599 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 77.9 t -88.9 119.54 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 113.112 -1.858 . . . . 0.0 109.442 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.421 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.1 tt0 -92.08 159.51 15.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.204 -1.816 . . . . 0.0 109.827 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 28.9 p80 -147.62 134.85 20.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.955 -174.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.421 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 83.3 m-85 -127.21 111.26 13.75 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 112.629 -2.078 . . . . 0.0 109.229 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -58.52 122.16 12.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 116.811 -1.955 . . . . 0.0 109.549 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.519 HG11 ' CD1' ' A' ' 80' ' ' LEU . 67.1 t -94.2 87.43 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 112.797 -2.002 . . . . 0.0 108.624 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.6 mt -89.17 159.34 17.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.393 -2.185 . . . . 0.0 110.855 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 . . . . . 0 N--CA 1.444 -0.733 0 CA-C-N 112.55 -2.114 . . . . 0.0 109.484 173.721 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.71 ' N ' ' HZ2' ' A' ' 66' ' ' LYS . 1.2 mmpm? . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 122.289 1.042 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -101.97 143.23 32.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 112.195 -2.275 . . . . 0.0 108.513 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 71' ' ' VAL . 52.6 p90 -149.23 -161.64 1.39 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 116.204 -2.198 . . . . 0.0 111.099 -174.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.4 mt -137.28 -37.89 0.62 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 111.677 -2.51 . . . . 0.0 110.545 -176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -112.15 -41.09 4.02 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.508 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 92.6 t -150.01 -79.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 117.183 -1.807 . . . . 0.0 109.689 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 71' ' ' VAL . 20.1 m -162.75 134.96 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.777 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.704 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -170.04 -33.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 114.206 -2.998 . . . . 0.0 112.977 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.5 ' CZ ' ' CD ' ' A' ' 73' ' ' LYS . 2.6 m-85 -112.29 149.07 32.89 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 116.439 -2.104 . . . . 0.0 109.758 -174.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.538 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 27.8 p30 -103.65 19.57 19.61 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.431 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.5 t -179.24 143.8 0.21 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.644 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.401 HD23 ' CD1' ' A' ' 34' ' ' ILE . 82.6 mt -43.02 -46.12 5.41 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.011 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 12.1 m120 -59.17 -38.1 78.93 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.924 -177.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 76' ' ' SER . 61.5 tt0 -70.38 -26.08 63.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 117.111 -1.836 . . . . 0.0 111.689 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.519 ' CD1' HG11 ' A' ' 59' ' ' VAL . 9.1 tt -66.81 -50.36 62.88 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.908 174.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.1 -30.54 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.026 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 84.7 m-20 -70.59 -44.46 67.29 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 118.341 -1.344 . . . . 0.0 110.307 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 2.0 t80 -83.57 29.2 0.53 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 116.366 -2.133 . . . . 0.0 111.989 -177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.604 ' C ' ' H ' ' A' ' 86' ' ' SER . 5.8 m-70 -130.21 -25.7 2.43 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.727 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 16.7 ptm180 -72.92 35.16 0.07 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 118.447 -1.301 . . . . 0.0 111.354 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.604 ' H ' ' C ' ' A' ' 84' ' ' HIS . 50.3 m -150.02 -43.6 0.13 Allowed 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.939 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 88' ' ' SER . 8.7 t -118.13 45.47 1.98 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.871 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 87' ' ' THR . 87.9 p 51.44 -163.59 0.06 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.811 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.31 -39.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 112.832 -1.986 . . . . 0.0 110.461 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.475 ' H ' HD11 ' A' ' 95' ' ' ILE . 43.3 t . . . . . 0 N--CA 1.45 -0.446 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.487 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.668 0.747 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.475 HD11 ' H ' ' A' ' 90' ' ' SER . 56.6 mt -131.93 121.23 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.215 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.461 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 83.3 m-85 -114.09 121.94 45.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.186 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 70.6 mt -90.09 104.32 16.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.122 -1.853 . . . . 0.0 110.054 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' ASP . 67.5 ttt-85 -170.53 -116.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 116.601 -2.04 . . . . 0.0 110.546 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' ARG . 10.0 t70 -30.0 112.94 0.09 Allowed 'General case' 0 C--N 1.35 0.59 0 CA-C-N 113.681 -1.6 . . . . 0.0 111.667 -172.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.443 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 15.1 tt -120.41 -39.93 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 112.389 -2.187 . . . . 0.0 111.359 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 . . . . . 0 N--CA 1.447 -0.591 0 CA-C-N 112.724 -2.034 . . . . 0.0 109.642 -176.5 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 CA--C 1.544 0.986 0 N-CA-C 114.087 0.764 . . . . 0.0 114.087 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.431 ' CZ3' ' CE1' ' A' ' 10' ' ' PHE . 1.6 p-90 -147.15 26.5 1.08 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.125 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.431 ' CE1' ' CZ3' ' A' ' 9' ' ' TRP . 92.8 m-85 -90.6 110.66 21.81 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 118.319 -1.353 . . . . 0.0 109.582 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.0 m-85 -94.96 99.38 11.41 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.184 -1.825 . . . . 0.0 108.446 174.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -70.09 140.47 32.72 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 112.202 -2.272 . . . . 0.0 111.618 -173.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' GLY . 60.4 tttp 27.73 48.24 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.007 -2.097 . . . . 0.0 111.447 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 14' ' ' ILE . 11.0 tp -80.02 124.62 82.91 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 113.227 -1.806 . . . . 0.0 108.961 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' ARG . 50.5 Cg_exo -47.24 122.19 6.18 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.622 1.548 . . . . 0.0 112.815 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.528 ' NH1' ' CG ' ' A' ' 20' ' ' GLU . 1.6 tmt_? -38.28 -42.45 0.7 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 112.922 -1.945 . . . . 0.0 110.401 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -64.62 -58.5 6.16 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.105 -1.862 . . . . 0.0 109.956 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 15' ' ' PRO . 59.1 tptt -42.93 -51.37 5.59 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 113.033 -1.894 . . . . 0.0 110.125 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.744 ' CB ' HH21 ' A' ' 35' ' ' ARG . . . -43.03 -49.31 6.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.829 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.528 ' CG ' ' NH1' ' A' ' 16' ' ' ARG . 57.0 mt-10 -63.89 -44.72 92.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.581 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.473 ' O ' ' OG ' ' A' ' 24' ' ' SER . 34.8 mt-10 -63.3 -78.75 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.811 -1.995 . . . . 0.0 110.759 -171.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.528 ' CE ' ' CD2' ' A' ' 33' ' ' LEU . 22.9 ptt? -46.41 -38.29 8.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.994 -175.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 31.7 tp -69.6 -35.88 75.72 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 117.558 -1.657 . . . . 0.0 111.232 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.569 ' C ' ' H ' ' A' ' 26' ' ' GLN . 92.5 p -62.87 -27.65 69.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 117.674 -1.61 . . . . 0.0 111.73 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 25.1 mtpp -74.23 36.5 0.1 Allowed 'General case' 0 C--N 1.349 0.549 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.972 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.571 HE21 HG13 ' A' ' 100' ' ' ILE . 21.7 mm-40 -112.55 142.43 45.14 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.423 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' HIS . 10.5 mpt_? -92.6 -62.85 1.31 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 112.408 -2.178 . . . . 0.0 109.995 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 27' ' ' ARG . 36.5 m170 -58.42 -154.41 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.61 -177.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -139.59 120.08 14.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.424 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.71 -17.47 3.47 Favored Glycine 0 CA--C 1.542 1.769 0 C-N-CA 117.985 -2.055 . . . . 0.0 113.0 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -46.54 118.22 1.91 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.22 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.489 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 10.3 p90 -132.11 158.67 41.03 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 116.516 -2.074 . . . . 0.0 111.384 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.528 ' CD2' ' CE ' ' A' ' 22' ' ' MET . 4.3 pp -155.61 155.89 34.09 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 111.925 -2.398 . . . . 0.0 108.76 168.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.19 114.34 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 117.254 -1.778 . . . . 0.0 109.247 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.744 HH21 ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -80.5 125.06 29.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.072 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.428 ' C ' ' H ' ' A' ' 38' ' ' GLU . 21.5 pt-20 -116.03 133.35 56.12 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.064 -172.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 38' ' ' GLU . 38.3 t 70.77 -14.11 0.45 Allowed 'General case' 0 C--N 1.346 0.442 0 CA-C-N 111.903 -2.408 . . . . 0.0 113.344 172.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 36' ' ' GLU . 56.1 tt0 -40.32 -35.74 0.46 Allowed 'General case' 0 C--N 1.35 0.623 0 C-N-CA 117.209 -1.797 . . . . 0.0 111.224 174.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 80.4 p -148.75 72.89 1.2 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.083 -1.871 . . . . 0.0 107.976 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -70.57 -165.22 0.04 OUTLIER Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 112.797 -2.001 . . . . 0.0 106.275 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.528 ' HA ' ' CB ' ' A' ' 40' ' ' ALA . 25.4 Cg_endo -63.1 -108.73 0.0 OUTLIER 'Cis proline' 0 C--N 1.353 0.769 0 O-C-N 122.299 0.631 . . . . 0.0 112.472 -0.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.42 74.56 0.87 Allowed Glycine 0 C--N 1.345 1.077 0 C-N-CA 118.952 -1.594 . . . . 0.0 109.906 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.457 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 0.9 OUTLIER -131.54 105.17 7.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.047 -2.077 . . . . 0.0 109.591 -178.038 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 22.0 m-85 -132.83 134.19 44.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.753 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.405 ' OG ' ' HD3' ' A' ' 35' ' ' ARG . 72.0 p -127.62 138.9 52.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 112.981 -1.918 . . . . 0.0 109.389 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.507 ' CD2' HG21 ' A' ' 48' ' ' VAL . 5.4 tt -97.22 117.28 31.06 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.507 -2.133 . . . . 0.0 109.969 -174.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.6 m -96.57 141.65 29.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.242 -1.799 . . . . 0.0 109.839 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.507 HG21 ' CD2' ' A' ' 46' ' ' LEU . 92.4 t -150.8 138.4 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.039 -1.891 . . . . 0.0 110.03 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.525 ' CE ' ' HB2' ' A' ' 26' ' ' GLN . 23.5 ttmm -78.53 109.32 12.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 116.503 -2.079 . . . . 0.0 108.979 171.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -77.39 -90.9 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.446 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.61 -77.98 1.39 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 112.502 -2.136 . . . . 0.0 109.974 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -117.17 -24.63 7.42 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 112.288 -1.956 . . . . 0.0 112.13 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.573 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 34.4 t0 -108.34 -178.49 3.62 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 118.029 -1.468 . . . . 0.0 109.868 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.573 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 95.1 t -98.21 117.83 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.899 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -98.27 157.81 15.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 112.874 -1.966 . . . . 0.0 109.428 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.529 ' HD1' ' H ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -146.02 136.88 24.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.421 -175.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -118.59 110.9 17.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.55 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.5 mtmm -62.62 109.48 1.41 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 117.059 -1.856 . . . . 0.0 109.405 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.521 HG13 ' CD2' ' A' ' 77' ' ' LEU . 40.6 t -77.86 92.17 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 116.896 -1.922 . . . . 0.0 107.86 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 61' ' ' ARG . 96.9 mt -73.35 179.73 3.83 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 112.216 -2.265 . . . . 0.0 112.342 -165.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 60' ' ' LEU . 14.7 ptm180 . . . . . 0 C--N 1.349 0.545 0 CA-C-N 110.04 -3.255 . . . . 0.0 112.409 -172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.677 ' HZ1' ' HA ' ' A' ' 75' ' ' ASN . 7.6 mtpm? . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.36 0.6 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 57.0 m-85 -78.37 143.08 37.17 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 113.974 -1.467 . . . . 0.0 109.303 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' O ' ' A' ' 70' ' ' TRP . 2.7 t80 -156.05 135.53 12.38 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 116.075 -2.25 . . . . 0.0 111.016 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.462 ' CG ' HD12 ' A' ' 80' ' ' LEU . 40.2 mt -100.98 -78.54 0.52 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.13 -1.85 . . . . 0.0 109.882 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.456 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 25.7 m0 -123.24 -69.03 0.84 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.116 -1.856 . . . . 0.0 111.607 -169.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.82 -41.96 5.31 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 C-N-CA 117.6 -1.64 . . . . 0.0 111.217 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.459 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 34.4 m -115.24 142.18 29.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.648 -1.615 . . . . 0.0 109.935 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.419 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 10.0 ptpp? -82.21 -169.53 2.45 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.557 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 10.2 m-85 -150.51 136.64 18.55 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.384 -1.726 . . . . 0.0 108.911 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.677 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 23.4 t-20 -91.76 47.55 1.37 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 116.47 -2.092 . . . . 0.0 109.904 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 23.1 p 141.02 143.42 0.0 OUTLIER 'General case' 0 C--N 1.349 0.563 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.041 175.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.521 ' CD2' HG13 ' A' ' 59' ' ' VAL . 98.6 mt -47.75 -44.11 27.79 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 117.171 -1.812 . . . . 0.0 109.647 175.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -57.96 -34.8 70.32 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 113.341 -1.754 . . . . 0.0 111.315 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 46.3 tp10 -62.81 -26.11 68.58 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 116.219 -2.192 . . . . 0.0 111.664 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.462 HD12 ' CG ' ' A' ' 69' ' ' LEU . 8.3 tt -85.66 -57.62 2.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.239 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 85' ' ' ARG . 97.5 t -49.43 -34.31 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 112.397 -2.183 . . . . 0.0 111.117 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 37.6 t70 -70.87 -41.0 71.97 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.627 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.472 ' O ' ' OG1' ' A' ' 87' ' ' THR . 10.3 m-30 -62.33 -54.83 34.84 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 117.32 -1.752 . . . . 0.0 109.43 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 25.0 m170 -62.52 -30.14 71.07 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 113.074 -1.876 . . . . 0.0 111.639 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 84' ' ' HIS . 53.2 tpt85 -37.73 -36.03 0.16 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.304 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.5 p -148.82 42.77 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 117.73 -1.588 . . . . 0.0 110.394 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.588 ' O ' ' CB ' ' A' ' 88' ' ' SER . 93.4 m -132.33 -41.86 0.97 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.507 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.754 ' HG ' ' H ' ' A' ' 95' ' ' ILE . 27.9 t 110.43 145.08 0.0 OUTLIER 'General case' 0 C--N 1.35 0.63 0 O-C-N 125.835 1.959 . . . . 0.0 109.693 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 90' ' ' SER . 3.6 m -92.0 21.91 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.218 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 9.2 t . . . . . 0 N--CA 1.445 -0.704 0 C-N-CA 117.315 -1.754 . . . . 0.0 109.321 -164.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.604 ' HA ' ' HG ' ' A' ' 88' ' ' SER . 4.1 pm0 . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 121.962 0.887 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.754 ' H ' ' HG ' ' A' ' 88' ' ' SER . 61.5 mt -122.3 117.6 52.68 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.921 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -92.69 142.51 27.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.532 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 95.4 mt -89.95 105.18 17.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.816 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 99' ' ' ASP . 62.2 ttt-85 -175.6 -119.36 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 112.581 -2.1 . . . . 0.0 108.344 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 98' ' ' ARG . 29.2 t70 25.79 48.33 0.01 OUTLIER 'General case' 0 C--N 1.348 0.508 0 O-C-N 125.234 1.584 . . . . 0.0 112.699 172.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.577 HG12 ' H ' ' A' ' 101' ' ' GLU . 7.5 tt -135.07 -146.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 117.503 -1.679 . . . . 0.0 108.991 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.577 ' H ' HG12 ' A' ' 100' ' ' ILE . 40.6 mm-40 . . . . . 0 N--CA 1.446 -0.659 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.473 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 57.2 Cg_endo . . . . . 0 CA--C 1.54 0.791 0 N-CA-C 110.972 -0.434 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.429 ' CB ' ' CZ ' ' A' ' 32' ' ' PHE . 36.8 p-90 -86.56 7.27 26.91 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.501 -174.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -89.37 111.07 21.83 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 117.322 -1.751 . . . . 0.0 109.879 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 12' ' ' GLY . 33.5 m-85 -112.08 121.73 45.8 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.25 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -56.33 -151.38 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.928 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.567 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -72.8 77.96 1.13 Allowed 'General case' 0 C--N 1.346 0.445 0 C-N-CA 117.153 -1.819 . . . . 0.0 109.618 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.4 ' O ' HG22 ' A' ' 14' ' ' ILE . 10.0 tp -79.1 130.76 68.51 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.247 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.2 Cg_exo -47.4 124.54 9.44 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.984 1.789 . . . . 0.0 113.133 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.824 ' CG ' HH22 ' A' ' 35' ' ' ARG . 69.0 mtp180 -37.33 -42.73 0.5 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.67 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -58.89 -75.46 0.05 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.212 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 17' ' ' ALA . 56.9 tptt -36.64 -36.81 0.12 Allowed 'General case' 0 C--N 1.345 0.379 0 CA-C-N 112.979 -1.919 . . . . 0.0 111.457 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -63.21 -66.5 0.53 Allowed 'General case' 0 C--N 1.347 0.469 0 C-N-CA 117.387 -1.725 . . . . 0.0 109.567 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 63.2 mt-10 -47.98 -54.69 12.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.864 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 24' ' ' SER . 11.4 mm-40 -52.8 -84.41 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.791 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.575 ' C ' ' SD ' ' A' ' 22' ' ' MET . 2.9 ppp? -43.18 -43.78 4.82 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.609 -172.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' N ' ' SD ' ' A' ' 22' ' ' MET . 37.2 tp -66.78 -35.32 79.8 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.998 -1.91 . . . . 0.0 111.475 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.557 ' C ' ' H ' ' A' ' 26' ' ' GLN . 37.4 t -70.47 -40.03 73.89 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 117.796 -1.562 . . . . 0.0 110.484 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.701 ' HB3' ' HZ2' ' A' ' 25' ' ' LYS . 4.7 mtpm? -73.11 35.42 0.08 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.859 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.557 ' H ' ' C ' ' A' ' 24' ' ' SER . 29.5 mm-40 -101.53 153.43 19.73 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 117.108 -1.837 . . . . 0.0 110.837 -174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -72.07 87.73 1.07 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 111.819 -2.446 . . . . 0.0 109.55 -177.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER 69.04 145.9 0.05 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 111.942 -2.39 . . . . 0.0 111.049 170.031 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' HIS . 22.7 t70 -31.94 133.99 0.09 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 111.5 -2.591 . . . . 0.0 111.462 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 96' ' ' PHE . . . 142.02 -41.62 1.2 Allowed Glycine 0 C--N 1.348 1.237 0 C-N-CA 117.665 -2.207 . . . . 0.0 112.198 169.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.517 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -47.49 136.17 10.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 117.533 -1.667 . . . . 0.0 109.512 -176.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.446 ' CB ' HG23 ' A' ' 48' ' ' VAL . 12.6 p90 -143.8 158.08 43.93 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 115.636 -2.426 . . . . 0.0 111.503 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 33' ' ' LEU . 4.6 pp -153.58 146.64 24.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 112.399 -2.182 . . . . 0.0 109.812 170.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 45' ' ' SER . 45.6 mt -108.05 115.56 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 112.562 -2.108 . . . . 0.0 108.549 172.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.824 HH22 ' CG ' ' A' ' 16' ' ' ARG . 10.0 ptm180 -101.74 128.91 47.86 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.57 -2.104 . . . . 0.0 110.865 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 37.8 mt-10 -76.76 144.86 38.95 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.317 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.595 ' HG ' ' C ' ' A' ' 40' ' ' ALA . 96.5 p -59.31 -168.2 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 117.292 -1.763 . . . . 0.0 109.029 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.551 ' HA ' ' HZ3' ' A' ' 13' ' ' LYS . 29.5 tp10 -100.47 -49.13 4.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.433 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.8 t -132.47 64.01 1.61 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.342 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.595 ' C ' ' HG ' ' A' ' 37' ' ' SER . . . 178.49 68.47 0.11 Allowed Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.462 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -64.37 -3.46 6.39 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.137 1.891 . . . . 0.0 115.302 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.86 34.23 5.34 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 118.575 -1.774 . . . . 0.0 111.364 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -150.08 121.96 8.16 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 118.464 -1.295 . . . . 0.0 109.45 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 59' ' ' VAL . 79.2 m-85 -130.75 156.15 45.44 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 113.052 -1.886 . . . . 0.0 109.796 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 77.5 p -141.51 154.07 45.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.231 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.522 ' CD2' HG21 ' A' ' 48' ' ' VAL . 4.9 tt -119.23 114.95 23.21 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 113.504 -1.68 . . . . 0.0 109.595 -177.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -108.62 133.59 52.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.671 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.522 HG21 ' CD2' ' A' ' 46' ' ' LEU . 91.1 t -134.16 133.9 55.52 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.548 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 29' ' ' ASP . 42.3 tptt -55.56 97.11 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 112.785 -2.007 . . . . 0.0 107.719 168.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 48' ' ' VAL . 5.7 t80 -107.97 118.19 36.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 117.74 -1.584 . . . . 0.0 109.858 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.57 -94.65 0.06 OUTLIER Glycine 0 C--N 1.344 1.028 0 C-N-CA 117.971 -2.061 . . . . 0.0 110.323 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -123.06 -26.74 4.31 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.862 -1.669 . . . . 0.0 112.175 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 29.0 t0 -110.04 -174.65 2.54 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 118.022 -1.471 . . . . 0.0 109.663 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.59 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 93.0 t -103.85 122.24 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 113.079 -1.873 . . . . 0.0 109.685 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.419 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.0 tt0 -98.89 162.78 12.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 112.913 -1.949 . . . . 0.0 109.779 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.41 ' CD2' ' C ' ' A' ' 56' ' ' HIS . 6.7 t60 -141.02 133.73 28.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 112.799 -2.0 . . . . 0.0 110.546 -171.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.419 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 85.7 m-85 -137.1 104.06 5.32 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.094 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -63.2 111.74 2.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.159 -1.837 . . . . 0.0 110.088 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.518 HG12 ' CD2' ' A' ' 77' ' ' LEU . 97.6 t -77.33 72.12 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 112.934 -1.939 . . . . 0.0 108.437 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 99.1 mt -76.74 168.36 20.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.521 -2.127 . . . . 0.0 110.335 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 9.3 ptm180 . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 116.868 -1.933 . . . . 0.0 109.56 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 6.0 mtpm? . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.506 0.669 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 89.7 m-85 -85.31 157.62 20.51 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.259 -168.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -174.99 155.05 1.93 Allowed 'General case' 0 C--N 1.348 0.543 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.34 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.448 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 4.7 mp -92.12 -44.08 9.02 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 116.896 -1.922 . . . . 0.0 109.928 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 13.7 m0 -136.97 -43.09 0.57 Allowed 'General case' 0 C--N 1.346 0.427 0 CA-C-N 113.381 -1.736 . . . . 0.0 110.466 -177.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.3 t -139.62 -84.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.34 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.1 m -49.11 130.75 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 112.904 -1.953 . . . . 0.0 110.106 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 56.2 mttp -101.38 148.12 25.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.119 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -117.03 150.13 39.13 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.634 -173.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.479 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 32.7 p-10 -75.37 -19.35 59.62 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.291 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 79' ' ' GLU . 83.3 p -167.37 154.06 8.28 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 118.666 -1.214 . . . . 0.0 109.342 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.518 ' CD2' HG12 ' A' ' 59' ' ' VAL . 90.4 mt -47.26 -43.69 22.35 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.042 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -50.05 -40.15 44.27 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 113.248 -1.796 . . . . 0.0 110.536 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 36.6 tp10 -70.05 -24.01 63.18 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.924 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 77' ' ' LEU . 7.8 tt -69.38 -58.29 4.19 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 117.905 -1.518 . . . . 0.0 108.351 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.6 t -48.8 -19.22 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 112.572 -2.104 . . . . 0.0 112.294 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 64.8 m-20 -90.03 -37.11 14.52 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.453 174.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -50.15 -50.55 48.5 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 116.952 -1.899 . . . . 0.0 108.689 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.543 ' HD1' HD13 ' A' ' 97' ' ' LEU . 57.7 m170 -61.98 -64.3 0.98 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 111.986 -2.37 . . . . 0.0 108.2 168.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 45.0 tpt85 67.79 -65.54 0.24 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 125.804 1.94 . . . . 0.0 108.657 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 84' ' ' HIS . 48.2 t -89.85 -113.27 0.07 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 112.002 -2.363 . . . . 0.0 105.16 156.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 88' ' ' SER . 9.7 t -170.36 -133.97 0.02 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 117.841 -1.543 . . . . 0.0 110.724 169.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 87' ' ' THR . 3.2 m 143.19 -58.98 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.117 -1.856 . . . . 0.0 107.872 -168.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG2' HG13 ' A' ' 95' ' ' ILE . 0.8 OUTLIER 51.44 4.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 112.661 -2.063 . . . . 0.0 113.537 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 88' ' ' SER . 22.6 t . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 117.552 -1.659 . . . . 0.0 112.198 -164.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 . . . . . 0 N--CA 1.445 -0.686 0 CA-C-O 121.973 0.892 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.594 HG21 ' H ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -91.47 -156.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 112.788 -2.006 . . . . 0.0 108.97 -177.141 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.594 ' H ' HG21 ' A' ' 95' ' ' ILE . 90.6 m-85 -150.07 145.19 26.23 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 113.406 -1.725 . . . . 0.0 109.289 170.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.543 HD13 ' HD1' ' A' ' 84' ' ' HIS . 83.2 mt -113.94 77.93 1.1 Allowed 'General case' 0 C--N 1.346 0.436 0 C-N-CA 117.376 -1.729 . . . . 0.0 109.317 173.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 42.6 mtp180 -154.73 -123.21 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 112.951 -1.931 . . . . 0.0 108.864 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.6 t0 39.13 -117.08 0.21 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.812 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.575 HG12 ' H ' ' A' ' 101' ' ' GLU . 6.8 tt 38.08 -149.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.545 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.99 -171.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.575 ' H ' HG12 ' A' ' 100' ' ' ILE . 79.1 mm-40 . . . . . 0 N--CA 1.445 -0.676 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.955 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 10' ' ' PHE . 64.6 Cg_endo . . . . . 0 CA--C 1.541 0.861 0 N-CA-C 110.468 -0.628 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.417 ' CG ' ' CE2' ' A' ' 32' ' ' PHE . 39.9 p-90 -62.85 1.17 0.43 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.557 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' A' ' 8' ' ' PRO . 63.7 t80 -84.0 119.75 25.3 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 117.097 -1.841 . . . . 0.0 109.952 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 12' ' ' GLY . 7.3 m-85 -115.69 121.92 43.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.167 -1.833 . . . . 0.0 107.838 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -57.39 -146.49 0.01 OUTLIER Glycine 0 CA--C 1.531 1.09 0 CA-C-N 112.685 -2.052 . . . . 0.0 110.85 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . 59.2 pttt -74.04 75.45 1.72 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 117.069 -1.853 . . . . 0.0 109.755 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.431 HG21 ' CB ' ' A' ' 35' ' ' ARG . 10.0 tp -85.12 129.33 56.36 Favored Pre-proline 0 N--CA 1.447 -0.591 0 CA-C-N 112.734 -2.03 . . . . 0.0 108.674 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.1 Cg_exo -45.55 120.83 3.52 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.542 1.495 . . . . 0.0 112.465 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 15' ' ' PRO . 61.2 ttt85 -39.49 -39.46 0.7 Allowed 'General case' 0 C--N 1.345 0.37 0 CA-C-N 112.976 -1.92 . . . . 0.0 110.806 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -65.35 -66.54 0.53 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.411 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 17' ' ' ALA . 24.4 tptm -37.12 -38.65 0.21 Allowed 'General case' 0 C--N 1.347 0.475 0 CA-C-N 112.95 -1.932 . . . . 0.0 111.118 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -54.79 -65.98 0.48 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.059 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 24' ' ' SER . 93.6 mt-10 -45.86 -44.02 14.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 112.396 -2.184 . . . . 0.0 110.313 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' OG ' ' A' ' 24' ' ' SER . 66.2 mt-10 -61.81 -78.7 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.719 -172.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.552 ' SD ' HD13 ' A' ' 100' ' ' ILE . 3.8 ppp? -54.39 -37.23 64.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 117.47 -1.692 . . . . 0.0 110.968 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.548 ' N ' ' SD ' ' A' ' 22' ' ' MET . 40.0 tp -69.22 -30.35 68.48 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.89 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.598 ' C ' ' H ' ' A' ' 26' ' ' GLN . 78.2 p -69.67 -29.13 66.51 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 117.326 -1.75 . . . . 0.0 111.407 176.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.703 ' HB3' ' HZ2' ' A' ' 25' ' ' LYS . 5.4 mtpm? -72.38 33.3 0.06 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.133 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.714 HE21 ' CB ' ' A' ' 31' ' ' ALA . 15.0 mm100 -107.52 145.15 33.5 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 117.829 -1.549 . . . . 0.0 109.498 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 28' ' ' HIS . 95.8 mtt180 -75.5 38.23 0.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 112.388 -2.187 . . . . 0.0 110.798 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.58 ' H ' ' C ' ' A' ' 26' ' ' GLN . 0.8 OUTLIER 44.62 89.79 0.01 OUTLIER 'General case' 0 C--N 1.348 0.527 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.541 -178.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 41.9 m-20 -158.06 37.21 0.25 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.092 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.581 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 81.75 -4.62 73.5 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 115.947 -3.025 . . . . 0.0 113.205 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.714 ' CB ' HE21 ' A' ' 26' ' ' GLN . . . -40.55 117.69 0.85 Allowed 'General case' 0 C--N 1.352 0.7 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.705 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.417 ' CE2' ' CG ' ' A' ' 9' ' ' TRP . 23.8 p90 -137.78 154.79 49.53 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 116.5 -2.08 . . . . 0.0 110.943 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.418 ' HG ' ' HG ' ' A' ' 47' ' ' SER . 4.5 pp -152.92 149.02 27.81 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 112.379 -2.191 . . . . 0.0 109.276 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.4 mt -109.51 115.89 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 112.418 -2.174 . . . . 0.0 108.569 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.431 ' CB ' HG21 ' A' ' 14' ' ' ILE . 8.5 ptm180 -99.22 125.48 44.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.678 -2.055 . . . . 0.0 110.422 -174.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 72.7 tt0 -89.62 120.64 31.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.354 -2.203 . . . . 0.0 109.748 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.5 t -46.05 138.36 5.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.887 -1.961 . . . . 0.0 110.026 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HA ' ' CB ' ' A' ' 13' ' ' LYS . 64.8 mt-10 -41.1 -76.53 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.569 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 t -102.09 51.02 0.83 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 112.514 -2.13 . . . . 0.0 110.367 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.35 97.84 0.41 Allowed Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.579 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.445 ' O ' ' CE1' ' A' ' 44' ' ' PHE . 54.2 Cg_endo -75.46 -4.27 15.05 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.744 1.629 . . . . 0.0 115.014 -177.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.67 40.06 2.6 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 118.697 -1.716 . . . . 0.0 110.876 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -145.99 118.4 8.46 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 118.227 -1.389 . . . . 0.0 109.604 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 84.9 m-85 -139.91 157.82 45.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 112.993 -1.912 . . . . 0.0 109.56 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.8 p -156.01 129.22 8.13 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.515 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tt -89.1 113.43 24.57 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 113.105 -1.861 . . . . 0.0 109.711 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.48 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 79.1 p -94.88 149.48 21.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.766 -2.015 . . . . 0.0 109.577 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 73.7 t -146.82 138.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.027 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.511 ' CG ' ' HA ' ' A' ' 28' ' ' HIS . 42.2 tptt -69.12 98.17 0.97 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 112.964 -1.925 . . . . 0.0 109.242 176.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 53' ' ' ASP . 7.2 t80 -115.21 108.98 17.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.934 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -25.97 144.44 0.01 OUTLIER Glycine 0 C--N 1.348 1.207 0 CA-C-N 112.325 -2.216 . . . . 0.0 112.294 -175.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 59.6 t30 86.99 -30.53 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 111.66 -2.27 . . . . 0.0 111.226 -175.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 22.1 t70 -174.68 -170.84 0.51 Allowed 'General case' 0 C--N 1.35 0.622 0 C-N-CA 116.232 -2.187 . . . . 0.0 110.388 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.588 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 86.4 t -102.15 118.68 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.338 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.418 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 10.9 tt0 -90.08 158.49 17.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 113.111 -1.859 . . . . 0.0 109.613 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.516 ' HD1' ' H ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -147.63 142.9 27.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.658 -2.065 . . . . 0.0 110.514 -175.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 88.3 m-85 -126.77 101.94 6.83 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.53 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.0 mtmm -60.08 122.68 14.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.908 -1.951 . . . . 0.0 109.594 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.523 HG13 ' CD2' ' A' ' 77' ' ' LEU . 37.1 t -79.89 97.57 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 112.845 -1.979 . . . . 0.0 108.047 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 94.6 mt -91.42 178.79 5.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.183 -165.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 9.9 tpt180 . . . . . 0 C--N 1.347 0.466 0 CA-C-N 111.207 -2.724 . . . . 0.0 109.519 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.541 ' HZ3' ' HA ' ' A' ' 75' ' ' ASN . 6.0 mtpm? . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 121.428 0.632 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 76.4 m-85 -97.52 134.34 40.89 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 117.881 -1.527 . . . . 0.0 110.342 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -152.17 148.69 27.91 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 116.606 -2.038 . . . . 0.0 110.679 176.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.454 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 5.4 mt -86.06 -49.01 8.12 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 112.773 -2.012 . . . . 0.0 109.456 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 20.7 m0 -133.15 -77.48 0.49 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.852 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.1 t -107.15 -83.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.901 -1.954 . . . . 0.0 109.611 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.3 m -50.8 131.27 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 112.648 -2.069 . . . . 0.0 110.023 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 66.7 mttm -88.93 -169.94 2.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.721 -2.036 . . . . 0.0 109.951 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 73' ' ' LYS . 37.7 m-85 -152.88 135.06 14.91 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.127 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.541 ' HA ' ' HZ3' ' A' ' 66' ' ' LYS . 1.7 m120 -64.12 -16.87 62.74 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.561 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 46.9 m -168.69 160.54 10.71 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.83 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.523 ' CD2' HG13 ' A' ' 59' ' ' VAL . 89.4 mt -45.51 -41.98 10.25 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 117.268 -1.773 . . . . 0.0 110.362 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 52.8 t30 -55.8 -39.34 71.18 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.382 -1.735 . . . . 0.0 110.893 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.4 OUTLIER -67.89 -28.64 67.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 117.347 -1.741 . . . . 0.0 111.452 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.414 ' CG ' HD13 ' A' ' 69' ' ' LEU . 8.6 tt -65.68 -47.37 75.7 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 118.708 -1.197 . . . . 0.0 109.088 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 70.6 t -64.57 -31.25 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 112.756 -2.02 . . . . 0.0 111.594 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 57.0 m-20 -74.57 -42.95 57.84 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.116 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -58.82 -46.05 88.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 117.104 -1.839 . . . . 0.0 109.096 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 85' ' ' ARG . 60.1 m-70 -92.76 32.39 1.25 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.143 -1.844 . . . . 0.0 110.965 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 35.2 ptt-85 -40.24 -35.09 0.37 Allowed 'General case' 0 C--N 1.349 0.568 0 C-N-CA 118.309 -1.356 . . . . 0.0 110.935 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.8 p -89.93 -80.61 0.31 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 117.803 -1.559 . . . . 0.0 108.206 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 95' ' ' ILE . 14.8 t -170.16 -169.97 0.92 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.51 -1.677 . . . . 0.0 109.925 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.57 ' H ' ' CG1' ' A' ' 89' ' ' VAL . 29.3 t -121.25 -96.02 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 112.116 -2.311 . . . . 0.0 107.622 160.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.57 ' CG1' ' H ' ' A' ' 88' ' ' SER . 4.0 m -142.18 41.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.953 1 C-N-CA 133.737 4.815 . . . . 0.0 108.684 -8.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.448 -0.531 0 CA-C-N 112.821 -1.99 . . . . 0.0 109.06 -154.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.279 0.561 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 89' ' ' VAL . 5.8 mm -142.97 165.39 15.8 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 117.779 -1.568 . . . . 0.0 109.298 -176.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.581 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 86.1 m-85 -150.07 155.16 39.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.657 -1.611 . . . . 0.0 109.894 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.412 ' C ' ' CE1' ' A' ' 32' ' ' PHE . 58.0 mt -116.2 90.92 3.44 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 113.659 -1.61 . . . . 0.0 109.083 169.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 99' ' ' ASP . 71.4 mtp180 -156.47 -147.79 0.2 Allowed 'General case' 0 C--N 1.346 0.446 0 CA-C-N 112.951 -1.932 . . . . 0.0 108.803 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 100' ' ' ILE . 33.7 t0 48.1 -177.87 0.01 OUTLIER 'General case' 0 C--N 1.348 0.506 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.674 172.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.552 HD13 ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER 84.29 6.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 112.93 -1.941 . . . . 0.0 113.967 177.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 . . . . . 0 N--CA 1.445 -0.685 0 C-N-CA 118.415 -1.314 . . . . 0.0 109.581 -178.052 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 N--CA 1.454 -0.808 0 N-CA-C 108.867 -1.244 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -83.72 16.34 2.77 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 118.386 -1.326 . . . . 0.0 112.782 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -93.36 125.06 37.77 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.419 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.453 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 83.5 m-85 -130.02 118.33 21.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 117.301 -1.76 . . . . 0.0 110.088 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.535 ' CA ' ' C ' ' A' ' 13' ' ' LYS . . . 137.83 -161.35 25.46 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 115.823 -3.084 . . . . 0.0 112.488 166.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' C ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -57.4 115.8 2.94 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 112.648 -1.776 . . . . 0.0 111.081 0.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.469 ' N ' ' CA ' ' A' ' 12' ' ' GLY . 9.8 tp -106.02 133.77 20.06 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.253 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.3 Cg_exo -46.24 121.75 4.83 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.788 1.659 . . . . 0.0 112.933 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 15' ' ' PRO . 95.0 mtt180 -42.94 -41.18 3.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.479 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -62.8 -61.61 2.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.795 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 17' ' ' ALA . 58.5 tptt -43.02 -44.24 4.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.051 -1.886 . . . . 0.0 110.275 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -48.4 -62.57 1.42 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.148 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 21' ' ' GLU . 46.8 mt-10 -44.95 -65.0 0.59 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.346 -2.206 . . . . 0.0 109.901 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.479 ' O ' ' OG ' ' A' ' 24' ' ' SER . 69.1 mt-10 -37.51 -85.7 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.039 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.513 ' CA ' ' HD3' ' A' ' 25' ' ' LYS . 26.5 ptt? -48.62 -52.39 23.32 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 117.495 -1.682 . . . . 0.0 110.233 -176.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 100' ' ' ILE . 42.0 tp -50.62 -22.92 2.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 117.145 -1.822 . . . . 0.0 112.708 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 21' ' ' GLU . 90.3 p -83.82 -33.13 24.99 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.115 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HD3' ' CA ' ' A' ' 22' ' ' MET . 8.2 pttm -42.29 -25.88 0.09 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 113.538 -1.664 . . . . 0.0 112.018 172.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.412 ' O ' ' HE2' ' A' ' 49' ' ' LYS . 35.5 mm-40 -55.58 161.37 2.07 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.282 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -119.0 -41.95 2.73 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.057 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.412 ' HD1' ' N ' ' A' ' 28' ' ' HIS . 0.4 OUTLIER -89.19 107.78 19.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.691 -178.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -47.76 125.51 8.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.505 -2.134 . . . . 0.0 109.728 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 138.5 -29.47 2.59 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 117.35 -2.357 . . . . 0.0 112.485 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.73 138.59 8.24 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 117.829 -1.549 . . . . 0.0 109.181 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.416 ' CE1' ' C ' ' A' ' 97' ' ' LEU . 37.5 p90 -142.94 156.11 44.83 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 116.09 -2.244 . . . . 0.0 111.515 -174.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.516 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -146.93 150.94 36.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.448 -2.16 . . . . 0.0 109.334 169.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.7 mt -111.08 108.16 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 113.025 -1.898 . . . . 0.0 108.577 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.498 ' HE ' ' HG ' ' A' ' 45' ' ' SER . 37.0 ptt180 -92.72 135.8 33.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.67 -2.059 . . . . 0.0 110.805 -172.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.8 pt-20 -91.71 128.38 37.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.694 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 36' ' ' GLU . 49.8 m -54.51 -165.27 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.182 -1.826 . . . . 0.0 109.822 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -81.61 -98.41 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.423 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.4 t -94.24 43.64 1.11 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.015 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.26 94.75 7.6 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 113.227 -1.806 . . . . 0.0 109.448 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.39 -4.79 15.48 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.954 1.769 . . . . 0.0 114.943 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.95 39.45 2.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 118.864 -1.636 . . . . 0.0 110.932 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HB3' ' HG ' ' A' ' 37' ' ' SER . 57.0 t0 -143.38 106.84 4.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 118.264 -1.375 . . . . 0.0 109.652 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 23.4 m-85 -133.85 120.22 20.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.533 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.498 ' HG ' ' HE ' ' A' ' 35' ' ' ARG . 80.3 p -113.6 125.95 54.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.643 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 48' ' ' VAL . 5.4 tt -85.44 117.2 24.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 112.817 -1.992 . . . . 0.0 109.562 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.471 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 49.9 m -94.83 144.52 25.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.533 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.505 HG21 ' CD2' ' A' ' 46' ' ' LEU . 78.6 t -151.57 131.41 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.735 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 66.2 tttp -76.32 106.13 7.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 116.754 -1.979 . . . . 0.0 108.427 174.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -104.37 37.53 2.08 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 113.212 -1.813 . . . . 0.0 111.524 -172.2 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.82 -95.34 0.26 Allowed Glycine 0 C--N 1.346 1.109 0 C-N-CA 117.249 -2.405 . . . . 0.0 110.811 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 52.2 t-20 -107.19 -31.42 8.24 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 112.675 -1.763 . . . . 0.0 111.411 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.595 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 34.2 t70 -120.85 -176.81 3.33 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.499 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.595 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 94.6 t -100.23 122.79 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.2 -175.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.42 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.1 tt0 -97.36 159.53 14.86 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.778 -2.01 . . . . 0.0 109.486 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -139.69 134.98 32.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.748 -2.023 . . . . 0.0 110.522 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.447 ' CZ ' ' O ' ' A' ' 89' ' ' VAL . 97.4 m-85 -123.88 101.56 7.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.409 176.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 55.1 mtmt -58.85 100.25 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 116.59 -2.044 . . . . 0.0 109.612 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.52 HG11 ' CD1' ' A' ' 80' ' ' LEU . 93.6 t -70.33 86.22 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 112.984 -1.917 . . . . 0.0 108.563 174.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 77.2 mt -78.76 163.04 25.71 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.752 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.2 ptm180 . . . . . 0 N--CA 1.448 -0.556 0 CA-C-N 113.075 -1.875 . . . . 0.0 109.205 173.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 21.8 mtpp . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.415 0.626 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 90.1 m-85 -71.13 147.68 48.16 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.476 -173.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.413 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 17.1 p90 -166.01 167.53 16.45 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.418 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 71' ' ' VAL . 4.7 mp -124.94 97.76 5.4 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.06 173.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.419 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 34.4 m0 73.63 -39.2 0.43 Allowed 'General case' 0 C--N 1.346 0.414 0 CA-C-N 112.774 -2.012 . . . . 0.0 110.786 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.549 ' H ' ' C ' ' A' ' 69' ' ' LEU . 84.5 t -150.04 -85.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 117.56 -1.656 . . . . 0.0 110.549 -174.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 31.0 m -49.33 135.8 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.591 -173.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 74' ' ' PHE . 2.5 mptp? -99.21 -179.25 4.18 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.797 -2.001 . . . . 0.0 111.04 -176.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.435 ' CG ' ' O ' ' A' ' 73' ' ' LYS . 19.4 m-85 -158.63 137.17 10.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 111.74 -2.482 . . . . 0.0 108.842 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 56.6 p30 -62.18 -9.3 7.28 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 113.227 -1.806 . . . . 0.0 112.963 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 79' ' ' GLU . 42.8 t -179.05 152.57 0.57 Allowed 'General case' 0 C--N 1.349 0.555 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.697 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.514 ' CD2' HG12 ' A' ' 59' ' ' VAL . 77.1 mt -43.14 -43.96 4.8 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 113.184 -1.826 . . . . 0.0 110.212 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.567 HD21 ' H ' ' A' ' 78' ' ' ASN . 5.3 m-80 -55.3 -39.52 69.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.918 -1.946 . . . . 0.0 110.791 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 36.0 tt0 -69.36 -35.12 75.55 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 116.882 -1.927 . . . . 0.0 110.812 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.52 ' CD1' HG11 ' A' ' 59' ' ' VAL . 6.5 tt -57.7 -49.09 77.66 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.949 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.6 t -63.58 -40.46 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 112.505 -2.134 . . . . 0.0 110.647 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.43 -44.57 96.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.204 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' O ' HG21 ' A' ' 87' ' ' THR . 4.1 m-85 -63.84 -42.84 97.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.854 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -93.48 41.69 1.09 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 117.684 -1.607 . . . . 0.0 110.294 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -94.54 -41.02 9.56 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.466 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.4 t -101.61 -42.58 6.17 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.279 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 83' ' ' TYR . 12.2 t -70.01 -147.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.441 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 83.6 p -123.81 -151.53 0.48 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.437 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.447 ' O ' ' CZ ' ' A' ' 57' ' ' PHE . 14.9 p -176.18 45.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 113.478 -1.692 . . . . 0.0 109.77 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 113.129 -1.85 . . . . 0.0 109.149 179.706 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.409 ' O ' HD11 ' A' ' 95' ' ' ILE . 56.6 tp60 . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.821 0.82 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.409 HD11 ' O ' ' A' ' 94' ' ' GLN . 14.2 mm -146.28 128.23 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.082 -1.872 . . . . 0.0 109.428 177.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.575 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 88.7 m-85 -149.98 139.58 21.61 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.532 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.416 ' C ' ' CE1' ' A' ' 32' ' ' PHE . 91.8 mt -89.93 94.87 9.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 117.114 -1.835 . . . . 0.0 109.249 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.492 ' NH1' ' CB ' ' A' ' 98' ' ' ARG . 4.4 ptm85 -105.46 149.07 26.5 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.614 -2.085 . . . . 0.0 109.997 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -47.26 119.55 2.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.309 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.516 ' CD1' HD12 ' A' ' 23' ' ' LEU . 12.1 tt -70.06 -41.78 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.846 -1.979 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 . . . . . 0 N--CA 1.442 -0.834 0 CA-C-N 112.407 -2.178 . . . . 0.0 110.259 -174.769 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 CA--C 1.542 0.88 0 N-CA-C 114.571 0.95 . . . . 0.0 114.571 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.436 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 3.2 p-90 -152.76 21.63 0.6 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.788 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 71.2 m-85 -90.45 115.3 27.51 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 118.452 -1.299 . . . . 0.0 109.115 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 60.6 m-85 -118.03 103.7 10.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.395 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.64 162.9 31.87 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 114.773 -3.584 . . . . 0.0 112.069 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.715 ' HB3' ' HZ2' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -88.65 110.25 20.8 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 113.155 -1.522 . . . . 0.0 109.059 -6.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.46 HG12 ' CE ' ' A' ' 22' ' ' MET . 10.2 tp -97.96 126.02 41.96 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.523 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.4 Cg_exo -48.36 121.67 6.57 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.661 1.574 . . . . 0.0 112.811 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 15' ' ' PRO . 71.3 ttt180 -38.53 -37.65 0.33 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 113.02 -1.9 . . . . 0.0 111.075 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -68.45 -59.79 2.91 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.635 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 22' ' ' MET . 58.5 tptt -42.01 -42.97 3.01 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.353 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -51.1 -63.46 1.12 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.186 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 24' ' ' SER . 90.3 mt-10 -43.05 -44.77 4.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.576 -2.102 . . . . 0.0 110.236 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 34.1 mt-10 -63.65 -80.59 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 112.907 -1.952 . . . . 0.0 110.588 -173.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.515 ' HE2' ' CD2' ' A' ' 33' ' ' LEU . 25.9 ptt? -48.92 -39.93 28.07 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 113.456 -1.702 . . . . 0.0 110.662 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.471 HD21 ' CG1' ' A' ' 54' ' ' VAL . 38.8 tp -63.97 -32.61 74.21 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 117.726 -1.59 . . . . 0.0 111.474 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 26' ' ' GLN . 44.2 t -68.0 -32.3 72.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 117.662 -1.615 . . . . 0.0 111.267 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -73.15 35.61 0.08 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.111 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.582 ' H ' ' C ' ' A' ' 24' ' ' SER . 12.8 mm100 -105.08 135.46 46.39 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.814 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.445 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 1.6 mpp_? -98.52 33.11 2.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 112.312 -2.222 . . . . 0.0 111.242 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 74.7 m80 -155.47 103.57 2.32 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.219 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.38 103.6 0.11 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.268 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 152.28 -31.45 0.87 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 117.419 -2.324 . . . . 0.0 112.134 -178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.573 ' HB3' HE21 ' A' ' 26' ' ' GLN . . . -46.86 141.39 4.03 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.539 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 98' ' ' ARG . 49.1 p90 -141.89 169.96 16.61 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 116.641 -2.023 . . . . 0.0 110.888 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.516 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -161.31 150.04 16.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.164 -2.289 . . . . 0.0 109.001 167.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.412 ' CG2' ' HB3' ' A' ' 44' ' ' PHE . 49.3 mt -110.11 114.57 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 113.133 -1.849 . . . . 0.0 108.349 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 33.7 ptt85 -90.07 130.48 36.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.041 -170.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -59.9 135.88 57.83 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 111.99 -2.368 . . . . 0.0 109.879 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.814 ' HG ' ' H ' ' A' ' 43' ' ' ASP . 50.0 m -52.35 119.65 4.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.855 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -50.54 -78.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.109 -1.859 . . . . 0.0 109.434 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -127.46 62.32 1.37 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.547 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -152.34 156.82 33.83 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 113.048 -1.887 . . . . 0.0 109.517 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ALA . 64.3 Cg_exo -44.29 -120.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.769 2.313 . . . . 0.0 114.157 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.51 66.26 0.34 Allowed Glycine 0 C--N 1.346 1.128 0 C-N-CA 118.226 -1.94 . . . . 0.0 110.498 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.814 ' H ' ' HG ' ' A' ' 37' ' ' SER . 1.0 OUTLIER -99.43 114.18 26.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.914 -1.643 . . . . 0.0 109.501 178.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.412 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 22.1 m-85 -128.39 124.2 35.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.025 -1.898 . . . . 0.0 109.745 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.2 p -117.99 133.24 56.11 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.007 -1.906 . . . . 0.0 109.662 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.3 tt -94.39 113.92 25.88 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 112.697 -2.047 . . . . 0.0 109.173 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 88.3 p -95.01 148.8 21.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.73 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.8 t -146.4 136.06 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.625 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.446 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 60.6 tttp -80.1 106.79 12.38 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 116.482 -2.087 . . . . 0.0 109.756 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 53' ' ' ASP . 49.1 t80 -126.51 114.91 18.75 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 112.553 -2.112 . . . . 0.0 108.863 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -27.43 144.51 0.01 OUTLIER Glycine 0 C--N 1.349 1.287 0 CA-C-N 112.648 -2.069 . . . . 0.0 111.884 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 74.9 m-20 102.53 -52.86 0.0 OUTLIER 'General case' 0 C--N 1.346 0.439 0 CA-C-N 111.52 -2.34 . . . . 0.0 108.189 -166.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 50' ' ' PHE . 56.3 p30 -179.64 -161.08 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 111.396 -2.638 . . . . 0.0 110.194 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG1' HD21 ' A' ' 23' ' ' LEU . 91.4 t -96.93 124.63 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.703 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -95.86 160.63 14.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.797 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -141.42 143.74 34.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.708 -2.042 . . . . 0.0 110.129 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -128.65 102.39 6.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.744 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -58.4 108.47 0.63 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.99 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.522 HG13 ' CD2' ' A' ' 77' ' ' LEU . 60.7 t -81.38 78.28 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 112.981 -1.918 . . . . 0.0 108.423 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 91.2 mt -83.66 172.49 12.24 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 112.417 -2.174 . . . . 0.0 109.845 -174.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.1 ptm180 . . . . . 0 N--CA 1.447 -0.614 0 C-N-CA 116.463 -2.095 . . . . 0.0 109.476 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.72 ' HZ1' ' N ' ' A' ' 75' ' ' ASN . 8.4 mtmp? . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 88.5 m-85 -71.93 158.12 36.6 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.723 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 72' ' ' VAL . 55.1 t80 -152.62 156.85 40.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.62 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 70' ' ' TRP . 33.3 tp -124.49 -66.84 0.95 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.449 -2.159 . . . . 0.0 109.826 -169.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.459 ' CD2' ' O ' ' A' ' 69' ' ' LEU . 27.7 m95 -147.09 -37.13 0.22 Allowed 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.101 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.416 ' C ' ' CE2' ' A' ' 68' ' ' PHE . 59.7 t -125.89 -37.59 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.471 0 C-N-CA 117.208 -1.797 . . . . 0.0 111.299 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 33.8 m -130.6 171.81 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 117.463 -1.695 . . . . 0.0 110.155 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.634 ' CD ' ' H ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -98.49 173.9 6.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.026 179.11 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.608 ' C ' ' HZ1' ' A' ' 66' ' ' LYS . 1.3 m-85 -145.6 132.27 19.93 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 117.063 -1.855 . . . . 0.0 109.551 -175.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.72 ' N ' ' HZ1' ' A' ' 66' ' ' LYS . 7.0 p30 -86.66 25.67 1.22 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.617 -2.083 . . . . 0.0 112.214 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.2 t 175.69 130.85 0.04 OUTLIER 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.971 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.522 ' CD2' HG13 ' A' ' 59' ' ' VAL . 85.1 mt -47.71 -41.12 22.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 116.879 -1.929 . . . . 0.0 109.998 174.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 82' ' ' ASP . 39.7 m-80 -60.67 -30.98 70.24 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 113.533 -1.667 . . . . 0.0 111.659 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 83' ' ' TYR . 10.2 tp10 -66.45 -26.39 67.18 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 117.114 -1.835 . . . . 0.0 111.694 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 tt -83.71 -53.12 5.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.384 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.59 -44.76 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 112.644 -2.071 . . . . 0.0 109.711 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 78' ' ' ASN . 25.1 t0 -63.62 -63.67 1.11 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.076 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.434 ' CB ' ' O ' ' A' ' 79' ' ' GLU . 38.7 t80 -48.76 -42.04 34.22 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.445 -176.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -100.15 44.14 1.03 Allowed 'General case' 0 C--N 1.345 0.393 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.088 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -86.08 -40.46 15.71 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.491 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 88' ' ' SER . 39.1 t -112.59 -36.6 5.17 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.73 -1.577 . . . . 0.0 111.048 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 83' ' ' TYR . 8.9 t -77.47 42.79 0.37 Allowed 'General case' 0 C--N 1.346 0.453 0 C-N-CA 118.044 -1.463 . . . . 0.0 110.797 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 86' ' ' SER . 45.0 m 49.93 -149.77 0.24 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.912 170.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.402 ' CG1' HG23 ' A' ' 95' ' ' ILE . 6.4 p -176.9 -41.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.434 0 CA-C-N 113.393 -1.731 . . . . 0.0 110.337 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.45 -0.453 0 CA-C-N 113.648 -1.614 . . . . 0.0 109.503 178.414 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.685 0.755 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.402 HG23 ' CG1' ' A' ' 89' ' ' VAL . 34.5 mm -114.75 145.68 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.858 -177.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.54 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 65.3 t80 -135.11 132.16 37.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.865 -1.97 . . . . 0.0 109.338 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.01 101.87 14.58 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 117.304 -1.758 . . . . 0.0 109.406 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.767 ' HE ' ' H ' ' A' ' 99' ' ' ASP . 5.1 tpm_? -97.3 151.76 19.57 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 112.602 -2.09 . . . . 0.0 109.976 -176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.767 ' H ' ' HE ' ' A' ' 98' ' ' ARG . 51.8 p-10 -72.59 33.66 0.07 Allowed 'General case' 0 C--N 1.346 0.428 0 CA-C-N 113.073 -1.876 . . . . 0.0 112.196 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.59 ' H ' ' C ' ' A' ' 98' ' ' ARG . 10.8 tt 40.9 -143.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.133 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.586 ' H ' HG12 ' A' ' 100' ' ' ILE . 85.5 mt-10 . . . . . 0 N--CA 1.447 -0.614 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.369 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo . . . . . 0 CA--C 1.542 0.904 0 N-CA-C 114.403 0.886 . . . . 0.0 114.403 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.44 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 2.6 p-90 -154.54 22.6 0.47 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.487 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.44 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 91.2 m-85 -90.48 119.48 30.79 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.843 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.54 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 32.7 m-85 -115.98 89.72 3.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.341 -1.754 . . . . 0.0 108.953 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -36.62 -106.67 0.01 OUTLIER Glycine 0 C--N 1.346 1.108 0 CA-C-N 111.979 -2.373 . . . . 0.0 112.918 -171.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 13' ' ' LYS . 14.7 ptmm? -95.3 67.38 2.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.415 -173.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.432 HG21 ' CB ' ' A' ' 35' ' ' ARG . 6.3 tp -95.87 128.51 37.24 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 116.996 -1.882 . . . . 0.0 107.603 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HG2' ' CB ' ' A' ' 18' ' ' LYS . 20.7 Cg_endo -66.54 -157.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 O-C-N 123.614 1.323 . . . . 0.0 111.496 -172.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.402 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 25.7 ttm180 -94.94 -49.94 5.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.629 -1.623 . . . . 0.0 108.884 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -48.42 -71.68 0.06 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 112.59 -2.096 . . . . 0.0 108.946 174.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' CB ' ' HG2' ' A' ' 15' ' ' PRO . 54.4 tptt -43.51 -56.23 3.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.588 -2.097 . . . . 0.0 110.725 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.39 -44.3 24.24 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 116.701 -2.0 . . . . 0.0 110.093 -178.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.579 ' O ' ' CB ' ' A' ' 24' ' ' SER . 95.1 mt-10 -66.98 -37.39 84.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.042 -1.89 . . . . 0.0 111.264 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 22' ' ' MET . 47.6 mt-10 -67.8 -80.27 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 117.365 -1.734 . . . . 0.0 110.478 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.568 ' CE ' ' CD2' ' A' ' 33' ' ' LEU . 23.6 ptt? -44.34 -39.76 4.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.7 -175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.601 HD23 ' HG ' ' A' ' 47' ' ' SER . 39.4 tp -72.73 -36.64 67.8 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 116.618 -2.033 . . . . 0.0 111.178 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 48.3 t -73.59 29.51 0.07 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 116.971 -1.892 . . . . 0.0 111.735 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.589 ' H ' ' C ' ' A' ' 23' ' ' LEU . 55.4 mtpt -134.88 44.05 2.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.59 177.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 26.5 mm-40 -112.16 144.25 41.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.291 -1.777 . . . . 0.0 110.142 -174.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.506 ' C ' ' H ' ' A' ' 29' ' ' ASP . 87.2 mtt180 -83.97 85.06 7.38 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 112.085 -2.325 . . . . 0.0 110.715 -172.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.406 ' HB3' ' O ' ' A' ' 27' ' ' ARG . 1.8 t-80 80.62 -45.64 0.26 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.199 -2.273 . . . . 0.0 110.904 173.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 27' ' ' ARG . 35.6 m-20 -47.42 166.08 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 111.905 -2.407 . . . . 0.0 108.199 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . 107.73 -39.51 2.86 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.552 1.072 . . . . 0.0 110.582 7.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -68.73 149.03 49.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 118.475 -1.29 . . . . 0.0 109.182 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.419 ' CB ' ' O ' ' A' ' 47' ' ' SER . 41.6 p90 -146.26 162.34 38.31 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 116.475 -2.09 . . . . 0.0 111.033 -172.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.568 ' CD2' ' CE ' ' A' ' 22' ' ' MET . 4.5 pp -149.61 148.85 29.82 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.49 -2.141 . . . . 0.0 109.335 170.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 44' ' ' PHE . 58.2 mt -113.74 111.6 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.651 -2.068 . . . . 0.0 108.444 174.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.432 ' CB ' HG21 ' A' ' 14' ' ' ILE . 11.6 ptm180 -95.85 136.12 36.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.446 -2.161 . . . . 0.0 110.934 -170.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 12' ' ' GLY . 68.6 tt0 -82.6 125.74 31.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.126 -2.306 . . . . 0.0 109.449 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.484 ' HG ' ' HB2' ' A' ' 40' ' ' ALA . 47.7 t -59.22 132.66 54.68 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.762 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -42.27 -42.91 3.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.616 -2.084 . . . . 0.0 110.356 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.409 ' O ' ' HB1' ' A' ' 40' ' ' ALA . 49.1 m -144.98 71.22 1.29 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 113.44 -1.709 . . . . 0.0 110.26 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.484 ' HB2' ' HG ' ' A' ' 37' ' ' SER . . . 179.05 101.35 0.16 Allowed Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 112.898 -1.956 . . . . 0.0 109.113 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.3 -4.07 14.77 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.719 1.613 . . . . 0.0 115.185 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.29 40.2 2.61 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 118.731 -1.7 . . . . 0.0 110.895 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.458 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 9.5 t0 -143.23 106.55 4.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.959 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.521 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 23.2 m-85 -133.96 107.01 7.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.433 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.3 p -104.73 126.55 51.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.906 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.3 tt -90.76 114.9 27.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.318 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.601 ' HG ' HD23 ' A' ' 23' ' ' LEU . 98.2 p -96.97 147.18 24.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.081 -1.872 . . . . 0.0 110.017 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.413 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 60.2 t -145.12 134.49 18.12 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.284 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' ASP . 13.7 tptp -76.31 96.62 4.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 112.654 -2.066 . . . . 0.0 108.417 174.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.51 -44.03 65.41 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 117.17 -1.812 . . . . 0.0 110.703 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . -166.92 -69.89 0.03 OUTLIER Glycine 0 CA--C 1.527 0.83 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.265 -177.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -116.28 -25.86 7.39 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 111.927 -2.137 . . . . 0.0 111.816 176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.05 153.63 29.09 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 118.397 -1.321 . . . . 0.0 110.291 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.59 131.28 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 112.41 -2.177 . . . . 0.0 109.569 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.453 ' OE1' ' CZ ' ' A' ' 57' ' ' PHE . 31.8 tt0 -101.51 164.47 11.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.674 -2.057 . . . . 0.0 109.868 -176.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 55' ' ' GLN . 42.1 m80 -150.06 140.54 22.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.007 -1.906 . . . . 0.0 110.723 -176.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.523 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 23.3 m-85 -135.88 111.98 9.66 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.381 173.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 37.9 mtmm -74.5 116.06 14.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 116.886 -1.925 . . . . 0.0 109.837 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.519 HG13 ' CD2' ' A' ' 77' ' ' LEU . 48.2 t -81.47 107.83 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 112.829 -1.987 . . . . 0.0 108.036 173.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 84.9 mt -96.68 162.2 13.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.162 -164.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 34.9 tpt85 . . . . . 0 N--CA 1.449 -0.5 0 CA-C-N 111.129 -2.759 . . . . 0.0 109.829 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 61' ' ' ARG . 5.8 mtpm? . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.328 0.585 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.517 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 26.7 m-85 -95.0 130.52 41.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.975 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 11.9 p90 -149.13 138.14 21.36 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 116.048 -2.261 . . . . 0.0 110.726 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.523 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 9.9 mt -81.33 -45.64 15.88 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 112.425 -2.17 . . . . 0.0 109.563 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -129.13 -86.19 0.55 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.188 -1.823 . . . . 0.0 109.934 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -106.87 -84.48 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.188 -1.824 . . . . 0.0 109.555 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.7 m -50.32 130.27 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.915 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -81.67 -169.48 2.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 112.819 -1.991 . . . . 0.0 109.93 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -148.13 134.49 19.56 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.421 -2.172 . . . . 0.0 108.7 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.471 ' O ' ' OG ' ' A' ' 76' ' ' SER . 17.9 m-20 -58.16 -22.26 50.59 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.153 -1.839 . . . . 0.0 112.336 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 50.3 m -168.04 161.33 12.61 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.953 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 59' ' ' VAL . 86.3 mt -45.6 -40.88 9.41 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 117.34 -1.744 . . . . 0.0 110.318 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -54.07 -38.25 65.07 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.068 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.4 OUTLIER -69.91 -28.17 65.39 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.51 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.0 tt -67.59 -49.86 61.1 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.819 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.3 -37.03 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 112.538 -2.119 . . . . 0.0 110.86 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 23.4 t70 -71.31 -35.97 71.46 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.145 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -55.29 -46.05 76.22 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 117.845 -1.542 . . . . 0.0 109.746 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 86' ' ' SER . 52.1 t60 -63.79 -9.38 14.31 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.646 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 85' ' ' ARG . 4.1 tpm_? -78.98 46.82 0.72 Allowed 'General case' 0 C--N 1.349 0.567 0 C-N-CA 117.799 -1.56 . . . . 0.0 109.402 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 84' ' ' HIS . 40.4 t -147.15 -41.44 0.18 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.787 -2.006 . . . . 0.0 110.248 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 t -149.16 -146.61 0.2 Allowed 'General case' 0 C--N 1.347 0.488 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.604 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.7 p -92.42 167.55 11.89 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 113.897 -1.501 . . . . 0.0 109.636 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.491 HG22 ' CB ' ' A' ' 90' ' ' SER . 11.8 m -73.32 -33.12 39.97 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 C-N-CA 117.103 -1.839 . . . . 0.0 111.587 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.491 ' CB ' HG22 ' A' ' 89' ' ' VAL . 13.4 t . . . . . 0 N--CA 1.445 -0.71 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.924 -165.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 94' ' ' GLN . 53.7 tp60 . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.974 0.892 . . . . 0.0 109.176 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.439 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 68.9 mt -133.0 128.02 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.979 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.406 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 45.2 t80 -127.17 139.83 52.67 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.922 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.7 mt -91.58 105.1 17.49 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.797 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.43 ' CZ ' ' H ' ' A' ' 99' ' ' ASP . 4.1 tpm_? -108.63 158.32 17.7 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.178 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.43 ' H ' ' CZ ' ' A' ' 98' ' ' ARG . 57.8 p30 -60.3 145.38 47.8 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 117.535 -1.666 . . . . 0.0 109.447 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.54 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 7.1 tt -99.45 29.27 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 113.076 -1.874 . . . . 0.0 111.937 -175.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 . . . . . 0 N--CA 1.447 -0.577 0 C-N-CA 117.616 -1.633 . . . . 0.0 110.065 -176.631 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 CA--C 1.541 0.828 0 N-CA-C 110.857 -0.478 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.502 ' CB ' ' CE2' ' A' ' 32' ' ' PHE . 37.7 p-90 -139.08 38.55 2.13 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.709 -174.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -121.91 115.09 21.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 117.812 -1.555 . . . . 0.0 110.162 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.434 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 18.7 m-85 -124.05 108.19 12.1 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.057 176.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -61.33 112.03 4.38 Favored Glycine 0 C--N 1.345 1.075 0 C-N-CA 118.127 -1.987 . . . . 0.0 111.127 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 36' ' ' GLU . 23.3 pttp 25.57 47.29 0.01 OUTLIER 'General case' 0 C--N 1.346 0.414 0 CA-C-N 111.481 -2.359 . . . . 0.0 111.472 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.7 tp -60.21 131.64 89.97 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.928 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.9 Cg_exo -45.52 122.54 4.87 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.742 1.628 . . . . 0.0 112.983 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.562 ' CB ' HH12 ' A' ' 35' ' ' ARG . 53.2 ttp180 -38.86 -41.24 0.72 Allowed 'General case' 0 C--N 1.345 0.388 0 CA-C-N 112.885 -1.961 . . . . 0.0 110.626 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -54.21 -79.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 113.345 -1.752 . . . . 0.0 109.442 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.708 ' HZ3' ' HE3' ' A' ' 22' ' ' MET . 28.1 tptp -37.91 -39.88 0.41 Allowed 'General case' 0 C--N 1.346 0.442 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.969 -177.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.94 -65.76 0.54 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 117.595 -1.642 . . . . 0.0 109.209 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 24' ' ' SER . 46.7 mt-10 -42.77 -41.01 3.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.696 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 22' ' ' MET . 65.5 mt-10 -62.58 -90.56 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 113.567 -1.652 . . . . 0.0 110.758 -173.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.708 ' HE3' ' HZ3' ' A' ' 18' ' ' LYS . 5.6 ptp -42.6 -38.32 1.96 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.995 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 45.6 tp -68.03 -41.92 81.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 117.654 -1.619 . . . . 0.0 110.801 -176.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 26' ' ' GLN . 77.3 p -62.72 -36.91 84.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 117.402 -1.719 . . . . 0.0 110.706 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -69.38 30.73 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.534 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.586 ' H ' ' C ' ' A' ' 24' ' ' SER . 35.2 mm-40 -104.14 142.46 34.45 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 117.786 -1.565 . . . . 0.0 109.247 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 28' ' ' HIS . 2.0 mpt_? -79.05 44.28 0.56 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.883 -177.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.529 ' H ' ' C ' ' A' ' 26' ' ' GLN . 0.9 OUTLIER 47.05 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.708 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -162.39 33.32 0.11 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.092 -1.867 . . . . 0.0 111.493 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.567 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 70.0 -1.98 15.17 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 116.576 -2.726 . . . . 0.0 113.241 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.408 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -46.23 134.56 8.56 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 118.297 -1.361 . . . . 0.0 108.899 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.502 ' CE2' ' CB ' ' A' ' 9' ' ' TRP . 15.3 p90 -150.77 163.23 39.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 115.897 -2.321 . . . . 0.0 111.087 -173.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.6 pp -149.92 146.66 27.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.172 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.44 109.87 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.844 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.562 HH12 ' CB ' ' A' ' 16' ' ' ARG . 27.7 ptt180 -92.1 126.31 37.13 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 112.022 -2.354 . . . . 0.0 110.167 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 67.4 tt0 -67.98 129.61 40.44 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.445 -2.161 . . . . 0.0 109.781 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.592 ' HG ' ' HB2' ' A' ' 43' ' ' ASP . 73.5 m -67.12 129.88 41.32 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.501 178.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.596 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 2.3 mp0 -38.41 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 112.423 -2.171 . . . . 0.0 110.644 -176.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 40' ' ' ALA . 37.1 t -89.94 -29.54 18.43 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.086 -172.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -44.06 148.95 0.73 Allowed Pre-proline 0 C--N 1.348 0.538 0 C-N-CA 117.921 -1.512 . . . . 0.0 110.09 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -74.65 -8.62 20.63 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.934 2.423 . . . . 0.0 116.081 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.22 33.34 0.02 OUTLIER Glycine 0 CA--C 1.537 1.415 0 C-N-CA 118.611 -1.757 . . . . 0.0 111.68 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.592 ' HB2' ' HG ' ' A' ' 37' ' ' SER . 1.3 m-20 -89.91 132.5 35.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 118.284 -1.366 . . . . 0.0 109.568 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 59' ' ' VAL . 91.8 m-85 -143.62 132.34 22.54 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.59 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.47 ' HG ' ' HE ' ' A' ' 35' ' ' ARG . 99.7 p -119.15 138.17 53.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.492 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -101.04 116.3 32.52 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 113.083 -1.871 . . . . 0.0 110.008 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.52 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 40.6 m -98.38 139.21 34.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.148 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -138.55 148.47 24.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.128 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.671 ' HZ3' ' HA ' ' A' ' 52' ' ' ASN . 24.2 tptp -79.0 106.11 10.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.98 -1.918 . . . . 0.0 108.775 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' O ' ' CE1' ' A' ' 28' ' ' HIS . 7.4 t80 -76.28 -102.73 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 116.784 -1.966 . . . . 0.0 109.071 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -99.1 -69.39 0.92 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.751 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.671 ' HA ' ' HZ3' ' A' ' 49' ' ' LYS . 25.6 t-20 -121.46 -23.26 5.69 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 111.917 -2.141 . . . . 0.0 112.174 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.27 158.54 18.28 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 118.404 -1.319 . . . . 0.0 110.32 -174.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 24' ' ' SER . 95.2 t -80.69 118.85 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.4 -2.182 . . . . 0.0 109.678 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -102.78 158.2 16.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.718 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.634 ' HD1' ' H ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -134.3 143.18 47.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.57 -2.104 . . . . 0.0 110.598 -175.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -129.57 100.64 5.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.494 -2.139 . . . . 0.0 108.795 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.56 113.06 5.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 112.984 -1.916 . . . . 0.0 110.345 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.526 HG13 ' CD2' ' A' ' 77' ' ' LEU . 58.8 t -74.04 83.59 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 112.522 -2.126 . . . . 0.0 108.633 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.0 mt -72.88 161.02 31.22 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 112.799 -2.001 . . . . 0.0 110.703 -173.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.665 ' HG3' HH11 ' A' ' 61' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.523 0 CA-C-N 112.006 -2.361 . . . . 0.0 109.227 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.552 ' HZ2' ' CA ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.97 0.891 . . . . 0.0 109.545 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -117.55 150.32 39.16 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.939 -1.937 . . . . 0.0 109.301 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -166.01 144.37 5.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.573 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.456 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 2.5 mm? -65.05 -52.79 53.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 116.714 -1.994 . . . . 0.0 109.043 176.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 10.7 m0 -139.75 -45.0 0.44 Allowed 'General case' 0 C--N 1.345 0.413 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.013 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 77.8 t -129.23 -81.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 112.965 -1.925 . . . . 0.0 110.175 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -50.17 133.75 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 112.614 -2.085 . . . . 0.0 110.275 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -93.36 160.9 14.61 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.464 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -133.88 137.8 45.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 111.936 -2.393 . . . . 0.0 109.444 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -62.61 -34.57 77.3 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 112.712 -2.04 . . . . 0.0 110.989 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 77' ' ' LEU . 42.1 t -153.29 152.79 31.55 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 118.278 -1.369 . . . . 0.0 109.888 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.526 ' CD2' HG13 ' A' ' 59' ' ' VAL . 76.0 mt -39.28 -40.42 0.76 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.823 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -48.67 -42.47 34.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.316 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -73.42 -34.1 65.29 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 115.729 -2.388 . . . . 0.0 110.893 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.476 ' CD1' HG12 ' A' ' 59' ' ' VAL . 6.9 tt -56.78 -46.38 81.53 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.234 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 77' ' ' LEU . 96.0 t -63.16 -40.56 89.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 112.801 -1.999 . . . . 0.0 110.904 -177.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -71.33 -40.02 71.01 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.895 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -56.53 -41.07 76.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.449 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -93.15 40.07 1.06 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.677 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -107.45 -13.18 15.15 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.663 -1.608 . . . . 0.0 112.693 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.4 t -132.25 -42.15 0.98 Allowed 'General case' 0 C--N 1.351 0.635 0 C-N-CA 117.982 -1.487 . . . . 0.0 110.296 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 88' ' ' SER . 62.0 p -89.76 37.43 0.88 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.618 -1.628 . . . . 0.0 111.082 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' THR . 34.1 t 41.97 -165.71 0.01 OUTLIER 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.136 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.416 HG11 ' CG2' ' A' ' 95' ' ' ILE . 12.8 p -147.71 47.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.582 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 45.5 t . . . . . 0 C--N 1.345 0.382 0 CA-C-N 112.805 -1.998 . . . . 0.0 109.512 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 31.1 tt0 . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.939 0.876 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.416 ' CG2' HG11 ' A' ' 89' ' ' VAL . 44.7 mt -138.9 153.87 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 113.115 -1.857 . . . . 0.0 109.579 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.567 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 88.2 m-85 -149.99 179.86 7.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.684 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.3 mt -125.03 108.46 11.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 112.854 -1.975 . . . . 0.0 109.182 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 17.4 mmm180 -125.0 154.37 41.35 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.872 -1.967 . . . . 0.0 109.88 -177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 101' ' ' GLU . 58.6 t0 -52.72 118.76 3.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.62 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.482 ' CD1' HD21 ' A' ' 33' ' ' LEU . 11.6 tt -71.99 29.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.774 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 99' ' ' ASP . 12.3 mm-40 . . . . . 0 N--CA 1.448 -0.572 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.681 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 64.5 Cg_exo . . . . . 0 CA--C 1.544 1.022 0 N-CA-C 114.283 0.84 . . . . 0.0 114.283 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' CZ ' ' A' ' 10' ' ' PHE . 5.2 p-90 -159.2 17.59 0.18 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.511 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.439 ' CZ ' ' CH2' ' A' ' 9' ' ' TRP . 96.8 m-85 -85.82 109.21 18.52 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.676 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.416 ' CD1' ' O ' ' A' ' 9' ' ' TRP . 56.0 m-85 -97.53 95.8 7.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.866 -1.97 . . . . 0.0 108.853 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -49.65 105.62 0.17 Allowed Glycine 0 C--N 1.345 1.077 0 CA-C-N 112.797 -2.002 . . . . 0.0 111.254 -173.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 12' ' ' GLY . 63.4 pttt 30.51 42.07 0.01 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 111.459 -2.37 . . . . 0.0 111.193 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.44 HG12 ' CE ' ' A' ' 22' ' ' MET . 9.3 tp -56.51 134.85 77.12 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 113.373 -1.74 . . . . 0.0 108.727 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.8 Cg_exo -44.74 121.23 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.807 1.671 . . . . 0.0 112.911 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' PRO . 74.6 ttt180 -37.28 -37.12 0.17 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.268 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -69.79 -63.24 1.11 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.766 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.71 ' HB2' ' HZ2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -42.78 -42.19 3.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.458 -177.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -48.07 -58.63 4.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.1 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 91.2 mt-10 -49.1 -45.06 42.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 112.392 -2.185 . . . . 0.0 110.068 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' O ' ' OG ' ' A' ' 24' ' ' SER . 35.5 mt-10 -59.08 -81.17 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.799 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.45 ' CE ' ' HG3' ' A' ' 18' ' ' LYS . 9.8 ptp -50.82 -41.17 57.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 116.491 -2.084 . . . . 0.0 110.422 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.469 HD12 ' CD1' ' A' ' 100' ' ' ILE . 39.3 tp -62.27 -26.96 68.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 117.725 -1.59 . . . . 0.0 112.531 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.592 ' C ' ' H ' ' A' ' 26' ' ' GLN . 93.3 p -71.84 -29.06 64.0 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 117.803 -1.559 . . . . 0.0 111.733 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -72.28 37.19 0.07 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.819 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.592 ' H ' ' C ' ' A' ' 24' ' ' SER . 29.1 mm-40 -119.27 19.52 12.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 117.86 -1.536 . . . . 0.0 113.095 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 28' ' ' HIS . 58.2 mmm-85 20.37 58.25 0.02 OUTLIER 'General case' 0 C--N 1.349 0.555 0 O-C-N 125.215 1.572 . . . . 0.0 111.952 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.568 ' HD1' ' N ' ' A' ' 51' ' ' GLY . 72.5 t60 43.53 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.015 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 55.0 m-20 -157.71 29.06 0.27 Allowed 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.858 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 78.16 -9.34 33.5 Favored Glycine 0 CA--C 1.542 1.777 0 C-N-CA 115.969 -3.015 . . . . 0.0 113.147 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.418 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -44.98 120.74 2.48 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.055 177.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.492 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 14.0 p90 -126.14 151.2 47.6 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 116.638 -2.025 . . . . 0.0 111.716 -173.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.534 ' HB3' ' H ' ' A' ' 47' ' ' SER . 0.6 OUTLIER -114.53 146.75 40.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 110.892 -2.867 . . . . 0.0 109.013 -169.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 33' ' ' LEU . 18.4 mt -147.16 121.83 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 114.935 -2.706 . . . . 0.0 109.42 154.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.593 ' NE ' ' HG ' ' A' ' 45' ' ' SER . 27.9 ptt180 -108.81 128.31 54.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.411 -2.177 . . . . 0.0 110.369 -174.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 31.2 tp10 -68.92 136.36 52.46 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 112.459 -2.155 . . . . 0.0 109.853 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.54 ' HB3' ' H ' ' A' ' 43' ' ' ASP . 88.9 p -42.07 118.55 1.16 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.299 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.32 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.141 -1.845 . . . . 0.0 109.271 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.6 p -112.01 44.36 1.42 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.318 -1.764 . . . . 0.0 109.809 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -135.11 156.88 77.92 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.507 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ALA . 74.0 Cg_exo -43.56 -119.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.873 2.382 . . . . 0.0 114.099 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.29 68.31 0.51 Allowed Glycine 0 C--N 1.346 1.119 0 C-N-CA 118.154 -1.974 . . . . 0.0 110.187 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.54 ' H ' ' HB3' ' A' ' 37' ' ' SER . 61.9 t0 -90.05 117.87 29.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 112.82 -1.69 . . . . 0.0 109.799 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 21.4 m-85 -130.18 115.85 17.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.491 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.593 ' HG ' ' NE ' ' A' ' 35' ' ' ARG . 79.2 p -124.51 137.71 54.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.476 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.508 ' CD2' HG21 ' A' ' 48' ' ' VAL . 6.0 tt -110.24 119.07 38.06 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.7 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.534 ' H ' ' HB3' ' A' ' 33' ' ' LEU . 49.4 m -112.85 122.45 47.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.216 -1.811 . . . . 0.0 109.795 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 46' ' ' LEU . 86.8 t -113.65 146.73 17.87 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.379 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.583 ' HZ2' ' CA ' ' A' ' 24' ' ' SER . 41.7 tptt -69.35 89.54 0.49 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 116.693 -2.003 . . . . 0.0 108.915 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 53' ' ' ASP . 63.3 t80 -91.31 134.33 34.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 117.27 -1.772 . . . . 0.0 108.549 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.568 ' N ' ' HD1' ' A' ' 28' ' ' HIS . . . -43.37 129.14 5.87 Favored Glycine 0 C--N 1.342 0.886 0 C-N-CA 117.286 -2.388 . . . . 0.0 111.299 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.519 HD21 ' CG ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 83.33 -31.19 0.08 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 111.471 -2.364 . . . . 0.0 111.222 176.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CG ' HD21 ' A' ' 52' ' ' ASN . 33.6 m-20 -155.24 150.63 27.17 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 114.441 -2.903 . . . . 0.0 112.37 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.2 t -70.46 119.22 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 111.742 -2.481 . . . . 0.0 108.927 171.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 10.3 tt0 -101.75 159.61 15.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.884 -177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -128.51 134.7 48.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.493 -2.14 . . . . 0.0 110.63 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 93.7 m-85 -129.37 102.84 6.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 112.258 -2.247 . . . . 0.0 108.803 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 54.5 mtmt -70.49 114.12 8.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 116.97 -1.892 . . . . 0.0 109.718 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' A' ' 77' ' ' LEU . 94.3 t -74.88 86.77 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.537 174.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 81.6 mt -78.24 159.13 28.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 112.741 -2.027 . . . . 0.0 110.955 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.401 HH11 ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 CA-C-N 111.948 -2.387 . . . . 0.0 108.583 175.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.698 ' HZ3' ' HB2' ' A' ' 66' ' ' LYS . 8.5 mtmp? . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 121.52 0.676 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.44 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 20.5 m-85 -105.95 144.08 33.19 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 113.571 -1.649 . . . . 0.0 110.085 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -151.82 -165.89 2.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 117.262 -1.775 . . . . 0.0 109.381 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 5.6 mp -125.87 -46.34 1.7 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.36 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 21.5 m0 -132.54 -42.92 0.93 Allowed 'General case' 0 C--N 1.346 0.437 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.125 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.6 t -141.7 -84.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.011 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.74 136.23 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.211 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.619 ' HG2' ' HZ2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -104.4 176.09 5.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.899 -177.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.485 ' C ' ' HZ1' ' A' ' 66' ' ' LYS . 21.5 m-85 -146.59 138.31 24.6 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.131 -1.849 . . . . 0.0 108.915 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.468 ' O ' ' OG ' ' A' ' 76' ' ' SER . 41.8 p30 -66.5 -8.98 30.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 113.253 -1.794 . . . . 0.0 113.266 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 49.2 m -167.96 150.16 5.52 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 117.791 -1.564 . . . . 0.0 109.422 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' CD2' HG13 ' A' ' 59' ' ' VAL . 97.7 mt -46.01 -42.51 13.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.114 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -55.87 -42.86 76.53 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.349 -1.751 . . . . 0.0 110.442 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 76' ' ' SER . 32.3 tp10 -63.68 -35.44 80.57 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 113.335 -1.757 . . . . 0.0 110.665 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.456 ' CD1' HG23 ' A' ' 59' ' ' VAL . 6.1 tt -58.43 -50.84 72.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.073 -1.422 . . . . 0.0 108.375 173.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.453 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 81.3 t -63.85 -14.25 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 112.393 -2.185 . . . . 0.0 112.834 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -84.61 -26.44 27.89 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.715 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.433 ' O ' ' C ' ' A' ' 84' ' ' HIS . 68.8 t80 -73.12 -40.85 64.6 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.104 -174.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.594 ' C ' ' H ' ' A' ' 86' ' ' SER . 7.1 p-80 -45.52 -36.84 4.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.299 -2.16 . . . . 0.0 110.842 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 85' ' ' ARG . 67.4 ttt-85 -73.4 37.35 0.09 Allowed 'General case' 0 C--N 1.348 0.516 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.877 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.594 ' H ' ' C ' ' A' ' 84' ' ' HIS . 42.4 t -136.74 -41.63 0.61 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.141 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.475 ' O ' ' OG ' ' A' ' 88' ' ' SER . 9.0 t -165.52 55.63 0.11 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.092 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.562 ' HB2' ' H ' ' A' ' 95' ' ' ILE . 69.7 p 50.56 -179.0 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.261 -1.791 . . . . 0.0 110.101 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 90' ' ' SER . 13.8 p -128.69 37.03 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.711 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.712 ' HG ' ' CD1' ' A' ' 95' ' ' ILE . 86.7 p . . . . . 0 N--CA 1.447 -0.613 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.505 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.511 ' HA ' ' CB ' ' A' ' 88' ' ' SER . 77.3 mt-30 . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 121.919 0.866 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.712 ' CD1' ' HG ' ' A' ' 90' ' ' SER . 35.9 mt -150.04 140.6 16.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.904 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.409 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 88.5 m-85 -118.81 133.04 56.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.618 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.401 ' O ' ' HD3' ' A' ' 98' ' ' ARG . 28.6 mt -90.0 102.02 14.73 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.451 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 27.7 mmt180 -150.29 -159.83 1.09 Allowed 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.144 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.4 t0 48.73 -120.67 1.37 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.136 170.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 5.0 tt 40.16 22.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 113.843 -1.526 . . . . 0.0 113.371 -174.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 . . . . . 0 N--CA 1.442 -0.875 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.0 -177.512 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.436 ' C ' ' CG ' ' A' ' 9' ' ' TRP . 38.2 Cg_exo . . . . . 0 N--CA 1.455 -0.773 0 N-CA-C 115.565 1.333 . . . . 0.0 115.565 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.436 ' CG ' ' C ' ' A' ' 8' ' ' PRO . 41.4 p-90 43.7 30.64 0.38 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 116.965 -1.894 . . . . 0.0 111.583 177.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -105.37 118.97 37.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.478 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 29.1 m-85 -121.58 83.93 2.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.113 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -49.81 111.37 1.07 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-N 112.641 -2.072 . . . . 0.0 110.778 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 37' ' ' SER . 26.2 pttm 26.44 46.16 0.01 OUTLIER 'General case' 0 C--N 1.344 0.357 0 CA-C-N 111.529 -2.335 . . . . 0.0 111.387 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.4 tp -61.61 135.61 94.2 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 112.96 -1.927 . . . . 0.0 108.912 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' ARG . 54.3 Cg_exo -44.08 121.74 3.16 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.855 1.703 . . . . 0.0 113.029 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.672 ' HB3' HH22 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -40.74 -41.81 1.62 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.702 -177.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.543 ' H ' ' HD3' ' A' ' 16' ' ' ARG . . . -59.16 -63.09 1.43 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.483 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -43.39 -52.0 6.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 112.766 -2.016 . . . . 0.0 110.421 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.75 -49.47 14.82 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.759 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 24' ' ' SER . 66.8 mt-10 -61.29 -44.65 96.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.775 -2.011 . . . . 0.0 110.114 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' SER . 44.2 mt-10 -67.09 -70.4 0.25 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.872 -173.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.57 ' C ' ' SD ' ' A' ' 22' ' ' MET . 3.5 ppp? -46.48 -42.48 15.57 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 117.088 -1.845 . . . . 0.0 110.474 -173.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.562 ' N ' ' SD ' ' A' ' 22' ' ' MET . 60.8 tp -75.89 -25.11 55.77 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 113.357 -1.747 . . . . 0.0 112.569 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.542 ' C ' ' H ' ' A' ' 26' ' ' GLN . 78.4 p -74.18 -33.31 63.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 117.186 -1.806 . . . . 0.0 111.151 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 50.1 mtpt -75.54 38.78 0.15 Allowed 'General case' 0 C--N 1.347 0.467 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.605 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.748 HE21 ' CB ' ' A' ' 31' ' ' ALA . 12.9 mm100 -102.25 136.05 42.77 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 117.687 -1.605 . . . . 0.0 110.225 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HA ' ' CB ' ' A' ' 28' ' ' HIS . 9.9 mpt_? -116.54 84.33 2.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 110.688 -2.96 . . . . 0.0 106.374 171.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.519 ' CB ' ' HA ' ' A' ' 27' ' ' ARG . 1.3 t-80 -171.24 12.07 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.702 13.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 7.0 m-20 -163.09 128.69 3.19 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.753 -1.579 . . . . 0.0 110.619 -173.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 103.26 -27.03 21.77 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 117.835 -2.126 . . . . 0.0 112.875 170.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.748 ' CB ' HE21 ' A' ' 26' ' ' GLN . . . -46.95 135.76 9.04 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 117.762 -1.575 . . . . 0.0 109.147 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.51 ' CB ' HD23 ' A' ' 97' ' ' LEU . 17.3 p90 -139.94 164.51 29.82 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 115.077 -2.649 . . . . 0.0 112.427 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.551 ' HB3' ' H ' ' A' ' 47' ' ' SER . 0.4 OUTLIER -129.03 145.96 51.12 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 110.31 -3.132 . . . . 0.0 108.658 -165.364 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.519 ' CG1' ' O ' ' A' ' 33' ' ' LEU . 16.5 mt -145.85 119.94 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 114.886 -2.726 . . . . 0.0 109.504 153.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.672 HH22 ' HB3' ' A' ' 16' ' ' ARG . 10.1 ptm180 -113.11 147.79 36.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 111.852 -2.431 . . . . 0.0 110.223 -172.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 13' ' ' LYS . 40.7 mt-10 -86.97 167.38 14.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.69 -2.05 . . . . 0.0 109.719 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 38.9 t -71.83 -134.41 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.255 -1.793 . . . . 0.0 108.679 175.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -101.26 -70.92 0.73 Allowed 'General case' 0 C--N 1.347 0.473 0 C-N-CA 118.097 -1.441 . . . . 0.0 109.114 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.4 t -128.81 45.52 2.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.666 -2.061 . . . . 0.0 109.566 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -156.44 110.21 2.04 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.841 -176.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.609 ' C ' ' H ' ' A' ' 43' ' ' ASP . 23.6 Cg_exo -57.48 -144.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.132 0 N-CA-C 107.798 -1.655 . . . . 0.0 107.798 171.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.78 -28.33 0.14 Allowed Glycine 0 CA--C 1.541 1.679 0 CA-C-N 114.091 -1.413 . . . . 0.0 113.376 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.609 ' H ' ' C ' ' A' ' 41' ' ' PRO . 11.2 m-20 -112.8 116.52 30.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.967 0.889 . . . . 0.0 109.253 -173.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.412 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 91.7 m-85 -149.19 91.14 1.81 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.986 -1.916 . . . . 0.0 109.791 -175.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.518 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 28.4 p -89.99 137.41 32.36 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 115.947 -2.301 . . . . 0.0 109.93 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.523 ' CD2' HG21 ' A' ' 48' ' ' VAL . 6.5 tt -100.01 121.02 40.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 111.965 -2.38 . . . . 0.0 109.562 -173.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.551 ' H ' ' HB3' ' A' ' 33' ' ' LEU . 49.2 m -114.38 130.29 56.69 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.25 -176.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.523 HG21 ' CD2' ' A' ' 46' ' ' LEU . 84.3 t -128.13 145.4 35.33 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 CA-C-N 113.287 -1.778 . . . . 0.0 110.317 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.41 ' NZ ' ' O ' ' A' ' 51' ' ' GLY . 22.0 tptp -72.39 96.69 1.92 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 113.332 -1.758 . . . . 0.0 108.034 172.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CD2' ' O ' ' A' ' 53' ' ' ASP . 24.4 p90 -89.12 -1.31 58.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 116.546 -2.061 . . . . 0.0 113.801 -170.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.41 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 153.8 -80.48 0.18 Allowed Glycine 0 C--N 1.346 1.124 0 C-N-CA 117.024 -2.512 . . . . 0.0 110.77 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -109.28 -29.3 8.55 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 112.4 -1.9 . . . . 0.0 111.642 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.6 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 32.2 t70 -133.36 -174.92 3.64 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 117.434 -1.706 . . . . 0.0 110.159 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.6 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 73.9 t -100.08 122.19 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 112.857 -1.974 . . . . 0.0 110.377 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' SER . 11.5 tt0 -94.48 166.52 12.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.583 -2.099 . . . . 0.0 108.491 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -150.08 144.52 25.8 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.495 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.464 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 98.6 m-85 -138.59 89.93 2.41 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.931 177.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.518 ' HA ' ' CB ' ' A' ' 45' ' ' SER . 9.1 ptmm? -45.06 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 112.535 -2.121 . . . . 0.0 109.912 169.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 22.9 t -79.09 71.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-N 113.237 -1.801 . . . . 0.0 108.912 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.434 ' CD1' ' NZ ' ' A' ' 58' ' ' LYS . 16.6 mt -73.06 -151.89 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.227 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.456 ' O ' ' CE1' ' A' ' 68' ' ' PHE . 8.7 ptm180 . . . . . 0 N--CA 1.446 -0.663 0 C-N-CA 116.982 -1.887 . . . . 0.0 109.885 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.715 ' HZ1' ' HA ' ' A' ' 75' ' ' ASN . 5.1 mtpm? . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 8.1 m-30 -71.09 140.79 50.79 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 118.196 -1.402 . . . . 0.0 109.91 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -156.58 151.23 25.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 117.094 -1.842 . . . . 0.0 110.745 174.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.464 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 4.9 mt -87.77 -43.44 11.87 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 112.441 -2.163 . . . . 0.0 109.956 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -147.4 -44.61 0.17 Allowed 'General case' 0 C--N 1.346 0.435 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.929 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.2 t -135.75 -83.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.903 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.6 m -53.92 131.64 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 112.814 -1.994 . . . . 0.0 110.09 -176.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.454 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 47.7 mtmt -88.04 176.24 7.39 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.693 -2.049 . . . . 0.0 110.053 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.485 ' C ' ' H ' ' A' ' 76' ' ' SER . 18.0 m-85 -147.25 132.76 18.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 112.507 -2.133 . . . . 0.0 108.725 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.715 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 1.7 t-20 -83.67 49.34 1.58 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.949 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 29.2 t 138.94 142.7 0.0 OUTLIER 'General case' 0 C--N 1.349 0.562 0 CA-C-N 112.249 -2.25 . . . . 0.0 109.344 173.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 80' ' ' LEU . 95.7 mt -49.09 -49.42 41.81 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.238 -1.801 . . . . 0.0 108.851 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -47.45 -39.46 15.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 112.624 -2.08 . . . . 0.0 110.621 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 79' ' ' GLU . 4.7 tm-20 -64.1 -35.76 81.8 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 116.772 -1.971 . . . . 0.0 110.5 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.464 HD13 ' CG ' ' A' ' 69' ' ' LEU . 6.8 tt -64.88 -66.67 0.51 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.692 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.6 t -39.69 -38.84 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 112.321 -2.218 . . . . 0.0 110.893 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.412 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 12.6 t70 -77.64 -36.25 51.72 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.209 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' LEU . 60.8 t80 -68.76 -28.29 66.66 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 117.942 -1.503 . . . . 0.0 111.948 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -107.45 35.2 3.15 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 117.953 -1.499 . . . . 0.0 111.328 -175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 12.7 ptm180 -97.38 30.55 2.8 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 117.426 -1.71 . . . . 0.0 111.656 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 88' ' ' SER . 80.5 p -149.98 -74.06 0.17 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 117.651 -1.62 . . . . 0.0 110.259 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.417 ' N ' ' OG ' ' A' ' 86' ' ' SER . 9.0 t -76.23 39.68 0.2 Allowed 'General case' 0 C--N 1.345 0.41 0 CA-C-N 112.966 -1.924 . . . . 0.0 110.862 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.565 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 32.7 t 50.93 -146.22 0.46 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 117.825 -1.55 . . . . 0.0 109.398 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 89' ' ' VAL . 15.0 p -160.12 45.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.678 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.2 t . . . . . 0 C--N 1.346 0.425 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.592 -179.347 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.565 ' H ' ' HB2' ' A' ' 88' ' ' SER . 11.3 pt20 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.434 ' CG2' HG13 ' A' ' 48' ' ' VAL . 37.0 mt -149.96 127.18 2.42 Favored 'Isoleucine or valine' 0 C--N 1.349 0.55 0 C-N-CA 117.831 -1.548 . . . . 0.0 110.054 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.577 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 29.9 t80 -123.74 135.76 54.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.965 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.51 HD23 ' CB ' ' A' ' 32' ' ' PHE . 95.5 mt -89.94 96.11 10.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 117.045 -1.862 . . . . 0.0 110.228 -174.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.567 ' HG2' ' H ' ' A' ' 99' ' ' ASP . 53.4 ttm-85 -153.8 -137.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.808 175.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.606 ' CG ' ' H ' ' A' ' 100' ' ' ILE . 35.9 t0 43.85 -170.84 0.01 OUTLIER 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.286 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.606 ' H ' ' CG ' ' A' ' 99' ' ' ASP . 0.5 OUTLIER 86.78 -38.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.361 173.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 24.2 mm-40 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-N 112.988 -1.914 . . . . 0.0 109.98 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 N--CA 1.453 -0.898 0 CA-C-O 121.089 0.37 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.456 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 5.0 m-90 -126.31 -29.88 2.94 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 117.779 -1.569 . . . . 0.0 111.856 -167.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 92.3 m-85 -67.59 116.99 8.93 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.159 -171.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 9' ' ' TRP . 97.4 m-85 -123.94 95.56 4.61 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.682 171.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.56 163.76 30.44 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 114.861 -3.542 . . . . 0.0 112.242 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.572 ' HD3' ' H ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -88.65 109.04 19.78 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 113.26 -1.47 . . . . 0.0 109.296 -6.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 14' ' ' ILE . 10.2 tp -87.71 123.26 69.59 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 113.198 -1.819 . . . . 0.0 109.341 -177.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 16' ' ' ARG . 49.2 Cg_exo -49.88 122.38 8.95 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.493 1.462 . . . . 0.0 112.199 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 15' ' ' PRO . 71.2 ttt180 -38.83 -40.17 0.6 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-N 113.33 -1.759 . . . . 0.0 110.73 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -57.84 -70.89 0.12 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.494 -1.684 . . . . 0.0 108.961 173.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.672 ' HZ1' ' HB3' ' A' ' 22' ' ' MET . 28.6 tptp -35.9 -48.52 0.58 Allowed 'General case' 0 C--N 1.346 0.414 0 CA-C-N 112.833 -1.985 . . . . 0.0 111.051 -176.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.14 -69.32 0.15 Allowed 'General case' 0 C--N 1.346 0.421 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.423 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 24' ' ' SER . 80.3 mt-10 -49.72 -23.42 1.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 112.388 -2.187 . . . . 0.0 112.245 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.459 ' O ' ' OG ' ' A' ' 24' ' ' SER . 81.6 mm-40 -81.34 -81.71 0.13 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 118.486 -1.286 . . . . 0.0 110.11 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.672 ' HB3' ' HZ1' ' A' ' 18' ' ' LYS . 18.4 ptm -47.05 -41.72 17.29 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 117.045 -1.862 . . . . 0.0 110.28 -176.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.6 HD23 ' HG ' ' A' ' 47' ' ' SER . 41.8 tp -63.42 -34.49 77.85 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.422 -178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.59 ' C ' ' H ' ' A' ' 26' ' ' GLN . 71.7 p -69.24 -33.67 73.63 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 116.616 -2.034 . . . . 0.0 110.954 176.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.715 ' HB3' ' HZ2' ' A' ' 25' ' ' LYS . 5.2 mtpm? -72.35 34.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.108 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.594 ' C ' ' H ' ' A' ' 28' ' ' HIS . 28.6 mm-40 -100.75 149.95 23.28 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.454 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 28' ' ' HIS . 24.7 tpt180 -73.57 36.41 0.09 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.107 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.6 ' CE1' ' H ' ' A' ' 51' ' ' GLY . 77.7 t60 44.13 93.13 0.01 OUTLIER 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.631 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -164.03 37.36 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 116.83 -1.948 . . . . 0.0 111.258 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 68.02 1.45 19.31 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 116.785 -2.626 . . . . 0.0 113.44 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.402 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -48.3 132.62 16.29 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 117.775 -1.57 . . . . 0.0 108.761 177.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.421 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 26.7 p90 -144.87 160.99 40.41 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 115.787 -2.365 . . . . 0.0 111.427 -173.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.526 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.6 pp -145.81 146.12 31.05 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.397 170.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' PHE . 71.3 mt -110.25 105.19 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 112.57 -2.105 . . . . 0.0 108.096 173.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 11.1 ptm180 -92.0 152.45 20.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 116.751 -1.98 . . . . 0.0 111.219 -170.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' SER . 47.4 mt-10 -113.59 129.25 56.6 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 111.73 -2.486 . . . . 0.0 109.315 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 36' ' ' GLU . 39.9 t -50.57 -179.46 0.01 OUTLIER 'General case' 0 C--N 1.346 0.415 0 C-N-CA 116.821 -1.952 . . . . 0.0 109.878 -178.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -42.79 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.345 0.392 0 CA-C-N 112.978 -1.919 . . . . 0.0 109.692 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 46.6 t -89.93 -49.18 6.75 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.497 174.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 70.95 119.49 0.03 OUTLIER Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 112.462 -2.154 . . . . 0.0 111.246 165.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.95 -112.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 170.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.49 58.57 0.39 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 117.346 -2.359 . . . . 0.0 109.99 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -101.46 107.63 19.0 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 117.481 -1.688 . . . . 0.0 109.587 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -129.64 127.59 40.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.494 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.427 ' HG ' ' HE1' ' A' ' 56' ' ' HIS . 80.7 p -134.06 127.31 31.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.717 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 32' ' ' PHE . 4.8 tt -90.79 115.51 27.91 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.786 -2.006 . . . . 0.0 109.55 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.6 ' HG ' HD23 ' A' ' 23' ' ' LEU . 90.1 p -100.54 146.73 26.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.898 -1.956 . . . . 0.0 109.735 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.8 t -140.6 149.24 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 117.553 -1.659 . . . . 0.0 110.515 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.48 ' CE ' ' O ' ' A' ' 24' ' ' SER . 20.7 tptm -75.44 102.73 5.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.747 -2.024 . . . . 0.0 108.795 174.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' ASN . 38.5 t80 -98.82 108.4 21.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.472 -1.695 . . . . 0.0 109.607 -178.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.6 ' H ' ' CE1' ' A' ' 28' ' ' HIS . . . 54.79 -97.37 0.04 OUTLIER Glycine 0 CA--C 1.53 1.02 0 C-N-CA 118.021 -2.038 . . . . 0.0 110.161 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 50' ' ' PHE . 51.7 t30 -112.16 -26.34 8.86 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 112.659 -1.771 . . . . 0.0 112.043 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.596 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 30.3 t0 -101.43 -173.23 2.31 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.223 -1.391 . . . . 0.0 109.528 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.596 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 96.0 t -111.47 120.5 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 113.259 -1.791 . . . . 0.0 109.742 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 10.2 tt0 -90.01 159.38 16.9 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 112.881 -1.963 . . . . 0.0 109.357 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.427 ' HE1' ' HG ' ' A' ' 45' ' ' SER . 27.6 t60 -136.31 121.55 19.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.733 -2.031 . . . . 0.0 110.47 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 46' ' ' LEU . 24.2 m-85 -112.71 126.28 55.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.79 -2.005 . . . . 0.0 109.191 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -95.87 118.12 31.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 116.733 -1.987 . . . . 0.0 109.538 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 68.0 t -75.97 92.76 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 113.031 -1.895 . . . . 0.0 108.734 176.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.0 mt -89.94 151.51 21.67 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 113.03 -1.895 . . . . 0.0 110.871 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 64.8 ttp85 . . . . . 0 N--CA 1.445 -0.713 0 CA-C-N 111.858 -2.428 . . . . 0.0 109.431 174.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.628 ' HZ1' ' HA ' ' A' ' 75' ' ' ASN . 1.9 mmpm? . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 122.167 0.984 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 86.6 m-85 -96.8 134.49 40.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.42 -2.173 . . . . 0.0 109.04 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 71' ' ' VAL . 50.7 p90 -152.75 -162.37 1.48 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 117.188 -1.805 . . . . 0.0 109.999 -176.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.27 -39.4 0.93 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 112.31 -2.223 . . . . 0.0 110.767 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -110.32 -38.67 5.18 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.84 -173.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 98.5 t -150.02 -83.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 117.148 -1.821 . . . . 0.0 109.365 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 71' ' ' VAL . 18.4 m -162.1 136.89 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.202 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.565 ' CD ' ' CZ ' ' A' ' 74' ' ' PHE . 17.3 ptpt -170.07 -24.26 0.02 OUTLIER 'General case' 0 C--N 1.347 0.483 0 C-N-CA 114.684 -2.806 . . . . 0.0 112.829 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.565 ' CZ ' ' CD ' ' A' ' 73' ' ' LYS . 10.8 m-85 -120.24 146.58 45.92 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 116.671 -2.011 . . . . 0.0 109.986 -174.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.628 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 53.1 p-10 -86.77 -22.6 25.83 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 113.087 -1.87 . . . . 0.0 112.065 175.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.416 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 41.0 t -155.6 162.34 40.65 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 118.201 -1.399 . . . . 0.0 109.703 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.521 ' CD2' HG13 ' A' ' 59' ' ' VAL . 95.9 mt -46.32 -45.48 17.51 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.932 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.406 ' OD1' ' CZ3' ' A' ' 9' ' ' TRP . 1.8 m-20 -48.49 -38.59 20.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.871 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' CB ' ' HB3' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -77.34 -19.98 55.53 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 113.994 -1.457 . . . . 0.0 112.17 -178.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.414 ' CD1' HG23 ' A' ' 59' ' ' VAL . 6.8 tt -72.62 -57.68 3.94 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 118.154 -1.418 . . . . 0.0 108.227 172.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 58.2 t -51.75 -41.72 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 111.911 -2.404 . . . . 0.0 110.573 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 11.2 t70 -63.43 -44.48 94.42 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.35 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CB ' ' CE1' ' A' ' 74' ' ' PHE . 64.5 t80 -70.04 -37.49 75.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.188 -1.824 . . . . 0.0 111.096 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.559 ' C ' ' H ' ' A' ' 86' ' ' SER . 1.0 OUTLIER -72.72 -32.53 65.79 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.397 -178.004 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 55.0 ptt85 -77.31 41.84 0.32 Allowed 'General case' 0 C--N 1.348 0.506 0 C-N-CA 117.276 -1.769 . . . . 0.0 110.396 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 84' ' ' HIS . 42.6 t -150.01 -44.93 0.13 Allowed 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.344 -1.753 . . . . 0.0 109.656 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -103.91 -137.6 0.35 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.192 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.575 ' HB2' ' H ' ' A' ' 95' ' ' ILE . 70.1 p -143.03 175.54 9.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 118.166 -1.414 . . . . 0.0 109.853 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 90' ' ' SER . 1.9 m -95.94 -41.4 11.65 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-N 113.054 -1.884 . . . . 0.0 110.427 176.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.523 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 16.6 t . . . . . 0 N--CA 1.446 -0.646 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.938 -172.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.401 ' O ' ' HG3' ' A' ' 94' ' ' GLN . 12.1 pt20 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.808 0.813 . . . . 0.0 109.868 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.575 ' H ' ' HB2' ' A' ' 88' ' ' SER . 14.9 mt -119.97 126.79 75.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.205 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 97' ' ' LEU . 67.4 t80 -103.46 155.45 18.5 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.062 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.455 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 91.2 mt -89.89 120.36 31.05 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 117.27 -1.772 . . . . 0.0 109.707 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -127.96 143.52 51.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.285 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -47.92 127.07 11.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.462 -2.154 . . . . 0.0 109.719 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 101' ' ' GLU . 17.8 tt -62.82 -121.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.707 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.567 ' H ' HG22 ' A' ' 100' ' ' ILE . 6.6 tp10 . . . . . 0 N--CA 1.442 -0.869 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.153 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 CA--C 1.542 0.882 0 N-CA-C 114.54 0.939 . . . . 0.0 114.54 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -146.43 27.69 1.11 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.93 -176.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -102.29 116.91 33.62 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.334 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 12' ' ' GLY . 7.5 m-85 -105.65 104.28 13.97 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 113.233 -1.803 . . . . 0.0 108.497 174.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -22.41 -108.23 0.0 OUTLIER Glycine 0 C--N 1.348 1.21 0 CA-C-N 111.63 -2.532 . . . . 0.0 112.883 -173.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.72 ' HZ3' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -115.99 50.01 1.06 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 112.727 -1.736 . . . . 0.0 108.885 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.522 HG23 ' CB ' ' A' ' 35' ' ' ARG . 7.6 tp -69.27 132.03 90.07 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.721 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' ARG . 21.1 Cg_endo -66.11 125.03 13.42 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.263 1.976 . . . . 0.0 112.122 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.449 HH11 HH21 ' A' ' 35' ' ' ARG . 60.0 ttt85 -31.9 -40.68 0.04 OUTLIER 'General case' 0 C--N 1.349 0.544 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.083 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -55.54 -76.35 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.281 -1.781 . . . . 0.0 109.405 177.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 17' ' ' ALA . 56.8 tptt -38.92 -39.81 0.57 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 112.993 -1.912 . . . . 0.0 110.915 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.576 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -54.61 -70.76 0.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 117.071 -1.852 . . . . 0.0 108.705 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 24' ' ' SER . 47.6 mt-10 -39.36 -43.25 1.16 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.504 -2.135 . . . . 0.0 110.753 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' O ' ' OG ' ' A' ' 24' ' ' SER . 34.6 mt-10 -61.8 -91.78 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.4 -175.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.0 ptm -45.02 -39.65 5.83 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 117.524 -1.67 . . . . 0.0 110.687 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 23.5 tp -59.93 -41.11 91.05 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.748 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.602 ' C ' ' H ' ' A' ' 26' ' ' GLN . 81.1 p -67.4 -37.35 82.97 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.471 176.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -70.66 35.16 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.613 -1.631 . . . . 0.0 111.053 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.602 ' H ' ' C ' ' A' ' 24' ' ' SER . 13.6 mm100 -107.95 145.67 33.5 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 118.082 -1.447 . . . . 0.0 109.397 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -91.21 -69.79 0.72 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.876 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -61.72 105.11 0.5 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.956 -1.929 . . . . 0.0 109.709 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -45.99 121.03 2.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.623 -2.08 . . . . 0.0 109.537 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.2 -22.11 4.03 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 117.98 -2.057 . . . . 0.0 112.674 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.57 ' HB3' HE21 ' A' ' 26' ' ' GLN . . . -46.98 114.14 0.79 Allowed 'General case' 0 C--N 1.35 0.605 0 C-N-CA 118.245 -1.382 . . . . 0.0 108.995 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.51 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 17.4 p90 -132.29 160.69 35.49 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 116.675 -2.01 . . . . 0.0 110.753 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.404 ' HG ' ' OG ' ' A' ' 47' ' ' SER . 4.5 pp -150.73 149.67 30.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 116.401 -2.12 . . . . 0.0 109.74 169.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.8 mt -108.44 106.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.62 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' CB ' HG23 ' A' ' 14' ' ' ILE . 31.8 ptt-85 -94.95 126.78 40.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 112.623 -2.08 . . . . 0.0 110.077 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 12' ' ' GLY . 63.7 tt0 -69.06 120.48 14.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.874 -1.967 . . . . 0.0 109.121 177.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 43.0 t -45.81 120.31 2.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.817 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.52 ' HA ' ' HZ3' ' A' ' 13' ' ' LYS . 61.3 tt0 -45.3 -40.1 7.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 112.743 -2.026 . . . . 0.0 110.81 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.8 m -89.93 -95.15 0.11 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.168 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 37' ' ' SER . . . -53.66 130.37 55.17 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 113.699 -1.591 . . . . 0.0 109.621 -176.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.35 -6.16 15.41 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.833 1.689 . . . . 0.0 114.968 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.61 40.37 2.35 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 118.506 -1.807 . . . . 0.0 111.065 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 1.0 OUTLIER -133.0 120.83 21.89 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 117.747 -1.581 . . . . 0.0 109.836 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.412 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 86.7 m-85 -125.61 130.39 51.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.558 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.7 p -127.72 132.92 49.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.162 -1.836 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 tt -94.8 115.26 27.28 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.806 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.509 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 91.4 p -102.58 130.96 49.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.85 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.77 149.38 30.51 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 117.768 -1.573 . . . . 0.0 110.281 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 41.7 tptt -82.28 101.94 10.86 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.888 -1.96 . . . . 0.0 108.842 172.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 53' ' ' ASP . 10.4 t80 -110.04 144.75 38.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 113.321 -1.763 . . . . 0.0 108.871 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . -45.47 135.56 7.86 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 117.225 -2.417 . . . . 0.0 110.912 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.442 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 58.4 t30 76.72 -34.57 0.22 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 111.536 -2.332 . . . . 0.0 111.075 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 51' ' ' GLY . 11.0 m-20 -157.35 153.35 27.18 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 114.955 -2.698 . . . . 0.0 111.592 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.486 ' CG2' ' HB3' ' A' ' 24' ' ' SER . 66.5 t -69.95 125.23 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 112.325 -2.216 . . . . 0.0 108.991 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.545 HE22 ' CD1' ' A' ' 95' ' ' ILE . 11.2 tt0 -90.04 164.0 14.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.542 -177.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.509 ' CE1' ' CG ' ' A' ' 58' ' ' LYS . 16.6 t-160 -140.86 129.58 22.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 112.959 -1.928 . . . . 0.0 111.124 -168.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 92.2 m-85 -138.31 103.15 4.83 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.263 175.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.509 ' CG ' ' CE1' ' A' ' 56' ' ' HIS . 53.6 mtmt -74.39 120.64 20.23 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 117.381 -1.728 . . . . 0.0 110.323 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG13 ' CD2' ' A' ' 77' ' ' LEU . 56.6 t -75.32 87.37 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 112.688 -2.051 . . . . 0.0 108.69 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 71.3 mt -80.47 158.2 25.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.023 -1.899 . . . . 0.0 110.182 -174.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.547 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.663 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.571 ' HZ2' ' CA ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 88.8 m-85 -76.67 125.23 28.89 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 116.886 -1.926 . . . . 0.0 109.303 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -159.29 145.9 16.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.942 -1.935 . . . . 0.0 110.968 -177.015 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 69' ' ' LEU . 1.7 mm? -74.09 -66.9 0.66 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.94 -1.936 . . . . 0.0 108.88 175.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 19.0 m0 -136.15 -44.48 0.63 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 112.395 -2.184 . . . . 0.0 110.137 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.2 t -125.75 -80.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 112.99 -1.914 . . . . 0.0 110.445 -173.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.0 m -48.74 134.36 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.421 -172.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -101.51 155.05 18.31 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.829 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 74' ' ' PHE . 5.6 p90 -170.05 138.62 1.73 Allowed 'General case' 0 C--N 1.342 0.275 0 CA-C-N 111.153 -2.748 . . . . 0.0 109.156 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -98.2 24.13 7.51 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 112.711 -2.041 . . . . 0.0 111.724 176.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 40.3 t -144.94 132.16 20.54 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 116.814 -1.955 . . . . 0.0 110.345 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.504 ' CD2' HG13 ' A' ' 59' ' ' VAL . 96.1 mt -56.88 -44.58 82.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 113.178 -1.828 . . . . 0.0 109.57 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -51.43 -45.63 62.69 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.756 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 76' ' ' SER . 31.7 tp10 -58.67 -38.2 77.69 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.62 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.468 ' CD1' HG21 ' A' ' 59' ' ' VAL . 7.9 tt -60.19 -46.27 90.29 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.331 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 77' ' ' LEU . 86.4 t -65.49 -35.53 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 112.78 -2.009 . . . . 0.0 111.337 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 24.6 t0 -58.7 -43.01 89.94 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.373 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.46 ' C ' ' H ' ' A' ' 85' ' ' ARG . 33.2 m-85 -64.55 -42.76 95.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.112 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.486 ' CB ' HD13 ' A' ' 97' ' ' LEU . 38.2 m170 -80.03 30.28 0.27 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 113.599 -1.637 . . . . 0.0 111.378 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 83' ' ' TYR . 79.7 ttt-85 -112.98 -38.58 4.46 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 117.973 -1.491 . . . . 0.0 110.762 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.5 p -99.6 -39.82 8.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 117.974 -1.49 . . . . 0.0 110.677 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 88' ' ' SER . 8.8 t -106.17 39.13 1.86 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 117.731 -1.588 . . . . 0.0 110.863 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 87' ' ' THR . 44.2 t 44.93 -169.35 0.01 OUTLIER 'General case' 0 C--N 1.347 0.473 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.842 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.403 ' N ' ' OG ' ' A' ' 88' ' ' SER . 10.9 p -117.81 -39.88 2.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.359 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.44 ' HB3' ' CD1' ' A' ' 95' ' ' ILE . 32.8 t . . . . . 0 CA--C 1.545 0.756 0 CA-C-N 113.796 -1.547 . . . . 0.0 112.164 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 N--CA 1.45 -0.433 0 CA-C-O 121.852 0.834 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.545 ' CD1' HE22 ' A' ' 55' ' ' GLN . 55.2 mt -116.57 137.33 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 113.064 -1.88 . . . . 0.0 110.258 -178.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -121.47 133.37 55.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.735 -2.03 . . . . 0.0 109.112 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.486 HD13 ' CB ' ' A' ' 84' ' ' HIS . 80.8 mt -89.93 105.88 18.1 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.749 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.74 ' CD ' ' H ' ' A' ' 99' ' ' ASP . 0.7 OUTLIER 177.98 -141.94 0.01 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 112.35 -2.204 . . . . 0.0 107.678 -178.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.74 ' H ' ' CD ' ' A' ' 98' ' ' ARG . 27.0 m-20 69.61 -27.44 0.16 Allowed 'General case' 0 C--N 1.347 0.461 0 O-C-N 125.383 1.677 . . . . 0.0 113.104 166.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.527 ' H ' ' C ' ' A' ' 98' ' ' ARG . 13.3 tt -75.04 30.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 116.653 -2.019 . . . . 0.0 112.119 -172.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 99' ' ' ASP . 43.2 tt0 . . . . . 0 N--CA 1.444 -0.74 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.596 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.423 ' HA2' ' CD ' ' A' ' 107' ' ' PRO . . . . . . . . 0 CA--C 1.53 0.976 0 CA-C-O 121.844 0.691 . . . . 0.0 111.993 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 2' ' ' ILE . 19.5 tt -134.96 44.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 113.112 -1.544 . . . . 0.0 109.951 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' C ' ' CD ' ' A' ' 3' ' ' GLU . 2.2 tm-20 -100.57 107.54 19.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 113.195 -1.821 . . . . 0.0 108.979 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' LYS . 71.3 mtp -95.22 117.94 31.12 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 112.981 -1.918 . . . . 0.0 110.401 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' MET . 86.9 tttt 39.08 94.11 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 112.643 -2.071 . . . . 0.0 110.928 174.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.1 Cg_exo -49.78 121.69 7.75 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.356 2.037 . . . . 0.0 112.185 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -90.68 115.39 64.1 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.964 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 6' ' ' PRO 0.252 60.9 Cg_endo -88.83 118.02 0.92 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.312 2.008 . . . . 0.0 110.883 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -135.22 60.68 1.69 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 -15.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CE1' ' CA ' ' A' ' 12' ' ' GLY . 50.9 t80 -90.58 124.0 34.68 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 110.928 -2.851 . . . . 0.0 112.379 -155.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.7 m-85 -127.78 92.01 3.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 112.105 -2.316 . . . . 0.0 107.862 167.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.517 ' CA ' ' CE1' ' A' ' 10' ' ' PHE . . . -54.91 116.33 6.6 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.958 -170.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' CD ' ' OE2' ' A' ' 38' ' ' GLU . 25.4 pttm 31.1 42.28 0.01 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 111.685 -2.257 . . . . 0.0 111.109 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.521 ' CG1' ' HD2' ' A' ' 18' ' ' LYS . 10.3 tp -62.79 129.2 92.85 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 112.971 -1.922 . . . . 0.0 108.843 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.4 Cg_exo -45.86 123.29 5.92 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.834 1.689 . . . . 0.0 113.194 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 15' ' ' PRO . 41.5 ttm180 -37.06 -41.86 0.38 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.707 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -56.32 -81.19 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.246 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.604 ' CE ' ' SD ' ' A' ' 22' ' ' MET . 8.1 tmtm? -31.48 -42.66 0.05 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 112.646 -2.07 . . . . 0.0 111.029 -176.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -58.05 -69.55 0.17 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.717 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' SER . 53.5 mt-10 -48.03 -52.9 18.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.592 -2.095 . . . . 0.0 110.255 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 24' ' ' SER . 77.4 mm-40 -40.4 -87.46 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.753 -2.021 . . . . 0.0 110.621 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.604 ' SD ' ' CE ' ' A' ' 18' ' ' LYS . 16.9 ptm -50.77 -53.08 34.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.088 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.52 HD12 ' CD1' ' A' ' 100' ' ' ILE . 48.3 tp -48.38 -21.93 0.62 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 117.223 -1.791 . . . . 0.0 112.681 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' GLU . 37.0 t -83.18 -35.97 25.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.78 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HD3' ' CA ' ' A' ' 22' ' ' MET . 5.2 pttp -42.75 -25.18 0.08 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.028 172.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' HG3' ' CB ' ' A' ' 31' ' ' ALA . 38.6 mm-40 -53.9 141.96 25.9 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.481 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -81.71 -69.49 0.61 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 111.936 -2.393 . . . . 0.0 110.455 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -76.1 -156.97 0.07 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.749 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -122.5 130.38 52.99 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 112.75 -2.023 . . . . 0.0 110.068 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.37 34.47 1.01 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 118.236 -1.935 . . . . 0.0 111.901 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.481 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -99.9 131.93 45.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 118.114 -1.434 . . . . 0.0 108.101 173.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 40.2 p90 -143.08 157.55 44.42 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 115.231 -2.588 . . . . 0.0 111.835 -173.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -148.43 151.83 35.9 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 112.003 -2.362 . . . . 0.0 109.451 171.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.85 110.71 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 112.492 -2.14 . . . . 0.0 108.976 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.676 ' HE ' ' HG ' ' A' ' 45' ' ' SER . 34.4 ptt180 -96.7 128.11 43.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.373 -2.194 . . . . 0.0 110.051 -174.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' O ' ' CA ' ' A' ' 13' ' ' LYS . 45.1 tt0 -79.05 126.06 30.21 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.062 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.669 ' HG ' ' CB ' ' A' ' 43' ' ' ASP . 49.9 m -58.57 138.58 56.74 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 112.781 -2.009 . . . . 0.0 109.955 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' OE2' ' CD ' ' A' ' 13' ' ' LYS . 9.7 tp10 -38.6 -90.65 0.0 OUTLIER 'General case' 0 C--N 1.345 0.375 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.624 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 40' ' ' ALA . 49.0 m -89.9 -36.55 14.97 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 113.601 -1.636 . . . . 0.0 111.259 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 37' ' ' SER . . . -42.58 150.23 0.43 Allowed Pre-proline 0 C--N 1.348 0.508 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.158 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.67 -116.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.995 2.463 . . . . 0.0 110.784 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.02 57.83 4.83 Favored Glycine 0 C--N 1.346 1.089 0 C-N-CA 118.145 -1.979 . . . . 0.0 110.869 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.669 ' CB ' ' HG ' ' A' ' 37' ' ' SER . 3.4 m-20 -102.9 117.1 33.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 117.903 -1.519 . . . . 0.0 109.32 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.401 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 95.3 m-85 -134.24 130.28 36.92 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 112.904 -1.953 . . . . 0.0 109.839 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.676 ' HG ' ' HE ' ' A' ' 35' ' ' ARG . 77.7 p -119.0 126.38 51.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.48 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.0 tt -93.51 115.07 27.57 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.354 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.413 ' OG ' ' HG ' ' A' ' 33' ' ' LEU . 90.3 p -94.04 144.64 25.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.789 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 60.7 t -146.44 137.4 18.51 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.726 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -73.36 93.66 1.95 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 116.83 -1.948 . . . . 0.0 108.824 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.477 ' O ' ' O ' ' A' ' 51' ' ' GLY . 4.6 t80 -92.6 40.6 1.06 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.615 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.59 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . 58.6 145.37 0.01 OUTLIER Glycine 0 C--N 1.346 1.131 0 C-N-CA 118.148 -1.977 . . . . 0.0 110.54 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 8.1 t-20 72.07 -35.04 0.32 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 112.475 -1.863 . . . . 0.0 110.854 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.59 ' H ' ' C ' ' A' ' 51' ' ' GLY . 56.2 p30 -171.45 -163.63 0.29 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 117.264 -1.775 . . . . 0.0 110.295 176.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' CG1' HD21 ' A' ' 23' ' ' LEU . 88.4 t -108.76 123.87 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 112.369 -2.196 . . . . 0.0 110.009 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -100.44 157.97 16.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.716 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -136.61 133.85 36.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 112.515 -2.129 . . . . 0.0 110.304 -176.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 92.6 m-85 -113.19 111.12 21.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.927 -1.942 . . . . 0.0 109.897 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 29.6 mmmt -72.25 100.36 2.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.089 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 98.9 t -72.09 88.47 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 113.041 -1.891 . . . . 0.0 108.553 173.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 82.0 mt -74.04 160.41 31.32 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.733 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.739 HH12 ' C ' ' A' ' 65' ' ' GLY . 23.2 tpt85 -99.43 178.58 4.83 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.032 -2.349 . . . . 0.0 108.628 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.566 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 34.1 t0 74.79 -129.74 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.661 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' H ' ' CG ' ' A' ' 62' ' ' ASP . . . 74.05 -70.14 1.54 Allowed Glycine 0 C--N 1.347 1.169 0 C-N-CA 117.774 -2.155 . . . . 0.0 109.317 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.627 ' CB ' ' HZ2' ' A' ' 73' ' ' LYS . . . -143.83 36.01 1.28 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.487 -1.856 . . . . 0.0 110.062 172.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.739 ' C ' HH12 ' A' ' 61' ' ' ARG . . . 86.73 11.8 70.24 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 118.318 -1.896 . . . . 0.0 113.341 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.496 ' HA ' ' HZ3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -138.78 178.41 7.17 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 118.463 -1.295 . . . . 0.0 110.579 -175.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 17.3 m-85 -86.82 142.37 28.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.244 -2.253 . . . . 0.0 109.503 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -160.22 124.71 3.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.989 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.488 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 1.7 mt -61.59 -83.49 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.155 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -110.16 -42.76 4.09 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.222 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.0 t -137.93 -82.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.599 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.402 HG13 ' OH ' ' A' ' 83' ' ' TYR . 24.4 m -47.03 134.2 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 112.649 -2.069 . . . . 0.0 110.544 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.627 ' HZ2' ' CB ' ' A' ' 64' ' ' ALA . 98.7 mttt -94.56 165.98 12.26 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.563 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -170.04 140.13 1.94 Allowed 'General case' 0 C--N 1.343 0.31 0 CA-C-N 111.505 -2.589 . . . . 0.0 109.631 -175.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -91.88 -13.43 31.31 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 111.692 -2.504 . . . . 0.0 112.558 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 79' ' ' GLU . 41.1 t -140.56 129.93 23.85 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 117.573 -1.651 . . . . 0.0 109.908 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 80' ' ' LEU . 99.3 mt -47.12 -39.81 14.18 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.455 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -52.0 -45.43 64.53 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.149 -1.82 . . . . 0.0 109.594 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 76' ' ' SER . 47.4 tp10 -57.0 -32.68 66.37 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 113.16 -1.836 . . . . 0.0 111.284 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 74' ' ' PHE . 7.1 tt -72.1 -70.83 0.31 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.333 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.6 t -37.98 -35.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 112.685 -2.052 . . . . 0.0 111.187 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -80.3 -42.07 23.72 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.563 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 80' ' ' LEU . 65.5 t80 -58.72 -43.08 90.05 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.2 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.421 ' NE2' ' CD1' ' A' ' 69' ' ' LEU . 87.7 m-70 -89.5 39.13 0.93 Allowed 'General case' 0 C--N 1.345 0.406 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.689 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.628 HH12 HH21 ' A' ' 98' ' ' ARG . 60.7 ttm-85 -107.33 -40.63 5.33 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.368 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -89.97 -40.89 12.07 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.476 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 88' ' ' SER . 23.6 m -110.97 41.29 1.85 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 117.831 -1.547 . . . . 0.0 110.903 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.56 ' HB3' ' H ' ' A' ' 95' ' ' ILE . 41.8 m 43.14 -153.59 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.527 169.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 89' ' ' VAL . 15.0 p -153.99 44.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-N 113.058 -1.883 . . . . 0.0 109.788 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 95' ' ' ILE . 43.0 t 179.55 124.48 0.06 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.731 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 92' ' ' ASN . 48.0 mtp180 -69.68 -32.86 71.72 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 112.949 -1.932 . . . . 0.0 111.381 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 91' ' ' ARG . 63.1 m-80 -40.63 -39.9 1.16 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.772 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -160.67 -148.69 0.17 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.993 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -116.16 120.16 38.12 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.019 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.56 ' H ' ' HB3' ' A' ' 88' ' ' SER . 64.2 mt -115.96 151.63 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 112.622 -2.081 . . . . 0.0 109.433 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -143.71 138.78 29.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.35 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.4 mt -89.92 118.54 29.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.995 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.628 HH21 HH12 ' A' ' 85' ' ' ARG . 2.0 mmp_? -126.17 149.36 49.05 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.521 -2.127 . . . . 0.0 109.875 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.589 ' C ' ' H ' ' A' ' 101' ' ' GLU . 7.1 m-20 -54.01 124.19 14.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 112.163 -2.29 . . . . 0.0 109.83 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.525 ' CD1' HD21 ' A' ' 33' ' ' LEU . 10.6 tt -71.95 31.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 112.533 -2.121 . . . . 0.0 111.578 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.589 ' H ' ' C ' ' A' ' 99' ' ' ASP . 47.3 mm-40 -150.15 119.49 6.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 118.001 -1.479 . . . . 0.0 109.651 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.463 ' OE1' ' O ' ' A' ' 103' ' ' VAL . 6.3 tm0? -74.62 132.66 41.93 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.65 -2.068 . . . . 0.0 109.64 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.658 ' CG1' ' H ' ' A' ' 105' ' ' GLN . 0.9 OUTLIER -33.98 149.0 0.08 OUTLIER Pre-proline 0 C--N 1.347 0.496 0 CA-C-N 112.623 -2.081 . . . . 0.0 110.85 -177.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 105' ' ' GLN . 19.3 Cg_endo -63.69 -7.73 13.6 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.069 2.513 . . . . 0.0 115.3 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.658 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 27.8 mt-30 36.59 -156.54 0.0 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.806 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -119.86 87.08 37.4 Favored Pre-proline 0 C--N 1.346 0.454 0 CA-C-N 113.01 -1.905 . . . . 0.0 109.466 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' THR . 45.6 Cg_exo -52.14 119.98 6.57 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.873 2.382 . . . . 0.0 113.685 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 107' ' ' PRO . 60.1 m 60.22 143.87 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.024 -1.898 . . . . 0.0 110.163 176.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 108' ' ' THR . 21.3 m-85 65.27 124.29 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.99 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 111' ' ' GLN . 7.4 p -113.09 122.96 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 112.803 -1.999 . . . . 0.0 109.6 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 110' ' ' VAL . 1.1 tm0? 57.9 114.31 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.469 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.408 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.409 0 CA-C-N 112.938 -1.937 . . . . 0.0 109.657 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 CA-C-O 121.958 0.755 . . . . 0.0 112.027 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 2' ' ' ILE . 15.7 tt -46.75 121.87 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.634 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -107.96 123.17 48.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 112.957 -1.929 . . . . 0.0 109.658 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.576 ' SD ' ' C ' ' A' ' 4' ' ' MET . 0.2 OUTLIER -110.05 120.33 42.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.012 -1.903 . . . . 0.0 109.565 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.773 ' HZ2' ' CG2' ' A' ' 103' ' ' VAL . 48.8 pttt -152.1 -174.64 0.42 Allowed Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.211 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 5' ' ' LYS . 44.0 Cg_exo -54.17 121.5 9.78 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.825 1.683 . . . . 0.0 112.606 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.431 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 5.8 p-80 -37.35 153.12 0.12 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.64 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' O ' ' CD2' ' A' ' 9' ' ' TRP . 75.2 Cg_exo -43.11 131.49 6.2 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.331 2.687 . . . . 0.0 116.93 -174.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.458 ' CD2' ' O ' ' A' ' 8' ' ' PRO . 32.5 p-90 49.25 16.65 0.16 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 111.872 -2.422 . . . . 0.0 113.502 170.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.431 ' CG ' ' CE1' ' A' ' 7' ' ' HIS . 49.2 t80 -97.77 119.13 35.82 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 116.229 -2.188 . . . . 0.0 109.653 175.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 8.6 m-85 -121.92 109.14 14.26 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 113.076 -1.875 . . . . 0.0 109.164 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -69.22 129.18 23.04 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 112.56 -2.109 . . . . 0.0 111.557 -174.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HZ1' ' CD ' ' A' ' 38' ' ' GLU . 83.7 tttt 25.89 47.66 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 111.713 -2.243 . . . . 0.0 111.899 176.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.434 HG21 ' CB ' ' A' ' 35' ' ' ARG . 8.7 tp -75.21 134.0 74.45 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 117.268 -1.773 . . . . 0.0 108.8 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' ARG . 20.8 Cg_endo -65.67 124.54 12.93 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.178 1.919 . . . . 0.0 111.332 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' CZ ' ' NH2' ' A' ' 35' ' ' ARG . 94.9 mtt-85 -34.22 -41.6 0.11 Allowed 'General case' 0 C--N 1.349 0.558 0 CA-C-N 112.779 -2.009 . . . . 0.0 110.983 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -54.72 -72.13 0.07 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.243 -1.798 . . . . 0.0 109.537 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 22' ' ' MET . 4.8 tppp? -41.74 -49.52 4.3 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.492 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -47.36 -58.53 4.04 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.479 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' O ' ' OG ' ' A' ' 24' ' ' SER . 89.4 mt-10 -49.96 -52.06 36.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.733 -2.03 . . . . 0.0 109.989 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 70.9 mt-10 -55.53 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.891 -1.958 . . . . 0.0 110.852 -173.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 3.0 ptm -45.46 -39.99 7.81 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.773 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.51 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 45.7 tp -68.56 -32.03 71.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 117.644 -1.623 . . . . 0.0 111.755 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 26' ' ' GLN . 59.3 m -68.58 -35.9 78.0 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 117.503 -1.679 . . . . 0.0 111.044 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -72.07 33.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.241 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.587 ' H ' ' C ' ' A' ' 24' ' ' SER . 13.6 mm-40 -101.69 132.37 47.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 117.818 -1.553 . . . . 0.0 110.022 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -81.26 -41.93 21.45 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 111.707 -2.497 . . . . 0.0 110.599 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.42 ' HD1' ' N ' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -92.49 106.88 18.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.583 -178.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 50' ' ' PHE . 70.9 m-20 -53.74 123.94 13.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.705 -2.043 . . . . 0.0 109.419 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 136.55 -31.77 2.54 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 117.585 -2.245 . . . . 0.0 112.037 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' HB3' HE21 ' A' ' 26' ' ' GLN . . . -46.32 136.61 7.04 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 118.078 -1.449 . . . . 0.0 109.358 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 47' ' ' SER . 28.2 p90 -145.3 162.76 36.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 116.384 -2.126 . . . . 0.0 110.982 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 33' ' ' LEU . 4.5 pp -147.95 150.17 33.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.343 -2.208 . . . . 0.0 109.577 172.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.7 mt -116.92 111.98 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 112.666 -2.061 . . . . 0.0 108.662 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.436 ' NH2' ' CZ ' ' A' ' 16' ' ' ARG . 40.7 ptt85 -95.59 129.09 42.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 112.634 -2.076 . . . . 0.0 110.259 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -96.96 128.36 43.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 112.45 -2.159 . . . . 0.0 109.869 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.433 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 43.2 t -60.54 155.63 18.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.845 -1.979 . . . . 0.0 109.613 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.509 ' CD ' ' HZ1' ' A' ' 13' ' ' LYS . 45.3 tt0 -41.08 -91.52 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 112.563 -2.108 . . . . 0.0 110.252 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.411 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 50.5 m -90.0 -44.25 9.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.1 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -41.44 102.58 0.27 Allowed Pre-proline 0 C--N 1.347 0.488 0 CA-C-N 113.218 -1.81 . . . . 0.0 110.059 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 39' ' ' SER . 58.2 Cg_endo -77.62 -4.45 14.6 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.88 1.72 . . . . 0.0 115.079 -177.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.45 39.63 2.69 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 118.422 -1.846 . . . . 0.0 111.108 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 54.9 m-20 -130.32 112.17 13.05 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 117.736 -1.586 . . . . 0.0 109.933 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 96.9 m-85 -147.64 117.54 7.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.867 -1.969 . . . . 0.0 109.389 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 79.0 p -122.98 128.04 49.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.486 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.519 ' CD2' HG21 ' A' ' 48' ' ' VAL . 6.2 tt -93.59 119.7 32.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.81 -1.995 . . . . 0.0 109.673 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.51 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 50.1 m -99.44 145.02 27.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.534 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.519 HG21 ' CD2' ' A' ' 46' ' ' LEU . 88.6 t -145.36 138.67 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 113.378 -1.737 . . . . 0.0 110.452 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.559 ' HZ3' ' C ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -80.35 106.56 12.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 112.869 -1.969 . . . . 0.0 108.721 173.046 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 72.8 t80 -79.76 -104.33 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 116.847 -1.941 . . . . 0.0 108.928 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.91 -69.08 1.35 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 118.718 -1.706 . . . . 0.0 109.633 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -130.4 -24.31 2.55 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 111.978 -2.111 . . . . 0.0 112.088 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.559 ' C ' ' HZ3' ' A' ' 49' ' ' LYS . 45.7 p-10 -99.9 157.37 16.57 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 118.661 -1.216 . . . . 0.0 110.473 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG2' ' OG ' ' A' ' 24' ' ' SER . 88.6 t -85.25 114.59 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.693 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.415 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 9.8 tt0 -90.27 158.74 17.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.933 -1.94 . . . . 0.0 109.399 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -130.66 131.62 44.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.779 -2.01 . . . . 0.0 110.746 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.415 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 96.3 m-85 -123.81 133.34 53.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.432 -2.167 . . . . 0.0 109.137 175.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.724 ' HB2' ' HZ3' ' A' ' 58' ' ' LYS . 10.6 mtmp? -104.06 107.97 19.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.321 -1.752 . . . . 0.0 110.242 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 72.1 t -76.57 85.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 112.683 -2.053 . . . . 0.0 108.565 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 71.9 mt -70.33 161.0 31.22 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 112.68 -2.055 . . . . 0.0 110.679 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 62' ' ' ASP . 1.9 tmt_? -128.68 156.99 42.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.392 -2.186 . . . . 0.0 109.884 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' A' ' 64' ' ' ALA . 43.4 t0 179.15 140.11 0.11 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 111.939 -2.391 . . . . 0.0 109.448 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.21 35.1 0.78 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 117.831 -2.128 . . . . 0.0 111.688 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.592 ' H ' ' C ' ' A' ' 62' ' ' ASP . . . -142.98 45.0 1.58 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.879 -1.161 . . . . 0.0 109.707 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.43 ' HA2' ' CD ' ' A' ' 73' ' ' LYS . . . 140.5 -12.33 2.97 Favored Glycine 0 CA--C 1.544 1.87 0 C-N-CA 118.41 -1.853 . . . . 0.0 113.154 -175.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.717 ' HZ1' ' HA ' ' A' ' 75' ' ' ASN . 7.6 mtpm? 71.53 -140.69 0.05 OUTLIER 'General case' 0 C--N 1.351 0.637 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.004 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 55.0 m-85 -88.05 129.53 35.25 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 115.848 -2.341 . . . . 0.0 109.899 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 74' ' ' PHE . 53.0 p90 -159.27 134.57 8.36 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 112.344 -2.207 . . . . 0.0 109.171 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.584 ' H ' HD13 ' A' ' 69' ' ' LEU . 4.2 mp -68.77 -52.95 24.9 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 116.682 -2.007 . . . . 0.0 109.247 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 18.2 m0 -135.53 -41.41 0.7 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.53 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.5 t -138.33 -83.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.546 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -47.19 133.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 112.552 -2.113 . . . . 0.0 110.782 -171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.692 ' HZ3' ' HB2' ' A' ' 73' ' ' LYS . 9.7 mtmp? -94.21 158.38 15.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.491 -2.141 . . . . 0.0 110.592 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 80' ' ' LEU . 6.6 p90 -159.13 140.14 12.78 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 111.156 -2.747 . . . . 0.0 109.213 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.717 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 6.0 m120 -81.41 -16.91 50.7 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 111.247 -2.706 . . . . 0.0 112.352 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 79' ' ' GLU . 40.3 t -147.28 134.89 20.99 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 117.681 -1.608 . . . . 0.0 109.97 -175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 80' ' ' LEU . 82.6 mt -46.61 -42.89 16.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 112.724 -2.035 . . . . 0.0 110.288 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 38.5 m-80 -49.53 -46.82 49.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.545 -1.661 . . . . 0.0 109.572 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 76' ' ' SER . 41.9 tt0 -57.92 -34.72 70.16 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 112.922 -1.944 . . . . 0.0 111.098 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 74' ' ' PHE . 5.4 tt -61.93 -65.54 0.67 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.783 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.5 t -43.83 -35.8 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 112.07 -2.332 . . . . 0.0 111.076 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 72.6 m-20 -59.87 -38.57 82.54 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.833 -178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.456 ' C ' ' H ' ' A' ' 85' ' ' ARG . 23.0 m-85 -66.24 -51.96 52.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.836 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.05 36.59 0.51 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.971 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 83' ' ' TYR . 6.1 tpm_? -101.12 7.7 43.13 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.389 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 79.4 p -89.93 -78.2 0.37 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 118.656 -1.218 . . . . 0.0 109.896 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.453 ' OG1' ' CZ ' ' A' ' 96' ' ' PHE . 9.2 t -170.02 39.48 0.02 OUTLIER 'General case' 0 C--N 1.346 0.451 0 C-N-CA 116.7 -2.0 . . . . 0.0 110.997 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.435 ' CB ' ' C ' ' A' ' 92' ' ' ASN . 77.6 p -177.22 140.98 0.31 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 116.887 -1.925 . . . . 0.0 110.537 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.3 -38.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 111.985 -2.371 . . . . 0.0 110.778 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.574 ' C ' ' H ' ' A' ' 92' ' ' ASN . 34.8 t -138.94 -69.4 0.43 Allowed 'General case' 0 C--N 1.346 0.446 0 C-N-CA 117.989 -1.484 . . . . 0.0 110.127 -175.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 52.6 mmm-85 -60.99 6.9 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 112.45 -2.159 . . . . 0.0 113.322 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.574 ' H ' ' C ' ' A' ' 90' ' ' SER . 70.7 m-20 70.86 -11.97 0.6 Allowed 'General case' 0 CA--C 1.545 0.756 0 O-C-N 124.054 0.846 . . . . 0.0 112.8 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.524 ' O ' ' CB ' ' A' ' 94' ' ' GLN . 4.0 pt20 -168.18 129.34 1.36 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 118.337 -1.345 . . . . 0.0 108.983 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 93' ' ' GLN . 18.3 mm100 102.22 26.85 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.504 -2.135 . . . . 0.0 112.053 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 25.0 mt -149.29 121.39 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 117.314 -1.754 . . . . 0.0 109.963 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.582 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 67.3 m-85 -120.62 140.6 51.32 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.76 -2.018 . . . . 0.0 109.499 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.97 106.67 18.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 117.311 -1.756 . . . . 0.0 108.825 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -121.5 152.81 38.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.4 -173.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -45.08 126.82 6.31 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 112.441 -2.163 . . . . 0.0 109.52 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.556 HG13 HE21 ' A' ' 26' ' ' GLN . 15.4 tt -84.63 2.64 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 112.766 -2.016 . . . . 0.0 113.656 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.536 ' HB2' ' HZ3' ' A' ' 5' ' ' LYS . 66.0 mm-40 -150.21 117.79 6.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 117.774 -1.571 . . . . 0.0 110.303 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -75.24 127.86 34.13 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 112.922 -1.945 . . . . 0.0 109.27 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.773 ' CG2' ' HZ2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -139.01 -66.88 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.573 -176.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.516 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 19.4 Cg_endo -65.81 2.33 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.674 1.582 . . . . 0.0 115.303 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -44.32 111.35 0.29 Allowed 'General case' 0 C--N 1.346 0.439 0 C-N-CA 118.526 -1.27 . . . . 0.0 109.62 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.408 ' CD ' ' C ' ' A' ' 106' ' ' GLN . 3.6 pp0? -158.75 155.46 24.95 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.665 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 106' ' ' GLN . 72.8 Cg_endo -78.2 -140.03 0.17 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.625 0 O-C-N 124.393 1.733 . . . . 0.0 109.734 -5.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.457 ' O ' ' CD1' ' A' ' 109' ' ' TYR . 5.2 t -144.76 42.33 1.33 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.05 -1.886 . . . . 0.0 110.216 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.457 ' CD1' ' O ' ' A' ' 108' ' ' THR . 66.0 m-85 -151.75 118.89 5.89 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.501 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 111' ' ' GLN . 36.0 m -91.96 118.5 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 113.098 -1.864 . . . . 0.0 109.557 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 110' ' ' VAL . 95.1 mt-30 25.73 101.52 0.0 OUTLIER 'General case' 0 C--N 1.349 0.572 0 CA-C-N 112.354 -2.203 . . . . 0.0 111.543 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 0.425 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.724 179.805 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 CA-C-O 121.875 0.708 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 2' ' ' ILE . 41.4 pt -148.54 129.13 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 113.031 -1.585 . . . . 0.0 109.624 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -129.65 121.08 26.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.503 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.583 ' SD ' ' C ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -70.17 116.13 10.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.469 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 6' ' ' PRO . 62.7 pttt -178.9 157.14 0.92 Allowed Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 112.987 -1.915 . . . . 0.0 108.888 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 5' ' ' LYS . 79.9 Cg_exo -42.02 -120.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.013 2.475 . . . . 0.0 114.29 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -147.3 147.29 28.03 Favored Pre-proline 0 N--CA 1.451 -0.418 0 C-N-CA 117.673 -1.611 . . . . 0.0 109.658 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -73.4 124.48 9.44 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.923 2.415 . . . . 0.0 111.621 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.467 ' CB ' ' CE2' ' A' ' 32' ' ' PHE . 59.2 p-90 38.57 47.37 1.1 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-N 112.538 -2.119 . . . . 0.0 110.545 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -142.67 108.4 5.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.438 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 12' ' ' GLY . 9.8 m-85 -125.03 97.23 5.17 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.195 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -27.79 -105.7 0.0 OUTLIER Glycine 0 C--N 1.347 1.167 0 CA-C-N 112.184 -2.28 . . . . 0.0 112.77 -174.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.677 ' HZ1' ' HB2' ' A' ' 38' ' ' GLU . 63.9 tttp -110.19 53.52 0.69 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 112.77 -1.715 . . . . 0.0 109.035 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.441 HG21 ' CB ' ' A' ' 35' ' ' ARG . 8.5 tp -71.08 133.74 85.68 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.977 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' ARG . 23.1 Cg_endo -66.24 124.05 12.02 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.184 1.923 . . . . 0.0 111.268 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 15' ' ' PRO . 68.1 ttt180 -33.74 -39.38 0.06 Allowed 'General case' 0 C--N 1.347 0.495 0 CA-C-N 112.766 -2.016 . . . . 0.0 111.124 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -53.55 -81.17 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.049 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 17' ' ' ALA . 16.8 tppt? -36.45 -36.54 0.1 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 112.977 -1.919 . . . . 0.0 111.374 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.549 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -59.23 -72.29 0.1 Allowed 'General case' 0 C--N 1.347 0.487 0 C-N-CA 117.375 -1.73 . . . . 0.0 109.061 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 24' ' ' SER . 94.3 mt-10 -43.97 -56.13 4.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 112.541 -2.118 . . . . 0.0 109.801 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 20' ' ' GLU . 11.9 mm-40 -37.05 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.317 -2.22 . . . . 0.0 110.887 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.41 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 17.7 ptm -56.84 -40.69 76.56 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 117.536 -1.666 . . . . 0.0 110.79 -172.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 39.5 tp -50.82 -32.78 21.17 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 116.922 -1.911 . . . . 0.0 111.433 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.597 ' C ' ' H ' ' A' ' 26' ' ' GLN . 41.6 t -75.51 -39.78 57.96 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.201 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -71.55 36.19 0.06 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.305 -1.77 . . . . 0.0 110.923 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.597 ' H ' ' C ' ' A' ' 24' ' ' SER . 12.9 mm100 -102.28 -172.96 2.23 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 117.926 -1.509 . . . . 0.0 109.697 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HE ' ' NE2' ' A' ' 102' ' ' GLN . 3.0 mpt_? -75.63 37.34 0.14 Allowed 'General case' 0 C--N 1.346 0.428 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.947 -176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.607 ' CD2' ' HZ2' ' A' ' 49' ' ' LYS . 78.9 m80 38.09 36.25 0.11 Allowed 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.258 176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 74.8 m-20 -141.49 76.33 1.54 Allowed 'General case' 0 C--N 1.347 0.498 0 C-N-CA 116.748 -1.981 . . . . 0.0 110.975 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' HA2' ' CG1' ' A' ' 48' ' ' VAL . . . 46.72 20.89 0.72 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 113.013 -1.903 . . . . 0.0 113.373 170.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . -52.29 135.81 31.94 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 116.765 -1.974 . . . . 0.0 108.043 172.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.467 ' CE2' ' CB ' ' A' ' 9' ' ' TRP . 30.5 p90 -139.48 148.62 42.95 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 115.656 -2.418 . . . . 0.0 111.926 -169.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -139.58 150.89 45.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 112.082 -2.326 . . . . 0.0 109.333 171.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.5 mt -117.69 107.93 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.622 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.515 ' NH2' ' HG ' ' A' ' 45' ' ' SER . 31.4 ptt-85 -98.38 140.21 32.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 112.904 -1.953 . . . . 0.0 110.556 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' GLY . 23.9 pt-20 -105.36 137.46 43.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.307 -2.224 . . . . 0.0 109.451 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 36' ' ' GLU . 49.9 m -57.88 -153.87 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.692 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.677 ' HB2' ' HZ1' ' A' ' 13' ' ' LYS . 59.2 tt0 -71.63 -95.35 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.558 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 40' ' ' ALA . 87.1 p -89.99 -41.9 11.47 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.223 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -38.83 100.68 0.21 Allowed Pre-proline 0 C--N 1.348 0.519 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.248 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' SER . 57.9 Cg_endo -77.37 -4.36 14.63 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.855 1.703 . . . . 0.0 115.034 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.49 37.37 3.63 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 118.579 -1.772 . . . . 0.0 111.378 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 49.9 m-20 -129.74 100.83 5.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 117.732 -1.587 . . . . 0.0 109.647 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 21.6 m-85 -132.32 121.33 23.37 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.662 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.515 ' HG ' ' NH2' ' A' ' 35' ' ' ARG . 78.8 p -119.04 126.56 51.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.096 -1.866 . . . . 0.0 109.37 178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.455 ' CD1' HD23 ' A' ' 80' ' ' LEU . 5.3 tt -90.36 114.34 26.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.765 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.51 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 33.8 m -97.34 149.51 22.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.314 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.517 ' CG1' ' HA2' ' A' ' 30' ' ' GLY . 75.5 t -140.64 141.56 32.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 113.397 -1.729 . . . . 0.0 110.29 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.607 ' HZ2' ' CD2' ' A' ' 28' ' ' HIS . 22.2 tptp -73.78 97.29 2.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.792 -2.004 . . . . 0.0 108.847 173.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.479 ' O ' ' O ' ' A' ' 53' ' ' ASP . 5.7 t80 -116.46 110.43 18.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.031 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 50' ' ' PHE . . . -30.97 143.8 0.01 OUTLIER Glycine 0 C--N 1.347 1.193 0 CA-C-N 112.734 -2.03 . . . . 0.0 111.826 -176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 14.0 t30 82.99 -28.69 0.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 111.848 -2.176 . . . . 0.0 111.39 -175.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.602 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 30.7 t0 -172.53 -148.01 0.04 OUTLIER 'General case' 0 C--N 1.35 0.62 0 C-N-CA 116.33 -2.148 . . . . 0.0 110.381 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.602 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 93.3 t -129.22 119.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.506 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.501 HE22 ' HB2' ' A' ' 90' ' ' SER . 10.2 tt0 -90.01 159.95 16.61 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.052 -1.885 . . . . 0.0 109.655 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.534 ' HD1' ' H ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -146.73 145.17 29.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.66 -175.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.41 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 41.0 m-85 -134.02 110.48 9.68 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.304 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 56.1 mtmt -65.83 115.28 5.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 116.299 -2.16 . . . . 0.0 109.415 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 46.7 t -78.81 102.01 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 113.244 -1.798 . . . . 0.0 108.426 174.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 78.7 mt -93.96 -167.93 1.78 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.183 -169.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.612 HH22 ' HB2' ' A' ' 64' ' ' ALA . 34.9 tpt85 75.0 -121.32 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 111.954 -2.385 . . . . 0.0 110.387 172.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 61' ' ' ARG . 2.3 p30 53.27 118.39 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.552 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.0 -44.15 1.02 Allowed Glycine 0 CA--C 1.532 1.109 0 CA-C-N 112.144 -2.298 . . . . 0.0 110.081 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.612 ' HB2' HH22 ' A' ' 61' ' ' ARG . . . -138.69 -39.82 0.5 Allowed 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.025 -1.588 . . . . 0.0 110.484 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.5 ' H ' ' NH1' ' A' ' 61' ' ' ARG . . . -111.02 22.07 21.65 Favored Glycine 0 CA--C 1.542 1.742 0 C-N-CA 118.129 -1.986 . . . . 0.0 112.975 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.509 ' O ' ' CG ' ' A' ' 61' ' ' ARG . 5.3 mtpm? 57.71 -166.51 0.15 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.829 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.514 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 28.1 m-85 -94.93 139.03 31.9 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 117.512 -1.675 . . . . 0.0 110.617 -168.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CB ' ' HA ' ' A' ' 73' ' ' LYS . 4.0 p90 -141.22 152.38 44.54 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 116.251 -2.18 . . . . 0.0 110.366 172.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD12 ' CG ' ' A' ' 80' ' ' LEU . 15.3 mt -90.49 -85.82 0.21 Allowed 'General case' 0 C--N 1.346 0.447 0 CA-C-N 112.744 -2.025 . . . . 0.0 109.633 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -91.13 -44.8 9.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.887 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.7 t -145.34 -87.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 113.196 -1.82 . . . . 0.0 109.85 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.0 m -53.58 132.37 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.838 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 23.2 pttp -82.42 -162.37 0.56 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 112.818 -1.992 . . . . 0.0 109.988 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -154.8 137.38 15.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.73 -2.032 . . . . 0.0 108.726 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.495 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 54.4 p30 -65.45 -0.91 2.14 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 112.981 -1.918 . . . . 0.0 113.042 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 79' ' ' GLU . 80.3 p 178.21 146.57 0.14 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.15 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' A' ' 80' ' ' LEU . 92.6 mt -47.28 -40.29 16.44 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 116.897 -1.921 . . . . 0.0 110.176 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.437 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 25.8 m-80 -55.59 -38.15 69.03 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.809 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 76' ' ' SER . 36.5 tt0 -70.18 -23.91 63.05 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 117.49 -1.684 . . . . 0.0 111.868 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.455 HD23 ' CD1' ' A' ' 46' ' ' LEU . 9.0 tt -71.95 -49.33 38.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.046 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.79 -37.11 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 112.434 -2.166 . . . . 0.0 110.827 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 66.1 m-20 -74.66 -37.82 62.63 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 113.943 -1.481 . . . . 0.0 111.01 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.41 ' O ' HG21 ' A' ' 87' ' ' THR . 44.8 t80 -64.45 -52.34 58.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.743 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -86.27 40.55 0.88 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.564 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 83' ' ' TYR . 61.8 ttt180 -73.28 -36.84 66.4 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.806 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.593 ' C ' ' H ' ' A' ' 88' ' ' SER . 46.3 m -136.87 -27.0 1.02 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 118.16 -1.416 . . . . 0.0 112.079 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' SER . 10.3 t -70.51 26.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 118.099 -1.44 . . . . 0.0 112.23 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.593 ' H ' ' C ' ' A' ' 86' ' ' SER . 80.2 p 43.21 -166.66 0.01 OUTLIER 'General case' 0 C--N 1.348 0.521 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.235 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 89' ' ' VAL . 13.8 p -178.58 43.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 112.59 -2.096 . . . . 0.0 109.794 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.501 ' HB2' HE22 ' A' ' 55' ' ' GLN . 33.0 t -175.21 96.91 0.08 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.406 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 68.0 mtt85 55.8 3.56 0.09 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 113.249 -1.796 . . . . 0.0 113.633 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.593 ' HA ' ' HG ' ' A' ' 88' ' ' SER . 27.0 m120 63.96 28.9 14.51 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.797 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 94' ' ' GLN . 24.8 pt20 -113.38 103.64 11.5 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.011 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.466 ' O ' ' OE1' ' A' ' 94' ' ' GLN . 5.9 tm0? 37.54 91.87 0.01 OUTLIER 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.427 -2.169 . . . . 0.0 110.793 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 88' ' ' SER . 12.7 mm -149.38 120.93 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.139 173.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.411 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 76.3 m-85 -138.8 139.45 38.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 113.118 -1.855 . . . . 0.0 108.879 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 86.2 mt -89.66 94.05 9.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.04 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' HD3' ' CB ' ' A' ' 29' ' ' ASP . 68.7 mtp85 -92.79 137.32 32.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 111.749 -2.478 . . . . 0.0 109.913 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.603 ' C ' ' H ' ' A' ' 101' ' ' GLU . 16.1 m-20 -48.58 118.75 2.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 112.412 -2.176 . . . . 0.0 109.377 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.538 HG13 HE21 ' A' ' 26' ' ' GLN . 11.0 tt -71.22 27.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 112.76 -2.018 . . . . 0.0 112.193 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.603 ' H ' ' C ' ' A' ' 99' ' ' ASP . 55.2 mm-40 -150.18 114.1 5.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.083 -176.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.443 ' NE2' ' HE ' ' A' ' 27' ' ' ARG . 10.7 mm100 -65.73 -177.97 0.51 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.971 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 104' ' ' PRO . 11.1 p -44.49 138.54 3.75 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.457 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 103' ' ' VAL . 72.5 Cg_exo -41.92 -119.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.728 2.286 . . . . 0.0 114.381 176.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -146.87 74.34 1.34 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 117.609 -1.636 . . . . 0.0 109.968 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -170.02 51.36 0.18 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.461 177.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 40.0 Cg_endo -68.85 124.66 11.69 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.259 1.973 . . . . 0.0 111.407 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.46 ' C ' ' O ' ' A' ' 107' ' ' PRO . 6.2 t -6.21 125.36 0.0 OUTLIER 'General case' 0 C--N 1.348 0.538 0 O-C-N 126.481 2.363 . . . . 0.0 112.394 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -128.27 123.64 34.63 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.87 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.92 121.5 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.913 -1.948 . . . . 0.0 109.624 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.577 ' CD ' ' H ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -81.95 -157.97 0.22 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.761 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.43 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.695 179.769 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 CA-C-O 121.91 0.728 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 2' ' ' ILE . 42.6 pt -147.61 129.14 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 112.981 -1.609 . . . . 0.0 109.75 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 3' ' ' GLU . 12.0 pt-20 -79.28 119.74 22.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.909 -1.95 . . . . 0.0 109.703 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.429 ' O ' ' C ' ' A' ' 5' ' ' LYS . 62.8 mtt -75.54 107.9 7.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.268 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' PRO . 87.9 tttt -37.38 99.06 0.18 Allowed Pre-proline 0 C--N 1.346 0.445 0 CA-C-N 112.86 -1.973 . . . . 0.0 110.726 -176.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 5' ' ' LYS . 58.8 Cg_exo -48.36 -123.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.526 2.151 . . . . 0.0 113.487 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 8' ' ' PRO . 48.9 t60 -147.82 137.4 12.14 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.092 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 7' ' ' HIS . 63.8 Cg_exo -44.79 -121.66 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.522 2.148 . . . . 0.0 114.163 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.69 35.04 3.15 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.265 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -110.97 109.14 19.14 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.894 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 15.7 m-85 -105.82 99.18 8.79 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 117.709 -1.596 . . . . 0.0 109.332 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -66.27 124.59 25.43 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 112.102 -2.317 . . . . 0.0 111.485 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' CA ' ' O ' ' A' ' 36' ' ' GLU . 26.0 pttm 32.39 40.31 0.02 OUTLIER 'General case' 0 C--N 1.344 0.341 0 CA-C-N 111.857 -2.171 . . . . 0.0 111.145 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.502 ' CG1' ' HD2' ' A' ' 18' ' ' LYS . 10.8 tp -68.5 127.31 93.24 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.6 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' ARG . 53.5 Cg_exo -44.98 121.89 3.88 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.753 1.635 . . . . 0.0 113.103 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 15' ' ' PRO . 43.8 ttp180 -36.68 -37.53 0.14 Allowed 'General case' 0 C--N 1.345 0.4 0 CA-C-N 112.811 -1.995 . . . . 0.0 111.178 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' GLU . . . -70.43 -59.06 3.08 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.748 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' HE3' ' SD ' ' A' ' 22' ' ' MET . 7.2 tmtm? -44.69 -49.76 10.27 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.863 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -41.58 -54.3 3.24 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.835 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' SER . 66.0 mt-10 -60.35 -34.69 74.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.214 -2.267 . . . . 0.0 111.548 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' O ' ' OG ' ' A' ' 24' ' ' SER . 61.7 mt-10 -64.41 -70.76 0.21 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 117.182 -1.807 . . . . 0.0 111.05 -171.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.545 ' SD ' ' HE3' ' A' ' 18' ' ' LYS . 26.6 ptm -61.44 -39.17 89.84 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 116.836 -1.945 . . . . 0.0 110.644 -175.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.425 HD21 ' CG1' ' A' ' 54' ' ' VAL . 32.1 tp -61.28 -41.4 96.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 117.805 -1.558 . . . . 0.0 110.5 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 26' ' ' GLN . 75.6 p -64.87 -37.77 88.76 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.593 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 53.9 mttt -70.98 35.9 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.001 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.589 ' H ' ' C ' ' A' ' 24' ' ' SER . 43.0 mm-40 -108.96 135.77 49.6 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 117.981 -1.488 . . . . 0.0 110.003 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' A' ' 28' ' ' HIS . 10.0 mpt_? -91.21 89.96 7.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 111.813 -2.449 . . . . 0.0 109.407 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.496 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER 117.38 121.51 0.0 OUTLIER 'General case' 0 C--N 1.349 0.547 0 CA-C-N 111.561 -2.563 . . . . 0.0 109.277 177.392 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 49' ' ' LYS . 66.7 m-20 -61.01 132.03 52.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.686 -2.052 . . . . 0.0 109.876 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 146.45 -35.14 1.34 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 118.091 -2.004 . . . . 0.0 111.732 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.447 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -43.08 150.85 0.16 Allowed 'General case' 0 C--N 1.349 0.56 0 C-N-CA 118.581 -1.248 . . . . 0.0 109.717 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.424 ' CB ' ' O ' ' A' ' 47' ' ' SER . 44.0 p90 -154.8 160.45 41.28 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 115.157 -2.617 . . . . 0.0 111.84 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.471 HD21 ' CD1' ' A' ' 100' ' ' ILE . 0.4 OUTLIER -116.91 -174.42 2.58 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.534 169.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.6 mt -147.36 103.33 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 111.103 -2.772 . . . . 0.0 107.382 153.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 50.1 ptt85 -97.47 149.34 22.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.054 -169.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 37' ' ' SER . 39.4 tt0 -114.45 142.96 45.7 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 112.021 -2.354 . . . . 0.0 110.024 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' GLU . 35.8 t -53.84 -167.52 0.0 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.783 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' ' OG ' ' A' ' 37' ' ' SER . 39.9 tt0 -98.58 -70.04 0.74 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.109 -1.859 . . . . 0.0 110.37 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.404 ' O ' ' HB1' ' A' ' 40' ' ' ALA . 89.3 p -89.97 30.67 1.04 Allowed 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.948 -173.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 39' ' ' SER . . . -179.46 136.44 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.637 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' C ' ' H ' ' A' ' 43' ' ' ASP . 57.0 Cg_endo -72.29 -143.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.981 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 172.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 -31.76 0.39 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 118.438 -1.839 . . . . 0.0 112.517 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 41' ' ' PRO . 17.5 t70 -90.05 108.74 19.91 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.945 -175.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 23.8 m-85 -133.41 123.08 24.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.544 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' A' ' 59' ' ' VAL . 79.6 p -133.82 128.67 35.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 112.952 -1.931 . . . . 0.0 109.348 177.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.49 HD21 ' CG2' ' A' ' 48' ' ' VAL . 5.5 tt -84.14 116.21 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.693 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 32' ' ' PHE . 50.8 m -93.2 143.17 26.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.965 -1.925 . . . . 0.0 108.932 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.49 ' CG2' HD21 ' A' ' 46' ' ' LEU . 58.2 t -135.05 141.54 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 117.041 -1.864 . . . . 0.0 110.43 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.725 ' HZ3' ' N ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -82.55 97.33 8.4 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.439 -2.164 . . . . 0.0 109.086 176.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.725 ' N ' ' HZ3' ' A' ' 49' ' ' LYS . 9.3 t80 -110.07 139.92 44.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 117.527 -1.669 . . . . 0.0 109.145 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . -46.33 143.01 4.77 Favored Glycine 0 C--N 1.343 0.958 0 C-N-CA 117.322 -2.37 . . . . 0.0 110.399 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 57.0 t30 77.65 -31.17 0.17 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 111.859 -2.17 . . . . 0.0 111.365 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 50' ' ' PHE . 2.8 p30 -174.93 154.31 1.84 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 115.346 -2.542 . . . . 0.0 111.829 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.425 ' CG1' HD21 ' A' ' 23' ' ' LEU . 92.2 t -72.92 125.84 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.459 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.0 tt0 -90.04 163.13 15.02 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.775 -177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -133.37 123.61 25.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 112.622 -2.081 . . . . 0.0 110.6 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.41 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 22.9 m-85 -123.19 144.99 49.0 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 112.816 -1.993 . . . . 0.0 109.403 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -105.89 116.62 32.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.232 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.518 HG21 ' CD1' ' A' ' 80' ' ' LEU . 33.4 t -89.36 101.21 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 112.667 -2.061 . . . . 0.0 108.171 173.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' ARG . 69.4 mt -82.61 152.58 25.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 112.933 -1.94 . . . . 0.0 111.743 -166.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 62' ' ' ASP . 22.6 ptt-85 5.9 -127.65 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 110.272 -3.149 . . . . 0.0 113.298 -172.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.57 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 23.2 t0 170.51 -37.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.759 -160.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 62' ' ' ASP . . . -37.68 -95.68 0.01 OUTLIER Glycine 0 C--N 1.348 1.213 0 CA-C-N 113.855 -1.52 . . . . 0.0 111.163 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.92 -47.11 5.96 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.056 -1.572 . . . . 0.0 109.373 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.78 -6.17 4.77 Favored Glycine 0 CA--C 1.545 1.95 0 CA-C-N 112.746 -2.025 . . . . 0.0 113.375 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.717 ' HZ3' ' HB2' ' A' ' 66' ' ' LYS . 10.3 mtmp? 53.16 -153.73 0.24 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 118.131 -1.428 . . . . 0.0 108.999 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.454 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 76.5 m-85 -97.2 127.49 43.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 117.509 -1.676 . . . . 0.0 108.987 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.499 ' HZ ' HH12 ' A' ' 61' ' ' ARG . 31.1 p90 -157.87 153.6 26.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 116.124 -2.23 . . . . 0.0 110.366 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 mp -95.07 -43.02 8.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.215 -1.812 . . . . 0.0 110.031 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -138.73 -78.12 0.35 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.163 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.9 t -105.46 -85.25 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.584 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.31 131.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 112.823 -1.99 . . . . 0.0 109.874 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.585 ' HB2' ' HZ2' ' A' ' 66' ' ' LYS . 64.0 mttm -102.79 179.91 4.15 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.853 -1.976 . . . . 0.0 110.304 -176.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 67' ' ' TYR . 14.1 m-85 -150.17 133.42 16.35 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 112.693 -2.049 . . . . 0.0 109.28 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.567 ' N ' HD21 ' A' ' 75' ' ' ASN . 0.1 OUTLIER -69.44 -5.46 23.94 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.119 -1.855 . . . . 0.0 113.449 -178.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 49.4 m -167.93 149.21 5.26 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 117.724 -1.591 . . . . 0.0 109.784 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.513 ' CD2' HG13 ' A' ' 59' ' ' VAL . 87.2 mt -45.71 -45.68 14.45 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.202 -1.817 . . . . 0.0 109.831 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -54.07 -41.59 68.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 112.821 -1.991 . . . . 0.0 110.512 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.462 ' HB2' HD22 ' A' ' 75' ' ' ASN . 48.5 tp10 -63.86 -31.87 73.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 116.627 -2.029 . . . . 0.0 110.941 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.575 ' CD2' ' HD1' ' A' ' 84' ' ' HIS . 5.9 tt -63.16 -50.88 68.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 118.522 -1.271 . . . . 0.0 108.4 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 82' ' ' ASP . 87.4 t -54.72 -75.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.673 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.474 ' HA ' ' CD ' ' A' ' 85' ' ' ARG . 33.2 t0 -34.22 -47.49 0.29 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.617 -2.083 . . . . 0.0 111.273 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -71.7 -32.62 68.01 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.863 -172.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.575 ' HD1' ' CD2' ' A' ' 80' ' ' LEU . 35.8 m170 -98.68 -6.73 29.1 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 117.688 -1.605 . . . . 0.0 113.18 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.474 ' CD ' ' HA ' ' A' ' 82' ' ' ASP . 9.0 ptm180 -82.42 39.11 0.58 Allowed 'General case' 0 C--N 1.348 0.533 0 C-N-CA 116.889 -1.924 . . . . 0.0 110.557 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 84' ' ' HIS . 79.9 p -150.0 -73.81 0.17 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.741 -1.572 . . . . 0.0 109.566 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.408 ' N ' ' OG ' ' A' ' 86' ' ' SER . 60.0 p -84.08 38.31 0.65 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 112.966 -1.925 . . . . 0.0 110.961 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.728 ' HG ' ' H ' ' A' ' 95' ' ' ILE . 48.4 t 48.54 -168.97 0.02 OUTLIER 'General case' 0 C--N 1.346 0.425 0 C-N-CA 117.919 -1.512 . . . . 0.0 109.888 177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.505 ' H ' ' HB ' ' A' ' 95' ' ' ILE . 13.6 p -152.51 43.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.439 0 CA-C-N 113.199 -1.818 . . . . 0.0 110.201 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 92' ' ' ASN . 19.2 t 178.59 112.02 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.145 -1.843 . . . . 0.0 108.793 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.428 ' O ' ' CG ' ' A' ' 92' ' ' ASN . 65.8 mtp180 59.8 0.75 0.26 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 117.01 -1.876 . . . . 0.0 112.999 -172.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.515 ' H ' ' C ' ' A' ' 90' ' ' SER . 11.0 p30 50.92 35.36 12.31 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 124.079 0.862 . . . . 0.0 111.796 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 21.3 pt20 -169.95 57.63 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 117.771 -1.571 . . . . 0.0 110.604 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.421 ' OE1' ' CZ ' ' A' ' 50' ' ' PHE . 42.8 tt0 -174.03 -34.35 0.01 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 116.458 -2.097 . . . . 0.0 111.644 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.728 ' H ' ' HG ' ' A' ' 88' ' ' SER . 13.0 mm -102.04 147.49 8.72 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 C-N-CA 117.367 -1.733 . . . . 0.0 110.499 -175.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.577 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 90.5 m-85 -149.99 135.55 18.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.631 -2.077 . . . . 0.0 109.101 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.3 mt -89.89 118.55 29.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 116.958 -1.897 . . . . 0.0 109.553 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 17.4 tpt180 -121.33 147.85 45.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.71 -2.041 . . . . 0.0 110.258 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.594 ' C ' ' H ' ' A' ' 101' ' ' GLU . 67.6 m-20 -61.0 116.21 4.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.431 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.471 ' CD1' HD21 ' A' ' 33' ' ' LEU . 12.0 tt -72.19 32.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.644 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.594 ' H ' ' C ' ' A' ' 99' ' ' ASP . 17.8 mm-40 -150.1 126.86 11.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 117.884 -1.526 . . . . 0.0 109.787 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -64.39 129.32 39.45 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 112.603 -2.089 . . . . 0.0 109.919 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.515 ' C ' ' H ' ' A' ' 105' ' ' GLN . 9.7 p -48.11 137.53 10.99 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 112.87 -1.968 . . . . 0.0 109.418 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 105' ' ' GLN . 51.2 Cg_exo -48.52 -4.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.283 1.989 . . . . 0.0 115.989 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 103' ' ' VAL . 47.9 mt-30 57.8 151.57 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 118.106 -1.438 . . . . 0.0 109.864 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.565 ' H ' ' HD2' ' A' ' 107' ' ' PRO . 2.3 mt-30 -154.02 -57.2 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.983 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.565 ' HD2' ' H ' ' A' ' 106' ' ' GLN . 52.9 Cg_exo -47.11 120.89 4.62 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.665 1.577 . . . . 0.0 113.777 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 107' ' ' PRO . 72.7 m 64.49 113.61 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.214 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 108' ' ' THR . 8.6 t80 179.45 106.06 0.03 OUTLIER 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.436 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 110' ' ' VAL . 11.9 p -170.01 51.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.737 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 111' ' ' GLN . 29.8 pt20 -97.83 121.7 40.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.004 -1.907 . . . . 0.0 109.702 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.445 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.705 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 2' ' ' ILE . . . . . . . . 0 CA--C 1.531 1.047 0 CA-C-O 121.796 0.665 . . . . 0.0 111.977 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.521 HG12 ' SD ' ' A' ' 4' ' ' MET . 14.6 tt 38.69 96.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 112.819 -1.69 . . . . 0.0 110.538 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 104' ' ' PRO . 60.0 mt-10 -66.87 93.4 0.26 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 112.763 -2.017 . . . . 0.0 109.862 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.521 ' SD ' HG12 ' A' ' 2' ' ' ILE . 70.1 mmm -93.11 113.2 25.38 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.841 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' O ' ' CD2' ' A' ' 7' ' ' HIS . 24.9 pttm -177.84 154.58 1.0 Allowed Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 113.134 -1.848 . . . . 0.0 109.419 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 7' ' ' HIS . 53.9 Cg_exo -47.02 118.65 2.88 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.42 2.08 . . . . 0.0 113.895 176.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER 175.97 76.78 0.08 OUTLIER Pre-proline 0 C--N 1.346 0.456 0 CA-C-N 112.915 -1.948 . . . . 0.0 110.269 175.045 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 7' ' ' HIS . 53.3 Cg_exo -44.92 -122.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.524 2.816 . . . . 0.0 113.872 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.15 32.94 3.67 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.473 -177.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -89.63 121.09 31.49 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 117.594 -1.642 . . . . 0.0 109.961 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.9 m-85 -105.28 92.38 4.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 112.962 -1.926 . . . . 0.0 108.598 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -55.82 120.46 19.03 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 112.447 -2.161 . . . . 0.0 111.584 -172.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.481 ' CA ' ' O ' ' A' ' 36' ' ' GLU . 17.4 ptpt 28.77 44.71 0.01 OUTLIER 'General case' 0 C--N 1.346 0.433 0 CA-C-N 111.591 -2.305 . . . . 0.0 111.384 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.8 tp -63.17 131.23 94.68 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.611 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.5 Cg_exo -45.25 121.43 3.75 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.719 1.612 . . . . 0.0 112.886 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.496 ' CB ' ' NH1' ' A' ' 16' ' ' ARG . 22.4 ttm105 -38.78 -40.53 0.63 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.818 -177.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -59.92 3.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 113.47 -1.695 . . . . 0.0 109.627 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 22' ' ' MET . 24.4 tptm -44.65 -51.09 9.46 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 112.917 -1.947 . . . . 0.0 110.182 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -45.49 -47.02 14.11 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 113.456 -1.702 . . . . 0.0 109.842 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' O ' ' OG ' ' A' ' 24' ' ' SER . 88.8 mt-10 -62.65 -46.38 88.47 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.116 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 24' ' ' SER . 40.5 mt-10 -60.82 -77.93 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.693 -2.049 . . . . 0.0 110.644 -173.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 21' ' ' GLU . 2.9 ptm -43.87 -38.78 3.53 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.884 -176.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.456 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 28.4 tp -71.55 -33.17 68.89 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.62 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 26' ' ' GLN . 53.5 m -70.41 -28.01 64.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 117.888 -1.525 . . . . 0.0 111.897 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.72 ' HB3' ' HZ2' ' A' ' 25' ' ' LYS . 5.2 mtpm? -76.98 42.36 0.31 Allowed 'General case' 0 C--N 1.349 0.55 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.314 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.567 HE21 HG13 ' A' ' 100' ' ' ILE . 22.6 mm-40 -112.28 136.11 52.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.224 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.463 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 74.9 mtp85 -38.64 -85.26 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 111.646 -2.525 . . . . 0.0 110.37 -177.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 1.2 m-70 163.27 117.33 0.0 OUTLIER 'General case' 0 C--N 1.348 0.505 0 CA-C-N 112.506 -2.134 . . . . 0.0 107.995 -175.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -166.75 135.68 2.87 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.956 1.703 . . . . 0.0 108.462 -0.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 138.71 -9.98 3.41 Favored Glycine 0 CA--C 1.544 1.896 0 C-N-CA 117.301 -2.38 . . . . 0.0 113.41 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -46.19 144.58 1.93 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 118.372 -1.331 . . . . 0.0 109.142 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' SER . 53.4 p90 -147.76 160.13 43.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 115.868 -2.333 . . . . 0.0 111.424 -174.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.4 pp -149.07 153.07 37.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.001 -2.363 . . . . 0.0 109.29 173.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 45' ' ' SER . 23.0 mt -115.91 112.52 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.785 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.602 ' NH2' ' HG ' ' A' ' 45' ' ' SER . 30.4 ptt-85 -96.71 128.52 43.74 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 112.153 -2.294 . . . . 0.0 110.394 -172.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' O ' ' CA ' ' A' ' 13' ' ' LYS . 2.9 mp0 -79.05 112.32 16.13 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.281 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.472 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 50.5 m -58.52 144.61 41.91 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 112.921 -1.945 . . . . 0.0 110.413 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.8 tp10 -46.28 -96.76 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 112.359 -2.2 . . . . 0.0 110.024 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.1 t -113.58 43.1 1.84 Allowed 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.403 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HB2' ' CB ' ' A' ' 37' ' ' SER . . . -99.05 154.65 37.21 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 113.134 -1.848 . . . . 0.0 108.983 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' ALA . 74.7 Cg_exo -34.82 -110.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.917 2.411 . . . . 0.0 114.54 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -47.7 -59.78 5.82 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 117.333 -2.365 . . . . 0.0 108.352 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -111.47 107.27 16.41 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 113.772 -1.214 . . . . 0.0 108.103 -45.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -90.36 137.36 32.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.128 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.602 ' HG ' ' NH2' ' A' ' 35' ' ' ARG . 27.4 t -133.39 132.35 41.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.621 -2.081 . . . . 0.0 109.335 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tt -103.05 115.93 31.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.953 -1.931 . . . . 0.0 109.319 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 49.8 m -97.41 149.17 22.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.948 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 85.6 t -143.51 140.95 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 113.048 -1.887 . . . . 0.0 109.731 176.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 66.3 tttp -73.06 102.59 3.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 116.64 -2.024 . . . . 0.0 108.931 173.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 50' ' ' PHE . 62.7 t80 -88.29 -8.99 54.31 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.256 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.602 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . 88.54 134.74 4.96 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 118.875 -1.631 . . . . 0.0 109.431 -174.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 7.3 t30 71.91 -33.36 0.27 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 112.307 -1.947 . . . . 0.0 110.826 -174.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.602 ' H ' ' C ' ' A' ' 51' ' ' GLY . 18.5 t70 -159.13 -175.57 5.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 117.416 -1.714 . . . . 0.0 109.436 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.575 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 85.5 t -114.42 121.8 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.701 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.451 ' OE1' ' CZ ' ' A' ' 57' ' ' PHE . 7.3 tt0 -90.69 159.29 16.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.769 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -141.76 143.7 33.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.024 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.522 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 83.5 m-85 -122.3 105.08 9.89 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.697 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.685 ' HZ3' ' HB3' ' A' ' 58' ' ' LYS . 3.1 mmmp? -65.58 105.0 1.11 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.942 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 64.9 t -75.05 96.92 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.274 172.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 88.7 mt -79.41 -161.52 0.33 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.165 -170.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.903 HH11 ' H ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER 93.55 -137.66 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 111.799 -2.455 . . . . 0.0 108.378 -175.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.903 ' H ' HH11 ' A' ' 61' ' ' ARG . 17.7 t70 110.88 -32.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 O-C-N 125.647 1.842 . . . . 0.0 111.252 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.557 ' H ' ' HD2' ' A' ' 61' ' ' ARG . . . -158.99 110.94 0.46 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 116.467 -2.778 . . . . 0.0 112.664 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.723 ' H ' HH21 ' A' ' 61' ' ' ARG . . . 151.81 -71.66 0.0 OUTLIER 'General case' 0 C--N 1.351 0.674 0 CA-C-N 112.238 -1.981 . . . . 0.0 106.467 -174.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.573 ' H ' ' NE ' ' A' ' 61' ' ' ARG . . . -176.8 85.01 0.07 OUTLIER Glycine 0 CA--C 1.54 1.624 0 CA-C-N 112.216 -2.265 . . . . 0.0 112.661 166.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.71 ' H ' ' CZ ' ' A' ' 61' ' ' ARG . 3.4 mtpm? 110.02 -126.98 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.247 -1.476 . . . . 0.0 113.29 153.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 94.0 m-85 -144.02 140.76 29.75 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.539 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -163.75 134.95 4.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 114.768 -2.773 . . . . 0.0 111.884 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.522 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -124.81 162.97 23.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 112.204 -2.271 . . . . 0.0 107.713 163.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.42 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 38.5 m0 64.86 -84.66 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 111.986 -2.37 . . . . 0.0 110.188 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 69' ' ' LEU . 51.6 t -139.16 -92.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 116.902 -1.919 . . . . 0.0 110.428 -173.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -55.28 141.29 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.677 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.419 ' C ' ' CG ' ' A' ' 74' ' ' PHE . 67.7 mttm -76.98 -165.88 0.62 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 112.821 -1.991 . . . . 0.0 109.438 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.419 ' CG ' ' C ' ' A' ' 73' ' ' LYS . 15.3 m-85 -157.06 136.45 12.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.059 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.518 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 2.6 p-10 -65.48 -5.14 7.02 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.076 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 79' ' ' GLU . 80.2 p 178.22 153.72 0.33 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.988 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' CD2' HG13 ' A' ' 59' ' ' VAL . 94.1 mt -45.35 -42.52 10.08 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 117.386 -1.726 . . . . 0.0 110.21 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 14.0 t-20 -58.4 -40.49 82.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.239 -1.8 . . . . 0.0 110.816 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 76' ' ' SER . 43.1 tp10 -63.18 -30.11 71.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 116.644 -2.022 . . . . 0.0 111.237 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.453 HD12 ' CG ' ' A' ' 69' ' ' LEU . 5.8 tt -71.42 -59.96 2.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.531 176.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 97.5 t -46.15 -31.99 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 112.618 -2.083 . . . . 0.0 111.501 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 90.2 m-20 -80.06 -42.08 24.41 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.362 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -59.63 -41.08 89.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.591 -1.641 . . . . 0.0 110.449 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.416 ' HD1' ' CD2' ' A' ' 80' ' ' LEU . 33.1 m170 -90.41 39.69 0.98 Allowed 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.54 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 85' ' ' ARG . 62.0 ttt180 -124.45 0.8 8.3 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.876 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -89.91 -45.84 8.95 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.795 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' SER . 9.3 t -170.05 119.21 0.6 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 117.02 -1.872 . . . . 0.0 110.597 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.502 ' HA ' ' H ' ' A' ' 95' ' ' ILE . 43.0 t 66.14 143.89 0.03 OUTLIER 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.689 -2.05 . . . . 0.0 110.963 172.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 90' ' ' SER . 14.0 p -147.74 42.98 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.879 172.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.498 ' CB ' HD11 ' A' ' 95' ' ' ILE . 48.1 t 176.38 113.65 0.02 OUTLIER 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.39 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -59.21 -1.36 0.19 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.121 -1.854 . . . . 0.0 113.101 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 90' ' ' SER . 75.7 m-20 -65.04 -58.15 6.83 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 118.354 -1.338 . . . . 0.0 110.078 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 94' ' ' GLN . 12.2 pt20 -163.53 39.8 0.09 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.658 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 93' ' ' GLN . 26.6 mt-30 62.52 126.84 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.115 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.502 ' H ' ' HA ' ' A' ' 88' ' ' SER . 40.6 mt -143.13 140.88 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.811 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.414 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 16.8 m-30 -111.67 146.45 37.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.524 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.6 mt -90.04 118.93 29.97 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 117.079 -1.848 . . . . 0.0 109.284 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 90.0 mtt-85 -122.23 146.79 46.94 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.905 -1.952 . . . . 0.0 109.97 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 100' ' ' ILE . 33.5 m-20 -57.12 122.63 12.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.759 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.592 ' C ' HE22 ' A' ' 102' ' ' GLN . 14.9 tt -59.74 -136.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 112.739 -2.028 . . . . 0.0 109.391 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.59 ' H ' HG12 ' A' ' 100' ' ' ILE . 81.0 mt-10 -90.02 108.63 19.84 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.777 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.592 HE22 ' C ' ' A' ' 100' ' ' ILE . 9.1 mp0 -108.32 107.98 18.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.517 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.436 ' CB ' ' HD3' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -49.29 -62.78 2.09 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.362 176.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 105' ' ' GLN . 52.4 Cg_exo -44.31 128.65 8.04 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.032 1.821 . . . . 0.0 113.625 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 104' ' ' PRO . 29.2 mt-30 108.65 115.53 0.0 OUTLIER 'General case' 0 C--N 1.345 0.41 0 CA-C-N 112.114 -2.312 . . . . 0.0 109.961 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.414 ' NE2' ' O ' ' A' ' 105' ' ' GLN . 92.4 mm-40 -128.0 151.57 76.08 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 112.519 -2.128 . . . . 0.0 109.302 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.471 ' O ' ' OG1' ' A' ' 108' ' ' THR . 53.4 Cg_endo -69.25 -138.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.629 2.219 . . . . 0.0 109.9 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 90.5 m -167.78 125.12 1.16 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 113.391 -1.731 . . . . 0.0 109.769 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 109' ' ' TYR . 8.5 t80 -166.76 44.7 0.06 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 112.902 -1.954 . . . . 0.0 109.955 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.36 122.01 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.783 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -48.14 120.6 3.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 112.922 -1.945 . . . . 0.0 109.705 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.444 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.689 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.972 0 CA-C-O 121.954 0.752 . . . . 0.0 111.995 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 3' ' ' GLU . 2.4 mp -62.9 92.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 112.974 -1.613 . . . . 0.0 109.209 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 2' ' ' ILE . 25.0 pt-20 34.59 56.13 0.69 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.835 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.412 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 14.9 tpt -116.17 54.25 0.84 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.917 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.555 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 41.3 tttm 174.02 -69.99 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.229 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 5' ' ' LYS . 35.7 Cg_endo -66.85 118.66 5.72 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.818 1.679 . . . . 0.0 111.301 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.555 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 59.0 t-80 -177.08 -44.19 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 113.077 -1.874 . . . . 0.0 112.073 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.555 ' HD2' ' H ' ' A' ' 7' ' ' HIS . 50.9 Cg_exo -50.33 -122.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 121.519 1.479 . . . . 0.0 114.166 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.438 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 4.6 p-90 -161.34 31.19 0.14 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.653 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.438 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 96.5 m-85 -103.11 120.23 40.31 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.013 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 12' ' ' GLY . 8.1 m-85 -108.51 108.58 19.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.746 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -16.7 -111.57 0.0 OUTLIER Glycine 0 C--N 1.349 1.259 0 CA-C-N 111.67 -2.514 . . . . 0.0 113.016 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -116.12 43.07 2.23 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 112.978 -1.611 . . . . 0.0 109.88 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.521 HD12 ' CD ' ' A' ' 18' ' ' LYS . 10.9 tp -53.12 114.46 6.01 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.315 -178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' ARG . 47.2 Cg_exo -50.15 125.84 15.83 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.581 1.52 . . . . 0.0 111.869 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.714 ' HB3' HH12 ' A' ' 35' ' ' ARG . 18.3 ptp180 -34.7 -38.14 0.07 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.481 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -69.52 -62.44 1.38 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.455 -1.702 . . . . 0.0 109.74 178.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.649 ' HZ2' ' H ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -38.22 -44.43 0.86 Allowed 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.219 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -54.38 -59.88 4.09 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 112.735 -2.029 . . . . 0.0 109.459 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' OG ' ' A' ' 24' ' ' SER . 89.3 mt-10 -43.26 -43.65 4.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 112.795 -2.002 . . . . 0.0 110.263 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 24' ' ' SER . 38.5 mt-10 -60.6 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.443 -175.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.649 ' H ' ' HZ2' ' A' ' 18' ' ' LYS . 17.3 ptm -43.28 -40.31 3.44 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.794 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.602 ' C ' ' H ' ' A' ' 25' ' ' LYS . 31.8 tp -64.71 -36.74 85.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.132 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.51 ' OG ' ' CG2' ' A' ' 54' ' ' VAL . 63.2 m -73.23 28.71 0.06 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 117.368 -1.733 . . . . 0.0 111.656 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.602 ' H ' ' C ' ' A' ' 23' ' ' LEU . 53.1 mtpt -135.03 46.21 2.45 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.198 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.548 HE21 HG13 ' A' ' 100' ' ' ILE . 17.6 mm-40 -119.77 117.56 28.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 112.877 -1.965 . . . . 0.0 109.926 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 31.8 tpt85 -98.56 30.95 3.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 111.453 -2.612 . . . . 0.0 112.327 -169.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 29' ' ' ASP . 73.4 m80 -149.39 11.84 0.8 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 116.019 -2.273 . . . . 0.0 113.593 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' HIS . 7.6 t70 58.77 141.9 0.01 OUTLIER 'General case' 0 C--N 1.347 0.474 0 CA-C-O 122.155 0.979 . . . . 0.0 110.79 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.25 -21.82 43.76 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 117.749 -2.167 . . . . 0.0 112.932 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.517 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -42.58 117.46 1.03 Allowed 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.774 -1.17 . . . . 0.0 109.748 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.461 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 29.6 p90 -130.9 158.87 39.06 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 116.399 -2.121 . . . . 0.0 111.632 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -151.87 153.53 34.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 112.618 -2.083 . . . . 0.0 109.753 172.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.536 HD12 ' CD1' ' A' ' 77' ' ' LEU . 15.6 mt -121.46 113.39 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.639 -2.073 . . . . 0.0 108.793 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.714 HH12 ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -84.57 131.16 34.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 115.423 -2.511 . . . . 0.0 110.156 -175.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.9 tp10 -72.27 69.53 0.8 Allowed 'General case' 0 C--N 1.346 0.42 0 CA-C-N 112.744 -2.025 . . . . 0.0 109.401 176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.585 ' HG ' ' HA ' ' A' ' 41' ' ' PRO . 60.0 p 24.7 -147.61 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 112.158 -2.292 . . . . 0.0 111.791 -177.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -130.58 -70.56 0.61 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 112.999 -1.909 . . . . 0.0 109.021 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.1 t -134.87 43.85 2.68 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 112.435 -2.166 . . . . 0.0 109.677 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.444 ' HB1' ' CA ' ' A' ' 41' ' ' PRO . . . -80.18 -65.14 0.29 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.471 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.585 ' HA ' ' HG ' ' A' ' 37' ' ' SER . 84.2 Cg_endo -93.02 -2.11 49.82 Favored 'Cis proline' 0 C--N 1.357 0.978 0 N-CA-C 114.903 1.078 . . . . 0.0 114.903 -4.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.5 55.35 4.41 Favored Glycine 0 C--N 1.346 1.111 0 C-N-CA 119.052 -1.546 . . . . 0.0 111.493 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 49.3 m-20 -130.35 94.63 3.71 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 117.675 -1.61 . . . . 0.0 109.676 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -110.64 127.29 55.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 112.931 -1.94 . . . . 0.0 109.698 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.669 ' HG ' ' CD ' ' A' ' 35' ' ' ARG . 20.4 p -125.17 132.34 53.06 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.25 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.411 HD22 ' O ' ' A' ' 47' ' ' SER . 5.4 tt -91.68 113.95 26.35 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.099 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.9 m -95.33 153.0 17.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.159 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.4 t -153.12 135.92 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 117.167 -1.813 . . . . 0.0 110.11 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.494 ' HZ1' ' H ' ' A' ' 26' ' ' GLN . 89.0 tttt -83.32 106.94 15.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 112.946 -1.933 . . . . 0.0 108.645 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -75.22 -79.44 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.57 -176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.3 -75.94 0.44 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-N 111.796 -2.456 . . . . 0.0 109.871 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.64 -24.35 9.26 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 112.107 -2.046 . . . . 0.0 111.99 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -111.6 156.78 21.26 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 118.464 -1.294 . . . . 0.0 110.115 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' CG2' ' OG ' ' A' ' 24' ' ' SER . 99.1 t -83.44 105.27 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 112.683 -2.053 . . . . 0.0 109.952 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 56' ' ' HIS . 1.0 OUTLIER -96.98 145.71 25.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.081 176.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.471 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 44.4 p-80 -134.0 168.62 18.47 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.044 -171.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.455 ' CZ ' ' OE1' ' A' ' 55' ' ' GLN . 85.3 m-85 -139.02 112.13 7.99 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 112.142 -2.299 . . . . 0.0 109.208 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 37.4 mtmm -77.74 108.93 11.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 116.203 -2.199 . . . . 0.0 109.771 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.518 HG23 ' CD1' ' A' ' 77' ' ' LEU . 89.6 t -74.68 89.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.71 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 55.2 mt -81.39 152.35 27.5 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 112.61 -2.086 . . . . 0.0 109.664 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.578 ' HG2' ' H ' ' A' ' 62' ' ' ASP . 10.7 ttt180 -90.06 -142.25 0.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.76 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.578 ' H ' ' HG2' ' A' ' 61' ' ' ARG . 9.7 t70 -168.55 -30.18 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 117.408 -1.717 . . . . 0.0 111.763 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' CZ ' ' A' ' 61' ' ' ARG . . . 106.63 -47.22 1.07 Allowed Glycine 0 C--N 1.346 1.129 0 C-N-CA 118.334 -1.889 . . . . 0.0 109.563 -174.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.98 -40.76 1.67 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.421 -1.889 . . . . 0.0 110.16 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.51 ' CA ' ' HD2' ' A' ' 73' ' ' LYS . . . -66.78 -12.74 60.11 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 118.639 -1.743 . . . . 0.0 113.545 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HZ1' ' HA ' ' A' ' 75' ' ' ASN . 4.6 mtpm? 79.41 -140.22 0.02 OUTLIER 'General case' 0 C--N 1.35 0.594 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.911 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 87.8 m-85 -106.33 134.23 49.79 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.335 -177.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -151.79 172.04 16.77 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 116.616 -2.034 . . . . 0.0 110.983 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.479 ' CD1' HD12 ' A' ' 80' ' ' LEU . 5.0 mp -112.17 -91.67 0.48 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 111.833 -2.44 . . . . 0.0 109.498 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -90.15 -40.59 12.13 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.789 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 82.4 t -149.44 -85.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 117.428 -1.709 . . . . 0.0 110.203 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.6 m -49.42 132.45 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.367 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.51 ' HD2' ' CA ' ' A' ' 65' ' ' GLY . 41.0 mtmt -87.5 151.0 23.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 112.238 -2.255 . . . . 0.0 109.963 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -125.71 141.72 51.87 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 112.557 -2.11 . . . . 0.0 108.603 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.71 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 1.7 p-10 -56.78 -33.64 66.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 116.856 -1.937 . . . . 0.0 111.126 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 69.0 m -170.67 170.47 6.67 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 118.465 -1.294 . . . . 0.0 109.451 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.536 ' CD1' HD12 ' A' ' 34' ' ' ILE . 3.7 mm? -39.8 -46.93 2.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.355 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 76' ' ' SER . 6.0 p-10 -52.35 -50.55 62.13 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 114.798 -2.761 . . . . 0.0 110.284 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 6.6 tp10 -64.08 -15.85 60.47 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 116.502 -2.079 . . . . 0.0 112.392 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.479 HD12 ' CD1' ' A' ' 69' ' ' LEU . 5.0 tt -83.04 -70.55 0.55 Allowed 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.42 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.0 t -35.87 -37.7 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 112.051 -2.34 . . . . 0.0 111.146 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 84' ' ' HIS . 25.1 t0 -70.81 -50.83 31.31 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.898 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 84' ' ' HIS . 16.3 m-30 -78.32 42.07 0.41 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.602 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.601 ' C ' ' H ' ' A' ' 86' ' ' SER . 58.8 m80 -152.44 -21.26 0.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.275 -1.784 . . . . 0.0 112.362 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 85' ' ' ARG . 11.7 ptp85 -75.08 38.84 0.13 Allowed 'General case' 0 C--N 1.348 0.543 0 C-N-CA 117.232 -1.787 . . . . 0.0 110.701 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.601 ' H ' ' C ' ' A' ' 84' ' ' HIS . 50.4 m -110.84 -45.73 3.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.566 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' SER . 8.9 t -169.95 105.9 0.34 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.173 -1.83 . . . . 0.0 109.991 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.672 ' HG ' ' CA ' ' A' ' 92' ' ' ASN . 39.2 t 54.28 164.33 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.749 -2.023 . . . . 0.0 110.491 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 89' ' ' VAL . 14.7 p -143.93 42.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.381 0 CA-C-N 112.607 -2.088 . . . . 0.0 110.039 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 37.4 t -176.65 -101.03 0.0 OUTLIER 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.607 -1.633 . . . . 0.0 109.979 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 56.8 mmm-85 -88.59 13.04 13.0 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 113.907 -1.497 . . . . 0.0 113.238 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.672 ' CA ' ' HG ' ' A' ' 88' ' ' SER . 22.1 m120 66.27 27.61 10.15 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.01 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -92.45 40.08 1.04 Allowed 'General case' 0 C--N 1.347 0.48 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.695 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 52.64 86.82 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.905 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.524 ' H ' ' HA ' ' A' ' 88' ' ' SER . 58.5 mt -132.75 125.81 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 112.896 -1.956 . . . . 0.0 109.717 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.81 145.84 47.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.844 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 98' ' ' ARG . 89.9 mt -89.95 106.7 18.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.488 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.604 ' HG2' ' H ' ' A' ' 99' ' ' ASP . 47.6 ttt180 -177.16 -159.63 0.05 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.413 -2.176 . . . . 0.0 107.567 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.604 ' H ' ' HG2' ' A' ' 98' ' ' ARG . 53.4 t0 80.35 -34.23 0.13 Allowed 'General case' 0 C--N 1.346 0.424 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.638 161.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.548 HG13 HE21 ' A' ' 26' ' ' GLN . 9.4 tt -69.84 20.61 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 115.886 -2.325 . . . . 0.0 112.92 -171.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 99' ' ' ASP . 75.5 tt0 -139.14 -101.95 0.17 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 117.712 -1.595 . . . . 0.0 109.592 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 40.53 71.58 0.19 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.068 -1.878 . . . . 0.0 110.111 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.533 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -135.51 -63.72 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 112.92 -1.946 . . . . 0.0 110.687 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.533 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 57.7 Cg_endo -80.91 126.53 5.82 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.412 2.074 . . . . 0.0 110.412 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 103' ' ' VAL . 80.3 mt-30 -73.81 141.65 46.19 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-O 121.776 0.798 . . . . 0.0 110.05 3.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.639 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 16.5 mt-30 -81.59 -77.35 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.291 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.639 ' CD ' ' CB ' ' A' ' 106' ' ' GLN . 38.2 Cg_endo -70.53 121.95 8.44 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.633 1.555 . . . . 0.0 111.648 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.1 m -41.32 122.48 1.87 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.415 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -105.52 119.41 39.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.129 -1.85 . . . . 0.0 109.235 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 110' ' ' VAL . 7.9 p -169.24 122.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.821 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.402 ' OE1' ' HB2' ' A' ' 112' ' ' ALA . 13.2 tm0? -71.66 118.71 14.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.949 -1.932 . . . . 0.0 109.309 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.402 ' HB2' ' OE1' ' A' ' 111' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.706 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 CA-C-O 121.908 0.727 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.86 -85.37 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 112.999 -1.601 . . . . 0.0 109.114 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 4' ' ' MET . 67.6 mm-40 -69.48 -168.0 0.15 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.988 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.512 ' CA ' ' HG2' ' A' ' 104' ' ' PRO . 33.4 tpp -34.44 118.98 0.42 Allowed 'General case' 0 C--N 1.344 0.339 0 CA-C-N 111.877 -2.42 . . . . 0.0 111.149 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.563 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 62.5 pttt -56.28 -166.22 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 112.433 -2.167 . . . . 0.0 107.471 173.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 5' ' ' LYS . 73.8 Cg_exo -44.78 119.18 2.19 Favored 'Trans proline' 0 C--N 1.357 0.98 0 CA-C-O 122.338 0.891 . . . . 0.0 112.935 -175.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.522 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 13.2 m170 -49.88 -46.03 80.71 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 111.988 -2.369 . . . . 0.0 113.291 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 7' ' ' HIS . 66.4 Cg_exo -46.1 -118.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.849 1.699 . . . . 0.0 114.708 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.1 36.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.731 -175.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -101.34 125.33 47.96 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.279 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 6.2 m-85 -120.91 114.67 21.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 113.199 -1.818 . . . . 0.0 108.577 175.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -75.91 124.54 7.46 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 112.447 -2.16 . . . . 0.0 111.554 -174.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.508 ' CG ' ' HA ' ' A' ' 38' ' ' GLU . 43.6 mtmt 32.3 45.42 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 111.739 -2.23 . . . . 0.0 111.243 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.45 130.84 81.23 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 113.319 -1.764 . . . . 0.0 108.836 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' ARG . 50.9 Cg_exo -46.04 121.26 4.21 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.618 1.545 . . . . 0.0 112.717 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 15' ' ' PRO . 53.3 ttp180 -40.59 -41.01 1.38 Allowed 'General case' 0 C--N 1.345 0.393 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.627 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -61.46 -68.65 0.3 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.61 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 17' ' ' ALA . 17.1 tppt? -38.5 -47.05 1.24 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.735 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.709 ' HB1' HH21 ' A' ' 35' ' ' ARG . . . -50.41 -65.97 0.47 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.226 -1.806 . . . . 0.0 109.072 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 47.4 mt-10 -42.65 -43.97 4.07 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.492 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 24' ' ' SER . 44.9 mt-10 -64.66 -82.3 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.602 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.412 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 27.0 ptm -47.19 -35.93 8.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.224 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' O ' ' CG ' ' A' ' 26' ' ' GLN . 49.3 tp -67.92 -32.25 72.57 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.571 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 26' ' ' GLN . 38.7 t -74.46 -34.18 63.08 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 117.915 -1.514 . . . . 0.0 111.219 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.7 ' HB3' ' HZ2' ' A' ' 25' ' ' LYS . 5.1 mtpm? -77.86 43.89 0.44 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.928 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.584 ' CG ' ' O ' ' A' ' 23' ' ' LEU . 23.1 mm-40 -114.35 -4.25 13.01 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.266 -1.788 . . . . 0.0 114.068 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 26' ' ' GLN . 10.6 tpp180 34.33 38.74 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.564 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.462 ' C ' ' HD1' ' A' ' 28' ' ' HIS . 1.7 t-80 -158.43 107.45 1.99 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.657 -1.611 . . . . 0.0 109.856 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.6 114.58 3.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.199 -1.818 . . . . 0.0 109.683 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 137.2 -31.96 2.47 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 117.611 -2.233 . . . . 0.0 112.101 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 30' ' ' GLY . . . -40.94 127.85 2.66 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.265 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.5 ' CD1' ' CD2' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -136.36 136.53 39.72 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.931 -1.94 . . . . 0.0 110.097 -177.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.593 ' HG ' ' HG ' ' A' ' 47' ' ' SER . 4.2 pp -128.03 147.97 50.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 111.289 -2.687 . . . . 0.0 108.195 160.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -107.7 104.46 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 113.568 -1.651 . . . . 0.0 108.708 178.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.709 HH21 ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -84.35 127.26 33.88 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.849 -175.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 39.6 tt0 -90.37 130.41 36.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 112.577 -2.101 . . . . 0.0 109.781 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 40' ' ' ALA . 1.6 p -39.95 122.11 1.41 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.414 -1.721 . . . . 0.0 110.257 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HA ' ' CG ' ' A' ' 13' ' ' LYS . 61.1 tt0 -49.55 -54.45 18.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.401 -2.181 . . . . 0.0 110.56 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 p -90.03 -94.59 0.11 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.065 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' O ' ' OG ' ' A' ' 37' ' ' SER . . . -53.76 139.64 50.85 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.04 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 43' ' ' ASP . 66.5 Cg_endo -77.44 -146.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 N-CA-C 106.879 -2.008 . . . . 0.0 106.879 171.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.76 -18.45 0.09 OUTLIER Glycine 0 CA--C 1.542 1.726 0 O-C-N 124.84 1.338 . . . . 0.0 113.794 172.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.595 ' H ' ' C ' ' A' ' 41' ' ' PRO . 70.2 m-20 -126.62 135.16 50.84 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 117.746 -1.582 . . . . 0.0 110.643 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.73 -169.82 2.37 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.285 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' A' ' 59' ' ' VAL . 74.7 p -170.05 137.86 1.63 Allowed 'General case' 0 C--N 1.345 0.408 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.465 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.509 HD23 ' CG2' ' A' ' 48' ' ' VAL . 2.6 tt -98.22 113.91 25.99 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 112.936 -1.938 . . . . 0.0 110.413 -172.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.593 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 88.8 p -95.24 133.48 39.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.385 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.509 ' CG2' HD23 ' A' ' 46' ' ' LEU . 46.9 t -135.28 147.93 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 117.496 -1.682 . . . . 0.0 109.299 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -83.79 100.69 11.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 115.914 -2.314 . . . . 0.0 108.955 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 53' ' ' ASP . 6.6 t80 -119.46 103.07 9.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.79 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -26.56 141.3 0.01 OUTLIER Glycine 0 C--N 1.348 1.227 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.942 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.576 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 87.6 m-20 104.68 -52.89 0.0 OUTLIER 'General case' 0 C--N 1.345 0.403 0 CA-C-N 111.356 -2.422 . . . . 0.0 108.111 -165.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.599 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 16.9 t70 -177.75 -173.23 0.39 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 111.584 -2.553 . . . . 0.0 109.799 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.599 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 77.9 t -88.9 119.54 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 113.112 -1.858 . . . . 0.0 109.442 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.421 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.1 tt0 -92.08 159.51 15.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.204 -1.816 . . . . 0.0 109.827 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 28.9 p80 -147.62 134.85 20.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.955 -174.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.421 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 83.3 m-85 -127.21 111.26 13.75 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 112.629 -2.078 . . . . 0.0 109.229 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -58.52 122.16 12.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 116.811 -1.955 . . . . 0.0 109.549 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.519 HG11 ' CD1' ' A' ' 80' ' ' LEU . 67.1 t -94.2 87.43 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 112.797 -2.002 . . . . 0.0 108.624 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.6 mt -89.17 159.34 17.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.393 -2.185 . . . . 0.0 110.855 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -86.79 167.7 14.16 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 112.55 -2.114 . . . . 0.0 109.484 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 63' ' ' GLY . 36.3 t70 -110.78 42.39 1.61 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.294 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 62' ' ' ASP . . . 38.77 34.75 0.29 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 118.192 -1.956 . . . . 0.0 111.725 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.85 -42.94 0.13 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.865 -1.167 . . . . 0.0 109.664 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.699 ' C ' ' HZ2' ' A' ' 66' ' ' LYS . . . 157.27 -30.68 0.53 Allowed Glycine 0 CA--C 1.537 1.445 0 C-N-CA 118.044 -2.027 . . . . 0.0 112.065 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.71 ' N ' ' HZ2' ' A' ' 66' ' ' LYS . 1.2 mmpm? -79.29 136.62 37.08 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 117.667 -1.613 . . . . 0.0 110.172 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -101.97 143.23 32.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 112.195 -2.275 . . . . 0.0 108.513 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 71' ' ' VAL . 52.6 p90 -149.23 -161.64 1.39 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 116.204 -2.198 . . . . 0.0 111.099 -174.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.4 mt -137.28 -37.89 0.62 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 111.677 -2.51 . . . . 0.0 110.545 -176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -112.15 -41.09 4.02 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.508 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 92.6 t -150.01 -79.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 117.183 -1.807 . . . . 0.0 109.689 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 71' ' ' VAL . 20.1 m -162.75 134.96 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.777 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.704 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -170.04 -33.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 114.206 -2.998 . . . . 0.0 112.977 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.5 ' CZ ' ' CD ' ' A' ' 73' ' ' LYS . 2.6 m-85 -112.29 149.07 32.89 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 116.439 -2.104 . . . . 0.0 109.758 -174.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.538 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 27.8 p30 -103.65 19.57 19.61 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.431 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.5 t -179.24 143.8 0.21 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.644 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.401 HD23 ' CD1' ' A' ' 34' ' ' ILE . 82.6 mt -43.02 -46.12 5.41 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.011 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 12.1 m120 -59.17 -38.1 78.93 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.924 -177.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 76' ' ' SER . 61.5 tt0 -70.38 -26.08 63.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 117.111 -1.836 . . . . 0.0 111.689 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.519 ' CD1' HG11 ' A' ' 59' ' ' VAL . 9.1 tt -66.81 -50.36 62.88 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.908 174.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.1 -30.54 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.026 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 84.7 m-20 -70.59 -44.46 67.29 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 118.341 -1.344 . . . . 0.0 110.307 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 2.0 t80 -83.57 29.2 0.53 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 116.366 -2.133 . . . . 0.0 111.989 -177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.604 ' C ' ' H ' ' A' ' 86' ' ' SER . 5.8 m-70 -130.21 -25.7 2.43 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.727 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 16.7 ptm180 -72.92 35.16 0.07 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 118.447 -1.301 . . . . 0.0 111.354 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.604 ' H ' ' C ' ' A' ' 84' ' ' HIS . 50.3 m -150.02 -43.6 0.13 Allowed 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.939 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 88' ' ' SER . 8.7 t -118.13 45.47 1.98 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.871 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.586 ' HG ' ' HA ' ' A' ' 93' ' ' GLN . 87.9 p 51.44 -163.59 0.06 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.811 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.31 -39.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 112.832 -1.986 . . . . 0.0 110.461 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.475 ' H ' HD11 ' A' ' 95' ' ' ILE . 43.3 t -99.4 155.51 17.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.487 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 90' ' ' SER . 9.5 ptp85 -40.15 -42.09 1.4 Allowed 'General case' 0 C--N 1.348 0.5 0 CA-C-N 113.21 -1.813 . . . . 0.0 110.624 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -70.76 93.36 0.94 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.796 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.586 ' HA ' ' HG ' ' A' ' 88' ' ' SER . 6.1 pt20 -69.91 104.98 2.66 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.091 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' A' ' 93' ' ' GLN . 5.9 pt20 175.49 43.41 0.0 OUTLIER 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.627 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.475 HD11 ' H ' ' A' ' 90' ' ' SER . 56.6 mt -131.93 121.23 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.215 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.461 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 83.3 m-85 -114.09 121.94 45.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.186 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 70.6 mt -90.09 104.32 16.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.122 -1.853 . . . . 0.0 110.054 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' ASP . 67.5 ttt-85 -170.53 -116.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 116.601 -2.04 . . . . 0.0 110.546 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' ARG . 10.0 t70 -30.0 112.94 0.09 Allowed 'General case' 0 C--N 1.35 0.59 0 CA-C-N 113.681 -1.6 . . . . 0.0 111.667 -172.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.443 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 15.1 tt -120.41 -39.93 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 112.389 -2.187 . . . . 0.0 111.359 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -150.05 125.84 10.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 112.724 -2.034 . . . . 0.0 109.642 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -127.46 116.7 20.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 113.072 -1.876 . . . . 0.0 109.714 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.543 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -138.72 -62.28 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 113.075 -1.875 . . . . 0.0 110.335 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.543 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 35.6 Cg_exo -50.18 126.83 18.2 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.317 2.011 . . . . 0.0 113.212 173.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 104' ' ' PRO . 88.3 mt-30 104.79 34.46 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 112.071 -2.331 . . . . 0.0 111.101 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.58 ' H ' ' HD2' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -142.92 -57.68 0.02 OUTLIER Pre-proline 0 C--N 1.347 0.499 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.406 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.58 ' HD2' ' H ' ' A' ' 106' ' ' GLN . 50.5 Cg_exo -51.49 118.74 4.67 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.555 1.503 . . . . 0.0 113.427 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.457 ' O ' ' CG ' ' A' ' 109' ' ' TYR . 82.3 m 41.2 91.15 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.857 -1.974 . . . . 0.0 110.531 178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.457 ' CD2' ' O ' ' A' ' 107' ' ' PRO . 47.0 m-85 -158.66 45.78 0.3 Allowed 'General case' 0 C--N 1.345 0.388 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.382 175.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 111' ' ' GLN . 11.1 p -145.53 52.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 113.207 -1.815 . . . . 0.0 109.643 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 110' ' ' VAL . 77.4 mt-30 30.63 99.0 0.0 OUTLIER 'General case' 0 C--N 1.348 0.519 0 CA-C-N 112.516 -2.129 . . . . 0.0 111.367 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.727 179.606 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 111.869 -0.493 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.26 131.33 34.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.821 -0.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -48.83 122.73 6.0 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.588 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' LYS . 9.2 tpt -93.06 95.75 9.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.983 -1.917 . . . . 0.0 109.778 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 4' ' ' MET . 87.4 tttt 60.16 134.2 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.688 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -74.32 120.58 6.32 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.219 1.946 . . . . 0.0 110.58 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 8' ' ' PRO . 58.3 t60 -65.63 131.38 94.76 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 117.045 -1.862 . . . . 0.0 109.498 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 7' ' ' HIS . 53.4 Cg_exo -45.45 -122.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.581 2.187 . . . . 0.0 114.087 176.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.431 ' CZ3' ' CE1' ' A' ' 10' ' ' PHE . 1.6 p-90 -147.15 26.5 1.08 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.125 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.431 ' CE1' ' CZ3' ' A' ' 9' ' ' TRP . 92.8 m-85 -90.6 110.66 21.81 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 118.319 -1.353 . . . . 0.0 109.582 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.0 m-85 -94.96 99.38 11.41 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.184 -1.825 . . . . 0.0 108.446 174.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -70.09 140.47 32.72 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 112.202 -2.272 . . . . 0.0 111.618 -173.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' GLY . 60.4 tttp 27.73 48.24 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.007 -2.097 . . . . 0.0 111.447 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 14' ' ' ILE . 11.0 tp -80.02 124.62 82.91 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 113.227 -1.806 . . . . 0.0 108.961 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' ARG . 50.5 Cg_exo -47.24 122.19 6.18 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.622 1.548 . . . . 0.0 112.815 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.528 ' NH1' ' CG ' ' A' ' 20' ' ' GLU . 1.6 tmt_? -38.28 -42.45 0.7 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 112.922 -1.945 . . . . 0.0 110.401 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -64.62 -58.5 6.16 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.105 -1.862 . . . . 0.0 109.956 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 15' ' ' PRO . 59.1 tptt -42.93 -51.37 5.59 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 113.033 -1.894 . . . . 0.0 110.125 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.744 ' CB ' HH21 ' A' ' 35' ' ' ARG . . . -43.03 -49.31 6.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.829 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.528 ' CG ' ' NH1' ' A' ' 16' ' ' ARG . 57.0 mt-10 -63.89 -44.72 92.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.581 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.473 ' O ' ' OG ' ' A' ' 24' ' ' SER . 34.8 mt-10 -63.3 -78.75 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.811 -1.995 . . . . 0.0 110.759 -171.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.528 ' CE ' ' CD2' ' A' ' 33' ' ' LEU . 22.9 ptt? -46.41 -38.29 8.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.994 -175.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 31.7 tp -69.6 -35.88 75.72 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 117.558 -1.657 . . . . 0.0 111.232 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.569 ' C ' ' H ' ' A' ' 26' ' ' GLN . 92.5 p -62.87 -27.65 69.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 117.674 -1.61 . . . . 0.0 111.73 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 25.1 mtpp -74.23 36.5 0.1 Allowed 'General case' 0 C--N 1.349 0.549 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.972 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.571 HE21 HG13 ' A' ' 100' ' ' ILE . 21.7 mm-40 -112.55 142.43 45.14 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.423 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' HIS . 10.5 mpt_? -92.6 -62.85 1.31 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 112.408 -2.178 . . . . 0.0 109.995 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 27' ' ' ARG . 36.5 m170 -58.42 -154.41 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.61 -177.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -139.59 120.08 14.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.424 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.71 -17.47 3.47 Favored Glycine 0 CA--C 1.542 1.769 0 C-N-CA 117.985 -2.055 . . . . 0.0 113.0 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -46.54 118.22 1.91 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.22 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.489 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 10.3 p90 -132.11 158.67 41.03 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 116.516 -2.074 . . . . 0.0 111.384 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.528 ' CD2' ' CE ' ' A' ' 22' ' ' MET . 4.3 pp -155.61 155.89 34.09 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 111.925 -2.398 . . . . 0.0 108.76 168.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.19 114.34 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 117.254 -1.778 . . . . 0.0 109.247 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.744 HH21 ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -80.5 125.06 29.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.072 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.428 ' C ' ' H ' ' A' ' 38' ' ' GLU . 21.5 pt-20 -116.03 133.35 56.12 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.064 -172.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 38' ' ' GLU . 38.3 t 70.77 -14.11 0.45 Allowed 'General case' 0 C--N 1.346 0.442 0 CA-C-N 111.903 -2.408 . . . . 0.0 113.344 172.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 36' ' ' GLU . 56.1 tt0 -40.32 -35.74 0.46 Allowed 'General case' 0 C--N 1.35 0.623 0 C-N-CA 117.209 -1.797 . . . . 0.0 111.224 174.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 80.4 p -148.75 72.89 1.2 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.083 -1.871 . . . . 0.0 107.976 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -70.57 -165.22 0.04 OUTLIER Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 112.797 -2.001 . . . . 0.0 106.275 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.528 ' HA ' ' CB ' ' A' ' 40' ' ' ALA . 25.4 Cg_endo -63.1 -108.73 0.0 OUTLIER 'Cis proline' 0 C--N 1.353 0.769 0 O-C-N 122.299 0.631 . . . . 0.0 112.472 -0.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.42 74.56 0.87 Allowed Glycine 0 C--N 1.345 1.077 0 C-N-CA 118.952 -1.594 . . . . 0.0 109.906 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.457 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 0.9 OUTLIER -131.54 105.17 7.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.047 -2.077 . . . . 0.0 109.591 -178.038 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 22.0 m-85 -132.83 134.19 44.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.753 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.405 ' OG ' ' HD3' ' A' ' 35' ' ' ARG . 72.0 p -127.62 138.9 52.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 112.981 -1.918 . . . . 0.0 109.389 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.507 ' CD2' HG21 ' A' ' 48' ' ' VAL . 5.4 tt -97.22 117.28 31.06 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.507 -2.133 . . . . 0.0 109.969 -174.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.6 m -96.57 141.65 29.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.242 -1.799 . . . . 0.0 109.839 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.507 HG21 ' CD2' ' A' ' 46' ' ' LEU . 92.4 t -150.8 138.4 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.039 -1.891 . . . . 0.0 110.03 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.525 ' CE ' ' HB2' ' A' ' 26' ' ' GLN . 23.5 ttmm -78.53 109.32 12.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 116.503 -2.079 . . . . 0.0 108.979 171.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CE1' ' OE1' ' A' ' 93' ' ' GLN . 6.6 t80 -77.39 -90.9 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.446 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.61 -77.98 1.39 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 112.502 -2.136 . . . . 0.0 109.974 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -117.17 -24.63 7.42 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 112.288 -1.956 . . . . 0.0 112.13 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.573 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 34.4 t0 -108.34 -178.49 3.62 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 118.029 -1.468 . . . . 0.0 109.868 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.573 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 95.1 t -98.21 117.83 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.899 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -98.27 157.81 15.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 112.874 -1.966 . . . . 0.0 109.428 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.529 ' HD1' ' H ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -146.02 136.88 24.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.421 -175.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -118.59 110.9 17.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.55 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.5 mtmm -62.62 109.48 1.41 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 117.059 -1.856 . . . . 0.0 109.405 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.521 HG13 ' CD2' ' A' ' 77' ' ' LEU . 40.6 t -77.86 92.17 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 116.896 -1.922 . . . . 0.0 107.86 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 61' ' ' ARG . 96.9 mt -73.35 179.73 3.83 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 112.216 -2.265 . . . . 0.0 112.342 -165.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.606 HH21 ' H ' ' A' ' 65' ' ' GLY . 14.7 ptm180 15.16 -144.6 0.0 OUTLIER 'General case' 0 C--N 1.349 0.545 0 CA-C-N 110.04 -3.255 . . . . 0.0 112.409 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 63' ' ' GLY . 16.4 t0 165.36 -33.93 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.829 -167.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 62' ' ' ASP . . . -37.86 -97.62 0.01 OUTLIER Glycine 0 C--N 1.348 1.232 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.529 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 66' ' ' LYS . . . -97.77 -44.35 6.77 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 113.045 -1.578 . . . . 0.0 109.791 -177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.606 ' H ' HH21 ' A' ' 61' ' ' ARG . . . -60.52 -18.79 52.38 Favored Glycine 0 CA--C 1.544 1.846 0 C-N-CA 118.446 -1.835 . . . . 0.0 112.833 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.677 ' HZ1' ' HA ' ' A' ' 75' ' ' ASN . 7.6 mtpm? 66.82 -141.74 0.14 Allowed 'General case' 0 C--N 1.348 0.541 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.411 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 57.0 m-85 -78.37 143.08 37.17 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 113.974 -1.467 . . . . 0.0 109.303 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' O ' ' A' ' 70' ' ' TRP . 2.7 t80 -156.05 135.53 12.38 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 116.075 -2.25 . . . . 0.0 111.016 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.462 ' CG ' HD12 ' A' ' 80' ' ' LEU . 40.2 mt -100.98 -78.54 0.52 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.13 -1.85 . . . . 0.0 109.882 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.456 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 25.7 m0 -123.24 -69.03 0.84 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.116 -1.856 . . . . 0.0 111.607 -169.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.82 -41.96 5.31 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 C-N-CA 117.6 -1.64 . . . . 0.0 111.217 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.459 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 34.4 m -115.24 142.18 29.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.648 -1.615 . . . . 0.0 109.935 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.419 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 10.0 ptpp? -82.21 -169.53 2.45 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.557 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 10.2 m-85 -150.51 136.64 18.55 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.384 -1.726 . . . . 0.0 108.911 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.677 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 23.4 t-20 -91.76 47.55 1.37 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 116.47 -2.092 . . . . 0.0 109.904 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 23.1 p 141.02 143.42 0.0 OUTLIER 'General case' 0 C--N 1.349 0.563 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.041 175.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.521 ' CD2' HG13 ' A' ' 59' ' ' VAL . 98.6 mt -47.75 -44.11 27.79 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 117.171 -1.812 . . . . 0.0 109.647 175.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -57.96 -34.8 70.32 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 113.341 -1.754 . . . . 0.0 111.315 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 46.3 tp10 -62.81 -26.11 68.58 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 116.219 -2.192 . . . . 0.0 111.664 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.462 HD12 ' CG ' ' A' ' 69' ' ' LEU . 8.3 tt -85.66 -57.62 2.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.239 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 85' ' ' ARG . 97.5 t -49.43 -34.31 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 112.397 -2.183 . . . . 0.0 111.117 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 37.6 t70 -70.87 -41.0 71.97 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.627 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.472 ' O ' ' OG1' ' A' ' 87' ' ' THR . 10.3 m-30 -62.33 -54.83 34.84 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 117.32 -1.752 . . . . 0.0 109.43 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 25.0 m170 -62.52 -30.14 71.07 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 113.074 -1.876 . . . . 0.0 111.639 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 84' ' ' HIS . 53.2 tpt85 -37.73 -36.03 0.16 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.304 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.5 p -148.82 42.77 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 117.73 -1.588 . . . . 0.0 110.394 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.588 ' O ' ' CB ' ' A' ' 88' ' ' SER . 93.4 m -132.33 -41.86 0.97 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.507 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.754 ' HG ' ' H ' ' A' ' 95' ' ' ILE . 27.9 t 110.43 145.08 0.0 OUTLIER 'General case' 0 C--N 1.35 0.63 0 O-C-N 125.835 1.959 . . . . 0.0 109.693 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 90' ' ' SER . 3.6 m -92.0 21.91 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.218 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.458 ' OG ' ' OD1' ' A' ' 92' ' ' ASN . 9.2 t 170.18 126.49 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 117.315 -1.754 . . . . 0.0 109.321 -164.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -66.38 -30.76 71.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.836 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.458 ' OD1' ' OG ' ' A' ' 90' ' ' SER . 30.1 p30 -50.87 -29.02 10.77 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 117.676 -1.61 . . . . 0.0 111.827 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.43 ' OE1' ' CE1' ' A' ' 50' ' ' PHE . 6.5 pt20 -170.08 146.91 3.12 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.982 177.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.604 ' HA ' ' HG ' ' A' ' 88' ' ' SER . 4.1 pm0 -70.13 121.57 17.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.282 -1.781 . . . . 0.0 110.005 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.754 ' H ' ' HG ' ' A' ' 88' ' ' SER . 61.5 mt -122.3 117.6 52.68 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.921 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -92.69 142.51 27.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.532 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 95.4 mt -89.95 105.18 17.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.816 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 99' ' ' ASP . 62.2 ttt-85 -175.6 -119.36 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 112.581 -2.1 . . . . 0.0 108.344 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 98' ' ' ARG . 29.2 t70 25.79 48.33 0.01 OUTLIER 'General case' 0 C--N 1.348 0.508 0 O-C-N 125.234 1.584 . . . . 0.0 112.699 172.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.577 HG12 ' H ' ' A' ' 101' ' ' GLU . 7.5 tt -135.07 -146.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 117.503 -1.679 . . . . 0.0 108.991 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.577 ' H ' HG12 ' A' ' 100' ' ' ILE . 40.6 mm-40 -89.96 94.84 9.96 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.473 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -148.76 161.01 42.65 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 113.055 -1.884 . . . . 0.0 109.602 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 104' ' ' PRO . 1.1 t 70.41 151.05 0.13 Allowed Pre-proline 0 C--N 1.346 0.432 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.365 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 103' ' ' VAL . 88.6 Cg_exo -34.55 -119.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.89 3.06 . . . . 0.0 115.018 174.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 104' ' ' PRO . 30.2 pt20 -175.78 137.8 0.35 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 114.76 -2.776 . . . . 0.0 110.738 -169.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.528 ' HB2' ' CD ' ' A' ' 107' ' ' PRO . 36.1 mt-30 -69.95 -65.39 1.14 Allowed Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 112.585 -2.098 . . . . 0.0 111.008 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.574 ' O ' ' CB ' ' A' ' 108' ' ' THR . 12.4 Cg_endo -55.96 123.86 14.86 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 120.964 1.109 . . . . 0.0 111.925 176.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.574 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 1.3 m 146.99 -40.77 0.01 OUTLIER 'General case' 0 C--N 1.347 0.489 0 CA-C-N 112.342 -2.208 . . . . 0.0 109.852 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -58.56 120.86 9.62 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.281 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.54 127.01 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 113.276 -1.783 . . . . 0.0 110.079 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -126.54 122.34 34.85 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 112.857 -1.974 . . . . 0.0 109.342 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.435 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.707 -179.883 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . . . . . . 0 CA--C 1.53 0.973 0 CA-C-O 121.83 0.683 . . . . 0.0 112.019 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 16.1 tt -177.87 136.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 113.037 -1.582 . . . . 0.0 109.736 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.441 ' OE1' ' CG2' ' A' ' 103' ' ' VAL . 11.8 pt-20 -41.1 128.05 2.78 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 112.957 -1.929 . . . . 0.0 110.298 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.404 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 42.6 tpp -94.09 115.36 27.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.041 -1.89 . . . . 0.0 109.385 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' O ' ' CD2' ' A' ' 7' ' ' HIS . 87.6 tttt 60.59 95.47 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.707 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 58.6 Cg_exo -46.34 122.98 6.12 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.501 2.134 . . . . 0.0 113.892 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.456 ' CD2' ' O ' ' A' ' 5' ' ' LYS . 95.1 m-70 -108.58 96.68 20.15 Favored Pre-proline 0 C--N 1.346 0.432 0 CA-C-N 112.834 -1.985 . . . . 0.0 109.209 177.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 57.2 Cg_endo -73.4 -118.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.159 1.906 . . . . 0.0 110.972 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.429 ' CB ' ' CZ ' ' A' ' 32' ' ' PHE . 36.8 p-90 -86.56 7.27 26.91 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.501 -174.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -89.37 111.07 21.83 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 117.322 -1.751 . . . . 0.0 109.879 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 12' ' ' GLY . 33.5 m-85 -112.08 121.73 45.8 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.25 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -56.33 -151.38 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.928 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.567 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -72.8 77.96 1.13 Allowed 'General case' 0 C--N 1.346 0.445 0 C-N-CA 117.153 -1.819 . . . . 0.0 109.618 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.4 ' O ' HG22 ' A' ' 14' ' ' ILE . 10.0 tp -79.1 130.76 68.51 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.247 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.2 Cg_exo -47.4 124.54 9.44 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.984 1.789 . . . . 0.0 113.133 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.824 ' CG ' HH22 ' A' ' 35' ' ' ARG . 69.0 mtp180 -37.33 -42.73 0.5 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.67 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -58.89 -75.46 0.05 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.212 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 17' ' ' ALA . 56.9 tptt -36.64 -36.81 0.12 Allowed 'General case' 0 C--N 1.345 0.379 0 CA-C-N 112.979 -1.919 . . . . 0.0 111.457 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -63.21 -66.5 0.53 Allowed 'General case' 0 C--N 1.347 0.469 0 C-N-CA 117.387 -1.725 . . . . 0.0 109.567 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 63.2 mt-10 -47.98 -54.69 12.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.864 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 24' ' ' SER . 11.4 mm-40 -52.8 -84.41 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.791 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.575 ' C ' ' SD ' ' A' ' 22' ' ' MET . 2.9 ppp? -43.18 -43.78 4.82 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.609 -172.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' N ' ' SD ' ' A' ' 22' ' ' MET . 37.2 tp -66.78 -35.32 79.8 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.998 -1.91 . . . . 0.0 111.475 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.557 ' C ' ' H ' ' A' ' 26' ' ' GLN . 37.4 t -70.47 -40.03 73.89 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 117.796 -1.562 . . . . 0.0 110.484 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.701 ' HB3' ' HZ2' ' A' ' 25' ' ' LYS . 4.7 mtpm? -73.11 35.42 0.08 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.859 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.557 ' H ' ' C ' ' A' ' 24' ' ' SER . 29.5 mm-40 -101.53 153.43 19.73 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 117.108 -1.837 . . . . 0.0 110.837 -174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -72.07 87.73 1.07 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 111.819 -2.446 . . . . 0.0 109.55 -177.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER 69.04 145.9 0.05 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 111.942 -2.39 . . . . 0.0 111.049 170.031 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' HIS . 22.7 t70 -31.94 133.99 0.09 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 111.5 -2.591 . . . . 0.0 111.462 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 96' ' ' PHE . . . 142.02 -41.62 1.2 Allowed Glycine 0 C--N 1.348 1.237 0 C-N-CA 117.665 -2.207 . . . . 0.0 112.198 169.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.517 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -47.49 136.17 10.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 117.533 -1.667 . . . . 0.0 109.512 -176.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.446 ' CB ' HG23 ' A' ' 48' ' ' VAL . 12.6 p90 -143.8 158.08 43.93 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 115.636 -2.426 . . . . 0.0 111.503 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 33' ' ' LEU . 4.6 pp -153.58 146.64 24.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 112.399 -2.182 . . . . 0.0 109.812 170.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 45' ' ' SER . 45.6 mt -108.05 115.56 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 112.562 -2.108 . . . . 0.0 108.549 172.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.824 HH22 ' CG ' ' A' ' 16' ' ' ARG . 10.0 ptm180 -101.74 128.91 47.86 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.57 -2.104 . . . . 0.0 110.865 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 37.8 mt-10 -76.76 144.86 38.95 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.317 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.595 ' HG ' ' C ' ' A' ' 40' ' ' ALA . 96.5 p -59.31 -168.2 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 117.292 -1.763 . . . . 0.0 109.029 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.551 ' HA ' ' HZ3' ' A' ' 13' ' ' LYS . 29.5 tp10 -100.47 -49.13 4.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.433 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.8 t -132.47 64.01 1.61 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.342 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.595 ' C ' ' HG ' ' A' ' 37' ' ' SER . . . 178.49 68.47 0.11 Allowed Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.462 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -64.37 -3.46 6.39 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.137 1.891 . . . . 0.0 115.302 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.86 34.23 5.34 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 118.575 -1.774 . . . . 0.0 111.364 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -150.08 121.96 8.16 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 118.464 -1.295 . . . . 0.0 109.45 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 59' ' ' VAL . 79.2 m-85 -130.75 156.15 45.44 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 113.052 -1.886 . . . . 0.0 109.796 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 77.5 p -141.51 154.07 45.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.231 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.522 ' CD2' HG21 ' A' ' 48' ' ' VAL . 4.9 tt -119.23 114.95 23.21 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 113.504 -1.68 . . . . 0.0 109.595 -177.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -108.62 133.59 52.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.671 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.522 HG21 ' CD2' ' A' ' 46' ' ' LEU . 91.1 t -134.16 133.9 55.52 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.548 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 29' ' ' ASP . 42.3 tptt -55.56 97.11 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 112.785 -2.007 . . . . 0.0 107.719 168.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 48' ' ' VAL . 5.7 t80 -107.97 118.19 36.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 117.74 -1.584 . . . . 0.0 109.858 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.57 -94.65 0.06 OUTLIER Glycine 0 C--N 1.344 1.028 0 C-N-CA 117.971 -2.061 . . . . 0.0 110.323 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -123.06 -26.74 4.31 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.862 -1.669 . . . . 0.0 112.175 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 29.0 t0 -110.04 -174.65 2.54 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 118.022 -1.471 . . . . 0.0 109.663 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.59 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 93.0 t -103.85 122.24 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 113.079 -1.873 . . . . 0.0 109.685 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.419 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.0 tt0 -98.89 162.78 12.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 112.913 -1.949 . . . . 0.0 109.779 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.41 ' CD2' ' C ' ' A' ' 56' ' ' HIS . 6.7 t60 -141.02 133.73 28.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 112.799 -2.0 . . . . 0.0 110.546 -171.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.419 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 85.7 m-85 -137.1 104.06 5.32 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.094 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -63.2 111.74 2.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.159 -1.837 . . . . 0.0 110.088 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.518 HG12 ' CD2' ' A' ' 77' ' ' LEU . 97.6 t -77.33 72.12 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 112.934 -1.939 . . . . 0.0 108.437 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 99.1 mt -76.74 168.36 20.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.521 -2.127 . . . . 0.0 110.335 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.592 ' C ' ' H ' ' A' ' 63' ' ' GLY . 9.3 ptm180 -139.91 -145.3 0.18 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 116.868 -1.933 . . . . 0.0 109.56 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 63' ' ' GLY . 38.2 t70 69.72 -23.47 0.15 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.71 -1.586 . . . . 0.0 112.329 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 61' ' ' ARG . . . -39.25 -56.77 2.25 Favored Glycine 0 C--N 1.35 1.306 0 C-N-CA 118.946 -1.597 . . . . 0.0 110.812 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' CB ' ' HE2' ' A' ' 73' ' ' LYS . . . -142.38 -2.51 1.1 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 113.096 -1.552 . . . . 0.0 112.754 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . 158.98 -25.47 0.35 Allowed Glycine 0 CA--C 1.538 1.476 0 C-N-CA 116.85 -2.595 . . . . 0.0 112.767 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 6.0 mtpm? -151.44 -157.68 0.83 Allowed 'General case' 0 C--N 1.347 0.486 0 C-N-CA 116.543 -2.063 . . . . 0.0 110.828 -175.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 89.7 m-85 -85.31 157.62 20.51 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.259 -168.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.4 ' HE1' ' H ' ' A' ' 63' ' ' GLY . 36.6 p90 -174.99 155.05 1.93 Allowed 'General case' 0 C--N 1.348 0.543 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.34 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.448 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 4.7 mp -92.12 -44.08 9.02 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 116.896 -1.922 . . . . 0.0 109.928 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 13.7 m0 -136.97 -43.09 0.57 Allowed 'General case' 0 C--N 1.346 0.427 0 CA-C-N 113.381 -1.736 . . . . 0.0 110.466 -177.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.3 t -139.62 -84.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.34 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.1 m -49.11 130.75 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 112.904 -1.953 . . . . 0.0 110.106 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.525 ' HE2' ' CB ' ' A' ' 64' ' ' ALA . 56.2 mttp -101.38 148.12 25.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.119 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -117.03 150.13 39.13 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.634 -173.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.479 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 32.7 p-10 -75.37 -19.35 59.62 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.291 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 79' ' ' GLU . 83.3 p -167.37 154.06 8.28 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 118.666 -1.214 . . . . 0.0 109.342 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.518 ' CD2' HG12 ' A' ' 59' ' ' VAL . 90.4 mt -47.26 -43.69 22.35 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.042 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -50.05 -40.15 44.27 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 113.248 -1.796 . . . . 0.0 110.536 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 36.6 tp10 -70.05 -24.01 63.18 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.924 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 77' ' ' LEU . 7.8 tt -69.38 -58.29 4.19 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 117.905 -1.518 . . . . 0.0 108.351 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.6 t -48.8 -19.22 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 112.572 -2.104 . . . . 0.0 112.294 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 64.8 m-20 -90.03 -37.11 14.52 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.453 174.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -50.15 -50.55 48.5 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 116.952 -1.899 . . . . 0.0 108.689 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.543 ' HD1' HD13 ' A' ' 97' ' ' LEU . 57.7 m170 -61.98 -64.3 0.98 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 111.986 -2.37 . . . . 0.0 108.2 168.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 45.0 tpt85 67.79 -65.54 0.24 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 125.804 1.94 . . . . 0.0 108.657 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 84' ' ' HIS . 48.2 t -89.85 -113.27 0.07 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 112.002 -2.363 . . . . 0.0 105.16 156.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 88' ' ' SER . 9.7 t -170.36 -133.97 0.02 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 117.841 -1.543 . . . . 0.0 110.724 169.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 87' ' ' THR . 3.2 m 143.19 -58.98 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.117 -1.856 . . . . 0.0 107.872 -168.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG2' HG13 ' A' ' 95' ' ' ILE . 0.8 OUTLIER 51.44 4.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 112.661 -2.063 . . . . 0.0 113.537 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.598 ' C ' ' H ' ' A' ' 92' ' ' ASN . 22.6 t -159.73 -26.0 0.07 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 117.552 -1.659 . . . . 0.0 112.198 -164.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 90' ' ' SER . 1.2 mpp_? 70.52 -31.33 0.22 Allowed 'General case' 0 C--N 1.351 0.67 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.492 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.598 ' H ' ' C ' ' A' ' 90' ' ' SER . 78.7 m-20 -74.88 -24.64 58.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 118.31 -1.356 . . . . 0.0 112.105 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' O ' ' OE1' ' A' ' 94' ' ' GLN . 17.8 mp0 -141.35 -150.93 0.34 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.474 ' OE1' ' O ' ' A' ' 93' ' ' GLN . 21.5 mm100 -149.5 120.76 7.83 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 116.348 -2.141 . . . . 0.0 109.849 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.594 HG21 ' H ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -91.47 -156.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 112.788 -2.006 . . . . 0.0 108.97 -177.141 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.594 ' H ' HG21 ' A' ' 95' ' ' ILE . 90.6 m-85 -150.07 145.19 26.23 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 113.406 -1.725 . . . . 0.0 109.289 170.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.543 HD13 ' HD1' ' A' ' 84' ' ' HIS . 83.2 mt -113.94 77.93 1.1 Allowed 'General case' 0 C--N 1.346 0.436 0 C-N-CA 117.376 -1.729 . . . . 0.0 109.317 173.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 42.6 mtp180 -154.73 -123.21 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 112.951 -1.931 . . . . 0.0 108.864 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.6 t0 39.13 -117.08 0.21 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.812 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.575 HG12 ' H ' ' A' ' 101' ' ' GLU . 6.8 tt 38.08 -149.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.545 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.99 -171.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.575 ' H ' HG12 ' A' ' 100' ' ' ILE . 79.1 mm-40 -89.94 121.08 31.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.955 -177.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.481 ' CD ' ' H ' ' A' ' 102' ' ' GLN . 0.0 OUTLIER -66.58 143.75 56.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.822 -1.99 . . . . 0.0 109.906 178.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.487 ' CG2' ' HD2' ' A' ' 104' ' ' PRO . 12.3 p -45.4 147.29 1.42 Allowed Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.05 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.487 ' HD2' ' CG2' ' A' ' 103' ' ' VAL . 22.9 Cg_exo -61.26 128.65 25.7 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.333 1.355 . . . . 0.0 113.547 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 104' ' ' PRO . 29.3 mm100 68.66 126.76 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.673 -2.058 . . . . 0.0 110.287 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.476 ' OE1' ' O ' ' A' ' 108' ' ' THR . 11.0 tm0? -77.69 135.64 64.02 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.779 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.41 ' O ' ' HB ' ' A' ' 108' ' ' THR . 36.6 Cg_endo -70.56 120.73 7.33 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.321 2.014 . . . . 0.0 112.215 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.476 ' O ' ' OE1' ' A' ' 106' ' ' GLN . 81.2 m 64.16 129.49 0.02 OUTLIER 'General case' 0 C--N 1.346 0.43 0 CA-C-N 112.821 -1.991 . . . . 0.0 110.158 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 108' ' ' THR . 63.1 t80 64.54 122.34 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 112.835 -1.984 . . . . 0.0 109.926 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 110' ' ' VAL . 12.1 p -165.04 50.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.834 -1.984 . . . . 0.0 109.512 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -122.41 43.04 3.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 112.801 -2.0 . . . . 0.0 110.152 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.424 0 CA-C-N 113.418 -1.719 . . . . 0.0 109.703 -179.859 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' H2 ' ' HA ' ' A' ' 2' ' ' ILE . . . . . . . . 0 CA--C 1.531 1.059 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.442 ' HA ' ' H2 ' ' A' ' 1' ' ' GLY . 2.6 mp -82.79 132.51 31.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 114.37 -0.915 . . . . 0.0 109.548 0.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 3' ' ' GLU . 40.1 tt0 -175.27 77.67 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.723 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.418 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 26.3 ttt -133.53 45.5 2.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.946 177.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.559 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 61.0 pttt 174.82 -35.2 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 112.654 -2.067 . . . . 0.0 113.724 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 50.6 Cg_exo -52.38 -122.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 120.847 1.031 . . . . 0.0 114.6 -174.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.445 ' CD2' ' O ' ' A' ' 7' ' ' HIS . 47.0 p-80 -142.74 118.91 6.76 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 118.111 -1.436 . . . . 0.0 109.593 -178.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 10' ' ' PHE . 64.6 Cg_endo -75.81 -118.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.986 1.791 . . . . 0.0 110.468 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.417 ' CG ' ' CE2' ' A' ' 32' ' ' PHE . 39.9 p-90 -62.85 1.17 0.43 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.557 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' A' ' 8' ' ' PRO . 63.7 t80 -84.0 119.75 25.3 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 117.097 -1.841 . . . . 0.0 109.952 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 12' ' ' GLY . 7.3 m-85 -115.69 121.92 43.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.167 -1.833 . . . . 0.0 107.838 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -57.39 -146.49 0.01 OUTLIER Glycine 0 CA--C 1.531 1.09 0 CA-C-N 112.685 -2.052 . . . . 0.0 110.85 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . 59.2 pttt -74.04 75.45 1.72 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 117.069 -1.853 . . . . 0.0 109.755 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.431 HG21 ' CB ' ' A' ' 35' ' ' ARG . 10.0 tp -85.12 129.33 56.36 Favored Pre-proline 0 N--CA 1.447 -0.591 0 CA-C-N 112.734 -2.03 . . . . 0.0 108.674 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.1 Cg_exo -45.55 120.83 3.52 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.542 1.495 . . . . 0.0 112.465 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 15' ' ' PRO . 61.2 ttt85 -39.49 -39.46 0.7 Allowed 'General case' 0 C--N 1.345 0.37 0 CA-C-N 112.976 -1.92 . . . . 0.0 110.806 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -65.35 -66.54 0.53 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.411 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 17' ' ' ALA . 24.4 tptm -37.12 -38.65 0.21 Allowed 'General case' 0 C--N 1.347 0.475 0 CA-C-N 112.95 -1.932 . . . . 0.0 111.118 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -54.79 -65.98 0.48 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.059 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 24' ' ' SER . 93.6 mt-10 -45.86 -44.02 14.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 112.396 -2.184 . . . . 0.0 110.313 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' OG ' ' A' ' 24' ' ' SER . 66.2 mt-10 -61.81 -78.7 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.719 -172.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.552 ' SD ' HD13 ' A' ' 100' ' ' ILE . 3.8 ppp? -54.39 -37.23 64.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 117.47 -1.692 . . . . 0.0 110.968 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.548 ' N ' ' SD ' ' A' ' 22' ' ' MET . 40.0 tp -69.22 -30.35 68.48 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.89 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.598 ' C ' ' H ' ' A' ' 26' ' ' GLN . 78.2 p -69.67 -29.13 66.51 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 117.326 -1.75 . . . . 0.0 111.407 176.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.703 ' HB3' ' HZ2' ' A' ' 25' ' ' LYS . 5.4 mtpm? -72.38 33.3 0.06 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.133 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.714 HE21 ' CB ' ' A' ' 31' ' ' ALA . 15.0 mm100 -107.52 145.15 33.5 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 117.829 -1.549 . . . . 0.0 109.498 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 28' ' ' HIS . 95.8 mtt180 -75.5 38.23 0.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 112.388 -2.187 . . . . 0.0 110.798 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.58 ' H ' ' C ' ' A' ' 26' ' ' GLN . 0.8 OUTLIER 44.62 89.79 0.01 OUTLIER 'General case' 0 C--N 1.348 0.527 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.541 -178.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 41.9 m-20 -158.06 37.21 0.25 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.092 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.581 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 81.75 -4.62 73.5 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 115.947 -3.025 . . . . 0.0 113.205 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.714 ' CB ' HE21 ' A' ' 26' ' ' GLN . . . -40.55 117.69 0.85 Allowed 'General case' 0 C--N 1.352 0.7 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.705 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.417 ' CE2' ' CG ' ' A' ' 9' ' ' TRP . 23.8 p90 -137.78 154.79 49.53 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 116.5 -2.08 . . . . 0.0 110.943 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.418 ' HG ' ' HG ' ' A' ' 47' ' ' SER . 4.5 pp -152.92 149.02 27.81 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 112.379 -2.191 . . . . 0.0 109.276 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.4 mt -109.51 115.89 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 112.418 -2.174 . . . . 0.0 108.569 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.431 ' CB ' HG21 ' A' ' 14' ' ' ILE . 8.5 ptm180 -99.22 125.48 44.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.678 -2.055 . . . . 0.0 110.422 -174.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 72.7 tt0 -89.62 120.64 31.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.354 -2.203 . . . . 0.0 109.748 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.5 t -46.05 138.36 5.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.887 -1.961 . . . . 0.0 110.026 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HA ' ' CB ' ' A' ' 13' ' ' LYS . 64.8 mt-10 -41.1 -76.53 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.569 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 t -102.09 51.02 0.83 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 112.514 -2.13 . . . . 0.0 110.367 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.35 97.84 0.41 Allowed Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.579 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.445 ' O ' ' CE1' ' A' ' 44' ' ' PHE . 54.2 Cg_endo -75.46 -4.27 15.05 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.744 1.629 . . . . 0.0 115.014 -177.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.67 40.06 2.6 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 118.697 -1.716 . . . . 0.0 110.876 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -145.99 118.4 8.46 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 118.227 -1.389 . . . . 0.0 109.604 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 84.9 m-85 -139.91 157.82 45.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 112.993 -1.912 . . . . 0.0 109.56 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.8 p -156.01 129.22 8.13 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.515 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tt -89.1 113.43 24.57 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 113.105 -1.861 . . . . 0.0 109.711 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.48 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 79.1 p -94.88 149.48 21.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.766 -2.015 . . . . 0.0 109.577 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 73.7 t -146.82 138.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.027 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.511 ' CG ' ' HA ' ' A' ' 28' ' ' HIS . 42.2 tptt -69.12 98.17 0.97 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 112.964 -1.925 . . . . 0.0 109.242 176.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 53' ' ' ASP . 7.2 t80 -115.21 108.98 17.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.934 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -25.97 144.44 0.01 OUTLIER Glycine 0 C--N 1.348 1.207 0 CA-C-N 112.325 -2.216 . . . . 0.0 112.294 -175.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 59.6 t30 86.99 -30.53 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 111.66 -2.27 . . . . 0.0 111.226 -175.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 22.1 t70 -174.68 -170.84 0.51 Allowed 'General case' 0 C--N 1.35 0.622 0 C-N-CA 116.232 -2.187 . . . . 0.0 110.388 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.588 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 86.4 t -102.15 118.68 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.338 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 10.9 tt0 -90.08 158.49 17.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 113.111 -1.859 . . . . 0.0 109.613 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.516 ' HD1' ' H ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -147.63 142.9 27.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.658 -2.065 . . . . 0.0 110.514 -175.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 88.3 m-85 -126.77 101.94 6.83 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.53 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.0 mtmm -60.08 122.68 14.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.908 -1.951 . . . . 0.0 109.594 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.523 HG13 ' CD2' ' A' ' 77' ' ' LEU . 37.1 t -79.89 97.57 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 112.845 -1.979 . . . . 0.0 108.047 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 94.6 mt -91.42 178.79 5.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.183 -165.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.563 ' HG3' ' H ' ' A' ' 62' ' ' ASP . 9.9 tpt180 66.64 -136.12 0.15 Allowed 'General case' 0 C--N 1.347 0.466 0 CA-C-N 111.207 -2.724 . . . . 0.0 109.519 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.563 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 25.5 t70 90.83 113.63 0.03 OUTLIER 'General case' 0 C--N 1.347 0.471 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.567 -178.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.92 -41.57 1.52 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 118.216 -1.945 . . . . 0.0 110.698 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.15 -45.13 1.71 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.34 -1.43 . . . . 0.0 109.509 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.689 ' HA3' ' HZ1' ' A' ' 73' ' ' LYS . . . -113.29 33.9 5.32 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 113.083 -1.871 . . . . 0.0 111.573 177.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.541 ' HZ3' ' HA ' ' A' ' 75' ' ' ASN . 6.0 mtpm? 37.3 -147.56 0.01 OUTLIER 'General case' 0 C--N 1.347 0.458 0 CA-C-N 113.992 -1.104 . . . . 0.0 110.313 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 76.4 m-85 -97.52 134.34 40.89 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 117.881 -1.527 . . . . 0.0 110.342 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -152.17 148.69 27.91 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 116.606 -2.038 . . . . 0.0 110.679 176.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.454 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 5.4 mt -86.06 -49.01 8.12 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 112.773 -2.012 . . . . 0.0 109.456 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 20.7 m0 -133.15 -77.48 0.49 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.852 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.1 t -107.15 -83.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.901 -1.954 . . . . 0.0 109.611 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.3 m -50.8 131.27 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 112.648 -2.069 . . . . 0.0 110.023 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.689 ' HZ1' ' HA3' ' A' ' 65' ' ' GLY . 66.7 mttm -88.93 -169.94 2.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.721 -2.036 . . . . 0.0 109.951 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 73' ' ' LYS . 37.7 m-85 -152.88 135.06 14.91 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.127 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.541 ' HA ' ' HZ3' ' A' ' 66' ' ' LYS . 1.7 m120 -64.12 -16.87 62.74 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.561 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 46.9 m -168.69 160.54 10.71 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.83 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.523 ' CD2' HG13 ' A' ' 59' ' ' VAL . 89.4 mt -45.51 -41.98 10.25 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 117.268 -1.773 . . . . 0.0 110.362 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 52.8 t30 -55.8 -39.34 71.18 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.382 -1.735 . . . . 0.0 110.893 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.4 OUTLIER -67.89 -28.64 67.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 117.347 -1.741 . . . . 0.0 111.452 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.414 ' CG ' HD13 ' A' ' 69' ' ' LEU . 8.6 tt -65.68 -47.37 75.7 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 118.708 -1.197 . . . . 0.0 109.088 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 70.6 t -64.57 -31.25 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 112.756 -2.02 . . . . 0.0 111.594 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 57.0 m-20 -74.57 -42.95 57.84 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.116 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -58.82 -46.05 88.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 117.104 -1.839 . . . . 0.0 109.096 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 85' ' ' ARG . 60.1 m-70 -92.76 32.39 1.25 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.143 -1.844 . . . . 0.0 110.965 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 35.2 ptt-85 -40.24 -35.09 0.37 Allowed 'General case' 0 C--N 1.349 0.568 0 C-N-CA 118.309 -1.356 . . . . 0.0 110.935 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.8 p -89.93 -80.61 0.31 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 117.803 -1.559 . . . . 0.0 108.206 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 95' ' ' ILE . 14.8 t -170.16 -169.97 0.92 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.51 -1.677 . . . . 0.0 109.925 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.57 ' H ' ' CG1' ' A' ' 89' ' ' VAL . 29.3 t -121.25 -96.02 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 112.116 -2.311 . . . . 0.0 107.622 160.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.57 ' CG1' ' H ' ' A' ' 88' ' ' SER . 4.0 m -142.18 41.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.953 1 C-N-CA 133.737 4.815 . . . . 0.0 108.684 -8.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.0 t 162.67 -86.04 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 112.821 -1.99 . . . . 0.0 109.06 -154.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.438 ' O ' ' CG ' ' A' ' 92' ' ' ASN . 85.9 mtt180 -99.94 5.63 45.23 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.171 -1.832 . . . . 0.0 113.352 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER 47.91 27.26 1.11 Allowed 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.02 0.825 . . . . 0.0 112.569 177.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' O ' ' CD ' ' A' ' 94' ' ' GLN . 8.4 pt20 -170.04 31.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 117.296 -1.762 . . . . 0.0 112.009 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' CD ' ' O ' ' A' ' 93' ' ' GLN . 23.1 mm100 -158.44 37.75 0.24 Allowed 'General case' 0 C--N 1.347 0.498 0 C-N-CA 118.218 -1.393 . . . . 0.0 110.661 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 89' ' ' VAL . 5.8 mm -142.97 165.39 15.8 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 117.779 -1.568 . . . . 0.0 109.298 -176.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.581 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 86.1 m-85 -150.07 155.16 39.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.657 -1.611 . . . . 0.0 109.894 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' C ' ' CE1' ' A' ' 32' ' ' PHE . 58.0 mt -116.2 90.92 3.44 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 113.659 -1.61 . . . . 0.0 109.083 169.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 99' ' ' ASP . 71.4 mtp180 -156.47 -147.79 0.2 Allowed 'General case' 0 C--N 1.346 0.446 0 CA-C-N 112.951 -1.932 . . . . 0.0 108.803 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 100' ' ' ILE . 33.7 t0 48.1 -177.87 0.01 OUTLIER 'General case' 0 C--N 1.348 0.506 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.674 172.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.552 HD13 ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER 84.29 6.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 112.93 -1.941 . . . . 0.0 113.967 177.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -150.17 83.29 1.38 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 118.415 -1.314 . . . . 0.0 109.581 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -115.08 99.94 7.8 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.055 -1.884 . . . . 0.0 109.691 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.483 HG21 ' CD ' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -163.64 -65.57 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 113.077 -1.874 . . . . 0.0 110.86 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.483 ' CD ' HG21 ' A' ' 103' ' ' VAL . 20.0 Cg_endo -69.13 122.94 9.79 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.931 1.754 . . . . 0.0 111.921 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 104' ' ' PRO . 70.8 mt-30 95.75 86.95 0.01 OUTLIER 'General case' 0 C--N 1.347 0.477 0 CA-C-N 112.038 -2.346 . . . . 0.0 109.848 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.519 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.7 OUTLIER -170.02 53.84 0.22 Allowed Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 112.81 -1.995 . . . . 0.0 110.991 179.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 44.7 Cg_endo -64.21 -139.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.218 1.946 . . . . 0.0 110.067 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.421 ' H ' ' HB2' ' A' ' 107' ' ' PRO . 4.4 t -144.24 136.96 26.96 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.271 -1.786 . . . . 0.0 109.441 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' A' ' 109' ' ' TYR . 54.9 p90 -93.09 121.49 34.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.638 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.95 122.64 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.788 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -73.66 120.49 19.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.034 -1.893 . . . . 0.0 109.664 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.422 0 CA-C-N 113.004 -1.907 . . . . 0.0 109.719 179.955 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.53 1.013 0 CA-C-O 122.006 0.781 . . . . 0.0 112.008 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 2' ' ' ILE . 8.3 tp -46.37 122.38 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-N 112.911 -1.645 . . . . 0.0 109.641 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.535 ' C ' ' HZ2' ' A' ' 5' ' ' LYS . 23.2 mm-40 -103.6 50.03 0.81 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.828 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 50.5 ttp -122.18 114.93 21.54 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 112.624 -2.08 . . . . 0.0 109.517 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.535 ' HZ2' ' C ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -177.86 153.24 0.92 Allowed Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.3 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -42.66 136.8 4.3 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.828 2.352 . . . . 0.0 112.586 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.414 ' N ' ' HD1' ' A' ' 7' ' ' HIS . 0.4 OUTLIER -87.46 141.64 32.52 Favored Pre-proline 0 C--N 1.351 0.663 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.988 11.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.55 -119.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.53 2.153 . . . . 0.0 108.867 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -83.72 16.34 2.77 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 118.386 -1.326 . . . . 0.0 112.782 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -93.36 125.06 37.77 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.419 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.453 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 83.5 m-85 -130.02 118.33 21.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 117.301 -1.76 . . . . 0.0 110.088 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.535 ' CA ' ' C ' ' A' ' 13' ' ' LYS . . . 137.83 -161.35 25.46 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 115.823 -3.084 . . . . 0.0 112.488 166.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' C ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -57.4 115.8 2.94 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 112.648 -1.776 . . . . 0.0 111.081 0.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.469 ' N ' ' CA ' ' A' ' 12' ' ' GLY . 9.8 tp -106.02 133.77 20.06 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.253 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.3 Cg_exo -46.24 121.75 4.83 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.788 1.659 . . . . 0.0 112.933 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 15' ' ' PRO . 95.0 mtt180 -42.94 -41.18 3.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.479 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -62.8 -61.61 2.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.795 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 17' ' ' ALA . 58.5 tptt -43.02 -44.24 4.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.051 -1.886 . . . . 0.0 110.275 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -48.4 -62.57 1.42 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.148 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 21' ' ' GLU . 46.8 mt-10 -44.95 -65.0 0.59 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.346 -2.206 . . . . 0.0 109.901 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.479 ' O ' ' OG ' ' A' ' 24' ' ' SER . 69.1 mt-10 -37.51 -85.7 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.039 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.513 ' CA ' ' HD3' ' A' ' 25' ' ' LYS . 26.5 ptt? -48.62 -52.39 23.32 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 117.495 -1.682 . . . . 0.0 110.233 -176.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 100' ' ' ILE . 42.0 tp -50.62 -22.92 2.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 117.145 -1.822 . . . . 0.0 112.708 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 21' ' ' GLU . 90.3 p -83.82 -33.13 24.99 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.115 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HD3' ' CA ' ' A' ' 22' ' ' MET . 8.2 pttm -42.29 -25.88 0.09 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 113.538 -1.664 . . . . 0.0 112.018 172.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.412 ' O ' ' HE2' ' A' ' 49' ' ' LYS . 35.5 mm-40 -55.58 161.37 2.07 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.282 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -119.0 -41.95 2.73 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.057 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' HD1' ' N ' ' A' ' 28' ' ' HIS . 0.4 OUTLIER -89.19 107.78 19.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.691 -178.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -47.76 125.51 8.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.505 -2.134 . . . . 0.0 109.728 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 138.5 -29.47 2.59 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 117.35 -2.357 . . . . 0.0 112.485 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.73 138.59 8.24 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 117.829 -1.549 . . . . 0.0 109.181 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.416 ' CE1' ' C ' ' A' ' 97' ' ' LEU . 37.5 p90 -142.94 156.11 44.83 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 116.09 -2.244 . . . . 0.0 111.515 -174.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.516 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -146.93 150.94 36.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.448 -2.16 . . . . 0.0 109.334 169.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.7 mt -111.08 108.16 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 113.025 -1.898 . . . . 0.0 108.577 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.498 ' HE ' ' HG ' ' A' ' 45' ' ' SER . 37.0 ptt180 -92.72 135.8 33.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.67 -2.059 . . . . 0.0 110.805 -172.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.8 pt-20 -91.71 128.38 37.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.694 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 36' ' ' GLU . 49.8 m -54.51 -165.27 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.182 -1.826 . . . . 0.0 109.822 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -81.61 -98.41 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.423 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.4 t -94.24 43.64 1.11 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.015 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.26 94.75 7.6 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 113.227 -1.806 . . . . 0.0 109.448 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.39 -4.79 15.48 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.954 1.769 . . . . 0.0 114.943 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.95 39.45 2.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 118.864 -1.636 . . . . 0.0 110.932 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HB3' ' HG ' ' A' ' 37' ' ' SER . 57.0 t0 -143.38 106.84 4.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 118.264 -1.375 . . . . 0.0 109.652 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 23.4 m-85 -133.85 120.22 20.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.533 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.498 ' HG ' ' HE ' ' A' ' 35' ' ' ARG . 80.3 p -113.6 125.95 54.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.643 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 48' ' ' VAL . 5.4 tt -85.44 117.2 24.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 112.817 -1.992 . . . . 0.0 109.562 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.471 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 49.9 m -94.83 144.52 25.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.533 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.505 HG21 ' CD2' ' A' ' 46' ' ' LEU . 78.6 t -151.57 131.41 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.735 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 66.2 tttp -76.32 106.13 7.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 116.754 -1.979 . . . . 0.0 108.427 174.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -104.37 37.53 2.08 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 113.212 -1.813 . . . . 0.0 111.524 -172.2 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.82 -95.34 0.26 Allowed Glycine 0 C--N 1.346 1.109 0 C-N-CA 117.249 -2.405 . . . . 0.0 110.811 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 52.2 t-20 -107.19 -31.42 8.24 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 112.675 -1.763 . . . . 0.0 111.411 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.595 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 34.2 t70 -120.85 -176.81 3.33 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.499 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.595 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 94.6 t -100.23 122.79 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.2 -175.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.42 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.1 tt0 -97.36 159.53 14.86 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.778 -2.01 . . . . 0.0 109.486 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -139.69 134.98 32.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.748 -2.023 . . . . 0.0 110.522 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.447 ' CZ ' ' O ' ' A' ' 89' ' ' VAL . 97.4 m-85 -123.88 101.56 7.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.409 176.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 55.1 mtmt -58.85 100.25 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 116.59 -2.044 . . . . 0.0 109.612 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.52 HG11 ' CD1' ' A' ' 80' ' ' LEU . 93.6 t -70.33 86.22 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 112.984 -1.917 . . . . 0.0 108.563 174.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 77.2 mt -78.76 163.04 25.71 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.752 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.2 ptm180 -132.42 -154.76 0.64 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.075 -1.875 . . . . 0.0 109.205 173.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -172.97 -37.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.063 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.76 -41.61 2.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 117.79 -2.148 . . . . 0.0 110.599 -176.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.85 53.25 1.1 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.141 -1.53 . . . . 0.0 108.089 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 73' ' ' LYS . . . 150.83 -31.52 1.0 Allowed Glycine 0 CA--C 1.54 1.636 0 CA-C-N 111.82 -2.445 . . . . 0.0 111.351 -168.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 21.8 mtpp 70.93 -151.38 0.09 Allowed 'General case' 0 C--N 1.349 0.573 0 CA-C-N 114.172 -1.014 . . . . 0.0 110.253 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 90.1 m-85 -71.13 147.68 48.16 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.476 -173.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.413 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 17.1 p90 -166.01 167.53 16.45 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.418 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 71' ' ' VAL . 4.7 mp -124.94 97.76 5.4 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.06 173.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.419 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 34.4 m0 73.63 -39.2 0.43 Allowed 'General case' 0 C--N 1.346 0.414 0 CA-C-N 112.774 -2.012 . . . . 0.0 110.786 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.549 ' H ' ' C ' ' A' ' 69' ' ' LEU . 84.5 t -150.04 -85.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 117.56 -1.656 . . . . 0.0 110.549 -174.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 31.0 m -49.33 135.8 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.591 -173.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 74' ' ' PHE . 2.5 mptp? -99.21 -179.25 4.18 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.797 -2.001 . . . . 0.0 111.04 -176.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.435 ' CG ' ' O ' ' A' ' 73' ' ' LYS . 19.4 m-85 -158.63 137.17 10.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 111.74 -2.482 . . . . 0.0 108.842 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 56.6 p30 -62.18 -9.3 7.28 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 113.227 -1.806 . . . . 0.0 112.963 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 79' ' ' GLU . 42.8 t -179.05 152.57 0.57 Allowed 'General case' 0 C--N 1.349 0.555 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.697 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.514 ' CD2' HG12 ' A' ' 59' ' ' VAL . 77.1 mt -43.14 -43.96 4.8 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 113.184 -1.826 . . . . 0.0 110.212 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.567 HD21 ' H ' ' A' ' 78' ' ' ASN . 5.3 m-80 -55.3 -39.52 69.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.918 -1.946 . . . . 0.0 110.791 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 36.0 tt0 -69.36 -35.12 75.55 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 116.882 -1.927 . . . . 0.0 110.812 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.52 ' CD1' HG11 ' A' ' 59' ' ' VAL . 6.5 tt -57.7 -49.09 77.66 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.949 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.6 t -63.58 -40.46 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 112.505 -2.134 . . . . 0.0 110.647 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.43 -44.57 96.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.204 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' O ' HG21 ' A' ' 87' ' ' THR . 4.1 m-85 -63.84 -42.84 97.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.854 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -93.48 41.69 1.09 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 117.684 -1.607 . . . . 0.0 110.294 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -94.54 -41.02 9.56 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.466 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.4 t -101.61 -42.58 6.17 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.279 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 83' ' ' TYR . 12.2 t -70.01 -147.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.441 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 83.6 p -123.81 -151.53 0.48 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.437 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.447 ' O ' ' CZ ' ' A' ' 57' ' ' PHE . 14.9 p -176.18 45.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 113.478 -1.692 . . . . 0.0 109.77 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 92' ' ' ASN . 32.2 t -171.25 -145.74 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.129 -1.85 . . . . 0.0 109.149 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 86.7 mtt180 -63.36 7.81 0.09 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 117.971 -1.492 . . . . 0.0 113.133 177.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 90' ' ' SER . 11.1 m120 64.3 28.33 13.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.824 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -112.3 97.11 6.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.378 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.409 ' O ' HD11 ' A' ' 95' ' ' ILE . 56.6 tp60 43.85 89.66 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 112.925 -1.943 . . . . 0.0 110.031 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.409 HD11 ' O ' ' A' ' 94' ' ' GLN . 14.2 mm -146.28 128.23 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.082 -1.872 . . . . 0.0 109.428 177.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.575 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 88.7 m-85 -149.98 139.58 21.61 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.532 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.416 ' C ' ' CE1' ' A' ' 32' ' ' PHE . 91.8 mt -89.93 94.87 9.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 117.114 -1.835 . . . . 0.0 109.249 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.492 ' NH1' ' CB ' ' A' ' 98' ' ' ARG . 4.4 ptm85 -105.46 149.07 26.5 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.614 -2.085 . . . . 0.0 109.997 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -47.26 119.55 2.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.309 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.516 ' CD1' HD12 ' A' ' 23' ' ' LEU . 12.1 tt -70.06 -41.78 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.846 -1.979 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -120.77 125.21 47.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 112.407 -2.178 . . . . 0.0 110.259 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -134.2 117.95 17.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.068 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.57 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -109.25 -62.72 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 112.909 -1.951 . . . . 0.0 110.25 177.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.57 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 34.2 Cg_exo -48.52 130.55 22.05 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.902 1.735 . . . . 0.0 113.07 174.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 104' ' ' PRO . 8.3 mm100 79.67 55.57 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.407 -2.179 . . . . 0.0 110.23 175.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -69.97 152.58 95.87 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 112.836 -1.984 . . . . 0.0 109.254 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.58 ' O ' ' CB ' ' A' ' 108' ' ' THR . 38.0 Cg_endo -73.58 119.78 6.11 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.286 1.99 . . . . 0.0 111.143 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.58 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 15.1 m 103.96 114.88 0.01 OUTLIER 'General case' 0 C--N 1.348 0.536 0 CA-C-N 112.273 -2.24 . . . . 0.0 109.465 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -48.9 117.11 1.91 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.095 -1.866 . . . . 0.0 109.688 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 110' ' ' VAL . 7.6 p -100.81 122.14 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 112.942 -1.935 . . . . 0.0 109.757 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -94.73 95.81 8.97 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.606 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 0.398 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.185 179.709 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.01 0 CA-C-O 121.919 0.733 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.3 tp -72.7 -39.64 60.54 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-N 113.009 -1.596 . . . . 0.0 110.649 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 4' ' ' MET . 0.9 OUTLIER -95.8 118.87 33.28 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.205 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' GLU . 22.4 ttt -42.85 165.64 0.01 OUTLIER 'General case' 0 C--N 1.346 0.416 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.86 -176.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.718 ' HB3' ' HZ2' ' A' ' 5' ' ' LYS . 7.5 ttpm? -43.82 -49.03 21.06 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.519 -176.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 60.5 Cg_endo -81.19 120.14 3.63 Favored 'Trans proline' 0 C--N 1.358 1.059 0 O-C-N 122.624 0.802 . . . . 0.0 111.262 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.546 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 14.4 t-160 -110.98 -43.72 0.09 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 113.01 -1.905 . . . . 0.0 112.162 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.546 ' CD ' ' H ' ' A' ' 7' ' ' HIS . 53.4 Cg_exo -48.99 -121.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.533 1.489 . . . . 0.0 114.571 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.436 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 3.2 p-90 -152.76 21.63 0.6 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.788 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 71.2 m-85 -90.45 115.3 27.51 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 118.452 -1.299 . . . . 0.0 109.115 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 60.6 m-85 -118.03 103.7 10.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.395 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.64 162.9 31.87 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 114.773 -3.584 . . . . 0.0 112.069 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.715 ' HB3' ' HZ2' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -88.65 110.25 20.8 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 113.155 -1.522 . . . . 0.0 109.059 -6.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.46 HG12 ' CE ' ' A' ' 22' ' ' MET . 10.2 tp -97.96 126.02 41.96 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.523 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.4 Cg_exo -48.36 121.67 6.57 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.661 1.574 . . . . 0.0 112.811 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 15' ' ' PRO . 71.3 ttt180 -38.53 -37.65 0.33 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 113.02 -1.9 . . . . 0.0 111.075 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -68.45 -59.79 2.91 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.635 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 22' ' ' MET . 58.5 tptt -42.01 -42.97 3.01 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.353 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -51.1 -63.46 1.12 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.186 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 24' ' ' SER . 90.3 mt-10 -43.05 -44.77 4.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.576 -2.102 . . . . 0.0 110.236 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 34.1 mt-10 -63.65 -80.59 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 112.907 -1.952 . . . . 0.0 110.588 -173.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.515 ' HE2' ' CD2' ' A' ' 33' ' ' LEU . 25.9 ptt? -48.92 -39.93 28.07 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 113.456 -1.702 . . . . 0.0 110.662 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.471 HD21 ' CG1' ' A' ' 54' ' ' VAL . 38.8 tp -63.97 -32.61 74.21 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 117.726 -1.59 . . . . 0.0 111.474 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 26' ' ' GLN . 44.2 t -68.0 -32.3 72.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 117.662 -1.615 . . . . 0.0 111.267 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -73.15 35.61 0.08 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.111 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.582 ' H ' ' C ' ' A' ' 24' ' ' SER . 12.8 mm100 -105.08 135.46 46.39 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.814 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.445 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 1.6 mpp_? -98.52 33.11 2.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 112.312 -2.222 . . . . 0.0 111.242 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 74.7 m80 -155.47 103.57 2.32 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.219 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.38 103.6 0.11 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.268 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 152.28 -31.45 0.87 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 117.419 -2.324 . . . . 0.0 112.134 -178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.573 ' HB3' HE21 ' A' ' 26' ' ' GLN . . . -46.86 141.39 4.03 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.539 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 98' ' ' ARG . 49.1 p90 -141.89 169.96 16.61 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 116.641 -2.023 . . . . 0.0 110.888 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.516 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -161.31 150.04 16.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.164 -2.289 . . . . 0.0 109.001 167.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.412 ' CG2' ' HB3' ' A' ' 44' ' ' PHE . 49.3 mt -110.11 114.57 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 113.133 -1.849 . . . . 0.0 108.349 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 33.7 ptt85 -90.07 130.48 36.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.041 -170.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -59.9 135.88 57.83 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 111.99 -2.368 . . . . 0.0 109.879 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.814 ' HG ' ' H ' ' A' ' 43' ' ' ASP . 50.0 m -52.35 119.65 4.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.855 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -50.54 -78.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.109 -1.859 . . . . 0.0 109.434 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -127.46 62.32 1.37 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.547 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -152.34 156.82 33.83 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 113.048 -1.887 . . . . 0.0 109.517 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ALA . 64.3 Cg_exo -44.29 -120.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.769 2.313 . . . . 0.0 114.157 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.51 66.26 0.34 Allowed Glycine 0 C--N 1.346 1.128 0 C-N-CA 118.226 -1.94 . . . . 0.0 110.498 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.814 ' H ' ' HG ' ' A' ' 37' ' ' SER . 1.0 OUTLIER -99.43 114.18 26.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.914 -1.643 . . . . 0.0 109.501 178.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.412 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 22.1 m-85 -128.39 124.2 35.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.025 -1.898 . . . . 0.0 109.745 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.2 p -117.99 133.24 56.11 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.007 -1.906 . . . . 0.0 109.662 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.3 tt -94.39 113.92 25.88 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 112.697 -2.047 . . . . 0.0 109.173 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 88.3 p -95.01 148.8 21.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.73 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.8 t -146.4 136.06 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.625 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.446 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 60.6 tttp -80.1 106.79 12.38 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 116.482 -2.087 . . . . 0.0 109.756 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 53' ' ' ASP . 49.1 t80 -126.51 114.91 18.75 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 112.553 -2.112 . . . . 0.0 108.863 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -27.43 144.51 0.01 OUTLIER Glycine 0 C--N 1.349 1.287 0 CA-C-N 112.648 -2.069 . . . . 0.0 111.884 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 74.9 m-20 102.53 -52.86 0.0 OUTLIER 'General case' 0 C--N 1.346 0.439 0 CA-C-N 111.52 -2.34 . . . . 0.0 108.189 -166.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 50' ' ' PHE . 56.3 p30 -179.64 -161.08 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 111.396 -2.638 . . . . 0.0 110.194 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG1' HD21 ' A' ' 23' ' ' LEU . 91.4 t -96.93 124.63 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.703 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -95.86 160.63 14.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.797 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -141.42 143.74 34.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.708 -2.042 . . . . 0.0 110.129 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -128.65 102.39 6.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.744 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -58.4 108.47 0.63 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.99 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.522 HG13 ' CD2' ' A' ' 77' ' ' LEU . 60.7 t -81.38 78.28 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 112.981 -1.918 . . . . 0.0 108.423 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 91.2 mt -83.66 172.49 12.24 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 112.417 -2.174 . . . . 0.0 109.845 -174.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 62' ' ' ASP . 9.1 ptm180 -145.95 -148.74 0.25 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 116.463 -2.095 . . . . 0.0 109.476 172.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 61' ' ' ARG . 24.4 t0 58.72 150.78 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.35 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.26 35.16 0.42 Allowed Glycine 0 CA--C 1.534 1.268 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.712 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.17 -42.18 0.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.045 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 66' ' ' LYS . . . 118.62 62.41 0.29 Allowed Glycine 0 C--N 1.347 1.149 0 C-N-CA 118.548 -1.787 . . . . 0.0 109.54 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.72 ' HZ1' ' N ' ' A' ' 75' ' ' ASN . 8.4 mtmp? 82.82 -150.89 0.01 OUTLIER 'General case' 0 C--N 1.347 0.489 0 CA-C-N 112.307 -1.946 . . . . 0.0 109.272 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 88.5 m-85 -71.93 158.12 36.6 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.723 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 72' ' ' VAL . 55.1 t80 -152.62 156.85 40.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.62 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 70' ' ' TRP . 33.3 tp -124.49 -66.84 0.95 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.449 -2.159 . . . . 0.0 109.826 -169.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.459 ' CD2' ' O ' ' A' ' 69' ' ' LEU . 27.7 m95 -147.09 -37.13 0.22 Allowed 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.101 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.416 ' C ' ' CE2' ' A' ' 68' ' ' PHE . 59.7 t -125.89 -37.59 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.471 0 C-N-CA 117.208 -1.797 . . . . 0.0 111.299 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 33.8 m -130.6 171.81 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 117.463 -1.695 . . . . 0.0 110.155 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.634 ' CD ' ' H ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -98.49 173.9 6.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.026 179.11 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.608 ' C ' ' HZ1' ' A' ' 66' ' ' LYS . 1.3 m-85 -145.6 132.27 19.93 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 117.063 -1.855 . . . . 0.0 109.551 -175.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.72 ' N ' ' HZ1' ' A' ' 66' ' ' LYS . 7.0 p30 -86.66 25.67 1.22 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.617 -2.083 . . . . 0.0 112.214 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.2 t 175.69 130.85 0.04 OUTLIER 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.971 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.522 ' CD2' HG13 ' A' ' 59' ' ' VAL . 85.1 mt -47.71 -41.12 22.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 116.879 -1.929 . . . . 0.0 109.998 174.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 82' ' ' ASP . 39.7 m-80 -60.67 -30.98 70.24 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 113.533 -1.667 . . . . 0.0 111.659 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 83' ' ' TYR . 10.2 tp10 -66.45 -26.39 67.18 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 117.114 -1.835 . . . . 0.0 111.694 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 tt -83.71 -53.12 5.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.384 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.59 -44.76 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 112.644 -2.071 . . . . 0.0 109.711 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 78' ' ' ASN . 25.1 t0 -63.62 -63.67 1.11 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.076 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.434 ' CB ' ' O ' ' A' ' 79' ' ' GLU . 38.7 t80 -48.76 -42.04 34.22 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.445 -176.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -100.15 44.14 1.03 Allowed 'General case' 0 C--N 1.345 0.393 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.088 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -86.08 -40.46 15.71 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.491 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 88' ' ' SER . 39.1 t -112.59 -36.6 5.17 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.73 -1.577 . . . . 0.0 111.048 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 83' ' ' TYR . 8.9 t -77.47 42.79 0.37 Allowed 'General case' 0 C--N 1.346 0.453 0 C-N-CA 118.044 -1.463 . . . . 0.0 110.797 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 86' ' ' SER . 45.0 m 49.93 -149.77 0.24 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.912 170.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.402 ' CG1' HG23 ' A' ' 95' ' ' ILE . 6.4 p -176.9 -41.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.434 0 CA-C-N 113.393 -1.731 . . . . 0.0 110.337 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.5 t -83.32 147.97 27.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.648 -1.614 . . . . 0.0 109.503 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.54 ' H ' ' HD2' ' A' ' 91' ' ' ARG . 2.2 mpt_? -41.26 -42.25 2.09 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.402 -1.726 . . . . 0.0 110.192 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -67.22 96.47 0.47 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 117.097 -1.841 . . . . 0.0 108.369 172.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 86.1 mm-40 -69.88 93.37 0.76 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.746 -175.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.407 ' HB3' ' O ' ' A' ' 93' ' ' GLN . 21.1 pt20 176.81 43.35 0.0 OUTLIER 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.135 -2.302 . . . . 0.0 109.685 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.402 HG23 ' CG1' ' A' ' 89' ' ' VAL . 34.5 mm -114.75 145.68 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.858 -177.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.54 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 65.3 t80 -135.11 132.16 37.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.865 -1.97 . . . . 0.0 109.338 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.01 101.87 14.58 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 117.304 -1.758 . . . . 0.0 109.406 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.767 ' HE ' ' H ' ' A' ' 99' ' ' ASP . 5.1 tpm_? -97.3 151.76 19.57 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 112.602 -2.09 . . . . 0.0 109.976 -176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.767 ' H ' ' HE ' ' A' ' 98' ' ' ARG . 51.8 p-10 -72.59 33.66 0.07 Allowed 'General case' 0 C--N 1.346 0.428 0 CA-C-N 113.073 -1.876 . . . . 0.0 112.196 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.59 ' H ' ' C ' ' A' ' 98' ' ' ARG . 10.8 tt 40.9 -143.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.133 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.586 ' H ' HG12 ' A' ' 100' ' ' ILE . 85.5 mt-10 -92.13 42.64 1.11 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.369 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.408 ' O ' ' HB ' ' A' ' 103' ' ' VAL . 36.6 tp60 -133.19 108.6 8.89 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 117.579 -1.648 . . . . 0.0 109.765 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.542 ' C ' ' H ' ' A' ' 105' ' ' GLN . 7.1 p -179.05 136.64 0.31 Allowed Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 113.127 -1.851 . . . . 0.0 109.775 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 105' ' ' GLN . 42.3 Cg_exo -51.05 1.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.293 1.996 . . . . 0.0 116.296 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.542 ' H ' ' C ' ' A' ' 103' ' ' VAL . 30.0 mm100 -37.02 121.96 0.82 Allowed 'General case' 0 C--N 1.348 0.501 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.749 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -104.61 152.61 39.45 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 112.583 -2.099 . . . . 0.0 109.689 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 108' ' ' THR . 32.1 Cg_endo -68.26 123.72 10.89 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.827 2.351 . . . . 0.0 111.222 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 107' ' ' PRO . 91.5 m -32.59 121.48 0.34 Allowed 'General case' 0 C--N 1.348 0.501 0 CA-C-N 112.623 -2.08 . . . . 0.0 111.12 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.406 ' HB3' ' OE1' ' A' ' 111' ' ' GLN . 83.9 m-85 -56.5 123.9 16.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.784 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 110' ' ' VAL . 7.3 p -109.55 120.7 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.706 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.592 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 4.1 mp0 -125.01 -157.24 0.77 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.304 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.592 ' CB ' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.349 0.554 0 CA-C-N 112.509 -2.132 . . . . 0.0 109.171 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.007 0 CA-C-O 121.887 0.715 . . . . 0.0 112.046 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 2' ' ' ILE . 15.8 tt -165.63 122.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.004 -1.598 . . . . 0.0 109.645 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 3' ' ' GLU . 23.7 pt-20 -105.38 58.78 0.67 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.743 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 5' ' ' LYS . 39.5 ttm -46.08 152.22 0.41 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 112.83 -1.987 . . . . 0.0 109.583 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 4' ' ' MET . 87.7 tttt -40.99 135.22 1.68 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.951 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -44.76 119.98 2.59 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.001 1.801 . . . . 0.0 113.187 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.481 ' O ' ' O ' ' A' ' 8' ' ' PRO . 57.8 t60 -66.14 137.09 95.59 Favored Pre-proline 0 C--N 1.346 0.451 0 CA-C-N 112.959 -1.928 . . . . 0.0 109.159 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 7' ' ' HIS . 77.8 Cg_exo -43.07 -120.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.603 2.202 . . . . 0.0 114.403 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.44 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 2.6 p-90 -154.54 22.6 0.47 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.487 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.44 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 91.2 m-85 -90.48 119.48 30.79 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.843 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.54 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 32.7 m-85 -115.98 89.72 3.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.341 -1.754 . . . . 0.0 108.953 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -36.62 -106.67 0.01 OUTLIER Glycine 0 C--N 1.346 1.108 0 CA-C-N 111.979 -2.373 . . . . 0.0 112.918 -171.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 13' ' ' LYS . 14.7 ptmm? -95.3 67.38 2.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.415 -173.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.432 HG21 ' CB ' ' A' ' 35' ' ' ARG . 6.3 tp -95.87 128.51 37.24 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 116.996 -1.882 . . . . 0.0 107.603 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HG2' ' CB ' ' A' ' 18' ' ' LYS . 20.7 Cg_endo -66.54 -157.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 O-C-N 123.614 1.323 . . . . 0.0 111.496 -172.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.402 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 25.7 ttm180 -94.94 -49.94 5.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.629 -1.623 . . . . 0.0 108.884 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -48.42 -71.68 0.06 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 112.59 -2.096 . . . . 0.0 108.946 174.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' CB ' ' HG2' ' A' ' 15' ' ' PRO . 54.4 tptt -43.51 -56.23 3.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.588 -2.097 . . . . 0.0 110.725 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.39 -44.3 24.24 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 116.701 -2.0 . . . . 0.0 110.093 -178.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.579 ' O ' ' CB ' ' A' ' 24' ' ' SER . 95.1 mt-10 -66.98 -37.39 84.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.042 -1.89 . . . . 0.0 111.264 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 22' ' ' MET . 47.6 mt-10 -67.8 -80.27 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 117.365 -1.734 . . . . 0.0 110.478 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.568 ' CE ' ' CD2' ' A' ' 33' ' ' LEU . 23.6 ptt? -44.34 -39.76 4.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.7 -175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.601 HD23 ' HG ' ' A' ' 47' ' ' SER . 39.4 tp -72.73 -36.64 67.8 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 116.618 -2.033 . . . . 0.0 111.178 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 48.3 t -73.59 29.51 0.07 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 116.971 -1.892 . . . . 0.0 111.735 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.589 ' H ' ' C ' ' A' ' 23' ' ' LEU . 55.4 mtpt -134.88 44.05 2.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.59 177.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 26.5 mm-40 -112.16 144.25 41.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.291 -1.777 . . . . 0.0 110.142 -174.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.506 ' C ' ' H ' ' A' ' 29' ' ' ASP . 87.2 mtt180 -83.97 85.06 7.38 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 112.085 -2.325 . . . . 0.0 110.715 -172.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.406 ' HB3' ' O ' ' A' ' 27' ' ' ARG . 1.8 t-80 80.62 -45.64 0.26 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.199 -2.273 . . . . 0.0 110.904 173.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 27' ' ' ARG . 35.6 m-20 -47.42 166.08 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 111.905 -2.407 . . . . 0.0 108.199 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . 107.73 -39.51 2.86 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.552 1.072 . . . . 0.0 110.582 7.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -68.73 149.03 49.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 118.475 -1.29 . . . . 0.0 109.182 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.419 ' CB ' ' O ' ' A' ' 47' ' ' SER . 41.6 p90 -146.26 162.34 38.31 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 116.475 -2.09 . . . . 0.0 111.033 -172.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.568 ' CD2' ' CE ' ' A' ' 22' ' ' MET . 4.5 pp -149.61 148.85 29.82 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.49 -2.141 . . . . 0.0 109.335 170.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 44' ' ' PHE . 58.2 mt -113.74 111.6 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.651 -2.068 . . . . 0.0 108.444 174.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.432 ' CB ' HG21 ' A' ' 14' ' ' ILE . 11.6 ptm180 -95.85 136.12 36.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.446 -2.161 . . . . 0.0 110.934 -170.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 12' ' ' GLY . 68.6 tt0 -82.6 125.74 31.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.126 -2.306 . . . . 0.0 109.449 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.484 ' HG ' ' HB2' ' A' ' 40' ' ' ALA . 47.7 t -59.22 132.66 54.68 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.762 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -42.27 -42.91 3.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.616 -2.084 . . . . 0.0 110.356 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.409 ' O ' ' HB1' ' A' ' 40' ' ' ALA . 49.1 m -144.98 71.22 1.29 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 113.44 -1.709 . . . . 0.0 110.26 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.484 ' HB2' ' HG ' ' A' ' 37' ' ' SER . . . 179.05 101.35 0.16 Allowed Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 112.898 -1.956 . . . . 0.0 109.113 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.3 -4.07 14.77 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.719 1.613 . . . . 0.0 115.185 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.29 40.2 2.61 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 118.731 -1.7 . . . . 0.0 110.895 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.458 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 9.5 t0 -143.23 106.55 4.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.959 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.521 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 23.2 m-85 -133.96 107.01 7.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.433 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.3 p -104.73 126.55 51.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.906 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.3 tt -90.76 114.9 27.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.318 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.601 ' HG ' HD23 ' A' ' 23' ' ' LEU . 98.2 p -96.97 147.18 24.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.081 -1.872 . . . . 0.0 110.017 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.413 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 60.2 t -145.12 134.49 18.12 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.284 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' ASP . 13.7 tptp -76.31 96.62 4.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 112.654 -2.066 . . . . 0.0 108.417 174.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CZ ' ' CG ' ' A' ' 92' ' ' ASN . 14.4 t80 -71.51 -44.03 65.41 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 117.17 -1.812 . . . . 0.0 110.703 -173.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . -166.92 -69.89 0.03 OUTLIER Glycine 0 CA--C 1.527 0.83 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.265 -177.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -116.28 -25.86 7.39 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 111.927 -2.137 . . . . 0.0 111.816 176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.05 153.63 29.09 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 118.397 -1.321 . . . . 0.0 110.291 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.59 131.28 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 112.41 -2.177 . . . . 0.0 109.569 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.453 ' OE1' ' CZ ' ' A' ' 57' ' ' PHE . 31.8 tt0 -101.51 164.47 11.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.674 -2.057 . . . . 0.0 109.868 -176.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 55' ' ' GLN . 42.1 m80 -150.06 140.54 22.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.007 -1.906 . . . . 0.0 110.723 -176.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.523 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 23.3 m-85 -135.88 111.98 9.66 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.381 173.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 37.9 mtmm -74.5 116.06 14.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 116.886 -1.925 . . . . 0.0 109.837 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.519 HG13 ' CD2' ' A' ' 77' ' ' LEU . 48.2 t -81.47 107.83 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 112.829 -1.987 . . . . 0.0 108.036 173.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 84.9 mt -96.68 162.2 13.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.162 -164.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.588 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 34.9 tpt85 74.46 -132.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 111.129 -2.759 . . . . 0.0 109.829 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 40.2 t0 100.01 88.14 0.01 OUTLIER 'General case' 0 C--N 1.347 0.487 0 O-C-N 125.405 1.69 . . . . 0.0 109.433 -175.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.66 -41.22 0.56 Allowed Glycine 0 CA--C 1.533 1.162 0 C-N-CA 117.905 -2.093 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.415 ' CB ' ' NH2' ' A' ' 61' ' ' ARG . . . -125.84 -48.16 1.65 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.2 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' LYS . . . -104.96 28.21 15.66 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.112 175.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' GLY . 5.8 mtpm? 35.93 -140.29 0.02 OUTLIER 'General case' 0 C--N 1.351 0.655 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.41 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.517 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 26.7 m-85 -95.0 130.52 41.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.975 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 11.9 p90 -149.13 138.14 21.36 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 116.048 -2.261 . . . . 0.0 110.726 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.523 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 9.9 mt -81.33 -45.64 15.88 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 112.425 -2.17 . . . . 0.0 109.563 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -129.13 -86.19 0.55 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.188 -1.823 . . . . 0.0 109.934 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -106.87 -84.48 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.188 -1.824 . . . . 0.0 109.555 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.7 m -50.32 130.27 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.915 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 65' ' ' GLY . 11.4 mptt -81.67 -169.48 2.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 112.819 -1.991 . . . . 0.0 109.93 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -148.13 134.49 19.56 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.421 -2.172 . . . . 0.0 108.7 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.471 ' O ' ' OG ' ' A' ' 76' ' ' SER . 17.9 m-20 -58.16 -22.26 50.59 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.153 -1.839 . . . . 0.0 112.336 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 50.3 m -168.04 161.33 12.61 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.953 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 59' ' ' VAL . 86.3 mt -45.6 -40.88 9.41 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 117.34 -1.744 . . . . 0.0 110.318 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -54.07 -38.25 65.07 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.068 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.4 OUTLIER -69.91 -28.17 65.39 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.51 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.0 tt -67.59 -49.86 61.1 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.819 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.3 -37.03 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 112.538 -2.119 . . . . 0.0 110.86 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 23.4 t70 -71.31 -35.97 71.46 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.145 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -55.29 -46.05 76.22 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 117.845 -1.542 . . . . 0.0 109.746 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 86' ' ' SER . 52.1 t60 -63.79 -9.38 14.31 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.646 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 85' ' ' ARG . 4.1 tpm_? -78.98 46.82 0.72 Allowed 'General case' 0 C--N 1.349 0.567 0 C-N-CA 117.799 -1.56 . . . . 0.0 109.402 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 84' ' ' HIS . 40.4 t -147.15 -41.44 0.18 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.787 -2.006 . . . . 0.0 110.248 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 t -149.16 -146.61 0.2 Allowed 'General case' 0 C--N 1.347 0.488 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.604 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.573 ' HG ' ' HA ' ' A' ' 93' ' ' GLN . 84.7 p -92.42 167.55 11.89 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 113.897 -1.501 . . . . 0.0 109.636 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.491 HG22 ' CB ' ' A' ' 90' ' ' SER . 11.8 m -73.32 -33.12 39.97 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 C-N-CA 117.103 -1.839 . . . . 0.0 111.587 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.491 ' CB ' HG22 ' A' ' 89' ' ' VAL . 13.4 t -149.12 178.87 8.34 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.924 -165.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 90' ' ' SER . 16.5 mmm180 -37.66 -40.82 0.44 Allowed 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.767 -2.015 . . . . 0.0 110.935 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 94' ' ' GLN . 16.3 m-80 -67.88 92.83 0.37 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 117.354 -1.738 . . . . 0.0 109.47 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.573 ' HA ' ' HG ' ' A' ' 88' ' ' SER . 80.7 mt-30 -71.06 75.15 0.66 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.968 -1.923 . . . . 0.0 109.757 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 92' ' ' ASN . 53.7 tp60 -179.71 47.13 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 112.872 -1.967 . . . . 0.0 109.176 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.439 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 68.9 mt -133.0 128.02 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.979 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.406 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 45.2 t80 -127.17 139.83 52.67 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.922 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.7 mt -91.58 105.1 17.49 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.797 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.43 ' CZ ' ' H ' ' A' ' 99' ' ' ASP . 4.1 tpm_? -108.63 158.32 17.7 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.178 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.43 ' H ' ' CZ ' ' A' ' 98' ' ' ARG . 57.8 p30 -60.3 145.38 47.8 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 117.535 -1.666 . . . . 0.0 109.447 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.54 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 7.1 tt -99.45 29.27 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 113.076 -1.874 . . . . 0.0 111.937 -175.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -150.1 115.88 5.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 117.616 -1.633 . . . . 0.0 110.065 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -144.72 117.83 8.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.163 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.451 ' CB ' ' HD3' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -155.24 -63.01 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.787 -178.511 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.456 ' O ' ' CG ' ' A' ' 105' ' ' GLN . 58.6 Cg_exo -43.68 117.18 1.07 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 121.901 1.734 . . . . 0.0 113.686 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 104' ' ' PRO . 88.5 mt-30 -158.91 77.26 0.74 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 112.818 -1.992 . . . . 0.0 109.304 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.628 ' H ' ' CD ' ' A' ' 107' ' ' PRO . 21.0 mt-30 -126.4 -44.48 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 113.066 -1.879 . . . . 0.0 112.339 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.628 ' CD ' ' H ' ' A' ' 106' ' ' GLN . 51.5 Cg_exo -50.56 119.69 5.46 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 120.975 1.117 . . . . 0.0 113.495 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 107' ' ' PRO . 91.3 m 53.95 106.92 0.01 OUTLIER 'General case' 0 C--N 1.346 0.435 0 CA-C-N 112.74 -2.027 . . . . 0.0 109.934 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 108' ' ' THR . 70.3 t80 -179.07 114.76 0.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.99 -1.913 . . . . 0.0 109.57 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.39 123.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 113.146 -1.843 . . . . 0.0 109.971 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -167.12 121.23 1.01 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.014 -1.903 . . . . 0.0 109.714 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.423 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.649 179.791 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.997 0 CA-C-O 121.937 0.743 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 3' ' ' GLU . 48.6 mm -52.0 -41.43 31.6 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 112.926 -1.637 . . . . 0.0 110.357 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 2' ' ' ILE . 40.9 tp10 61.07 121.95 0.01 OUTLIER 'General case' 0 C--N 1.347 0.483 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.604 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.586 ' SD ' ' C ' ' A' ' 4' ' ' MET . 0.2 OUTLIER -80.98 102.15 9.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.066 -1.879 . . . . 0.0 109.604 -178.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 4' ' ' MET . 6.2 pttp 53.27 152.74 0.05 OUTLIER Pre-proline 0 C--N 1.346 0.436 0 CA-C-N 112.428 -2.169 . . . . 0.0 110.959 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.508 ' HB3' ' CD ' ' A' ' 104' ' ' PRO . 39.1 Cg_endo -72.93 122.43 8.13 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.935 2.423 . . . . 0.0 111.605 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -46.21 133.68 7.34 Favored Pre-proline 0 C--N 1.346 0.443 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.092 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.83 -117.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.99 1.793 . . . . 0.0 110.857 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.502 ' CB ' ' CE2' ' A' ' 32' ' ' PHE . 37.7 p-90 -139.08 38.55 2.13 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.709 -174.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -121.91 115.09 21.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 117.812 -1.555 . . . . 0.0 110.162 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.434 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 18.7 m-85 -124.05 108.19 12.1 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.057 176.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -61.33 112.03 4.38 Favored Glycine 0 C--N 1.345 1.075 0 C-N-CA 118.127 -1.987 . . . . 0.0 111.127 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 36' ' ' GLU . 23.3 pttp 25.57 47.29 0.01 OUTLIER 'General case' 0 C--N 1.346 0.414 0 CA-C-N 111.481 -2.359 . . . . 0.0 111.472 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.7 tp -60.21 131.64 89.97 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.928 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.9 Cg_exo -45.52 122.54 4.87 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.742 1.628 . . . . 0.0 112.983 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.562 ' CB ' HH12 ' A' ' 35' ' ' ARG . 53.2 ttp180 -38.86 -41.24 0.72 Allowed 'General case' 0 C--N 1.345 0.388 0 CA-C-N 112.885 -1.961 . . . . 0.0 110.626 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -54.21 -79.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 113.345 -1.752 . . . . 0.0 109.442 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.708 ' HZ3' ' HE3' ' A' ' 22' ' ' MET . 28.1 tptp -37.91 -39.88 0.41 Allowed 'General case' 0 C--N 1.346 0.442 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.969 -177.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.94 -65.76 0.54 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 117.595 -1.642 . . . . 0.0 109.209 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 24' ' ' SER . 46.7 mt-10 -42.77 -41.01 3.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.696 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 22' ' ' MET . 65.5 mt-10 -62.58 -90.56 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 113.567 -1.652 . . . . 0.0 110.758 -173.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.708 ' HE3' ' HZ3' ' A' ' 18' ' ' LYS . 5.6 ptp -42.6 -38.32 1.96 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.995 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 45.6 tp -68.03 -41.92 81.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 117.654 -1.619 . . . . 0.0 110.801 -176.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 26' ' ' GLN . 77.3 p -62.72 -36.91 84.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 117.402 -1.719 . . . . 0.0 110.706 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -69.38 30.73 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.534 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.586 ' H ' ' C ' ' A' ' 24' ' ' SER . 35.2 mm-40 -104.14 142.46 34.45 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 117.786 -1.565 . . . . 0.0 109.247 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 28' ' ' HIS . 2.0 mpt_? -79.05 44.28 0.56 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.883 -177.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.529 ' H ' ' C ' ' A' ' 26' ' ' GLN . 0.9 OUTLIER 47.05 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.708 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -162.39 33.32 0.11 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.092 -1.867 . . . . 0.0 111.493 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.567 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 70.0 -1.98 15.17 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 116.576 -2.726 . . . . 0.0 113.241 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -46.23 134.56 8.56 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 118.297 -1.361 . . . . 0.0 108.899 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.502 ' CE2' ' CB ' ' A' ' 9' ' ' TRP . 15.3 p90 -150.77 163.23 39.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 115.897 -2.321 . . . . 0.0 111.087 -173.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.6 pp -149.92 146.66 27.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.172 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.44 109.87 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.844 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.562 HH12 ' CB ' ' A' ' 16' ' ' ARG . 27.7 ptt180 -92.1 126.31 37.13 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 112.022 -2.354 . . . . 0.0 110.167 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 67.4 tt0 -67.98 129.61 40.44 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.445 -2.161 . . . . 0.0 109.781 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.592 ' HG ' ' HB2' ' A' ' 43' ' ' ASP . 73.5 m -67.12 129.88 41.32 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.501 178.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.596 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 2.3 mp0 -38.41 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 112.423 -2.171 . . . . 0.0 110.644 -176.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 40' ' ' ALA . 37.1 t -89.94 -29.54 18.43 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.086 -172.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -44.06 148.95 0.73 Allowed Pre-proline 0 C--N 1.348 0.538 0 C-N-CA 117.921 -1.512 . . . . 0.0 110.09 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -74.65 -8.62 20.63 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.934 2.423 . . . . 0.0 116.081 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.22 33.34 0.02 OUTLIER Glycine 0 CA--C 1.537 1.415 0 C-N-CA 118.611 -1.757 . . . . 0.0 111.68 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.592 ' HB2' ' HG ' ' A' ' 37' ' ' SER . 1.3 m-20 -89.91 132.5 35.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 118.284 -1.366 . . . . 0.0 109.568 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 59' ' ' VAL . 91.8 m-85 -143.62 132.34 22.54 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.59 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.47 ' HG ' ' HE ' ' A' ' 35' ' ' ARG . 99.7 p -119.15 138.17 53.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.492 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -101.04 116.3 32.52 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 113.083 -1.871 . . . . 0.0 110.008 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.52 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 40.6 m -98.38 139.21 34.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.148 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -138.55 148.47 24.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.128 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.671 ' HZ3' ' HA ' ' A' ' 52' ' ' ASN . 24.2 tptp -79.0 106.11 10.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.98 -1.918 . . . . 0.0 108.775 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' O ' ' CE1' ' A' ' 28' ' ' HIS . 7.4 t80 -76.28 -102.73 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 116.784 -1.966 . . . . 0.0 109.071 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -99.1 -69.39 0.92 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.751 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.671 ' HA ' ' HZ3' ' A' ' 49' ' ' LYS . 25.6 t-20 -121.46 -23.26 5.69 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 111.917 -2.141 . . . . 0.0 112.174 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.27 158.54 18.28 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 118.404 -1.319 . . . . 0.0 110.32 -174.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 24' ' ' SER . 95.2 t -80.69 118.85 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.4 -2.182 . . . . 0.0 109.678 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -102.78 158.2 16.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.718 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.634 ' HD1' ' H ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -134.3 143.18 47.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.57 -2.104 . . . . 0.0 110.598 -175.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -129.57 100.64 5.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.494 -2.139 . . . . 0.0 108.795 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.56 113.06 5.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 112.984 -1.916 . . . . 0.0 110.345 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.526 HG13 ' CD2' ' A' ' 77' ' ' LEU . 58.8 t -74.04 83.59 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 112.522 -2.126 . . . . 0.0 108.633 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.0 mt -72.88 161.02 31.22 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 112.799 -2.001 . . . . 0.0 110.703 -173.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.665 ' HG3' HH11 ' A' ' 61' ' ' ARG . 0.0 OUTLIER -143.65 164.92 29.07 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.006 -2.361 . . . . 0.0 109.227 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.572 ' H ' ' HG2' ' A' ' 61' ' ' ARG . 52.3 m-20 102.28 -151.69 0.0 OUTLIER 'General case' 0 C--N 1.348 0.517 0 CA-C-N 112.218 -2.265 . . . . 0.0 108.949 -173.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 -54.64 4.57 Favored Glycine 0 C--N 1.346 1.116 0 C-N-CA 118.157 -1.973 . . . . 0.0 110.436 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.726 ' CB ' ' HZ2' ' A' ' 73' ' ' LYS . . . -141.98 -45.73 0.35 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 112.839 -1.681 . . . . 0.0 109.296 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.401 ' O ' ' HE2' ' A' ' 66' ' ' LYS . . . 151.67 27.5 0.05 OUTLIER Glycine 0 CA--C 1.538 1.523 0 C-N-CA 117.655 -2.212 . . . . 0.0 112.679 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.552 ' HZ2' ' CA ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -137.21 -161.36 1.16 Allowed 'General case' 0 C--N 1.348 0.538 0 C-N-CA 117.952 -1.499 . . . . 0.0 109.545 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -117.55 150.32 39.16 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.939 -1.937 . . . . 0.0 109.301 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -166.01 144.37 5.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.573 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 2.5 mm? -65.05 -52.79 53.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 116.714 -1.994 . . . . 0.0 109.043 176.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 10.7 m0 -139.75 -45.0 0.44 Allowed 'General case' 0 C--N 1.345 0.413 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.013 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 77.8 t -129.23 -81.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 112.965 -1.925 . . . . 0.0 110.175 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -50.17 133.75 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 112.614 -2.085 . . . . 0.0 110.275 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.726 ' HZ2' ' CB ' ' A' ' 64' ' ' ALA . 94.0 mttt -93.36 160.9 14.61 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.464 -176.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -133.88 137.8 45.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 111.936 -2.393 . . . . 0.0 109.444 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -62.61 -34.57 77.3 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 112.712 -2.04 . . . . 0.0 110.989 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 77' ' ' LEU . 42.1 t -153.29 152.79 31.55 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 118.278 -1.369 . . . . 0.0 109.888 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.526 ' CD2' HG13 ' A' ' 59' ' ' VAL . 76.0 mt -39.28 -40.42 0.76 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.823 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -48.67 -42.47 34.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.316 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -73.42 -34.1 65.29 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 115.729 -2.388 . . . . 0.0 110.893 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.476 ' CD1' HG12 ' A' ' 59' ' ' VAL . 6.9 tt -56.78 -46.38 81.53 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.234 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 77' ' ' LEU . 96.0 t -63.16 -40.56 89.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 112.801 -1.999 . . . . 0.0 110.904 -177.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -71.33 -40.02 71.01 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.895 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -56.53 -41.07 76.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.449 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -93.15 40.07 1.06 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.677 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -107.45 -13.18 15.15 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.663 -1.608 . . . . 0.0 112.693 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.4 t -132.25 -42.15 0.98 Allowed 'General case' 0 C--N 1.351 0.635 0 C-N-CA 117.982 -1.487 . . . . 0.0 110.296 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 88' ' ' SER . 62.0 p -89.76 37.43 0.88 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.618 -1.628 . . . . 0.0 111.082 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' THR . 34.1 t 41.97 -165.71 0.01 OUTLIER 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.136 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.416 HG11 ' CG2' ' A' ' 95' ' ' ILE . 12.8 p -147.71 47.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.582 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 91' ' ' ARG . 45.5 t 179.1 142.84 0.12 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.805 -1.998 . . . . 0.0 109.512 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 90' ' ' SER . 8.7 ptm180 -41.51 -42.48 2.39 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.371 -1.74 . . . . 0.0 110.372 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.24 94.33 1.98 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.629 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 94' ' ' GLN . 48.9 mt-30 -69.86 100.06 1.49 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.949 -1.932 . . . . 0.0 109.893 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 93' ' ' GLN . 31.1 tt0 -178.89 45.41 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 112.34 -2.209 . . . . 0.0 109.429 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.416 ' CG2' HG11 ' A' ' 89' ' ' VAL . 44.7 mt -138.9 153.87 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 113.115 -1.857 . . . . 0.0 109.579 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.567 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 88.2 m-85 -149.99 179.86 7.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.684 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.3 mt -125.03 108.46 11.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 112.854 -1.975 . . . . 0.0 109.182 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 17.4 mmm180 -125.0 154.37 41.35 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.872 -1.967 . . . . 0.0 109.88 -177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 101' ' ' GLU . 58.6 t0 -52.72 118.76 3.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.62 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.482 ' CD1' HD21 ' A' ' 33' ' ' LEU . 11.6 tt -71.99 29.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.774 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 99' ' ' ASP . 12.3 mm-40 -150.17 129.19 12.63 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.681 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -43.15 129.64 4.63 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.017 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.3 p -68.44 135.37 90.83 Favored Pre-proline 0 C--N 1.346 0.421 0 CA-C-N 112.812 -1.994 . . . . 0.0 109.329 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.508 ' CD ' ' HB3' ' A' ' 6' ' ' PRO . 37.1 Cg_endo -70.5 125.08 11.38 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.367 2.045 . . . . 0.0 111.653 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.448 ' CB ' ' O ' ' A' ' 104' ' ' PRO . 18.2 mt-30 88.54 121.51 0.03 OUTLIER 'General case' 0 C--N 1.346 0.428 0 CA-C-N 112.357 -2.201 . . . . 0.0 109.959 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -101.99 155.33 36.57 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 112.899 -1.955 . . . . 0.0 109.499 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.411 ' O ' ' HB ' ' A' ' 108' ' ' THR . 50.3 Cg_exo -46.94 121.16 4.75 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.373 2.049 . . . . 0.0 113.43 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 107' ' ' PRO . 78.4 m 63.51 123.24 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.895 -1.957 . . . . 0.0 109.989 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -127.3 119.9 27.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.856 -1.975 . . . . 0.0 109.574 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.539 ' O ' ' CG ' ' A' ' 111' ' ' GLN . 7.8 p -147.88 123.47 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.728 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 110' ' ' VAL . 11.7 pt20 52.65 144.84 0.0 OUTLIER 'General case' 0 C--N 1.348 0.508 0 CA-C-N 112.41 -2.177 . . . . 0.0 111.633 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.553 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.739 4.378 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 2' ' ' ILE . . . . . . . . 0 CA--C 1.531 1.04 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.406 ' O ' ' HA2' ' A' ' 1' ' ' GLY . 2.5 pp -79.0 -159.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-N 114.177 -1.012 . . . . 0.0 109.872 -0.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.566 ' HG3' HE22 ' A' ' 105' ' ' GLN . 24.4 pt-20 -119.54 121.53 39.58 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.722 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.0 mtm -73.29 149.83 42.4 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 112.882 -1.963 . . . . 0.0 109.455 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.703 ' HB3' ' HZ2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -44.85 154.34 0.44 Allowed Pre-proline 0 C--N 1.346 0.43 0 CA-C-N 113.193 -1.821 . . . . 0.0 109.499 -178.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.25 119.99 6.97 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.213 1.942 . . . . 0.0 111.354 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' PRO . 57.8 t60 -84.16 135.55 41.79 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 113.155 -1.839 . . . . 0.0 109.194 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 7' ' ' HIS . 64.5 Cg_exo -44.39 -121.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.436 2.091 . . . . 0.0 114.283 177.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' CZ ' ' A' ' 10' ' ' PHE . 5.2 p-90 -159.2 17.59 0.18 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.511 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.439 ' CZ ' ' CH2' ' A' ' 9' ' ' TRP . 96.8 m-85 -85.82 109.21 18.52 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.676 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.416 ' CD1' ' O ' ' A' ' 9' ' ' TRP . 56.0 m-85 -97.53 95.8 7.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.866 -1.97 . . . . 0.0 108.853 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -49.65 105.62 0.17 Allowed Glycine 0 C--N 1.345 1.077 0 CA-C-N 112.797 -2.002 . . . . 0.0 111.254 -173.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 12' ' ' GLY . 63.4 pttt 30.51 42.07 0.01 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 111.459 -2.37 . . . . 0.0 111.193 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.44 HG12 ' CE ' ' A' ' 22' ' ' MET . 9.3 tp -56.51 134.85 77.12 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 113.373 -1.74 . . . . 0.0 108.727 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.8 Cg_exo -44.74 121.23 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.807 1.671 . . . . 0.0 112.911 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' PRO . 74.6 ttt180 -37.28 -37.12 0.17 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.268 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -69.79 -63.24 1.11 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.766 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.71 ' HB2' ' HZ2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -42.78 -42.19 3.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.458 -177.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -48.07 -58.63 4.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.1 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 91.2 mt-10 -49.1 -45.06 42.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 112.392 -2.185 . . . . 0.0 110.068 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' O ' ' OG ' ' A' ' 24' ' ' SER . 35.5 mt-10 -59.08 -81.17 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.799 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.45 ' CE ' ' HG3' ' A' ' 18' ' ' LYS . 9.8 ptp -50.82 -41.17 57.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 116.491 -2.084 . . . . 0.0 110.422 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.469 HD12 ' CD1' ' A' ' 100' ' ' ILE . 39.3 tp -62.27 -26.96 68.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 117.725 -1.59 . . . . 0.0 112.531 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.592 ' C ' ' H ' ' A' ' 26' ' ' GLN . 93.3 p -71.84 -29.06 64.0 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 117.803 -1.559 . . . . 0.0 111.733 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -72.28 37.19 0.07 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.819 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.592 ' H ' ' C ' ' A' ' 24' ' ' SER . 29.1 mm-40 -119.27 19.52 12.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 117.86 -1.536 . . . . 0.0 113.095 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 28' ' ' HIS . 58.2 mmm-85 20.37 58.25 0.02 OUTLIER 'General case' 0 C--N 1.349 0.555 0 O-C-N 125.215 1.572 . . . . 0.0 111.952 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.568 ' HD1' ' N ' ' A' ' 51' ' ' GLY . 72.5 t60 43.53 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.015 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 55.0 m-20 -157.71 29.06 0.27 Allowed 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.858 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 78.16 -9.34 33.5 Favored Glycine 0 CA--C 1.542 1.777 0 C-N-CA 115.969 -3.015 . . . . 0.0 113.147 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.418 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -44.98 120.74 2.48 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.055 177.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.492 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 14.0 p90 -126.14 151.2 47.6 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 116.638 -2.025 . . . . 0.0 111.716 -173.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.534 ' HB3' ' H ' ' A' ' 47' ' ' SER . 0.6 OUTLIER -114.53 146.75 40.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 110.892 -2.867 . . . . 0.0 109.013 -169.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 33' ' ' LEU . 18.4 mt -147.16 121.83 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 114.935 -2.706 . . . . 0.0 109.42 154.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.593 ' NE ' ' HG ' ' A' ' 45' ' ' SER . 27.9 ptt180 -108.81 128.31 54.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.411 -2.177 . . . . 0.0 110.369 -174.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 31.2 tp10 -68.92 136.36 52.46 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 112.459 -2.155 . . . . 0.0 109.853 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.54 ' HB3' ' H ' ' A' ' 43' ' ' ASP . 88.9 p -42.07 118.55 1.16 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.299 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.32 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.141 -1.845 . . . . 0.0 109.271 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.6 p -112.01 44.36 1.42 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.318 -1.764 . . . . 0.0 109.809 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -135.11 156.88 77.92 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.507 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ALA . 74.0 Cg_exo -43.56 -119.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.873 2.382 . . . . 0.0 114.099 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.29 68.31 0.51 Allowed Glycine 0 C--N 1.346 1.119 0 C-N-CA 118.154 -1.974 . . . . 0.0 110.187 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.54 ' H ' ' HB3' ' A' ' 37' ' ' SER . 61.9 t0 -90.05 117.87 29.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 112.82 -1.69 . . . . 0.0 109.799 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 21.4 m-85 -130.18 115.85 17.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.491 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.593 ' HG ' ' NE ' ' A' ' 35' ' ' ARG . 79.2 p -124.51 137.71 54.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.476 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.508 ' CD2' HG21 ' A' ' 48' ' ' VAL . 6.0 tt -110.24 119.07 38.06 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.7 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.534 ' H ' ' HB3' ' A' ' 33' ' ' LEU . 49.4 m -112.85 122.45 47.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.216 -1.811 . . . . 0.0 109.795 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 46' ' ' LEU . 86.8 t -113.65 146.73 17.87 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.379 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.583 ' HZ2' ' CA ' ' A' ' 24' ' ' SER . 41.7 tptt -69.35 89.54 0.49 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 116.693 -2.003 . . . . 0.0 108.915 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 53' ' ' ASP . 63.3 t80 -91.31 134.33 34.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 117.27 -1.772 . . . . 0.0 108.549 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.568 ' N ' ' HD1' ' A' ' 28' ' ' HIS . . . -43.37 129.14 5.87 Favored Glycine 0 C--N 1.342 0.886 0 C-N-CA 117.286 -2.388 . . . . 0.0 111.299 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.519 HD21 ' CG ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 83.33 -31.19 0.08 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 111.471 -2.364 . . . . 0.0 111.222 176.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CG ' HD21 ' A' ' 52' ' ' ASN . 33.6 m-20 -155.24 150.63 27.17 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 114.441 -2.903 . . . . 0.0 112.37 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.2 t -70.46 119.22 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 111.742 -2.481 . . . . 0.0 108.927 171.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 10.3 tt0 -101.75 159.61 15.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.884 -177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -128.51 134.7 48.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.493 -2.14 . . . . 0.0 110.63 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 93.7 m-85 -129.37 102.84 6.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 112.258 -2.247 . . . . 0.0 108.803 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 54.5 mtmt -70.49 114.12 8.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 116.97 -1.892 . . . . 0.0 109.718 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' A' ' 77' ' ' LEU . 94.3 t -74.88 86.77 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.537 174.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 81.6 mt -78.24 159.13 28.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 112.741 -2.027 . . . . 0.0 110.955 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.593 ' HE ' ' C ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -122.31 164.78 17.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 111.948 -2.387 . . . . 0.0 108.583 175.46 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.593 ' C ' ' HE ' ' A' ' 61' ' ' ARG . 69.0 m-20 -128.68 -96.85 0.39 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 117.112 -1.835 . . . . 0.0 110.354 -176.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.538 ' HA2' HH21 ' A' ' 61' ' ' ARG . . . 156.12 72.96 0.01 OUTLIER Glycine 0 C--N 1.345 1.055 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -140.95 51.78 1.61 Allowed 'General case' 0 C--N 1.351 0.664 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 7.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 73' ' ' LYS . . . -64.09 10.4 0.26 Allowed Glycine 0 CA--C 1.55 2.251 0 CA-C-N 112.507 -2.133 . . . . 0.0 112.969 171.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.698 ' HZ3' ' HB2' ' A' ' 66' ' ' LYS . 8.5 mtmp? 76.56 -146.34 0.03 OUTLIER 'General case' 0 C--N 1.351 0.631 0 CA-C-O 121.52 0.676 . . . . 0.0 110.632 171.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.44 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 20.5 m-85 -105.95 144.08 33.19 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 113.571 -1.649 . . . . 0.0 110.085 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -151.82 -165.89 2.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 117.262 -1.775 . . . . 0.0 109.381 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 5.6 mp -125.87 -46.34 1.7 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.36 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 21.5 m0 -132.54 -42.92 0.93 Allowed 'General case' 0 C--N 1.346 0.437 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.125 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.6 t -141.7 -84.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.011 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.74 136.23 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.211 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.619 ' HG2' ' HZ2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -104.4 176.09 5.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.899 -177.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.485 ' C ' ' HZ1' ' A' ' 66' ' ' LYS . 21.5 m-85 -146.59 138.31 24.6 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.131 -1.849 . . . . 0.0 108.915 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.468 ' O ' ' OG ' ' A' ' 76' ' ' SER . 41.8 p30 -66.5 -8.98 30.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 113.253 -1.794 . . . . 0.0 113.266 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 49.2 m -167.96 150.16 5.52 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 117.791 -1.564 . . . . 0.0 109.422 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' CD2' HG13 ' A' ' 59' ' ' VAL . 97.7 mt -46.01 -42.51 13.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.114 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -55.87 -42.86 76.53 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.349 -1.751 . . . . 0.0 110.442 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 76' ' ' SER . 32.3 tp10 -63.68 -35.44 80.57 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 113.335 -1.757 . . . . 0.0 110.665 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.456 ' CD1' HG23 ' A' ' 59' ' ' VAL . 6.1 tt -58.43 -50.84 72.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.073 -1.422 . . . . 0.0 108.375 173.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 81.3 t -63.85 -14.25 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 112.393 -2.185 . . . . 0.0 112.834 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -84.61 -26.44 27.89 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.715 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.433 ' O ' ' C ' ' A' ' 84' ' ' HIS . 68.8 t80 -73.12 -40.85 64.6 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.104 -174.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.594 ' C ' ' H ' ' A' ' 86' ' ' SER . 7.1 p-80 -45.52 -36.84 4.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.299 -2.16 . . . . 0.0 110.842 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 85' ' ' ARG . 67.4 ttt-85 -73.4 37.35 0.09 Allowed 'General case' 0 C--N 1.348 0.516 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.877 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.594 ' H ' ' C ' ' A' ' 84' ' ' HIS . 42.4 t -136.74 -41.63 0.61 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.141 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.475 ' O ' ' OG ' ' A' ' 88' ' ' SER . 9.0 t -165.52 55.63 0.11 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.092 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.562 ' HB2' ' H ' ' A' ' 95' ' ' ILE . 69.7 p 50.56 -179.0 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.261 -1.791 . . . . 0.0 110.101 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 90' ' ' SER . 13.8 p -128.69 37.03 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.711 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.712 ' HG ' ' CD1' ' A' ' 95' ' ' ILE . 86.7 p 179.99 121.82 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.505 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.473 ' CB ' ' NH1' ' A' ' 91' ' ' ARG . 15.0 mtp-105 -67.97 2.42 2.07 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 113.356 -1.747 . . . . 0.0 113.209 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.564 HD21 ' HB2' ' A' ' 90' ' ' SER . 17.5 m-80 -68.16 -57.2 6.43 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 118.348 -1.341 . . . . 0.0 110.548 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 94' ' ' GLN . 8.3 pt20 -163.33 37.67 0.09 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 116.962 -1.895 . . . . 0.0 111.164 -176.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.511 ' HA ' ' CB ' ' A' ' 88' ' ' SER . 77.3 mt-30 62.54 137.73 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 117.841 -1.543 . . . . 0.0 110.255 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.712 ' CD1' ' HG ' ' A' ' 90' ' ' SER . 35.9 mt -150.04 140.6 16.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.904 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.409 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 88.5 m-85 -118.81 133.04 56.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.618 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.401 ' O ' ' HD3' ' A' ' 98' ' ' ARG . 28.6 mt -90.0 102.02 14.73 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.451 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 27.7 mmt180 -150.29 -159.83 1.09 Allowed 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.144 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.4 t0 48.73 -120.67 1.37 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.136 170.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 5.0 tt 40.16 22.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 113.843 -1.526 . . . . 0.0 113.371 -174.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 102' ' ' GLN . 6.1 tm-20 -145.94 93.49 2.34 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.0 -177.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 101' ' ' GLU . 61.7 mt-30 30.17 -151.67 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.911 -1.949 . . . . 0.0 111.465 177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.461 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -102.16 -66.04 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 112.53 -2.123 . . . . 0.0 109.922 175.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.461 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 62.0 Cg_exo -40.24 132.15 2.24 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.679 1.586 . . . . 0.0 111.445 174.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.566 HE22 ' HG3' ' A' ' 3' ' ' GLU . 8.3 mm100 -93.03 36.56 1.03 Allowed 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.609 0.764 . . . . 0.0 111.065 12.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.633 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 21.9 mt-30 -69.91 -84.91 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 116.034 -2.266 . . . . 0.0 111.045 -172.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.633 ' CD ' ' CB ' ' A' ' 106' ' ' GLN . 44.0 Cg_endo -72.34 122.58 8.46 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.255 1.303 . . . . 0.0 112.281 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 109' ' ' TYR . 99.1 m -46.17 -83.81 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.711 -2.04 . . . . 0.0 109.298 172.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 108' ' ' THR . 9.4 t80 61.27 125.29 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.181 177.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.67 117.78 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.681 -2.054 . . . . 0.0 109.413 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -79.67 121.99 26.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.041 -1.89 . . . . 0.0 109.815 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.504 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.737 179.96 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.984 0 CA-C-O 121.88 0.711 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 2' ' ' ILE . 8.1 tp -110.79 120.67 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 113.01 -1.595 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.516 ' CB ' ' HB2' ' A' ' 104' ' ' PRO . 43.2 tt0 -98.63 124.84 43.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.928 -1.942 . . . . 0.0 109.632 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.582 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 44.2 ttp -103.95 124.91 49.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.933 -1.939 . . . . 0.0 109.878 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 4' ' ' MET . 38.3 ttpt 110.11 133.84 0.0 OUTLIER Pre-proline 0 C--N 1.35 0.599 0 CA-C-N 112.26 -2.245 . . . . 0.0 109.304 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 7' ' ' HIS . 61.5 Cg_endo -74.05 -119.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.148 1.899 . . . . 0.0 109.85 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 9' ' ' TRP . 1.9 p80 -140.83 84.55 13.31 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 118.714 -1.195 . . . . 0.0 109.71 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' C ' ' CG ' ' A' ' 9' ' ' TRP . 38.2 Cg_exo -51.4 1.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.159 2.573 . . . . 0.0 115.565 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.517 ' H ' ' C ' ' A' ' 7' ' ' HIS . 41.4 p-90 43.7 30.64 0.38 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 116.965 -1.894 . . . . 0.0 111.583 177.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -105.37 118.97 37.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.478 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 29.1 m-85 -121.58 83.93 2.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.113 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -49.81 111.37 1.07 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-N 112.641 -2.072 . . . . 0.0 110.778 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 37' ' ' SER . 26.2 pttm 26.44 46.16 0.01 OUTLIER 'General case' 0 C--N 1.344 0.357 0 CA-C-N 111.529 -2.335 . . . . 0.0 111.387 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.4 tp -61.61 135.61 94.2 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 112.96 -1.927 . . . . 0.0 108.912 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' ARG . 54.3 Cg_exo -44.08 121.74 3.16 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.855 1.703 . . . . 0.0 113.029 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.672 ' HB3' HH22 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -40.74 -41.81 1.62 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.702 -177.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.543 ' H ' ' HD3' ' A' ' 16' ' ' ARG . . . -59.16 -63.09 1.43 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.483 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -43.39 -52.0 6.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 112.766 -2.016 . . . . 0.0 110.421 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.75 -49.47 14.82 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.759 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 24' ' ' SER . 66.8 mt-10 -61.29 -44.65 96.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.775 -2.011 . . . . 0.0 110.114 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' SER . 44.2 mt-10 -67.09 -70.4 0.25 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.872 -173.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.57 ' C ' ' SD ' ' A' ' 22' ' ' MET . 3.5 ppp? -46.48 -42.48 15.57 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 117.088 -1.845 . . . . 0.0 110.474 -173.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.562 ' N ' ' SD ' ' A' ' 22' ' ' MET . 60.8 tp -75.89 -25.11 55.77 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 113.357 -1.747 . . . . 0.0 112.569 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.542 ' C ' ' H ' ' A' ' 26' ' ' GLN . 78.4 p -74.18 -33.31 63.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 117.186 -1.806 . . . . 0.0 111.151 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 50.1 mtpt -75.54 38.78 0.15 Allowed 'General case' 0 C--N 1.347 0.467 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.605 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.748 HE21 ' CB ' ' A' ' 31' ' ' ALA . 12.9 mm100 -102.25 136.05 42.77 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 117.687 -1.605 . . . . 0.0 110.225 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HA ' ' CB ' ' A' ' 28' ' ' HIS . 9.9 mpt_? -116.54 84.33 2.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 110.688 -2.96 . . . . 0.0 106.374 171.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.519 ' CB ' ' HA ' ' A' ' 27' ' ' ARG . 1.3 t-80 -171.24 12.07 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.702 13.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 7.0 m-20 -163.09 128.69 3.19 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.753 -1.579 . . . . 0.0 110.619 -173.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 103.26 -27.03 21.77 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 117.835 -2.126 . . . . 0.0 112.875 170.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.748 ' CB ' HE21 ' A' ' 26' ' ' GLN . . . -46.95 135.76 9.04 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 117.762 -1.575 . . . . 0.0 109.147 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.51 ' CB ' HD23 ' A' ' 97' ' ' LEU . 17.3 p90 -139.94 164.51 29.82 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 115.077 -2.649 . . . . 0.0 112.427 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.551 ' HB3' ' H ' ' A' ' 47' ' ' SER . 0.4 OUTLIER -129.03 145.96 51.12 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 110.31 -3.132 . . . . 0.0 108.658 -165.364 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.519 ' CG1' ' O ' ' A' ' 33' ' ' LEU . 16.5 mt -145.85 119.94 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 114.886 -2.726 . . . . 0.0 109.504 153.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.672 HH22 ' HB3' ' A' ' 16' ' ' ARG . 10.1 ptm180 -113.11 147.79 36.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 111.852 -2.431 . . . . 0.0 110.223 -172.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 13' ' ' LYS . 40.7 mt-10 -86.97 167.38 14.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.69 -2.05 . . . . 0.0 109.719 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 38.9 t -71.83 -134.41 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.255 -1.793 . . . . 0.0 108.679 175.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -101.26 -70.92 0.73 Allowed 'General case' 0 C--N 1.347 0.473 0 C-N-CA 118.097 -1.441 . . . . 0.0 109.114 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.4 t -128.81 45.52 2.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.666 -2.061 . . . . 0.0 109.566 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -156.44 110.21 2.04 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.841 -176.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.609 ' C ' ' H ' ' A' ' 43' ' ' ASP . 23.6 Cg_exo -57.48 -144.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.132 0 N-CA-C 107.798 -1.655 . . . . 0.0 107.798 171.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.78 -28.33 0.14 Allowed Glycine 0 CA--C 1.541 1.679 0 CA-C-N 114.091 -1.413 . . . . 0.0 113.376 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.609 ' H ' ' C ' ' A' ' 41' ' ' PRO . 11.2 m-20 -112.8 116.52 30.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.967 0.889 . . . . 0.0 109.253 -173.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.412 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 91.7 m-85 -149.19 91.14 1.81 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.986 -1.916 . . . . 0.0 109.791 -175.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.518 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 28.4 p -89.99 137.41 32.36 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 115.947 -2.301 . . . . 0.0 109.93 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.523 ' CD2' HG21 ' A' ' 48' ' ' VAL . 6.5 tt -100.01 121.02 40.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 111.965 -2.38 . . . . 0.0 109.562 -173.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.551 ' H ' ' HB3' ' A' ' 33' ' ' LEU . 49.2 m -114.38 130.29 56.69 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.25 -176.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.523 HG21 ' CD2' ' A' ' 46' ' ' LEU . 84.3 t -128.13 145.4 35.33 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 CA-C-N 113.287 -1.778 . . . . 0.0 110.317 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.41 ' NZ ' ' O ' ' A' ' 51' ' ' GLY . 22.0 tptp -72.39 96.69 1.92 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 113.332 -1.758 . . . . 0.0 108.034 172.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CD2' ' O ' ' A' ' 53' ' ' ASP . 24.4 p90 -89.12 -1.31 58.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 116.546 -2.061 . . . . 0.0 113.801 -170.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.41 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 153.8 -80.48 0.18 Allowed Glycine 0 C--N 1.346 1.124 0 C-N-CA 117.024 -2.512 . . . . 0.0 110.77 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -109.28 -29.3 8.55 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 112.4 -1.9 . . . . 0.0 111.642 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.6 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 32.2 t70 -133.36 -174.92 3.64 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 117.434 -1.706 . . . . 0.0 110.159 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.6 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 73.9 t -100.08 122.19 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 112.857 -1.974 . . . . 0.0 110.377 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' SER . 11.5 tt0 -94.48 166.52 12.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.583 -2.099 . . . . 0.0 108.491 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -150.08 144.52 25.8 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.495 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.464 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 98.6 m-85 -138.59 89.93 2.41 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.931 177.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.518 ' HA ' ' CB ' ' A' ' 45' ' ' SER . 9.1 ptmm? -45.06 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 112.535 -2.121 . . . . 0.0 109.912 169.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 22.9 t -79.09 71.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-N 113.237 -1.801 . . . . 0.0 108.912 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.434 ' CD1' ' NZ ' ' A' ' 58' ' ' LYS . 16.6 mt -73.06 -151.89 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.227 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 62' ' ' ASP . 8.7 ptm180 -157.23 -136.82 0.05 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 116.982 -1.887 . . . . 0.0 109.885 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 61' ' ' ARG . 36.9 m-20 -24.49 147.46 0.0 OUTLIER 'General case' 0 C--N 1.349 0.566 0 O-C-N 125.284 1.615 . . . . 0.0 111.502 174.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.44 110.62 4.07 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 122.417 1.009 . . . . 0.0 111.875 7.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.421 ' H ' ' HA ' ' A' ' 62' ' ' ASP . . . -161.02 -46.68 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 112.085 -2.057 . . . . 0.0 108.396 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.589 ' HA3' ' HZ3' ' A' ' 73' ' ' LYS . . . 171.29 -44.56 0.19 Allowed Glycine 0 C--N 1.348 1.229 0 CA-C-N 112.832 -1.985 . . . . 0.0 110.353 174.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.715 ' HZ1' ' HA ' ' A' ' 75' ' ' ASN . 5.1 mtpm? -160.94 -147.91 0.15 Allowed 'General case' 0 C--N 1.349 0.559 0 CA-C-N 112.855 -1.673 . . . . 0.0 108.715 -173.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 8.1 m-30 -71.09 140.79 50.79 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 118.196 -1.402 . . . . 0.0 109.91 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -156.58 151.23 25.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 117.094 -1.842 . . . . 0.0 110.745 174.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.464 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 4.9 mt -87.77 -43.44 11.87 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 112.441 -2.163 . . . . 0.0 109.956 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -147.4 -44.61 0.17 Allowed 'General case' 0 C--N 1.346 0.435 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.929 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.2 t -135.75 -83.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.903 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.6 m -53.92 131.64 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 112.814 -1.994 . . . . 0.0 110.09 -176.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HZ3' ' HA3' ' A' ' 65' ' ' GLY . 47.7 mtmt -88.04 176.24 7.39 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.693 -2.049 . . . . 0.0 110.053 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.485 ' C ' ' H ' ' A' ' 76' ' ' SER . 18.0 m-85 -147.25 132.76 18.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 112.507 -2.133 . . . . 0.0 108.725 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.715 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 1.7 t-20 -83.67 49.34 1.58 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.949 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 29.2 t 138.94 142.7 0.0 OUTLIER 'General case' 0 C--N 1.349 0.562 0 CA-C-N 112.249 -2.25 . . . . 0.0 109.344 173.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 80' ' ' LEU . 95.7 mt -49.09 -49.42 41.81 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.238 -1.801 . . . . 0.0 108.851 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -47.45 -39.46 15.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 112.624 -2.08 . . . . 0.0 110.621 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 79' ' ' GLU . 4.7 tm-20 -64.1 -35.76 81.8 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 116.772 -1.971 . . . . 0.0 110.5 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.464 HD13 ' CG ' ' A' ' 69' ' ' LEU . 6.8 tt -64.88 -66.67 0.51 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.692 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.6 t -39.69 -38.84 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 112.321 -2.218 . . . . 0.0 110.893 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.412 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 12.6 t70 -77.64 -36.25 51.72 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.209 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' LEU . 60.8 t80 -68.76 -28.29 66.66 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 117.942 -1.503 . . . . 0.0 111.948 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -107.45 35.2 3.15 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 117.953 -1.499 . . . . 0.0 111.328 -175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 12.7 ptm180 -97.38 30.55 2.8 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 117.426 -1.71 . . . . 0.0 111.656 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 88' ' ' SER . 80.5 p -149.98 -74.06 0.17 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 117.651 -1.62 . . . . 0.0 110.259 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 92' ' ' ASN . 9.0 t -76.23 39.68 0.2 Allowed 'General case' 0 C--N 1.345 0.41 0 CA-C-N 112.966 -1.924 . . . . 0.0 110.862 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.565 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 32.7 t 50.93 -146.22 0.46 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 117.825 -1.55 . . . . 0.0 109.398 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 89' ' ' VAL . 15.0 p -160.12 45.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.678 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.2 t -170.78 -96.94 0.01 OUTLIER 'General case' 0 C--N 1.346 0.425 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.592 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.562 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 87.9 mtt180 -72.18 4.64 3.4 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.859 -1.518 . . . . 0.0 113.421 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 91' ' ' ARG . 11.6 m120 101.91 -37.87 0.01 OUTLIER 'General case' 0 C--N 1.352 0.702 0 O-C-N 124.455 1.097 . . . . 0.0 110.904 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.442 ' O ' ' CB ' ' A' ' 94' ' ' GLN . 22.0 pt20 -153.87 114.23 3.95 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 117.052 -1.859 . . . . 0.0 110.371 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.565 ' H ' ' HB2' ' A' ' 88' ' ' SER . 11.3 pt20 158.39 21.55 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 112.314 -2.221 . . . . 0.0 111.908 176.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.434 ' CG2' HG13 ' A' ' 48' ' ' VAL . 37.0 mt -149.96 127.18 2.42 Favored 'Isoleucine or valine' 0 C--N 1.349 0.55 0 C-N-CA 117.831 -1.548 . . . . 0.0 110.054 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.577 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 29.9 t80 -123.74 135.76 54.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.965 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.51 HD23 ' CB ' ' A' ' 32' ' ' PHE . 95.5 mt -89.94 96.11 10.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 117.045 -1.862 . . . . 0.0 110.228 -174.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.567 ' HG2' ' H ' ' A' ' 99' ' ' ASP . 53.4 ttm-85 -153.8 -137.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.808 175.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.606 ' CG ' ' H ' ' A' ' 100' ' ' ILE . 35.9 t0 43.85 -170.84 0.01 OUTLIER 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.286 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.606 ' H ' ' CG ' ' A' ' 99' ' ' ASP . 0.5 OUTLIER 86.78 -38.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.361 173.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 24.2 mm-40 -150.12 -163.99 1.91 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 112.988 -1.914 . . . . 0.0 109.98 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.404 ' O ' ' O ' ' A' ' 101' ' ' GLU . 61.8 tt0 39.55 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.802 -1.999 . . . . 0.0 110.588 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.575 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -107.7 -53.38 0.07 OUTLIER Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.607 173.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.575 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 31.3 Cg_exo -58.14 115.86 2.83 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.545 2.163 . . . . 0.0 112.683 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 104' ' ' PRO . 53.9 mt-30 -159.63 -89.16 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.969 -1.923 . . . . 0.0 109.185 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.603 ' H ' ' CD ' ' A' ' 107' ' ' PRO . 21.4 mt-30 -116.92 -44.32 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.616 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.603 ' CD ' ' H ' ' A' ' 106' ' ' GLN . 49.3 Cg_exo -52.25 119.63 6.09 Favored 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 120.826 1.017 . . . . 0.0 112.817 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 6.7 m 95.79 72.26 0.0 OUTLIER 'General case' 0 C--N 1.346 0.446 0 CA-C-N 112.394 -2.184 . . . . 0.0 109.475 -178.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -74.32 117.68 16.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 112.887 -1.96 . . . . 0.0 109.688 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 110' ' ' VAL . 34.1 m -76.09 124.08 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.63 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -49.91 119.0 3.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 113.0 -1.909 . . . . 0.0 109.741 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.595 -179.765 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.455 ' HA2' ' H ' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.533 1.163 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 2' ' ' ILE . 4.1 mp -94.84 45.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.693 0 CA-C-O 122.234 1.016 . . . . 0.0 109.739 -0.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.455 ' H ' ' HA2' ' A' ' 1' ' ' GLY . 78.7 mm-40 -69.64 118.53 12.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.56 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' LYS . 13.4 tpp -108.76 116.4 31.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.828 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' MET . 87.6 tttt 60.77 134.25 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 112.891 -1.958 . . . . 0.0 109.397 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' A' ' 7' ' ' HIS . 60.8 Cg_endo -73.26 -119.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.159 1.906 . . . . 0.0 109.838 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.426 ' N ' ' HD1' ' A' ' 7' ' ' HIS . 0.3 OUTLIER -167.57 136.72 2.14 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 118.526 -1.27 . . . . 0.0 109.342 178.357 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.08 -113.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.317 2.011 . . . . 0.0 111.415 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.456 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 5.0 m-90 -126.31 -29.88 2.94 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 117.779 -1.569 . . . . 0.0 111.856 -167.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 92.3 m-85 -67.59 116.99 8.93 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.159 -171.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 9' ' ' TRP . 97.4 m-85 -123.94 95.56 4.61 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.682 171.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.56 163.76 30.44 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 114.861 -3.542 . . . . 0.0 112.242 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.572 ' HD3' ' H ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -88.65 109.04 19.78 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 113.26 -1.47 . . . . 0.0 109.296 -6.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 14' ' ' ILE . 10.2 tp -87.71 123.26 69.59 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 113.198 -1.819 . . . . 0.0 109.341 -177.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 16' ' ' ARG . 49.2 Cg_exo -49.88 122.38 8.95 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.493 1.462 . . . . 0.0 112.199 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 15' ' ' PRO . 71.2 ttt180 -38.83 -40.17 0.6 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-N 113.33 -1.759 . . . . 0.0 110.73 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -57.84 -70.89 0.12 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.494 -1.684 . . . . 0.0 108.961 173.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.672 ' HZ1' ' HB3' ' A' ' 22' ' ' MET . 28.6 tptp -35.9 -48.52 0.58 Allowed 'General case' 0 C--N 1.346 0.414 0 CA-C-N 112.833 -1.985 . . . . 0.0 111.051 -176.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.14 -69.32 0.15 Allowed 'General case' 0 C--N 1.346 0.421 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.423 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 24' ' ' SER . 80.3 mt-10 -49.72 -23.42 1.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 112.388 -2.187 . . . . 0.0 112.245 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.459 ' O ' ' OG ' ' A' ' 24' ' ' SER . 81.6 mm-40 -81.34 -81.71 0.13 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 118.486 -1.286 . . . . 0.0 110.11 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.672 ' HB3' ' HZ1' ' A' ' 18' ' ' LYS . 18.4 ptm -47.05 -41.72 17.29 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 117.045 -1.862 . . . . 0.0 110.28 -176.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD23 ' HG ' ' A' ' 47' ' ' SER . 41.8 tp -63.42 -34.49 77.85 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.422 -178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.59 ' C ' ' H ' ' A' ' 26' ' ' GLN . 71.7 p -69.24 -33.67 73.63 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 116.616 -2.034 . . . . 0.0 110.954 176.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.715 ' HB3' ' HZ2' ' A' ' 25' ' ' LYS . 5.2 mtpm? -72.35 34.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.108 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.594 ' C ' ' H ' ' A' ' 28' ' ' HIS . 28.6 mm-40 -100.75 149.95 23.28 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.454 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 28' ' ' HIS . 24.7 tpt180 -73.57 36.41 0.09 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.107 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.6 ' CE1' ' H ' ' A' ' 51' ' ' GLY . 77.7 t60 44.13 93.13 0.01 OUTLIER 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.631 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -164.03 37.36 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 116.83 -1.948 . . . . 0.0 111.258 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 68.02 1.45 19.31 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 116.785 -2.626 . . . . 0.0 113.44 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.402 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -48.3 132.62 16.29 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 117.775 -1.57 . . . . 0.0 108.761 177.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.421 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 26.7 p90 -144.87 160.99 40.41 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 115.787 -2.365 . . . . 0.0 111.427 -173.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.526 HD21 ' CD1' ' A' ' 100' ' ' ILE . 4.6 pp -145.81 146.12 31.05 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.397 170.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' PHE . 71.3 mt -110.25 105.19 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 112.57 -2.105 . . . . 0.0 108.096 173.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 11.1 ptm180 -92.0 152.45 20.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 116.751 -1.98 . . . . 0.0 111.219 -170.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' SER . 47.4 mt-10 -113.59 129.25 56.6 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 111.73 -2.486 . . . . 0.0 109.315 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 36' ' ' GLU . 39.9 t -50.57 -179.46 0.01 OUTLIER 'General case' 0 C--N 1.346 0.415 0 C-N-CA 116.821 -1.952 . . . . 0.0 109.878 -178.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -42.79 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.345 0.392 0 CA-C-N 112.978 -1.919 . . . . 0.0 109.692 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 46.6 t -89.93 -49.18 6.75 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.497 174.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 70.95 119.49 0.03 OUTLIER Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 112.462 -2.154 . . . . 0.0 111.246 165.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.95 -112.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 170.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.49 58.57 0.39 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 117.346 -2.359 . . . . 0.0 109.99 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -101.46 107.63 19.0 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 117.481 -1.688 . . . . 0.0 109.587 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -129.64 127.59 40.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.494 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.427 ' HG ' ' HE1' ' A' ' 56' ' ' HIS . 80.7 p -134.06 127.31 31.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.717 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 32' ' ' PHE . 4.8 tt -90.79 115.51 27.91 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.786 -2.006 . . . . 0.0 109.55 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.6 ' HG ' HD23 ' A' ' 23' ' ' LEU . 90.1 p -100.54 146.73 26.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.898 -1.956 . . . . 0.0 109.735 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.8 t -140.6 149.24 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 117.553 -1.659 . . . . 0.0 110.515 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.48 ' CE ' ' O ' ' A' ' 24' ' ' SER . 20.7 tptm -75.44 102.73 5.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.747 -2.024 . . . . 0.0 108.795 174.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' ASN . 38.5 t80 -98.82 108.4 21.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.472 -1.695 . . . . 0.0 109.607 -178.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.6 ' H ' ' CE1' ' A' ' 28' ' ' HIS . . . 54.79 -97.37 0.04 OUTLIER Glycine 0 CA--C 1.53 1.02 0 C-N-CA 118.021 -2.038 . . . . 0.0 110.161 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 50' ' ' PHE . 51.7 t30 -112.16 -26.34 8.86 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 112.659 -1.771 . . . . 0.0 112.043 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.596 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 30.3 t0 -101.43 -173.23 2.31 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.223 -1.391 . . . . 0.0 109.528 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.596 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 96.0 t -111.47 120.5 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 113.259 -1.791 . . . . 0.0 109.742 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 10.2 tt0 -90.01 159.38 16.9 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 112.881 -1.963 . . . . 0.0 109.357 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.427 ' HE1' ' HG ' ' A' ' 45' ' ' SER . 27.6 t60 -136.31 121.55 19.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.733 -2.031 . . . . 0.0 110.47 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 46' ' ' LEU . 24.2 m-85 -112.71 126.28 55.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.79 -2.005 . . . . 0.0 109.191 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -95.87 118.12 31.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 116.733 -1.987 . . . . 0.0 109.538 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 68.0 t -75.97 92.76 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 113.031 -1.895 . . . . 0.0 108.734 176.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.0 mt -89.94 151.51 21.67 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 113.03 -1.895 . . . . 0.0 110.871 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 64.8 ttp85 -103.24 168.89 8.88 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 111.858 -2.428 . . . . 0.0 109.431 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -119.64 -148.52 0.42 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.376 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -102.39 36.89 3.97 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 117.909 -2.091 . . . . 0.0 111.446 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -146.4 -45.16 0.19 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.717 -1.242 . . . . 0.0 109.618 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.737 ' C ' ' HZ2' ' A' ' 66' ' ' LYS . . . 134.27 19.6 0.86 Allowed Glycine 0 CA--C 1.542 1.741 0 CA-C-N 112.955 -1.93 . . . . 0.0 112.936 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.737 ' HZ2' ' C ' ' A' ' 65' ' ' GLY . 1.9 mmpm? -92.41 138.7 31.3 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 118.237 -1.385 . . . . 0.0 109.532 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 86.6 m-85 -96.8 134.49 40.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.42 -2.173 . . . . 0.0 109.04 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 71' ' ' VAL . 50.7 p90 -152.75 -162.37 1.48 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 117.188 -1.805 . . . . 0.0 109.999 -176.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.27 -39.4 0.93 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 112.31 -2.223 . . . . 0.0 110.767 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -110.32 -38.67 5.18 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.84 -173.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 98.5 t -150.02 -83.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 117.148 -1.821 . . . . 0.0 109.365 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 71' ' ' VAL . 18.4 m -162.1 136.89 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.202 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.565 ' CD ' ' CZ ' ' A' ' 74' ' ' PHE . 17.3 ptpt -170.07 -24.26 0.02 OUTLIER 'General case' 0 C--N 1.347 0.483 0 C-N-CA 114.684 -2.806 . . . . 0.0 112.829 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.565 ' CZ ' ' CD ' ' A' ' 73' ' ' LYS . 10.8 m-85 -120.24 146.58 45.92 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 116.671 -2.011 . . . . 0.0 109.986 -174.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.628 ' HA ' ' HZ1' ' A' ' 66' ' ' LYS . 53.1 p-10 -86.77 -22.6 25.83 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 113.087 -1.87 . . . . 0.0 112.065 175.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.416 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 41.0 t -155.6 162.34 40.65 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 118.201 -1.399 . . . . 0.0 109.703 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.521 ' CD2' HG13 ' A' ' 59' ' ' VAL . 95.9 mt -46.32 -45.48 17.51 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.932 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.406 ' OD1' ' CZ3' ' A' ' 9' ' ' TRP . 1.8 m-20 -48.49 -38.59 20.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.871 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' CB ' ' HB3' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -77.34 -19.98 55.53 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 113.994 -1.457 . . . . 0.0 112.17 -178.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.414 ' CD1' HG23 ' A' ' 59' ' ' VAL . 6.8 tt -72.62 -57.68 3.94 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 118.154 -1.418 . . . . 0.0 108.227 172.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 58.2 t -51.75 -41.72 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 111.911 -2.404 . . . . 0.0 110.573 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 11.2 t70 -63.43 -44.48 94.42 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.35 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CB ' ' CE1' ' A' ' 74' ' ' PHE . 64.5 t80 -70.04 -37.49 75.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.188 -1.824 . . . . 0.0 111.096 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.559 ' C ' ' H ' ' A' ' 86' ' ' SER . 1.0 OUTLIER -72.72 -32.53 65.79 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.397 -178.004 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 55.0 ptt85 -77.31 41.84 0.32 Allowed 'General case' 0 C--N 1.348 0.506 0 C-N-CA 117.276 -1.769 . . . . 0.0 110.396 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 84' ' ' HIS . 42.6 t -150.01 -44.93 0.13 Allowed 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.344 -1.753 . . . . 0.0 109.656 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -103.91 -137.6 0.35 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.192 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.575 ' HB2' ' H ' ' A' ' 95' ' ' ILE . 70.1 p -143.03 175.54 9.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 118.166 -1.414 . . . . 0.0 109.853 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 90' ' ' SER . 1.9 m -95.94 -41.4 11.65 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-N 113.054 -1.884 . . . . 0.0 110.427 176.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.523 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 16.6 t -120.52 119.36 32.71 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.938 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -54.82 -38.69 67.68 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.698 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -50.73 -39.37 51.66 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.848 -1.524 . . . . 0.0 110.711 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 90' ' ' SER . 5.1 pt20 -150.68 128.62 11.76 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.247 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.401 ' O ' ' HG3' ' A' ' 94' ' ' GLN . 12.1 pt20 -68.89 123.1 20.06 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.868 -178.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.575 ' H ' ' HB2' ' A' ' 88' ' ' SER . 14.9 mt -119.97 126.79 75.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.205 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 97' ' ' LEU . 67.4 t80 -103.46 155.45 18.5 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.062 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.455 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 91.2 mt -89.89 120.36 31.05 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 117.27 -1.772 . . . . 0.0 109.707 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -127.96 143.52 51.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.285 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -47.92 127.07 11.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.462 -2.154 . . . . 0.0 109.719 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 101' ' ' GLU . 17.8 tt -62.82 -121.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.707 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.567 ' H ' HG22 ' A' ' 100' ' ' ILE . 6.6 tp10 -89.9 -177.91 5.34 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.153 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.562 ' H ' ' HG3' ' A' ' 101' ' ' GLU . 26.7 tt0 57.01 118.48 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.709 176.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 9.0 p -142.79 135.46 13.64 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.046 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -43.88 124.01 4.36 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.085 1.857 . . . . 0.0 113.815 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.412 ' O ' ' NE2' ' A' ' 106' ' ' GLN . 21.0 pt20 -172.29 122.88 0.47 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 111.944 -2.389 . . . . 0.0 109.758 -172.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 105' ' ' GLN . 89.0 mm-40 -127.05 154.68 76.59 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.03 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.595 ' O ' ' CB ' ' A' ' 108' ' ' THR . 52.1 Cg_exo -46.65 124.29 8.08 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.784 2.323 . . . . 0.0 113.482 176.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.595 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 18.7 m 132.0 122.6 0.0 OUTLIER 'General case' 0 C--N 1.35 0.613 0 CA-C-N 112.411 -2.177 . . . . 0.0 109.489 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -153.58 116.45 4.5 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 112.518 -2.128 . . . . 0.0 109.353 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 110' ' ' VAL . 34.1 m -86.61 124.78 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 113.143 -1.844 . . . . 0.0 109.915 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.401 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 9.1 pt20 -100.51 122.8 43.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.888 -1.96 . . . . 0.0 109.681 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.448 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.725 -179.676 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.036 0 CA-C-O 121.803 0.668 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.3 tt -46.37 128.52 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 113.061 -1.569 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 71.5 mt-10 -45.61 121.17 2.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.017 -1.902 . . . . 0.0 110.161 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.559 ' SD ' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -42.88 137.97 2.16 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 112.497 -2.138 . . . . 0.0 109.514 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 19.9 pttm 49.79 156.17 0.04 OUTLIER Pre-proline 0 C--N 1.349 0.576 0 CA-C-N 112.864 -1.971 . . . . 0.0 110.488 -174.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 5' ' ' LYS . 80.1 Cg_exo -44.19 -120.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.506 2.137 . . . . 0.0 114.534 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.606 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 87.1 m-70 -151.52 -46.77 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 116.813 -1.955 . . . . 0.0 113.264 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HD2' ' H ' ' A' ' 7' ' ' HIS . 50.3 Cg_exo -49.61 -121.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 121.717 1.612 . . . . 0.0 114.54 -174.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -146.43 27.69 1.11 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.93 -176.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -102.29 116.91 33.62 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.334 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 12' ' ' GLY . 7.5 m-85 -105.65 104.28 13.97 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 113.233 -1.803 . . . . 0.0 108.497 174.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -22.41 -108.23 0.0 OUTLIER Glycine 0 C--N 1.348 1.21 0 CA-C-N 111.63 -2.532 . . . . 0.0 112.883 -173.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.72 ' HZ3' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -115.99 50.01 1.06 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 112.727 -1.736 . . . . 0.0 108.885 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.522 HG23 ' CB ' ' A' ' 35' ' ' ARG . 7.6 tp -69.27 132.03 90.07 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.721 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' ARG . 21.1 Cg_endo -66.11 125.03 13.42 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.263 1.976 . . . . 0.0 112.122 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.449 HH11 HH21 ' A' ' 35' ' ' ARG . 60.0 ttt85 -31.9 -40.68 0.04 OUTLIER 'General case' 0 C--N 1.349 0.544 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.083 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -55.54 -76.35 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.281 -1.781 . . . . 0.0 109.405 177.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 17' ' ' ALA . 56.8 tptt -38.92 -39.81 0.57 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 112.993 -1.912 . . . . 0.0 110.915 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.576 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -54.61 -70.76 0.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 117.071 -1.852 . . . . 0.0 108.705 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 24' ' ' SER . 47.6 mt-10 -39.36 -43.25 1.16 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.504 -2.135 . . . . 0.0 110.753 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' O ' ' OG ' ' A' ' 24' ' ' SER . 34.6 mt-10 -61.8 -91.78 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.4 -175.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.0 ptm -45.02 -39.65 5.83 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 117.524 -1.67 . . . . 0.0 110.687 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 23.5 tp -59.93 -41.11 91.05 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.748 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.602 ' C ' ' H ' ' A' ' 26' ' ' GLN . 81.1 p -67.4 -37.35 82.97 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.471 176.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -70.66 35.16 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.613 -1.631 . . . . 0.0 111.053 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.602 ' H ' ' C ' ' A' ' 24' ' ' SER . 13.6 mm100 -107.95 145.67 33.5 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 118.082 -1.447 . . . . 0.0 109.397 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -91.21 -69.79 0.72 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.876 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -61.72 105.11 0.5 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.956 -1.929 . . . . 0.0 109.709 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -45.99 121.03 2.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.623 -2.08 . . . . 0.0 109.537 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.2 -22.11 4.03 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 117.98 -2.057 . . . . 0.0 112.674 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.57 ' HB3' HE21 ' A' ' 26' ' ' GLN . . . -46.98 114.14 0.79 Allowed 'General case' 0 C--N 1.35 0.605 0 C-N-CA 118.245 -1.382 . . . . 0.0 108.995 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.51 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 17.4 p90 -132.29 160.69 35.49 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 116.675 -2.01 . . . . 0.0 110.753 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.404 ' HG ' ' OG ' ' A' ' 47' ' ' SER . 4.5 pp -150.73 149.67 30.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 116.401 -2.12 . . . . 0.0 109.74 169.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.8 mt -108.44 106.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.62 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' CB ' HG23 ' A' ' 14' ' ' ILE . 31.8 ptt-85 -94.95 126.78 40.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 112.623 -2.08 . . . . 0.0 110.077 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 12' ' ' GLY . 63.7 tt0 -69.06 120.48 14.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.874 -1.967 . . . . 0.0 109.121 177.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 43.0 t -45.81 120.31 2.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.817 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.52 ' HA ' ' HZ3' ' A' ' 13' ' ' LYS . 61.3 tt0 -45.3 -40.1 7.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 112.743 -2.026 . . . . 0.0 110.81 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.8 m -89.93 -95.15 0.11 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.168 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 37' ' ' SER . . . -53.66 130.37 55.17 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 113.699 -1.591 . . . . 0.0 109.621 -176.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.35 -6.16 15.41 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.833 1.689 . . . . 0.0 114.968 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.61 40.37 2.35 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 118.506 -1.807 . . . . 0.0 111.065 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 1.0 OUTLIER -133.0 120.83 21.89 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 117.747 -1.581 . . . . 0.0 109.836 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.412 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 86.7 m-85 -125.61 130.39 51.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.558 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.7 p -127.72 132.92 49.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.162 -1.836 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 tt -94.8 115.26 27.28 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.806 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.509 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 91.4 p -102.58 130.96 49.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.85 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.77 149.38 30.51 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 117.768 -1.573 . . . . 0.0 110.281 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 41.7 tptt -82.28 101.94 10.86 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.888 -1.96 . . . . 0.0 108.842 172.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 53' ' ' ASP . 10.4 t80 -110.04 144.75 38.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 113.321 -1.763 . . . . 0.0 108.871 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . -45.47 135.56 7.86 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 117.225 -2.417 . . . . 0.0 110.912 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.442 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 58.4 t30 76.72 -34.57 0.22 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 111.536 -2.332 . . . . 0.0 111.075 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 51' ' ' GLY . 11.0 m-20 -157.35 153.35 27.18 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 114.955 -2.698 . . . . 0.0 111.592 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.486 ' CG2' ' HB3' ' A' ' 24' ' ' SER . 66.5 t -69.95 125.23 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 112.325 -2.216 . . . . 0.0 108.991 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.545 HE22 ' CD1' ' A' ' 95' ' ' ILE . 11.2 tt0 -90.04 164.0 14.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.542 -177.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.509 ' CE1' ' CG ' ' A' ' 58' ' ' LYS . 16.6 t-160 -140.86 129.58 22.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 112.959 -1.928 . . . . 0.0 111.124 -168.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 92.2 m-85 -138.31 103.15 4.83 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.263 175.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.509 ' CG ' ' CE1' ' A' ' 56' ' ' HIS . 53.6 mtmt -74.39 120.64 20.23 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 117.381 -1.728 . . . . 0.0 110.323 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG13 ' CD2' ' A' ' 77' ' ' LEU . 56.6 t -75.32 87.37 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 112.688 -2.051 . . . . 0.0 108.69 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 71.3 mt -80.47 158.2 25.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.023 -1.899 . . . . 0.0 110.182 -174.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -131.04 157.19 43.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.663 -178.296 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -153.31 153.73 33.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 112.215 -2.266 . . . . 0.0 109.797 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -48.6 -40.61 25.0 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.126 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -116.11 -42.21 3.08 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 118.026 -1.47 . . . . 0.0 110.373 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 66' ' ' LYS . . . -53.31 -24.96 24.78 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 118.293 -1.908 . . . . 0.0 112.613 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.571 ' HZ2' ' CA ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 58.71 -156.14 0.34 Allowed 'General case' 0 C--N 1.349 0.548 0 C-N-CA 117.956 -1.498 . . . . 0.0 108.959 -177.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 88.8 m-85 -76.67 125.23 28.89 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 116.886 -1.926 . . . . 0.0 109.303 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -159.29 145.9 16.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.942 -1.935 . . . . 0.0 110.968 -177.015 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 69' ' ' LEU . 1.7 mm? -74.09 -66.9 0.66 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.94 -1.936 . . . . 0.0 108.88 175.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 19.0 m0 -136.15 -44.48 0.63 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 112.395 -2.184 . . . . 0.0 110.137 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.2 t -125.75 -80.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 112.99 -1.914 . . . . 0.0 110.445 -173.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.0 m -48.74 134.36 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.421 -172.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -101.51 155.05 18.31 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.829 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 74' ' ' PHE . 5.6 p90 -170.05 138.62 1.73 Allowed 'General case' 0 C--N 1.342 0.275 0 CA-C-N 111.153 -2.748 . . . . 0.0 109.156 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -98.2 24.13 7.51 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 112.711 -2.041 . . . . 0.0 111.724 176.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 40.3 t -144.94 132.16 20.54 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 116.814 -1.955 . . . . 0.0 110.345 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.504 ' CD2' HG13 ' A' ' 59' ' ' VAL . 96.1 mt -56.88 -44.58 82.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 113.178 -1.828 . . . . 0.0 109.57 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -51.43 -45.63 62.69 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.756 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 76' ' ' SER . 31.7 tp10 -58.67 -38.2 77.69 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.62 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.468 ' CD1' HG21 ' A' ' 59' ' ' VAL . 7.9 tt -60.19 -46.27 90.29 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.331 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 77' ' ' LEU . 86.4 t -65.49 -35.53 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 112.78 -2.009 . . . . 0.0 111.337 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 24.6 t0 -58.7 -43.01 89.94 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.373 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.46 ' C ' ' H ' ' A' ' 85' ' ' ARG . 33.2 m-85 -64.55 -42.76 95.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.112 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.486 ' CB ' HD13 ' A' ' 97' ' ' LEU . 38.2 m170 -80.03 30.28 0.27 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 113.599 -1.637 . . . . 0.0 111.378 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 83' ' ' TYR . 79.7 ttt-85 -112.98 -38.58 4.46 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 117.973 -1.491 . . . . 0.0 110.762 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.5 p -99.6 -39.82 8.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 117.974 -1.49 . . . . 0.0 110.677 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 88' ' ' SER . 8.8 t -106.17 39.13 1.86 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 117.731 -1.588 . . . . 0.0 110.863 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 87' ' ' THR . 44.2 t 44.93 -169.35 0.01 OUTLIER 'General case' 0 C--N 1.347 0.473 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.842 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.403 ' N ' ' OG ' ' A' ' 88' ' ' SER . 10.9 p -117.81 -39.88 2.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.359 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.605 ' HG ' ' CG ' ' A' ' 92' ' ' ASN . 32.8 t -109.38 -23.94 11.3 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 113.796 -1.547 . . . . 0.0 112.164 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 90' ' ' SER . 59.0 mtp85 66.61 -5.98 0.57 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.213 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.605 ' CG ' ' HG ' ' A' ' 90' ' ' SER . 15.9 m120 -48.21 -68.22 0.2 Allowed 'General case' 0 C--N 1.348 0.53 0 C-N-CA 117.481 -1.688 . . . . 0.0 109.323 177.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 94' ' ' GLN . 54.6 mt-30 -123.46 40.74 3.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.41 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 93' ' ' GLN . 23.2 tt0 57.32 111.44 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.485 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.545 ' CD1' HE22 ' A' ' 55' ' ' GLN . 55.2 mt -116.57 137.33 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 113.064 -1.88 . . . . 0.0 110.258 -178.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -121.47 133.37 55.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.735 -2.03 . . . . 0.0 109.112 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.486 HD13 ' CB ' ' A' ' 84' ' ' HIS . 80.8 mt -89.93 105.88 18.1 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.749 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.74 ' CD ' ' H ' ' A' ' 99' ' ' ASP . 0.7 OUTLIER 177.98 -141.94 0.01 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 112.35 -2.204 . . . . 0.0 107.678 -178.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.74 ' H ' ' CD ' ' A' ' 98' ' ' ARG . 27.0 m-20 69.61 -27.44 0.16 Allowed 'General case' 0 C--N 1.347 0.461 0 O-C-N 125.383 1.677 . . . . 0.0 113.104 166.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.527 ' H ' ' C ' ' A' ' 98' ' ' ARG . 13.3 tt -75.04 30.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 116.653 -2.019 . . . . 0.0 112.119 -172.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 99' ' ' ASP . 43.2 tt0 -150.06 111.96 4.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.596 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 48.7 tt0 -140.15 47.61 1.8 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.191 -1.822 . . . . 0.0 109.565 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.521 ' CG1' ' HD3' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -147.22 -61.97 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 112.613 -2.085 . . . . 0.0 110.245 -178.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.521 ' HD3' ' CG1' ' A' ' 103' ' ' VAL . 32.8 Cg_exo -50.23 131.36 31.12 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.347 2.031 . . . . 0.0 113.24 172.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.438 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 19.1 mm100 88.65 12.88 0.08 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 112.168 -2.287 . . . . 0.0 113.299 175.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.441 ' CD ' ' O ' ' A' ' 106' ' ' GLN . 0.1 OUTLIER -170.06 74.38 0.64 Allowed Pre-proline 0 C--N 1.349 0.557 0 C-N-CA 117.829 -1.548 . . . . 0.0 109.493 175.455 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 108' ' ' THR . 58.7 Cg_endo -81.26 117.72 3.19 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.841 2.36 . . . . 0.0 111.214 -178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 107' ' ' PRO . 6.1 t 45.74 117.06 0.0 OUTLIER 'General case' 0 C--N 1.347 0.471 0 CA-C-N 112.699 -2.046 . . . . 0.0 112.263 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.45 ' O ' ' CD2' ' A' ' 109' ' ' TYR . 52.3 p90 -65.99 118.35 9.65 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.669 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 108' ' ' THR . 34.3 m -115.83 127.23 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.768 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 111' ' ' GLN . 20.7 pt20 -45.8 122.26 3.63 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 112.996 -1.911 . . . . 0.0 109.734 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.438 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.666 -179.843 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 9' ' ' TRP 0.252 60.9 Cg_endo . . . . . 0 N--CA 1.452 -0.912 0 N-CA-C 110.883 -0.468 . . . . 0.0 110.883 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 1.3 m-90 -135.22 60.68 1.69 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 -15.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CE1' ' CA ' ' A' ' 12' ' ' GLY . 50.9 t80 -90.58 124.0 34.68 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 110.928 -2.851 . . . . 0.0 112.379 -155.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.7 m-85 -127.78 92.01 3.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 112.105 -2.316 . . . . 0.0 107.862 167.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.517 ' CA ' ' CE1' ' A' ' 10' ' ' PHE . . . -54.91 116.33 6.6 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.958 -170.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' CD ' ' OE2' ' A' ' 38' ' ' GLU . 25.4 pttm 31.1 42.28 0.01 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 111.685 -2.257 . . . . 0.0 111.109 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.518 ' CG1' ' HD2' ' A' ' 18' ' ' LYS . 10.3 tp -62.79 129.2 92.85 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 112.971 -1.922 . . . . 0.0 108.843 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.4 Cg_exo -45.86 123.29 5.92 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.834 1.689 . . . . 0.0 113.194 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 15' ' ' PRO . 41.5 ttm180 -37.06 -41.86 0.38 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.707 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -56.32 -81.19 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.246 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.604 ' CE ' ' SD ' ' A' ' 22' ' ' MET . 8.1 tmtm? -31.48 -42.66 0.05 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 112.646 -2.07 . . . . 0.0 111.029 -176.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -58.05 -69.55 0.17 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.717 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' SER . 53.5 mt-10 -48.03 -52.9 18.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.592 -2.095 . . . . 0.0 110.255 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 24' ' ' SER . 77.4 mm-40 -40.4 -87.46 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.753 -2.021 . . . . 0.0 110.621 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.604 ' SD ' ' CE ' ' A' ' 18' ' ' LYS . 16.9 ptm -50.77 -53.08 34.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.088 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.543 HD13 ' CD1' ' A' ' 100' ' ' ILE . 48.3 tp -48.38 -21.93 0.62 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 117.223 -1.791 . . . . 0.0 112.681 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 37.0 t -83.18 -35.97 25.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.78 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HD3' ' CA ' ' A' ' 22' ' ' MET . 5.2 pttp -42.75 -25.18 0.08 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.028 172.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.473 ' HG3' ' CB ' ' A' ' 31' ' ' ALA . 38.6 mm-40 -53.9 141.96 25.9 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.481 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -81.71 -69.49 0.61 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 111.936 -2.393 . . . . 0.0 110.455 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -76.1 -156.97 0.07 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.749 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -122.5 130.38 52.99 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 112.75 -2.023 . . . . 0.0 110.068 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.37 34.47 1.01 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 118.236 -1.935 . . . . 0.0 111.901 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.473 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -99.9 131.93 45.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 118.114 -1.434 . . . . 0.0 108.101 173.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' SER . 40.2 p90 -143.08 157.55 44.42 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 115.231 -2.588 . . . . 0.0 111.835 -173.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -148.43 151.83 35.9 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 112.003 -2.362 . . . . 0.0 109.451 171.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.85 110.71 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 112.492 -2.14 . . . . 0.0 108.976 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 34.4 ptt180 -96.7 128.11 43.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.373 -2.194 . . . . 0.0 110.051 -174.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.439 ' O ' ' CA ' ' A' ' 13' ' ' LYS . 45.1 tt0 -79.05 126.06 30.21 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.062 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.464 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 49.9 m -58.57 138.58 56.74 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 112.781 -2.009 . . . . 0.0 109.955 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' OE2' ' CD ' ' A' ' 13' ' ' LYS . 9.7 tp10 -38.6 -90.65 0.0 OUTLIER 'General case' 0 C--N 1.345 0.375 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.624 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 40' ' ' ALA . 49.0 m -89.9 -36.55 14.97 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 113.601 -1.636 . . . . 0.0 111.259 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HB3' ' CB ' ' A' ' 37' ' ' SER . . . -42.58 150.23 0.43 Allowed Pre-proline 0 C--N 1.348 0.508 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.158 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.67 -116.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.995 2.463 . . . . 0.0 110.784 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.02 57.83 4.83 Favored Glycine 0 C--N 1.346 1.089 0 C-N-CA 118.145 -1.979 . . . . 0.0 110.869 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 3.4 m-20 -102.9 117.1 33.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 117.903 -1.519 . . . . 0.0 109.32 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.403 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 95.3 m-85 -134.24 130.28 36.92 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 112.904 -1.953 . . . . 0.0 109.839 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 77.7 p -119.0 126.38 51.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.48 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.0 tt -93.51 115.07 27.57 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.354 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.434 ' OG ' ' HG ' ' A' ' 33' ' ' LEU . 90.3 p -94.04 144.64 25.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.789 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 60.7 t -146.44 137.4 18.51 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.726 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 66.3 tttp -73.36 93.66 1.95 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 116.83 -1.948 . . . . 0.0 108.824 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.477 ' O ' ' O ' ' A' ' 51' ' ' GLY . 4.6 t80 -92.6 40.6 1.06 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.615 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . 58.6 145.37 0.01 OUTLIER Glycine 0 C--N 1.346 1.131 0 C-N-CA 118.148 -1.977 . . . . 0.0 110.54 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 58.6 t30 72.07 -35.04 0.32 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 112.475 -1.863 . . . . 0.0 110.854 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 51' ' ' GLY . 56.2 p30 -171.45 -163.63 0.29 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 117.264 -1.775 . . . . 0.0 110.295 176.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.474 ' CG1' HD23 ' A' ' 23' ' ' LEU . 88.4 t -108.76 123.87 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 112.369 -2.196 . . . . 0.0 110.009 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -100.44 157.97 16.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.716 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.61 133.85 36.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 112.515 -2.129 . . . . 0.0 110.304 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.499 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 92.6 m-85 -113.19 111.12 21.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.927 -1.942 . . . . 0.0 109.897 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 29.6 mmmt -72.25 100.36 2.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.089 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 98.9 t -72.09 88.47 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 113.041 -1.891 . . . . 0.0 108.553 173.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 82.0 mt -74.04 160.41 31.32 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.733 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 . . . . . 0 N--CA 1.447 -0.586 0 CA-C-N 112.032 -2.349 . . . . 0.0 108.628 177.19 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 122.291 1.044 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 17.3 m-85 -86.82 142.37 28.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.244 -2.253 . . . . 0.0 109.503 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -160.22 124.71 3.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.989 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.499 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 1.7 mt -61.59 -83.49 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.155 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -110.16 -42.76 4.09 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.222 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.0 t -137.93 -82.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.599 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.4 HG11 ' CZ ' ' A' ' 83' ' ' TYR . 24.4 m -47.03 134.2 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 112.649 -2.069 . . . . 0.0 110.544 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.56 165.98 12.26 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.563 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.783 ' CZ ' HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -170.04 140.13 1.94 Allowed 'General case' 0 C--N 1.343 0.31 0 CA-C-N 111.505 -2.589 . . . . 0.0 109.631 -175.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -91.88 -13.43 31.31 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 111.692 -2.504 . . . . 0.0 112.558 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 79' ' ' GLU . 41.1 t -140.56 129.93 23.85 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 117.573 -1.651 . . . . 0.0 109.908 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 80' ' ' LEU . 99.3 mt -47.12 -39.81 14.18 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.455 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -52.0 -45.43 64.53 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.149 -1.82 . . . . 0.0 109.594 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 83' ' ' TYR . 47.4 tp10 -57.0 -32.68 66.37 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 113.16 -1.836 . . . . 0.0 111.284 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.783 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 7.1 tt -72.1 -70.83 0.31 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.333 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.6 t -37.98 -35.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 112.685 -2.052 . . . . 0.0 111.187 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -80.3 -42.07 23.72 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.563 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 65.5 t80 -58.72 -43.08 90.05 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.2 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.421 ' NE2' ' CD1' ' A' ' 69' ' ' LEU . 87.7 m-70 -89.5 39.13 0.93 Allowed 'General case' 0 C--N 1.345 0.406 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.689 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.66 HH12 HH21 ' A' ' 98' ' ' ARG . 60.7 ttm-85 -107.33 -40.63 5.33 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.368 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -89.97 -40.89 12.07 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.476 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 87' ' ' THR . 23.6 m -110.97 41.29 1.85 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 117.831 -1.547 . . . . 0.0 110.903 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.606 ' HB3' ' H ' ' A' ' 95' ' ' ILE . 41.8 m 43.14 -153.59 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.527 169.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.437 ' O ' HG22 ' A' ' 89' ' ' VAL . 15.0 p -153.99 44.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-N 113.058 -1.883 . . . . 0.0 109.788 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' A' ' 95' ' ' ILE . 43.0 t . . . . . 0 C--N 1.347 0.482 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.731 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.418 ' O ' ' HG3' ' A' ' 94' ' ' GLN . 21.4 pt20 . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 122.103 0.954 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.606 ' H ' ' HB3' ' A' ' 88' ' ' SER . 64.2 mt -115.96 151.63 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 112.622 -2.081 . . . . 0.0 109.433 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -143.71 138.78 29.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.35 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.4 mt -89.92 118.54 29.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.995 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.66 HH21 HH12 ' A' ' 85' ' ' ARG . 2.0 mmp_? -126.17 149.36 49.05 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.521 -2.127 . . . . 0.0 109.875 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 101' ' ' GLU . 7.1 m-20 -54.01 124.19 14.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 112.163 -2.29 . . . . 0.0 109.83 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.543 ' CD1' HD13 ' A' ' 23' ' ' LEU . 10.6 tt -71.95 31.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 112.533 -2.121 . . . . 0.0 111.578 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 99' ' ' ASP . 47.3 mm-40 . . . . . 0 N--CA 1.448 -0.569 0 C-N-CA 118.001 -1.479 . . . . 0.0 109.651 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' O ' ' CD2' ' A' ' 9' ' ' TRP . 75.2 Cg_exo . . . . . 0 N--CA 1.459 -0.538 0 N-CA-C 116.93 1.858 . . . . 0.0 116.93 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.458 ' CD2' ' O ' ' A' ' 8' ' ' PRO . 32.5 p-90 49.25 16.65 0.16 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 111.872 -2.422 . . . . 0.0 113.502 170.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -97.77 119.13 35.82 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 116.229 -2.188 . . . . 0.0 109.653 175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 8.6 m-85 -121.92 109.14 14.26 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 113.076 -1.875 . . . . 0.0 109.164 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -69.22 129.18 23.04 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 112.56 -2.109 . . . . 0.0 111.557 -174.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.467 ' CE ' ' HB2' ' A' ' 38' ' ' GLU . 83.7 tttt 25.89 47.66 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 111.713 -2.243 . . . . 0.0 111.899 176.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.427 HG22 ' CB ' ' A' ' 35' ' ' ARG . 8.7 tp -75.21 134.0 74.45 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 117.268 -1.773 . . . . 0.0 108.8 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' ARG . 20.8 Cg_endo -65.67 124.54 12.93 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.178 1.919 . . . . 0.0 111.332 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' CZ ' ' NH2' ' A' ' 35' ' ' ARG . 94.9 mtt-85 -34.22 -41.6 0.11 Allowed 'General case' 0 C--N 1.349 0.558 0 CA-C-N 112.779 -2.009 . . . . 0.0 110.983 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -54.72 -72.13 0.07 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.243 -1.798 . . . . 0.0 109.537 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 22' ' ' MET . 4.8 tppp? -41.74 -49.52 4.3 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.492 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -47.36 -58.53 4.04 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.479 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 89.4 mt-10 -49.96 -52.06 36.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.733 -2.03 . . . . 0.0 109.989 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 70.9 mt-10 -55.53 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.891 -1.958 . . . . 0.0 110.852 -173.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 3.0 ptm -45.46 -39.99 7.81 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.773 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.532 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 45.7 tp -68.56 -32.03 71.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 117.644 -1.623 . . . . 0.0 111.755 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.534 ' C ' ' H ' ' A' ' 26' ' ' GLN . 59.3 m -68.58 -35.9 78.0 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 117.503 -1.679 . . . . 0.0 111.044 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -72.07 33.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.241 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.757 HE21 ' HA ' ' A' ' 26' ' ' GLN . 1.3 mm-40 -101.69 132.37 47.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 117.818 -1.553 . . . . 0.0 110.022 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -81.26 -41.93 21.45 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 111.707 -2.497 . . . . 0.0 110.599 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.49 106.88 18.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.583 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -53.74 123.94 13.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.705 -2.043 . . . . 0.0 109.419 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 136.55 -31.77 2.54 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 117.585 -2.245 . . . . 0.0 112.037 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -46.32 136.61 7.04 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 118.078 -1.449 . . . . 0.0 109.358 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 47' ' ' SER . 28.2 p90 -145.3 162.76 36.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 116.384 -2.126 . . . . 0.0 110.982 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 33' ' ' LEU . 4.5 pp -147.95 150.17 33.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.343 -2.208 . . . . 0.0 109.577 172.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.7 mt -116.92 111.98 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 112.666 -2.061 . . . . 0.0 108.662 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 40.7 ptt85 -95.59 129.09 42.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 112.634 -2.076 . . . . 0.0 110.259 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -96.96 128.36 43.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 112.45 -2.159 . . . . 0.0 109.869 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 43.2 t -60.54 155.63 18.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.845 -1.979 . . . . 0.0 109.613 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.467 ' HB2' ' CE ' ' A' ' 13' ' ' LYS . 45.3 tt0 -41.08 -91.52 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 112.563 -2.108 . . . . 0.0 110.252 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 40' ' ' ALA . 50.5 m -90.0 -44.25 9.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.1 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -41.44 102.58 0.27 Allowed Pre-proline 0 C--N 1.347 0.488 0 CA-C-N 113.218 -1.81 . . . . 0.0 110.059 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.62 -4.45 14.6 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.88 1.72 . . . . 0.0 115.079 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.45 39.63 2.69 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 118.422 -1.846 . . . . 0.0 111.108 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 54.9 m-20 -130.32 112.17 13.05 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 117.736 -1.586 . . . . 0.0 109.933 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 96.9 m-85 -147.64 117.54 7.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.867 -1.969 . . . . 0.0 109.389 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 79.0 p -122.98 128.04 49.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.486 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.487 ' CD2' ' CG2' ' A' ' 48' ' ' VAL . 6.2 tt -93.59 119.7 32.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.81 -1.995 . . . . 0.0 109.673 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 50.1 m -99.44 145.02 27.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.534 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.487 ' CG2' ' CD2' ' A' ' 46' ' ' LEU . 88.6 t -145.36 138.67 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 113.378 -1.737 . . . . 0.0 110.452 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.604 ' HZ2' ' C ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -80.35 106.56 12.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 112.869 -1.969 . . . . 0.0 108.721 173.046 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 95' ' ' ILE . 72.8 t80 -79.76 -104.33 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 116.847 -1.941 . . . . 0.0 108.928 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.91 -69.08 1.35 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 118.718 -1.706 . . . . 0.0 109.633 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.604 ' C ' ' HZ2' ' A' ' 49' ' ' LYS . 29.1 t-20 -130.4 -24.31 2.55 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 111.978 -2.111 . . . . 0.0 112.088 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -99.9 157.37 16.57 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 118.661 -1.216 . . . . 0.0 110.473 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG2' ' OG ' ' A' ' 24' ' ' SER . 88.6 t -85.25 114.59 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.693 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.415 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 62.0 tt0 -90.27 158.74 17.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.933 -1.94 . . . . 0.0 109.399 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -130.66 131.62 44.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.779 -2.01 . . . . 0.0 110.746 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 45' ' ' SER . 96.3 m-85 -123.81 133.34 53.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.432 -2.167 . . . . 0.0 109.137 175.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.6 ' HZ2' ' HB2' ' A' ' 58' ' ' LYS . 10.6 mtmp? -104.06 107.97 19.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.321 -1.752 . . . . 0.0 110.242 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 72.1 t -76.57 85.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 112.683 -2.053 . . . . 0.0 108.565 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.597 HD21 ' HZ3' ' A' ' 58' ' ' LYS . 71.9 mt -70.33 161.0 31.22 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 112.68 -2.055 . . . . 0.0 110.679 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HG3' ' CE1' ' A' ' 67' ' ' TYR . 1.9 tmt_? . . . . . 0 N--CA 1.449 -0.501 0 CA-C-N 112.392 -2.186 . . . . 0.0 109.884 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.129 0.49 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 55.0 m-85 -88.05 129.53 35.25 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 115.848 -2.341 . . . . 0.0 109.899 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -159.27 134.57 8.36 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 112.344 -2.207 . . . . 0.0 109.171 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.678 ' H ' HD12 ' A' ' 69' ' ' LEU . 4.2 mp -68.77 -52.95 24.9 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 116.682 -2.007 . . . . 0.0 109.247 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 18.2 m0 -135.53 -41.41 0.7 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.53 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.5 t -138.33 -83.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.546 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -47.19 133.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 112.552 -2.113 . . . . 0.0 110.782 -171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -94.21 158.38 15.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.491 -2.141 . . . . 0.0 110.592 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.878 ' CZ ' HD12 ' A' ' 80' ' ' LEU . 6.6 p90 -159.13 140.14 12.78 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 111.156 -2.747 . . . . 0.0 109.213 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -81.41 -16.91 50.7 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 111.247 -2.706 . . . . 0.0 112.352 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 79' ' ' GLU . 40.3 t -147.28 134.89 20.99 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 117.681 -1.608 . . . . 0.0 109.97 -175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 80' ' ' LEU . 82.6 mt -46.61 -42.89 16.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 112.724 -2.035 . . . . 0.0 110.288 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 38.5 m-80 -49.53 -46.82 49.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.545 -1.661 . . . . 0.0 109.572 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 76' ' ' SER . 41.9 tt0 -57.92 -34.72 70.16 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 112.922 -1.944 . . . . 0.0 111.098 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.878 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 5.4 tt -61.93 -65.54 0.67 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.783 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.5 t -43.83 -35.8 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 112.07 -2.332 . . . . 0.0 111.076 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 72.6 m-20 -59.87 -38.57 82.54 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.833 -178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.406 ' N ' ' O ' ' A' ' 80' ' ' LEU . 23.0 m-85 -66.24 -51.96 52.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.836 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.05 36.59 0.51 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.971 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 6.1 tpm_? -101.12 7.7 43.13 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.389 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 87' ' ' THR . 79.4 p -89.93 -78.2 0.37 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 118.656 -1.218 . . . . 0.0 109.896 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.418 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 9.2 t -170.02 39.48 0.02 OUTLIER 'General case' 0 C--N 1.346 0.451 0 C-N-CA 116.7 -2.0 . . . . 0.0 110.997 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 87' ' ' THR . 77.6 p -177.22 140.98 0.31 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 116.887 -1.925 . . . . 0.0 110.537 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.4 ' CG2' HG22 ' A' ' 95' ' ' ILE . 38.4 t -114.3 -38.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 111.985 -2.371 . . . . 0.0 110.778 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 C--N 1.346 0.446 0 C-N-CA 117.989 -1.484 . . . . 0.0 110.127 -175.372 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 50' ' ' PHE . 25.0 mt -149.29 121.39 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 117.314 -1.754 . . . . 0.0 109.963 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.582 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 67.3 m-85 -120.62 140.6 51.32 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.76 -2.018 . . . . 0.0 109.499 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.97 106.67 18.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 117.311 -1.756 . . . . 0.0 108.825 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -121.5 152.81 38.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.4 -173.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -45.08 126.82 6.31 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 112.441 -2.163 . . . . 0.0 109.52 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.492 ' CD1' HD13 ' A' ' 23' ' ' LEU . 15.4 tt -84.63 2.64 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 112.766 -2.016 . . . . 0.0 113.656 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 . . . . . 0 N--CA 1.447 -0.61 0 C-N-CA 117.774 -1.571 . . . . 0.0 110.303 -176.539 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.453 -0.853 0 CA-C-O 122.076 0.782 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.467 ' CB ' ' CE2' ' A' ' 32' ' ' PHE . 59.2 p-90 38.57 47.37 1.1 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-N 112.538 -2.119 . . . . 0.0 110.545 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -142.67 108.4 5.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.438 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 12' ' ' GLY . 9.8 m-85 -125.03 97.23 5.17 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.195 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -27.79 -105.7 0.0 OUTLIER Glycine 0 C--N 1.347 1.167 0 CA-C-N 112.184 -2.28 . . . . 0.0 112.77 -174.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 63.9 tttp -110.19 53.52 0.69 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 112.77 -1.715 . . . . 0.0 109.035 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.43 HG22 ' CB ' ' A' ' 35' ' ' ARG . 8.5 tp -71.08 133.74 85.68 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.977 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' ARG . 23.1 Cg_endo -66.24 124.05 12.02 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.184 1.923 . . . . 0.0 111.268 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 15' ' ' PRO . 68.1 ttt180 -33.74 -39.38 0.06 Allowed 'General case' 0 C--N 1.347 0.495 0 CA-C-N 112.766 -2.016 . . . . 0.0 111.124 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -53.55 -81.17 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.049 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 17' ' ' ALA . 16.8 tppt? -36.45 -36.54 0.1 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 112.977 -1.919 . . . . 0.0 111.374 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.549 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -59.23 -72.29 0.1 Allowed 'General case' 0 C--N 1.347 0.487 0 C-N-CA 117.375 -1.73 . . . . 0.0 109.061 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 21' ' ' GLU . 94.3 mt-10 -43.97 -56.13 4.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 112.541 -2.118 . . . . 0.0 109.801 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 11.9 mm-40 -37.05 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.317 -2.22 . . . . 0.0 110.887 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 17.7 ptm -56.84 -40.69 76.56 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 117.536 -1.666 . . . . 0.0 110.79 -172.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 39.5 tp -50.82 -32.78 21.17 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 116.922 -1.911 . . . . 0.0 111.433 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.555 ' C ' ' H ' ' A' ' 26' ' ' GLN . 41.6 t -75.51 -39.78 57.96 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.201 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -71.55 36.19 0.06 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.305 -1.77 . . . . 0.0 110.923 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.555 ' H ' ' C ' ' A' ' 24' ' ' SER . 5.4 mm-40 -102.28 -172.96 2.23 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 117.926 -1.509 . . . . 0.0 109.697 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.439 ' O ' ' C ' ' A' ' 28' ' ' HIS . 3.0 mpt_? -75.63 37.34 0.14 Allowed 'General case' 0 C--N 1.346 0.428 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.947 -176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 26' ' ' GLN . 82.1 m-70 38.09 36.25 0.11 Allowed 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.258 176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 74.8 m-20 -141.49 76.33 1.54 Allowed 'General case' 0 C--N 1.347 0.498 0 C-N-CA 116.748 -1.981 . . . . 0.0 110.975 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.547 ' HA2' ' CG1' ' A' ' 48' ' ' VAL . . . 46.72 20.89 0.72 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 113.013 -1.903 . . . . 0.0 113.373 170.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.412 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -52.29 135.81 31.94 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 116.765 -1.974 . . . . 0.0 108.043 172.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.467 ' CE2' ' CB ' ' A' ' 9' ' ' TRP . 30.5 p90 -139.48 148.62 42.95 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 115.656 -2.418 . . . . 0.0 111.926 -169.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -139.58 150.89 45.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 112.082 -2.326 . . . . 0.0 109.333 171.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.403 HD12 ' CE3' ' A' ' 9' ' ' TRP . 60.5 mt -117.69 107.93 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.622 175.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 31.4 ptt-85 -98.38 140.21 32.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 112.904 -1.953 . . . . 0.0 110.556 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' GLY . 23.9 pt-20 -105.36 137.46 43.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.307 -2.224 . . . . 0.0 109.451 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 36' ' ' GLU . 49.9 m -57.88 -153.87 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.692 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -71.63 -95.35 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.558 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 40' ' ' ALA . 87.1 p -89.99 -41.9 11.47 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.223 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -38.83 100.68 0.21 Allowed Pre-proline 0 C--N 1.348 0.519 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.248 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' SER . 57.9 Cg_endo -77.37 -4.36 14.63 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.855 1.703 . . . . 0.0 115.034 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.49 37.37 3.63 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 118.579 -1.772 . . . . 0.0 111.378 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 49.9 m-20 -129.74 100.83 5.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 117.732 -1.587 . . . . 0.0 109.647 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 21.6 m-85 -132.32 121.33 23.37 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.662 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.439 ' OG ' ' CZ ' ' A' ' 35' ' ' ARG . 78.8 p -119.04 126.56 51.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.096 -1.866 . . . . 0.0 109.37 178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.465 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.3 tt -90.36 114.34 26.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.765 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 33.8 m -97.34 149.51 22.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.314 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.547 ' CG1' ' HA2' ' A' ' 30' ' ' GLY . 75.5 t -140.64 141.56 32.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 113.397 -1.729 . . . . 0.0 110.29 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.509 ' CG ' ' HA ' ' A' ' 28' ' ' HIS . 22.2 tptp -73.78 97.29 2.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.792 -2.004 . . . . 0.0 108.847 173.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.479 ' O ' ' O ' ' A' ' 53' ' ' ASP . 5.7 t80 -116.46 110.43 18.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.031 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 50' ' ' PHE . . . -30.97 143.8 0.01 OUTLIER Glycine 0 C--N 1.347 1.193 0 CA-C-N 112.734 -2.03 . . . . 0.0 111.826 -176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 14.0 t30 82.99 -28.69 0.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 111.848 -2.176 . . . . 0.0 111.39 -175.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.557 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 30.7 t0 -172.53 -148.01 0.04 OUTLIER 'General case' 0 C--N 1.35 0.62 0 C-N-CA 116.33 -2.148 . . . . 0.0 110.381 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.557 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 93.3 t -129.22 119.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.506 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 60.1 tt0 -90.01 159.95 16.61 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.052 -1.885 . . . . 0.0 109.655 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -146.73 145.17 29.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.66 -175.069 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.419 ' CE2' HG13 ' A' ' 89' ' ' VAL . 41.0 m-85 -134.02 110.48 9.68 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.304 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 56.1 mtmt -65.83 115.28 5.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 116.299 -2.16 . . . . 0.0 109.415 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 46.7 t -78.81 102.01 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 113.244 -1.798 . . . . 0.0 108.426 174.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 78.7 mt -93.96 -167.93 1.78 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.183 -169.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 66' ' ' LYS . 34.9 tpt85 . . . . . 0 CA--C 1.539 0.528 0 CA-C-N 111.954 -2.385 . . . . 0.0 110.387 172.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.517 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 5.3 mtpm? . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 121.318 0.58 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 28.1 m-85 -94.93 139.03 31.9 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 117.512 -1.675 . . . . 0.0 110.617 -168.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.527 ' CB ' ' HA ' ' A' ' 73' ' ' LYS . 4.0 p90 -141.22 152.38 44.54 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 116.251 -2.18 . . . . 0.0 110.366 172.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.458 HD11 ' CG ' ' A' ' 80' ' ' LEU . 15.3 mt -90.49 -85.82 0.21 Allowed 'General case' 0 C--N 1.346 0.447 0 CA-C-N 112.744 -2.025 . . . . 0.0 109.633 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.403 ' CZ2' HG22 ' A' ' 89' ' ' VAL . 34.7 m0 -91.13 -44.8 9.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.887 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.7 t -145.34 -87.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 113.196 -1.82 . . . . 0.0 109.85 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.0 m -53.58 132.37 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.838 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.527 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 23.2 pttp -82.42 -162.37 0.56 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 112.818 -1.992 . . . . 0.0 109.988 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 67' ' ' TYR . 20.9 m-85 -154.8 137.38 15.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.73 -2.032 . . . . 0.0 108.726 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.517 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 54.4 p30 -65.45 -0.91 2.14 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 112.981 -1.918 . . . . 0.0 113.042 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 80.3 p 178.21 146.57 0.14 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.15 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 80' ' ' LEU . 92.6 mt -47.28 -40.29 16.44 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 116.897 -1.921 . . . . 0.0 110.176 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.437 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 14.9 m120 -55.59 -38.15 69.03 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.809 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 76' ' ' SER . 36.5 tt0 -70.18 -23.91 63.05 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 117.49 -1.684 . . . . 0.0 111.868 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 80' ' ' LEU . 9.0 tt -71.95 -49.33 38.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.046 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.79 -37.11 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 112.434 -2.166 . . . . 0.0 110.827 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 66.1 m-20 -74.66 -37.82 62.63 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 113.943 -1.481 . . . . 0.0 111.01 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 44.8 t80 -64.45 -52.34 58.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.743 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -86.27 40.55 0.88 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.564 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -73.28 -36.84 66.4 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.806 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.542 ' C ' ' H ' ' A' ' 88' ' ' SER . 46.3 m -136.87 -27.0 1.02 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 118.16 -1.416 . . . . 0.0 112.079 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' SER . 10.3 t -70.51 26.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 118.099 -1.44 . . . . 0.0 112.23 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 86' ' ' SER . 80.2 p 43.21 -166.66 0.01 OUTLIER 'General case' 0 C--N 1.348 0.521 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.235 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.457 ' O ' HG22 ' A' ' 89' ' ' VAL . 13.8 p -178.58 43.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 112.59 -2.096 . . . . 0.0 109.794 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.449 -0.476 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.406 -179.052 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.466 ' O ' ' OE1' ' A' ' 94' ' ' GLN . 5.9 tm0? . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.842 0.83 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.415 HD13 ' O ' ' A' ' 94' ' ' GLN . 12.7 mm -149.38 120.93 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.139 173.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.425 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 76.3 m-85 -138.8 139.45 38.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 113.118 -1.855 . . . . 0.0 108.879 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 86.2 mt -89.66 94.05 9.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.04 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.414 ' HD3' ' CB ' ' A' ' 29' ' ' ASP . 68.7 mtp85 -92.79 137.32 32.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 111.749 -2.478 . . . . 0.0 109.913 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 101' ' ' GLU . 16.1 m-20 -48.58 118.75 2.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 112.412 -2.176 . . . . 0.0 109.377 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.467 ' CD1' HD23 ' A' ' 33' ' ' LEU . 11.0 tt -71.22 27.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 112.76 -2.018 . . . . 0.0 112.193 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 99' ' ' ASP . 55.2 mm-40 . . . . . 0 N--CA 1.446 -0.642 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.083 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 CA--C 1.543 0.946 0 N-CA-C 114.163 0.793 . . . . 0.0 114.163 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.69 35.04 3.15 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.265 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -110.97 109.14 19.14 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.894 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 15.7 m-85 -105.82 99.18 8.79 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 117.709 -1.596 . . . . 0.0 109.332 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -66.27 124.59 25.43 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 112.102 -2.317 . . . . 0.0 111.485 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' CA ' ' O ' ' A' ' 36' ' ' GLU . 26.0 pttm 32.39 40.31 0.02 OUTLIER 'General case' 0 C--N 1.344 0.341 0 CA-C-N 111.857 -2.171 . . . . 0.0 111.145 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.501 ' CG1' ' HD2' ' A' ' 18' ' ' LYS . 10.8 tp -68.5 127.31 93.24 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.6 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' ARG . 53.5 Cg_exo -44.98 121.89 3.88 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.753 1.635 . . . . 0.0 113.103 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 15' ' ' PRO . 43.8 ttp180 -36.68 -37.53 0.14 Allowed 'General case' 0 C--N 1.345 0.4 0 CA-C-N 112.811 -1.995 . . . . 0.0 111.178 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' GLU . . . -70.43 -59.06 3.08 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.748 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.54 ' HE3' ' SD ' ' A' ' 22' ' ' MET . 7.2 tmtm? -44.69 -49.76 10.27 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.863 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -41.58 -54.3 3.24 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.835 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' SER . 66.0 mt-10 -60.35 -34.69 74.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.214 -2.267 . . . . 0.0 111.548 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' OG ' ' A' ' 24' ' ' SER . 61.7 mt-10 -64.41 -70.76 0.21 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 117.182 -1.807 . . . . 0.0 111.05 -171.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.54 ' SD ' ' HE3' ' A' ' 18' ' ' LYS . 26.6 ptm -61.44 -39.17 89.84 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 116.836 -1.945 . . . . 0.0 110.644 -175.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.464 HD23 ' CG1' ' A' ' 54' ' ' VAL . 32.1 tp -61.28 -41.4 96.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 117.805 -1.558 . . . . 0.0 110.5 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.547 ' C ' ' H ' ' A' ' 26' ' ' GLN . 75.6 p -64.87 -37.77 88.76 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.593 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 53.9 mttt -70.98 35.9 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.001 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.547 ' H ' ' C ' ' A' ' 24' ' ' SER . 43.0 mm-40 -108.96 135.77 49.6 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 117.981 -1.488 . . . . 0.0 110.003 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' A' ' 28' ' ' HIS . 10.0 mpt_? -91.21 89.96 7.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 111.813 -2.449 . . . . 0.0 109.407 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.496 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER 117.38 121.51 0.0 OUTLIER 'General case' 0 C--N 1.349 0.547 0 CA-C-N 111.561 -2.563 . . . . 0.0 109.277 177.392 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 49' ' ' LYS . 66.7 m-20 -61.01 132.03 52.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.686 -2.052 . . . . 0.0 109.876 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 146.45 -35.14 1.34 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 118.091 -2.004 . . . . 0.0 111.732 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -43.08 150.85 0.16 Allowed 'General case' 0 C--N 1.349 0.56 0 C-N-CA 118.581 -1.248 . . . . 0.0 109.717 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 47' ' ' SER . 44.0 p90 -154.8 160.45 41.28 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 115.157 -2.617 . . . . 0.0 111.84 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.495 HD23 ' CD1' ' A' ' 100' ' ' ILE . 0.4 OUTLIER -116.91 -174.42 2.58 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.534 169.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.6 mt -147.36 103.33 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 111.103 -2.772 . . . . 0.0 107.382 153.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 50.1 ptt85 -97.47 149.34 22.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.054 -169.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 37' ' ' SER . 39.4 tt0 -114.45 142.96 45.7 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 112.021 -2.354 . . . . 0.0 110.024 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' GLU . 35.8 t -53.84 -167.52 0.0 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.783 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' ' OG ' ' A' ' 37' ' ' SER . 39.9 tt0 -98.58 -70.04 0.74 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.109 -1.859 . . . . 0.0 110.37 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 89.3 p -89.97 30.67 1.04 Allowed 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.948 -173.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -179.46 136.44 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.637 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.574 ' C ' ' H ' ' A' ' 43' ' ' ASP . 57.0 Cg_endo -72.29 -143.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.981 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 172.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 -31.76 0.39 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 118.438 -1.839 . . . . 0.0 112.517 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 41' ' ' PRO . 17.5 t70 -90.05 108.74 19.91 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.945 -175.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 23.8 m-85 -133.41 123.08 24.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.544 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 57' ' ' PHE . 79.6 p -133.82 128.67 35.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 112.952 -1.931 . . . . 0.0 109.348 177.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.463 HD22 ' CG2' ' A' ' 48' ' ' VAL . 5.5 tt -84.14 116.21 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.693 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.8 m -93.2 143.17 26.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.965 -1.925 . . . . 0.0 108.932 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.463 ' CG2' HD22 ' A' ' 46' ' ' LEU . 58.2 t -135.05 141.54 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 117.041 -1.864 . . . . 0.0 110.43 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.821 ' HA ' ' HZ3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -82.55 97.33 8.4 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.439 -2.164 . . . . 0.0 109.086 176.386 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.482 ' N ' ' HZ2' ' A' ' 49' ' ' LYS . 9.3 t80 -110.07 139.92 44.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 117.527 -1.669 . . . . 0.0 109.145 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 52' ' ' ASN . . . -46.33 143.01 4.77 Favored Glycine 0 C--N 1.343 0.958 0 C-N-CA 117.322 -2.37 . . . . 0.0 110.399 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 57.0 t30 77.65 -31.17 0.17 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 111.859 -2.17 . . . . 0.0 111.365 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 50' ' ' PHE . 2.8 p30 -174.93 154.31 1.84 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 115.346 -2.542 . . . . 0.0 111.829 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.464 ' CG1' HD23 ' A' ' 23' ' ' LEU . 92.2 t -72.92 125.84 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.459 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 60.3 tt0 -90.04 163.13 15.02 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.775 -177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -133.37 123.61 25.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 112.622 -2.081 . . . . 0.0 110.6 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.41 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 22.9 m-85 -123.19 144.99 49.0 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 112.816 -1.993 . . . . 0.0 109.403 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -105.89 116.62 32.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.232 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 80' ' ' LEU . 33.4 t -89.36 101.21 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 112.667 -2.061 . . . . 0.0 108.171 173.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' ARG . 69.4 mt -82.61 152.58 25.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 112.933 -1.94 . . . . 0.0 111.743 -166.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.507 HH12 ' HZ ' ' A' ' 68' ' ' PHE . 22.6 ptt-85 . . . . . 0 CA--C 1.538 0.484 0 CA-C-N 110.272 -3.149 . . . . 0.0 113.298 -172.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.711 ' HZ2' ' HB3' ' A' ' 73' ' ' LYS . 10.3 mtmp? . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.454 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 76.5 m-85 -97.2 127.49 43.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 117.509 -1.676 . . . . 0.0 108.987 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' HZ ' HH12 ' A' ' 61' ' ' ARG . 31.1 p90 -157.87 153.6 26.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 116.124 -2.23 . . . . 0.0 110.366 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 80' ' ' LEU . 4.7 mp -95.07 -43.02 8.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.215 -1.812 . . . . 0.0 110.031 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -138.73 -78.12 0.35 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.163 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.9 t -105.46 -85.25 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.584 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.31 131.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 112.823 -1.99 . . . . 0.0 109.874 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.711 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 64.0 mttm -102.79 179.91 4.15 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.853 -1.976 . . . . 0.0 110.304 -176.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 67' ' ' TYR . 14.1 m-85 -150.17 133.42 16.35 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 112.693 -2.049 . . . . 0.0 109.28 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.438 ' O ' ' OG ' ' A' ' 76' ' ' SER . 40.6 p-10 -69.44 -5.46 23.94 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.119 -1.855 . . . . 0.0 113.449 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 49.4 m -167.93 149.21 5.26 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 117.724 -1.591 . . . . 0.0 109.784 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.507 ' CD2' HG11 ' A' ' 59' ' ' VAL . 87.2 mt -45.71 -45.68 14.45 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.202 -1.817 . . . . 0.0 109.831 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -54.07 -41.59 68.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 112.821 -1.991 . . . . 0.0 110.512 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 76' ' ' SER . 48.5 tp10 -63.86 -31.87 73.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 116.627 -2.029 . . . . 0.0 110.941 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 69' ' ' LEU . 5.9 tt -63.16 -50.88 68.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 118.522 -1.271 . . . . 0.0 108.4 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 82' ' ' ASP . 87.4 t -54.72 -75.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.673 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.464 ' HA ' ' CD ' ' A' ' 85' ' ' ARG . 33.2 t0 -34.22 -47.49 0.29 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.617 -2.083 . . . . 0.0 111.273 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -71.7 -32.62 68.01 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.863 -172.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.421 ' C ' ' H ' ' A' ' 86' ' ' SER . 35.8 m170 -98.68 -6.73 29.1 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 117.688 -1.605 . . . . 0.0 113.18 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.464 ' CD ' ' HA ' ' A' ' 82' ' ' ASP . 9.0 ptm180 -82.42 39.11 0.58 Allowed 'General case' 0 C--N 1.348 0.533 0 C-N-CA 116.889 -1.924 . . . . 0.0 110.557 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 84' ' ' HIS . 79.9 p -150.0 -73.81 0.17 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.741 -1.572 . . . . 0.0 109.566 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.408 ' N ' ' OG ' ' A' ' 86' ' ' SER . 60.0 p -84.08 38.31 0.65 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 112.966 -1.925 . . . . 0.0 110.961 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 95' ' ' ILE . 48.4 t 48.54 -168.97 0.02 OUTLIER 'General case' 0 C--N 1.346 0.425 0 C-N-CA 117.919 -1.512 . . . . 0.0 109.888 177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.506 ' H ' ' HB ' ' A' ' 95' ' ' ILE . 13.6 p -152.51 43.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.439 0 CA-C-N 113.199 -1.818 . . . . 0.0 110.201 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.483 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 19.2 t . . . . . 0 N--CA 1.45 -0.426 0 CA-C-N 113.145 -1.843 . . . . 0.0 108.793 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' OE1' ' CZ ' ' A' ' 50' ' ' PHE . 42.8 tt0 . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 111.644 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.506 ' HB ' ' H ' ' A' ' 89' ' ' VAL . 13.0 mm -102.04 147.49 8.72 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 C-N-CA 117.367 -1.733 . . . . 0.0 110.499 -175.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.577 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 90.5 m-85 -149.99 135.55 18.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.631 -2.077 . . . . 0.0 109.101 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.3 mt -89.89 118.55 29.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 116.958 -1.897 . . . . 0.0 109.553 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 17.4 tpt180 -121.33 147.85 45.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.71 -2.041 . . . . 0.0 110.258 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 101' ' ' GLU . 67.6 m-20 -61.0 116.21 4.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.431 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.495 ' CD1' HD23 ' A' ' 33' ' ' LEU . 12.0 tt -72.19 32.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.644 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' A' ' 99' ' ' ASP . 17.8 mm-40 . . . . . 0 N--CA 1.447 -0.598 0 C-N-CA 117.884 -1.526 . . . . 0.0 109.787 -174.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 CA--C 1.54 0.821 0 N-CA-C 113.872 0.682 . . . . 0.0 113.872 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.41 ' CZ3' HD12 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -133.15 32.94 3.67 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.473 -177.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -89.63 121.09 31.49 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 117.594 -1.642 . . . . 0.0 109.961 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.9 m-85 -105.28 92.38 4.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 112.962 -1.926 . . . . 0.0 108.598 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -55.82 120.46 19.03 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 112.447 -2.161 . . . . 0.0 111.584 -172.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.481 ' CA ' ' O ' ' A' ' 36' ' ' GLU . 17.4 ptpt 28.77 44.71 0.01 OUTLIER 'General case' 0 C--N 1.346 0.433 0 CA-C-N 111.591 -2.305 . . . . 0.0 111.384 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.8 tp -63.17 131.23 94.68 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.611 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.5 Cg_exo -45.25 121.43 3.75 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.719 1.612 . . . . 0.0 112.886 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.496 ' NH1' ' CB ' ' A' ' 16' ' ' ARG . 22.4 ttm105 -38.78 -40.53 0.63 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.818 -177.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -63.8 -59.92 3.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 113.47 -1.695 . . . . 0.0 109.627 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -44.65 -51.09 9.46 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 112.917 -1.947 . . . . 0.0 110.182 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -45.49 -47.02 14.11 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 113.456 -1.702 . . . . 0.0 109.842 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 88.8 mt-10 -62.65 -46.38 88.47 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.116 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 24' ' ' SER . 40.5 mt-10 -60.82 -77.93 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.693 -2.049 . . . . 0.0 110.644 -173.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 21' ' ' GLU . 2.9 ptm -43.87 -38.78 3.53 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.884 -176.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.505 HD23 ' CG1' ' A' ' 54' ' ' VAL . 28.4 tp -71.55 -33.17 68.89 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.62 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.474 ' C ' ' H ' ' A' ' 26' ' ' GLN . 53.5 m -70.41 -28.01 64.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 117.888 -1.525 . . . . 0.0 111.897 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -76.98 42.36 0.31 Allowed 'General case' 0 C--N 1.349 0.55 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.314 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.609 HE21 HG13 ' A' ' 100' ' ' ILE . 22.6 mm-40 -112.28 136.11 52.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.224 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.463 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 74.9 mtp85 -38.64 -85.26 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 111.646 -2.525 . . . . 0.0 110.37 -177.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 1.2 m-70 163.27 117.33 0.0 OUTLIER 'General case' 0 C--N 1.348 0.505 0 CA-C-N 112.506 -2.134 . . . . 0.0 107.995 -175.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -166.75 135.68 2.87 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.956 1.703 . . . . 0.0 108.462 -0.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 138.71 -9.98 3.41 Favored Glycine 0 CA--C 1.544 1.896 0 C-N-CA 117.301 -2.38 . . . . 0.0 113.41 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -46.19 144.58 1.93 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 118.372 -1.331 . . . . 0.0 109.142 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 47' ' ' SER . 53.4 p90 -147.76 160.13 43.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 115.868 -2.333 . . . . 0.0 111.424 -174.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.4 pp -149.07 153.07 37.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.001 -2.363 . . . . 0.0 109.29 173.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 45' ' ' SER . 23.0 mt -115.91 112.52 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.785 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 30.4 ptt-85 -96.71 128.52 43.74 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 112.153 -2.294 . . . . 0.0 110.394 -172.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' O ' ' CA ' ' A' ' 13' ' ' LYS . 2.9 mp0 -79.05 112.32 16.13 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.281 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.477 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 50.5 m -58.52 144.61 41.91 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 112.921 -1.945 . . . . 0.0 110.413 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.8 tp10 -46.28 -96.76 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 112.359 -2.2 . . . . 0.0 110.024 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.1 t -113.58 43.1 1.84 Allowed 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.403 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.477 ' HB3' ' CB ' ' A' ' 37' ' ' SER . . . -99.05 154.65 37.21 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 113.134 -1.848 . . . . 0.0 108.983 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' ALA . 74.7 Cg_exo -34.82 -110.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.917 2.411 . . . . 0.0 114.54 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . -47.7 -59.78 5.82 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 117.333 -2.365 . . . . 0.0 108.352 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -111.47 107.27 16.41 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 113.772 -1.214 . . . . 0.0 108.103 -45.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -90.36 137.36 32.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.128 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 27.4 t -133.39 132.35 41.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.621 -2.081 . . . . 0.0 109.335 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.501 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.7 tt -103.05 115.93 31.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.953 -1.931 . . . . 0.0 109.319 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 49.8 m -97.41 149.17 22.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.948 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 85.6 t -143.51 140.95 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 113.048 -1.887 . . . . 0.0 109.731 176.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 66.3 tttp -73.06 102.59 3.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 116.64 -2.024 . . . . 0.0 108.931 173.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' O ' ' CD1' ' A' ' 50' ' ' PHE . 62.7 t80 -88.29 -8.99 54.31 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.256 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . 88.54 134.74 4.96 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 118.875 -1.631 . . . . 0.0 109.431 -174.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 7.3 t30 71.91 -33.36 0.27 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 112.307 -1.947 . . . . 0.0 110.826 -174.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 51' ' ' GLY . 18.5 t70 -159.13 -175.57 5.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 117.416 -1.714 . . . . 0.0 109.436 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.539 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 85.5 t -114.42 121.8 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.701 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.601 ' NE2' ' CZ ' ' A' ' 57' ' ' PHE . 55.9 tt0 -90.69 159.29 16.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.769 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -141.76 143.7 33.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.024 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.601 ' CZ ' ' NE2' ' A' ' 55' ' ' GLN . 83.5 m-85 -122.3 105.08 9.89 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.697 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.1 mmmp? -65.58 105.0 1.11 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.942 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 64.9 t -75.05 96.92 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.274 172.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 88.7 mt -79.41 -161.52 0.33 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.165 -170.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.578 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 111.799 -2.455 . . . . 0.0 108.378 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.539 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 3.4 mtpm? . . . . . 0 CA--C 1.543 0.7 0 CA-C-O 121.927 0.87 . . . . 0.0 113.29 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 94.0 m-85 -144.02 140.76 29.75 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.539 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -163.75 134.95 4.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 114.768 -2.773 . . . . 0.0 111.884 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -124.81 162.97 23.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 112.204 -2.271 . . . . 0.0 107.713 163.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 38.5 m0 64.86 -84.66 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 111.986 -2.37 . . . . 0.0 110.188 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 69' ' ' LEU . 51.6 t -139.16 -92.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 116.902 -1.919 . . . . 0.0 110.428 -173.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -55.28 141.29 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.677 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.419 ' C ' ' CG ' ' A' ' 74' ' ' PHE . 67.7 mttm -76.98 -165.88 0.62 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 112.821 -1.991 . . . . 0.0 109.438 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.419 ' CG ' ' C ' ' A' ' 73' ' ' LYS . 15.3 m-85 -157.06 136.45 12.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.059 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.539 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 2.6 p-10 -65.48 -5.14 7.02 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.076 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 80.2 p 178.22 153.72 0.33 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.988 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.441 ' CD2' HG11 ' A' ' 59' ' ' VAL . 94.1 mt -45.35 -42.52 10.08 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 117.386 -1.726 . . . . 0.0 110.21 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 14.0 t-20 -58.4 -40.49 82.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.239 -1.8 . . . . 0.0 110.816 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 76' ' ' SER . 43.1 tp10 -63.18 -30.11 71.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 116.644 -2.022 . . . . 0.0 111.237 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.484 HD23 ' C ' ' A' ' 80' ' ' LEU . 5.8 tt -71.42 -59.96 2.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.531 176.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 97.5 t -46.15 -31.99 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 112.618 -2.083 . . . . 0.0 111.501 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 90.2 m-20 -80.06 -42.08 24.41 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.362 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -59.63 -41.08 89.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.591 -1.641 . . . . 0.0 110.449 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.436 ' CG ' HG23 ' A' ' 89' ' ' VAL . 33.1 m170 -90.41 39.69 0.98 Allowed 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.54 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 62.0 ttt180 -124.45 0.8 8.3 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.876 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -89.91 -45.84 8.95 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.795 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 87' ' ' THR . 9.3 t -170.05 119.21 0.6 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 117.02 -1.872 . . . . 0.0 110.597 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.561 ' HA ' ' H ' ' A' ' 95' ' ' ILE . 43.0 t 66.14 143.89 0.03 OUTLIER 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.689 -2.05 . . . . 0.0 110.963 172.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 89' ' ' VAL . 14.0 p -147.74 42.98 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.879 172.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.53 ' CB ' HD12 ' A' ' 95' ' ' ILE . 48.1 t . . . . . 0 C--N 1.347 0.469 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.39 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.418 ' HA ' ' OG ' ' A' ' 88' ' ' SER . 93.3 mt-30 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.93 0.871 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.561 ' H ' ' HA ' ' A' ' 88' ' ' SER . 40.6 mt -143.13 140.88 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.811 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.45 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 16.8 m-30 -111.67 146.45 37.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.524 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.6 mt -90.04 118.93 29.97 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 117.079 -1.848 . . . . 0.0 109.284 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 90.0 mtt-85 -122.23 146.79 46.94 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.905 -1.952 . . . . 0.0 109.97 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 100' ' ' ILE . 33.5 m-20 -57.12 122.63 12.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.759 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.621 HG12 ' H ' ' A' ' 101' ' ' GLU . 14.9 tt -59.74 -136.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 112.739 -2.028 . . . . 0.0 109.391 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.621 ' H ' HG12 ' A' ' 100' ' ' ILE . 81.0 mt-10 . . . . . 0 N--CA 1.447 -0.593 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.777 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 CA--C 1.543 0.946 0 N-CA-C 114.166 0.794 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.438 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 4.6 p-90 -161.34 31.19 0.14 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.653 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.438 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 96.5 m-85 -103.11 120.23 40.31 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.013 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 12' ' ' GLY . 8.1 m-85 -108.51 108.58 19.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.746 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -16.7 -111.57 0.0 OUTLIER Glycine 0 C--N 1.349 1.259 0 CA-C-N 111.67 -2.514 . . . . 0.0 113.016 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -116.12 43.07 2.23 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 112.978 -1.611 . . . . 0.0 109.88 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.9 tp -53.12 114.46 6.01 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.315 -178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' ARG . 47.2 Cg_exo -50.15 125.84 15.83 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.581 1.52 . . . . 0.0 111.869 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.734 ' HB3' HH12 ' A' ' 35' ' ' ARG . 18.3 ptp180 -34.7 -38.14 0.07 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.481 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -69.52 -62.44 1.38 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.455 -1.702 . . . . 0.0 109.74 178.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.521 ' CD ' HD11 ' A' ' 14' ' ' ILE . 0.1 OUTLIER -38.22 -44.43 0.86 Allowed 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.219 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -54.38 -59.88 4.09 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 112.735 -2.029 . . . . 0.0 109.459 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' ALA . 89.3 mt-10 -43.26 -43.65 4.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 112.795 -2.002 . . . . 0.0 110.263 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 24' ' ' SER . 38.5 mt-10 -60.6 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.443 -175.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.519 ' HB3' ' HZ3' ' A' ' 18' ' ' LYS . 17.3 ptm -43.28 -40.31 3.44 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.794 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 25' ' ' LYS . 31.8 tp -64.71 -36.74 85.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.132 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.51 ' OG ' ' CG2' ' A' ' 54' ' ' VAL . 63.2 m -73.23 28.71 0.06 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 117.368 -1.733 . . . . 0.0 111.656 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.551 ' H ' ' C ' ' A' ' 23' ' ' LEU . 53.1 mtpt -135.03 46.21 2.45 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.198 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.548 HE21 HG13 ' A' ' 100' ' ' ILE . 17.6 mm-40 -119.77 117.56 28.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 112.877 -1.965 . . . . 0.0 109.926 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 31.8 tpt85 -98.56 30.95 3.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 111.453 -2.612 . . . . 0.0 112.327 -169.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 29' ' ' ASP . 73.4 m80 -149.39 11.84 0.8 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 116.019 -2.273 . . . . 0.0 113.593 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' HIS . 7.6 t70 58.77 141.9 0.01 OUTLIER 'General case' 0 C--N 1.347 0.474 0 CA-C-O 122.155 0.979 . . . . 0.0 110.79 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.25 -21.82 43.76 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 117.749 -2.167 . . . . 0.0 112.932 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.514 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -42.58 117.46 1.03 Allowed 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.774 -1.17 . . . . 0.0 109.748 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.461 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 29.6 p90 -130.9 158.87 39.06 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 116.399 -2.121 . . . . 0.0 111.632 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 33' ' ' LEU . 4.5 pp -151.87 153.53 34.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 112.618 -2.083 . . . . 0.0 109.753 172.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.717 ' CD1' HD12 ' A' ' 77' ' ' LEU . 15.6 mt -121.46 113.39 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.639 -2.073 . . . . 0.0 108.793 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.734 HH12 ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -84.57 131.16 34.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 115.423 -2.511 . . . . 0.0 110.156 -175.541 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.9 tp10 -72.27 69.53 0.8 Allowed 'General case' 0 C--N 1.346 0.42 0 CA-C-N 112.744 -2.025 . . . . 0.0 109.401 176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' GLU . 60.0 p 24.7 -147.61 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 112.158 -2.292 . . . . 0.0 111.791 -177.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -130.58 -70.56 0.61 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 112.999 -1.909 . . . . 0.0 109.021 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.1 t -134.87 43.85 2.68 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 112.435 -2.166 . . . . 0.0 109.677 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.596 ' HB3' ' CA ' ' A' ' 41' ' ' PRO . . . -80.18 -65.14 0.29 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.471 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.596 ' CA ' ' HB3' ' A' ' 40' ' ' ALA . 84.2 Cg_endo -93.02 -2.11 49.82 Favored 'Cis proline' 0 C--N 1.357 0.978 0 N-CA-C 114.903 1.078 . . . . 0.0 114.903 -4.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.5 55.35 4.41 Favored Glycine 0 C--N 1.346 1.111 0 C-N-CA 119.052 -1.546 . . . . 0.0 111.493 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' A' ' 37' ' ' SER . 49.3 m-20 -130.35 94.63 3.71 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 117.675 -1.61 . . . . 0.0 109.676 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -110.64 127.29 55.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 112.931 -1.94 . . . . 0.0 109.698 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 20.4 p -125.17 132.34 53.06 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.25 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.473 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.4 tt -91.68 113.95 26.35 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.099 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.9 m -95.33 153.0 17.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.159 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.4 t -153.12 135.92 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 117.167 -1.813 . . . . 0.0 110.11 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 89.0 tttt -83.32 106.94 15.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 112.946 -1.933 . . . . 0.0 108.645 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -75.22 -79.44 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.57 -176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.3 -75.94 0.44 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-N 111.796 -2.456 . . . . 0.0 109.871 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.64 -24.35 9.26 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 112.107 -2.046 . . . . 0.0 111.99 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -111.6 156.78 21.26 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 118.464 -1.294 . . . . 0.0 110.115 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' CG2' ' OG ' ' A' ' 24' ' ' SER . 99.1 t -83.44 105.27 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 112.683 -2.053 . . . . 0.0 109.952 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 56' ' ' HIS . 7.0 tm0? -96.98 145.71 25.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.081 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.616 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 44.4 p-80 -134.0 168.62 18.47 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.044 -171.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.599 ' CZ ' ' NE2' ' A' ' 55' ' ' GLN . 85.3 m-85 -139.02 112.13 7.99 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 112.142 -2.299 . . . . 0.0 109.208 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.41 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 37.4 mtmm -77.74 108.93 11.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 116.203 -2.199 . . . . 0.0 109.771 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.512 HG21 ' CD1' ' A' ' 77' ' ' LEU . 89.6 t -74.68 89.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.71 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 55.2 mt -81.39 152.35 27.5 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 112.61 -2.086 . . . . 0.0 109.664 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 10.7 ttt180 . . . . . 0 N--CA 1.445 -0.69 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.76 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 4.6 mtpm? . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.236 0.541 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 87.8 m-85 -106.33 134.23 49.79 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.335 -177.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -151.79 172.04 16.77 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 116.616 -2.034 . . . . 0.0 110.983 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 80' ' ' LEU . 5.0 mp -112.17 -91.67 0.48 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 111.833 -2.44 . . . . 0.0 109.498 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -90.15 -40.59 12.13 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.789 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 82.4 t -149.44 -85.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 117.428 -1.709 . . . . 0.0 110.203 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.404 HG23 ' CE1' ' A' ' 74' ' ' PHE . 32.6 m -49.42 132.45 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.367 -174.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -87.5 151.0 23.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 112.238 -2.255 . . . . 0.0 109.963 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.404 ' CE1' HG23 ' A' ' 72' ' ' VAL . 7.2 m-85 -125.71 141.72 51.87 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 112.557 -2.11 . . . . 0.0 108.603 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.443 ' O ' ' OG ' ' A' ' 76' ' ' SER . 1.7 p-10 -56.78 -33.64 66.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 116.856 -1.937 . . . . 0.0 111.126 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 69.0 m -170.67 170.47 6.67 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 118.465 -1.294 . . . . 0.0 109.451 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.717 HD12 ' CD1' ' A' ' 34' ' ' ILE . 3.7 mm? -39.8 -46.93 2.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.355 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 76' ' ' SER . 6.0 p-10 -52.35 -50.55 62.13 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 114.798 -2.761 . . . . 0.0 110.284 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 6.6 tp10 -64.08 -15.85 60.47 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 116.502 -2.079 . . . . 0.0 112.392 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 69' ' ' LEU . 5.0 tt -83.04 -70.55 0.55 Allowed 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.42 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 81' ' ' VAL . 92.0 t -35.87 -37.7 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 112.051 -2.34 . . . . 0.0 111.146 174.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 84' ' ' HIS . 25.1 t0 -70.81 -50.83 31.31 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.898 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 84' ' ' HIS . 16.3 m-30 -78.32 42.07 0.41 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.602 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.553 ' C ' ' H ' ' A' ' 86' ' ' SER . 58.8 m80 -152.44 -21.26 0.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.275 -1.784 . . . . 0.0 112.362 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 85' ' ' ARG . 11.7 ptp85 -75.08 38.84 0.13 Allowed 'General case' 0 C--N 1.348 0.543 0 C-N-CA 117.232 -1.787 . . . . 0.0 110.701 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.553 ' H ' ' C ' ' A' ' 84' ' ' HIS . 50.4 m -110.84 -45.73 3.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.566 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' SER . 8.9 t -169.95 105.9 0.34 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.173 -1.83 . . . . 0.0 109.991 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.588 ' HA ' ' H ' ' A' ' 95' ' ' ILE . 39.2 t 54.28 164.33 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.749 -2.023 . . . . 0.0 110.491 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 89' ' ' VAL . 14.7 p -143.93 42.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.381 0 CA-C-N 112.607 -2.088 . . . . 0.0 110.039 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 37.4 t . . . . . 0 C--N 1.348 0.504 0 CA-C-N 113.607 -1.633 . . . . 0.0 109.979 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 121.952 0.882 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.588 ' H ' ' HA ' ' A' ' 88' ' ' SER . 58.5 mt -132.75 125.81 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 112.896 -1.956 . . . . 0.0 109.717 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.81 145.84 47.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.844 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.9 mt -89.95 106.7 18.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.488 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HG2' ' H ' ' A' ' 99' ' ' ASP . 47.6 ttt180 -177.16 -159.63 0.05 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.413 -2.176 . . . . 0.0 107.567 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.586 ' H ' ' HG2' ' A' ' 98' ' ' ARG . 53.4 t0 80.35 -34.23 0.13 Allowed 'General case' 0 C--N 1.346 0.424 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.638 161.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.548 HG13 HE21 ' A' ' 26' ' ' GLN . 9.4 tt -69.84 20.61 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 115.886 -2.325 . . . . 0.0 112.92 -171.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 99' ' ' ASP . 75.5 tt0 . . . . . 0 N--CA 1.444 -0.768 0 C-N-CA 117.712 -1.595 . . . . 0.0 109.592 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo . . . . . 0 CA--C 1.543 0.927 0 N-CA-C 114.708 1.003 . . . . 0.0 114.708 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.401 ' CZ2' HG21 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -165.1 36.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.731 -175.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -101.34 125.33 47.96 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.279 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 6.2 m-85 -120.91 114.67 21.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 113.199 -1.818 . . . . 0.0 108.577 175.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -75.91 124.54 7.46 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 112.447 -2.16 . . . . 0.0 111.554 -174.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.497 ' CG ' ' HA ' ' A' ' 38' ' ' GLU . 43.6 mtmt 32.3 45.42 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 111.739 -2.23 . . . . 0.0 111.243 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 14' ' ' ILE . 10.4 tp -74.45 130.84 81.23 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 113.319 -1.764 . . . . 0.0 108.836 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' ARG . 50.9 Cg_exo -46.04 121.26 4.21 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.618 1.545 . . . . 0.0 112.717 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 15' ' ' PRO . 53.3 ttp180 -40.59 -41.01 1.38 Allowed 'General case' 0 C--N 1.345 0.393 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.627 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -61.46 -68.65 0.3 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.61 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 17' ' ' ALA . 17.1 tppt? -38.5 -47.05 1.24 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.735 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.715 ' HB3' HH21 ' A' ' 35' ' ' ARG . . . -50.41 -65.97 0.47 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.226 -1.806 . . . . 0.0 109.072 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -42.65 -43.97 4.07 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.492 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 24' ' ' SER . 44.9 mt-10 -64.66 -82.3 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.602 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.409 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 27.0 ptm -47.19 -35.93 8.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.224 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.584 ' O ' ' CG ' ' A' ' 26' ' ' GLN . 49.3 tp -67.92 -32.25 72.57 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.571 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 26' ' ' GLN . 38.7 t -74.46 -34.18 63.08 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 117.915 -1.514 . . . . 0.0 111.219 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -77.86 43.89 0.44 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.928 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.584 ' CG ' ' O ' ' A' ' 23' ' ' LEU . 23.1 mm-40 -114.35 -4.25 13.01 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.266 -1.788 . . . . 0.0 114.068 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 26' ' ' GLN . 10.6 tpp180 34.33 38.74 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.564 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 26' ' ' GLN . 1.7 t-80 -158.43 107.45 1.99 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.657 -1.611 . . . . 0.0 109.856 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.6 114.58 3.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.199 -1.818 . . . . 0.0 109.683 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 137.2 -31.96 2.47 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 117.611 -2.233 . . . . 0.0 112.101 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 30' ' ' GLY . . . -40.94 127.85 2.66 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.265 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.525 ' CD1' HD23 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -136.36 136.53 39.72 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.931 -1.94 . . . . 0.0 110.097 -177.487 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 33' ' ' LEU . 4.2 pp -128.03 147.97 50.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 111.289 -2.687 . . . . 0.0 108.195 160.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -107.7 104.46 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 113.568 -1.651 . . . . 0.0 108.708 178.343 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.715 HH21 ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -84.35 127.26 33.88 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.849 -175.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 37' ' ' SER . 39.6 tt0 -90.37 130.41 36.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 112.577 -2.101 . . . . 0.0 109.781 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 40' ' ' ALA . 1.6 p -39.95 122.11 1.41 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.414 -1.721 . . . . 0.0 110.257 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HA ' ' CG ' ' A' ' 13' ' ' LYS . 61.1 tt0 -49.55 -54.45 18.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.401 -2.181 . . . . 0.0 110.56 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 p -90.03 -94.59 0.11 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.065 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' O ' ' OG ' ' A' ' 37' ' ' SER . . . -53.76 139.64 50.85 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.04 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 43' ' ' ASP . 66.5 Cg_endo -77.44 -146.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 N-CA-C 106.879 -2.008 . . . . 0.0 106.879 171.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . 63.76 -18.45 0.09 OUTLIER Glycine 0 CA--C 1.542 1.726 0 O-C-N 124.84 1.338 . . . . 0.0 113.794 172.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 41' ' ' PRO . 70.2 m-20 -126.62 135.16 50.84 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 117.746 -1.582 . . . . 0.0 110.643 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.73 -169.82 2.37 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.285 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.456 ' OG ' ' HD3' ' A' ' 35' ' ' ARG . 74.7 p -170.05 137.86 1.63 Allowed 'General case' 0 C--N 1.345 0.408 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.465 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 32' ' ' PHE . 2.6 tt -98.22 113.91 25.99 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 112.936 -1.938 . . . . 0.0 110.413 -172.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.492 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 88.8 p -95.24 133.48 39.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.385 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' CG2' HD22 ' A' ' 46' ' ' LEU . 46.9 t -135.28 147.93 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 117.496 -1.682 . . . . 0.0 109.299 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HD3' ' H ' ' A' ' 28' ' ' HIS . 63.9 tttp -83.79 100.69 11.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 115.914 -2.314 . . . . 0.0 108.955 172.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 53' ' ' ASP . 6.6 t80 -119.46 103.07 9.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.79 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -26.56 141.3 0.01 OUTLIER Glycine 0 C--N 1.348 1.227 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.942 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.576 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 87.6 m-20 104.68 -52.89 0.0 OUTLIER 'General case' 0 C--N 1.345 0.403 0 CA-C-N 111.356 -2.422 . . . . 0.0 108.111 -165.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 16.9 t70 -177.75 -173.23 0.39 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 111.584 -2.553 . . . . 0.0 109.799 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.532 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 77.9 t -88.9 119.54 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 113.112 -1.858 . . . . 0.0 109.442 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.469 ' NE2' ' CZ ' ' A' ' 57' ' ' PHE . 59.3 tt0 -92.08 159.51 15.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.204 -1.816 . . . . 0.0 109.827 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 28.9 p80 -147.62 134.85 20.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.955 -174.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.469 ' CZ ' ' NE2' ' A' ' 55' ' ' GLN . 83.3 m-85 -127.21 111.26 13.75 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 112.629 -2.078 . . . . 0.0 109.229 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -58.52 122.16 12.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 116.811 -1.955 . . . . 0.0 109.549 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' A' ' 80' ' ' LEU . 67.1 t -94.2 87.43 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 112.797 -2.002 . . . . 0.0 108.624 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.6 mt -89.17 159.34 17.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.393 -2.185 . . . . 0.0 110.855 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 . . . . . 0 N--CA 1.444 -0.733 0 CA-C-N 112.55 -2.114 . . . . 0.0 109.484 173.721 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.687 ' N ' ' HZ3' ' A' ' 66' ' ' LYS . 1.2 mmpm? . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 122.289 1.042 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -101.97 143.23 32.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 112.195 -2.275 . . . . 0.0 108.513 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 71' ' ' VAL . 52.6 p90 -149.23 -161.64 1.39 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 116.204 -2.198 . . . . 0.0 111.099 -174.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.416 ' CG ' HD11 ' A' ' 80' ' ' LEU . 11.4 mt -137.28 -37.89 0.62 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 111.677 -2.51 . . . . 0.0 110.545 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -112.15 -41.09 4.02 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.508 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 92.6 t -150.01 -79.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 117.183 -1.807 . . . . 0.0 109.689 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 71' ' ' VAL . 20.1 m -162.75 134.96 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.777 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.5 ' CD ' ' CZ ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -170.04 -33.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 114.206 -2.998 . . . . 0.0 112.977 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.5 ' CZ ' ' CD ' ' A' ' 73' ' ' LYS . 2.6 m-85 -112.29 149.07 32.89 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 116.439 -2.104 . . . . 0.0 109.758 -174.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.577 ' HA ' ' HZ2' ' A' ' 66' ' ' LYS . 27.8 p30 -103.65 19.57 19.61 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.431 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.5 t -179.24 143.8 0.21 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.644 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 34' ' ' ILE . 82.6 mt -43.02 -46.12 5.41 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.011 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 12.1 m120 -59.17 -38.1 78.93 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.924 -177.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 76' ' ' SER . 61.5 tt0 -70.38 -26.08 63.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 117.111 -1.836 . . . . 0.0 111.689 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.566 ' CD1' HG13 ' A' ' 59' ' ' VAL . 9.1 tt -66.81 -50.36 62.88 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.908 174.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.401 HG21 ' CZ2' ' A' ' 9' ' ' TRP . 95.0 t -68.1 -30.54 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.026 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 84.7 m-20 -70.59 -44.46 67.29 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 118.341 -1.344 . . . . 0.0 110.307 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 2.0 t80 -83.57 29.2 0.53 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 116.366 -2.133 . . . . 0.0 111.989 -177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.558 ' C ' ' H ' ' A' ' 86' ' ' SER . 5.8 m-70 -130.21 -25.7 2.43 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.727 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 16.7 ptm180 -72.92 35.16 0.07 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 118.447 -1.301 . . . . 0.0 111.354 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 84' ' ' HIS . 50.3 m -150.02 -43.6 0.13 Allowed 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.939 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.412 ' O ' ' OG ' ' A' ' 88' ' ' SER . 8.7 t -118.13 45.47 1.98 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.871 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 87' ' ' THR . 87.9 p 51.44 -163.59 0.06 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.811 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.31 -39.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 112.832 -1.986 . . . . 0.0 110.461 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.511 ' H ' HD12 ' A' ' 95' ' ' ILE . 43.3 t . . . . . 0 N--CA 1.45 -0.446 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.487 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.668 0.747 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 90' ' ' SER . 56.6 mt -131.93 121.23 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.215 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.461 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 83.3 m-85 -114.09 121.94 45.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.186 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 70.6 mt -90.09 104.32 16.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.122 -1.853 . . . . 0.0 110.054 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' ASP . 67.5 ttt-85 -170.53 -116.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 116.601 -2.04 . . . . 0.0 110.546 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' ARG . 10.0 t70 -30.0 112.94 0.09 Allowed 'General case' 0 C--N 1.35 0.59 0 CA-C-N 113.681 -1.6 . . . . 0.0 111.667 -172.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.443 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 15.1 tt -120.41 -39.93 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 112.389 -2.187 . . . . 0.0 111.359 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 . . . . . 0 N--CA 1.447 -0.591 0 CA-C-N 112.724 -2.034 . . . . 0.0 109.642 -176.5 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 CA--C 1.544 0.986 0 N-CA-C 114.087 0.764 . . . . 0.0 114.087 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.431 ' CZ3' ' CE1' ' A' ' 10' ' ' PHE . 1.6 p-90 -147.15 26.5 1.08 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.125 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.431 ' CE1' ' CZ3' ' A' ' 9' ' ' TRP . 92.8 m-85 -90.6 110.66 21.81 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 118.319 -1.353 . . . . 0.0 109.582 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.0 m-85 -94.96 99.38 11.41 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.184 -1.825 . . . . 0.0 108.446 174.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -70.09 140.47 32.72 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 112.202 -2.272 . . . . 0.0 111.618 -173.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' GLY . 60.4 tttp 27.73 48.24 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.007 -2.097 . . . . 0.0 111.447 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 14' ' ' ILE . 11.0 tp -80.02 124.62 82.91 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 113.227 -1.806 . . . . 0.0 108.961 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' ARG . 50.5 Cg_exo -47.24 122.19 6.18 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.622 1.548 . . . . 0.0 112.815 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.528 ' NH1' ' CG ' ' A' ' 20' ' ' GLU . 1.6 tmt_? -38.28 -42.45 0.7 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 112.922 -1.945 . . . . 0.0 110.401 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -64.62 -58.5 6.16 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.105 -1.862 . . . . 0.0 109.956 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 15' ' ' PRO . 59.1 tptt -42.93 -51.37 5.59 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 113.033 -1.894 . . . . 0.0 110.125 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.765 ' CB ' HH21 ' A' ' 35' ' ' ARG . . . -43.03 -49.31 6.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.829 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.528 ' CG ' ' NH1' ' A' ' 16' ' ' ARG . 57.0 mt-10 -63.89 -44.72 92.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.581 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 34.8 mt-10 -63.3 -78.75 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.811 -1.995 . . . . 0.0 110.759 -171.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.528 ' CE ' ' CD2' ' A' ' 33' ' ' LEU . 22.9 ptt? -46.41 -38.29 8.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.994 -175.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 31.7 tp -69.6 -35.88 75.72 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 117.558 -1.657 . . . . 0.0 111.232 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 26' ' ' GLN . 92.5 p -62.87 -27.65 69.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 117.674 -1.61 . . . . 0.0 111.73 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 25.1 mtpp -74.23 36.5 0.1 Allowed 'General case' 0 C--N 1.349 0.549 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.972 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.592 HE21 HG13 ' A' ' 100' ' ' ILE . 21.7 mm-40 -112.55 142.43 45.14 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.423 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' HIS . 10.5 mpt_? -92.6 -62.85 1.31 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 112.408 -2.178 . . . . 0.0 109.995 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 27' ' ' ARG . 36.5 m170 -58.42 -154.41 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.61 -177.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -139.59 120.08 14.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.424 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.71 -17.47 3.47 Favored Glycine 0 CA--C 1.542 1.769 0 C-N-CA 117.985 -2.055 . . . . 0.0 113.0 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -46.54 118.22 1.91 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.22 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.489 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 10.3 p90 -132.11 158.67 41.03 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 116.516 -2.074 . . . . 0.0 111.384 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.528 ' CD2' ' CE ' ' A' ' 22' ' ' MET . 4.3 pp -155.61 155.89 34.09 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 111.925 -2.398 . . . . 0.0 108.76 168.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.19 114.34 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 117.254 -1.778 . . . . 0.0 109.247 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.765 HH21 ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -80.5 125.06 29.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.072 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 37' ' ' SER . 21.5 pt-20 -116.03 133.35 56.12 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.064 -172.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.585 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 38.3 t 70.77 -14.11 0.45 Allowed 'General case' 0 C--N 1.346 0.442 0 CA-C-N 111.903 -2.408 . . . . 0.0 113.344 172.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 37' ' ' SER . 56.1 tt0 -40.32 -35.74 0.46 Allowed 'General case' 0 C--N 1.35 0.623 0 C-N-CA 117.209 -1.797 . . . . 0.0 111.224 174.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 80.4 p -148.75 72.89 1.2 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.083 -1.871 . . . . 0.0 107.976 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.93 ' HB1' ' HA ' ' A' ' 41' ' ' PRO . . . -70.57 -165.22 0.04 OUTLIER Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 112.797 -2.001 . . . . 0.0 106.275 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.93 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . 25.4 Cg_endo -63.1 -108.73 0.0 OUTLIER 'Cis proline' 0 C--N 1.353 0.769 0 O-C-N 122.299 0.631 . . . . 0.0 112.472 -0.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . -72.42 74.56 0.87 Allowed Glycine 0 C--N 1.345 1.077 0 C-N-CA 118.952 -1.594 . . . . 0.0 109.906 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.457 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 0.9 OUTLIER -131.54 105.17 7.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.047 -2.077 . . . . 0.0 109.591 -178.038 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 22.0 m-85 -132.83 134.19 44.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.753 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.434 ' OG ' ' HD3' ' A' ' 35' ' ' ARG . 72.0 p -127.62 138.9 52.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 112.981 -1.918 . . . . 0.0 109.389 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.494 ' CD2' HG23 ' A' ' 48' ' ' VAL . 5.4 tt -97.22 117.28 31.06 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.507 -2.133 . . . . 0.0 109.969 -174.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.6 m -96.57 141.65 29.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.242 -1.799 . . . . 0.0 109.839 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.494 HG23 ' CD2' ' A' ' 46' ' ' LEU . 92.4 t -150.8 138.4 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.039 -1.891 . . . . 0.0 110.03 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.579 ' HE3' ' H ' ' A' ' 26' ' ' GLN . 23.5 ttmm -78.53 109.32 12.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 116.503 -2.079 . . . . 0.0 108.979 171.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -77.39 -90.9 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.446 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.61 -77.98 1.39 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 112.502 -2.136 . . . . 0.0 109.974 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -117.17 -24.63 7.42 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 112.288 -1.956 . . . . 0.0 112.13 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 34.4 t0 -108.34 -178.49 3.62 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 118.029 -1.468 . . . . 0.0 109.868 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 95.1 t -98.21 117.83 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.899 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -98.27 157.81 15.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 112.874 -1.966 . . . . 0.0 109.428 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -146.02 136.88 24.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.421 -175.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HB3' HD22 ' A' ' 69' ' ' LEU . 26.5 m-85 -118.59 110.9 17.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.55 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.5 mtmm -62.62 109.48 1.41 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 117.059 -1.856 . . . . 0.0 109.405 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 77' ' ' LEU . 40.6 t -77.86 92.17 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 116.896 -1.922 . . . . 0.0 107.86 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 61' ' ' ARG . 96.9 mt -73.35 179.73 3.83 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 112.216 -2.265 . . . . 0.0 112.342 -165.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 60' ' ' LEU . 14.7 ptm180 . . . . . 0 C--N 1.349 0.545 0 CA-C-N 110.04 -3.255 . . . . 0.0 112.409 -172.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HZ2' ' HA ' ' A' ' 75' ' ' ASN . 7.6 mtpm? . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.36 0.6 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.518 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 57.0 m-85 -78.37 143.08 37.17 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 113.974 -1.467 . . . . 0.0 109.303 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' O ' ' A' ' 70' ' ' TRP . 2.7 t80 -156.05 135.53 12.38 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 116.075 -2.25 . . . . 0.0 111.016 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.536 ' CG ' HD11 ' A' ' 80' ' ' LEU . 40.2 mt -100.98 -78.54 0.52 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.13 -1.85 . . . . 0.0 109.882 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.456 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 25.7 m0 -123.24 -69.03 0.84 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.116 -1.856 . . . . 0.0 111.607 -169.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.82 -41.96 5.31 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 C-N-CA 117.6 -1.64 . . . . 0.0 111.217 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.459 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 34.4 m -115.24 142.18 29.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.648 -1.615 . . . . 0.0 109.935 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.419 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 10.0 ptpp? -82.21 -169.53 2.45 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.557 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 10.2 m-85 -150.51 136.64 18.55 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.384 -1.726 . . . . 0.0 108.911 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER -91.76 47.55 1.37 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 116.47 -2.092 . . . . 0.0 109.904 -177.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 23.1 p 141.02 143.42 0.0 OUTLIER 'General case' 0 C--N 1.349 0.563 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.041 175.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.52 ' CD2' HG11 ' A' ' 59' ' ' VAL . 98.6 mt -47.75 -44.11 27.79 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 117.171 -1.812 . . . . 0.0 109.647 175.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 23.5 t-20 -57.96 -34.8 70.32 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 113.341 -1.754 . . . . 0.0 111.315 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 46.3 tp10 -62.81 -26.11 68.58 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 116.219 -2.192 . . . . 0.0 111.664 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.536 HD11 ' CG ' ' A' ' 69' ' ' LEU . 8.3 tt -85.66 -57.62 2.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.239 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 85' ' ' ARG . 97.5 t -49.43 -34.31 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 112.397 -2.183 . . . . 0.0 111.117 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 37.6 t70 -70.87 -41.0 71.97 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.627 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 79' ' ' GLU . 10.3 m-30 -62.33 -54.83 34.84 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 117.32 -1.752 . . . . 0.0 109.43 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 25.0 m170 -62.52 -30.14 71.07 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 113.074 -1.876 . . . . 0.0 111.639 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 84' ' ' HIS . 53.2 tpt85 -37.73 -36.03 0.16 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.304 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.5 p -148.82 42.77 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 117.73 -1.588 . . . . 0.0 110.394 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.588 ' O ' ' CB ' ' A' ' 88' ' ' SER . 93.4 m -132.33 -41.86 0.97 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.507 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.588 ' CB ' ' O ' ' A' ' 87' ' ' THR . 27.9 t 110.43 145.08 0.0 OUTLIER 'General case' 0 C--N 1.35 0.63 0 O-C-N 125.835 1.959 . . . . 0.0 109.693 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 90' ' ' SER . 3.6 m -92.0 21.91 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.218 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 9.2 t . . . . . 0 N--CA 1.445 -0.704 0 C-N-CA 117.315 -1.754 . . . . 0.0 109.321 -164.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 4.1 pm0 . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 121.962 0.887 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.5 mt -122.3 117.6 52.68 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.921 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -92.69 142.51 27.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.532 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 95.4 mt -89.95 105.18 17.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.816 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 99' ' ' ASP . 62.2 ttt-85 -175.6 -119.36 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 112.581 -2.1 . . . . 0.0 108.344 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 29.2 t70 25.79 48.33 0.01 OUTLIER 'General case' 0 C--N 1.348 0.508 0 O-C-N 125.234 1.584 . . . . 0.0 112.699 172.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.62 HG12 ' H ' ' A' ' 101' ' ' GLU . 7.5 tt -135.07 -146.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 117.503 -1.679 . . . . 0.0 108.991 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.62 ' H ' HG12 ' A' ' 100' ' ' ILE . 40.6 mm-40 . . . . . 0 N--CA 1.446 -0.659 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.473 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.54 0.791 0 N-CA-C 110.972 -0.434 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.429 ' CB ' ' CZ ' ' A' ' 32' ' ' PHE . 36.8 p-90 -86.56 7.27 26.91 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.501 -174.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -89.37 111.07 21.83 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 117.322 -1.751 . . . . 0.0 109.879 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 12' ' ' GLY . 33.5 m-85 -112.08 121.73 45.8 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.25 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -56.33 -151.38 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.928 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.633 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -72.8 77.96 1.13 Allowed 'General case' 0 C--N 1.346 0.445 0 C-N-CA 117.153 -1.819 . . . . 0.0 109.618 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.0 tp -79.1 130.76 68.51 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.247 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.2 Cg_exo -47.4 124.54 9.44 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.984 1.789 . . . . 0.0 113.133 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.843 ' CG ' HH22 ' A' ' 35' ' ' ARG . 69.0 mtp180 -37.33 -42.73 0.5 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.67 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -58.89 -75.46 0.05 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.212 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 17' ' ' ALA . 56.9 tptt -36.64 -36.81 0.12 Allowed 'General case' 0 C--N 1.345 0.379 0 CA-C-N 112.979 -1.919 . . . . 0.0 111.457 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -63.21 -66.5 0.53 Allowed 'General case' 0 C--N 1.347 0.469 0 C-N-CA 117.387 -1.725 . . . . 0.0 109.567 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.409 ' HA ' HG21 ' A' ' 54' ' ' VAL . 63.2 mt-10 -47.98 -54.69 12.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.864 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 24' ' ' SER . 11.4 mm-40 -52.8 -84.41 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.791 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.575 ' C ' ' SD ' ' A' ' 22' ' ' MET . 2.9 ppp? -43.18 -43.78 4.82 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.609 -172.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' N ' ' SD ' ' A' ' 22' ' ' MET . 37.2 tp -66.78 -35.32 79.8 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.998 -1.91 . . . . 0.0 111.475 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 26' ' ' GLN . 37.4 t -70.47 -40.03 73.89 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 117.796 -1.562 . . . . 0.0 110.484 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -73.11 35.42 0.08 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.859 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.516 ' HG3' ' CB ' ' A' ' 31' ' ' ALA . 29.5 mm-40 -101.53 153.43 19.73 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 117.108 -1.837 . . . . 0.0 110.837 -174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -72.07 87.73 1.07 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 111.819 -2.446 . . . . 0.0 109.55 -177.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER 69.04 145.9 0.05 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 111.942 -2.39 . . . . 0.0 111.049 170.031 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 22.7 t70 -31.94 133.99 0.09 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 111.5 -2.591 . . . . 0.0 111.462 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 96' ' ' PHE . . . 142.02 -41.62 1.2 Allowed Glycine 0 C--N 1.348 1.237 0 C-N-CA 117.665 -2.207 . . . . 0.0 112.198 169.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HB2' ' H ' ' A' ' 100' ' ' ILE . . . -47.49 136.17 10.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 117.533 -1.667 . . . . 0.0 109.512 -176.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' CB ' HG22 ' A' ' 48' ' ' VAL . 12.6 p90 -143.8 158.08 43.93 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 115.636 -2.426 . . . . 0.0 111.503 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 33' ' ' LEU . 4.6 pp -153.58 146.64 24.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 112.399 -2.182 . . . . 0.0 109.812 170.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 45' ' ' SER . 45.6 mt -108.05 115.56 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 112.562 -2.108 . . . . 0.0 108.549 172.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.843 HH22 ' CG ' ' A' ' 16' ' ' ARG . 10.0 ptm180 -101.74 128.91 47.86 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.57 -2.104 . . . . 0.0 110.865 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 37.8 mt-10 -76.76 144.86 38.95 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.317 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 40' ' ' ALA . 96.5 p -59.31 -168.2 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 117.292 -1.763 . . . . 0.0 109.029 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 29.5 tp10 -100.47 -49.13 4.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.433 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 44.8 t -132.47 64.01 1.61 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.342 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' O ' ' OG ' ' A' ' 37' ' ' SER . . . 178.49 68.47 0.11 Allowed Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.462 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -64.37 -3.46 6.39 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.137 1.891 . . . . 0.0 115.302 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.86 34.23 5.34 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 118.575 -1.774 . . . . 0.0 111.364 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -150.08 121.96 8.16 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 118.464 -1.295 . . . . 0.0 109.45 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 59' ' ' VAL . 79.2 m-85 -130.75 156.15 45.44 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 113.052 -1.886 . . . . 0.0 109.796 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 77.5 p -141.51 154.07 45.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.231 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' A' ' 48' ' ' VAL . 4.9 tt -119.23 114.95 23.21 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 113.504 -1.68 . . . . 0.0 109.595 -177.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 49.8 m -108.62 133.59 52.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.671 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' A' ' 46' ' ' LEU . 91.1 t -134.16 133.9 55.52 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.548 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 29' ' ' ASP . 42.3 tptt -55.56 97.11 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 112.785 -2.007 . . . . 0.0 107.719 168.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 48' ' ' VAL . 5.7 t80 -107.97 118.19 36.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 117.74 -1.584 . . . . 0.0 109.858 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.57 -94.65 0.06 OUTLIER Glycine 0 C--N 1.344 1.028 0 C-N-CA 117.971 -2.061 . . . . 0.0 110.323 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -123.06 -26.74 4.31 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.862 -1.669 . . . . 0.0 112.175 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 29.0 t0 -110.04 -174.65 2.54 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 118.022 -1.471 . . . . 0.0 109.663 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.543 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 93.0 t -103.85 122.24 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 113.079 -1.873 . . . . 0.0 109.685 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.419 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 56.6 tt0 -98.89 162.78 12.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 112.913 -1.949 . . . . 0.0 109.779 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.41 ' CD2' ' C ' ' A' ' 56' ' ' HIS . 6.7 t60 -141.02 133.73 28.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 112.799 -2.0 . . . . 0.0 110.546 -171.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.419 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 85.7 m-85 -137.1 104.06 5.32 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.094 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -63.2 111.74 2.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.159 -1.837 . . . . 0.0 110.088 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.514 HG11 ' CD2' ' A' ' 77' ' ' LEU . 97.6 t -77.33 72.12 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 112.934 -1.939 . . . . 0.0 108.437 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 99.1 mt -76.74 168.36 20.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.521 -2.127 . . . . 0.0 110.335 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.3 ptm180 . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 116.868 -1.933 . . . . 0.0 109.56 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.495 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 6.0 mtpm? . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.506 0.669 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 89.7 m-85 -85.31 157.62 20.51 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.259 -168.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -174.99 155.05 1.93 Allowed 'General case' 0 C--N 1.348 0.543 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.34 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.448 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 4.7 mp -92.12 -44.08 9.02 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 116.896 -1.922 . . . . 0.0 109.928 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 13.7 m0 -136.97 -43.09 0.57 Allowed 'General case' 0 C--N 1.346 0.427 0 CA-C-N 113.381 -1.736 . . . . 0.0 110.466 -177.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.3 t -139.62 -84.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.34 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.1 m -49.11 130.75 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 112.904 -1.953 . . . . 0.0 110.106 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 56.2 mttp -101.38 148.12 25.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.119 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.411 ' CE2' HD12 ' A' ' 69' ' ' LEU . 4.3 m-85 -117.03 150.13 39.13 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.634 -173.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.495 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 32.7 p-10 -75.37 -19.35 59.62 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.291 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 79' ' ' GLU . 83.3 p -167.37 154.06 8.28 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 118.666 -1.214 . . . . 0.0 109.342 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.514 ' CD2' HG11 ' A' ' 59' ' ' VAL . 90.4 mt -47.26 -43.69 22.35 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.042 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -50.05 -40.15 44.27 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 113.248 -1.796 . . . . 0.0 110.536 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 76' ' ' SER . 36.6 tp10 -70.05 -24.01 63.18 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.924 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.489 HD23 ' C ' ' A' ' 80' ' ' LEU . 7.8 tt -69.38 -58.29 4.19 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 117.905 -1.518 . . . . 0.0 108.351 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.6 t -48.8 -19.22 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 112.572 -2.104 . . . . 0.0 112.294 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 64.8 m-20 -90.03 -37.11 14.52 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.453 174.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -50.15 -50.55 48.5 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 116.952 -1.899 . . . . 0.0 108.689 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.459 ' CE1' HD21 ' A' ' 80' ' ' LEU . 57.7 m170 -61.98 -64.3 0.98 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 111.986 -2.37 . . . . 0.0 108.2 168.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 45.0 tpt85 67.79 -65.54 0.24 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 125.804 1.94 . . . . 0.0 108.657 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 87' ' ' THR . 48.2 t -89.85 -113.27 0.07 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 112.002 -2.363 . . . . 0.0 105.16 156.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 88' ' ' SER . 9.7 t -170.36 -133.97 0.02 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 117.841 -1.543 . . . . 0.0 110.724 169.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 87' ' ' THR . 3.2 m 143.19 -58.98 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.117 -1.856 . . . . 0.0 107.872 -168.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.553 ' CG2' HG13 ' A' ' 95' ' ' ILE . 0.8 OUTLIER 51.44 4.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 112.661 -2.063 . . . . 0.0 113.537 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 117.552 -1.659 . . . . 0.0 112.198 -164.028 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 . . . . . 0 N--CA 1.445 -0.686 0 CA-C-O 121.973 0.892 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.617 HG22 ' H ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -91.47 -156.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 112.788 -2.006 . . . . 0.0 108.97 -177.141 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.617 ' H ' HG22 ' A' ' 95' ' ' ILE . 90.6 m-85 -150.07 145.19 26.23 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 113.406 -1.725 . . . . 0.0 109.289 170.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.455 ' O ' ' CG ' ' A' ' 98' ' ' ARG . 83.2 mt -113.94 77.93 1.1 Allowed 'General case' 0 C--N 1.346 0.436 0 C-N-CA 117.376 -1.729 . . . . 0.0 109.317 173.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 42.6 mtp180 -154.73 -123.21 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 112.951 -1.931 . . . . 0.0 108.864 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.6 t0 39.13 -117.08 0.21 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.812 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.604 HG12 ' H ' ' A' ' 101' ' ' GLU . 6.8 tt 38.08 -149.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.545 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.99 -171.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.604 ' H ' HG12 ' A' ' 100' ' ' ILE . 79.1 mm-40 . . . . . 0 N--CA 1.445 -0.676 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.955 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 64.6 Cg_endo . . . . . 0 CA--C 1.541 0.861 0 N-CA-C 110.468 -0.628 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.417 ' CG ' ' CE2' ' A' ' 32' ' ' PHE . 39.9 p-90 -62.85 1.17 0.43 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.557 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -84.0 119.75 25.3 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 117.097 -1.841 . . . . 0.0 109.952 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 12' ' ' GLY . 7.3 m-85 -115.69 121.92 43.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.167 -1.833 . . . . 0.0 107.838 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -57.39 -146.49 0.01 OUTLIER Glycine 0 CA--C 1.531 1.09 0 CA-C-N 112.685 -2.052 . . . . 0.0 110.85 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 59.2 pttt -74.04 75.45 1.72 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 117.069 -1.853 . . . . 0.0 109.755 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.0 tp -85.12 129.33 56.36 Favored Pre-proline 0 N--CA 1.447 -0.591 0 CA-C-N 112.734 -2.03 . . . . 0.0 108.674 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.1 Cg_exo -45.55 120.83 3.52 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.542 1.495 . . . . 0.0 112.465 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 15' ' ' PRO . 61.2 ttt85 -39.49 -39.46 0.7 Allowed 'General case' 0 C--N 1.345 0.37 0 CA-C-N 112.976 -1.92 . . . . 0.0 110.806 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -65.35 -66.54 0.53 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.411 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 17' ' ' ALA . 24.4 tptm -37.12 -38.65 0.21 Allowed 'General case' 0 C--N 1.347 0.475 0 CA-C-N 112.95 -1.932 . . . . 0.0 111.118 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -54.79 -65.98 0.48 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.059 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 24' ' ' SER . 93.6 mt-10 -45.86 -44.02 14.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 112.396 -2.184 . . . . 0.0 110.313 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.465 ' O ' ' OG ' ' A' ' 24' ' ' SER . 66.2 mt-10 -61.81 -78.7 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.719 -172.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.573 ' SD ' HD11 ' A' ' 100' ' ' ILE . 3.8 ppp? -54.39 -37.23 64.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 117.47 -1.692 . . . . 0.0 110.968 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.548 ' N ' ' SD ' ' A' ' 22' ' ' MET . 40.0 tp -69.22 -30.35 68.48 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.89 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.549 ' C ' ' H ' ' A' ' 26' ' ' GLN . 78.2 p -69.67 -29.13 66.51 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 117.326 -1.75 . . . . 0.0 111.407 176.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 5.4 mtpm? -72.38 33.3 0.06 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.133 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 24' ' ' SER . 20.5 mm-40 -107.52 145.15 33.5 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 117.829 -1.549 . . . . 0.0 109.498 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 28' ' ' HIS . 95.8 mtt180 -75.5 38.23 0.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 112.388 -2.187 . . . . 0.0 110.798 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.528 ' H ' ' C ' ' A' ' 26' ' ' GLN . 0.8 OUTLIER 44.62 89.79 0.01 OUTLIER 'General case' 0 C--N 1.348 0.527 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.541 -178.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 41.9 m-20 -158.06 37.21 0.25 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.092 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.581 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 81.75 -4.62 73.5 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 115.947 -3.025 . . . . 0.0 113.205 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.473 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -40.55 117.69 0.85 Allowed 'General case' 0 C--N 1.352 0.7 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.705 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 47' ' ' SER . 23.8 p90 -137.78 154.79 49.53 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 116.5 -2.08 . . . . 0.0 110.943 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 33' ' ' LEU . 4.5 pp -152.92 149.02 27.81 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 112.379 -2.191 . . . . 0.0 109.276 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 45' ' ' SER . 46.4 mt -109.51 115.89 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 112.418 -2.174 . . . . 0.0 108.569 174.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.427 ' CB ' HG22 ' A' ' 14' ' ' ILE . 8.5 ptm180 -99.22 125.48 44.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.678 -2.055 . . . . 0.0 110.422 -174.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 72.7 tt0 -89.62 120.64 31.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.354 -2.203 . . . . 0.0 109.748 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 46.5 t -46.05 138.36 5.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.887 -1.961 . . . . 0.0 110.026 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.413 ' HA ' ' CB ' ' A' ' 13' ' ' LYS . 64.8 mt-10 -41.1 -76.53 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.569 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 t -102.09 51.02 0.83 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 112.514 -2.13 . . . . 0.0 110.367 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 37' ' ' SER . . . -171.35 97.84 0.41 Allowed Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.579 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.445 ' O ' ' CE1' ' A' ' 44' ' ' PHE . 54.2 Cg_endo -75.46 -4.27 15.05 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.744 1.629 . . . . 0.0 115.014 -177.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.67 40.06 2.6 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 118.697 -1.716 . . . . 0.0 110.876 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -145.99 118.4 8.46 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 118.227 -1.389 . . . . 0.0 109.604 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 84.9 m-85 -139.91 157.82 45.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 112.993 -1.912 . . . . 0.0 109.56 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.8 p -156.01 129.22 8.13 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.515 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 46' ' ' LEU . 4.5 tt -89.1 113.43 24.57 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 113.105 -1.861 . . . . 0.0 109.711 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.458 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 79.1 p -94.88 149.48 21.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.766 -2.015 . . . . 0.0 109.577 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 73.7 t -146.82 138.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.027 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.482 ' HG2' ' H ' ' A' ' 28' ' ' HIS . 42.2 tptt -69.12 98.17 0.97 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 112.964 -1.925 . . . . 0.0 109.242 176.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 53' ' ' ASP . 7.2 t80 -115.21 108.98 17.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.934 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.526 ' H ' ' CD2' ' A' ' 28' ' ' HIS . . . -25.97 144.44 0.01 OUTLIER Glycine 0 C--N 1.348 1.207 0 CA-C-N 112.325 -2.216 . . . . 0.0 112.294 -175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 59.6 t30 86.99 -30.53 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 111.66 -2.27 . . . . 0.0 111.226 -175.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 22.1 t70 -174.68 -170.84 0.51 Allowed 'General case' 0 C--N 1.35 0.622 0 C-N-CA 116.232 -2.187 . . . . 0.0 110.388 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.551 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 86.4 t -102.15 118.68 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.338 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.418 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 60.7 tt0 -90.08 158.49 17.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 113.111 -1.859 . . . . 0.0 109.613 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.63 142.9 27.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.658 -2.065 . . . . 0.0 110.514 -175.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 88.3 m-85 -126.77 101.94 6.83 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.53 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.0 mtmm -60.08 122.68 14.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.908 -1.951 . . . . 0.0 109.594 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.525 HG11 ' CD2' ' A' ' 77' ' ' LEU . 37.1 t -79.89 97.57 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 112.845 -1.979 . . . . 0.0 108.047 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 94.6 mt -91.42 178.79 5.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.183 -165.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 9.9 tpt180 . . . . . 0 C--N 1.347 0.466 0 CA-C-N 111.207 -2.724 . . . . 0.0 109.519 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HZ2' ' HB3' ' A' ' 66' ' ' LYS . 6.0 mtpm? . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 121.428 0.632 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.516 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 76.4 m-85 -97.52 134.34 40.89 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 117.881 -1.527 . . . . 0.0 110.342 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.458 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -152.17 148.69 27.91 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 116.606 -2.038 . . . . 0.0 110.679 176.129 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.454 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 5.4 mt -86.06 -49.01 8.12 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 112.773 -2.012 . . . . 0.0 109.456 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 20.7 m0 -133.15 -77.48 0.49 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.852 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.1 t -107.15 -83.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.901 -1.954 . . . . 0.0 109.611 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.3 m -50.8 131.27 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 112.648 -2.069 . . . . 0.0 110.023 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 66.7 mttm -88.93 -169.94 2.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.721 -2.036 . . . . 0.0 109.951 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 73' ' ' LYS . 37.7 m-85 -152.88 135.06 14.91 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.127 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.425 ' O ' ' OG ' ' A' ' 76' ' ' SER . 1.7 m120 -64.12 -16.87 62.74 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.561 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 46.9 m -168.69 160.54 10.71 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.83 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' CD2' HG11 ' A' ' 59' ' ' VAL . 89.4 mt -45.51 -41.98 10.25 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 117.268 -1.773 . . . . 0.0 110.362 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 52.8 t30 -55.8 -39.34 71.18 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.382 -1.735 . . . . 0.0 110.893 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.4 OUTLIER -67.89 -28.64 67.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 117.347 -1.741 . . . . 0.0 111.452 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.483 HD23 ' C ' ' A' ' 80' ' ' LEU . 8.6 tt -65.68 -47.37 75.7 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 118.708 -1.197 . . . . 0.0 109.088 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 85' ' ' ARG . 70.6 t -64.57 -31.25 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 112.756 -2.02 . . . . 0.0 111.594 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 57.0 m-20 -74.57 -42.95 57.84 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.116 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -58.82 -46.05 88.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 117.104 -1.839 . . . . 0.0 109.096 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 85' ' ' ARG . 60.1 m-70 -92.76 32.39 1.25 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.143 -1.844 . . . . 0.0 110.965 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 84' ' ' HIS . 35.2 ptt-85 -40.24 -35.09 0.37 Allowed 'General case' 0 C--N 1.349 0.568 0 C-N-CA 118.309 -1.356 . . . . 0.0 110.935 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.8 p -89.93 -80.61 0.31 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 117.803 -1.559 . . . . 0.0 108.206 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 95' ' ' ILE . 14.8 t -170.16 -169.97 0.92 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.51 -1.677 . . . . 0.0 109.925 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.659 ' H ' ' CG1' ' A' ' 89' ' ' VAL . 29.3 t -121.25 -96.02 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 112.116 -2.311 . . . . 0.0 107.622 160.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.659 ' CG1' ' H ' ' A' ' 88' ' ' SER . 4.0 m -142.18 41.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.953 1 C-N-CA 133.737 4.815 . . . . 0.0 108.684 -8.497 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 12.0 t . . . . . 0 N--CA 1.448 -0.531 0 CA-C-N 112.821 -1.99 . . . . 0.0 109.06 -154.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.417 ' C ' HG12 ' A' ' 95' ' ' ILE . 94.1 mm-40 . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.279 0.561 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.602 HG13 ' H ' ' A' ' 89' ' ' VAL . 5.8 mm -142.97 165.39 15.8 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 117.779 -1.568 . . . . 0.0 109.298 -176.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.581 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 86.1 m-85 -150.07 155.16 39.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.657 -1.611 . . . . 0.0 109.894 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.412 ' C ' ' CE1' ' A' ' 32' ' ' PHE . 58.0 mt -116.2 90.92 3.44 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 113.659 -1.61 . . . . 0.0 109.083 169.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 99' ' ' ASP . 71.4 mtp180 -156.47 -147.79 0.2 Allowed 'General case' 0 C--N 1.346 0.446 0 CA-C-N 112.951 -1.932 . . . . 0.0 108.803 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 100' ' ' ILE . 33.7 t0 48.1 -177.87 0.01 OUTLIER 'General case' 0 C--N 1.348 0.506 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.674 172.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.573 HD11 ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER 84.29 6.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 112.93 -1.941 . . . . 0.0 113.967 177.109 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 . . . . . 0 N--CA 1.445 -0.685 0 C-N-CA 118.415 -1.314 . . . . 0.0 109.581 -178.052 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 69.6 Cg_endo . . . . . 0 N--CA 1.454 -0.808 0 N-CA-C 108.867 -1.244 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.413 ' H ' ' HB2' ' A' ' 8' ' ' PRO . 5.9 p-90 -83.72 16.34 2.77 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 118.386 -1.326 . . . . 0.0 112.782 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -93.36 125.06 37.77 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.419 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.453 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 83.5 m-85 -130.02 118.33 21.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 117.301 -1.76 . . . . 0.0 110.088 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.535 ' CA ' ' C ' ' A' ' 13' ' ' LYS . . . 137.83 -161.35 25.46 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 115.823 -3.084 . . . . 0.0 112.488 166.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' C ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -57.4 115.8 2.94 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 112.648 -1.776 . . . . 0.0 111.081 0.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.469 ' N ' ' CA ' ' A' ' 12' ' ' GLY . 9.8 tp -106.02 133.77 20.06 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.253 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.3 Cg_exo -46.24 121.75 4.83 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.788 1.659 . . . . 0.0 112.933 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 15' ' ' PRO . 95.0 mtt180 -42.94 -41.18 3.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.479 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -62.8 -61.61 2.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.795 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 17' ' ' ALA . 58.5 tptt -43.02 -44.24 4.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.051 -1.886 . . . . 0.0 110.275 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -48.4 -62.57 1.42 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.148 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 21' ' ' GLU . 46.8 mt-10 -44.95 -65.0 0.59 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.346 -2.206 . . . . 0.0 109.901 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 20' ' ' GLU . 69.1 mt-10 -37.51 -85.7 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.039 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.505 ' CA ' ' HD3' ' A' ' 25' ' ' LYS . 26.5 ptt? -48.62 -52.39 23.32 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 117.495 -1.682 . . . . 0.0 110.233 -176.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.517 HD13 ' CD1' ' A' ' 100' ' ' ILE . 42.0 tp -50.62 -22.92 2.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 117.145 -1.822 . . . . 0.0 112.708 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 21' ' ' GLU . 90.3 p -83.82 -33.13 24.99 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.115 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.505 ' HD3' ' CA ' ' A' ' 22' ' ' MET . 8.2 pttm -42.29 -25.88 0.09 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 113.538 -1.664 . . . . 0.0 112.018 172.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 35.5 mm-40 -55.58 161.37 2.07 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.282 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 6.5 mpt_? -119.0 -41.95 2.73 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.057 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.19 107.78 19.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.691 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -47.76 125.51 8.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.505 -2.134 . . . . 0.0 109.728 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 138.5 -29.47 2.59 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 117.35 -2.357 . . . . 0.0 112.485 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.73 138.59 8.24 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 117.829 -1.549 . . . . 0.0 109.181 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' SER . 37.5 p90 -142.94 156.11 44.83 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 116.09 -2.244 . . . . 0.0 111.515 -174.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -146.93 150.94 36.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.448 -2.16 . . . . 0.0 109.334 169.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.7 mt -111.08 108.16 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 113.025 -1.898 . . . . 0.0 108.577 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 37.0 ptt180 -92.72 135.8 33.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.67 -2.059 . . . . 0.0 110.805 -172.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.8 pt-20 -91.71 128.38 37.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.694 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 36' ' ' GLU . 49.8 m -54.51 -165.27 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.182 -1.826 . . . . 0.0 109.822 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -81.61 -98.41 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.423 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.4 t -94.24 43.64 1.11 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.015 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.26 94.75 7.6 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 113.227 -1.806 . . . . 0.0 109.448 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.39 -4.79 15.48 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.954 1.769 . . . . 0.0 114.943 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.95 39.45 2.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 118.864 -1.636 . . . . 0.0 110.932 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 57.0 t0 -143.38 106.84 4.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 118.264 -1.375 . . . . 0.0 109.652 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 23.4 m-85 -133.85 120.22 20.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.533 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.3 p -113.6 125.95 54.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.643 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' A' ' 48' ' ' VAL . 5.4 tt -85.44 117.2 24.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 112.817 -1.992 . . . . 0.0 109.562 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.484 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 49.9 m -94.83 144.52 25.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.533 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' A' ' 46' ' ' LEU . 78.6 t -151.57 131.41 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.735 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 66.2 tttp -76.32 106.13 7.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 116.754 -1.979 . . . . 0.0 108.427 174.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -104.37 37.53 2.08 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 113.212 -1.813 . . . . 0.0 111.524 -172.2 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.82 -95.34 0.26 Allowed Glycine 0 C--N 1.346 1.109 0 C-N-CA 117.249 -2.405 . . . . 0.0 110.811 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 52.2 t-20 -107.19 -31.42 8.24 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 112.675 -1.763 . . . . 0.0 111.411 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 34.2 t70 -120.85 -176.81 3.33 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.499 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.549 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 94.6 t -100.23 122.79 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.2 -175.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.42 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 59.5 tt0 -97.36 159.53 14.86 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.778 -2.01 . . . . 0.0 109.486 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -139.69 134.98 32.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.748 -2.023 . . . . 0.0 110.522 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.447 ' CZ ' ' O ' ' A' ' 89' ' ' VAL . 97.4 m-85 -123.88 101.56 7.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.409 176.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 55.1 mtmt -58.85 100.25 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 116.59 -2.044 . . . . 0.0 109.612 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.528 HG13 ' CD1' ' A' ' 80' ' ' LEU . 93.6 t -70.33 86.22 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 112.984 -1.917 . . . . 0.0 108.563 174.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 77.2 mt -78.76 163.04 25.71 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.752 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.2 ptm180 . . . . . 0 N--CA 1.448 -0.556 0 CA-C-N 113.075 -1.875 . . . . 0.0 109.205 173.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.502 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 21.8 mtpp . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.415 0.626 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 90.1 m-85 -71.13 147.68 48.16 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.476 -173.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 17.1 p90 -166.01 167.53 16.45 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.418 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 80' ' ' LEU . 4.7 mp -124.94 97.76 5.4 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.06 173.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.44 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 34.4 m0 73.63 -39.2 0.43 Allowed 'General case' 0 C--N 1.346 0.414 0 CA-C-N 112.774 -2.012 . . . . 0.0 110.786 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' A' ' 69' ' ' LEU . 84.5 t -150.04 -85.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 117.56 -1.656 . . . . 0.0 110.549 -174.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 31.0 m -49.33 135.8 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.591 -173.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 74' ' ' PHE . 2.5 mptp? -99.21 -179.25 4.18 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.797 -2.001 . . . . 0.0 111.04 -176.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.435 ' CG ' ' O ' ' A' ' 73' ' ' LYS . 19.4 m-85 -158.63 137.17 10.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 111.74 -2.482 . . . . 0.0 108.842 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.502 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 56.6 p30 -62.18 -9.3 7.28 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 113.227 -1.806 . . . . 0.0 112.963 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 42.8 t -179.05 152.57 0.57 Allowed 'General case' 0 C--N 1.349 0.555 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.697 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.518 ' CD2' HG11 ' A' ' 59' ' ' VAL . 77.1 mt -43.14 -43.96 4.8 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 113.184 -1.826 . . . . 0.0 110.212 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -55.3 -39.52 69.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.918 -1.946 . . . . 0.0 110.791 -177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 36.0 tt0 -69.36 -35.12 75.55 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 116.882 -1.927 . . . . 0.0 110.812 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 69' ' ' LEU . 6.5 tt -57.7 -49.09 77.66 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.949 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.6 t -63.58 -40.46 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 112.505 -2.134 . . . . 0.0 110.647 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.43 -44.57 96.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.204 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 87' ' ' THR . 4.1 m-85 -63.84 -42.84 97.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.854 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.422 ' O ' HD12 ' A' ' 97' ' ' LEU . 9.0 m-70 -93.48 41.69 1.09 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 117.684 -1.607 . . . . 0.0 110.294 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -94.54 -41.02 9.56 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.466 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.4 t -101.61 -42.58 6.17 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.279 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 83' ' ' TYR . 12.2 t -70.01 -147.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.441 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 83.6 p -123.81 -151.53 0.48 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.437 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.447 ' O ' ' CZ ' ' A' ' 57' ' ' PHE . 14.9 p -176.18 45.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 113.478 -1.692 . . . . 0.0 109.77 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 113.129 -1.85 . . . . 0.0 109.149 179.706 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.429 ' O ' HD13 ' A' ' 95' ' ' ILE . 56.6 tp60 . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.821 0.82 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 94' ' ' GLN . 14.2 mm -146.28 128.23 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.082 -1.872 . . . . 0.0 109.428 177.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.575 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 88.7 m-85 -149.98 139.58 21.61 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.532 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 84' ' ' HIS . 91.8 mt -89.93 94.87 9.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 117.114 -1.835 . . . . 0.0 109.249 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.492 ' NH1' ' CB ' ' A' ' 98' ' ' ARG . 4.4 ptm85 -105.46 149.07 26.5 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.614 -2.085 . . . . 0.0 109.997 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -47.26 119.55 2.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.309 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CD1' HD23 ' A' ' 33' ' ' LEU . 12.1 tt -70.06 -41.78 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.846 -1.979 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.435 ' N ' HG23 ' A' ' 100' ' ' ILE . 2.5 tm-20 . . . . . 0 N--CA 1.442 -0.834 0 CA-C-N 112.407 -2.178 . . . . 0.0 110.259 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 CA--C 1.542 0.88 0 N-CA-C 114.571 0.95 . . . . 0.0 114.571 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.436 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 3.2 p-90 -152.76 21.63 0.6 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.788 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 71.2 m-85 -90.45 115.3 27.51 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 118.452 -1.299 . . . . 0.0 109.115 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 60.6 m-85 -118.03 103.7 10.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.395 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.64 162.9 31.87 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 114.773 -3.584 . . . . 0.0 112.069 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -88.65 110.25 20.8 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 113.155 -1.522 . . . . 0.0 109.059 -6.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.46 HG12 ' CE ' ' A' ' 22' ' ' MET . 10.2 tp -97.96 126.02 41.96 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.523 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.4 Cg_exo -48.36 121.67 6.57 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.661 1.574 . . . . 0.0 112.811 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 15' ' ' PRO . 71.3 ttt180 -38.53 -37.65 0.33 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 113.02 -1.9 . . . . 0.0 111.075 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -68.45 -59.79 2.91 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.635 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 22' ' ' MET . 58.5 tptt -42.01 -42.97 3.01 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.353 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -51.1 -63.46 1.12 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.186 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 24' ' ' SER . 90.3 mt-10 -43.05 -44.77 4.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.576 -2.102 . . . . 0.0 110.236 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 34.1 mt-10 -63.65 -80.59 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 112.907 -1.952 . . . . 0.0 110.588 -173.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.499 ' HE3' ' CD2' ' A' ' 33' ' ' LEU . 25.9 ptt? -48.92 -39.93 28.07 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 113.456 -1.702 . . . . 0.0 110.662 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.503 HD23 ' CG1' ' A' ' 54' ' ' VAL . 38.8 tp -63.97 -32.61 74.21 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 117.726 -1.59 . . . . 0.0 111.474 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 26' ' ' GLN . 44.2 t -68.0 -32.3 72.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 117.662 -1.615 . . . . 0.0 111.267 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -73.15 35.61 0.08 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.111 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.575 ' NE2' ' HA ' ' A' ' 26' ' ' GLN . 4.3 mm-40 -105.08 135.46 46.39 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.814 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.445 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 1.6 mpp_? -98.52 33.11 2.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 112.312 -2.222 . . . . 0.0 111.242 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 74.7 m80 -155.47 103.57 2.32 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.219 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.38 103.6 0.11 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.268 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 152.28 -31.45 0.87 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 117.419 -2.324 . . . . 0.0 112.134 -178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -46.86 141.39 4.03 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.539 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 98' ' ' ARG . 49.1 p90 -141.89 169.96 16.61 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 116.641 -2.023 . . . . 0.0 110.888 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -161.31 150.04 16.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.164 -2.289 . . . . 0.0 109.001 167.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 45' ' ' SER . 49.3 mt -110.11 114.57 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 113.133 -1.849 . . . . 0.0 108.349 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 33.7 ptt85 -90.07 130.48 36.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.041 -170.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -59.9 135.88 57.83 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 111.99 -2.368 . . . . 0.0 109.879 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 43' ' ' ASP . 50.0 m -52.35 119.65 4.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.855 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -50.54 -78.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.109 -1.859 . . . . 0.0 109.434 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -127.46 62.32 1.37 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.547 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -152.34 156.82 33.83 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 113.048 -1.887 . . . . 0.0 109.517 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ALA . 64.3 Cg_exo -44.29 -120.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.769 2.313 . . . . 0.0 114.157 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . -103.51 66.26 0.34 Allowed Glycine 0 C--N 1.346 1.128 0 C-N-CA 118.226 -1.94 . . . . 0.0 110.498 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' O ' ' OG ' ' A' ' 37' ' ' SER . 1.0 OUTLIER -99.43 114.18 26.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.914 -1.643 . . . . 0.0 109.501 178.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.415 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 22.1 m-85 -128.39 124.2 35.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.025 -1.898 . . . . 0.0 109.745 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.2 p -117.99 133.24 56.11 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.007 -1.906 . . . . 0.0 109.662 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.3 tt -94.39 113.92 25.88 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 112.697 -2.047 . . . . 0.0 109.173 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 88.3 p -95.01 148.8 21.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.73 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 73.8 t -146.4 136.06 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.625 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.447 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 60.6 tttp -80.1 106.79 12.38 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 116.482 -2.087 . . . . 0.0 109.756 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 53' ' ' ASP . 49.1 t80 -126.51 114.91 18.75 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 112.553 -2.112 . . . . 0.0 108.863 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -27.43 144.51 0.01 OUTLIER Glycine 0 C--N 1.349 1.287 0 CA-C-N 112.648 -2.069 . . . . 0.0 111.884 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 74.9 m-20 102.53 -52.86 0.0 OUTLIER 'General case' 0 C--N 1.346 0.439 0 CA-C-N 111.52 -2.34 . . . . 0.0 108.189 -166.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 50' ' ' PHE . 56.3 p30 -179.64 -161.08 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 111.396 -2.638 . . . . 0.0 110.194 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.503 ' CG1' HD23 ' A' ' 23' ' ' LEU . 91.4 t -96.93 124.63 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.703 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -95.86 160.63 14.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.797 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -141.42 143.74 34.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.708 -2.042 . . . . 0.0 110.129 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -128.65 102.39 6.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.744 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -58.4 108.47 0.63 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.99 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' CD2' ' A' ' 77' ' ' LEU . 60.7 t -81.38 78.28 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 112.981 -1.918 . . . . 0.0 108.423 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 91.2 mt -83.66 172.49 12.24 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 112.417 -2.174 . . . . 0.0 109.845 -174.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.1 ptm180 . . . . . 0 N--CA 1.447 -0.614 0 C-N-CA 116.463 -2.095 . . . . 0.0 109.476 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HZ3' ' C ' ' A' ' 74' ' ' PHE . 8.4 mtmp? . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 88.5 m-85 -71.93 158.12 36.6 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.723 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 72' ' ' VAL . 55.1 t80 -152.62 156.85 40.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.62 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.607 HD13 HD11 ' A' ' 80' ' ' LEU . 33.3 tp -124.49 -66.84 0.95 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.449 -2.159 . . . . 0.0 109.826 -169.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.459 ' CD2' ' O ' ' A' ' 69' ' ' LEU . 27.7 m95 -147.09 -37.13 0.22 Allowed 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.101 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.416 ' C ' ' CE2' ' A' ' 68' ' ' PHE . 59.7 t -125.89 -37.59 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.471 0 C-N-CA 117.208 -1.797 . . . . 0.0 111.299 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 33.8 m -130.6 171.81 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 117.463 -1.695 . . . . 0.0 110.155 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.697 ' CD ' ' H ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -98.49 173.9 6.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.026 179.11 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.594 ' C ' ' HZ3' ' A' ' 66' ' ' LYS . 1.3 m-85 -145.6 132.27 19.93 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 117.063 -1.855 . . . . 0.0 109.551 -175.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' SER . 4.9 p-10 -86.66 25.67 1.22 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.617 -2.083 . . . . 0.0 112.214 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.2 t 175.69 130.85 0.04 OUTLIER 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.971 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.511 ' CD2' HG11 ' A' ' 59' ' ' VAL . 85.1 mt -47.71 -41.12 22.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 116.879 -1.929 . . . . 0.0 109.998 174.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 82' ' ' ASP . 39.7 m-80 -60.67 -30.98 70.24 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 113.533 -1.667 . . . . 0.0 111.659 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 83' ' ' TYR . 10.2 tp10 -66.45 -26.39 67.18 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 117.114 -1.835 . . . . 0.0 111.694 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 69' ' ' LEU . 10.4 tt -83.71 -53.12 5.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.384 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.59 -44.76 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 112.644 -2.071 . . . . 0.0 109.711 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 78' ' ' ASN . 25.1 t0 -63.62 -63.67 1.11 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.076 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.434 ' CB ' ' O ' ' A' ' 79' ' ' GLU . 38.7 t80 -48.76 -42.04 34.22 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.445 -176.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.457 ' HE2' ' HZ ' ' A' ' 74' ' ' PHE . 92.4 m-70 -100.15 44.14 1.03 Allowed 'General case' 0 C--N 1.345 0.393 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.088 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -86.08 -40.46 15.71 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.491 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 88' ' ' SER . 39.1 t -112.59 -36.6 5.17 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.73 -1.577 . . . . 0.0 111.048 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -77.47 42.79 0.37 Allowed 'General case' 0 C--N 1.346 0.453 0 C-N-CA 118.044 -1.463 . . . . 0.0 110.797 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 86' ' ' SER . 45.0 m 49.93 -149.77 0.24 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.912 170.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 90' ' ' SER . 6.4 p -176.9 -41.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.434 0 CA-C-N 113.393 -1.731 . . . . 0.0 110.337 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.404 ' N ' HG13 ' A' ' 89' ' ' VAL . 41.5 t . . . . . 0 N--CA 1.45 -0.453 0 CA-C-N 113.648 -1.614 . . . . 0.0 109.503 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.685 0.755 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 34.5 mm -114.75 145.68 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.858 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.54 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 65.3 t80 -135.11 132.16 37.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.865 -1.97 . . . . 0.0 109.338 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.01 101.87 14.58 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 117.304 -1.758 . . . . 0.0 109.406 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.729 ' HE ' ' H ' ' A' ' 99' ' ' ASP . 5.1 tpm_? -97.3 151.76 19.57 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 112.602 -2.09 . . . . 0.0 109.976 -176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.729 ' H ' ' HE ' ' A' ' 98' ' ' ARG . 51.8 p-10 -72.59 33.66 0.07 Allowed 'General case' 0 C--N 1.346 0.428 0 CA-C-N 113.073 -1.876 . . . . 0.0 112.196 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.601 HG12 ' H ' ' A' ' 101' ' ' GLU . 10.8 tt 40.9 -143.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.133 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 100' ' ' ILE . 85.5 mt-10 . . . . . 0 N--CA 1.447 -0.614 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.369 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo . . . . . 0 CA--C 1.542 0.904 0 N-CA-C 114.403 0.886 . . . . 0.0 114.403 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.44 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 2.6 p-90 -154.54 22.6 0.47 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.487 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.44 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 91.2 m-85 -90.48 119.48 30.79 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.843 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.54 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 32.7 m-85 -115.98 89.72 3.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.341 -1.754 . . . . 0.0 108.953 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -36.62 -106.67 0.01 OUTLIER Glycine 0 C--N 1.346 1.108 0 CA-C-N 111.979 -2.373 . . . . 0.0 112.918 -171.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 14.7 ptmm? -95.3 67.38 2.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.415 -173.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.428 HG22 ' CB ' ' A' ' 35' ' ' ARG . 6.3 tp -95.87 128.51 37.24 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 116.996 -1.882 . . . . 0.0 107.603 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.414 ' HG2' ' CB ' ' A' ' 18' ' ' LYS . 20.7 Cg_endo -66.54 -157.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 O-C-N 123.614 1.323 . . . . 0.0 111.496 -172.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 25.7 ttm180 -94.94 -49.94 5.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.629 -1.623 . . . . 0.0 108.884 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -48.42 -71.68 0.06 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 112.59 -2.096 . . . . 0.0 108.946 174.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.417 ' HG2' HD11 ' A' ' 14' ' ' ILE . 54.4 tptt -43.51 -56.23 3.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.588 -2.097 . . . . 0.0 110.725 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.39 -44.3 24.24 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 116.701 -2.0 . . . . 0.0 110.093 -178.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.579 ' O ' ' CB ' ' A' ' 24' ' ' SER . 95.1 mt-10 -66.98 -37.39 84.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.042 -1.89 . . . . 0.0 111.264 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 47.6 mt-10 -67.8 -80.27 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 117.365 -1.734 . . . . 0.0 110.478 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.616 ' HE3' ' CD2' ' A' ' 33' ' ' LEU . 23.6 ptt? -44.34 -39.76 4.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.7 -175.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' A' ' 25' ' ' LYS . 39.4 tp -72.73 -36.64 67.8 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 116.618 -2.033 . . . . 0.0 111.178 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 48.3 t -73.59 29.51 0.07 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 116.971 -1.892 . . . . 0.0 111.735 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 23' ' ' LEU . 55.4 mtpt -134.88 44.05 2.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.59 177.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 26.5 mm-40 -112.16 144.25 41.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.291 -1.777 . . . . 0.0 110.142 -174.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 28' ' ' HIS . 87.2 mtt180 -83.97 85.06 7.38 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 112.085 -2.325 . . . . 0.0 110.715 -172.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.424 ' HB3' ' O ' ' A' ' 27' ' ' ARG . 1.8 t-80 80.62 -45.64 0.26 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.199 -2.273 . . . . 0.0 110.904 173.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' LYS . 35.6 m-20 -47.42 166.08 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 111.905 -2.407 . . . . 0.0 108.199 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 96' ' ' PHE . . . 107.73 -39.51 2.86 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.552 1.072 . . . . 0.0 110.582 7.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -68.73 149.03 49.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 118.475 -1.29 . . . . 0.0 109.182 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' SER . 41.6 p90 -146.26 162.34 38.31 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 116.475 -2.09 . . . . 0.0 111.033 -172.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.616 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 4.5 pp -149.61 148.85 29.82 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.49 -2.141 . . . . 0.0 109.335 170.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 44' ' ' PHE . 58.2 mt -113.74 111.6 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.651 -2.068 . . . . 0.0 108.444 174.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 11.6 ptm180 -95.85 136.12 36.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.446 -2.161 . . . . 0.0 110.934 -170.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 12' ' ' GLY . 68.6 tt0 -82.6 125.74 31.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.126 -2.306 . . . . 0.0 109.449 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 47.7 t -59.22 132.66 54.68 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.762 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -42.27 -42.91 3.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.616 -2.084 . . . . 0.0 110.356 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 49.1 m -144.98 71.22 1.29 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 113.44 -1.709 . . . . 0.0 110.26 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 179.05 101.35 0.16 Allowed Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 112.898 -1.956 . . . . 0.0 109.113 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.3 -4.07 14.77 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.719 1.613 . . . . 0.0 115.185 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.29 40.2 2.61 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 118.731 -1.7 . . . . 0.0 110.895 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.458 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 9.5 t0 -143.23 106.55 4.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.959 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.521 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 23.2 m-85 -133.96 107.01 7.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.433 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 80.3 p -104.73 126.55 51.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.906 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.458 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.3 tt -90.76 114.9 27.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.318 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 98.2 p -96.97 147.18 24.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.081 -1.872 . . . . 0.0 110.017 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 60.2 t -145.12 134.49 18.12 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.284 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' ASP . 13.7 tptp -76.31 96.62 4.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 112.654 -2.066 . . . . 0.0 108.417 174.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.51 -44.03 65.41 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 117.17 -1.812 . . . . 0.0 110.703 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.92 -69.89 0.03 OUTLIER Glycine 0 CA--C 1.527 0.83 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.265 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -116.28 -25.86 7.39 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 111.927 -2.137 . . . . 0.0 111.816 176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.05 153.63 29.09 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 118.397 -1.321 . . . . 0.0 110.291 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 20' ' ' GLU . 74.8 t -79.59 131.28 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 112.41 -2.177 . . . . 0.0 109.569 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.453 ' OE1' ' CZ ' ' A' ' 57' ' ' PHE . 31.8 tt0 -101.51 164.47 11.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.674 -2.057 . . . . 0.0 109.868 -176.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 55' ' ' GLN . 42.1 m80 -150.06 140.54 22.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.007 -1.906 . . . . 0.0 110.723 -176.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 23.3 m-85 -135.88 111.98 9.66 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.381 173.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 37.9 mtmm -74.5 116.06 14.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 116.886 -1.925 . . . . 0.0 109.837 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.522 HG11 ' CD2' ' A' ' 77' ' ' LEU . 48.2 t -81.47 107.83 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 112.829 -1.987 . . . . 0.0 108.036 173.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 84.9 mt -96.68 162.2 13.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.162 -164.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 34.9 tpt85 . . . . . 0 N--CA 1.449 -0.5 0 CA-C-N 111.129 -2.759 . . . . 0.0 109.829 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.518 ' HZ2' ' HB3' ' A' ' 66' ' ' LYS . 5.8 mtpm? . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.328 0.585 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.517 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 26.7 m-85 -95.0 130.52 41.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.975 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 11.9 p90 -149.13 138.14 21.36 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 116.048 -2.261 . . . . 0.0 110.726 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 9.9 mt -81.33 -45.64 15.88 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 112.425 -2.17 . . . . 0.0 109.563 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -129.13 -86.19 0.55 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.188 -1.823 . . . . 0.0 109.934 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -106.87 -84.48 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.188 -1.824 . . . . 0.0 109.555 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.7 m -50.32 130.27 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.915 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -81.67 -169.48 2.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 112.819 -1.991 . . . . 0.0 109.93 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -148.13 134.49 19.56 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.421 -2.172 . . . . 0.0 108.7 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' O ' ' OG ' ' A' ' 76' ' ' SER . 17.9 m-20 -58.16 -22.26 50.59 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.153 -1.839 . . . . 0.0 112.336 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 50.3 m -168.04 161.33 12.61 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.953 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.522 ' CD2' HG11 ' A' ' 59' ' ' VAL . 86.3 mt -45.6 -40.88 9.41 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 117.34 -1.744 . . . . 0.0 110.318 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -54.07 -38.25 65.07 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.068 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.4 OUTLIER -69.91 -28.17 65.39 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.51 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 80' ' ' LEU . 9.0 tt -67.59 -49.86 61.1 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.819 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.3 -37.03 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 112.538 -2.119 . . . . 0.0 110.86 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.31 -35.97 71.46 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.145 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -55.29 -46.05 76.22 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 117.845 -1.542 . . . . 0.0 109.746 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.486 ' C ' ' H ' ' A' ' 86' ' ' SER . 52.1 t60 -63.79 -9.38 14.31 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.646 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 4.1 tpm_? -78.98 46.82 0.72 Allowed 'General case' 0 C--N 1.349 0.567 0 C-N-CA 117.799 -1.56 . . . . 0.0 109.402 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 84' ' ' HIS . 40.4 t -147.15 -41.44 0.18 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.787 -2.006 . . . . 0.0 110.248 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 t -149.16 -146.61 0.2 Allowed 'General case' 0 C--N 1.347 0.488 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.604 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.7 p -92.42 167.55 11.89 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 113.897 -1.501 . . . . 0.0 109.636 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.49 HG23 ' CB ' ' A' ' 90' ' ' SER . 11.8 m -73.32 -33.12 39.97 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 C-N-CA 117.103 -1.839 . . . . 0.0 111.587 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.49 ' CB ' HG23 ' A' ' 89' ' ' VAL . 13.4 t . . . . . 0 N--CA 1.445 -0.71 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.924 -165.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.423 ' O ' ' HG3' ' A' ' 94' ' ' GLN . 53.7 tp60 . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.974 0.892 . . . . 0.0 109.176 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.442 HD12 HG22 ' A' ' 89' ' ' VAL . 68.9 mt -133.0 128.02 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.979 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.461 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 45.2 t80 -127.17 139.83 52.67 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.922 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.7 mt -91.58 105.1 17.49 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.797 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.452 ' CZ ' ' H ' ' A' ' 99' ' ' ASP . 4.1 tpm_? -108.63 158.32 17.7 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.178 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.452 ' H ' ' CZ ' ' A' ' 98' ' ' ARG . 57.8 p30 -60.3 145.38 47.8 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 117.535 -1.666 . . . . 0.0 109.447 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.54 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 7.1 tt -99.45 29.27 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 113.076 -1.874 . . . . 0.0 111.937 -175.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 . . . . . 0 N--CA 1.447 -0.577 0 C-N-CA 117.616 -1.633 . . . . 0.0 110.065 -176.631 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.429 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 58.4 Cg_endo . . . . . 0 CA--C 1.541 0.828 0 N-CA-C 110.857 -0.478 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.502 ' CB ' ' CE2' ' A' ' 32' ' ' PHE . 37.7 p-90 -139.08 38.55 2.13 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.709 -174.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -121.91 115.09 21.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 117.812 -1.555 . . . . 0.0 110.162 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.434 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 18.7 m-85 -124.05 108.19 12.1 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.057 176.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -61.33 112.03 4.38 Favored Glycine 0 C--N 1.345 1.075 0 C-N-CA 118.127 -1.987 . . . . 0.0 111.127 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 36' ' ' GLU . 23.3 pttp 25.57 47.29 0.01 OUTLIER 'General case' 0 C--N 1.346 0.414 0 CA-C-N 111.481 -2.359 . . . . 0.0 111.472 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.7 tp -60.21 131.64 89.97 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.928 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.9 Cg_exo -45.52 122.54 4.87 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.742 1.628 . . . . 0.0 112.983 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.573 ' CB ' HH12 ' A' ' 35' ' ' ARG . 53.2 ttp180 -38.86 -41.24 0.72 Allowed 'General case' 0 C--N 1.345 0.388 0 CA-C-N 112.885 -1.961 . . . . 0.0 110.626 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -54.21 -79.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 113.345 -1.752 . . . . 0.0 109.442 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HG3' ' HE2' ' A' ' 22' ' ' MET . 28.1 tptp -37.91 -39.88 0.41 Allowed 'General case' 0 C--N 1.346 0.442 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.969 -177.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.94 -65.76 0.54 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 117.595 -1.642 . . . . 0.0 109.209 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 24' ' ' SER . 46.7 mt-10 -42.77 -41.01 3.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.696 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 22' ' ' MET . 65.5 mt-10 -62.58 -90.56 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 113.567 -1.652 . . . . 0.0 110.758 -173.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.564 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 5.6 ptp -42.6 -38.32 1.96 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.995 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.543 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 45.6 tp -68.03 -41.92 81.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 117.654 -1.619 . . . . 0.0 110.801 -176.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 26' ' ' GLN . 77.3 p -62.72 -36.91 84.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 117.402 -1.719 . . . . 0.0 110.706 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -69.38 30.73 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.534 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.553 ' H ' ' C ' ' A' ' 24' ' ' SER . 35.2 mm-40 -104.14 142.46 34.45 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 117.786 -1.565 . . . . 0.0 109.247 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 28' ' ' HIS . 2.0 mpt_? -79.05 44.28 0.56 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.883 -177.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.484 ' H ' ' HG2' ' A' ' 49' ' ' LYS . 0.9 OUTLIER 47.05 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.708 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -162.39 33.32 0.11 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.092 -1.867 . . . . 0.0 111.493 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.567 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 70.0 -1.98 15.17 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 116.576 -2.726 . . . . 0.0 113.241 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.401 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -46.23 134.56 8.56 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 118.297 -1.361 . . . . 0.0 108.899 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.502 ' CE2' ' CB ' ' A' ' 9' ' ' TRP . 15.3 p90 -150.77 163.23 39.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 115.897 -2.321 . . . . 0.0 111.087 -173.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.487 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.6 pp -149.92 146.66 27.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.172 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.44 109.87 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.844 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.573 HH12 ' CB ' ' A' ' 16' ' ' ARG . 27.7 ptt180 -92.1 126.31 37.13 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 112.022 -2.354 . . . . 0.0 110.167 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 67.4 tt0 -67.98 129.61 40.44 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.445 -2.161 . . . . 0.0 109.781 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 43' ' ' ASP . 73.5 m -67.12 129.88 41.32 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.501 178.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.649 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 2.3 mp0 -38.41 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 112.423 -2.171 . . . . 0.0 110.644 -176.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 40' ' ' ALA . 37.1 t -89.94 -29.54 18.43 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.086 -172.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -44.06 148.95 0.73 Allowed Pre-proline 0 C--N 1.348 0.538 0 C-N-CA 117.921 -1.512 . . . . 0.0 110.09 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -74.65 -8.62 20.63 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.934 2.423 . . . . 0.0 116.081 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.22 33.34 0.02 OUTLIER Glycine 0 CA--C 1.537 1.415 0 C-N-CA 118.611 -1.757 . . . . 0.0 111.68 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.474 ' O ' ' OG ' ' A' ' 37' ' ' SER . 1.3 m-20 -89.91 132.5 35.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 118.284 -1.366 . . . . 0.0 109.568 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.411 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 91.8 m-85 -143.62 132.34 22.54 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.59 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 99.7 p -119.15 138.17 53.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.492 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.4 tt -101.04 116.3 32.52 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 113.083 -1.871 . . . . 0.0 110.008 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.543 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 40.6 m -98.38 139.21 34.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.148 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -138.55 148.47 24.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.128 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.573 ' HZ3' ' C ' ' A' ' 52' ' ' ASN . 24.2 tptp -79.0 106.11 10.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.98 -1.918 . . . . 0.0 108.775 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' O ' ' CE1' ' A' ' 28' ' ' HIS . 7.4 t80 -76.28 -102.73 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 116.784 -1.966 . . . . 0.0 109.071 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -99.1 -69.39 0.92 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.751 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.573 ' C ' ' HZ3' ' A' ' 49' ' ' LYS . 25.6 t-20 -121.46 -23.26 5.69 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 111.917 -2.141 . . . . 0.0 112.174 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.27 158.54 18.28 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 118.404 -1.319 . . . . 0.0 110.32 -174.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 24' ' ' SER . 95.2 t -80.69 118.85 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.4 -2.182 . . . . 0.0 109.678 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -102.78 158.2 16.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.718 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.3 143.18 47.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.57 -2.104 . . . . 0.0 110.598 -175.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -129.57 100.64 5.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.494 -2.139 . . . . 0.0 108.795 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 51.2 mtmt -67.56 113.06 5.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 112.984 -1.916 . . . . 0.0 110.345 -174.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.523 HG11 ' CD2' ' A' ' 77' ' ' LEU . 58.8 t -74.04 83.59 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 112.522 -2.126 . . . . 0.0 108.633 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 79.0 mt -72.88 161.02 31.22 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 112.799 -2.001 . . . . 0.0 110.703 -173.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.702 HH11 ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.523 0 CA-C-N 112.006 -2.361 . . . . 0.0 109.227 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HA ' ' HZ3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.97 0.891 . . . . 0.0 109.545 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 87.5 m-85 -117.55 150.32 39.16 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.939 -1.937 . . . . 0.0 109.301 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -166.01 144.37 5.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.573 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.634 HD22 ' H ' ' A' ' 69' ' ' LEU . 2.5 mm? -65.05 -52.79 53.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 116.714 -1.994 . . . . 0.0 109.043 176.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 10.7 m0 -139.75 -45.0 0.44 Allowed 'General case' 0 C--N 1.345 0.413 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.013 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 77.8 t -129.23 -81.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 112.965 -1.925 . . . . 0.0 110.175 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -50.17 133.75 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 112.614 -2.085 . . . . 0.0 110.275 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 94.0 mttt -93.36 160.9 14.61 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.464 -176.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -133.88 137.8 45.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 111.936 -2.393 . . . . 0.0 109.444 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -62.61 -34.57 77.3 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 112.712 -2.04 . . . . 0.0 110.989 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 77' ' ' LEU . 42.1 t -153.29 152.79 31.55 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 118.278 -1.369 . . . . 0.0 109.888 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.523 ' CD2' HG11 ' A' ' 59' ' ' VAL . 76.0 mt -39.28 -40.42 0.76 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.823 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -48.67 -42.47 34.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.316 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -73.42 -34.1 65.29 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 115.729 -2.388 . . . . 0.0 110.893 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.496 HD23 ' C ' ' A' ' 80' ' ' LEU . 6.9 tt -56.78 -46.38 81.53 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.234 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' LEU . 96.0 t -63.16 -40.56 89.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 112.801 -1.999 . . . . 0.0 110.904 -177.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -71.33 -40.02 71.01 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.895 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -56.53 -41.07 76.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.449 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -93.15 40.07 1.06 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.677 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -107.45 -13.18 15.15 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.663 -1.608 . . . . 0.0 112.693 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.4 t -132.25 -42.15 0.98 Allowed 'General case' 0 C--N 1.351 0.635 0 C-N-CA 117.982 -1.487 . . . . 0.0 110.296 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 88' ' ' SER . 62.0 p -89.76 37.43 0.88 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.618 -1.628 . . . . 0.0 111.082 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' THR . 34.1 t 41.97 -165.71 0.01 OUTLIER 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.136 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 89' ' ' VAL . 12.8 p -147.71 47.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.582 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 45.5 t . . . . . 0 C--N 1.345 0.382 0 CA-C-N 112.805 -1.998 . . . . 0.0 109.512 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 31.1 tt0 . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.939 0.876 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 88' ' ' SER . 44.7 mt -138.9 153.87 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 113.115 -1.857 . . . . 0.0 109.579 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.567 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 88.2 m-85 -149.99 179.86 7.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.684 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.3 mt -125.03 108.46 11.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 112.854 -1.975 . . . . 0.0 109.182 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 17.4 mmm180 -125.0 154.37 41.35 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.872 -1.967 . . . . 0.0 109.88 -177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 101' ' ' GLU . 58.6 t0 -52.72 118.76 3.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.62 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.487 ' CD1' HD23 ' A' ' 33' ' ' LEU . 11.6 tt -71.99 29.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.774 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 99' ' ' ASP . 12.3 mm-40 . . . . . 0 N--CA 1.448 -0.572 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.681 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo . . . . . 0 CA--C 1.544 1.022 0 N-CA-C 114.283 0.84 . . . . 0.0 114.283 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' CZ ' ' A' ' 10' ' ' PHE . 5.2 p-90 -159.2 17.59 0.18 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.511 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.439 ' CZ ' ' CH2' ' A' ' 9' ' ' TRP . 96.8 m-85 -85.82 109.21 18.52 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.676 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 56.0 m-85 -97.53 95.8 7.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.866 -1.97 . . . . 0.0 108.853 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -49.65 105.62 0.17 Allowed Glycine 0 C--N 1.345 1.077 0 CA-C-N 112.797 -2.002 . . . . 0.0 111.254 -173.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 12' ' ' GLY . 63.4 pttt 30.51 42.07 0.01 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 111.459 -2.37 . . . . 0.0 111.193 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.437 HG12 ' CE ' ' A' ' 22' ' ' MET . 9.3 tp -56.51 134.85 77.12 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 113.373 -1.74 . . . . 0.0 108.727 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.8 Cg_exo -44.74 121.23 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.807 1.671 . . . . 0.0 112.911 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' PRO . 74.6 ttt180 -37.28 -37.12 0.17 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.268 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -69.79 -63.24 1.11 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.766 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.461 ' HG3' ' CE ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -42.78 -42.19 3.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.458 -177.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -48.07 -58.63 4.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.1 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 91.2 mt-10 -49.1 -45.06 42.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 112.392 -2.185 . . . . 0.0 110.068 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 35.5 mt-10 -59.08 -81.17 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.799 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.461 ' CE ' ' HG3' ' A' ' 18' ' ' LYS . 9.8 ptp -50.82 -41.17 57.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 116.491 -2.084 . . . . 0.0 110.422 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.459 ' O ' ' CG ' ' A' ' 26' ' ' GLN . 39.3 tp -62.27 -26.96 68.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 117.725 -1.59 . . . . 0.0 112.531 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.545 ' C ' ' H ' ' A' ' 26' ' ' GLN . 93.3 p -71.84 -29.06 64.0 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 117.803 -1.559 . . . . 0.0 111.733 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -72.28 37.19 0.07 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.819 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 24' ' ' SER . 29.1 mm-40 -119.27 19.52 12.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 117.86 -1.536 . . . . 0.0 113.095 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 28' ' ' HIS . 58.2 mmm-85 20.37 58.25 0.02 OUTLIER 'General case' 0 C--N 1.349 0.555 0 O-C-N 125.215 1.572 . . . . 0.0 111.952 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 27' ' ' ARG . 72.5 t60 43.53 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.015 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 55.0 m-20 -157.71 29.06 0.27 Allowed 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.858 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 78.16 -9.34 33.5 Favored Glycine 0 CA--C 1.542 1.777 0 C-N-CA 115.969 -3.015 . . . . 0.0 113.147 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.409 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -44.98 120.74 2.48 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.055 177.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.492 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 14.0 p90 -126.14 151.2 47.6 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 116.638 -2.025 . . . . 0.0 111.716 -173.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.583 ' HB3' ' H ' ' A' ' 47' ' ' SER . 0.6 OUTLIER -114.53 146.75 40.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 110.892 -2.867 . . . . 0.0 109.013 -169.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 33' ' ' LEU . 18.4 mt -147.16 121.83 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 114.935 -2.706 . . . . 0.0 109.42 154.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 27.9 ptt180 -108.81 128.31 54.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.411 -2.177 . . . . 0.0 110.369 -174.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 31.2 tp10 -68.92 136.36 52.46 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 112.459 -2.155 . . . . 0.0 109.853 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.61 ' HB3' ' H ' ' A' ' 43' ' ' ASP . 88.9 p -42.07 118.55 1.16 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.299 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.32 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.141 -1.845 . . . . 0.0 109.271 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.6 p -112.01 44.36 1.42 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.318 -1.764 . . . . 0.0 109.809 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -135.11 156.88 77.92 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.507 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ALA . 74.0 Cg_exo -43.56 -119.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.873 2.382 . . . . 0.0 114.099 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.29 68.31 0.51 Allowed Glycine 0 C--N 1.346 1.119 0 C-N-CA 118.154 -1.974 . . . . 0.0 110.187 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.61 ' H ' ' HB3' ' A' ' 37' ' ' SER . 61.9 t0 -90.05 117.87 29.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 112.82 -1.69 . . . . 0.0 109.799 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 21.4 m-85 -130.18 115.85 17.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.491 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.2 p -124.51 137.71 54.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.476 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.483 ' CD2' HG23 ' A' ' 48' ' ' VAL . 6.0 tt -110.24 119.07 38.06 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.7 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.583 ' H ' ' HB3' ' A' ' 33' ' ' LEU . 49.4 m -112.85 122.45 47.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.216 -1.811 . . . . 0.0 109.795 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.483 HG23 ' CD2' ' A' ' 46' ' ' LEU . 86.8 t -113.65 146.73 17.87 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.379 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 26' ' ' GLN . 41.7 tptt -69.35 89.54 0.49 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 116.693 -2.003 . . . . 0.0 108.915 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 53' ' ' ASP . 63.3 t80 -91.31 134.33 34.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 117.27 -1.772 . . . . 0.0 108.549 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -43.37 129.14 5.87 Favored Glycine 0 C--N 1.342 0.886 0 C-N-CA 117.286 -2.388 . . . . 0.0 111.299 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 14.9 t-20 83.33 -31.19 0.08 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 111.471 -2.364 . . . . 0.0 111.222 176.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 50' ' ' PHE . 33.6 m-20 -155.24 150.63 27.17 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 114.441 -2.903 . . . . 0.0 112.37 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG12 ' CE1' ' A' ' 56' ' ' HIS . 46.2 t -70.46 119.22 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 111.742 -2.481 . . . . 0.0 108.927 171.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 47' ' ' SER . 60.0 tt0 -101.75 159.61 15.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.884 -177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.523 ' CE1' HG12 ' A' ' 54' ' ' VAL . 16.9 m-70 -128.51 134.7 48.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.493 -2.14 . . . . 0.0 110.63 -174.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 93.7 m-85 -129.37 102.84 6.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 112.258 -2.247 . . . . 0.0 108.803 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 54.5 mtmt -70.49 114.12 8.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 116.97 -1.892 . . . . 0.0 109.718 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' CD2' ' A' ' 77' ' ' LEU . 94.3 t -74.88 86.77 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.537 174.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 81.6 mt -78.24 159.13 28.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 112.741 -2.027 . . . . 0.0 110.955 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 CA-C-N 111.948 -2.387 . . . . 0.0 108.583 175.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.729 ' HZ2' ' CG ' ' A' ' 73' ' ' LYS . 8.5 mtmp? . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 121.52 0.676 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 20.5 m-85 -105.95 144.08 33.19 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 113.571 -1.649 . . . . 0.0 110.085 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.409 ' C ' HD12 ' A' ' 69' ' ' LEU . 11.3 p90 -151.82 -165.89 2.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 117.262 -1.775 . . . . 0.0 109.381 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.516 HD11 HD11 ' A' ' 80' ' ' LEU . 5.6 mp -125.87 -46.34 1.7 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.36 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 21.5 m0 -132.54 -42.92 0.93 Allowed 'General case' 0 C--N 1.346 0.437 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.125 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.6 t -141.7 -84.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.011 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.403 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 32.9 m -51.74 136.23 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.211 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.729 ' CG ' ' HZ2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -104.4 176.09 5.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.899 -177.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.455 ' C ' ' HZ3' ' A' ' 66' ' ' LYS . 21.5 m-85 -146.59 138.31 24.6 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.131 -1.849 . . . . 0.0 108.915 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.468 ' O ' ' OG ' ' A' ' 76' ' ' SER . 41.8 p30 -66.5 -8.98 30.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 113.253 -1.794 . . . . 0.0 113.266 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 49.2 m -167.96 150.16 5.52 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 117.791 -1.564 . . . . 0.0 109.422 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.511 ' CD2' HG11 ' A' ' 59' ' ' VAL . 97.7 mt -46.01 -42.51 13.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.114 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -55.87 -42.86 76.53 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.349 -1.751 . . . . 0.0 110.442 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 76' ' ' SER . 32.3 tp10 -63.68 -35.44 80.57 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 113.335 -1.757 . . . . 0.0 110.665 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 80' ' ' LEU . 6.1 tt -58.43 -50.84 72.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.073 -1.422 . . . . 0.0 108.375 173.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.453 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 81.3 t -63.85 -14.25 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 112.393 -2.185 . . . . 0.0 112.834 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -84.61 -26.44 27.89 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.715 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.433 ' O ' ' C ' ' A' ' 84' ' ' HIS . 68.8 t80 -73.12 -40.85 64.6 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.104 -174.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.546 ' C ' ' H ' ' A' ' 86' ' ' SER . 7.1 p-80 -45.52 -36.84 4.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.299 -2.16 . . . . 0.0 110.842 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 67.4 ttt-85 -73.4 37.35 0.09 Allowed 'General case' 0 C--N 1.348 0.516 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.877 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 84' ' ' HIS . 42.4 t -136.74 -41.63 0.61 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.141 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 88' ' ' SER . 9.0 t -165.52 55.63 0.11 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.092 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.567 ' HB2' ' H ' ' A' ' 95' ' ' ILE . 69.7 p 50.56 -179.0 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.261 -1.791 . . . . 0.0 110.101 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 89' ' ' VAL . 13.8 p -128.69 37.03 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.711 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.588 ' OG ' ' CD1' ' A' ' 95' ' ' ILE . 86.7 p . . . . . 0 N--CA 1.447 -0.613 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.505 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.54 ' HA ' ' CB ' ' A' ' 88' ' ' SER . 77.3 mt-30 . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 121.919 0.866 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.588 ' CD1' ' OG ' ' A' ' 90' ' ' SER . 35.9 mt -150.04 140.6 16.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.904 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.45 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 88.5 m-85 -118.81 133.04 56.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.618 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.406 ' O ' ' HD3' ' A' ' 98' ' ' ARG . 28.6 mt -90.0 102.02 14.73 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.451 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 97' ' ' LEU . 27.7 mmt180 -150.29 -159.83 1.09 Allowed 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.144 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.44 ' O ' HG22 ' A' ' 100' ' ' ILE . 55.4 t0 48.73 -120.67 1.37 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.136 170.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 5.0 tt 40.16 22.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 113.843 -1.526 . . . . 0.0 113.371 -174.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 . . . . . 0 N--CA 1.442 -0.875 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.0 -177.512 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.436 ' C ' ' CG ' ' A' ' 9' ' ' TRP . 38.2 Cg_exo . . . . . 0 N--CA 1.455 -0.773 0 N-CA-C 115.565 1.333 . . . . 0.0 115.565 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.436 ' CG ' ' C ' ' A' ' 8' ' ' PRO . 41.4 p-90 43.7 30.64 0.38 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 116.965 -1.894 . . . . 0.0 111.583 177.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -105.37 118.97 37.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.478 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 29.1 m-85 -121.58 83.93 2.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.113 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -49.81 111.37 1.07 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-N 112.641 -2.072 . . . . 0.0 110.778 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.497 ' H ' ' HB2' ' A' ' 36' ' ' GLU . 26.2 pttm 26.44 46.16 0.01 OUTLIER 'General case' 0 C--N 1.344 0.357 0 CA-C-N 111.529 -2.335 . . . . 0.0 111.387 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.4 tp -61.61 135.61 94.2 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 112.96 -1.927 . . . . 0.0 108.912 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' ARG . 54.3 Cg_exo -44.08 121.74 3.16 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.855 1.703 . . . . 0.0 113.029 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.689 ' HB3' HH22 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -40.74 -41.81 1.62 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.702 -177.472 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.557 ' H ' ' HD3' ' A' ' 16' ' ' ARG . . . -59.16 -63.09 1.43 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.483 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -43.39 -52.0 6.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 112.766 -2.016 . . . . 0.0 110.421 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.75 -49.47 14.82 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.759 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.29 -44.65 96.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.775 -2.011 . . . . 0.0 110.114 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' SER . 44.2 mt-10 -67.09 -70.4 0.25 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.872 -173.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.57 ' C ' ' SD ' ' A' ' 22' ' ' MET . 3.5 ppp? -46.48 -42.48 15.57 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 117.088 -1.845 . . . . 0.0 110.474 -173.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.562 ' N ' ' SD ' ' A' ' 22' ' ' MET . 60.8 tp -75.89 -25.11 55.77 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 113.357 -1.747 . . . . 0.0 112.569 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 26' ' ' GLN . 78.4 p -74.18 -33.31 63.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 117.186 -1.806 . . . . 0.0 111.151 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 50.1 mtpt -75.54 38.78 0.15 Allowed 'General case' 0 C--N 1.347 0.467 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.605 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 26' ' ' GLN . 4.2 mm-40 -102.25 136.05 42.77 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 117.687 -1.605 . . . . 0.0 110.225 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HA ' ' CB ' ' A' ' 28' ' ' HIS . 9.9 mpt_? -116.54 84.33 2.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 110.688 -2.96 . . . . 0.0 106.374 171.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 27' ' ' ARG . 1.3 t-80 -171.24 12.07 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.702 13.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 7.0 m-20 -163.09 128.69 3.19 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.753 -1.579 . . . . 0.0 110.619 -173.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 103.26 -27.03 21.77 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 117.835 -2.126 . . . . 0.0 112.875 170.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.432 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -46.95 135.76 9.04 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 117.762 -1.575 . . . . 0.0 109.147 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.512 ' CB ' HD22 ' A' ' 97' ' ' LEU . 17.3 p90 -139.94 164.51 29.82 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 115.077 -2.649 . . . . 0.0 112.427 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.608 ' HB3' ' H ' ' A' ' 47' ' ' SER . 0.4 OUTLIER -129.03 145.96 51.12 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 110.31 -3.132 . . . . 0.0 108.658 -165.364 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.519 ' CG1' ' O ' ' A' ' 33' ' ' LEU . 16.5 mt -145.85 119.94 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 114.886 -2.726 . . . . 0.0 109.504 153.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.689 HH22 ' HB3' ' A' ' 16' ' ' ARG . 10.1 ptm180 -113.11 147.79 36.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 111.852 -2.431 . . . . 0.0 110.223 -172.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.497 ' HB2' ' H ' ' A' ' 13' ' ' LYS . 40.7 mt-10 -86.97 167.38 14.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.69 -2.05 . . . . 0.0 109.719 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 38.9 t -71.83 -134.41 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.255 -1.793 . . . . 0.0 108.679 175.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -101.26 -70.92 0.73 Allowed 'General case' 0 C--N 1.347 0.473 0 C-N-CA 118.097 -1.441 . . . . 0.0 109.114 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.4 t -128.81 45.52 2.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.666 -2.061 . . . . 0.0 109.566 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -156.44 110.21 2.04 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.841 -176.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' A' ' 43' ' ' ASP . 23.6 Cg_exo -57.48 -144.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.132 0 N-CA-C 107.798 -1.655 . . . . 0.0 107.798 171.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.78 -28.33 0.14 Allowed Glycine 0 CA--C 1.541 1.679 0 CA-C-N 114.091 -1.413 . . . . 0.0 113.376 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 41' ' ' PRO . 11.2 m-20 -112.8 116.52 30.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.967 0.889 . . . . 0.0 109.253 -173.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.433 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 91.7 m-85 -149.19 91.14 1.81 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.986 -1.916 . . . . 0.0 109.791 -175.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.473 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 28.4 p -89.99 137.41 32.36 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 115.947 -2.301 . . . . 0.0 109.93 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.499 ' CD2' HG23 ' A' ' 48' ' ' VAL . 6.5 tt -100.01 121.02 40.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 111.965 -2.38 . . . . 0.0 109.562 -173.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.608 ' H ' ' HB3' ' A' ' 33' ' ' LEU . 49.2 m -114.38 130.29 56.69 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.25 -176.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.517 ' CA ' HD21 ' A' ' 23' ' ' LEU . 84.3 t -128.13 145.4 35.33 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 CA-C-N 113.287 -1.778 . . . . 0.0 110.317 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 24' ' ' SER . 22.0 tptp -72.39 96.69 1.92 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 113.332 -1.758 . . . . 0.0 108.034 172.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CD2' ' O ' ' A' ' 53' ' ' ASP . 24.4 p90 -89.12 -1.31 58.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 116.546 -2.061 . . . . 0.0 113.801 -170.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.41 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 153.8 -80.48 0.18 Allowed Glycine 0 C--N 1.346 1.124 0 C-N-CA 117.024 -2.512 . . . . 0.0 110.77 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -109.28 -29.3 8.55 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 112.4 -1.9 . . . . 0.0 111.642 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 32.2 t70 -133.36 -174.92 3.64 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 117.434 -1.706 . . . . 0.0 110.159 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.561 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 73.9 t -100.08 122.19 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 112.857 -1.974 . . . . 0.0 110.377 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' SER . 57.1 tt0 -94.48 166.52 12.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.583 -2.099 . . . . 0.0 108.491 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 43.6 p-80 -150.08 144.52 25.8 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.495 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.491 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 98.6 m-85 -138.59 89.93 2.41 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.931 177.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.473 ' HA ' ' CB ' ' A' ' 45' ' ' SER . 9.1 ptmm? -45.06 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 112.535 -2.121 . . . . 0.0 109.912 169.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 22.9 t -79.09 71.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-N 113.237 -1.801 . . . . 0.0 108.912 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.434 ' CD1' ' NZ ' ' A' ' 58' ' ' LYS . 16.6 mt -73.06 -151.89 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.227 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 8.7 ptm180 . . . . . 0 N--CA 1.446 -0.663 0 C-N-CA 116.982 -1.887 . . . . 0.0 109.885 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 5.1 mtpm? . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 8.1 m-30 -71.09 140.79 50.79 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 118.196 -1.402 . . . . 0.0 109.91 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -156.58 151.23 25.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 117.094 -1.842 . . . . 0.0 110.745 174.698 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.491 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 4.9 mt -87.77 -43.44 11.87 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 112.441 -2.163 . . . . 0.0 109.956 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -147.4 -44.61 0.17 Allowed 'General case' 0 C--N 1.346 0.435 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.929 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.2 t -135.75 -83.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.903 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.6 m -53.92 131.64 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 112.814 -1.994 . . . . 0.0 110.09 -176.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.454 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 47.7 mtmt -88.04 176.24 7.39 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.693 -2.049 . . . . 0.0 110.053 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.454 ' CD1' ' O ' ' A' ' 73' ' ' LYS . 18.0 m-85 -147.25 132.76 18.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 112.507 -2.133 . . . . 0.0 108.725 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 76' ' ' SER . 18.3 t30 -83.67 49.34 1.58 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.949 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 29.2 t 138.94 142.7 0.0 OUTLIER 'General case' 0 C--N 1.349 0.562 0 CA-C-N 112.249 -2.25 . . . . 0.0 109.344 173.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 80' ' ' LEU . 95.7 mt -49.09 -49.42 41.81 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.238 -1.801 . . . . 0.0 108.851 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -47.45 -39.46 15.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 112.624 -2.08 . . . . 0.0 110.621 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 79' ' ' GLU . 4.7 tm-20 -64.1 -35.76 81.8 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 116.772 -1.971 . . . . 0.0 110.5 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.464 HD11 ' CG ' ' A' ' 69' ' ' LEU . 6.8 tt -64.88 -66.67 0.51 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.692 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.6 t -39.69 -38.84 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 112.321 -2.218 . . . . 0.0 110.893 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 12.6 t70 -77.64 -36.25 51.72 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.209 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' LEU . 60.8 t80 -68.76 -28.29 66.66 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 117.942 -1.503 . . . . 0.0 111.948 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -107.45 35.2 3.15 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 117.953 -1.499 . . . . 0.0 111.328 -175.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 12.7 ptm180 -97.38 30.55 2.8 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 117.426 -1.71 . . . . 0.0 111.656 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 88' ' ' SER . 80.5 p -149.98 -74.06 0.17 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 117.651 -1.62 . . . . 0.0 110.259 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.417 ' N ' ' OG ' ' A' ' 86' ' ' SER . 9.0 t -76.23 39.68 0.2 Allowed 'General case' 0 C--N 1.345 0.41 0 CA-C-N 112.966 -1.924 . . . . 0.0 110.862 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 86' ' ' SER . 32.7 t 50.93 -146.22 0.46 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 117.825 -1.55 . . . . 0.0 109.398 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.452 ' O ' HG22 ' A' ' 89' ' ' VAL . 15.0 p -160.12 45.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.678 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.2 t . . . . . 0 C--N 1.346 0.425 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.592 -179.347 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.428 ' CG2' HG11 ' A' ' 48' ' ' VAL . 37.0 mt -149.96 127.18 2.42 Favored 'Isoleucine or valine' 0 C--N 1.349 0.55 0 C-N-CA 117.831 -1.548 . . . . 0.0 110.054 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.577 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 29.9 t80 -123.74 135.76 54.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.965 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.512 HD22 ' CB ' ' A' ' 32' ' ' PHE . 95.5 mt -89.94 96.11 10.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 117.045 -1.862 . . . . 0.0 110.228 -174.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' A' ' 99' ' ' ASP . 53.4 ttm-85 -153.8 -137.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.808 175.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.584 ' H ' ' HG2' ' A' ' 98' ' ' ARG . 35.9 t0 43.85 -170.84 0.01 OUTLIER 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.286 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.531 ' H ' ' CG ' ' A' ' 99' ' ' ASP . 0.5 OUTLIER 86.78 -38.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.361 173.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.418 ' HG2' HG23 ' A' ' 100' ' ' ILE . 24.2 mm-40 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-N 112.988 -1.914 . . . . 0.0 109.98 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 N--CA 1.453 -0.898 0 CA-C-O 121.089 0.37 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.456 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 5.0 m-90 -126.31 -29.88 2.94 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 117.779 -1.569 . . . . 0.0 111.856 -167.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 92.3 m-85 -67.59 116.99 8.93 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.159 -171.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 9' ' ' TRP . 97.4 m-85 -123.94 95.56 4.61 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.682 171.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.56 163.76 30.44 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 114.861 -3.542 . . . . 0.0 112.242 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.658 ' HD3' ' H ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -88.65 109.04 19.78 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 113.26 -1.47 . . . . 0.0 109.296 -6.66 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.2 tp -87.71 123.26 69.59 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 113.198 -1.819 . . . . 0.0 109.341 -177.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 16' ' ' ARG . 49.2 Cg_exo -49.88 122.38 8.95 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.493 1.462 . . . . 0.0 112.199 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 15' ' ' PRO . 71.2 ttt180 -38.83 -40.17 0.6 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-N 113.33 -1.759 . . . . 0.0 110.73 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -57.84 -70.89 0.12 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.494 -1.684 . . . . 0.0 108.961 173.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.56 ' NZ ' ' SD ' ' A' ' 22' ' ' MET . 28.6 tptp -35.9 -48.52 0.58 Allowed 'General case' 0 C--N 1.346 0.414 0 CA-C-N 112.833 -1.985 . . . . 0.0 111.051 -176.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.14 -69.32 0.15 Allowed 'General case' 0 C--N 1.346 0.421 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.423 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 80.3 mt-10 -49.72 -23.42 1.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 112.388 -2.187 . . . . 0.0 112.245 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 81.6 mm-40 -81.34 -81.71 0.13 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 118.486 -1.286 . . . . 0.0 110.11 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.56 ' SD ' ' NZ ' ' A' ' 18' ' ' LYS . 18.4 ptm -47.05 -41.72 17.29 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 117.045 -1.862 . . . . 0.0 110.28 -176.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.495 HD13 ' CD1' ' A' ' 100' ' ' ILE . 41.8 tp -63.42 -34.49 77.85 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.422 -178.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.55 ' C ' ' H ' ' A' ' 26' ' ' GLN . 71.7 p -69.24 -33.67 73.63 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 116.616 -2.034 . . . . 0.0 110.954 176.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -72.35 34.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.108 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.55 ' H ' ' C ' ' A' ' 24' ' ' SER . 28.6 mm-40 -100.75 149.95 23.28 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.454 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 28' ' ' HIS . 24.7 tpt180 -73.57 36.41 0.09 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.107 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.678 ' CE1' ' H ' ' A' ' 51' ' ' GLY . 77.7 t60 44.13 93.13 0.01 OUTLIER 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.631 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -164.03 37.36 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 116.83 -1.948 . . . . 0.0 111.258 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 68.02 1.45 19.31 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 116.785 -2.626 . . . . 0.0 113.44 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.3 132.62 16.29 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 117.775 -1.57 . . . . 0.0 108.761 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' SER . 26.7 p90 -144.87 160.99 40.41 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 115.787 -2.365 . . . . 0.0 111.427 -173.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.532 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.6 pp -145.81 146.12 31.05 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.397 170.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 45' ' ' SER . 71.3 mt -110.25 105.19 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 112.57 -2.105 . . . . 0.0 108.096 173.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 11.1 ptm180 -92.0 152.45 20.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 116.751 -1.98 . . . . 0.0 111.219 -170.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' SER . 47.4 mt-10 -113.59 129.25 56.6 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 111.73 -2.486 . . . . 0.0 109.315 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 39.9 t -50.57 -179.46 0.01 OUTLIER 'General case' 0 C--N 1.346 0.415 0 C-N-CA 116.821 -1.952 . . . . 0.0 109.878 -178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -42.79 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.345 0.392 0 CA-C-N 112.978 -1.919 . . . . 0.0 109.692 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 46.6 t -89.93 -49.18 6.75 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.497 174.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' A' ' 37' ' ' SER . . . 70.95 119.49 0.03 OUTLIER Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 112.462 -2.154 . . . . 0.0 111.246 165.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.95 -112.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 170.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.49 58.57 0.39 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 117.346 -2.359 . . . . 0.0 109.99 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -101.46 107.63 19.0 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 117.481 -1.688 . . . . 0.0 109.587 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 19.8 m-85 -129.64 127.59 40.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.494 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.7 p -134.06 127.31 31.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.717 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.423 ' CD2' ' HB2' ' A' ' 32' ' ' PHE . 4.8 tt -90.79 115.51 27.91 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.786 -2.006 . . . . 0.0 109.55 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.435 ' OG ' ' HG ' ' A' ' 33' ' ' LEU . 90.1 p -100.54 146.73 26.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.898 -1.956 . . . . 0.0 109.735 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.8 t -140.6 149.24 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 117.553 -1.659 . . . . 0.0 110.515 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.48 ' CE ' ' O ' ' A' ' 24' ' ' SER . 20.7 tptm -75.44 102.73 5.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.747 -2.024 . . . . 0.0 108.795 174.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' ASN . 38.5 t80 -98.82 108.4 21.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.472 -1.695 . . . . 0.0 109.607 -178.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.678 ' H ' ' CE1' ' A' ' 28' ' ' HIS . . . 54.79 -97.37 0.04 OUTLIER Glycine 0 CA--C 1.53 1.02 0 C-N-CA 118.021 -2.038 . . . . 0.0 110.161 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 50' ' ' PHE . 51.7 t30 -112.16 -26.34 8.86 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 112.659 -1.771 . . . . 0.0 112.043 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.544 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 30.3 t0 -101.43 -173.23 2.31 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.223 -1.391 . . . . 0.0 109.528 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.544 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 96.0 t -111.47 120.5 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 113.259 -1.791 . . . . 0.0 109.742 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 61.2 tt0 -90.01 159.38 16.9 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 112.881 -1.963 . . . . 0.0 109.357 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -136.31 121.55 19.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.733 -2.031 . . . . 0.0 110.47 -173.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 46' ' ' LEU . 24.2 m-85 -112.71 126.28 55.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.79 -2.005 . . . . 0.0 109.191 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.0 mtmm -95.87 118.12 31.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 116.733 -1.987 . . . . 0.0 109.538 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.534 HG11 ' CD2' ' A' ' 77' ' ' LEU . 68.0 t -75.97 92.76 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 113.031 -1.895 . . . . 0.0 108.734 176.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 54.0 mt -89.94 151.51 21.67 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 113.03 -1.895 . . . . 0.0 110.871 -174.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 64.8 ttp85 . . . . . 0 N--CA 1.445 -0.713 0 CA-C-N 111.858 -2.428 . . . . 0.0 109.431 174.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.659 ' HZ2' ' HA ' ' A' ' 75' ' ' ASN . 1.9 mmpm? . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 122.167 0.984 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.521 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 86.6 m-85 -96.8 134.49 40.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.42 -2.173 . . . . 0.0 109.04 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 71' ' ' VAL . 50.7 p90 -152.75 -162.37 1.48 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 117.188 -1.805 . . . . 0.0 109.999 -176.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 69' ' ' LEU . 5.6 mp -133.27 -39.4 0.93 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 112.31 -2.223 . . . . 0.0 110.767 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -110.32 -38.67 5.18 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.84 -173.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 98.5 t -150.02 -83.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 117.148 -1.821 . . . . 0.0 109.365 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 71' ' ' VAL . 18.4 m -162.1 136.89 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.202 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.565 ' CD ' ' CZ ' ' A' ' 74' ' ' PHE . 17.3 ptpt -170.07 -24.26 0.02 OUTLIER 'General case' 0 C--N 1.347 0.483 0 C-N-CA 114.684 -2.806 . . . . 0.0 112.829 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.565 ' CZ ' ' CD ' ' A' ' 73' ' ' LYS . 10.8 m-85 -120.24 146.58 45.92 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 116.671 -2.011 . . . . 0.0 109.986 -174.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.659 ' HA ' ' HZ2' ' A' ' 66' ' ' LYS . 53.1 p-10 -86.77 -22.6 25.83 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 113.087 -1.87 . . . . 0.0 112.065 175.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.416 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 41.0 t -155.6 162.34 40.65 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 118.201 -1.399 . . . . 0.0 109.703 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.534 ' CD2' HG11 ' A' ' 59' ' ' VAL . 95.9 mt -46.32 -45.48 17.51 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.932 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.406 ' OD1' ' CZ3' ' A' ' 9' ' ' TRP . 1.8 m-20 -48.49 -38.59 20.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.871 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' CB ' ' HB3' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -77.34 -19.98 55.53 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 113.994 -1.457 . . . . 0.0 112.17 -178.805 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 80' ' ' LEU . 6.8 tt -72.62 -57.68 3.94 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 118.154 -1.418 . . . . 0.0 108.227 172.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 58.2 t -51.75 -41.72 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 111.911 -2.404 . . . . 0.0 110.573 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 11.2 t70 -63.43 -44.48 94.42 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.35 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CB ' ' CE1' ' A' ' 74' ' ' PHE . 64.5 t80 -70.04 -37.49 75.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.188 -1.824 . . . . 0.0 111.096 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 86' ' ' SER . 1.0 OUTLIER -72.72 -32.53 65.79 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.397 -178.004 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 55.0 ptt85 -77.31 41.84 0.32 Allowed 'General case' 0 C--N 1.348 0.506 0 C-N-CA 117.276 -1.769 . . . . 0.0 110.396 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 84' ' ' HIS . 42.6 t -150.01 -44.93 0.13 Allowed 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.344 -1.753 . . . . 0.0 109.656 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 88' ' ' SER . 9.5 t -103.91 -137.6 0.35 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.192 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' A' ' 95' ' ' ILE . 70.1 p -143.03 175.54 9.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 118.166 -1.414 . . . . 0.0 109.853 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 90' ' ' SER . 1.9 m -95.94 -41.4 11.65 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-N 113.054 -1.884 . . . . 0.0 110.427 176.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.523 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 16.6 t . . . . . 0 N--CA 1.446 -0.646 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.938 -172.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.418 ' O ' ' HG3' ' A' ' 94' ' ' GLN . 12.1 pt20 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.808 0.813 . . . . 0.0 109.868 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.587 ' H ' ' HB2' ' A' ' 88' ' ' SER . 14.9 mt -119.97 126.79 75.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.205 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 97' ' ' LEU . 67.4 t80 -103.46 155.45 18.5 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.062 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.45 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 91.2 mt -89.89 120.36 31.05 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 117.27 -1.772 . . . . 0.0 109.707 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -127.96 143.52 51.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.285 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -47.92 127.07 11.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.462 -2.154 . . . . 0.0 109.719 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.746 HG23 ' H ' ' A' ' 101' ' ' GLU . 17.8 tt -62.82 -121.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.707 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.746 ' H ' HG23 ' A' ' 100' ' ' ILE . 6.6 tp10 . . . . . 0 N--CA 1.442 -0.869 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.153 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 50.3 Cg_exo . . . . . 0 CA--C 1.542 0.882 0 N-CA-C 114.54 0.939 . . . . 0.0 114.54 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.402 ' H ' ' HB2' ' A' ' 8' ' ' PRO . 1.6 p-90 -146.43 27.69 1.11 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.93 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -102.29 116.91 33.62 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.334 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 12' ' ' GLY . 7.5 m-85 -105.65 104.28 13.97 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 113.233 -1.803 . . . . 0.0 108.497 174.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -22.41 -108.23 0.0 OUTLIER Glycine 0 C--N 1.348 1.21 0 CA-C-N 111.63 -2.532 . . . . 0.0 112.883 -173.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.623 ' HZ2' ' HA ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -115.99 50.01 1.06 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 112.727 -1.736 . . . . 0.0 108.885 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.554 HG22 ' CB ' ' A' ' 35' ' ' ARG . 7.6 tp -69.27 132.03 90.07 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.721 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' ARG . 21.1 Cg_endo -66.11 125.03 13.42 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.263 1.976 . . . . 0.0 112.122 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.473 HH11 HH21 ' A' ' 35' ' ' ARG . 60.0 ttt85 -31.9 -40.68 0.04 OUTLIER 'General case' 0 C--N 1.349 0.544 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.083 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -55.54 -76.35 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.281 -1.781 . . . . 0.0 109.405 177.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 17' ' ' ALA . 56.8 tptt -38.92 -39.81 0.57 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 112.993 -1.912 . . . . 0.0 110.915 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.576 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -54.61 -70.76 0.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 117.071 -1.852 . . . . 0.0 108.705 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 24' ' ' SER . 47.6 mt-10 -39.36 -43.25 1.16 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.504 -2.135 . . . . 0.0 110.753 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.464 ' O ' ' OG ' ' A' ' 24' ' ' SER . 34.6 mt-10 -61.8 -91.78 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.4 -175.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.0 ptm -45.02 -39.65 5.83 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 117.524 -1.67 . . . . 0.0 110.687 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 23.5 tp -59.93 -41.11 91.05 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.748 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 26' ' ' GLN . 81.1 p -67.4 -37.35 82.97 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.471 176.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -70.66 35.16 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.613 -1.631 . . . . 0.0 111.053 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.621 HE21 ' HA ' ' A' ' 26' ' ' GLN . 2.3 mm-40 -107.95 145.67 33.5 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 118.082 -1.447 . . . . 0.0 109.397 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 1.9 mpt_? -91.21 -69.79 0.72 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.876 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -61.72 105.11 0.5 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.956 -1.929 . . . . 0.0 109.709 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -45.99 121.03 2.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.623 -2.08 . . . . 0.0 109.537 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.2 -22.11 4.03 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 117.98 -2.057 . . . . 0.0 112.674 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.454 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -46.98 114.14 0.79 Allowed 'General case' 0 C--N 1.35 0.605 0 C-N-CA 118.245 -1.382 . . . . 0.0 108.995 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.51 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 17.4 p90 -132.29 160.69 35.49 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 116.675 -2.01 . . . . 0.0 110.753 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.431 ' HG ' ' OG ' ' A' ' 47' ' ' SER . 4.5 pp -150.73 149.67 30.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 116.401 -2.12 . . . . 0.0 109.74 169.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.8 mt -108.44 106.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.62 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.554 ' CB ' HG22 ' A' ' 14' ' ' ILE . 31.8 ptt-85 -94.95 126.78 40.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 112.623 -2.08 . . . . 0.0 110.077 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' GLY . 63.7 tt0 -69.06 120.48 14.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.874 -1.967 . . . . 0.0 109.121 177.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.466 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 43.0 t -45.81 120.31 2.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.817 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.623 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 61.3 tt0 -45.3 -40.1 7.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 112.743 -2.026 . . . . 0.0 110.81 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.8 m -89.93 -95.15 0.11 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.168 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.66 130.37 55.17 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 113.699 -1.591 . . . . 0.0 109.621 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.35 -6.16 15.41 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.833 1.689 . . . . 0.0 114.968 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.61 40.37 2.35 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 118.506 -1.807 . . . . 0.0 111.065 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.466 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 1.0 OUTLIER -133.0 120.83 21.89 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 117.747 -1.581 . . . . 0.0 109.836 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.412 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 86.7 m-85 -125.61 130.39 51.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.558 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.7 p -127.72 132.92 49.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.162 -1.836 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 tt -94.8 115.26 27.28 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.806 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.493 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 91.4 p -102.58 130.96 49.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.85 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.77 149.38 30.51 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 117.768 -1.573 . . . . 0.0 110.281 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 41.7 tptt -82.28 101.94 10.86 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.888 -1.96 . . . . 0.0 108.842 172.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 53' ' ' ASP . 10.4 t80 -110.04 144.75 38.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 113.321 -1.763 . . . . 0.0 108.871 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 52' ' ' ASN . . . -45.47 135.56 7.86 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 117.225 -2.417 . . . . 0.0 110.912 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 58.4 t30 76.72 -34.57 0.22 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 111.536 -2.332 . . . . 0.0 111.075 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 50' ' ' PHE . 11.0 m-20 -157.35 153.35 27.18 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 114.955 -2.698 . . . . 0.0 111.592 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 24' ' ' SER . 66.5 t -69.95 125.23 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 112.325 -2.216 . . . . 0.0 108.991 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.649 HE22 ' HB2' ' A' ' 90' ' ' SER . 58.4 tt0 -90.04 164.0 14.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.542 -177.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.509 ' CE1' ' CG ' ' A' ' 58' ' ' LYS . 16.6 t-160 -140.86 129.58 22.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 112.959 -1.928 . . . . 0.0 111.124 -168.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 92.2 m-85 -138.31 103.15 4.83 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.263 175.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.509 ' CG ' ' CE1' ' A' ' 56' ' ' HIS . 53.6 mtmt -74.39 120.64 20.23 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 117.381 -1.728 . . . . 0.0 110.323 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 77' ' ' LEU . 56.6 t -75.32 87.37 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 112.688 -2.051 . . . . 0.0 108.69 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 71.3 mt -80.47 158.2 25.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.023 -1.899 . . . . 0.0 110.182 -174.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.547 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.663 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.563 ' HA ' ' HZ3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 88.8 m-85 -76.67 125.23 28.89 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 116.886 -1.926 . . . . 0.0 109.303 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.451 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -159.29 145.9 16.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.942 -1.935 . . . . 0.0 110.968 -177.015 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.556 HD22 ' H ' ' A' ' 69' ' ' LEU . 1.7 mm? -74.09 -66.9 0.66 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.94 -1.936 . . . . 0.0 108.88 175.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 19.0 m0 -136.15 -44.48 0.63 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 112.395 -2.184 . . . . 0.0 110.137 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.2 t -125.75 -80.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 112.99 -1.914 . . . . 0.0 110.445 -173.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.0 m -48.74 134.36 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.421 -172.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -101.51 155.05 18.31 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.829 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 80' ' ' LEU . 5.6 p90 -170.05 138.62 1.73 Allowed 'General case' 0 C--N 1.342 0.275 0 CA-C-N 111.153 -2.748 . . . . 0.0 109.156 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -98.2 24.13 7.51 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 112.711 -2.041 . . . . 0.0 111.724 176.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 40.3 t -144.94 132.16 20.54 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 116.814 -1.955 . . . . 0.0 110.345 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.504 ' CD2' HG11 ' A' ' 59' ' ' VAL . 96.1 mt -56.88 -44.58 82.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 113.178 -1.828 . . . . 0.0 109.57 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -51.43 -45.63 62.69 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.756 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 76' ' ' SER . 31.7 tp10 -58.67 -38.2 77.69 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.62 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' A' ' 59' ' ' VAL . 7.9 tt -60.19 -46.27 90.29 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.331 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 77' ' ' LEU . 86.4 t -65.49 -35.53 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 112.78 -2.009 . . . . 0.0 111.337 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 24.6 t0 -58.7 -43.01 89.94 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.373 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.404 ' C ' ' H ' ' A' ' 85' ' ' ARG . 33.2 m-85 -64.55 -42.76 95.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.112 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.47 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 38.2 m170 -80.03 30.28 0.27 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 113.599 -1.637 . . . . 0.0 111.378 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 83' ' ' TYR . 79.7 ttt-85 -112.98 -38.58 4.46 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 117.973 -1.491 . . . . 0.0 110.762 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.5 p -99.6 -39.82 8.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 117.974 -1.49 . . . . 0.0 110.677 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 88' ' ' SER . 8.8 t -106.17 39.13 1.86 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 117.731 -1.588 . . . . 0.0 110.863 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 87' ' ' THR . 44.2 t 44.93 -169.35 0.01 OUTLIER 'General case' 0 C--N 1.347 0.473 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.842 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.403 ' N ' ' OG ' ' A' ' 88' ' ' SER . 10.9 p -117.81 -39.88 2.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.359 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.649 ' HB2' HE22 ' A' ' 55' ' ' GLN . 32.8 t . . . . . 0 CA--C 1.545 0.756 0 CA-C-N 113.796 -1.547 . . . . 0.0 112.164 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 N--CA 1.45 -0.433 0 CA-C-O 121.852 0.834 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 90' ' ' SER . 55.2 mt -116.57 137.33 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 113.064 -1.88 . . . . 0.0 110.258 -178.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -121.47 133.37 55.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.735 -2.03 . . . . 0.0 109.112 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.47 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 80.8 mt -89.93 105.88 18.1 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.749 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.802 ' CD ' ' H ' ' A' ' 99' ' ' ASP . 0.7 OUTLIER 177.98 -141.94 0.01 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 112.35 -2.204 . . . . 0.0 107.678 -178.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.802 ' H ' ' CD ' ' A' ' 98' ' ' ARG . 27.0 m-20 69.61 -27.44 0.16 Allowed 'General case' 0 C--N 1.347 0.461 0 O-C-N 125.383 1.677 . . . . 0.0 113.104 166.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 13.3 tt -75.04 30.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 116.653 -2.019 . . . . 0.0 112.119 -172.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.518 ' H ' ' C ' ' A' ' 99' ' ' ASP . 43.2 tt0 . . . . . 0 N--CA 1.444 -0.74 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.596 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' HA2' ' CD ' ' A' ' 107' ' ' PRO . . . . . . . . 0 CA--C 1.53 0.976 0 CA-C-O 121.844 0.691 . . . . 0.0 111.993 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 2' ' ' ILE . 19.5 tt -134.96 44.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 113.112 -1.544 . . . . 0.0 109.951 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' C ' ' CD ' ' A' ' 3' ' ' GLU . 2.2 tm-20 -100.57 107.54 19.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 113.195 -1.821 . . . . 0.0 108.979 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' LYS . 71.3 mtp -95.22 117.94 31.12 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 112.981 -1.918 . . . . 0.0 110.401 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' MET . 86.9 tttt 39.08 94.11 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 112.643 -2.071 . . . . 0.0 110.928 174.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.1 Cg_exo -49.78 121.69 7.75 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.356 2.037 . . . . 0.0 112.185 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -90.68 115.39 64.1 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.964 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 9' ' ' TRP 0.252 60.9 Cg_endo -88.83 118.02 0.92 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.312 2.008 . . . . 0.0 110.883 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 1.3 m-90 -135.22 60.68 1.69 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 -15.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CE1' ' CA ' ' A' ' 12' ' ' GLY . 50.9 t80 -90.58 124.0 34.68 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 110.928 -2.851 . . . . 0.0 112.379 -155.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.7 m-85 -127.78 92.01 3.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 112.105 -2.316 . . . . 0.0 107.862 167.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.517 ' CA ' ' CE1' ' A' ' 10' ' ' PHE . . . -54.91 116.33 6.6 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.958 -170.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' CD ' ' OE2' ' A' ' 38' ' ' GLU . 25.4 pttm 31.1 42.28 0.01 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 111.685 -2.257 . . . . 0.0 111.109 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.518 ' CG1' ' HD2' ' A' ' 18' ' ' LYS . 10.3 tp -62.79 129.2 92.85 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 112.971 -1.922 . . . . 0.0 108.843 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.4 Cg_exo -45.86 123.29 5.92 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.834 1.689 . . . . 0.0 113.194 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 15' ' ' PRO . 41.5 ttm180 -37.06 -41.86 0.38 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.707 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -56.32 -81.19 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.246 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.604 ' CE ' ' SD ' ' A' ' 22' ' ' MET . 8.1 tmtm? -31.48 -42.66 0.05 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 112.646 -2.07 . . . . 0.0 111.029 -176.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -58.05 -69.55 0.17 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.717 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' SER . 53.5 mt-10 -48.03 -52.9 18.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.592 -2.095 . . . . 0.0 110.255 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 24' ' ' SER . 77.4 mm-40 -40.4 -87.46 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.753 -2.021 . . . . 0.0 110.621 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.604 ' SD ' ' CE ' ' A' ' 18' ' ' LYS . 16.9 ptm -50.77 -53.08 34.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.088 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.543 HD13 ' CD1' ' A' ' 100' ' ' ILE . 48.3 tp -48.38 -21.93 0.62 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 117.223 -1.791 . . . . 0.0 112.681 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 37.0 t -83.18 -35.97 25.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.78 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HD3' ' CA ' ' A' ' 22' ' ' MET . 5.2 pttp -42.75 -25.18 0.08 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.028 172.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.473 ' HG3' ' CB ' ' A' ' 31' ' ' ALA . 38.6 mm-40 -53.9 141.96 25.9 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.481 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -81.71 -69.49 0.61 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 111.936 -2.393 . . . . 0.0 110.455 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -76.1 -156.97 0.07 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.749 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -122.5 130.38 52.99 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 112.75 -2.023 . . . . 0.0 110.068 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.37 34.47 1.01 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 118.236 -1.935 . . . . 0.0 111.901 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.473 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -99.9 131.93 45.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 118.114 -1.434 . . . . 0.0 108.101 173.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' SER . 40.2 p90 -143.08 157.55 44.42 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 115.231 -2.588 . . . . 0.0 111.835 -173.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -148.43 151.83 35.9 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 112.003 -2.362 . . . . 0.0 109.451 171.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.85 110.71 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 112.492 -2.14 . . . . 0.0 108.976 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 34.4 ptt180 -96.7 128.11 43.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.373 -2.194 . . . . 0.0 110.051 -174.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' O ' ' CA ' ' A' ' 13' ' ' LYS . 45.1 tt0 -79.05 126.06 30.21 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.062 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.464 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 49.9 m -58.57 138.58 56.74 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 112.781 -2.009 . . . . 0.0 109.955 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' OE2' ' CD ' ' A' ' 13' ' ' LYS . 9.7 tp10 -38.6 -90.65 0.0 OUTLIER 'General case' 0 C--N 1.345 0.375 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.624 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 40' ' ' ALA . 49.0 m -89.9 -36.55 14.97 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 113.601 -1.636 . . . . 0.0 111.259 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HB3' ' CB ' ' A' ' 37' ' ' SER . . . -42.58 150.23 0.43 Allowed Pre-proline 0 C--N 1.348 0.508 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.158 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.67 -116.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.995 2.463 . . . . 0.0 110.784 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.02 57.83 4.83 Favored Glycine 0 C--N 1.346 1.089 0 C-N-CA 118.145 -1.979 . . . . 0.0 110.869 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 3.4 m-20 -102.9 117.1 33.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 117.903 -1.519 . . . . 0.0 109.32 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.403 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 95.3 m-85 -134.24 130.28 36.92 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 112.904 -1.953 . . . . 0.0 109.839 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 77.7 p -119.0 126.38 51.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.48 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.0 tt -93.51 115.07 27.57 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.354 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.434 ' OG ' ' HG ' ' A' ' 33' ' ' LEU . 90.3 p -94.04 144.64 25.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.789 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 60.7 t -146.44 137.4 18.51 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.726 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 66.3 tttp -73.36 93.66 1.95 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 116.83 -1.948 . . . . 0.0 108.824 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.477 ' O ' ' O ' ' A' ' 51' ' ' GLY . 4.6 t80 -92.6 40.6 1.06 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.615 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . 58.6 145.37 0.01 OUTLIER Glycine 0 C--N 1.346 1.131 0 C-N-CA 118.148 -1.977 . . . . 0.0 110.54 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 58.6 t30 72.07 -35.04 0.32 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 112.475 -1.863 . . . . 0.0 110.854 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 51' ' ' GLY . 56.2 p30 -171.45 -163.63 0.29 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 117.264 -1.775 . . . . 0.0 110.295 176.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.474 ' CG1' HD23 ' A' ' 23' ' ' LEU . 88.4 t -108.76 123.87 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 112.369 -2.196 . . . . 0.0 110.009 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -100.44 157.97 16.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.716 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.61 133.85 36.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 112.515 -2.129 . . . . 0.0 110.304 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.499 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 92.6 m-85 -113.19 111.12 21.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.927 -1.942 . . . . 0.0 109.897 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 29.6 mmmt -72.25 100.36 2.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.089 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 98.9 t -72.09 88.47 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 113.041 -1.891 . . . . 0.0 108.553 173.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 82.0 mt -74.04 160.41 31.32 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.733 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.757 HH12 ' C ' ' A' ' 65' ' ' GLY . 23.2 tpt85 -99.43 178.58 4.83 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.032 -2.349 . . . . 0.0 108.628 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.589 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 34.1 t0 74.79 -129.74 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.661 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 62' ' ' ASP . . . 74.05 -70.14 1.54 Allowed Glycine 0 C--N 1.347 1.169 0 C-N-CA 117.774 -2.155 . . . . 0.0 109.317 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.83 36.01 1.28 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.487 -1.856 . . . . 0.0 110.062 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.757 ' C ' HH12 ' A' ' 61' ' ' ARG . . . 86.73 11.8 70.24 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 118.318 -1.896 . . . . 0.0 113.341 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.78 178.41 7.17 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 118.463 -1.295 . . . . 0.0 110.579 -175.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 17.3 m-85 -86.82 142.37 28.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.244 -2.253 . . . . 0.0 109.503 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -160.22 124.71 3.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.989 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.499 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 1.7 mt -61.59 -83.49 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.155 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -110.16 -42.76 4.09 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.222 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.0 t -137.93 -82.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.599 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.4 HG11 ' CZ ' ' A' ' 83' ' ' TYR . 24.4 m -47.03 134.2 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 112.649 -2.069 . . . . 0.0 110.544 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.56 165.98 12.26 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.563 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.783 ' CZ ' HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -170.04 140.13 1.94 Allowed 'General case' 0 C--N 1.343 0.31 0 CA-C-N 111.505 -2.589 . . . . 0.0 109.631 -175.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -91.88 -13.43 31.31 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 111.692 -2.504 . . . . 0.0 112.558 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 79' ' ' GLU . 41.1 t -140.56 129.93 23.85 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 117.573 -1.651 . . . . 0.0 109.908 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 80' ' ' LEU . 99.3 mt -47.12 -39.81 14.18 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.455 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -52.0 -45.43 64.53 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.149 -1.82 . . . . 0.0 109.594 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 83' ' ' TYR . 47.4 tp10 -57.0 -32.68 66.37 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 113.16 -1.836 . . . . 0.0 111.284 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.783 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 7.1 tt -72.1 -70.83 0.31 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.333 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.6 t -37.98 -35.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 112.685 -2.052 . . . . 0.0 111.187 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -80.3 -42.07 23.72 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.563 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 65.5 t80 -58.72 -43.08 90.05 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.2 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.421 ' NE2' ' CD1' ' A' ' 69' ' ' LEU . 87.7 m-70 -89.5 39.13 0.93 Allowed 'General case' 0 C--N 1.345 0.406 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.689 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.66 HH12 HH21 ' A' ' 98' ' ' ARG . 60.7 ttm-85 -107.33 -40.63 5.33 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.368 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -89.97 -40.89 12.07 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.476 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 87' ' ' THR . 23.6 m -110.97 41.29 1.85 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 117.831 -1.547 . . . . 0.0 110.903 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.606 ' HB3' ' H ' ' A' ' 95' ' ' ILE . 41.8 m 43.14 -153.59 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.527 169.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.437 ' O ' HG22 ' A' ' 89' ' ' VAL . 15.0 p -153.99 44.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-N 113.058 -1.883 . . . . 0.0 109.788 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' A' ' 95' ' ' ILE . 43.0 t 179.55 124.48 0.06 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.731 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 92' ' ' ASN . 48.0 mtp180 -69.68 -32.86 71.72 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 112.949 -1.932 . . . . 0.0 111.381 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 91' ' ' ARG . 63.1 m-80 -40.63 -39.9 1.16 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.772 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -160.67 -148.69 0.17 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.993 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.418 ' O ' ' HG3' ' A' ' 94' ' ' GLN . 21.4 pt20 -116.16 120.16 38.12 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.019 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.606 ' H ' ' HB3' ' A' ' 88' ' ' SER . 64.2 mt -115.96 151.63 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 112.622 -2.081 . . . . 0.0 109.433 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -143.71 138.78 29.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.35 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.4 mt -89.92 118.54 29.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.995 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.66 HH21 HH12 ' A' ' 85' ' ' ARG . 2.0 mmp_? -126.17 149.36 49.05 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.521 -2.127 . . . . 0.0 109.875 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 101' ' ' GLU . 7.1 m-20 -54.01 124.19 14.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 112.163 -2.29 . . . . 0.0 109.83 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.543 ' CD1' HD13 ' A' ' 23' ' ' LEU . 10.6 tt -71.95 31.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 112.533 -2.121 . . . . 0.0 111.578 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 99' ' ' ASP . 47.3 mm-40 -150.15 119.49 6.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 118.001 -1.479 . . . . 0.0 109.651 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.623 ' NE2' ' O ' ' A' ' 103' ' ' VAL . 1.1 tm0? -74.62 132.66 41.93 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.65 -2.068 . . . . 0.0 109.64 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.708 ' CG1' ' H ' ' A' ' 105' ' ' GLN . 0.9 OUTLIER -33.98 149.0 0.08 OUTLIER Pre-proline 0 C--N 1.347 0.496 0 CA-C-N 112.623 -2.081 . . . . 0.0 110.85 -177.302 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 105' ' ' GLN . 19.3 Cg_endo -63.69 -7.73 13.6 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.069 2.513 . . . . 0.0 115.3 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.708 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 27.8 mt-30 36.59 -156.54 0.0 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.806 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -119.86 87.08 37.4 Favored Pre-proline 0 C--N 1.346 0.454 0 CA-C-N 113.01 -1.905 . . . . 0.0 109.466 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' THR . 45.6 Cg_exo -52.14 119.98 6.57 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.873 2.382 . . . . 0.0 113.685 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 107' ' ' PRO . 60.1 m 60.22 143.87 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.024 -1.898 . . . . 0.0 110.163 176.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 108' ' ' THR . 21.3 m-85 65.27 124.29 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.99 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 111' ' ' GLN . 7.4 p -113.09 122.96 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 112.803 -1.999 . . . . 0.0 109.6 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 110' ' ' VAL . 1.1 tm0? 57.9 114.31 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.469 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.409 0 CA-C-N 112.938 -1.937 . . . . 0.0 109.657 -179.518 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 CA-C-O 121.958 0.755 . . . . 0.0 112.027 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 2' ' ' ILE . 15.7 tt -46.75 121.87 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.634 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -107.96 123.17 48.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 112.957 -1.929 . . . . 0.0 109.658 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.576 ' C ' ' SD ' ' A' ' 4' ' ' MET . 0.2 OUTLIER -110.05 120.33 42.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.012 -1.903 . . . . 0.0 109.565 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.569 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 48.8 pttt -152.1 -174.64 0.42 Allowed Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.211 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 5' ' ' LYS . 44.0 Cg_exo -54.17 121.5 9.78 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.825 1.683 . . . . 0.0 112.606 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.431 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 5.8 p-80 -37.35 153.12 0.12 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.64 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' O ' ' CD2' ' A' ' 9' ' ' TRP . 75.2 Cg_exo -43.11 131.49 6.2 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.331 2.687 . . . . 0.0 116.93 -174.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.458 ' CD2' ' O ' ' A' ' 8' ' ' PRO . 32.5 p-90 49.25 16.65 0.16 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 111.872 -2.422 . . . . 0.0 113.502 170.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.431 ' CG ' ' CE1' ' A' ' 7' ' ' HIS . 49.2 t80 -97.77 119.13 35.82 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 116.229 -2.188 . . . . 0.0 109.653 175.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 8.6 m-85 -121.92 109.14 14.26 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 113.076 -1.875 . . . . 0.0 109.164 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -69.22 129.18 23.04 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 112.56 -2.109 . . . . 0.0 111.557 -174.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' CE ' ' HB2' ' A' ' 38' ' ' GLU . 83.7 tttt 25.89 47.66 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 111.713 -2.243 . . . . 0.0 111.899 176.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.427 HG22 ' CB ' ' A' ' 35' ' ' ARG . 8.7 tp -75.21 134.0 74.45 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 117.268 -1.773 . . . . 0.0 108.8 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' ARG . 20.8 Cg_endo -65.67 124.54 12.93 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.178 1.919 . . . . 0.0 111.332 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' CZ ' ' NH2' ' A' ' 35' ' ' ARG . 94.9 mtt-85 -34.22 -41.6 0.11 Allowed 'General case' 0 C--N 1.349 0.558 0 CA-C-N 112.779 -2.009 . . . . 0.0 110.983 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -54.72 -72.13 0.07 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.243 -1.798 . . . . 0.0 109.537 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 22' ' ' MET . 4.8 tppp? -41.74 -49.52 4.3 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.492 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -47.36 -58.53 4.04 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.479 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 89.4 mt-10 -49.96 -52.06 36.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.733 -2.03 . . . . 0.0 109.989 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 70.9 mt-10 -55.53 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.891 -1.958 . . . . 0.0 110.852 -173.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 3.0 ptm -45.46 -39.99 7.81 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.773 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.532 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 45.7 tp -68.56 -32.03 71.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 117.644 -1.623 . . . . 0.0 111.755 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.534 ' C ' ' H ' ' A' ' 26' ' ' GLN . 59.3 m -68.58 -35.9 78.0 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 117.503 -1.679 . . . . 0.0 111.044 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -72.07 33.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.241 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.757 HE21 ' HA ' ' A' ' 26' ' ' GLN . 1.3 mm-40 -101.69 132.37 47.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 117.818 -1.553 . . . . 0.0 110.022 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -81.26 -41.93 21.45 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 111.707 -2.497 . . . . 0.0 110.599 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.49 106.88 18.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.583 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -53.74 123.94 13.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.705 -2.043 . . . . 0.0 109.419 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 136.55 -31.77 2.54 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 117.585 -2.245 . . . . 0.0 112.037 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -46.32 136.61 7.04 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 118.078 -1.449 . . . . 0.0 109.358 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 47' ' ' SER . 28.2 p90 -145.3 162.76 36.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 116.384 -2.126 . . . . 0.0 110.982 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 33' ' ' LEU . 4.5 pp -147.95 150.17 33.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.343 -2.208 . . . . 0.0 109.577 172.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.7 mt -116.92 111.98 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 112.666 -2.061 . . . . 0.0 108.662 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 40.7 ptt85 -95.59 129.09 42.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 112.634 -2.076 . . . . 0.0 110.259 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -96.96 128.36 43.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 112.45 -2.159 . . . . 0.0 109.869 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 43.2 t -60.54 155.63 18.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.845 -1.979 . . . . 0.0 109.613 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.467 ' HB2' ' CE ' ' A' ' 13' ' ' LYS . 45.3 tt0 -41.08 -91.52 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 112.563 -2.108 . . . . 0.0 110.252 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 40' ' ' ALA . 50.5 m -90.0 -44.25 9.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.1 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -41.44 102.58 0.27 Allowed Pre-proline 0 C--N 1.347 0.488 0 CA-C-N 113.218 -1.81 . . . . 0.0 110.059 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.62 -4.45 14.6 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.88 1.72 . . . . 0.0 115.079 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.45 39.63 2.69 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 118.422 -1.846 . . . . 0.0 111.108 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 54.9 m-20 -130.32 112.17 13.05 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 117.736 -1.586 . . . . 0.0 109.933 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 96.9 m-85 -147.64 117.54 7.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.867 -1.969 . . . . 0.0 109.389 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 79.0 p -122.98 128.04 49.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.486 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.487 ' CD2' ' CG2' ' A' ' 48' ' ' VAL . 6.2 tt -93.59 119.7 32.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.81 -1.995 . . . . 0.0 109.673 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 50.1 m -99.44 145.02 27.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.534 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.487 ' CG2' ' CD2' ' A' ' 46' ' ' LEU . 88.6 t -145.36 138.67 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 113.378 -1.737 . . . . 0.0 110.452 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.604 ' HZ2' ' C ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -80.35 106.56 12.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 112.869 -1.969 . . . . 0.0 108.721 173.046 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 95' ' ' ILE . 72.8 t80 -79.76 -104.33 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 116.847 -1.941 . . . . 0.0 108.928 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.91 -69.08 1.35 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 118.718 -1.706 . . . . 0.0 109.633 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.604 ' C ' ' HZ2' ' A' ' 49' ' ' LYS . 29.1 t-20 -130.4 -24.31 2.55 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 111.978 -2.111 . . . . 0.0 112.088 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -99.9 157.37 16.57 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 118.661 -1.216 . . . . 0.0 110.473 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG2' ' OG ' ' A' ' 24' ' ' SER . 88.6 t -85.25 114.59 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.693 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.415 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 62.0 tt0 -90.27 158.74 17.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.933 -1.94 . . . . 0.0 109.399 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -130.66 131.62 44.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.779 -2.01 . . . . 0.0 110.746 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 45' ' ' SER . 96.3 m-85 -123.81 133.34 53.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.432 -2.167 . . . . 0.0 109.137 175.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.6 ' HZ2' ' HB2' ' A' ' 58' ' ' LYS . 10.6 mtmp? -104.06 107.97 19.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.321 -1.752 . . . . 0.0 110.242 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 72.1 t -76.57 85.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 112.683 -2.053 . . . . 0.0 108.565 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.597 HD21 ' HZ3' ' A' ' 58' ' ' LYS . 71.9 mt -70.33 161.0 31.22 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 112.68 -2.055 . . . . 0.0 110.679 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 1.9 tmt_? -128.68 156.99 42.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.392 -2.186 . . . . 0.0 109.884 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.557 ' C ' ' H ' ' A' ' 64' ' ' ALA . 43.4 t0 179.15 140.11 0.11 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 111.939 -2.391 . . . . 0.0 109.448 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.21 35.1 0.78 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 117.831 -2.128 . . . . 0.0 111.688 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 62' ' ' ASP . . . -142.98 45.0 1.58 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.879 -1.161 . . . . 0.0 109.707 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.467 ' HA2' ' CD ' ' A' ' 73' ' ' LYS . . . 140.5 -12.33 2.97 Favored Glycine 0 CA--C 1.544 1.87 0 C-N-CA 118.41 -1.853 . . . . 0.0 113.154 -175.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 7.6 mtpm? 71.53 -140.69 0.05 OUTLIER 'General case' 0 C--N 1.351 0.637 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.004 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 55.0 m-85 -88.05 129.53 35.25 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 115.848 -2.341 . . . . 0.0 109.899 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -159.27 134.57 8.36 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 112.344 -2.207 . . . . 0.0 109.171 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.678 ' H ' HD12 ' A' ' 69' ' ' LEU . 4.2 mp -68.77 -52.95 24.9 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 116.682 -2.007 . . . . 0.0 109.247 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 18.2 m0 -135.53 -41.41 0.7 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.53 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.5 t -138.33 -83.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.546 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -47.19 133.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 112.552 -2.113 . . . . 0.0 110.782 -171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.467 ' CD ' ' HA2' ' A' ' 65' ' ' GLY . 9.7 mtmp? -94.21 158.38 15.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.491 -2.141 . . . . 0.0 110.592 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.878 ' CZ ' HD12 ' A' ' 80' ' ' LEU . 6.6 p90 -159.13 140.14 12.78 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 111.156 -2.747 . . . . 0.0 109.213 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -81.41 -16.91 50.7 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 111.247 -2.706 . . . . 0.0 112.352 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 79' ' ' GLU . 40.3 t -147.28 134.89 20.99 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 117.681 -1.608 . . . . 0.0 109.97 -175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 80' ' ' LEU . 82.6 mt -46.61 -42.89 16.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 112.724 -2.035 . . . . 0.0 110.288 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 38.5 m-80 -49.53 -46.82 49.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.545 -1.661 . . . . 0.0 109.572 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 76' ' ' SER . 41.9 tt0 -57.92 -34.72 70.16 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 112.922 -1.944 . . . . 0.0 111.098 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.878 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 5.4 tt -61.93 -65.54 0.67 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.783 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.5 t -43.83 -35.8 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 112.07 -2.332 . . . . 0.0 111.076 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 72.6 m-20 -59.87 -38.57 82.54 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.833 -178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.406 ' N ' ' O ' ' A' ' 80' ' ' LEU . 23.0 m-85 -66.24 -51.96 52.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.836 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.05 36.59 0.51 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.971 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 6.1 tpm_? -101.12 7.7 43.13 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.389 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 87' ' ' THR . 79.4 p -89.93 -78.2 0.37 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 118.656 -1.218 . . . . 0.0 109.896 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.418 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 9.2 t -170.02 39.48 0.02 OUTLIER 'General case' 0 C--N 1.346 0.451 0 C-N-CA 116.7 -2.0 . . . . 0.0 110.997 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.435 ' CB ' ' C ' ' A' ' 92' ' ' ASN . 77.6 p -177.22 140.98 0.31 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 116.887 -1.925 . . . . 0.0 110.537 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.4 ' CG2' HG22 ' A' ' 95' ' ' ILE . 38.4 t -114.3 -38.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 111.985 -2.371 . . . . 0.0 110.778 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.502 ' C ' ' H ' ' A' ' 92' ' ' ASN . 34.8 t -138.94 -69.4 0.43 Allowed 'General case' 0 C--N 1.346 0.446 0 C-N-CA 117.989 -1.484 . . . . 0.0 110.127 -175.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 52.6 mmm-85 -60.99 6.9 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 112.45 -2.159 . . . . 0.0 113.322 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.502 ' H ' ' C ' ' A' ' 90' ' ' SER . 70.7 m-20 70.86 -11.97 0.6 Allowed 'General case' 0 CA--C 1.545 0.756 0 O-C-N 124.054 0.846 . . . . 0.0 112.8 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.524 ' O ' ' CB ' ' A' ' 94' ' ' GLN . 14.3 pt20 -168.18 129.34 1.36 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 118.337 -1.345 . . . . 0.0 108.983 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 93' ' ' GLN . 18.3 mm100 102.22 26.85 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.504 -2.135 . . . . 0.0 112.053 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 50' ' ' PHE . 25.0 mt -149.29 121.39 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 117.314 -1.754 . . . . 0.0 109.963 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.582 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 67.3 m-85 -120.62 140.6 51.32 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.76 -2.018 . . . . 0.0 109.499 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.97 106.67 18.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 117.311 -1.756 . . . . 0.0 108.825 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -121.5 152.81 38.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.4 -173.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -45.08 126.82 6.31 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 112.441 -2.163 . . . . 0.0 109.52 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.492 ' CD1' HD13 ' A' ' 23' ' ' LEU . 15.4 tt -84.63 2.64 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 112.766 -2.016 . . . . 0.0 113.656 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -150.21 117.79 6.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 117.774 -1.571 . . . . 0.0 110.303 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -75.24 127.86 34.13 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 112.922 -1.945 . . . . 0.0 109.27 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.579 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -139.01 -66.88 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.573 -176.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.579 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 19.4 Cg_endo -65.81 2.33 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.674 1.582 . . . . 0.0 115.303 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -44.32 111.35 0.29 Allowed 'General case' 0 C--N 1.346 0.439 0 C-N-CA 118.526 -1.27 . . . . 0.0 109.62 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.408 ' CD ' ' C ' ' A' ' 106' ' ' GLN . 3.6 pp0? -158.75 155.46 24.95 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.665 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.405 ' O ' ' HA ' ' A' ' 106' ' ' GLN . 72.8 Cg_endo -78.2 -140.03 0.17 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.625 0 O-C-N 124.393 1.733 . . . . 0.0 109.734 -5.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.457 ' O ' ' CD1' ' A' ' 109' ' ' TYR . 5.2 t -144.76 42.33 1.33 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.05 -1.886 . . . . 0.0 110.216 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.457 ' CD1' ' O ' ' A' ' 108' ' ' THR . 66.0 m-85 -151.75 118.89 5.89 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.501 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 111' ' ' GLN . 36.0 m -91.96 118.5 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 113.098 -1.864 . . . . 0.0 109.557 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 110' ' ' VAL . 95.1 mt-30 25.73 101.52 0.0 OUTLIER 'General case' 0 C--N 1.349 0.572 0 CA-C-N 112.354 -2.203 . . . . 0.0 111.543 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 0.425 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.724 179.805 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 CA-C-O 121.875 0.708 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.412 ' O ' HG13 ' A' ' 2' ' ' ILE . 41.4 pt -148.54 129.13 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 113.031 -1.585 . . . . 0.0 109.624 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -129.65 121.08 26.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.503 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.583 ' C ' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -70.17 116.13 10.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.469 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 6' ' ' PRO . 62.7 pttt -178.9 157.14 0.92 Allowed Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 112.987 -1.915 . . . . 0.0 108.888 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 5' ' ' LYS . 79.9 Cg_exo -42.02 -120.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.013 2.475 . . . . 0.0 114.29 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -147.3 147.29 28.03 Favored Pre-proline 0 N--CA 1.451 -0.418 0 C-N-CA 117.673 -1.611 . . . . 0.0 109.658 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -73.4 124.48 9.44 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.923 2.415 . . . . 0.0 111.621 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.467 ' CB ' ' CE2' ' A' ' 32' ' ' PHE . 59.2 p-90 38.57 47.37 1.1 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-N 112.538 -2.119 . . . . 0.0 110.545 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -142.67 108.4 5.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.438 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 12' ' ' GLY . 9.8 m-85 -125.03 97.23 5.17 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.195 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -27.79 -105.7 0.0 OUTLIER Glycine 0 C--N 1.347 1.167 0 CA-C-N 112.184 -2.28 . . . . 0.0 112.77 -174.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 63.9 tttp -110.19 53.52 0.69 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 112.77 -1.715 . . . . 0.0 109.035 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.43 HG22 ' CB ' ' A' ' 35' ' ' ARG . 8.5 tp -71.08 133.74 85.68 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.977 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' ARG . 23.1 Cg_endo -66.24 124.05 12.02 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.184 1.923 . . . . 0.0 111.268 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 15' ' ' PRO . 68.1 ttt180 -33.74 -39.38 0.06 Allowed 'General case' 0 C--N 1.347 0.495 0 CA-C-N 112.766 -2.016 . . . . 0.0 111.124 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -53.55 -81.17 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.049 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 17' ' ' ALA . 16.8 tppt? -36.45 -36.54 0.1 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 112.977 -1.919 . . . . 0.0 111.374 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.549 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -59.23 -72.29 0.1 Allowed 'General case' 0 C--N 1.347 0.487 0 C-N-CA 117.375 -1.73 . . . . 0.0 109.061 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 21' ' ' GLU . 94.3 mt-10 -43.97 -56.13 4.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 112.541 -2.118 . . . . 0.0 109.801 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 11.9 mm-40 -37.05 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.317 -2.22 . . . . 0.0 110.887 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 17.7 ptm -56.84 -40.69 76.56 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 117.536 -1.666 . . . . 0.0 110.79 -172.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 39.5 tp -50.82 -32.78 21.17 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 116.922 -1.911 . . . . 0.0 111.433 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.555 ' C ' ' H ' ' A' ' 26' ' ' GLN . 41.6 t -75.51 -39.78 57.96 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.201 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -71.55 36.19 0.06 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.305 -1.77 . . . . 0.0 110.923 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.555 ' H ' ' C ' ' A' ' 24' ' ' SER . 5.4 mm-40 -102.28 -172.96 2.23 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 117.926 -1.509 . . . . 0.0 109.697 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HE ' ' NE2' ' A' ' 102' ' ' GLN . 3.0 mpt_? -75.63 37.34 0.14 Allowed 'General case' 0 C--N 1.346 0.428 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.947 -176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 26' ' ' GLN . 82.1 m-70 38.09 36.25 0.11 Allowed 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.258 176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 74.8 m-20 -141.49 76.33 1.54 Allowed 'General case' 0 C--N 1.347 0.498 0 C-N-CA 116.748 -1.981 . . . . 0.0 110.975 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.547 ' HA2' ' CG1' ' A' ' 48' ' ' VAL . . . 46.72 20.89 0.72 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 113.013 -1.903 . . . . 0.0 113.373 170.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.412 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -52.29 135.81 31.94 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 116.765 -1.974 . . . . 0.0 108.043 172.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.467 ' CE2' ' CB ' ' A' ' 9' ' ' TRP . 30.5 p90 -139.48 148.62 42.95 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 115.656 -2.418 . . . . 0.0 111.926 -169.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -139.58 150.89 45.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 112.082 -2.326 . . . . 0.0 109.333 171.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.403 HD12 ' CE3' ' A' ' 9' ' ' TRP . 60.5 mt -117.69 107.93 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.622 175.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 31.4 ptt-85 -98.38 140.21 32.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 112.904 -1.953 . . . . 0.0 110.556 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' GLY . 23.9 pt-20 -105.36 137.46 43.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.307 -2.224 . . . . 0.0 109.451 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 36' ' ' GLU . 49.9 m -57.88 -153.87 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.692 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -71.63 -95.35 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.558 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 40' ' ' ALA . 87.1 p -89.99 -41.9 11.47 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.223 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -38.83 100.68 0.21 Allowed Pre-proline 0 C--N 1.348 0.519 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.248 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' SER . 57.9 Cg_endo -77.37 -4.36 14.63 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.855 1.703 . . . . 0.0 115.034 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.49 37.37 3.63 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 118.579 -1.772 . . . . 0.0 111.378 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 49.9 m-20 -129.74 100.83 5.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 117.732 -1.587 . . . . 0.0 109.647 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 21.6 m-85 -132.32 121.33 23.37 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.662 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.439 ' OG ' ' CZ ' ' A' ' 35' ' ' ARG . 78.8 p -119.04 126.56 51.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.096 -1.866 . . . . 0.0 109.37 178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.465 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.3 tt -90.36 114.34 26.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.765 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 33.8 m -97.34 149.51 22.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.314 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.547 ' CG1' ' HA2' ' A' ' 30' ' ' GLY . 75.5 t -140.64 141.56 32.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 113.397 -1.729 . . . . 0.0 110.29 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.509 ' CG ' ' HA ' ' A' ' 28' ' ' HIS . 22.2 tptp -73.78 97.29 2.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.792 -2.004 . . . . 0.0 108.847 173.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.479 ' O ' ' O ' ' A' ' 53' ' ' ASP . 5.7 t80 -116.46 110.43 18.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.031 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 50' ' ' PHE . . . -30.97 143.8 0.01 OUTLIER Glycine 0 C--N 1.347 1.193 0 CA-C-N 112.734 -2.03 . . . . 0.0 111.826 -176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 14.0 t30 82.99 -28.69 0.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 111.848 -2.176 . . . . 0.0 111.39 -175.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.557 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 30.7 t0 -172.53 -148.01 0.04 OUTLIER 'General case' 0 C--N 1.35 0.62 0 C-N-CA 116.33 -2.148 . . . . 0.0 110.381 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.557 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 93.3 t -129.22 119.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.506 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 60.1 tt0 -90.01 159.95 16.61 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.052 -1.885 . . . . 0.0 109.655 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -146.73 145.17 29.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.66 -175.069 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.419 ' CE2' HG13 ' A' ' 89' ' ' VAL . 41.0 m-85 -134.02 110.48 9.68 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.304 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 56.1 mtmt -65.83 115.28 5.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 116.299 -2.16 . . . . 0.0 109.415 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 46.7 t -78.81 102.01 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 113.244 -1.798 . . . . 0.0 108.426 174.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 78.7 mt -93.96 -167.93 1.78 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.183 -169.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.619 HH22 ' HB3' ' A' ' 64' ' ' ALA . 34.9 tpt85 75.0 -121.32 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 111.954 -2.385 . . . . 0.0 110.387 172.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 61' ' ' ARG . 2.3 p30 53.27 118.39 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.552 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.0 -44.15 1.02 Allowed Glycine 0 CA--C 1.532 1.109 0 CA-C-N 112.144 -2.298 . . . . 0.0 110.081 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.619 ' HB3' HH22 ' A' ' 61' ' ' ARG . . . -138.69 -39.82 0.5 Allowed 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.025 -1.588 . . . . 0.0 110.484 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.512 ' H ' ' CZ ' ' A' ' 61' ' ' ARG . . . -111.02 22.07 21.65 Favored Glycine 0 CA--C 1.542 1.742 0 C-N-CA 118.129 -1.986 . . . . 0.0 112.975 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.517 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 5.3 mtpm? 57.71 -166.51 0.15 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.829 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 28.1 m-85 -94.93 139.03 31.9 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 117.512 -1.675 . . . . 0.0 110.617 -168.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.527 ' CB ' ' HA ' ' A' ' 73' ' ' LYS . 4.0 p90 -141.22 152.38 44.54 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 116.251 -2.18 . . . . 0.0 110.366 172.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.458 HD11 ' CG ' ' A' ' 80' ' ' LEU . 15.3 mt -90.49 -85.82 0.21 Allowed 'General case' 0 C--N 1.346 0.447 0 CA-C-N 112.744 -2.025 . . . . 0.0 109.633 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.403 ' CZ2' HG22 ' A' ' 89' ' ' VAL . 34.7 m0 -91.13 -44.8 9.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.887 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.7 t -145.34 -87.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 113.196 -1.82 . . . . 0.0 109.85 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.0 m -53.58 132.37 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.838 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.527 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 23.2 pttp -82.42 -162.37 0.56 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 112.818 -1.992 . . . . 0.0 109.988 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 67' ' ' TYR . 20.9 m-85 -154.8 137.38 15.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.73 -2.032 . . . . 0.0 108.726 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.517 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 54.4 p30 -65.45 -0.91 2.14 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 112.981 -1.918 . . . . 0.0 113.042 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 80.3 p 178.21 146.57 0.14 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.15 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 80' ' ' LEU . 92.6 mt -47.28 -40.29 16.44 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 116.897 -1.921 . . . . 0.0 110.176 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.437 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 14.9 m120 -55.59 -38.15 69.03 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.809 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 76' ' ' SER . 36.5 tt0 -70.18 -23.91 63.05 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 117.49 -1.684 . . . . 0.0 111.868 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 80' ' ' LEU . 9.0 tt -71.95 -49.33 38.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.046 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.79 -37.11 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 112.434 -2.166 . . . . 0.0 110.827 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 66.1 m-20 -74.66 -37.82 62.63 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 113.943 -1.481 . . . . 0.0 111.01 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 44.8 t80 -64.45 -52.34 58.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.743 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -86.27 40.55 0.88 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.564 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -73.28 -36.84 66.4 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.806 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.542 ' C ' ' H ' ' A' ' 88' ' ' SER . 46.3 m -136.87 -27.0 1.02 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 118.16 -1.416 . . . . 0.0 112.079 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' SER . 10.3 t -70.51 26.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 118.099 -1.44 . . . . 0.0 112.23 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 86' ' ' SER . 80.2 p 43.21 -166.66 0.01 OUTLIER 'General case' 0 C--N 1.348 0.521 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.235 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.457 ' O ' HG22 ' A' ' 89' ' ' VAL . 13.8 p -178.58 43.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 112.59 -2.096 . . . . 0.0 109.794 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 92' ' ' ASN . 33.0 t -175.21 96.91 0.08 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.406 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 68.0 mtt85 55.8 3.56 0.09 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 113.249 -1.796 . . . . 0.0 113.633 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 90' ' ' SER . 27.0 m120 63.96 28.9 14.51 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.797 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 24.8 pt20 -113.38 103.64 11.5 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.011 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.466 ' O ' ' OE1' ' A' ' 94' ' ' GLN . 5.9 tm0? 37.54 91.87 0.01 OUTLIER 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.427 -2.169 . . . . 0.0 110.793 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.415 HD13 ' O ' ' A' ' 94' ' ' GLN . 12.7 mm -149.38 120.93 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.139 173.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.425 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 76.3 m-85 -138.8 139.45 38.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 113.118 -1.855 . . . . 0.0 108.879 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 86.2 mt -89.66 94.05 9.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.04 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.414 ' HD3' ' CB ' ' A' ' 29' ' ' ASP . 68.7 mtp85 -92.79 137.32 32.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 111.749 -2.478 . . . . 0.0 109.913 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 101' ' ' GLU . 16.1 m-20 -48.58 118.75 2.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 112.412 -2.176 . . . . 0.0 109.377 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.467 ' CD1' HD23 ' A' ' 33' ' ' LEU . 11.0 tt -71.22 27.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 112.76 -2.018 . . . . 0.0 112.193 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 99' ' ' ASP . 55.2 mm-40 -150.18 114.1 5.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.083 -176.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.46 ' NE2' ' HE ' ' A' ' 27' ' ' ARG . 10.7 mm100 -65.73 -177.97 0.51 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.971 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 104' ' ' PRO . 11.1 p -44.49 138.54 3.75 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.457 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 103' ' ' VAL . 72.5 Cg_exo -41.92 -119.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.728 2.286 . . . . 0.0 114.381 176.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -146.87 74.34 1.34 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 117.609 -1.636 . . . . 0.0 109.968 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -170.02 51.36 0.18 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.461 177.335 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 40.0 Cg_endo -68.85 124.66 11.69 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.259 1.973 . . . . 0.0 111.407 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.46 ' C ' ' O ' ' A' ' 107' ' ' PRO . 6.2 t -6.21 125.36 0.0 OUTLIER 'General case' 0 C--N 1.348 0.538 0 O-C-N 126.481 2.363 . . . . 0.0 112.394 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -128.27 123.64 34.63 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.87 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.2 p -105.92 121.5 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.913 -1.948 . . . . 0.0 109.624 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 111' ' ' GLN . 3.7 pm0 -81.95 -157.97 0.22 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.761 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.43 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.695 179.769 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 CA-C-O 121.91 0.728 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.409 ' O ' HG13 ' A' ' 2' ' ' ILE . 42.6 pt -147.61 129.14 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 112.981 -1.609 . . . . 0.0 109.75 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 3' ' ' GLU . 12.0 pt-20 -79.28 119.74 22.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.909 -1.95 . . . . 0.0 109.703 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.429 ' O ' ' C ' ' A' ' 5' ' ' LYS . 62.8 mtt -75.54 107.9 7.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.268 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' PRO . 87.9 tttt -37.38 99.06 0.18 Allowed Pre-proline 0 C--N 1.346 0.445 0 CA-C-N 112.86 -1.973 . . . . 0.0 110.726 -176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 5' ' ' LYS . 58.8 Cg_exo -48.36 -123.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.526 2.151 . . . . 0.0 113.487 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 8' ' ' PRO . 48.9 t60 -147.82 137.4 12.14 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.092 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 7' ' ' HIS . 63.8 Cg_exo -44.79 -121.66 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.522 2.148 . . . . 0.0 114.163 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.69 35.04 3.15 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.265 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -110.97 109.14 19.14 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.894 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 15.7 m-85 -105.82 99.18 8.79 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 117.709 -1.596 . . . . 0.0 109.332 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -66.27 124.59 25.43 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 112.102 -2.317 . . . . 0.0 111.485 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' CA ' ' O ' ' A' ' 36' ' ' GLU . 26.0 pttm 32.39 40.31 0.02 OUTLIER 'General case' 0 C--N 1.344 0.341 0 CA-C-N 111.857 -2.171 . . . . 0.0 111.145 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.501 ' CG1' ' HD2' ' A' ' 18' ' ' LYS . 10.8 tp -68.5 127.31 93.24 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.6 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' ARG . 53.5 Cg_exo -44.98 121.89 3.88 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.753 1.635 . . . . 0.0 113.103 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 15' ' ' PRO . 43.8 ttp180 -36.68 -37.53 0.14 Allowed 'General case' 0 C--N 1.345 0.4 0 CA-C-N 112.811 -1.995 . . . . 0.0 111.178 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' GLU . . . -70.43 -59.06 3.08 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.748 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' HE3' ' SD ' ' A' ' 22' ' ' MET . 7.2 tmtm? -44.69 -49.76 10.27 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.863 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -41.58 -54.3 3.24 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.835 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' SER . 66.0 mt-10 -60.35 -34.69 74.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.214 -2.267 . . . . 0.0 111.548 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' OG ' ' A' ' 24' ' ' SER . 61.7 mt-10 -64.41 -70.76 0.21 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 117.182 -1.807 . . . . 0.0 111.05 -171.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.54 ' SD ' ' HE3' ' A' ' 18' ' ' LYS . 26.6 ptm -61.44 -39.17 89.84 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 116.836 -1.945 . . . . 0.0 110.644 -175.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.464 HD23 ' CG1' ' A' ' 54' ' ' VAL . 32.1 tp -61.28 -41.4 96.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 117.805 -1.558 . . . . 0.0 110.5 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.547 ' C ' ' H ' ' A' ' 26' ' ' GLN . 75.6 p -64.87 -37.77 88.76 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.593 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 53.9 mttt -70.98 35.9 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.001 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.547 ' H ' ' C ' ' A' ' 24' ' ' SER . 43.0 mm-40 -108.96 135.77 49.6 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 117.981 -1.488 . . . . 0.0 110.003 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' A' ' 28' ' ' HIS . 10.0 mpt_? -91.21 89.96 7.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 111.813 -2.449 . . . . 0.0 109.407 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.496 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER 117.38 121.51 0.0 OUTLIER 'General case' 0 C--N 1.349 0.547 0 CA-C-N 111.561 -2.563 . . . . 0.0 109.277 177.392 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 49' ' ' LYS . 66.7 m-20 -61.01 132.03 52.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.686 -2.052 . . . . 0.0 109.876 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 146.45 -35.14 1.34 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 118.091 -2.004 . . . . 0.0 111.732 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -43.08 150.85 0.16 Allowed 'General case' 0 C--N 1.349 0.56 0 C-N-CA 118.581 -1.248 . . . . 0.0 109.717 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 47' ' ' SER . 44.0 p90 -154.8 160.45 41.28 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 115.157 -2.617 . . . . 0.0 111.84 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.495 HD23 ' CD1' ' A' ' 100' ' ' ILE . 0.4 OUTLIER -116.91 -174.42 2.58 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.534 169.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.6 mt -147.36 103.33 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 111.103 -2.772 . . . . 0.0 107.382 153.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 50.1 ptt85 -97.47 149.34 22.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.054 -169.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 37' ' ' SER . 39.4 tt0 -114.45 142.96 45.7 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 112.021 -2.354 . . . . 0.0 110.024 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' GLU . 35.8 t -53.84 -167.52 0.0 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.783 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' ' OG ' ' A' ' 37' ' ' SER . 39.9 tt0 -98.58 -70.04 0.74 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.109 -1.859 . . . . 0.0 110.37 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 89.3 p -89.97 30.67 1.04 Allowed 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.948 -173.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -179.46 136.44 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.637 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.574 ' C ' ' H ' ' A' ' 43' ' ' ASP . 57.0 Cg_endo -72.29 -143.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.981 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 172.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 -31.76 0.39 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 118.438 -1.839 . . . . 0.0 112.517 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 41' ' ' PRO . 17.5 t70 -90.05 108.74 19.91 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.945 -175.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 23.8 m-85 -133.41 123.08 24.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.544 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 57' ' ' PHE . 79.6 p -133.82 128.67 35.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 112.952 -1.931 . . . . 0.0 109.348 177.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.463 HD22 ' CG2' ' A' ' 48' ' ' VAL . 5.5 tt -84.14 116.21 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.693 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.8 m -93.2 143.17 26.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.965 -1.925 . . . . 0.0 108.932 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.463 ' CG2' HD22 ' A' ' 46' ' ' LEU . 58.2 t -135.05 141.54 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 117.041 -1.864 . . . . 0.0 110.43 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.821 ' HA ' ' HZ3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -82.55 97.33 8.4 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.439 -2.164 . . . . 0.0 109.086 176.386 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.482 ' N ' ' HZ2' ' A' ' 49' ' ' LYS . 9.3 t80 -110.07 139.92 44.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 117.527 -1.669 . . . . 0.0 109.145 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 52' ' ' ASN . . . -46.33 143.01 4.77 Favored Glycine 0 C--N 1.343 0.958 0 C-N-CA 117.322 -2.37 . . . . 0.0 110.399 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 57.0 t30 77.65 -31.17 0.17 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 111.859 -2.17 . . . . 0.0 111.365 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 50' ' ' PHE . 2.8 p30 -174.93 154.31 1.84 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 115.346 -2.542 . . . . 0.0 111.829 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.464 ' CG1' HD23 ' A' ' 23' ' ' LEU . 92.2 t -72.92 125.84 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.459 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 60.3 tt0 -90.04 163.13 15.02 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.775 -177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -133.37 123.61 25.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 112.622 -2.081 . . . . 0.0 110.6 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.41 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 22.9 m-85 -123.19 144.99 49.0 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 112.816 -1.993 . . . . 0.0 109.403 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -105.89 116.62 32.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.232 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 80' ' ' LEU . 33.4 t -89.36 101.21 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 112.667 -2.061 . . . . 0.0 108.171 173.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' ARG . 69.4 mt -82.61 152.58 25.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 112.933 -1.94 . . . . 0.0 111.743 -166.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.571 ' HG3' ' H ' ' A' ' 62' ' ' ASP . 22.6 ptt-85 5.9 -127.65 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 110.272 -3.149 . . . . 0.0 113.298 -172.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.571 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 23.2 t0 170.51 -37.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.759 -160.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 62' ' ' ASP . . . -37.68 -95.68 0.01 OUTLIER Glycine 0 C--N 1.348 1.213 0 CA-C-N 113.855 -1.52 . . . . 0.0 111.163 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.92 -47.11 5.96 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.056 -1.572 . . . . 0.0 109.373 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 73' ' ' LYS . . . -59.78 -6.17 4.77 Favored Glycine 0 CA--C 1.545 1.95 0 CA-C-N 112.746 -2.025 . . . . 0.0 113.375 175.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.711 ' HZ2' ' HB3' ' A' ' 73' ' ' LYS . 10.3 mtmp? 53.16 -153.73 0.24 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 118.131 -1.428 . . . . 0.0 108.999 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.454 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 76.5 m-85 -97.2 127.49 43.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 117.509 -1.676 . . . . 0.0 108.987 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' HZ ' HH12 ' A' ' 61' ' ' ARG . 31.1 p90 -157.87 153.6 26.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 116.124 -2.23 . . . . 0.0 110.366 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 80' ' ' LEU . 4.7 mp -95.07 -43.02 8.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.215 -1.812 . . . . 0.0 110.031 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -138.73 -78.12 0.35 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.163 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.9 t -105.46 -85.25 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.584 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.31 131.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 112.823 -1.99 . . . . 0.0 109.874 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.711 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 64.0 mttm -102.79 179.91 4.15 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.853 -1.976 . . . . 0.0 110.304 -176.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 67' ' ' TYR . 14.1 m-85 -150.17 133.42 16.35 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 112.693 -2.049 . . . . 0.0 109.28 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.438 ' O ' ' OG ' ' A' ' 76' ' ' SER . 40.6 p-10 -69.44 -5.46 23.94 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.119 -1.855 . . . . 0.0 113.449 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 49.4 m -167.93 149.21 5.26 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 117.724 -1.591 . . . . 0.0 109.784 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.507 ' CD2' HG11 ' A' ' 59' ' ' VAL . 87.2 mt -45.71 -45.68 14.45 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.202 -1.817 . . . . 0.0 109.831 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -54.07 -41.59 68.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 112.821 -1.991 . . . . 0.0 110.512 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 76' ' ' SER . 48.5 tp10 -63.86 -31.87 73.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 116.627 -2.029 . . . . 0.0 110.941 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 69' ' ' LEU . 5.9 tt -63.16 -50.88 68.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 118.522 -1.271 . . . . 0.0 108.4 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 82' ' ' ASP . 87.4 t -54.72 -75.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.673 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.464 ' HA ' ' CD ' ' A' ' 85' ' ' ARG . 33.2 t0 -34.22 -47.49 0.29 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.617 -2.083 . . . . 0.0 111.273 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -71.7 -32.62 68.01 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.863 -172.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.421 ' C ' ' H ' ' A' ' 86' ' ' SER . 35.8 m170 -98.68 -6.73 29.1 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 117.688 -1.605 . . . . 0.0 113.18 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.464 ' CD ' ' HA ' ' A' ' 82' ' ' ASP . 9.0 ptm180 -82.42 39.11 0.58 Allowed 'General case' 0 C--N 1.348 0.533 0 C-N-CA 116.889 -1.924 . . . . 0.0 110.557 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 84' ' ' HIS . 79.9 p -150.0 -73.81 0.17 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.741 -1.572 . . . . 0.0 109.566 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.408 ' N ' ' OG ' ' A' ' 86' ' ' SER . 60.0 p -84.08 38.31 0.65 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 112.966 -1.925 . . . . 0.0 110.961 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 95' ' ' ILE . 48.4 t 48.54 -168.97 0.02 OUTLIER 'General case' 0 C--N 1.346 0.425 0 C-N-CA 117.919 -1.512 . . . . 0.0 109.888 177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.506 ' H ' ' HB ' ' A' ' 95' ' ' ILE . 13.6 p -152.51 43.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.439 0 CA-C-N 113.199 -1.818 . . . . 0.0 110.201 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.483 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 19.2 t 178.59 112.02 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.145 -1.843 . . . . 0.0 108.793 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.428 ' O ' ' CG ' ' A' ' 92' ' ' ASN . 65.8 mtp180 59.8 0.75 0.26 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 117.01 -1.876 . . . . 0.0 112.999 -172.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 90' ' ' SER . 2.3 p-10 50.92 35.36 12.31 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 124.079 0.862 . . . . 0.0 111.796 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 21.3 pt20 -169.95 57.63 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 117.771 -1.571 . . . . 0.0 110.604 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.421 ' OE1' ' CZ ' ' A' ' 50' ' ' PHE . 42.8 tt0 -174.03 -34.35 0.01 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 116.458 -2.097 . . . . 0.0 111.644 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.506 ' HB ' ' H ' ' A' ' 89' ' ' VAL . 13.0 mm -102.04 147.49 8.72 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 C-N-CA 117.367 -1.733 . . . . 0.0 110.499 -175.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.577 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 90.5 m-85 -149.99 135.55 18.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.631 -2.077 . . . . 0.0 109.101 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.3 mt -89.89 118.55 29.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 116.958 -1.897 . . . . 0.0 109.553 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 17.4 tpt180 -121.33 147.85 45.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.71 -2.041 . . . . 0.0 110.258 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 101' ' ' GLU . 67.6 m-20 -61.0 116.21 4.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.431 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.495 ' CD1' HD23 ' A' ' 33' ' ' LEU . 12.0 tt -72.19 32.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.644 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' A' ' 99' ' ' ASP . 17.8 mm-40 -150.1 126.86 11.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 117.884 -1.526 . . . . 0.0 109.787 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -64.39 129.32 39.45 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 112.603 -2.089 . . . . 0.0 109.919 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.472 ' C ' ' H ' ' A' ' 105' ' ' GLN . 9.7 p -48.11 137.53 10.99 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 112.87 -1.968 . . . . 0.0 109.418 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 105' ' ' GLN . 51.2 Cg_exo -48.52 -4.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.283 1.989 . . . . 0.0 115.989 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.472 ' H ' ' C ' ' A' ' 103' ' ' VAL . 47.9 mt-30 57.8 151.57 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 118.106 -1.438 . . . . 0.0 109.864 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.637 ' H ' ' HD2' ' A' ' 107' ' ' PRO . 10.6 mt-30 -154.02 -57.2 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.983 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.637 ' HD2' ' H ' ' A' ' 106' ' ' GLN . 52.9 Cg_exo -47.11 120.89 4.62 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.665 1.577 . . . . 0.0 113.777 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 107' ' ' PRO . 72.7 m 64.49 113.61 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.214 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 108' ' ' THR . 8.6 t80 179.45 106.06 0.03 OUTLIER 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.436 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 110' ' ' VAL . 11.9 p -170.01 51.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.737 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 29.8 pt20 -97.83 121.7 40.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.004 -1.907 . . . . 0.0 109.702 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.445 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.705 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 2' ' ' ILE . . . . . . . . 0 CA--C 1.531 1.047 0 CA-C-O 121.796 0.665 . . . . 0.0 111.977 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.521 HG12 ' SD ' ' A' ' 4' ' ' MET . 14.6 tt 38.69 96.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 112.819 -1.69 . . . . 0.0 110.538 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 104' ' ' PRO . 60.0 mt-10 -66.87 93.4 0.26 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 112.763 -2.017 . . . . 0.0 109.862 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.521 ' SD ' HG12 ' A' ' 2' ' ' ILE . 70.1 mmm -93.11 113.2 25.38 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.841 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.41 ' O ' ' CE1' ' A' ' 7' ' ' HIS . 24.9 pttm -177.84 154.58 1.0 Allowed Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 113.134 -1.848 . . . . 0.0 109.419 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 7' ' ' HIS . 53.9 Cg_exo -47.02 118.65 2.88 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.42 2.08 . . . . 0.0 113.895 176.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER 175.97 76.78 0.08 OUTLIER Pre-proline 0 C--N 1.346 0.456 0 CA-C-N 112.915 -1.948 . . . . 0.0 110.269 175.045 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 7' ' ' HIS . 53.3 Cg_exo -44.92 -122.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.524 2.816 . . . . 0.0 113.872 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.41 ' CZ3' HD12 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -133.15 32.94 3.67 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.473 -177.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -89.63 121.09 31.49 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 117.594 -1.642 . . . . 0.0 109.961 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.9 m-85 -105.28 92.38 4.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 112.962 -1.926 . . . . 0.0 108.598 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -55.82 120.46 19.03 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 112.447 -2.161 . . . . 0.0 111.584 -172.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.481 ' CA ' ' O ' ' A' ' 36' ' ' GLU . 17.4 ptpt 28.77 44.71 0.01 OUTLIER 'General case' 0 C--N 1.346 0.433 0 CA-C-N 111.591 -2.305 . . . . 0.0 111.384 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.8 tp -63.17 131.23 94.68 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.611 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.5 Cg_exo -45.25 121.43 3.75 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.719 1.612 . . . . 0.0 112.886 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.496 ' NH1' ' CB ' ' A' ' 16' ' ' ARG . 22.4 ttm105 -38.78 -40.53 0.63 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.818 -177.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -63.8 -59.92 3.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 113.47 -1.695 . . . . 0.0 109.627 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -44.65 -51.09 9.46 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 112.917 -1.947 . . . . 0.0 110.182 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -45.49 -47.02 14.11 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 113.456 -1.702 . . . . 0.0 109.842 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 88.8 mt-10 -62.65 -46.38 88.47 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.116 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 24' ' ' SER . 40.5 mt-10 -60.82 -77.93 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.693 -2.049 . . . . 0.0 110.644 -173.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 21' ' ' GLU . 2.9 ptm -43.87 -38.78 3.53 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.884 -176.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.505 HD23 ' CG1' ' A' ' 54' ' ' VAL . 28.4 tp -71.55 -33.17 68.89 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.62 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.474 ' C ' ' H ' ' A' ' 26' ' ' GLN . 53.5 m -70.41 -28.01 64.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 117.888 -1.525 . . . . 0.0 111.897 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -76.98 42.36 0.31 Allowed 'General case' 0 C--N 1.349 0.55 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.314 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.609 HE21 HG13 ' A' ' 100' ' ' ILE . 22.6 mm-40 -112.28 136.11 52.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.224 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.463 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 74.9 mtp85 -38.64 -85.26 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 111.646 -2.525 . . . . 0.0 110.37 -177.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 1.2 m-70 163.27 117.33 0.0 OUTLIER 'General case' 0 C--N 1.348 0.505 0 CA-C-N 112.506 -2.134 . . . . 0.0 107.995 -175.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -166.75 135.68 2.87 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.956 1.703 . . . . 0.0 108.462 -0.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 138.71 -9.98 3.41 Favored Glycine 0 CA--C 1.544 1.896 0 C-N-CA 117.301 -2.38 . . . . 0.0 113.41 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -46.19 144.58 1.93 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 118.372 -1.331 . . . . 0.0 109.142 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 47' ' ' SER . 53.4 p90 -147.76 160.13 43.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 115.868 -2.333 . . . . 0.0 111.424 -174.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.4 pp -149.07 153.07 37.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.001 -2.363 . . . . 0.0 109.29 173.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 45' ' ' SER . 23.0 mt -115.91 112.52 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.785 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 30.4 ptt-85 -96.71 128.52 43.74 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 112.153 -2.294 . . . . 0.0 110.394 -172.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' O ' ' CA ' ' A' ' 13' ' ' LYS . 2.9 mp0 -79.05 112.32 16.13 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.281 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.477 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 50.5 m -58.52 144.61 41.91 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 112.921 -1.945 . . . . 0.0 110.413 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.8 tp10 -46.28 -96.76 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 112.359 -2.2 . . . . 0.0 110.024 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.1 t -113.58 43.1 1.84 Allowed 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.403 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.477 ' HB3' ' CB ' ' A' ' 37' ' ' SER . . . -99.05 154.65 37.21 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 113.134 -1.848 . . . . 0.0 108.983 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' ALA . 74.7 Cg_exo -34.82 -110.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.917 2.411 . . . . 0.0 114.54 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . -47.7 -59.78 5.82 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 117.333 -2.365 . . . . 0.0 108.352 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -111.47 107.27 16.41 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 113.772 -1.214 . . . . 0.0 108.103 -45.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -90.36 137.36 32.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.128 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 27.4 t -133.39 132.35 41.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.621 -2.081 . . . . 0.0 109.335 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.501 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.7 tt -103.05 115.93 31.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.953 -1.931 . . . . 0.0 109.319 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 49.8 m -97.41 149.17 22.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.948 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 85.6 t -143.51 140.95 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 113.048 -1.887 . . . . 0.0 109.731 176.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 66.3 tttp -73.06 102.59 3.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 116.64 -2.024 . . . . 0.0 108.931 173.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' O ' ' CD1' ' A' ' 50' ' ' PHE . 62.7 t80 -88.29 -8.99 54.31 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.256 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . 88.54 134.74 4.96 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 118.875 -1.631 . . . . 0.0 109.431 -174.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 7.3 t30 71.91 -33.36 0.27 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 112.307 -1.947 . . . . 0.0 110.826 -174.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 51' ' ' GLY . 18.5 t70 -159.13 -175.57 5.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 117.416 -1.714 . . . . 0.0 109.436 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.539 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 85.5 t -114.42 121.8 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.701 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.601 ' NE2' ' CZ ' ' A' ' 57' ' ' PHE . 55.9 tt0 -90.69 159.29 16.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.769 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -141.76 143.7 33.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.024 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.601 ' CZ ' ' NE2' ' A' ' 55' ' ' GLN . 83.5 m-85 -122.3 105.08 9.89 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.697 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.1 mmmp? -65.58 105.0 1.11 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.942 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 64.9 t -75.05 96.92 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.274 172.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 88.7 mt -79.41 -161.52 0.33 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.165 -170.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.877 HH11 ' H ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER 93.55 -137.66 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 111.799 -2.455 . . . . 0.0 108.378 -175.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.877 ' H ' HH11 ' A' ' 61' ' ' ARG . 17.7 t70 110.88 -32.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 O-C-N 125.647 1.842 . . . . 0.0 111.252 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.523 ' H ' ' HD2' ' A' ' 61' ' ' ARG . . . -158.99 110.94 0.46 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 116.467 -2.778 . . . . 0.0 112.664 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.616 ' HB3' ' HE ' ' A' ' 61' ' ' ARG . . . 151.81 -71.66 0.0 OUTLIER 'General case' 0 C--N 1.351 0.674 0 CA-C-N 112.238 -1.981 . . . . 0.0 106.467 -174.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.507 ' H ' ' NE ' ' A' ' 61' ' ' ARG . . . -176.8 85.01 0.07 OUTLIER Glycine 0 CA--C 1.54 1.624 0 CA-C-N 112.216 -2.265 . . . . 0.0 112.661 166.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.772 ' H ' ' CZ ' ' A' ' 61' ' ' ARG . 3.4 mtpm? 110.02 -126.98 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.247 -1.476 . . . . 0.0 113.29 153.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 94.0 m-85 -144.02 140.76 29.75 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.539 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -163.75 134.95 4.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 114.768 -2.773 . . . . 0.0 111.884 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -124.81 162.97 23.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 112.204 -2.271 . . . . 0.0 107.713 163.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 38.5 m0 64.86 -84.66 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 111.986 -2.37 . . . . 0.0 110.188 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 69' ' ' LEU . 51.6 t -139.16 -92.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 116.902 -1.919 . . . . 0.0 110.428 -173.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -55.28 141.29 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.677 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.419 ' C ' ' CG ' ' A' ' 74' ' ' PHE . 67.7 mttm -76.98 -165.88 0.62 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 112.821 -1.991 . . . . 0.0 109.438 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.419 ' CG ' ' C ' ' A' ' 73' ' ' LYS . 15.3 m-85 -157.06 136.45 12.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.059 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.539 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 2.6 p-10 -65.48 -5.14 7.02 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.076 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 80.2 p 178.22 153.72 0.33 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.988 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.441 ' CD2' HG11 ' A' ' 59' ' ' VAL . 94.1 mt -45.35 -42.52 10.08 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 117.386 -1.726 . . . . 0.0 110.21 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 14.0 t-20 -58.4 -40.49 82.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.239 -1.8 . . . . 0.0 110.816 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 76' ' ' SER . 43.1 tp10 -63.18 -30.11 71.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 116.644 -2.022 . . . . 0.0 111.237 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.484 HD23 ' C ' ' A' ' 80' ' ' LEU . 5.8 tt -71.42 -59.96 2.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.531 176.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 97.5 t -46.15 -31.99 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 112.618 -2.083 . . . . 0.0 111.501 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 90.2 m-20 -80.06 -42.08 24.41 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.362 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -59.63 -41.08 89.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.591 -1.641 . . . . 0.0 110.449 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.436 ' CG ' HG23 ' A' ' 89' ' ' VAL . 33.1 m170 -90.41 39.69 0.98 Allowed 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.54 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 62.0 ttt180 -124.45 0.8 8.3 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.876 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -89.91 -45.84 8.95 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.795 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 87' ' ' THR . 9.3 t -170.05 119.21 0.6 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 117.02 -1.872 . . . . 0.0 110.597 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.561 ' HA ' ' H ' ' A' ' 95' ' ' ILE . 43.0 t 66.14 143.89 0.03 OUTLIER 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.689 -2.05 . . . . 0.0 110.963 172.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 89' ' ' VAL . 14.0 p -147.74 42.98 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.879 172.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.53 ' CB ' HD12 ' A' ' 95' ' ' ILE . 48.1 t 176.38 113.65 0.02 OUTLIER 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.39 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -59.21 -1.36 0.19 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.121 -1.854 . . . . 0.0 113.101 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 90' ' ' SER . 13.3 m120 -65.04 -58.15 6.83 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 118.354 -1.338 . . . . 0.0 110.078 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 94' ' ' GLN . 12.2 pt20 -163.53 39.8 0.09 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.658 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 93' ' ' GLN . 93.3 mt-30 62.52 126.84 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.115 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.561 ' H ' ' HA ' ' A' ' 88' ' ' SER . 40.6 mt -143.13 140.88 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.811 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.45 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 16.8 m-30 -111.67 146.45 37.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.524 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.6 mt -90.04 118.93 29.97 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 117.079 -1.848 . . . . 0.0 109.284 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 90.0 mtt-85 -122.23 146.79 46.94 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.905 -1.952 . . . . 0.0 109.97 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.567 ' HB3' ' NE2' ' A' ' 102' ' ' GLN . 33.5 m-20 -57.12 122.63 12.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.759 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.621 HG12 ' H ' ' A' ' 101' ' ' GLU . 14.9 tt -59.74 -136.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 112.739 -2.028 . . . . 0.0 109.391 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.621 ' H ' HG12 ' A' ' 100' ' ' ILE . 81.0 mt-10 -90.02 108.63 19.84 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.777 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 100' ' ' ILE . 4.1 mp0 -108.32 107.98 18.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.517 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.496 HG23 ' HD3' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -49.29 -62.78 2.09 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.362 176.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 105' ' ' GLN . 52.4 Cg_exo -44.31 128.65 8.04 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.032 1.821 . . . . 0.0 113.625 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 104' ' ' PRO . 77.3 mt-30 108.65 115.53 0.0 OUTLIER 'General case' 0 C--N 1.345 0.41 0 CA-C-N 112.114 -2.312 . . . . 0.0 109.961 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -128.0 151.57 76.08 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 112.519 -2.128 . . . . 0.0 109.302 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.499 ' HB2' ' H ' ' A' ' 108' ' ' THR . 53.4 Cg_endo -69.25 -138.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.629 2.219 . . . . 0.0 109.9 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.499 ' H ' ' HB2' ' A' ' 107' ' ' PRO . 90.5 m -167.78 125.12 1.16 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 113.391 -1.731 . . . . 0.0 109.769 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 109' ' ' TYR . 8.5 t80 -166.76 44.7 0.06 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 112.902 -1.954 . . . . 0.0 109.955 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.4 p -88.36 122.01 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.783 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -48.14 120.6 3.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 112.922 -1.945 . . . . 0.0 109.705 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.444 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.689 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.972 0 CA-C-O 121.954 0.752 . . . . 0.0 111.995 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 2' ' ' ILE . 2.4 mp -62.9 92.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 112.974 -1.613 . . . . 0.0 109.209 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 2' ' ' ILE . 25.0 pt-20 34.59 56.13 0.69 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.835 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.432 ' O ' ' HG3' ' A' ' 4' ' ' MET . 14.9 tpt -116.17 54.25 0.84 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.917 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HB3' ' CD ' ' A' ' 6' ' ' PRO . 41.3 tttm 174.02 -69.99 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.229 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' CD ' ' HB3' ' A' ' 5' ' ' LYS . 35.7 Cg_endo -66.85 118.66 5.72 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.818 1.679 . . . . 0.0 111.301 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.613 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 59.0 t-80 -177.08 -44.19 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 113.077 -1.874 . . . . 0.0 112.073 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 7' ' ' HIS . 50.9 Cg_exo -50.33 -122.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 121.519 1.479 . . . . 0.0 114.166 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.438 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 4.6 p-90 -161.34 31.19 0.14 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.653 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.438 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 96.5 m-85 -103.11 120.23 40.31 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.013 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 12' ' ' GLY . 8.1 m-85 -108.51 108.58 19.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.746 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -16.7 -111.57 0.0 OUTLIER Glycine 0 C--N 1.349 1.259 0 CA-C-N 111.67 -2.514 . . . . 0.0 113.016 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -116.12 43.07 2.23 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 112.978 -1.611 . . . . 0.0 109.88 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.9 tp -53.12 114.46 6.01 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.315 -178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' ARG . 47.2 Cg_exo -50.15 125.84 15.83 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.581 1.52 . . . . 0.0 111.869 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.734 ' HB3' HH12 ' A' ' 35' ' ' ARG . 18.3 ptp180 -34.7 -38.14 0.07 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.481 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -69.52 -62.44 1.38 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.455 -1.702 . . . . 0.0 109.74 178.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.521 ' CD ' HD11 ' A' ' 14' ' ' ILE . 0.1 OUTLIER -38.22 -44.43 0.86 Allowed 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.219 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -54.38 -59.88 4.09 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 112.735 -2.029 . . . . 0.0 109.459 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' ALA . 89.3 mt-10 -43.26 -43.65 4.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 112.795 -2.002 . . . . 0.0 110.263 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 24' ' ' SER . 38.5 mt-10 -60.6 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.443 -175.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.519 ' HB3' ' HZ3' ' A' ' 18' ' ' LYS . 17.3 ptm -43.28 -40.31 3.44 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.794 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 25' ' ' LYS . 31.8 tp -64.71 -36.74 85.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.132 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.51 ' OG ' ' CG2' ' A' ' 54' ' ' VAL . 63.2 m -73.23 28.71 0.06 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 117.368 -1.733 . . . . 0.0 111.656 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.551 ' H ' ' C ' ' A' ' 23' ' ' LEU . 53.1 mtpt -135.03 46.21 2.45 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.198 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.548 HE21 HG13 ' A' ' 100' ' ' ILE . 17.6 mm-40 -119.77 117.56 28.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 112.877 -1.965 . . . . 0.0 109.926 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 31.8 tpt85 -98.56 30.95 3.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 111.453 -2.612 . . . . 0.0 112.327 -169.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 29' ' ' ASP . 73.4 m80 -149.39 11.84 0.8 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 116.019 -2.273 . . . . 0.0 113.593 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' HIS . 7.6 t70 58.77 141.9 0.01 OUTLIER 'General case' 0 C--N 1.347 0.474 0 CA-C-O 122.155 0.979 . . . . 0.0 110.79 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.25 -21.82 43.76 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 117.749 -2.167 . . . . 0.0 112.932 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.514 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -42.58 117.46 1.03 Allowed 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.774 -1.17 . . . . 0.0 109.748 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.461 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 29.6 p90 -130.9 158.87 39.06 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 116.399 -2.121 . . . . 0.0 111.632 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 33' ' ' LEU . 4.5 pp -151.87 153.53 34.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 112.618 -2.083 . . . . 0.0 109.753 172.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.717 ' CD1' HD12 ' A' ' 77' ' ' LEU . 15.6 mt -121.46 113.39 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.639 -2.073 . . . . 0.0 108.793 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.734 HH12 ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -84.57 131.16 34.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 115.423 -2.511 . . . . 0.0 110.156 -175.541 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.9 tp10 -72.27 69.53 0.8 Allowed 'General case' 0 C--N 1.346 0.42 0 CA-C-N 112.744 -2.025 . . . . 0.0 109.401 176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' GLU . 60.0 p 24.7 -147.61 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 112.158 -2.292 . . . . 0.0 111.791 -177.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -130.58 -70.56 0.61 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 112.999 -1.909 . . . . 0.0 109.021 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.1 t -134.87 43.85 2.68 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 112.435 -2.166 . . . . 0.0 109.677 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.596 ' HB3' ' CA ' ' A' ' 41' ' ' PRO . . . -80.18 -65.14 0.29 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.471 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.596 ' CA ' ' HB3' ' A' ' 40' ' ' ALA . 84.2 Cg_endo -93.02 -2.11 49.82 Favored 'Cis proline' 0 C--N 1.357 0.978 0 N-CA-C 114.903 1.078 . . . . 0.0 114.903 -4.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.5 55.35 4.41 Favored Glycine 0 C--N 1.346 1.111 0 C-N-CA 119.052 -1.546 . . . . 0.0 111.493 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' A' ' 37' ' ' SER . 49.3 m-20 -130.35 94.63 3.71 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 117.675 -1.61 . . . . 0.0 109.676 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -110.64 127.29 55.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 112.931 -1.94 . . . . 0.0 109.698 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 20.4 p -125.17 132.34 53.06 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.25 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.473 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.4 tt -91.68 113.95 26.35 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.099 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.9 m -95.33 153.0 17.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.159 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.4 t -153.12 135.92 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 117.167 -1.813 . . . . 0.0 110.11 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 89.0 tttt -83.32 106.94 15.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 112.946 -1.933 . . . . 0.0 108.645 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -75.22 -79.44 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.57 -176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.3 -75.94 0.44 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-N 111.796 -2.456 . . . . 0.0 109.871 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.64 -24.35 9.26 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 112.107 -2.046 . . . . 0.0 111.99 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -111.6 156.78 21.26 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 118.464 -1.294 . . . . 0.0 110.115 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' CG2' ' OG ' ' A' ' 24' ' ' SER . 99.1 t -83.44 105.27 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 112.683 -2.053 . . . . 0.0 109.952 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 56' ' ' HIS . 7.0 tm0? -96.98 145.71 25.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.081 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.616 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 44.4 p-80 -134.0 168.62 18.47 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.044 -171.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.599 ' CZ ' ' NE2' ' A' ' 55' ' ' GLN . 85.3 m-85 -139.02 112.13 7.99 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 112.142 -2.299 . . . . 0.0 109.208 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.41 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 37.4 mtmm -77.74 108.93 11.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 116.203 -2.199 . . . . 0.0 109.771 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.512 HG21 ' CD1' ' A' ' 77' ' ' LEU . 89.6 t -74.68 89.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.71 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 55.2 mt -81.39 152.35 27.5 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 112.61 -2.086 . . . . 0.0 109.664 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.507 ' HG2' ' H ' ' A' ' 62' ' ' ASP . 10.7 ttt180 -90.06 -142.25 0.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.76 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.507 ' H ' ' HG2' ' A' ' 61' ' ' ARG . 9.7 t70 -168.55 -30.18 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 117.408 -1.717 . . . . 0.0 111.763 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 61' ' ' ARG . . . 106.63 -47.22 1.07 Allowed Glycine 0 C--N 1.346 1.129 0 C-N-CA 118.334 -1.889 . . . . 0.0 109.563 -174.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.98 -40.76 1.67 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.421 -1.889 . . . . 0.0 110.16 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.502 ' CA ' ' HD2' ' A' ' 73' ' ' LYS . . . -66.78 -12.74 60.11 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 118.639 -1.743 . . . . 0.0 113.545 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 4.6 mtpm? 79.41 -140.22 0.02 OUTLIER 'General case' 0 C--N 1.35 0.594 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.911 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 87.8 m-85 -106.33 134.23 49.79 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.335 -177.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -151.79 172.04 16.77 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 116.616 -2.034 . . . . 0.0 110.983 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 80' ' ' LEU . 5.0 mp -112.17 -91.67 0.48 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 111.833 -2.44 . . . . 0.0 109.498 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -90.15 -40.59 12.13 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.789 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 82.4 t -149.44 -85.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 117.428 -1.709 . . . . 0.0 110.203 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.404 HG23 ' CE1' ' A' ' 74' ' ' PHE . 32.6 m -49.42 132.45 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.367 -174.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.502 ' HD2' ' CA ' ' A' ' 65' ' ' GLY . 41.0 mtmt -87.5 151.0 23.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 112.238 -2.255 . . . . 0.0 109.963 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.404 ' CE1' HG23 ' A' ' 72' ' ' VAL . 7.2 m-85 -125.71 141.72 51.87 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 112.557 -2.11 . . . . 0.0 108.603 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.443 ' O ' ' OG ' ' A' ' 76' ' ' SER . 1.7 p-10 -56.78 -33.64 66.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 116.856 -1.937 . . . . 0.0 111.126 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 69.0 m -170.67 170.47 6.67 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 118.465 -1.294 . . . . 0.0 109.451 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.717 HD12 ' CD1' ' A' ' 34' ' ' ILE . 3.7 mm? -39.8 -46.93 2.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.355 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 76' ' ' SER . 6.0 p-10 -52.35 -50.55 62.13 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 114.798 -2.761 . . . . 0.0 110.284 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 6.6 tp10 -64.08 -15.85 60.47 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 116.502 -2.079 . . . . 0.0 112.392 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 69' ' ' LEU . 5.0 tt -83.04 -70.55 0.55 Allowed 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.42 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 81' ' ' VAL . 92.0 t -35.87 -37.7 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 112.051 -2.34 . . . . 0.0 111.146 174.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 84' ' ' HIS . 25.1 t0 -70.81 -50.83 31.31 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.898 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 84' ' ' HIS . 16.3 m-30 -78.32 42.07 0.41 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.602 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.553 ' C ' ' H ' ' A' ' 86' ' ' SER . 58.8 m80 -152.44 -21.26 0.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.275 -1.784 . . . . 0.0 112.362 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 85' ' ' ARG . 11.7 ptp85 -75.08 38.84 0.13 Allowed 'General case' 0 C--N 1.348 0.543 0 C-N-CA 117.232 -1.787 . . . . 0.0 110.701 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.553 ' H ' ' C ' ' A' ' 84' ' ' HIS . 50.4 m -110.84 -45.73 3.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.566 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' SER . 8.9 t -169.95 105.9 0.34 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.173 -1.83 . . . . 0.0 109.991 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.588 ' HA ' ' H ' ' A' ' 95' ' ' ILE . 39.2 t 54.28 164.33 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.749 -2.023 . . . . 0.0 110.491 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 89' ' ' VAL . 14.7 p -143.93 42.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.381 0 CA-C-N 112.607 -2.088 . . . . 0.0 110.039 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 37.4 t -176.65 -101.03 0.0 OUTLIER 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.607 -1.633 . . . . 0.0 109.979 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 56.8 mmm-85 -88.59 13.04 13.0 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 113.907 -1.497 . . . . 0.0 113.238 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.512 ' HA ' ' CB ' ' A' ' 88' ' ' SER . 22.1 m120 66.27 27.61 10.15 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.01 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -92.45 40.08 1.04 Allowed 'General case' 0 C--N 1.347 0.48 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.695 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 52.64 86.82 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.905 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.588 ' H ' ' HA ' ' A' ' 88' ' ' SER . 58.5 mt -132.75 125.81 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 112.896 -1.956 . . . . 0.0 109.717 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.81 145.84 47.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.844 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.9 mt -89.95 106.7 18.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.488 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HG2' ' H ' ' A' ' 99' ' ' ASP . 47.6 ttt180 -177.16 -159.63 0.05 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.413 -2.176 . . . . 0.0 107.567 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.586 ' H ' ' HG2' ' A' ' 98' ' ' ARG . 53.4 t0 80.35 -34.23 0.13 Allowed 'General case' 0 C--N 1.346 0.424 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.638 161.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.548 HG13 HE21 ' A' ' 26' ' ' GLN . 9.4 tt -69.84 20.61 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 115.886 -2.325 . . . . 0.0 112.92 -171.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 99' ' ' ASP . 75.5 tt0 -139.14 -101.95 0.17 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 117.712 -1.595 . . . . 0.0 109.592 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 40.53 71.58 0.19 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.068 -1.878 . . . . 0.0 110.111 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.75 HG23 ' CG ' ' A' ' 106' ' ' GLN . 0.3 OUTLIER -135.51 -63.72 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 112.92 -1.946 . . . . 0.0 110.687 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.661 ' HD3' HG22 ' A' ' 103' ' ' VAL . 57.7 Cg_endo -80.91 126.53 5.82 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.412 2.074 . . . . 0.0 110.412 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 103' ' ' VAL . 34.6 mt-30 -73.81 141.65 46.19 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-O 121.776 0.798 . . . . 0.0 110.05 3.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.75 ' CG ' HG23 ' A' ' 103' ' ' VAL . 67.2 mt-30 -81.59 -77.35 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.291 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.639 ' CD ' ' CB ' ' A' ' 106' ' ' GLN . 38.2 Cg_endo -70.53 121.95 8.44 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.633 1.555 . . . . 0.0 111.648 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.1 m -41.32 122.48 1.87 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.415 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -105.52 119.41 39.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.129 -1.85 . . . . 0.0 109.235 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.9 p -169.24 122.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.821 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.414 ' OE1' ' HB3' ' A' ' 112' ' ' ALA . 13.2 tm0? -71.66 118.71 14.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.949 -1.932 . . . . 0.0 109.309 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB3' ' OE1' ' A' ' 111' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.706 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.407 ' C ' HD12 ' A' ' 2' ' ' ILE . . . . . . . . 0 CA--C 1.53 1.009 0 CA-C-O 121.908 0.727 . . . . 0.0 112.051 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 2' ' ' ILE . 3.7 mp -121.86 -85.37 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 112.999 -1.601 . . . . 0.0 109.114 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 4' ' ' MET . 67.6 mm-40 -69.48 -168.0 0.15 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.988 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.488 ' CA ' ' HG2' ' A' ' 104' ' ' PRO . 33.4 tpp -34.44 118.98 0.42 Allowed 'General case' 0 C--N 1.344 0.339 0 CA-C-N 111.877 -2.42 . . . . 0.0 111.149 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.618 ' HB2' ' CD ' ' A' ' 6' ' ' PRO . 62.5 pttt -56.28 -166.22 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 112.433 -2.167 . . . . 0.0 107.471 173.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.618 ' CD ' ' HB2' ' A' ' 5' ' ' LYS . 73.8 Cg_exo -44.78 119.18 2.19 Favored 'Trans proline' 0 C--N 1.357 0.98 0 CA-C-O 122.338 0.891 . . . . 0.0 112.935 -175.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.522 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 13.2 m170 -49.88 -46.03 80.71 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 111.988 -2.369 . . . . 0.0 113.291 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 7' ' ' HIS . 66.4 Cg_exo -46.1 -118.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.849 1.699 . . . . 0.0 114.708 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.401 ' CZ2' HG21 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -165.1 36.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.731 -175.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -101.34 125.33 47.96 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.279 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 6.2 m-85 -120.91 114.67 21.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 113.199 -1.818 . . . . 0.0 108.577 175.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -75.91 124.54 7.46 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 112.447 -2.16 . . . . 0.0 111.554 -174.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' CG ' ' HA ' ' A' ' 38' ' ' GLU . 43.6 mtmt 32.3 45.42 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 111.739 -2.23 . . . . 0.0 111.243 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 14' ' ' ILE . 10.4 tp -74.45 130.84 81.23 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 113.319 -1.764 . . . . 0.0 108.836 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' ARG . 50.9 Cg_exo -46.04 121.26 4.21 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.618 1.545 . . . . 0.0 112.717 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 15' ' ' PRO . 53.3 ttp180 -40.59 -41.01 1.38 Allowed 'General case' 0 C--N 1.345 0.393 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.627 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -61.46 -68.65 0.3 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.61 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 17' ' ' ALA . 17.1 tppt? -38.5 -47.05 1.24 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.735 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.715 ' HB3' HH21 ' A' ' 35' ' ' ARG . . . -50.41 -65.97 0.47 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.226 -1.806 . . . . 0.0 109.072 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -42.65 -43.97 4.07 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.492 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 24' ' ' SER . 44.9 mt-10 -64.66 -82.3 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.602 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.409 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 27.0 ptm -47.19 -35.93 8.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.224 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' O ' ' CG ' ' A' ' 26' ' ' GLN . 49.3 tp -67.92 -32.25 72.57 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.571 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 26' ' ' GLN . 38.7 t -74.46 -34.18 63.08 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 117.915 -1.514 . . . . 0.0 111.219 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -77.86 43.89 0.44 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.928 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.584 ' CG ' ' O ' ' A' ' 23' ' ' LEU . 23.1 mm-40 -114.35 -4.25 13.01 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.266 -1.788 . . . . 0.0 114.068 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 26' ' ' GLN . 10.6 tpp180 34.33 38.74 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.564 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 26' ' ' GLN . 1.7 t-80 -158.43 107.45 1.99 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.657 -1.611 . . . . 0.0 109.856 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.6 114.58 3.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.199 -1.818 . . . . 0.0 109.683 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 137.2 -31.96 2.47 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 117.611 -2.233 . . . . 0.0 112.101 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 30' ' ' GLY . . . -40.94 127.85 2.66 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.265 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' CD1' HD23 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -136.36 136.53 39.72 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.931 -1.94 . . . . 0.0 110.097 -177.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 33' ' ' LEU . 4.2 pp -128.03 147.97 50.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 111.289 -2.687 . . . . 0.0 108.195 160.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -107.7 104.46 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 113.568 -1.651 . . . . 0.0 108.708 178.343 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.715 HH21 ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -84.35 127.26 33.88 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.849 -175.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 37' ' ' SER . 39.6 tt0 -90.37 130.41 36.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 112.577 -2.101 . . . . 0.0 109.781 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 40' ' ' ALA . 1.6 p -39.95 122.11 1.41 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.414 -1.721 . . . . 0.0 110.257 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HA ' ' CG ' ' A' ' 13' ' ' LYS . 61.1 tt0 -49.55 -54.45 18.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.401 -2.181 . . . . 0.0 110.56 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 p -90.03 -94.59 0.11 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.065 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' O ' ' OG ' ' A' ' 37' ' ' SER . . . -53.76 139.64 50.85 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.04 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 43' ' ' ASP . 66.5 Cg_endo -77.44 -146.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 N-CA-C 106.879 -2.008 . . . . 0.0 106.879 171.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . 63.76 -18.45 0.09 OUTLIER Glycine 0 CA--C 1.542 1.726 0 O-C-N 124.84 1.338 . . . . 0.0 113.794 172.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 41' ' ' PRO . 70.2 m-20 -126.62 135.16 50.84 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 117.746 -1.582 . . . . 0.0 110.643 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.73 -169.82 2.37 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.285 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.456 ' OG ' ' HD3' ' A' ' 35' ' ' ARG . 74.7 p -170.05 137.86 1.63 Allowed 'General case' 0 C--N 1.345 0.408 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.465 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 32' ' ' PHE . 2.6 tt -98.22 113.91 25.99 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 112.936 -1.938 . . . . 0.0 110.413 -172.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.492 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 88.8 p -95.24 133.48 39.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.385 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' CG2' HD22 ' A' ' 46' ' ' LEU . 46.9 t -135.28 147.93 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 117.496 -1.682 . . . . 0.0 109.299 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HD3' ' H ' ' A' ' 28' ' ' HIS . 63.9 tttp -83.79 100.69 11.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 115.914 -2.314 . . . . 0.0 108.955 172.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 53' ' ' ASP . 6.6 t80 -119.46 103.07 9.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.79 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -26.56 141.3 0.01 OUTLIER Glycine 0 C--N 1.348 1.227 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.942 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.576 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 87.6 m-20 104.68 -52.89 0.0 OUTLIER 'General case' 0 C--N 1.345 0.403 0 CA-C-N 111.356 -2.422 . . . . 0.0 108.111 -165.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 16.9 t70 -177.75 -173.23 0.39 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 111.584 -2.553 . . . . 0.0 109.799 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.532 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 77.9 t -88.9 119.54 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 113.112 -1.858 . . . . 0.0 109.442 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.469 ' NE2' ' CZ ' ' A' ' 57' ' ' PHE . 59.3 tt0 -92.08 159.51 15.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.204 -1.816 . . . . 0.0 109.827 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 28.9 p80 -147.62 134.85 20.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.955 -174.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.469 ' CZ ' ' NE2' ' A' ' 55' ' ' GLN . 83.3 m-85 -127.21 111.26 13.75 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 112.629 -2.078 . . . . 0.0 109.229 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -58.52 122.16 12.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 116.811 -1.955 . . . . 0.0 109.549 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' A' ' 80' ' ' LEU . 67.1 t -94.2 87.43 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 112.797 -2.002 . . . . 0.0 108.624 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.6 mt -89.17 159.34 17.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.393 -2.185 . . . . 0.0 110.855 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -86.79 167.7 14.16 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 112.55 -2.114 . . . . 0.0 109.484 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 63' ' ' GLY . 36.3 t70 -110.78 42.39 1.61 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.294 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 62' ' ' ASP . . . 38.77 34.75 0.29 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 118.192 -1.956 . . . . 0.0 111.725 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.85 -42.94 0.13 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.865 -1.167 . . . . 0.0 109.664 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.4 ' C ' ' HZ3' ' A' ' 66' ' ' LYS . . . 157.27 -30.68 0.53 Allowed Glycine 0 CA--C 1.537 1.445 0 C-N-CA 118.044 -2.027 . . . . 0.0 112.065 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.797 ' HA ' ' HZ2' ' A' ' 66' ' ' LYS . 1.2 mmpm? -79.29 136.62 37.08 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 117.667 -1.613 . . . . 0.0 110.172 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -101.97 143.23 32.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 112.195 -2.275 . . . . 0.0 108.513 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 71' ' ' VAL . 52.6 p90 -149.23 -161.64 1.39 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 116.204 -2.198 . . . . 0.0 111.099 -174.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.416 ' CG ' HD11 ' A' ' 80' ' ' LEU . 11.4 mt -137.28 -37.89 0.62 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 111.677 -2.51 . . . . 0.0 110.545 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -112.15 -41.09 4.02 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.508 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 92.6 t -150.01 -79.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 117.183 -1.807 . . . . 0.0 109.689 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 71' ' ' VAL . 20.1 m -162.75 134.96 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.777 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.5 ' CD ' ' CZ ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -170.04 -33.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 114.206 -2.998 . . . . 0.0 112.977 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.5 ' CZ ' ' CD ' ' A' ' 73' ' ' LYS . 2.6 m-85 -112.29 149.07 32.89 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 116.439 -2.104 . . . . 0.0 109.758 -174.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 76' ' ' SER . 27.8 p30 -103.65 19.57 19.61 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.431 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.5 t -179.24 143.8 0.21 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.644 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 34' ' ' ILE . 82.6 mt -43.02 -46.12 5.41 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.011 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 12.1 m120 -59.17 -38.1 78.93 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.924 -177.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 76' ' ' SER . 61.5 tt0 -70.38 -26.08 63.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 117.111 -1.836 . . . . 0.0 111.689 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.566 ' CD1' HG13 ' A' ' 59' ' ' VAL . 9.1 tt -66.81 -50.36 62.88 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.908 174.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.401 HG21 ' CZ2' ' A' ' 9' ' ' TRP . 95.0 t -68.1 -30.54 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.026 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 84.7 m-20 -70.59 -44.46 67.29 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 118.341 -1.344 . . . . 0.0 110.307 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 2.0 t80 -83.57 29.2 0.53 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 116.366 -2.133 . . . . 0.0 111.989 -177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.558 ' C ' ' H ' ' A' ' 86' ' ' SER . 5.8 m-70 -130.21 -25.7 2.43 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.727 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 16.7 ptm180 -72.92 35.16 0.07 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 118.447 -1.301 . . . . 0.0 111.354 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 84' ' ' HIS . 50.3 m -150.02 -43.6 0.13 Allowed 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.939 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 88' ' ' SER . 8.7 t -118.13 45.47 1.98 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.871 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.517 ' CB ' ' HA ' ' A' ' 93' ' ' GLN . 87.9 p 51.44 -163.59 0.06 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.811 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.31 -39.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 112.832 -1.986 . . . . 0.0 110.461 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.511 ' H ' HD12 ' A' ' 95' ' ' ILE . 43.3 t -99.4 155.51 17.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.487 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 90' ' ' SER . 9.5 ptp85 -40.15 -42.09 1.4 Allowed 'General case' 0 C--N 1.348 0.5 0 CA-C-N 113.21 -1.813 . . . . 0.0 110.624 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -70.76 93.36 0.94 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.796 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.517 ' HA ' ' CB ' ' A' ' 88' ' ' SER . 28.0 pt20 -69.91 104.98 2.66 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.091 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' A' ' 93' ' ' GLN . 5.9 pt20 175.49 43.41 0.0 OUTLIER 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.627 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 90' ' ' SER . 56.6 mt -131.93 121.23 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.215 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.461 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 83.3 m-85 -114.09 121.94 45.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.186 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 70.6 mt -90.09 104.32 16.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.122 -1.853 . . . . 0.0 110.054 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' ASP . 67.5 ttt-85 -170.53 -116.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 116.601 -2.04 . . . . 0.0 110.546 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' ARG . 10.0 t70 -30.0 112.94 0.09 Allowed 'General case' 0 C--N 1.35 0.59 0 CA-C-N 113.681 -1.6 . . . . 0.0 111.667 -172.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.443 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 15.1 tt -120.41 -39.93 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 112.389 -2.187 . . . . 0.0 111.359 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -150.05 125.84 10.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 112.724 -2.034 . . . . 0.0 109.642 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -127.46 116.7 20.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 113.072 -1.876 . . . . 0.0 109.714 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.687 HG13 ' HD3' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -138.72 -62.28 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 113.075 -1.875 . . . . 0.0 110.335 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.687 ' HD3' HG13 ' A' ' 103' ' ' VAL . 35.6 Cg_exo -50.18 126.83 18.2 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.317 2.011 . . . . 0.0 113.212 173.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 104' ' ' PRO . 88.3 mt-30 104.79 34.46 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 112.071 -2.331 . . . . 0.0 111.101 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.66 ' H ' ' HD2' ' A' ' 107' ' ' PRO . 2.2 mp0 -142.92 -57.68 0.02 OUTLIER Pre-proline 0 C--N 1.347 0.499 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.406 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.66 ' HD2' ' H ' ' A' ' 106' ' ' GLN . 50.5 Cg_exo -51.49 118.74 4.67 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.555 1.503 . . . . 0.0 113.427 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.457 ' O ' ' CG ' ' A' ' 109' ' ' TYR . 82.3 m 41.2 91.15 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.857 -1.974 . . . . 0.0 110.531 178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.457 ' CG ' ' O ' ' A' ' 108' ' ' THR . 47.0 m-85 -158.66 45.78 0.3 Allowed 'General case' 0 C--N 1.345 0.388 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.382 175.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 111' ' ' GLN . 11.1 p -145.53 52.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 113.207 -1.815 . . . . 0.0 109.643 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 110' ' ' VAL . 77.4 mt-30 30.63 99.0 0.0 OUTLIER 'General case' 0 C--N 1.348 0.519 0 CA-C-N 112.516 -2.129 . . . . 0.0 111.367 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.727 179.606 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 111.869 -0.493 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.26 131.33 34.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.821 -0.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -48.83 122.73 6.0 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.588 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' LYS . 9.2 tpt -93.06 95.75 9.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.983 -1.917 . . . . 0.0 109.778 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 4' ' ' MET . 87.4 tttt 60.16 134.2 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.688 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -74.32 120.58 6.32 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.219 1.946 . . . . 0.0 110.58 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 8' ' ' PRO . 58.3 t60 -65.63 131.38 94.76 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 117.045 -1.862 . . . . 0.0 109.498 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 7' ' ' HIS . 53.4 Cg_exo -45.45 -122.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.581 2.187 . . . . 0.0 114.087 176.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.431 ' CZ3' ' CE1' ' A' ' 10' ' ' PHE . 1.6 p-90 -147.15 26.5 1.08 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.125 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.431 ' CE1' ' CZ3' ' A' ' 9' ' ' TRP . 92.8 m-85 -90.6 110.66 21.81 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 118.319 -1.353 . . . . 0.0 109.582 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.0 m-85 -94.96 99.38 11.41 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.184 -1.825 . . . . 0.0 108.446 174.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -70.09 140.47 32.72 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 112.202 -2.272 . . . . 0.0 111.618 -173.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' GLY . 60.4 tttp 27.73 48.24 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.007 -2.097 . . . . 0.0 111.447 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 14' ' ' ILE . 11.0 tp -80.02 124.62 82.91 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 113.227 -1.806 . . . . 0.0 108.961 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' ARG . 50.5 Cg_exo -47.24 122.19 6.18 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.622 1.548 . . . . 0.0 112.815 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.528 ' NH1' ' CG ' ' A' ' 20' ' ' GLU . 1.6 tmt_? -38.28 -42.45 0.7 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 112.922 -1.945 . . . . 0.0 110.401 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -64.62 -58.5 6.16 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.105 -1.862 . . . . 0.0 109.956 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 15' ' ' PRO . 59.1 tptt -42.93 -51.37 5.59 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 113.033 -1.894 . . . . 0.0 110.125 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.765 ' CB ' HH21 ' A' ' 35' ' ' ARG . . . -43.03 -49.31 6.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.829 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.528 ' CG ' ' NH1' ' A' ' 16' ' ' ARG . 57.0 mt-10 -63.89 -44.72 92.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.581 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 34.8 mt-10 -63.3 -78.75 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.811 -1.995 . . . . 0.0 110.759 -171.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.528 ' CE ' ' CD2' ' A' ' 33' ' ' LEU . 22.9 ptt? -46.41 -38.29 8.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.994 -175.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 31.7 tp -69.6 -35.88 75.72 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 117.558 -1.657 . . . . 0.0 111.232 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 26' ' ' GLN . 92.5 p -62.87 -27.65 69.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 117.674 -1.61 . . . . 0.0 111.73 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 25.1 mtpp -74.23 36.5 0.1 Allowed 'General case' 0 C--N 1.349 0.549 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.972 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.592 HE21 HG13 ' A' ' 100' ' ' ILE . 21.7 mm-40 -112.55 142.43 45.14 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.423 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' HIS . 10.5 mpt_? -92.6 -62.85 1.31 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 112.408 -2.178 . . . . 0.0 109.995 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 27' ' ' ARG . 36.5 m170 -58.42 -154.41 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.61 -177.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -139.59 120.08 14.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.424 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.71 -17.47 3.47 Favored Glycine 0 CA--C 1.542 1.769 0 C-N-CA 117.985 -2.055 . . . . 0.0 113.0 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -46.54 118.22 1.91 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.22 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.489 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 10.3 p90 -132.11 158.67 41.03 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 116.516 -2.074 . . . . 0.0 111.384 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.528 ' CD2' ' CE ' ' A' ' 22' ' ' MET . 4.3 pp -155.61 155.89 34.09 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 111.925 -2.398 . . . . 0.0 108.76 168.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.19 114.34 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 117.254 -1.778 . . . . 0.0 109.247 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.765 HH21 ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -80.5 125.06 29.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.072 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 37' ' ' SER . 21.5 pt-20 -116.03 133.35 56.12 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.064 -172.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.585 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 38.3 t 70.77 -14.11 0.45 Allowed 'General case' 0 C--N 1.346 0.442 0 CA-C-N 111.903 -2.408 . . . . 0.0 113.344 172.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 37' ' ' SER . 56.1 tt0 -40.32 -35.74 0.46 Allowed 'General case' 0 C--N 1.35 0.623 0 C-N-CA 117.209 -1.797 . . . . 0.0 111.224 174.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 80.4 p -148.75 72.89 1.2 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.083 -1.871 . . . . 0.0 107.976 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.93 ' HB1' ' HA ' ' A' ' 41' ' ' PRO . . . -70.57 -165.22 0.04 OUTLIER Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 112.797 -2.001 . . . . 0.0 106.275 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.93 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . 25.4 Cg_endo -63.1 -108.73 0.0 OUTLIER 'Cis proline' 0 C--N 1.353 0.769 0 O-C-N 122.299 0.631 . . . . 0.0 112.472 -0.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . -72.42 74.56 0.87 Allowed Glycine 0 C--N 1.345 1.077 0 C-N-CA 118.952 -1.594 . . . . 0.0 109.906 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.457 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 0.9 OUTLIER -131.54 105.17 7.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.047 -2.077 . . . . 0.0 109.591 -178.038 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 22.0 m-85 -132.83 134.19 44.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.753 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.434 ' OG ' ' HD3' ' A' ' 35' ' ' ARG . 72.0 p -127.62 138.9 52.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 112.981 -1.918 . . . . 0.0 109.389 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.494 ' CD2' HG23 ' A' ' 48' ' ' VAL . 5.4 tt -97.22 117.28 31.06 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.507 -2.133 . . . . 0.0 109.969 -174.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.6 m -96.57 141.65 29.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.242 -1.799 . . . . 0.0 109.839 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.494 HG23 ' CD2' ' A' ' 46' ' ' LEU . 92.4 t -150.8 138.4 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.039 -1.891 . . . . 0.0 110.03 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.579 ' HE3' ' H ' ' A' ' 26' ' ' GLN . 23.5 ttmm -78.53 109.32 12.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 116.503 -2.079 . . . . 0.0 108.979 171.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.651 ' HE1' HE21 ' A' ' 93' ' ' GLN . 6.6 t80 -77.39 -90.9 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.446 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.61 -77.98 1.39 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 112.502 -2.136 . . . . 0.0 109.974 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -117.17 -24.63 7.42 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 112.288 -1.956 . . . . 0.0 112.13 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 34.4 t0 -108.34 -178.49 3.62 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 118.029 -1.468 . . . . 0.0 109.868 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 95.1 t -98.21 117.83 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.899 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -98.27 157.81 15.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 112.874 -1.966 . . . . 0.0 109.428 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -146.02 136.88 24.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.421 -175.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HB3' HD22 ' A' ' 69' ' ' LEU . 26.5 m-85 -118.59 110.9 17.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.55 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.5 mtmm -62.62 109.48 1.41 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 117.059 -1.856 . . . . 0.0 109.405 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 77' ' ' LEU . 40.6 t -77.86 92.17 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 116.896 -1.922 . . . . 0.0 107.86 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 61' ' ' ARG . 96.9 mt -73.35 179.73 3.83 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 112.216 -2.265 . . . . 0.0 112.342 -165.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.606 ' NH2' ' H ' ' A' ' 65' ' ' GLY . 14.7 ptm180 15.16 -144.6 0.0 OUTLIER 'General case' 0 C--N 1.349 0.545 0 CA-C-N 110.04 -3.255 . . . . 0.0 112.409 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 63' ' ' GLY . 16.4 t0 165.36 -33.93 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.829 -167.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 62' ' ' ASP . . . -37.86 -97.62 0.01 OUTLIER Glycine 0 C--N 1.348 1.232 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.529 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' H ' HH21 ' A' ' 61' ' ' ARG . . . -97.77 -44.35 6.77 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 113.045 -1.578 . . . . 0.0 109.791 -177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.606 ' H ' ' NH2' ' A' ' 61' ' ' ARG . . . -60.52 -18.79 52.38 Favored Glycine 0 CA--C 1.544 1.846 0 C-N-CA 118.446 -1.835 . . . . 0.0 112.833 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HZ2' ' HA ' ' A' ' 75' ' ' ASN . 7.6 mtpm? 66.82 -141.74 0.14 Allowed 'General case' 0 C--N 1.348 0.541 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.411 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.518 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 57.0 m-85 -78.37 143.08 37.17 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 113.974 -1.467 . . . . 0.0 109.303 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' O ' ' A' ' 70' ' ' TRP . 2.7 t80 -156.05 135.53 12.38 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 116.075 -2.25 . . . . 0.0 111.016 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.536 ' CG ' HD11 ' A' ' 80' ' ' LEU . 40.2 mt -100.98 -78.54 0.52 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.13 -1.85 . . . . 0.0 109.882 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.456 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 25.7 m0 -123.24 -69.03 0.84 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.116 -1.856 . . . . 0.0 111.607 -169.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.82 -41.96 5.31 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 C-N-CA 117.6 -1.64 . . . . 0.0 111.217 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.459 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 34.4 m -115.24 142.18 29.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.648 -1.615 . . . . 0.0 109.935 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.419 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 10.0 ptpp? -82.21 -169.53 2.45 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.557 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 10.2 m-85 -150.51 136.64 18.55 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.384 -1.726 . . . . 0.0 108.911 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER -91.76 47.55 1.37 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 116.47 -2.092 . . . . 0.0 109.904 -177.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 23.1 p 141.02 143.42 0.0 OUTLIER 'General case' 0 C--N 1.349 0.563 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.041 175.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.52 ' CD2' HG11 ' A' ' 59' ' ' VAL . 98.6 mt -47.75 -44.11 27.79 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 117.171 -1.812 . . . . 0.0 109.647 175.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 23.5 t-20 -57.96 -34.8 70.32 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 113.341 -1.754 . . . . 0.0 111.315 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 46.3 tp10 -62.81 -26.11 68.58 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 116.219 -2.192 . . . . 0.0 111.664 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.536 HD11 ' CG ' ' A' ' 69' ' ' LEU . 8.3 tt -85.66 -57.62 2.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.239 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 85' ' ' ARG . 97.5 t -49.43 -34.31 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 112.397 -2.183 . . . . 0.0 111.117 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 37.6 t70 -70.87 -41.0 71.97 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.627 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 79' ' ' GLU . 10.3 m-30 -62.33 -54.83 34.84 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 117.32 -1.752 . . . . 0.0 109.43 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 25.0 m170 -62.52 -30.14 71.07 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 113.074 -1.876 . . . . 0.0 111.639 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 84' ' ' HIS . 53.2 tpt85 -37.73 -36.03 0.16 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.304 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.5 p -148.82 42.77 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 117.73 -1.588 . . . . 0.0 110.394 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.588 ' O ' ' CB ' ' A' ' 88' ' ' SER . 93.4 m -132.33 -41.86 0.97 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.507 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.588 ' CB ' ' O ' ' A' ' 87' ' ' THR . 27.9 t 110.43 145.08 0.0 OUTLIER 'General case' 0 C--N 1.35 0.63 0 O-C-N 125.835 1.959 . . . . 0.0 109.693 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 90' ' ' SER . 3.6 m -92.0 21.91 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.218 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.533 ' HG ' ' CG ' ' A' ' 92' ' ' ASN . 9.2 t 170.18 126.49 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 117.315 -1.754 . . . . 0.0 109.321 -164.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -66.38 -30.76 71.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.836 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.533 ' CG ' ' HG ' ' A' ' 90' ' ' SER . 30.1 p30 -50.87 -29.02 10.77 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 117.676 -1.61 . . . . 0.0 111.827 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.651 HE21 ' HE1' ' A' ' 50' ' ' PHE . 29.8 pt20 -170.08 146.91 3.12 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.982 177.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.562 ' CD ' ' H ' ' A' ' 94' ' ' GLN . 4.1 pm0 -70.13 121.57 17.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.282 -1.781 . . . . 0.0 110.005 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 93' ' ' GLN . 61.5 mt -122.3 117.6 52.68 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.921 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -92.69 142.51 27.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.532 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 95.4 mt -89.95 105.18 17.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.816 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 99' ' ' ASP . 62.2 ttt-85 -175.6 -119.36 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 112.581 -2.1 . . . . 0.0 108.344 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 29.2 t70 25.79 48.33 0.01 OUTLIER 'General case' 0 C--N 1.348 0.508 0 O-C-N 125.234 1.584 . . . . 0.0 112.699 172.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.62 HG12 ' H ' ' A' ' 101' ' ' GLU . 7.5 tt -135.07 -146.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 117.503 -1.679 . . . . 0.0 108.991 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.62 ' H ' HG12 ' A' ' 100' ' ' ILE . 40.6 mm-40 -89.96 94.84 9.96 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.473 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.424 ' O ' ' HB ' ' A' ' 103' ' ' VAL . 47.8 tt0 -148.76 161.01 42.65 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 113.055 -1.884 . . . . 0.0 109.602 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 104' ' ' PRO . 1.1 t 70.41 151.05 0.13 Allowed Pre-proline 0 C--N 1.346 0.432 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.365 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 103' ' ' VAL . 88.6 Cg_exo -34.55 -119.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.89 3.06 . . . . 0.0 115.018 174.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 104' ' ' PRO . 30.2 pt20 -175.78 137.8 0.35 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 114.76 -2.776 . . . . 0.0 110.738 -169.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.547 ' HB2' ' CD ' ' A' ' 107' ' ' PRO . 36.1 mt-30 -69.95 -65.39 1.14 Allowed Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 112.585 -2.098 . . . . 0.0 111.008 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.574 ' O ' ' CB ' ' A' ' 108' ' ' THR . 12.4 Cg_endo -55.96 123.86 14.86 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 120.964 1.109 . . . . 0.0 111.925 176.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.574 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 1.3 m 146.99 -40.77 0.01 OUTLIER 'General case' 0 C--N 1.347 0.489 0 CA-C-N 112.342 -2.208 . . . . 0.0 109.852 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -58.56 120.86 9.62 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.281 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.54 127.01 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 113.276 -1.783 . . . . 0.0 110.079 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -126.54 122.34 34.85 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 112.857 -1.974 . . . . 0.0 109.342 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.435 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.707 -179.883 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . . . . . . 0 CA--C 1.53 0.973 0 CA-C-O 121.83 0.683 . . . . 0.0 112.019 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 16.1 tt -177.87 136.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 113.037 -1.582 . . . . 0.0 109.736 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.441 ' OE1' ' CG2' ' A' ' 103' ' ' VAL . 11.8 pt-20 -41.1 128.05 2.78 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 112.957 -1.929 . . . . 0.0 110.298 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 42.6 tpp -94.09 115.36 27.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.041 -1.89 . . . . 0.0 109.385 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' O ' ' CD2' ' A' ' 7' ' ' HIS . 87.6 tttt 60.59 95.47 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.707 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 58.6 Cg_exo -46.34 122.98 6.12 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.501 2.134 . . . . 0.0 113.892 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.456 ' CD2' ' O ' ' A' ' 5' ' ' LYS . 95.1 m-70 -108.58 96.68 20.15 Favored Pre-proline 0 C--N 1.346 0.432 0 CA-C-N 112.834 -1.985 . . . . 0.0 109.209 177.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 6' ' ' PRO . 57.2 Cg_endo -73.4 -118.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.159 1.906 . . . . 0.0 110.972 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.429 ' CB ' ' CZ ' ' A' ' 32' ' ' PHE . 36.8 p-90 -86.56 7.27 26.91 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.501 -174.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -89.37 111.07 21.83 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 117.322 -1.751 . . . . 0.0 109.879 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 12' ' ' GLY . 33.5 m-85 -112.08 121.73 45.8 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.25 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -56.33 -151.38 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.928 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.633 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -72.8 77.96 1.13 Allowed 'General case' 0 C--N 1.346 0.445 0 C-N-CA 117.153 -1.819 . . . . 0.0 109.618 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.0 tp -79.1 130.76 68.51 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.247 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.2 Cg_exo -47.4 124.54 9.44 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.984 1.789 . . . . 0.0 113.133 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.843 ' CG ' HH22 ' A' ' 35' ' ' ARG . 69.0 mtp180 -37.33 -42.73 0.5 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.67 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -58.89 -75.46 0.05 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.212 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 17' ' ' ALA . 56.9 tptt -36.64 -36.81 0.12 Allowed 'General case' 0 C--N 1.345 0.379 0 CA-C-N 112.979 -1.919 . . . . 0.0 111.457 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -63.21 -66.5 0.53 Allowed 'General case' 0 C--N 1.347 0.469 0 C-N-CA 117.387 -1.725 . . . . 0.0 109.567 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.409 ' HA ' HG21 ' A' ' 54' ' ' VAL . 63.2 mt-10 -47.98 -54.69 12.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.864 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 24' ' ' SER . 11.4 mm-40 -52.8 -84.41 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.791 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.575 ' C ' ' SD ' ' A' ' 22' ' ' MET . 2.9 ppp? -43.18 -43.78 4.82 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.609 -172.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' N ' ' SD ' ' A' ' 22' ' ' MET . 37.2 tp -66.78 -35.32 79.8 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.998 -1.91 . . . . 0.0 111.475 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 26' ' ' GLN . 37.4 t -70.47 -40.03 73.89 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 117.796 -1.562 . . . . 0.0 110.484 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -73.11 35.42 0.08 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.859 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.516 ' HG3' ' CB ' ' A' ' 31' ' ' ALA . 29.5 mm-40 -101.53 153.43 19.73 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 117.108 -1.837 . . . . 0.0 110.837 -174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -72.07 87.73 1.07 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 111.819 -2.446 . . . . 0.0 109.55 -177.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER 69.04 145.9 0.05 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 111.942 -2.39 . . . . 0.0 111.049 170.031 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 22.7 t70 -31.94 133.99 0.09 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 111.5 -2.591 . . . . 0.0 111.462 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 96' ' ' PHE . . . 142.02 -41.62 1.2 Allowed Glycine 0 C--N 1.348 1.237 0 C-N-CA 117.665 -2.207 . . . . 0.0 112.198 169.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HB2' ' H ' ' A' ' 100' ' ' ILE . . . -47.49 136.17 10.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 117.533 -1.667 . . . . 0.0 109.512 -176.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' CB ' HG22 ' A' ' 48' ' ' VAL . 12.6 p90 -143.8 158.08 43.93 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 115.636 -2.426 . . . . 0.0 111.503 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 33' ' ' LEU . 4.6 pp -153.58 146.64 24.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 112.399 -2.182 . . . . 0.0 109.812 170.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 45' ' ' SER . 45.6 mt -108.05 115.56 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 112.562 -2.108 . . . . 0.0 108.549 172.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.843 HH22 ' CG ' ' A' ' 16' ' ' ARG . 10.0 ptm180 -101.74 128.91 47.86 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.57 -2.104 . . . . 0.0 110.865 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 37.8 mt-10 -76.76 144.86 38.95 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.317 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 40' ' ' ALA . 96.5 p -59.31 -168.2 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 117.292 -1.763 . . . . 0.0 109.029 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 29.5 tp10 -100.47 -49.13 4.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.433 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 44.8 t -132.47 64.01 1.61 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.342 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' O ' ' OG ' ' A' ' 37' ' ' SER . . . 178.49 68.47 0.11 Allowed Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.462 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -64.37 -3.46 6.39 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.137 1.891 . . . . 0.0 115.302 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.86 34.23 5.34 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 118.575 -1.774 . . . . 0.0 111.364 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -150.08 121.96 8.16 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 118.464 -1.295 . . . . 0.0 109.45 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 59' ' ' VAL . 79.2 m-85 -130.75 156.15 45.44 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 113.052 -1.886 . . . . 0.0 109.796 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 77.5 p -141.51 154.07 45.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.231 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' A' ' 48' ' ' VAL . 4.9 tt -119.23 114.95 23.21 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 113.504 -1.68 . . . . 0.0 109.595 -177.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 49.8 m -108.62 133.59 52.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.671 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' A' ' 46' ' ' LEU . 91.1 t -134.16 133.9 55.52 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.548 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 29' ' ' ASP . 42.3 tptt -55.56 97.11 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 112.785 -2.007 . . . . 0.0 107.719 168.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 48' ' ' VAL . 5.7 t80 -107.97 118.19 36.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 117.74 -1.584 . . . . 0.0 109.858 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.57 -94.65 0.06 OUTLIER Glycine 0 C--N 1.344 1.028 0 C-N-CA 117.971 -2.061 . . . . 0.0 110.323 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -123.06 -26.74 4.31 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.862 -1.669 . . . . 0.0 112.175 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 29.0 t0 -110.04 -174.65 2.54 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 118.022 -1.471 . . . . 0.0 109.663 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.543 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 93.0 t -103.85 122.24 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 113.079 -1.873 . . . . 0.0 109.685 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.419 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 56.6 tt0 -98.89 162.78 12.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 112.913 -1.949 . . . . 0.0 109.779 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.41 ' CD2' ' C ' ' A' ' 56' ' ' HIS . 6.7 t60 -141.02 133.73 28.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 112.799 -2.0 . . . . 0.0 110.546 -171.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.419 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 85.7 m-85 -137.1 104.06 5.32 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.094 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -63.2 111.74 2.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.159 -1.837 . . . . 0.0 110.088 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.514 HG11 ' CD2' ' A' ' 77' ' ' LEU . 97.6 t -77.33 72.12 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 112.934 -1.939 . . . . 0.0 108.437 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 99.1 mt -76.74 168.36 20.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.521 -2.127 . . . . 0.0 110.335 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 63' ' ' GLY . 9.3 ptm180 -139.91 -145.3 0.18 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 116.868 -1.933 . . . . 0.0 109.56 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 61' ' ' ARG . 38.2 t70 69.72 -23.47 0.15 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.71 -1.586 . . . . 0.0 112.329 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 61' ' ' ARG . . . -39.25 -56.77 2.25 Favored Glycine 0 C--N 1.35 1.306 0 C-N-CA 118.946 -1.597 . . . . 0.0 110.812 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.536 ' CB ' ' HE2' ' A' ' 73' ' ' LYS . . . -142.38 -2.51 1.1 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 113.096 -1.552 . . . . 0.0 112.754 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.406 ' C ' ' CG ' ' A' ' 66' ' ' LYS . . . 158.98 -25.47 0.35 Allowed Glycine 0 CA--C 1.538 1.476 0 C-N-CA 116.85 -2.595 . . . . 0.0 112.767 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.495 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 6.0 mtpm? -151.44 -157.68 0.83 Allowed 'General case' 0 C--N 1.347 0.486 0 C-N-CA 116.543 -2.063 . . . . 0.0 110.828 -175.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 89.7 m-85 -85.31 157.62 20.51 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.259 -168.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.473 ' HE1' ' H ' ' A' ' 63' ' ' GLY . 36.6 p90 -174.99 155.05 1.93 Allowed 'General case' 0 C--N 1.348 0.543 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.34 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.448 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 4.7 mp -92.12 -44.08 9.02 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 116.896 -1.922 . . . . 0.0 109.928 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 13.7 m0 -136.97 -43.09 0.57 Allowed 'General case' 0 C--N 1.346 0.427 0 CA-C-N 113.381 -1.736 . . . . 0.0 110.466 -177.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.3 t -139.62 -84.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.34 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.1 m -49.11 130.75 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 112.904 -1.953 . . . . 0.0 110.106 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.536 ' HE2' ' CB ' ' A' ' 64' ' ' ALA . 56.2 mttp -101.38 148.12 25.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.119 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.411 ' CE2' HD12 ' A' ' 69' ' ' LEU . 4.3 m-85 -117.03 150.13 39.13 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.634 -173.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.495 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 32.7 p-10 -75.37 -19.35 59.62 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.291 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 79' ' ' GLU . 83.3 p -167.37 154.06 8.28 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 118.666 -1.214 . . . . 0.0 109.342 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.514 ' CD2' HG11 ' A' ' 59' ' ' VAL . 90.4 mt -47.26 -43.69 22.35 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.042 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -50.05 -40.15 44.27 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 113.248 -1.796 . . . . 0.0 110.536 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 76' ' ' SER . 36.6 tp10 -70.05 -24.01 63.18 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.924 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.489 HD23 ' C ' ' A' ' 80' ' ' LEU . 7.8 tt -69.38 -58.29 4.19 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 117.905 -1.518 . . . . 0.0 108.351 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.6 t -48.8 -19.22 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 112.572 -2.104 . . . . 0.0 112.294 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 64.8 m-20 -90.03 -37.11 14.52 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.453 174.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -50.15 -50.55 48.5 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 116.952 -1.899 . . . . 0.0 108.689 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.459 ' CE1' HD21 ' A' ' 80' ' ' LEU . 57.7 m170 -61.98 -64.3 0.98 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 111.986 -2.37 . . . . 0.0 108.2 168.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 45.0 tpt85 67.79 -65.54 0.24 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 125.804 1.94 . . . . 0.0 108.657 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 87' ' ' THR . 48.2 t -89.85 -113.27 0.07 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 112.002 -2.363 . . . . 0.0 105.16 156.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 88' ' ' SER . 9.7 t -170.36 -133.97 0.02 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 117.841 -1.543 . . . . 0.0 110.724 169.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 87' ' ' THR . 3.2 m 143.19 -58.98 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.117 -1.856 . . . . 0.0 107.872 -168.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.553 ' CG2' HG13 ' A' ' 95' ' ' ILE . 0.8 OUTLIER 51.44 4.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 112.661 -2.063 . . . . 0.0 113.537 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.549 ' C ' ' H ' ' A' ' 92' ' ' ASN . 22.6 t -159.73 -26.0 0.07 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 117.552 -1.659 . . . . 0.0 112.198 -164.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 90' ' ' SER . 1.2 mpp_? 70.52 -31.33 0.22 Allowed 'General case' 0 C--N 1.351 0.67 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.492 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.549 ' H ' ' C ' ' A' ' 90' ' ' SER . 78.7 m-20 -74.88 -24.64 58.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 118.31 -1.356 . . . . 0.0 112.105 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' O ' ' OE1' ' A' ' 94' ' ' GLN . 17.8 mp0 -141.35 -150.93 0.34 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.474 ' OE1' ' O ' ' A' ' 93' ' ' GLN . 21.5 mm100 -149.5 120.76 7.83 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 116.348 -2.141 . . . . 0.0 109.849 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.617 HG22 ' H ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -91.47 -156.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 112.788 -2.006 . . . . 0.0 108.97 -177.141 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.617 ' H ' HG22 ' A' ' 95' ' ' ILE . 90.6 m-85 -150.07 145.19 26.23 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 113.406 -1.725 . . . . 0.0 109.289 170.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.455 ' O ' ' CG ' ' A' ' 98' ' ' ARG . 83.2 mt -113.94 77.93 1.1 Allowed 'General case' 0 C--N 1.346 0.436 0 C-N-CA 117.376 -1.729 . . . . 0.0 109.317 173.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 42.6 mtp180 -154.73 -123.21 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 112.951 -1.931 . . . . 0.0 108.864 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.6 t0 39.13 -117.08 0.21 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.812 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.604 HG12 ' H ' ' A' ' 101' ' ' GLU . 6.8 tt 38.08 -149.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.545 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.99 -171.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.604 ' H ' HG12 ' A' ' 100' ' ' ILE . 79.1 mm-40 -89.94 121.08 31.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.955 -177.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.542 ' CD ' ' H ' ' A' ' 102' ' ' GLN . 0.0 OUTLIER -66.58 143.75 56.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.822 -1.99 . . . . 0.0 109.906 178.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.51 ' CG2' ' HD2' ' A' ' 104' ' ' PRO . 12.3 p -45.4 147.29 1.42 Allowed Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.05 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.51 ' HD2' ' CG2' ' A' ' 103' ' ' VAL . 22.9 Cg_exo -61.26 128.65 25.7 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.333 1.355 . . . . 0.0 113.547 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 104' ' ' PRO . 29.3 mm100 68.66 126.76 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.673 -2.058 . . . . 0.0 110.287 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.476 ' OE1' ' O ' ' A' ' 108' ' ' THR . 11.0 tm0? -77.69 135.64 64.02 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.779 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.419 ' O ' ' HB ' ' A' ' 108' ' ' THR . 36.6 Cg_endo -70.56 120.73 7.33 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.321 2.014 . . . . 0.0 112.215 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.476 ' O ' ' OE1' ' A' ' 106' ' ' GLN . 81.2 m 64.16 129.49 0.02 OUTLIER 'General case' 0 C--N 1.346 0.43 0 CA-C-N 112.821 -1.991 . . . . 0.0 110.158 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 108' ' ' THR . 63.1 t80 64.54 122.34 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 112.835 -1.984 . . . . 0.0 109.926 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 110' ' ' VAL . 12.1 p -165.04 50.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.834 -1.984 . . . . 0.0 109.512 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -122.41 43.04 3.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 112.801 -2.0 . . . . 0.0 110.152 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.424 0 CA-C-N 113.418 -1.719 . . . . 0.0 109.703 -179.859 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.059 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 2' ' ' ILE . 2.6 mp -82.79 132.51 31.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 114.37 -0.915 . . . . 0.0 109.548 0.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 3' ' ' GLU . 40.1 tt0 -175.27 77.67 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.723 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.442 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 26.3 ttt -133.53 45.5 2.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.946 177.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.561 ' H ' ' CD ' ' A' ' 6' ' ' PRO . 61.0 pttt 174.82 -35.2 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 112.654 -2.067 . . . . 0.0 113.724 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.561 ' CD ' ' H ' ' A' ' 5' ' ' LYS . 50.6 Cg_exo -52.38 -122.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 120.847 1.031 . . . . 0.0 114.6 -174.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -142.74 118.91 6.76 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 118.111 -1.436 . . . . 0.0 109.593 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 64.6 Cg_endo -75.81 -118.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.986 1.791 . . . . 0.0 110.468 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.417 ' CG ' ' CE2' ' A' ' 32' ' ' PHE . 39.9 p-90 -62.85 1.17 0.43 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.557 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -84.0 119.75 25.3 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 117.097 -1.841 . . . . 0.0 109.952 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 12' ' ' GLY . 7.3 m-85 -115.69 121.92 43.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.167 -1.833 . . . . 0.0 107.838 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -57.39 -146.49 0.01 OUTLIER Glycine 0 CA--C 1.531 1.09 0 CA-C-N 112.685 -2.052 . . . . 0.0 110.85 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 59.2 pttt -74.04 75.45 1.72 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 117.069 -1.853 . . . . 0.0 109.755 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.0 tp -85.12 129.33 56.36 Favored Pre-proline 0 N--CA 1.447 -0.591 0 CA-C-N 112.734 -2.03 . . . . 0.0 108.674 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.1 Cg_exo -45.55 120.83 3.52 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.542 1.495 . . . . 0.0 112.465 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 15' ' ' PRO . 61.2 ttt85 -39.49 -39.46 0.7 Allowed 'General case' 0 C--N 1.345 0.37 0 CA-C-N 112.976 -1.92 . . . . 0.0 110.806 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -65.35 -66.54 0.53 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.411 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 17' ' ' ALA . 24.4 tptm -37.12 -38.65 0.21 Allowed 'General case' 0 C--N 1.347 0.475 0 CA-C-N 112.95 -1.932 . . . . 0.0 111.118 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -54.79 -65.98 0.48 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.059 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 24' ' ' SER . 93.6 mt-10 -45.86 -44.02 14.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 112.396 -2.184 . . . . 0.0 110.313 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.465 ' O ' ' OG ' ' A' ' 24' ' ' SER . 66.2 mt-10 -61.81 -78.7 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.719 -172.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.573 ' SD ' HD11 ' A' ' 100' ' ' ILE . 3.8 ppp? -54.39 -37.23 64.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 117.47 -1.692 . . . . 0.0 110.968 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.548 ' N ' ' SD ' ' A' ' 22' ' ' MET . 40.0 tp -69.22 -30.35 68.48 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.89 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.549 ' C ' ' H ' ' A' ' 26' ' ' GLN . 78.2 p -69.67 -29.13 66.51 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 117.326 -1.75 . . . . 0.0 111.407 176.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 5.4 mtpm? -72.38 33.3 0.06 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.133 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 24' ' ' SER . 20.5 mm-40 -107.52 145.15 33.5 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 117.829 -1.549 . . . . 0.0 109.498 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 28' ' ' HIS . 95.8 mtt180 -75.5 38.23 0.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 112.388 -2.187 . . . . 0.0 110.798 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.528 ' H ' ' C ' ' A' ' 26' ' ' GLN . 0.8 OUTLIER 44.62 89.79 0.01 OUTLIER 'General case' 0 C--N 1.348 0.527 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.541 -178.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 41.9 m-20 -158.06 37.21 0.25 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.092 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.581 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 81.75 -4.62 73.5 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 115.947 -3.025 . . . . 0.0 113.205 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.473 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -40.55 117.69 0.85 Allowed 'General case' 0 C--N 1.352 0.7 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.705 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 47' ' ' SER . 23.8 p90 -137.78 154.79 49.53 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 116.5 -2.08 . . . . 0.0 110.943 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 33' ' ' LEU . 4.5 pp -152.92 149.02 27.81 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 112.379 -2.191 . . . . 0.0 109.276 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 45' ' ' SER . 46.4 mt -109.51 115.89 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 112.418 -2.174 . . . . 0.0 108.569 174.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.427 ' CB ' HG22 ' A' ' 14' ' ' ILE . 8.5 ptm180 -99.22 125.48 44.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.678 -2.055 . . . . 0.0 110.422 -174.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 72.7 tt0 -89.62 120.64 31.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.354 -2.203 . . . . 0.0 109.748 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 46.5 t -46.05 138.36 5.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.887 -1.961 . . . . 0.0 110.026 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.413 ' HA ' ' CB ' ' A' ' 13' ' ' LYS . 64.8 mt-10 -41.1 -76.53 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.569 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 t -102.09 51.02 0.83 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 112.514 -2.13 . . . . 0.0 110.367 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 37' ' ' SER . . . -171.35 97.84 0.41 Allowed Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.579 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.445 ' O ' ' CE1' ' A' ' 44' ' ' PHE . 54.2 Cg_endo -75.46 -4.27 15.05 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.744 1.629 . . . . 0.0 115.014 -177.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.67 40.06 2.6 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 118.697 -1.716 . . . . 0.0 110.876 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -145.99 118.4 8.46 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 118.227 -1.389 . . . . 0.0 109.604 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 84.9 m-85 -139.91 157.82 45.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 112.993 -1.912 . . . . 0.0 109.56 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.8 p -156.01 129.22 8.13 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.515 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 46' ' ' LEU . 4.5 tt -89.1 113.43 24.57 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 113.105 -1.861 . . . . 0.0 109.711 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.458 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 79.1 p -94.88 149.48 21.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.766 -2.015 . . . . 0.0 109.577 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 73.7 t -146.82 138.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.027 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.482 ' HG2' ' H ' ' A' ' 28' ' ' HIS . 42.2 tptt -69.12 98.17 0.97 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 112.964 -1.925 . . . . 0.0 109.242 176.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 53' ' ' ASP . 7.2 t80 -115.21 108.98 17.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.934 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.526 ' H ' ' CD2' ' A' ' 28' ' ' HIS . . . -25.97 144.44 0.01 OUTLIER Glycine 0 C--N 1.348 1.207 0 CA-C-N 112.325 -2.216 . . . . 0.0 112.294 -175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 59.6 t30 86.99 -30.53 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 111.66 -2.27 . . . . 0.0 111.226 -175.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 22.1 t70 -174.68 -170.84 0.51 Allowed 'General case' 0 C--N 1.35 0.622 0 C-N-CA 116.232 -2.187 . . . . 0.0 110.388 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.551 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 86.4 t -102.15 118.68 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.338 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 60.7 tt0 -90.08 158.49 17.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 113.111 -1.859 . . . . 0.0 109.613 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.63 142.9 27.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.658 -2.065 . . . . 0.0 110.514 -175.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 88.3 m-85 -126.77 101.94 6.83 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.53 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.0 mtmm -60.08 122.68 14.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.908 -1.951 . . . . 0.0 109.594 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.525 HG11 ' CD2' ' A' ' 77' ' ' LEU . 37.1 t -79.89 97.57 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 112.845 -1.979 . . . . 0.0 108.047 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 94.6 mt -91.42 178.79 5.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.183 -165.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 62' ' ' ASP . 9.9 tpt180 66.64 -136.12 0.15 Allowed 'General case' 0 C--N 1.347 0.466 0 CA-C-N 111.207 -2.724 . . . . 0.0 109.519 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 25.5 t70 90.83 113.63 0.03 OUTLIER 'General case' 0 C--N 1.347 0.471 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.567 -178.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.92 -41.57 1.52 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 118.216 -1.945 . . . . 0.0 110.698 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.15 -45.13 1.71 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.34 -1.43 . . . . 0.0 109.509 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 66' ' ' LYS . . . -113.29 33.9 5.32 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 113.083 -1.871 . . . . 0.0 111.573 177.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HZ2' ' HB3' ' A' ' 66' ' ' LYS . 6.0 mtpm? 37.3 -147.56 0.01 OUTLIER 'General case' 0 C--N 1.347 0.458 0 CA-C-N 113.992 -1.104 . . . . 0.0 110.313 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.516 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 76.4 m-85 -97.52 134.34 40.89 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 117.881 -1.527 . . . . 0.0 110.342 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -152.17 148.69 27.91 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 116.606 -2.038 . . . . 0.0 110.679 176.129 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.454 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 5.4 mt -86.06 -49.01 8.12 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 112.773 -2.012 . . . . 0.0 109.456 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 20.7 m0 -133.15 -77.48 0.49 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.852 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.1 t -107.15 -83.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.901 -1.954 . . . . 0.0 109.611 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.3 m -50.8 131.27 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 112.648 -2.069 . . . . 0.0 110.023 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 66.7 mttm -88.93 -169.94 2.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.721 -2.036 . . . . 0.0 109.951 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 73' ' ' LYS . 37.7 m-85 -152.88 135.06 14.91 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.127 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.425 ' O ' ' OG ' ' A' ' 76' ' ' SER . 1.7 m120 -64.12 -16.87 62.74 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.561 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 46.9 m -168.69 160.54 10.71 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.83 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' CD2' HG11 ' A' ' 59' ' ' VAL . 89.4 mt -45.51 -41.98 10.25 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 117.268 -1.773 . . . . 0.0 110.362 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 52.8 t30 -55.8 -39.34 71.18 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.382 -1.735 . . . . 0.0 110.893 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.4 OUTLIER -67.89 -28.64 67.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 117.347 -1.741 . . . . 0.0 111.452 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.483 HD23 ' C ' ' A' ' 80' ' ' LEU . 8.6 tt -65.68 -47.37 75.7 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 118.708 -1.197 . . . . 0.0 109.088 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 85' ' ' ARG . 70.6 t -64.57 -31.25 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 112.756 -2.02 . . . . 0.0 111.594 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 57.0 m-20 -74.57 -42.95 57.84 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.116 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -58.82 -46.05 88.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 117.104 -1.839 . . . . 0.0 109.096 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 85' ' ' ARG . 60.1 m-70 -92.76 32.39 1.25 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.143 -1.844 . . . . 0.0 110.965 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 84' ' ' HIS . 35.2 ptt-85 -40.24 -35.09 0.37 Allowed 'General case' 0 C--N 1.349 0.568 0 C-N-CA 118.309 -1.356 . . . . 0.0 110.935 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.8 p -89.93 -80.61 0.31 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 117.803 -1.559 . . . . 0.0 108.206 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 95' ' ' ILE . 14.8 t -170.16 -169.97 0.92 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.51 -1.677 . . . . 0.0 109.925 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.659 ' H ' ' CG1' ' A' ' 89' ' ' VAL . 29.3 t -121.25 -96.02 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 112.116 -2.311 . . . . 0.0 107.622 160.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.659 ' CG1' ' H ' ' A' ' 88' ' ' SER . 4.0 m -142.18 41.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.953 1 C-N-CA 133.737 4.815 . . . . 0.0 108.684 -8.497 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 12.0 t 162.67 -86.04 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 112.821 -1.99 . . . . 0.0 109.06 -154.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.438 ' O ' ' CG ' ' A' ' 92' ' ' ASN . 85.9 mtt180 -99.94 5.63 45.23 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.171 -1.832 . . . . 0.0 113.352 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 91' ' ' ARG . 19.9 p30 47.91 27.26 1.11 Allowed 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.02 0.825 . . . . 0.0 112.569 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.57 ' O ' ' NE2' ' A' ' 94' ' ' GLN . 8.4 pt20 -170.04 31.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 117.296 -1.762 . . . . 0.0 112.009 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.57 ' NE2' ' O ' ' A' ' 93' ' ' GLN . 94.1 mm-40 -158.44 37.75 0.24 Allowed 'General case' 0 C--N 1.347 0.498 0 C-N-CA 118.218 -1.393 . . . . 0.0 110.661 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.602 HG13 ' H ' ' A' ' 89' ' ' VAL . 5.8 mm -142.97 165.39 15.8 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 117.779 -1.568 . . . . 0.0 109.298 -176.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.581 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 86.1 m-85 -150.07 155.16 39.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.657 -1.611 . . . . 0.0 109.894 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' C ' ' CE1' ' A' ' 32' ' ' PHE . 58.0 mt -116.2 90.92 3.44 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 113.659 -1.61 . . . . 0.0 109.083 169.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 99' ' ' ASP . 71.4 mtp180 -156.47 -147.79 0.2 Allowed 'General case' 0 C--N 1.346 0.446 0 CA-C-N 112.951 -1.932 . . . . 0.0 108.803 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 100' ' ' ILE . 33.7 t0 48.1 -177.87 0.01 OUTLIER 'General case' 0 C--N 1.348 0.506 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.674 172.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.573 HD11 ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER 84.29 6.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 112.93 -1.941 . . . . 0.0 113.967 177.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -150.17 83.29 1.38 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 118.415 -1.314 . . . . 0.0 109.581 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.493 ' C ' HG22 ' A' ' 103' ' ' VAL . 37.7 mt-30 -115.08 99.94 7.8 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.055 -1.884 . . . . 0.0 109.691 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.553 HG23 ' CD ' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -163.64 -65.57 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 113.077 -1.874 . . . . 0.0 110.86 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.553 ' CD ' HG23 ' A' ' 103' ' ' VAL . 20.0 Cg_endo -69.13 122.94 9.79 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.931 1.754 . . . . 0.0 111.921 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 104' ' ' PRO . 70.8 mt-30 95.75 86.95 0.01 OUTLIER 'General case' 0 C--N 1.347 0.477 0 CA-C-N 112.038 -2.346 . . . . 0.0 109.848 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.519 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -170.02 53.84 0.22 Allowed Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 112.81 -1.995 . . . . 0.0 110.991 179.08 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 44.7 Cg_endo -64.21 -139.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.218 1.946 . . . . 0.0 110.067 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.423 ' H ' ' HB2' ' A' ' 107' ' ' PRO . 4.4 t -144.24 136.96 26.96 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.271 -1.786 . . . . 0.0 109.441 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.451 ' CD2' ' O ' ' A' ' 109' ' ' TYR . 54.9 p90 -93.09 121.49 34.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.638 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.7 p -140.95 122.64 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.788 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -73.66 120.49 19.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.034 -1.893 . . . . 0.0 109.664 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.422 0 CA-C-N 113.004 -1.907 . . . . 0.0 109.719 179.955 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 CA-C-O 122.006 0.781 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 2' ' ' ILE . 8.3 tp -46.37 122.38 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-N 112.911 -1.645 . . . . 0.0 109.641 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 104' ' ' PRO . 23.2 mm-40 -103.6 50.03 0.81 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.828 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 50.5 ttp -122.18 114.93 21.54 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 112.624 -2.08 . . . . 0.0 109.517 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -177.86 153.24 0.92 Allowed Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.3 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' HA ' ' C ' ' A' ' 7' ' ' HIS . 77.2 Cg_exo -42.66 136.8 4.3 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.828 2.352 . . . . 0.0 112.586 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.431 ' C ' ' HA ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -87.46 141.64 32.52 Favored Pre-proline 0 C--N 1.351 0.663 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.988 11.519 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 69.6 Cg_endo -76.55 -119.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.53 2.153 . . . . 0.0 108.867 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.413 ' H ' ' HB2' ' A' ' 8' ' ' PRO . 5.9 p-90 -83.72 16.34 2.77 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 118.386 -1.326 . . . . 0.0 112.782 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -93.36 125.06 37.77 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.419 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.453 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 83.5 m-85 -130.02 118.33 21.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 117.301 -1.76 . . . . 0.0 110.088 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.535 ' CA ' ' C ' ' A' ' 13' ' ' LYS . . . 137.83 -161.35 25.46 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 115.823 -3.084 . . . . 0.0 112.488 166.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' C ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -57.4 115.8 2.94 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 112.648 -1.776 . . . . 0.0 111.081 0.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.469 ' N ' ' CA ' ' A' ' 12' ' ' GLY . 9.8 tp -106.02 133.77 20.06 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.253 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.3 Cg_exo -46.24 121.75 4.83 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.788 1.659 . . . . 0.0 112.933 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 15' ' ' PRO . 95.0 mtt180 -42.94 -41.18 3.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.479 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -62.8 -61.61 2.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.795 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 17' ' ' ALA . 58.5 tptt -43.02 -44.24 4.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.051 -1.886 . . . . 0.0 110.275 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -48.4 -62.57 1.42 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.148 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 21' ' ' GLU . 46.8 mt-10 -44.95 -65.0 0.59 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.346 -2.206 . . . . 0.0 109.901 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 20' ' ' GLU . 69.1 mt-10 -37.51 -85.7 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.039 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.505 ' CA ' ' HD3' ' A' ' 25' ' ' LYS . 26.5 ptt? -48.62 -52.39 23.32 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 117.495 -1.682 . . . . 0.0 110.233 -176.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.517 HD13 ' CD1' ' A' ' 100' ' ' ILE . 42.0 tp -50.62 -22.92 2.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 117.145 -1.822 . . . . 0.0 112.708 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 21' ' ' GLU . 90.3 p -83.82 -33.13 24.99 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.115 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.505 ' HD3' ' CA ' ' A' ' 22' ' ' MET . 8.2 pttm -42.29 -25.88 0.09 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 113.538 -1.664 . . . . 0.0 112.018 172.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 35.5 mm-40 -55.58 161.37 2.07 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.282 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 6.5 mpt_? -119.0 -41.95 2.73 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.057 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.19 107.78 19.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.691 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -47.76 125.51 8.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.505 -2.134 . . . . 0.0 109.728 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 138.5 -29.47 2.59 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 117.35 -2.357 . . . . 0.0 112.485 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.73 138.59 8.24 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 117.829 -1.549 . . . . 0.0 109.181 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' SER . 37.5 p90 -142.94 156.11 44.83 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 116.09 -2.244 . . . . 0.0 111.515 -174.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -146.93 150.94 36.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.448 -2.16 . . . . 0.0 109.334 169.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.7 mt -111.08 108.16 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 113.025 -1.898 . . . . 0.0 108.577 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 37.0 ptt180 -92.72 135.8 33.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.67 -2.059 . . . . 0.0 110.805 -172.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.8 pt-20 -91.71 128.38 37.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.694 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 36' ' ' GLU . 49.8 m -54.51 -165.27 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.182 -1.826 . . . . 0.0 109.822 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -81.61 -98.41 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.423 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.4 t -94.24 43.64 1.11 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.015 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.26 94.75 7.6 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 113.227 -1.806 . . . . 0.0 109.448 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.39 -4.79 15.48 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.954 1.769 . . . . 0.0 114.943 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.95 39.45 2.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 118.864 -1.636 . . . . 0.0 110.932 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 57.0 t0 -143.38 106.84 4.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 118.264 -1.375 . . . . 0.0 109.652 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 23.4 m-85 -133.85 120.22 20.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.533 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.3 p -113.6 125.95 54.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.643 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' A' ' 48' ' ' VAL . 5.4 tt -85.44 117.2 24.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 112.817 -1.992 . . . . 0.0 109.562 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.484 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 49.9 m -94.83 144.52 25.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.533 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' A' ' 46' ' ' LEU . 78.6 t -151.57 131.41 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.735 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 66.2 tttp -76.32 106.13 7.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 116.754 -1.979 . . . . 0.0 108.427 174.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -104.37 37.53 2.08 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 113.212 -1.813 . . . . 0.0 111.524 -172.2 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.82 -95.34 0.26 Allowed Glycine 0 C--N 1.346 1.109 0 C-N-CA 117.249 -2.405 . . . . 0.0 110.811 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 52.2 t-20 -107.19 -31.42 8.24 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 112.675 -1.763 . . . . 0.0 111.411 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 34.2 t70 -120.85 -176.81 3.33 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.499 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.549 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 94.6 t -100.23 122.79 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.2 -175.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.42 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 59.5 tt0 -97.36 159.53 14.86 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.778 -2.01 . . . . 0.0 109.486 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -139.69 134.98 32.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.748 -2.023 . . . . 0.0 110.522 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.447 ' CZ ' ' O ' ' A' ' 89' ' ' VAL . 97.4 m-85 -123.88 101.56 7.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.409 176.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 55.1 mtmt -58.85 100.25 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 116.59 -2.044 . . . . 0.0 109.612 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.528 HG13 ' CD1' ' A' ' 80' ' ' LEU . 93.6 t -70.33 86.22 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 112.984 -1.917 . . . . 0.0 108.563 174.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 77.2 mt -78.76 163.04 25.71 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.752 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.2 ptm180 -132.42 -154.76 0.64 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.075 -1.875 . . . . 0.0 109.205 173.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -172.97 -37.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.063 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.76 -41.61 2.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 117.79 -2.148 . . . . 0.0 110.599 -176.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.85 53.25 1.1 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.141 -1.53 . . . . 0.0 108.089 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 66' ' ' LYS . . . 150.83 -31.52 1.0 Allowed Glycine 0 CA--C 1.54 1.636 0 CA-C-N 111.82 -2.445 . . . . 0.0 111.351 -168.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.502 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 21.8 mtpp 70.93 -151.38 0.09 Allowed 'General case' 0 C--N 1.349 0.573 0 CA-C-N 114.172 -1.014 . . . . 0.0 110.253 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 90.1 m-85 -71.13 147.68 48.16 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.476 -173.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 17.1 p90 -166.01 167.53 16.45 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.418 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 80' ' ' LEU . 4.7 mp -124.94 97.76 5.4 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.06 173.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.44 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 34.4 m0 73.63 -39.2 0.43 Allowed 'General case' 0 C--N 1.346 0.414 0 CA-C-N 112.774 -2.012 . . . . 0.0 110.786 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' A' ' 69' ' ' LEU . 84.5 t -150.04 -85.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 117.56 -1.656 . . . . 0.0 110.549 -174.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 31.0 m -49.33 135.8 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.591 -173.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 74' ' ' PHE . 2.5 mptp? -99.21 -179.25 4.18 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.797 -2.001 . . . . 0.0 111.04 -176.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.435 ' CG ' ' O ' ' A' ' 73' ' ' LYS . 19.4 m-85 -158.63 137.17 10.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 111.74 -2.482 . . . . 0.0 108.842 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.502 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 56.6 p30 -62.18 -9.3 7.28 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 113.227 -1.806 . . . . 0.0 112.963 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 42.8 t -179.05 152.57 0.57 Allowed 'General case' 0 C--N 1.349 0.555 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.697 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.518 ' CD2' HG11 ' A' ' 59' ' ' VAL . 77.1 mt -43.14 -43.96 4.8 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 113.184 -1.826 . . . . 0.0 110.212 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -55.3 -39.52 69.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.918 -1.946 . . . . 0.0 110.791 -177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 36.0 tt0 -69.36 -35.12 75.55 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 116.882 -1.927 . . . . 0.0 110.812 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 69' ' ' LEU . 6.5 tt -57.7 -49.09 77.66 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.949 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.6 t -63.58 -40.46 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 112.505 -2.134 . . . . 0.0 110.647 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.43 -44.57 96.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.204 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 87' ' ' THR . 4.1 m-85 -63.84 -42.84 97.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.854 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.422 ' O ' HD12 ' A' ' 97' ' ' LEU . 9.0 m-70 -93.48 41.69 1.09 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 117.684 -1.607 . . . . 0.0 110.294 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -94.54 -41.02 9.56 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.466 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.4 t -101.61 -42.58 6.17 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.279 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 83' ' ' TYR . 12.2 t -70.01 -147.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.441 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 83.6 p -123.81 -151.53 0.48 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.437 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.447 ' O ' ' CZ ' ' A' ' 57' ' ' PHE . 14.9 p -176.18 45.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 113.478 -1.692 . . . . 0.0 109.77 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 92' ' ' ASN . 32.2 t -171.25 -145.74 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.129 -1.85 . . . . 0.0 109.149 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 86.7 mtt180 -63.36 7.81 0.09 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 117.971 -1.492 . . . . 0.0 113.133 177.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 90' ' ' SER . 11.1 m120 64.3 28.33 13.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.824 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -112.3 97.11 6.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.378 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.429 ' O ' HD13 ' A' ' 95' ' ' ILE . 56.6 tp60 43.85 89.66 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 112.925 -1.943 . . . . 0.0 110.031 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 94' ' ' GLN . 14.2 mm -146.28 128.23 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.082 -1.872 . . . . 0.0 109.428 177.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.575 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 88.7 m-85 -149.98 139.58 21.61 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.532 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 84' ' ' HIS . 91.8 mt -89.93 94.87 9.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 117.114 -1.835 . . . . 0.0 109.249 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.492 ' NH1' ' CB ' ' A' ' 98' ' ' ARG . 4.4 ptm85 -105.46 149.07 26.5 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.614 -2.085 . . . . 0.0 109.997 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -47.26 119.55 2.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.309 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CD1' HD23 ' A' ' 33' ' ' LEU . 12.1 tt -70.06 -41.78 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.846 -1.979 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.435 ' N ' HG23 ' A' ' 100' ' ' ILE . 2.5 tm-20 -120.77 125.21 47.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 112.407 -2.178 . . . . 0.0 110.259 -174.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -134.2 117.95 17.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.068 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.634 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -109.25 -62.72 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 112.909 -1.951 . . . . 0.0 110.25 177.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.634 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 34.2 Cg_exo -48.52 130.55 22.05 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.902 1.735 . . . . 0.0 113.07 174.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 104' ' ' PRO . 8.3 mm100 79.67 55.57 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.407 -2.179 . . . . 0.0 110.23 175.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -69.97 152.58 95.87 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 112.836 -1.984 . . . . 0.0 109.254 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.58 ' O ' ' CB ' ' A' ' 108' ' ' THR . 38.0 Cg_endo -73.58 119.78 6.11 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.286 1.99 . . . . 0.0 111.143 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.58 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 15.1 m 103.96 114.88 0.01 OUTLIER 'General case' 0 C--N 1.348 0.536 0 CA-C-N 112.273 -2.24 . . . . 0.0 109.465 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -48.9 117.11 1.91 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.095 -1.866 . . . . 0.0 109.688 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.6 p -100.81 122.14 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 112.942 -1.935 . . . . 0.0 109.757 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -94.73 95.81 8.97 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.606 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 0.398 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.185 179.709 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.01 0 CA-C-O 121.919 0.733 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 3' ' ' GLU . 8.3 tp -72.7 -39.64 60.54 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-N 113.009 -1.596 . . . . 0.0 110.649 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 4' ' ' MET . 0.9 OUTLIER -95.8 118.87 33.28 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.205 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' GLU . 22.4 ttt -42.85 165.64 0.01 OUTLIER 'General case' 0 C--N 1.346 0.416 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.86 -176.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 7.5 ttpm? -43.82 -49.03 21.06 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.519 -176.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 60.5 Cg_endo -81.19 120.14 3.63 Favored 'Trans proline' 0 C--N 1.358 1.059 0 O-C-N 122.624 0.802 . . . . 0.0 111.262 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.617 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 14.4 t-160 -110.98 -43.72 0.09 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 113.01 -1.905 . . . . 0.0 112.162 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.617 ' CD ' ' H ' ' A' ' 7' ' ' HIS . 53.4 Cg_exo -48.99 -121.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.533 1.489 . . . . 0.0 114.571 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.436 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 3.2 p-90 -152.76 21.63 0.6 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.788 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 71.2 m-85 -90.45 115.3 27.51 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 118.452 -1.299 . . . . 0.0 109.115 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 60.6 m-85 -118.03 103.7 10.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.395 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.64 162.9 31.87 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 114.773 -3.584 . . . . 0.0 112.069 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -88.65 110.25 20.8 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 113.155 -1.522 . . . . 0.0 109.059 -6.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.46 HG12 ' CE ' ' A' ' 22' ' ' MET . 10.2 tp -97.96 126.02 41.96 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.523 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.4 Cg_exo -48.36 121.67 6.57 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.661 1.574 . . . . 0.0 112.811 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 15' ' ' PRO . 71.3 ttt180 -38.53 -37.65 0.33 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 113.02 -1.9 . . . . 0.0 111.075 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -68.45 -59.79 2.91 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.635 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 22' ' ' MET . 58.5 tptt -42.01 -42.97 3.01 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.353 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -51.1 -63.46 1.12 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.186 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 24' ' ' SER . 90.3 mt-10 -43.05 -44.77 4.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.576 -2.102 . . . . 0.0 110.236 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 34.1 mt-10 -63.65 -80.59 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 112.907 -1.952 . . . . 0.0 110.588 -173.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.499 ' HE3' ' CD2' ' A' ' 33' ' ' LEU . 25.9 ptt? -48.92 -39.93 28.07 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 113.456 -1.702 . . . . 0.0 110.662 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.503 HD23 ' CG1' ' A' ' 54' ' ' VAL . 38.8 tp -63.97 -32.61 74.21 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 117.726 -1.59 . . . . 0.0 111.474 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 26' ' ' GLN . 44.2 t -68.0 -32.3 72.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 117.662 -1.615 . . . . 0.0 111.267 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -73.15 35.61 0.08 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.111 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.575 ' NE2' ' HA ' ' A' ' 26' ' ' GLN . 4.3 mm-40 -105.08 135.46 46.39 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.814 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.445 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 1.6 mpp_? -98.52 33.11 2.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 112.312 -2.222 . . . . 0.0 111.242 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 74.7 m80 -155.47 103.57 2.32 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.219 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.38 103.6 0.11 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.268 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 152.28 -31.45 0.87 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 117.419 -2.324 . . . . 0.0 112.134 -178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -46.86 141.39 4.03 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.539 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 98' ' ' ARG . 49.1 p90 -141.89 169.96 16.61 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 116.641 -2.023 . . . . 0.0 110.888 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -161.31 150.04 16.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.164 -2.289 . . . . 0.0 109.001 167.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 45' ' ' SER . 49.3 mt -110.11 114.57 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 113.133 -1.849 . . . . 0.0 108.349 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 33.7 ptt85 -90.07 130.48 36.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.041 -170.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -59.9 135.88 57.83 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 111.99 -2.368 . . . . 0.0 109.879 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 43' ' ' ASP . 50.0 m -52.35 119.65 4.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.855 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -50.54 -78.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.109 -1.859 . . . . 0.0 109.434 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -127.46 62.32 1.37 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.547 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -152.34 156.82 33.83 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 113.048 -1.887 . . . . 0.0 109.517 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ALA . 64.3 Cg_exo -44.29 -120.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.769 2.313 . . . . 0.0 114.157 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . -103.51 66.26 0.34 Allowed Glycine 0 C--N 1.346 1.128 0 C-N-CA 118.226 -1.94 . . . . 0.0 110.498 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' O ' ' OG ' ' A' ' 37' ' ' SER . 1.0 OUTLIER -99.43 114.18 26.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.914 -1.643 . . . . 0.0 109.501 178.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.415 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 22.1 m-85 -128.39 124.2 35.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.025 -1.898 . . . . 0.0 109.745 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.2 p -117.99 133.24 56.11 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.007 -1.906 . . . . 0.0 109.662 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.3 tt -94.39 113.92 25.88 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 112.697 -2.047 . . . . 0.0 109.173 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 88.3 p -95.01 148.8 21.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.73 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 73.8 t -146.4 136.06 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.625 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.447 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 60.6 tttp -80.1 106.79 12.38 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 116.482 -2.087 . . . . 0.0 109.756 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 53' ' ' ASP . 49.1 t80 -126.51 114.91 18.75 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 112.553 -2.112 . . . . 0.0 108.863 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -27.43 144.51 0.01 OUTLIER Glycine 0 C--N 1.349 1.287 0 CA-C-N 112.648 -2.069 . . . . 0.0 111.884 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 74.9 m-20 102.53 -52.86 0.0 OUTLIER 'General case' 0 C--N 1.346 0.439 0 CA-C-N 111.52 -2.34 . . . . 0.0 108.189 -166.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 50' ' ' PHE . 56.3 p30 -179.64 -161.08 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 111.396 -2.638 . . . . 0.0 110.194 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.503 ' CG1' HD23 ' A' ' 23' ' ' LEU . 91.4 t -96.93 124.63 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.703 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -95.86 160.63 14.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.797 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -141.42 143.74 34.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.708 -2.042 . . . . 0.0 110.129 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -128.65 102.39 6.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.744 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -58.4 108.47 0.63 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.99 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' CD2' ' A' ' 77' ' ' LEU . 60.7 t -81.38 78.28 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 112.981 -1.918 . . . . 0.0 108.423 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 91.2 mt -83.66 172.49 12.24 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 112.417 -2.174 . . . . 0.0 109.845 -174.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.1 ptm180 -145.95 -148.74 0.25 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 116.463 -2.095 . . . . 0.0 109.476 172.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 61' ' ' ARG . 24.4 t0 58.72 150.78 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.35 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.26 35.16 0.42 Allowed Glycine 0 CA--C 1.534 1.268 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.712 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.17 -42.18 0.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.045 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 66' ' ' LYS . . . 118.62 62.41 0.29 Allowed Glycine 0 C--N 1.347 1.149 0 C-N-CA 118.548 -1.787 . . . . 0.0 109.54 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HZ3' ' C ' ' A' ' 74' ' ' PHE . 8.4 mtmp? 82.82 -150.89 0.01 OUTLIER 'General case' 0 C--N 1.347 0.489 0 CA-C-N 112.307 -1.946 . . . . 0.0 109.272 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 88.5 m-85 -71.93 158.12 36.6 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.723 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 72' ' ' VAL . 55.1 t80 -152.62 156.85 40.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.62 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.607 HD13 HD11 ' A' ' 80' ' ' LEU . 33.3 tp -124.49 -66.84 0.95 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.449 -2.159 . . . . 0.0 109.826 -169.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.459 ' CD2' ' O ' ' A' ' 69' ' ' LEU . 27.7 m95 -147.09 -37.13 0.22 Allowed 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.101 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.416 ' C ' ' CE2' ' A' ' 68' ' ' PHE . 59.7 t -125.89 -37.59 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.471 0 C-N-CA 117.208 -1.797 . . . . 0.0 111.299 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 33.8 m -130.6 171.81 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 117.463 -1.695 . . . . 0.0 110.155 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.697 ' CD ' ' H ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -98.49 173.9 6.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.026 179.11 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.594 ' C ' ' HZ3' ' A' ' 66' ' ' LYS . 1.3 m-85 -145.6 132.27 19.93 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 117.063 -1.855 . . . . 0.0 109.551 -175.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' SER . 4.9 p-10 -86.66 25.67 1.22 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.617 -2.083 . . . . 0.0 112.214 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.2 t 175.69 130.85 0.04 OUTLIER 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.971 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.511 ' CD2' HG11 ' A' ' 59' ' ' VAL . 85.1 mt -47.71 -41.12 22.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 116.879 -1.929 . . . . 0.0 109.998 174.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 82' ' ' ASP . 39.7 m-80 -60.67 -30.98 70.24 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 113.533 -1.667 . . . . 0.0 111.659 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 83' ' ' TYR . 10.2 tp10 -66.45 -26.39 67.18 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 117.114 -1.835 . . . . 0.0 111.694 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 69' ' ' LEU . 10.4 tt -83.71 -53.12 5.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.384 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.59 -44.76 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 112.644 -2.071 . . . . 0.0 109.711 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 78' ' ' ASN . 25.1 t0 -63.62 -63.67 1.11 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.076 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.434 ' CB ' ' O ' ' A' ' 79' ' ' GLU . 38.7 t80 -48.76 -42.04 34.22 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.445 -176.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.457 ' HE2' ' HZ ' ' A' ' 74' ' ' PHE . 92.4 m-70 -100.15 44.14 1.03 Allowed 'General case' 0 C--N 1.345 0.393 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.088 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -86.08 -40.46 15.71 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.491 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 88' ' ' SER . 39.1 t -112.59 -36.6 5.17 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.73 -1.577 . . . . 0.0 111.048 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -77.47 42.79 0.37 Allowed 'General case' 0 C--N 1.346 0.453 0 C-N-CA 118.044 -1.463 . . . . 0.0 110.797 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 86' ' ' SER . 45.0 m 49.93 -149.77 0.24 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.912 170.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 90' ' ' SER . 6.4 p -176.9 -41.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.434 0 CA-C-N 113.393 -1.731 . . . . 0.0 110.337 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.404 ' N ' HG13 ' A' ' 89' ' ' VAL . 41.5 t -83.32 147.97 27.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.648 -1.614 . . . . 0.0 109.503 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.646 ' HD2' ' H ' ' A' ' 91' ' ' ARG . 2.2 mpt_? -41.26 -42.25 2.09 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.402 -1.726 . . . . 0.0 110.192 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -67.22 96.47 0.47 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 117.097 -1.841 . . . . 0.0 108.369 172.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 86.1 mm-40 -69.88 93.37 0.76 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.746 -175.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 93' ' ' GLN . 21.1 pt20 176.81 43.35 0.0 OUTLIER 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.135 -2.302 . . . . 0.0 109.685 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 34.5 mm -114.75 145.68 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.858 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.54 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 65.3 t80 -135.11 132.16 37.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.865 -1.97 . . . . 0.0 109.338 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.01 101.87 14.58 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 117.304 -1.758 . . . . 0.0 109.406 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.729 ' HE ' ' H ' ' A' ' 99' ' ' ASP . 5.1 tpm_? -97.3 151.76 19.57 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 112.602 -2.09 . . . . 0.0 109.976 -176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.729 ' H ' ' HE ' ' A' ' 98' ' ' ARG . 51.8 p-10 -72.59 33.66 0.07 Allowed 'General case' 0 C--N 1.346 0.428 0 CA-C-N 113.073 -1.876 . . . . 0.0 112.196 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.601 HG12 ' H ' ' A' ' 101' ' ' GLU . 10.8 tt 40.9 -143.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.133 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 100' ' ' ILE . 85.5 mt-10 -92.13 42.64 1.11 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.369 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 7' ' ' HIS . 36.6 tp60 -133.19 108.6 8.89 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 117.579 -1.648 . . . . 0.0 109.765 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.508 ' CG1' ' HG2' ' A' ' 105' ' ' GLN . 7.1 p -179.05 136.64 0.31 Allowed Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 113.127 -1.851 . . . . 0.0 109.775 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 105' ' ' GLN . 42.3 Cg_exo -51.05 1.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.293 1.996 . . . . 0.0 116.296 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.508 ' HG2' ' CG1' ' A' ' 103' ' ' VAL . 30.0 mm100 -37.02 121.96 0.82 Allowed 'General case' 0 C--N 1.348 0.501 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.749 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -104.61 152.61 39.45 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 112.583 -2.099 . . . . 0.0 109.689 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 108' ' ' THR . 32.1 Cg_endo -68.26 123.72 10.89 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.827 2.351 . . . . 0.0 111.222 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 107' ' ' PRO . 91.5 m -32.59 121.48 0.34 Allowed 'General case' 0 C--N 1.348 0.501 0 CA-C-N 112.623 -2.08 . . . . 0.0 111.12 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.416 ' HB3' ' OE1' ' A' ' 111' ' ' GLN . 83.9 m-85 -56.5 123.9 16.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.784 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.3 p -109.55 120.7 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.706 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.592 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 4.1 mp0 -125.01 -157.24 0.77 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.304 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.592 ' CB ' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.349 0.554 0 CA-C-N 112.509 -2.132 . . . . 0.0 109.171 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.007 0 CA-C-O 121.887 0.715 . . . . 0.0 112.046 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 2' ' ' ILE . 15.8 tt -165.63 122.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.004 -1.598 . . . . 0.0 109.645 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 3' ' ' GLU . 23.7 pt-20 -105.38 58.78 0.67 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.743 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 5' ' ' LYS . 39.5 ttm -46.08 152.22 0.41 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 112.83 -1.987 . . . . 0.0 109.583 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 4' ' ' MET . 87.7 tttt -40.99 135.22 1.68 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.951 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -44.76 119.98 2.59 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.001 1.801 . . . . 0.0 113.187 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.481 ' O ' ' O ' ' A' ' 8' ' ' PRO . 57.8 t60 -66.14 137.09 95.59 Favored Pre-proline 0 C--N 1.346 0.451 0 CA-C-N 112.959 -1.928 . . . . 0.0 109.159 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 7' ' ' HIS . 77.8 Cg_exo -43.07 -120.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.603 2.202 . . . . 0.0 114.403 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.44 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 2.6 p-90 -154.54 22.6 0.47 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.487 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.44 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 91.2 m-85 -90.48 119.48 30.79 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.843 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.54 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 32.7 m-85 -115.98 89.72 3.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.341 -1.754 . . . . 0.0 108.953 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -36.62 -106.67 0.01 OUTLIER Glycine 0 C--N 1.346 1.108 0 CA-C-N 111.979 -2.373 . . . . 0.0 112.918 -171.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 14.7 ptmm? -95.3 67.38 2.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.415 -173.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.428 HG22 ' CB ' ' A' ' 35' ' ' ARG . 6.3 tp -95.87 128.51 37.24 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 116.996 -1.882 . . . . 0.0 107.603 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.414 ' HG2' ' CB ' ' A' ' 18' ' ' LYS . 20.7 Cg_endo -66.54 -157.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 O-C-N 123.614 1.323 . . . . 0.0 111.496 -172.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 25.7 ttm180 -94.94 -49.94 5.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.629 -1.623 . . . . 0.0 108.884 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -48.42 -71.68 0.06 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 112.59 -2.096 . . . . 0.0 108.946 174.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.417 ' HG2' HD11 ' A' ' 14' ' ' ILE . 54.4 tptt -43.51 -56.23 3.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.588 -2.097 . . . . 0.0 110.725 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.39 -44.3 24.24 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 116.701 -2.0 . . . . 0.0 110.093 -178.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.579 ' O ' ' CB ' ' A' ' 24' ' ' SER . 95.1 mt-10 -66.98 -37.39 84.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.042 -1.89 . . . . 0.0 111.264 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 47.6 mt-10 -67.8 -80.27 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 117.365 -1.734 . . . . 0.0 110.478 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.616 ' HE3' ' CD2' ' A' ' 33' ' ' LEU . 23.6 ptt? -44.34 -39.76 4.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.7 -175.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' A' ' 25' ' ' LYS . 39.4 tp -72.73 -36.64 67.8 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 116.618 -2.033 . . . . 0.0 111.178 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 48.3 t -73.59 29.51 0.07 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 116.971 -1.892 . . . . 0.0 111.735 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 23' ' ' LEU . 55.4 mtpt -134.88 44.05 2.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.59 177.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 26.5 mm-40 -112.16 144.25 41.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.291 -1.777 . . . . 0.0 110.142 -174.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 28' ' ' HIS . 87.2 mtt180 -83.97 85.06 7.38 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 112.085 -2.325 . . . . 0.0 110.715 -172.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.424 ' HB3' ' O ' ' A' ' 27' ' ' ARG . 1.8 t-80 80.62 -45.64 0.26 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.199 -2.273 . . . . 0.0 110.904 173.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' LYS . 35.6 m-20 -47.42 166.08 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 111.905 -2.407 . . . . 0.0 108.199 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 96' ' ' PHE . . . 107.73 -39.51 2.86 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.552 1.072 . . . . 0.0 110.582 7.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -68.73 149.03 49.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 118.475 -1.29 . . . . 0.0 109.182 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' SER . 41.6 p90 -146.26 162.34 38.31 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 116.475 -2.09 . . . . 0.0 111.033 -172.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.616 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 4.5 pp -149.61 148.85 29.82 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.49 -2.141 . . . . 0.0 109.335 170.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 44' ' ' PHE . 58.2 mt -113.74 111.6 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.651 -2.068 . . . . 0.0 108.444 174.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 11.6 ptm180 -95.85 136.12 36.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.446 -2.161 . . . . 0.0 110.934 -170.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 12' ' ' GLY . 68.6 tt0 -82.6 125.74 31.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.126 -2.306 . . . . 0.0 109.449 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 47.7 t -59.22 132.66 54.68 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.762 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -42.27 -42.91 3.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.616 -2.084 . . . . 0.0 110.356 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 49.1 m -144.98 71.22 1.29 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 113.44 -1.709 . . . . 0.0 110.26 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 179.05 101.35 0.16 Allowed Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 112.898 -1.956 . . . . 0.0 109.113 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.3 -4.07 14.77 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.719 1.613 . . . . 0.0 115.185 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.29 40.2 2.61 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 118.731 -1.7 . . . . 0.0 110.895 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.458 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 9.5 t0 -143.23 106.55 4.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.959 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.521 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 23.2 m-85 -133.96 107.01 7.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.433 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 80.3 p -104.73 126.55 51.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.906 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.458 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.3 tt -90.76 114.9 27.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.318 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 98.2 p -96.97 147.18 24.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.081 -1.872 . . . . 0.0 110.017 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 60.2 t -145.12 134.49 18.12 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.284 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' ASP . 13.7 tptp -76.31 96.62 4.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 112.654 -2.066 . . . . 0.0 108.417 174.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CZ ' ' CG ' ' A' ' 92' ' ' ASN . 14.4 t80 -71.51 -44.03 65.41 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 117.17 -1.812 . . . . 0.0 110.703 -173.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.92 -69.89 0.03 OUTLIER Glycine 0 CA--C 1.527 0.83 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.265 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -116.28 -25.86 7.39 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 111.927 -2.137 . . . . 0.0 111.816 176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.05 153.63 29.09 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 118.397 -1.321 . . . . 0.0 110.291 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 20' ' ' GLU . 74.8 t -79.59 131.28 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 112.41 -2.177 . . . . 0.0 109.569 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.453 ' OE1' ' CZ ' ' A' ' 57' ' ' PHE . 31.8 tt0 -101.51 164.47 11.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.674 -2.057 . . . . 0.0 109.868 -176.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 55' ' ' GLN . 42.1 m80 -150.06 140.54 22.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.007 -1.906 . . . . 0.0 110.723 -176.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 23.3 m-85 -135.88 111.98 9.66 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.381 173.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 37.9 mtmm -74.5 116.06 14.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 116.886 -1.925 . . . . 0.0 109.837 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.522 HG11 ' CD2' ' A' ' 77' ' ' LEU . 48.2 t -81.47 107.83 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 112.829 -1.987 . . . . 0.0 108.036 173.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 84.9 mt -96.68 162.2 13.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.162 -164.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.588 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 34.9 tpt85 74.46 -132.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 111.129 -2.759 . . . . 0.0 109.829 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 40.2 t0 100.01 88.14 0.01 OUTLIER 'General case' 0 C--N 1.347 0.487 0 O-C-N 125.405 1.69 . . . . 0.0 109.433 -175.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.66 -41.22 0.56 Allowed Glycine 0 CA--C 1.533 1.162 0 C-N-CA 117.905 -2.093 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.415 ' CB ' ' NH2' ' A' ' 61' ' ' ARG . . . -125.84 -48.16 1.65 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.2 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' LYS . . . -104.96 28.21 15.66 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.112 175.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.518 ' HZ2' ' HB3' ' A' ' 66' ' ' LYS . 5.8 mtpm? 35.93 -140.29 0.02 OUTLIER 'General case' 0 C--N 1.351 0.655 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.41 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.517 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 26.7 m-85 -95.0 130.52 41.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.975 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 11.9 p90 -149.13 138.14 21.36 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 116.048 -2.261 . . . . 0.0 110.726 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 9.9 mt -81.33 -45.64 15.88 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 112.425 -2.17 . . . . 0.0 109.563 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -129.13 -86.19 0.55 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.188 -1.823 . . . . 0.0 109.934 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -106.87 -84.48 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.188 -1.824 . . . . 0.0 109.555 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.7 m -50.32 130.27 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.915 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 65' ' ' GLY . 11.4 mptt -81.67 -169.48 2.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 112.819 -1.991 . . . . 0.0 109.93 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -148.13 134.49 19.56 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.421 -2.172 . . . . 0.0 108.7 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' O ' ' OG ' ' A' ' 76' ' ' SER . 17.9 m-20 -58.16 -22.26 50.59 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.153 -1.839 . . . . 0.0 112.336 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 50.3 m -168.04 161.33 12.61 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.953 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.522 ' CD2' HG11 ' A' ' 59' ' ' VAL . 86.3 mt -45.6 -40.88 9.41 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 117.34 -1.744 . . . . 0.0 110.318 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -54.07 -38.25 65.07 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.068 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.4 OUTLIER -69.91 -28.17 65.39 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.51 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 80' ' ' LEU . 9.0 tt -67.59 -49.86 61.1 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.819 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.3 -37.03 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 112.538 -2.119 . . . . 0.0 110.86 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.31 -35.97 71.46 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.145 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -55.29 -46.05 76.22 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 117.845 -1.542 . . . . 0.0 109.746 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.486 ' C ' ' H ' ' A' ' 86' ' ' SER . 52.1 t60 -63.79 -9.38 14.31 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.646 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 4.1 tpm_? -78.98 46.82 0.72 Allowed 'General case' 0 C--N 1.349 0.567 0 C-N-CA 117.799 -1.56 . . . . 0.0 109.402 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 84' ' ' HIS . 40.4 t -147.15 -41.44 0.18 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.787 -2.006 . . . . 0.0 110.248 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 t -149.16 -146.61 0.2 Allowed 'General case' 0 C--N 1.347 0.488 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.604 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.7 p -92.42 167.55 11.89 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 113.897 -1.501 . . . . 0.0 109.636 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.49 HG23 ' CB ' ' A' ' 90' ' ' SER . 11.8 m -73.32 -33.12 39.97 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 C-N-CA 117.103 -1.839 . . . . 0.0 111.587 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.49 ' CB ' HG23 ' A' ' 89' ' ' VAL . 13.4 t -149.12 178.87 8.34 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.924 -165.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 90' ' ' SER . 16.5 mmm180 -37.66 -40.82 0.44 Allowed 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.767 -2.015 . . . . 0.0 110.935 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.453 ' HB2' HD11 ' A' ' 95' ' ' ILE . 12.8 m120 -67.88 92.83 0.37 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 117.354 -1.738 . . . . 0.0 109.47 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 94' ' ' GLN . 80.7 mt-30 -71.06 75.15 0.66 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.968 -1.923 . . . . 0.0 109.757 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.423 ' O ' ' HG3' ' A' ' 94' ' ' GLN . 53.7 tp60 -179.71 47.13 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 112.872 -1.967 . . . . 0.0 109.176 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' A' ' 92' ' ' ASN . 68.9 mt -133.0 128.02 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.979 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.461 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 45.2 t80 -127.17 139.83 52.67 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.922 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.7 mt -91.58 105.1 17.49 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.797 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.452 ' CZ ' ' H ' ' A' ' 99' ' ' ASP . 4.1 tpm_? -108.63 158.32 17.7 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.178 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.452 ' H ' ' CZ ' ' A' ' 98' ' ' ARG . 57.8 p30 -60.3 145.38 47.8 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 117.535 -1.666 . . . . 0.0 109.447 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.54 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 7.1 tt -99.45 29.27 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 113.076 -1.874 . . . . 0.0 111.937 -175.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -150.1 115.88 5.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 117.616 -1.633 . . . . 0.0 110.065 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -144.72 117.83 8.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.163 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.513 HG23 ' HD3' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -155.24 -63.01 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.787 -178.511 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.513 ' HD3' HG23 ' A' ' 103' ' ' VAL . 58.6 Cg_exo -43.68 117.18 1.07 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 121.901 1.734 . . . . 0.0 113.686 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 104' ' ' PRO . 88.5 mt-30 -158.91 77.26 0.74 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 112.818 -1.992 . . . . 0.0 109.304 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.725 ' H ' ' CD ' ' A' ' 107' ' ' PRO . 75.0 mt-30 -126.4 -44.48 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 113.066 -1.879 . . . . 0.0 112.339 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.725 ' CD ' ' H ' ' A' ' 106' ' ' GLN . 51.5 Cg_exo -50.56 119.69 5.46 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 120.975 1.117 . . . . 0.0 113.495 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 107' ' ' PRO . 91.3 m 53.95 106.92 0.01 OUTLIER 'General case' 0 C--N 1.346 0.435 0 CA-C-N 112.74 -2.027 . . . . 0.0 109.934 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 108' ' ' THR . 70.3 t80 -179.07 114.76 0.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.99 -1.913 . . . . 0.0 109.57 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 110' ' ' VAL . 8.0 p -74.39 123.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 113.146 -1.843 . . . . 0.0 109.971 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -167.12 121.23 1.01 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.014 -1.903 . . . . 0.0 109.714 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.423 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.649 179.791 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.997 0 CA-C-O 121.937 0.743 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 3' ' ' GLU . 48.6 mm -52.0 -41.43 31.6 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 112.926 -1.637 . . . . 0.0 110.357 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 2' ' ' ILE . 40.9 tp10 61.07 121.95 0.01 OUTLIER 'General case' 0 C--N 1.347 0.483 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.604 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.586 ' C ' ' SD ' ' A' ' 4' ' ' MET . 0.2 OUTLIER -80.98 102.15 9.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.066 -1.879 . . . . 0.0 109.604 -178.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 4' ' ' MET . 6.2 pttp 53.27 152.74 0.05 OUTLIER Pre-proline 0 C--N 1.346 0.436 0 CA-C-N 112.428 -2.169 . . . . 0.0 110.959 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.471 ' HB3' ' CD ' ' A' ' 104' ' ' PRO . 39.1 Cg_endo -72.93 122.43 8.13 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.935 2.423 . . . . 0.0 111.605 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -46.21 133.68 7.34 Favored Pre-proline 0 C--N 1.346 0.443 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.092 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.429 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 58.4 Cg_endo -74.83 -117.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.99 1.793 . . . . 0.0 110.857 -174.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.502 ' CB ' ' CE2' ' A' ' 32' ' ' PHE . 37.7 p-90 -139.08 38.55 2.13 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.709 -174.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -121.91 115.09 21.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 117.812 -1.555 . . . . 0.0 110.162 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.434 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 18.7 m-85 -124.05 108.19 12.1 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.057 176.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -61.33 112.03 4.38 Favored Glycine 0 C--N 1.345 1.075 0 C-N-CA 118.127 -1.987 . . . . 0.0 111.127 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 36' ' ' GLU . 23.3 pttp 25.57 47.29 0.01 OUTLIER 'General case' 0 C--N 1.346 0.414 0 CA-C-N 111.481 -2.359 . . . . 0.0 111.472 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.7 tp -60.21 131.64 89.97 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.928 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.9 Cg_exo -45.52 122.54 4.87 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.742 1.628 . . . . 0.0 112.983 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.573 ' CB ' HH12 ' A' ' 35' ' ' ARG . 53.2 ttp180 -38.86 -41.24 0.72 Allowed 'General case' 0 C--N 1.345 0.388 0 CA-C-N 112.885 -1.961 . . . . 0.0 110.626 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -54.21 -79.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 113.345 -1.752 . . . . 0.0 109.442 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HG3' ' HE2' ' A' ' 22' ' ' MET . 28.1 tptp -37.91 -39.88 0.41 Allowed 'General case' 0 C--N 1.346 0.442 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.969 -177.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.94 -65.76 0.54 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 117.595 -1.642 . . . . 0.0 109.209 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 24' ' ' SER . 46.7 mt-10 -42.77 -41.01 3.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.696 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 22' ' ' MET . 65.5 mt-10 -62.58 -90.56 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 113.567 -1.652 . . . . 0.0 110.758 -173.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.564 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 5.6 ptp -42.6 -38.32 1.96 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.995 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.543 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 45.6 tp -68.03 -41.92 81.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 117.654 -1.619 . . . . 0.0 110.801 -176.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 26' ' ' GLN . 77.3 p -62.72 -36.91 84.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 117.402 -1.719 . . . . 0.0 110.706 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -69.38 30.73 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.534 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.553 ' H ' ' C ' ' A' ' 24' ' ' SER . 35.2 mm-40 -104.14 142.46 34.45 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 117.786 -1.565 . . . . 0.0 109.247 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 28' ' ' HIS . 2.0 mpt_? -79.05 44.28 0.56 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.883 -177.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.484 ' H ' ' HG2' ' A' ' 49' ' ' LYS . 0.9 OUTLIER 47.05 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.708 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -162.39 33.32 0.11 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.092 -1.867 . . . . 0.0 111.493 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.567 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 70.0 -1.98 15.17 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 116.576 -2.726 . . . . 0.0 113.241 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.401 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -46.23 134.56 8.56 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 118.297 -1.361 . . . . 0.0 108.899 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.502 ' CE2' ' CB ' ' A' ' 9' ' ' TRP . 15.3 p90 -150.77 163.23 39.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 115.897 -2.321 . . . . 0.0 111.087 -173.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.487 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.6 pp -149.92 146.66 27.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.172 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.44 109.87 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.844 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.573 HH12 ' CB ' ' A' ' 16' ' ' ARG . 27.7 ptt180 -92.1 126.31 37.13 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 112.022 -2.354 . . . . 0.0 110.167 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 67.4 tt0 -67.98 129.61 40.44 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.445 -2.161 . . . . 0.0 109.781 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 43' ' ' ASP . 73.5 m -67.12 129.88 41.32 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.501 178.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.649 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 2.3 mp0 -38.41 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 112.423 -2.171 . . . . 0.0 110.644 -176.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 40' ' ' ALA . 37.1 t -89.94 -29.54 18.43 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.086 -172.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -44.06 148.95 0.73 Allowed Pre-proline 0 C--N 1.348 0.538 0 C-N-CA 117.921 -1.512 . . . . 0.0 110.09 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -74.65 -8.62 20.63 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.934 2.423 . . . . 0.0 116.081 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.22 33.34 0.02 OUTLIER Glycine 0 CA--C 1.537 1.415 0 C-N-CA 118.611 -1.757 . . . . 0.0 111.68 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.474 ' O ' ' OG ' ' A' ' 37' ' ' SER . 1.3 m-20 -89.91 132.5 35.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 118.284 -1.366 . . . . 0.0 109.568 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.411 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 91.8 m-85 -143.62 132.34 22.54 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.59 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 99.7 p -119.15 138.17 53.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.492 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 46' ' ' LEU . 5.4 tt -101.04 116.3 32.52 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 113.083 -1.871 . . . . 0.0 110.008 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.543 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 40.6 m -98.38 139.21 34.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.148 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -138.55 148.47 24.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.128 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.573 ' HZ3' ' C ' ' A' ' 52' ' ' ASN . 24.2 tptp -79.0 106.11 10.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.98 -1.918 . . . . 0.0 108.775 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' O ' ' CE1' ' A' ' 28' ' ' HIS . 7.4 t80 -76.28 -102.73 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 116.784 -1.966 . . . . 0.0 109.071 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -99.1 -69.39 0.92 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.751 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.573 ' C ' ' HZ3' ' A' ' 49' ' ' LYS . 25.6 t-20 -121.46 -23.26 5.69 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 111.917 -2.141 . . . . 0.0 112.174 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.27 158.54 18.28 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 118.404 -1.319 . . . . 0.0 110.32 -174.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 24' ' ' SER . 95.2 t -80.69 118.85 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.4 -2.182 . . . . 0.0 109.678 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -102.78 158.2 16.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.718 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.3 143.18 47.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.57 -2.104 . . . . 0.0 110.598 -175.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -129.57 100.64 5.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.494 -2.139 . . . . 0.0 108.795 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 51.2 mtmt -67.56 113.06 5.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 112.984 -1.916 . . . . 0.0 110.345 -174.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.523 HG11 ' CD2' ' A' ' 77' ' ' LEU . 58.8 t -74.04 83.59 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 112.522 -2.126 . . . . 0.0 108.633 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 79.0 mt -72.88 161.02 31.22 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 112.799 -2.001 . . . . 0.0 110.703 -173.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.702 HH11 ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -143.65 164.92 29.07 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.006 -2.361 . . . . 0.0 109.227 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.567 ' H ' ' HG2' ' A' ' 61' ' ' ARG . 52.3 m-20 102.28 -151.69 0.0 OUTLIER 'General case' 0 C--N 1.348 0.517 0 CA-C-N 112.218 -2.265 . . . . 0.0 108.949 -173.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 -54.64 4.57 Favored Glycine 0 C--N 1.346 1.116 0 C-N-CA 118.157 -1.973 . . . . 0.0 110.436 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.494 ' CB ' ' NZ ' ' A' ' 73' ' ' LYS . . . -141.98 -45.73 0.35 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 112.839 -1.681 . . . . 0.0 109.296 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' O ' ' HE2' ' A' ' 66' ' ' LYS . . . 151.67 27.5 0.05 OUTLIER Glycine 0 CA--C 1.538 1.523 0 C-N-CA 117.655 -2.212 . . . . 0.0 112.679 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HA ' ' HZ3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -137.21 -161.36 1.16 Allowed 'General case' 0 C--N 1.348 0.538 0 C-N-CA 117.952 -1.499 . . . . 0.0 109.545 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 87.5 m-85 -117.55 150.32 39.16 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.939 -1.937 . . . . 0.0 109.301 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -166.01 144.37 5.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.573 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.634 HD22 ' H ' ' A' ' 69' ' ' LEU . 2.5 mm? -65.05 -52.79 53.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 116.714 -1.994 . . . . 0.0 109.043 176.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 10.7 m0 -139.75 -45.0 0.44 Allowed 'General case' 0 C--N 1.345 0.413 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.013 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 77.8 t -129.23 -81.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 112.965 -1.925 . . . . 0.0 110.175 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -50.17 133.75 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 112.614 -2.085 . . . . 0.0 110.275 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.494 ' NZ ' ' CB ' ' A' ' 64' ' ' ALA . 94.0 mttt -93.36 160.9 14.61 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.464 -176.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -133.88 137.8 45.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 111.936 -2.393 . . . . 0.0 109.444 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -62.61 -34.57 77.3 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 112.712 -2.04 . . . . 0.0 110.989 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 77' ' ' LEU . 42.1 t -153.29 152.79 31.55 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 118.278 -1.369 . . . . 0.0 109.888 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.523 ' CD2' HG11 ' A' ' 59' ' ' VAL . 76.0 mt -39.28 -40.42 0.76 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.823 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -48.67 -42.47 34.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.316 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -73.42 -34.1 65.29 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 115.729 -2.388 . . . . 0.0 110.893 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.496 HD23 ' C ' ' A' ' 80' ' ' LEU . 6.9 tt -56.78 -46.38 81.53 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.234 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' LEU . 96.0 t -63.16 -40.56 89.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 112.801 -1.999 . . . . 0.0 110.904 -177.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -71.33 -40.02 71.01 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.895 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -56.53 -41.07 76.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.449 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -93.15 40.07 1.06 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.677 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -107.45 -13.18 15.15 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.663 -1.608 . . . . 0.0 112.693 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.4 t -132.25 -42.15 0.98 Allowed 'General case' 0 C--N 1.351 0.635 0 C-N-CA 117.982 -1.487 . . . . 0.0 110.296 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 88' ' ' SER . 62.0 p -89.76 37.43 0.88 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.618 -1.628 . . . . 0.0 111.082 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' THR . 34.1 t 41.97 -165.71 0.01 OUTLIER 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.136 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 89' ' ' VAL . 12.8 p -147.71 47.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.582 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 45.5 t 179.1 142.84 0.12 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.805 -1.998 . . . . 0.0 109.512 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 90' ' ' SER . 8.7 ptm180 -41.51 -42.48 2.39 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.371 -1.74 . . . . 0.0 110.372 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.24 94.33 1.98 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.629 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 94' ' ' GLN . 48.9 mt-30 -69.86 100.06 1.49 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.949 -1.932 . . . . 0.0 109.893 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 31.1 tt0 -178.89 45.41 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 112.34 -2.209 . . . . 0.0 109.429 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 88' ' ' SER . 44.7 mt -138.9 153.87 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 113.115 -1.857 . . . . 0.0 109.579 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.567 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 88.2 m-85 -149.99 179.86 7.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.684 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.3 mt -125.03 108.46 11.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 112.854 -1.975 . . . . 0.0 109.182 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 17.4 mmm180 -125.0 154.37 41.35 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.872 -1.967 . . . . 0.0 109.88 -177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 101' ' ' GLU . 58.6 t0 -52.72 118.76 3.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.62 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.487 ' CD1' HD23 ' A' ' 33' ' ' LEU . 11.6 tt -71.99 29.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.774 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 99' ' ' ASP . 12.3 mm-40 -150.17 129.19 12.63 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.681 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -43.15 129.64 4.63 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.017 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.3 p -68.44 135.37 90.83 Favored Pre-proline 0 C--N 1.346 0.421 0 CA-C-N 112.812 -1.994 . . . . 0.0 109.329 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.471 ' CD ' ' HB3' ' A' ' 6' ' ' PRO . 37.1 Cg_endo -70.5 125.08 11.38 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.367 2.045 . . . . 0.0 111.653 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 104' ' ' PRO . 70.2 mt-30 88.54 121.51 0.03 OUTLIER 'General case' 0 C--N 1.346 0.428 0 CA-C-N 112.357 -2.201 . . . . 0.0 109.959 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -101.99 155.33 36.57 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 112.899 -1.955 . . . . 0.0 109.499 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' O ' ' HB ' ' A' ' 108' ' ' THR . 50.3 Cg_exo -46.94 121.16 4.75 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.373 2.049 . . . . 0.0 113.43 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 107' ' ' PRO . 78.4 m 63.51 123.24 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.895 -1.957 . . . . 0.0 109.989 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -127.3 119.9 27.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.856 -1.975 . . . . 0.0 109.574 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.539 ' O ' ' CG ' ' A' ' 111' ' ' GLN . 7.8 p -147.88 123.47 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.728 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 110' ' ' VAL . 11.7 pt20 52.65 144.84 0.0 OUTLIER 'General case' 0 C--N 1.348 0.508 0 CA-C-N 112.41 -2.177 . . . . 0.0 111.633 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.553 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.739 4.378 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 2' ' ' ILE . . . . . . . . 0 CA--C 1.531 1.04 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.518 ' C ' HD12 ' A' ' 2' ' ' ILE . 2.5 pp -79.0 -159.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-N 114.177 -1.012 . . . . 0.0 109.872 -0.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.571 ' HG3' HE22 ' A' ' 105' ' ' GLN . 24.4 pt-20 -119.54 121.53 39.58 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.722 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.0 mtm -73.29 149.83 42.4 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 112.882 -1.963 . . . . 0.0 109.455 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.85 154.34 0.44 Allowed Pre-proline 0 C--N 1.346 0.43 0 CA-C-N 113.193 -1.821 . . . . 0.0 109.499 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.25 119.99 6.97 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.213 1.942 . . . . 0.0 111.354 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' PRO . 57.8 t60 -84.16 135.55 41.79 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 113.155 -1.839 . . . . 0.0 109.194 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 7' ' ' HIS . 64.5 Cg_exo -44.39 -121.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.436 2.091 . . . . 0.0 114.283 177.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' CZ ' ' A' ' 10' ' ' PHE . 5.2 p-90 -159.2 17.59 0.18 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.511 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.439 ' CZ ' ' CH2' ' A' ' 9' ' ' TRP . 96.8 m-85 -85.82 109.21 18.52 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.676 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 56.0 m-85 -97.53 95.8 7.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.866 -1.97 . . . . 0.0 108.853 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -49.65 105.62 0.17 Allowed Glycine 0 C--N 1.345 1.077 0 CA-C-N 112.797 -2.002 . . . . 0.0 111.254 -173.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 12' ' ' GLY . 63.4 pttt 30.51 42.07 0.01 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 111.459 -2.37 . . . . 0.0 111.193 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.437 HG12 ' CE ' ' A' ' 22' ' ' MET . 9.3 tp -56.51 134.85 77.12 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 113.373 -1.74 . . . . 0.0 108.727 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.8 Cg_exo -44.74 121.23 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.807 1.671 . . . . 0.0 112.911 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' PRO . 74.6 ttt180 -37.28 -37.12 0.17 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.268 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -69.79 -63.24 1.11 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.766 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.461 ' HG3' ' CE ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -42.78 -42.19 3.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.458 -177.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -48.07 -58.63 4.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.1 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 91.2 mt-10 -49.1 -45.06 42.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 112.392 -2.185 . . . . 0.0 110.068 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 35.5 mt-10 -59.08 -81.17 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.799 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.461 ' CE ' ' HG3' ' A' ' 18' ' ' LYS . 9.8 ptp -50.82 -41.17 57.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 116.491 -2.084 . . . . 0.0 110.422 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.459 ' O ' ' CG ' ' A' ' 26' ' ' GLN . 39.3 tp -62.27 -26.96 68.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 117.725 -1.59 . . . . 0.0 112.531 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.545 ' C ' ' H ' ' A' ' 26' ' ' GLN . 93.3 p -71.84 -29.06 64.0 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 117.803 -1.559 . . . . 0.0 111.733 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -72.28 37.19 0.07 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.819 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 24' ' ' SER . 29.1 mm-40 -119.27 19.52 12.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 117.86 -1.536 . . . . 0.0 113.095 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 28' ' ' HIS . 58.2 mmm-85 20.37 58.25 0.02 OUTLIER 'General case' 0 C--N 1.349 0.555 0 O-C-N 125.215 1.572 . . . . 0.0 111.952 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 27' ' ' ARG . 72.5 t60 43.53 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.015 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 55.0 m-20 -157.71 29.06 0.27 Allowed 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.858 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 78.16 -9.34 33.5 Favored Glycine 0 CA--C 1.542 1.777 0 C-N-CA 115.969 -3.015 . . . . 0.0 113.147 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.409 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -44.98 120.74 2.48 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.055 177.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.492 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 14.0 p90 -126.14 151.2 47.6 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 116.638 -2.025 . . . . 0.0 111.716 -173.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.583 ' HB3' ' H ' ' A' ' 47' ' ' SER . 0.6 OUTLIER -114.53 146.75 40.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 110.892 -2.867 . . . . 0.0 109.013 -169.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 33' ' ' LEU . 18.4 mt -147.16 121.83 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 114.935 -2.706 . . . . 0.0 109.42 154.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 27.9 ptt180 -108.81 128.31 54.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.411 -2.177 . . . . 0.0 110.369 -174.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 31.2 tp10 -68.92 136.36 52.46 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 112.459 -2.155 . . . . 0.0 109.853 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.61 ' HB3' ' H ' ' A' ' 43' ' ' ASP . 88.9 p -42.07 118.55 1.16 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.299 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.32 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.141 -1.845 . . . . 0.0 109.271 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.6 p -112.01 44.36 1.42 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.318 -1.764 . . . . 0.0 109.809 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -135.11 156.88 77.92 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.507 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ALA . 74.0 Cg_exo -43.56 -119.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.873 2.382 . . . . 0.0 114.099 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.29 68.31 0.51 Allowed Glycine 0 C--N 1.346 1.119 0 C-N-CA 118.154 -1.974 . . . . 0.0 110.187 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.61 ' H ' ' HB3' ' A' ' 37' ' ' SER . 61.9 t0 -90.05 117.87 29.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 112.82 -1.69 . . . . 0.0 109.799 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 21.4 m-85 -130.18 115.85 17.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.491 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.2 p -124.51 137.71 54.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.476 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.483 ' CD2' HG23 ' A' ' 48' ' ' VAL . 6.0 tt -110.24 119.07 38.06 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.7 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.583 ' H ' ' HB3' ' A' ' 33' ' ' LEU . 49.4 m -112.85 122.45 47.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.216 -1.811 . . . . 0.0 109.795 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.483 HG23 ' CD2' ' A' ' 46' ' ' LEU . 86.8 t -113.65 146.73 17.87 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.379 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 26' ' ' GLN . 41.7 tptt -69.35 89.54 0.49 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 116.693 -2.003 . . . . 0.0 108.915 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 53' ' ' ASP . 63.3 t80 -91.31 134.33 34.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 117.27 -1.772 . . . . 0.0 108.549 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -43.37 129.14 5.87 Favored Glycine 0 C--N 1.342 0.886 0 C-N-CA 117.286 -2.388 . . . . 0.0 111.299 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 14.9 t-20 83.33 -31.19 0.08 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 111.471 -2.364 . . . . 0.0 111.222 176.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 50' ' ' PHE . 33.6 m-20 -155.24 150.63 27.17 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 114.441 -2.903 . . . . 0.0 112.37 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG12 ' CE1' ' A' ' 56' ' ' HIS . 46.2 t -70.46 119.22 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 111.742 -2.481 . . . . 0.0 108.927 171.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 47' ' ' SER . 60.0 tt0 -101.75 159.61 15.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.884 -177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.523 ' CE1' HG12 ' A' ' 54' ' ' VAL . 16.9 m-70 -128.51 134.7 48.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.493 -2.14 . . . . 0.0 110.63 -174.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 93.7 m-85 -129.37 102.84 6.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 112.258 -2.247 . . . . 0.0 108.803 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 54.5 mtmt -70.49 114.12 8.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 116.97 -1.892 . . . . 0.0 109.718 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' CD2' ' A' ' 77' ' ' LEU . 94.3 t -74.88 86.77 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.537 174.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 81.6 mt -78.24 159.13 28.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 112.741 -2.027 . . . . 0.0 110.955 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.602 ' HE ' ' C ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -122.31 164.78 17.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 111.948 -2.387 . . . . 0.0 108.583 175.46 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.602 ' C ' ' HE ' ' A' ' 61' ' ' ARG . 69.0 m-20 -128.68 -96.85 0.39 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 117.112 -1.835 . . . . 0.0 110.354 -176.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.545 ' HA2' HH21 ' A' ' 61' ' ' ARG . . . 156.12 72.96 0.01 OUTLIER Glycine 0 C--N 1.345 1.055 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -140.95 51.78 1.61 Allowed 'General case' 0 C--N 1.351 0.664 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 7.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 73' ' ' LYS . . . -64.09 10.4 0.26 Allowed Glycine 0 CA--C 1.55 2.251 0 CA-C-N 112.507 -2.133 . . . . 0.0 112.969 171.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.729 ' HZ2' ' CG ' ' A' ' 73' ' ' LYS . 8.5 mtmp? 76.56 -146.34 0.03 OUTLIER 'General case' 0 C--N 1.351 0.631 0 CA-C-O 121.52 0.676 . . . . 0.0 110.632 171.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 20.5 m-85 -105.95 144.08 33.19 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 113.571 -1.649 . . . . 0.0 110.085 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.409 ' C ' HD12 ' A' ' 69' ' ' LEU . 11.3 p90 -151.82 -165.89 2.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 117.262 -1.775 . . . . 0.0 109.381 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.516 HD11 HD11 ' A' ' 80' ' ' LEU . 5.6 mp -125.87 -46.34 1.7 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.36 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 21.5 m0 -132.54 -42.92 0.93 Allowed 'General case' 0 C--N 1.346 0.437 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.125 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.6 t -141.7 -84.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.011 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.403 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 32.9 m -51.74 136.23 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.211 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.729 ' CG ' ' HZ2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -104.4 176.09 5.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.899 -177.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' C ' ' HZ3' ' A' ' 66' ' ' LYS . 21.5 m-85 -146.59 138.31 24.6 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.131 -1.849 . . . . 0.0 108.915 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.468 ' O ' ' OG ' ' A' ' 76' ' ' SER . 41.8 p30 -66.5 -8.98 30.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 113.253 -1.794 . . . . 0.0 113.266 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 49.2 m -167.96 150.16 5.52 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 117.791 -1.564 . . . . 0.0 109.422 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.511 ' CD2' HG11 ' A' ' 59' ' ' VAL . 97.7 mt -46.01 -42.51 13.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.114 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -55.87 -42.86 76.53 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.349 -1.751 . . . . 0.0 110.442 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 76' ' ' SER . 32.3 tp10 -63.68 -35.44 80.57 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 113.335 -1.757 . . . . 0.0 110.665 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 80' ' ' LEU . 6.1 tt -58.43 -50.84 72.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.073 -1.422 . . . . 0.0 108.375 173.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 81.3 t -63.85 -14.25 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 112.393 -2.185 . . . . 0.0 112.834 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -84.61 -26.44 27.89 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.715 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.433 ' O ' ' C ' ' A' ' 84' ' ' HIS . 68.8 t80 -73.12 -40.85 64.6 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.104 -174.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.546 ' C ' ' H ' ' A' ' 86' ' ' SER . 7.1 p-80 -45.52 -36.84 4.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.299 -2.16 . . . . 0.0 110.842 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 67.4 ttt-85 -73.4 37.35 0.09 Allowed 'General case' 0 C--N 1.348 0.516 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.877 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 84' ' ' HIS . 42.4 t -136.74 -41.63 0.61 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.141 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 88' ' ' SER . 9.0 t -165.52 55.63 0.11 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.092 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.567 ' HB2' ' H ' ' A' ' 95' ' ' ILE . 69.7 p 50.56 -179.0 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.261 -1.791 . . . . 0.0 110.101 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 89' ' ' VAL . 13.8 p -128.69 37.03 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.711 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.588 ' OG ' ' CD1' ' A' ' 95' ' ' ILE . 86.7 p 179.99 121.82 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.505 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.473 ' CB ' ' NH1' ' A' ' 91' ' ' ARG . 15.0 mtp-105 -67.97 2.42 2.07 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 113.356 -1.747 . . . . 0.0 113.209 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -68.16 -57.2 6.43 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 118.348 -1.341 . . . . 0.0 110.548 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 94' ' ' GLN . 8.3 pt20 -163.33 37.67 0.09 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 116.962 -1.895 . . . . 0.0 111.164 -176.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.54 ' HA ' ' CB ' ' A' ' 88' ' ' SER . 77.3 mt-30 62.54 137.73 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 117.841 -1.543 . . . . 0.0 110.255 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.588 ' CD1' ' OG ' ' A' ' 90' ' ' SER . 35.9 mt -150.04 140.6 16.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.904 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.45 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 88.5 m-85 -118.81 133.04 56.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.618 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.406 ' O ' ' HD3' ' A' ' 98' ' ' ARG . 28.6 mt -90.0 102.02 14.73 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.451 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 97' ' ' LEU . 27.7 mmt180 -150.29 -159.83 1.09 Allowed 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.144 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.44 ' O ' HG22 ' A' ' 100' ' ' ILE . 55.4 t0 48.73 -120.67 1.37 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.136 170.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 5.0 tt 40.16 22.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 113.843 -1.526 . . . . 0.0 113.371 -174.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 102' ' ' GLN . 6.1 tm-20 -145.94 93.49 2.34 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.0 -177.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 101' ' ' GLU . 61.7 mt-30 30.17 -151.67 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.911 -1.949 . . . . 0.0 111.465 177.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.548 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -102.16 -66.04 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 112.53 -2.123 . . . . 0.0 109.922 175.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.548 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 62.0 Cg_exo -40.24 132.15 2.24 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.679 1.586 . . . . 0.0 111.445 174.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.571 HE22 ' HG3' ' A' ' 3' ' ' GLU . 8.3 mm100 -93.03 36.56 1.03 Allowed 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.609 0.764 . . . . 0.0 111.065 12.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.633 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 78.4 mt-30 -69.91 -84.91 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 116.034 -2.266 . . . . 0.0 111.045 -172.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.633 ' CD ' ' CB ' ' A' ' 106' ' ' GLN . 44.0 Cg_endo -72.34 122.58 8.46 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.255 1.303 . . . . 0.0 112.281 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 109' ' ' TYR . 99.1 m -46.17 -83.81 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.711 -2.04 . . . . 0.0 109.298 172.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 108' ' ' THR . 9.4 t80 61.27 125.29 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.181 177.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.1 p -157.67 117.78 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.681 -2.054 . . . . 0.0 109.413 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -79.67 121.99 26.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.041 -1.89 . . . . 0.0 109.815 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.504 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.737 179.96 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.984 0 CA-C-O 121.88 0.711 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 2' ' ' ILE . 8.1 tp -110.79 120.67 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 113.01 -1.595 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.54 ' CB ' ' HB2' ' A' ' 104' ' ' PRO . 43.2 tt0 -98.63 124.84 43.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.928 -1.942 . . . . 0.0 109.632 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.582 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 44.2 ttp -103.95 124.91 49.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.933 -1.939 . . . . 0.0 109.878 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 4' ' ' MET . 38.3 ttpt 110.11 133.84 0.0 OUTLIER Pre-proline 0 C--N 1.35 0.599 0 CA-C-N 112.26 -2.245 . . . . 0.0 109.304 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' HA ' ' CD ' ' A' ' 102' ' ' GLN . 61.5 Cg_endo -74.05 -119.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.148 1.899 . . . . 0.0 109.85 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.468 ' C ' ' H ' ' A' ' 9' ' ' TRP . 8.3 p-80 -140.83 84.55 13.31 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 118.714 -1.195 . . . . 0.0 109.71 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' C ' ' CG ' ' A' ' 9' ' ' TRP . 38.2 Cg_exo -51.4 1.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.159 2.573 . . . . 0.0 115.565 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.468 ' H ' ' C ' ' A' ' 7' ' ' HIS . 41.4 p-90 43.7 30.64 0.38 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 116.965 -1.894 . . . . 0.0 111.583 177.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -105.37 118.97 37.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.478 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 29.1 m-85 -121.58 83.93 2.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.113 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -49.81 111.37 1.07 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-N 112.641 -2.072 . . . . 0.0 110.778 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' H ' ' HB2' ' A' ' 36' ' ' GLU . 26.2 pttm 26.44 46.16 0.01 OUTLIER 'General case' 0 C--N 1.344 0.357 0 CA-C-N 111.529 -2.335 . . . . 0.0 111.387 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.4 tp -61.61 135.61 94.2 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 112.96 -1.927 . . . . 0.0 108.912 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' ARG . 54.3 Cg_exo -44.08 121.74 3.16 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.855 1.703 . . . . 0.0 113.029 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.689 ' HB3' HH22 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -40.74 -41.81 1.62 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.702 -177.472 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.557 ' H ' ' HD3' ' A' ' 16' ' ' ARG . . . -59.16 -63.09 1.43 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.483 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -43.39 -52.0 6.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 112.766 -2.016 . . . . 0.0 110.421 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.75 -49.47 14.82 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.759 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.29 -44.65 96.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.775 -2.011 . . . . 0.0 110.114 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' SER . 44.2 mt-10 -67.09 -70.4 0.25 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.872 -173.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.57 ' C ' ' SD ' ' A' ' 22' ' ' MET . 3.5 ppp? -46.48 -42.48 15.57 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 117.088 -1.845 . . . . 0.0 110.474 -173.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.562 ' N ' ' SD ' ' A' ' 22' ' ' MET . 60.8 tp -75.89 -25.11 55.77 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 113.357 -1.747 . . . . 0.0 112.569 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 26' ' ' GLN . 78.4 p -74.18 -33.31 63.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 117.186 -1.806 . . . . 0.0 111.151 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 50.1 mtpt -75.54 38.78 0.15 Allowed 'General case' 0 C--N 1.347 0.467 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.605 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 26' ' ' GLN . 4.2 mm-40 -102.25 136.05 42.77 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 117.687 -1.605 . . . . 0.0 110.225 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HA ' ' CB ' ' A' ' 28' ' ' HIS . 9.9 mpt_? -116.54 84.33 2.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 110.688 -2.96 . . . . 0.0 106.374 171.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 27' ' ' ARG . 1.3 t-80 -171.24 12.07 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.702 13.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 7.0 m-20 -163.09 128.69 3.19 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.753 -1.579 . . . . 0.0 110.619 -173.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 103.26 -27.03 21.77 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 117.835 -2.126 . . . . 0.0 112.875 170.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.432 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -46.95 135.76 9.04 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 117.762 -1.575 . . . . 0.0 109.147 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.512 ' CB ' HD22 ' A' ' 97' ' ' LEU . 17.3 p90 -139.94 164.51 29.82 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 115.077 -2.649 . . . . 0.0 112.427 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.608 ' HB3' ' H ' ' A' ' 47' ' ' SER . 0.4 OUTLIER -129.03 145.96 51.12 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 110.31 -3.132 . . . . 0.0 108.658 -165.364 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.519 ' CG1' ' O ' ' A' ' 33' ' ' LEU . 16.5 mt -145.85 119.94 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 114.886 -2.726 . . . . 0.0 109.504 153.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.689 HH22 ' HB3' ' A' ' 16' ' ' ARG . 10.1 ptm180 -113.11 147.79 36.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 111.852 -2.431 . . . . 0.0 110.223 -172.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.497 ' HB2' ' H ' ' A' ' 13' ' ' LYS . 40.7 mt-10 -86.97 167.38 14.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.69 -2.05 . . . . 0.0 109.719 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 38.9 t -71.83 -134.41 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.255 -1.793 . . . . 0.0 108.679 175.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -101.26 -70.92 0.73 Allowed 'General case' 0 C--N 1.347 0.473 0 C-N-CA 118.097 -1.441 . . . . 0.0 109.114 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.4 t -128.81 45.52 2.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.666 -2.061 . . . . 0.0 109.566 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -156.44 110.21 2.04 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.841 -176.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' A' ' 43' ' ' ASP . 23.6 Cg_exo -57.48 -144.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.132 0 N-CA-C 107.798 -1.655 . . . . 0.0 107.798 171.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.78 -28.33 0.14 Allowed Glycine 0 CA--C 1.541 1.679 0 CA-C-N 114.091 -1.413 . . . . 0.0 113.376 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 41' ' ' PRO . 11.2 m-20 -112.8 116.52 30.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.967 0.889 . . . . 0.0 109.253 -173.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.433 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 91.7 m-85 -149.19 91.14 1.81 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.986 -1.916 . . . . 0.0 109.791 -175.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.473 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 28.4 p -89.99 137.41 32.36 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 115.947 -2.301 . . . . 0.0 109.93 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.499 ' CD2' HG23 ' A' ' 48' ' ' VAL . 6.5 tt -100.01 121.02 40.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 111.965 -2.38 . . . . 0.0 109.562 -173.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.608 ' H ' ' HB3' ' A' ' 33' ' ' LEU . 49.2 m -114.38 130.29 56.69 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.25 -176.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.517 ' CA ' HD21 ' A' ' 23' ' ' LEU . 84.3 t -128.13 145.4 35.33 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 CA-C-N 113.287 -1.778 . . . . 0.0 110.317 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 24' ' ' SER . 22.0 tptp -72.39 96.69 1.92 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 113.332 -1.758 . . . . 0.0 108.034 172.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CD2' ' O ' ' A' ' 53' ' ' ASP . 24.4 p90 -89.12 -1.31 58.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 116.546 -2.061 . . . . 0.0 113.801 -170.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.41 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 153.8 -80.48 0.18 Allowed Glycine 0 C--N 1.346 1.124 0 C-N-CA 117.024 -2.512 . . . . 0.0 110.77 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -109.28 -29.3 8.55 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 112.4 -1.9 . . . . 0.0 111.642 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 32.2 t70 -133.36 -174.92 3.64 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 117.434 -1.706 . . . . 0.0 110.159 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.561 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 73.9 t -100.08 122.19 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 112.857 -1.974 . . . . 0.0 110.377 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' SER . 57.1 tt0 -94.48 166.52 12.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.583 -2.099 . . . . 0.0 108.491 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 43.6 p-80 -150.08 144.52 25.8 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.495 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.491 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 98.6 m-85 -138.59 89.93 2.41 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.931 177.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.473 ' HA ' ' CB ' ' A' ' 45' ' ' SER . 9.1 ptmm? -45.06 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 112.535 -2.121 . . . . 0.0 109.912 169.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 22.9 t -79.09 71.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-N 113.237 -1.801 . . . . 0.0 108.912 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.434 ' CD1' ' NZ ' ' A' ' 58' ' ' LYS . 16.6 mt -73.06 -151.89 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.227 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 8.7 ptm180 -157.23 -136.82 0.05 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 116.982 -1.887 . . . . 0.0 109.885 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 61' ' ' ARG . 36.9 m-20 -24.49 147.46 0.0 OUTLIER 'General case' 0 C--N 1.349 0.566 0 O-C-N 125.284 1.615 . . . . 0.0 111.502 174.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.44 110.62 4.07 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 122.417 1.009 . . . . 0.0 111.875 7.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.412 ' CB ' ' HD3' ' A' ' 73' ' ' LYS . . . -161.02 -46.68 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 112.085 -2.057 . . . . 0.0 108.396 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . 171.29 -44.56 0.19 Allowed Glycine 0 C--N 1.348 1.229 0 CA-C-N 112.832 -1.985 . . . . 0.0 110.353 174.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 5.1 mtpm? -160.94 -147.91 0.15 Allowed 'General case' 0 C--N 1.349 0.559 0 CA-C-N 112.855 -1.673 . . . . 0.0 108.715 -173.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 8.1 m-30 -71.09 140.79 50.79 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 118.196 -1.402 . . . . 0.0 109.91 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -156.58 151.23 25.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 117.094 -1.842 . . . . 0.0 110.745 174.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.491 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 4.9 mt -87.77 -43.44 11.87 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 112.441 -2.163 . . . . 0.0 109.956 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -147.4 -44.61 0.17 Allowed 'General case' 0 C--N 1.346 0.435 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.929 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.2 t -135.75 -83.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.903 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.6 m -53.92 131.64 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 112.814 -1.994 . . . . 0.0 110.09 -176.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 47.7 mtmt -88.04 176.24 7.39 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.693 -2.049 . . . . 0.0 110.053 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.454 ' CD1' ' O ' ' A' ' 73' ' ' LYS . 18.0 m-85 -147.25 132.76 18.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 112.507 -2.133 . . . . 0.0 108.725 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 76' ' ' SER . 18.3 t30 -83.67 49.34 1.58 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.949 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 29.2 t 138.94 142.7 0.0 OUTLIER 'General case' 0 C--N 1.349 0.562 0 CA-C-N 112.249 -2.25 . . . . 0.0 109.344 173.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 80' ' ' LEU . 95.7 mt -49.09 -49.42 41.81 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.238 -1.801 . . . . 0.0 108.851 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -47.45 -39.46 15.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 112.624 -2.08 . . . . 0.0 110.621 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 79' ' ' GLU . 4.7 tm-20 -64.1 -35.76 81.8 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 116.772 -1.971 . . . . 0.0 110.5 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.464 HD11 ' CG ' ' A' ' 69' ' ' LEU . 6.8 tt -64.88 -66.67 0.51 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.692 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.6 t -39.69 -38.84 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 112.321 -2.218 . . . . 0.0 110.893 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 12.6 t70 -77.64 -36.25 51.72 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.209 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' LEU . 60.8 t80 -68.76 -28.29 66.66 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 117.942 -1.503 . . . . 0.0 111.948 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -107.45 35.2 3.15 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 117.953 -1.499 . . . . 0.0 111.328 -175.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 12.7 ptm180 -97.38 30.55 2.8 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 117.426 -1.71 . . . . 0.0 111.656 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 88' ' ' SER . 80.5 p -149.98 -74.06 0.17 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 117.651 -1.62 . . . . 0.0 110.259 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 92' ' ' ASN . 9.0 t -76.23 39.68 0.2 Allowed 'General case' 0 C--N 1.345 0.41 0 CA-C-N 112.966 -1.924 . . . . 0.0 110.862 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.543 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 32.7 t 50.93 -146.22 0.46 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 117.825 -1.55 . . . . 0.0 109.398 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.452 ' O ' HG22 ' A' ' 89' ' ' VAL . 15.0 p -160.12 45.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.678 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.2 t -170.78 -96.94 0.01 OUTLIER 'General case' 0 C--N 1.346 0.425 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.592 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.562 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 87.9 mtt180 -72.18 4.64 3.4 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.859 -1.518 . . . . 0.0 113.421 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 91' ' ' ARG . 11.6 m120 101.91 -37.87 0.01 OUTLIER 'General case' 0 C--N 1.352 0.702 0 O-C-N 124.455 1.097 . . . . 0.0 110.904 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 22.0 pt20 -153.87 114.23 3.95 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 117.052 -1.859 . . . . 0.0 110.371 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.543 ' H ' ' HB2' ' A' ' 88' ' ' SER . 11.3 pt20 158.39 21.55 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 112.314 -2.221 . . . . 0.0 111.908 176.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.428 ' CG2' HG11 ' A' ' 48' ' ' VAL . 37.0 mt -149.96 127.18 2.42 Favored 'Isoleucine or valine' 0 C--N 1.349 0.55 0 C-N-CA 117.831 -1.548 . . . . 0.0 110.054 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.577 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 29.9 t80 -123.74 135.76 54.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.965 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.512 HD22 ' CB ' ' A' ' 32' ' ' PHE . 95.5 mt -89.94 96.11 10.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 117.045 -1.862 . . . . 0.0 110.228 -174.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' A' ' 99' ' ' ASP . 53.4 ttm-85 -153.8 -137.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.808 175.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.584 ' H ' ' HG2' ' A' ' 98' ' ' ARG . 35.9 t0 43.85 -170.84 0.01 OUTLIER 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.286 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.531 ' H ' ' CG ' ' A' ' 99' ' ' ASP . 0.5 OUTLIER 86.78 -38.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.361 173.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.418 ' HG2' HG23 ' A' ' 100' ' ' ILE . 24.2 mm-40 -150.12 -163.99 1.91 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 112.988 -1.914 . . . . 0.0 109.98 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.44 ' CD ' ' HA ' ' A' ' 6' ' ' PRO . 8.2 tt0 39.55 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.802 -1.999 . . . . 0.0 110.588 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.627 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -107.7 -53.38 0.07 OUTLIER Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.607 173.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.627 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 31.3 Cg_exo -58.14 115.86 2.83 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.545 2.163 . . . . 0.0 112.683 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 104' ' ' PRO . 53.9 mt-30 -159.63 -89.16 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.969 -1.923 . . . . 0.0 109.185 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.667 ' H ' ' CD ' ' A' ' 107' ' ' PRO . 73.0 mt-30 -116.92 -44.32 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.616 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.667 ' CD ' ' H ' ' A' ' 106' ' ' GLN . 49.3 Cg_exo -52.25 119.63 6.09 Favored 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 120.826 1.017 . . . . 0.0 112.817 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 6.7 m 95.79 72.26 0.0 OUTLIER 'General case' 0 C--N 1.346 0.446 0 CA-C-N 112.394 -2.184 . . . . 0.0 109.475 -178.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -74.32 117.68 16.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 112.887 -1.96 . . . . 0.0 109.688 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 110' ' ' VAL . 34.1 m -76.09 124.08 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.63 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -49.91 119.0 3.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 113.0 -1.909 . . . . 0.0 109.741 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.595 -179.765 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 106' ' ' GLN . . . . . . . . 0 CA--C 1.533 1.163 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 2' ' ' ILE . 4.1 mp -94.84 45.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.693 0 CA-C-O 122.234 1.016 . . . . 0.0 109.739 -0.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.406 ' H ' ' HA2' ' A' ' 1' ' ' GLY . 78.7 mm-40 -69.64 118.53 12.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.56 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' LYS . 13.4 tpp -108.76 116.4 31.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.828 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' MET . 87.6 tttt 60.77 134.25 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 112.891 -1.958 . . . . 0.0 109.397 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.26 -119.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.159 1.906 . . . . 0.0 109.838 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.57 136.72 2.14 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 118.526 -1.27 . . . . 0.0 109.342 178.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.08 -113.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.317 2.011 . . . . 0.0 111.415 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.456 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 5.0 m-90 -126.31 -29.88 2.94 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 117.779 -1.569 . . . . 0.0 111.856 -167.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 92.3 m-85 -67.59 116.99 8.93 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.159 -171.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 9' ' ' TRP . 97.4 m-85 -123.94 95.56 4.61 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.682 171.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.56 163.76 30.44 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 114.861 -3.542 . . . . 0.0 112.242 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.658 ' HD3' ' H ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -88.65 109.04 19.78 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 113.26 -1.47 . . . . 0.0 109.296 -6.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.2 tp -87.71 123.26 69.59 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 113.198 -1.819 . . . . 0.0 109.341 -177.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 16' ' ' ARG . 49.2 Cg_exo -49.88 122.38 8.95 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.493 1.462 . . . . 0.0 112.199 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 15' ' ' PRO . 71.2 ttt180 -38.83 -40.17 0.6 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-N 113.33 -1.759 . . . . 0.0 110.73 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -57.84 -70.89 0.12 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.494 -1.684 . . . . 0.0 108.961 173.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.56 ' NZ ' ' SD ' ' A' ' 22' ' ' MET . 28.6 tptp -35.9 -48.52 0.58 Allowed 'General case' 0 C--N 1.346 0.414 0 CA-C-N 112.833 -1.985 . . . . 0.0 111.051 -176.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.14 -69.32 0.15 Allowed 'General case' 0 C--N 1.346 0.421 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.423 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 80.3 mt-10 -49.72 -23.42 1.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 112.388 -2.187 . . . . 0.0 112.245 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 81.6 mm-40 -81.34 -81.71 0.13 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 118.486 -1.286 . . . . 0.0 110.11 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.56 ' SD ' ' NZ ' ' A' ' 18' ' ' LYS . 18.4 ptm -47.05 -41.72 17.29 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 117.045 -1.862 . . . . 0.0 110.28 -176.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.495 HD13 ' CD1' ' A' ' 100' ' ' ILE . 41.8 tp -63.42 -34.49 77.85 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.422 -178.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.55 ' C ' ' H ' ' A' ' 26' ' ' GLN . 71.7 p -69.24 -33.67 73.63 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 116.616 -2.034 . . . . 0.0 110.954 176.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -72.35 34.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.108 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.55 ' H ' ' C ' ' A' ' 24' ' ' SER . 28.6 mm-40 -100.75 149.95 23.28 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.454 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 28' ' ' HIS . 24.7 tpt180 -73.57 36.41 0.09 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.107 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.548 ' H ' ' C ' ' A' ' 26' ' ' GLN . 57.0 t-80 44.13 93.13 0.01 OUTLIER 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.631 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -164.03 37.36 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 116.83 -1.948 . . . . 0.0 111.258 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 68.02 1.45 19.31 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 116.785 -2.626 . . . . 0.0 113.44 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.3 132.62 16.29 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 117.775 -1.57 . . . . 0.0 108.761 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' SER . 26.7 p90 -144.87 160.99 40.41 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 115.787 -2.365 . . . . 0.0 111.427 -173.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.532 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.6 pp -145.81 146.12 31.05 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.397 170.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 45' ' ' SER . 71.3 mt -110.25 105.19 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 112.57 -2.105 . . . . 0.0 108.096 173.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 11.1 ptm180 -92.0 152.45 20.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 116.751 -1.98 . . . . 0.0 111.219 -170.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' SER . 47.4 mt-10 -113.59 129.25 56.6 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 111.73 -2.486 . . . . 0.0 109.315 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 39.9 t -50.57 -179.46 0.01 OUTLIER 'General case' 0 C--N 1.346 0.415 0 C-N-CA 116.821 -1.952 . . . . 0.0 109.878 -178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -42.79 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.345 0.392 0 CA-C-N 112.978 -1.919 . . . . 0.0 109.692 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 46.6 t -89.93 -49.18 6.75 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.497 174.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' A' ' 37' ' ' SER . . . 70.95 119.49 0.03 OUTLIER Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 112.462 -2.154 . . . . 0.0 111.246 165.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.95 -112.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 170.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.49 58.57 0.39 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 117.346 -2.359 . . . . 0.0 109.99 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -101.46 107.63 19.0 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 117.481 -1.688 . . . . 0.0 109.587 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 19.8 m-85 -129.64 127.59 40.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.494 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.7 p -134.06 127.31 31.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.717 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' CD2' ' HB2' ' A' ' 32' ' ' PHE . 4.8 tt -90.79 115.51 27.91 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.786 -2.006 . . . . 0.0 109.55 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.435 ' OG ' ' HG ' ' A' ' 33' ' ' LEU . 90.1 p -100.54 146.73 26.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.898 -1.956 . . . . 0.0 109.735 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.8 t -140.6 149.24 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 117.553 -1.659 . . . . 0.0 110.515 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.48 ' CE ' ' O ' ' A' ' 24' ' ' SER . 20.7 tptm -75.44 102.73 5.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.747 -2.024 . . . . 0.0 108.795 174.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' ASN . 38.5 t80 -98.82 108.4 21.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.472 -1.695 . . . . 0.0 109.607 -178.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.546 ' N ' ' CD2' ' A' ' 28' ' ' HIS . . . 54.79 -97.37 0.04 OUTLIER Glycine 0 CA--C 1.53 1.02 0 C-N-CA 118.021 -2.038 . . . . 0.0 110.161 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 50' ' ' PHE . 51.7 t30 -112.16 -26.34 8.86 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 112.659 -1.771 . . . . 0.0 112.043 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.544 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 30.3 t0 -101.43 -173.23 2.31 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.223 -1.391 . . . . 0.0 109.528 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.544 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 96.0 t -111.47 120.5 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 113.259 -1.791 . . . . 0.0 109.742 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 61.2 tt0 -90.01 159.38 16.9 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 112.881 -1.963 . . . . 0.0 109.357 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -136.31 121.55 19.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.733 -2.031 . . . . 0.0 110.47 -173.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 46' ' ' LEU . 24.2 m-85 -112.71 126.28 55.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.79 -2.005 . . . . 0.0 109.191 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.0 mtmm -95.87 118.12 31.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 116.733 -1.987 . . . . 0.0 109.538 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.534 HG11 ' CD2' ' A' ' 77' ' ' LEU . 68.0 t -75.97 92.76 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 113.031 -1.895 . . . . 0.0 108.734 176.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 54.0 mt -89.94 151.51 21.67 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 113.03 -1.895 . . . . 0.0 110.871 -174.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 64.8 ttp85 -103.24 168.89 8.88 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 111.858 -2.428 . . . . 0.0 109.431 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -119.64 -148.52 0.42 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.376 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -102.39 36.89 3.97 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 117.909 -2.091 . . . . 0.0 111.446 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -146.4 -45.16 0.19 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.717 -1.242 . . . . 0.0 109.618 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.412 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 134.27 19.6 0.86 Allowed Glycine 0 CA--C 1.542 1.741 0 CA-C-N 112.955 -1.93 . . . . 0.0 112.936 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.797 ' HA ' ' HZ2' ' A' ' 66' ' ' LYS . 1.9 mmpm? -92.41 138.7 31.3 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 118.237 -1.385 . . . . 0.0 109.532 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 86.6 m-85 -96.8 134.49 40.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.42 -2.173 . . . . 0.0 109.04 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 71' ' ' VAL . 50.7 p90 -152.75 -162.37 1.48 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 117.188 -1.805 . . . . 0.0 109.999 -176.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 69' ' ' LEU . 5.6 mp -133.27 -39.4 0.93 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 112.31 -2.223 . . . . 0.0 110.767 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -110.32 -38.67 5.18 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.84 -173.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 98.5 t -150.02 -83.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 117.148 -1.821 . . . . 0.0 109.365 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 71' ' ' VAL . 18.4 m -162.1 136.89 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.202 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.565 ' CD ' ' CZ ' ' A' ' 74' ' ' PHE . 17.3 ptpt -170.07 -24.26 0.02 OUTLIER 'General case' 0 C--N 1.347 0.483 0 C-N-CA 114.684 -2.806 . . . . 0.0 112.829 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.565 ' CZ ' ' CD ' ' A' ' 73' ' ' LYS . 10.8 m-85 -120.24 146.58 45.92 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 116.671 -2.011 . . . . 0.0 109.986 -174.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 76' ' ' SER . 53.1 p-10 -86.77 -22.6 25.83 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 113.087 -1.87 . . . . 0.0 112.065 175.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.416 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 41.0 t -155.6 162.34 40.65 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 118.201 -1.399 . . . . 0.0 109.703 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.534 ' CD2' HG11 ' A' ' 59' ' ' VAL . 95.9 mt -46.32 -45.48 17.51 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.932 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.406 ' OD1' ' CZ3' ' A' ' 9' ' ' TRP . 1.8 m-20 -48.49 -38.59 20.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.871 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' CB ' ' HB3' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -77.34 -19.98 55.53 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 113.994 -1.457 . . . . 0.0 112.17 -178.805 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 80' ' ' LEU . 6.8 tt -72.62 -57.68 3.94 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 118.154 -1.418 . . . . 0.0 108.227 172.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 58.2 t -51.75 -41.72 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 111.911 -2.404 . . . . 0.0 110.573 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 11.2 t70 -63.43 -44.48 94.42 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.35 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CB ' ' CE1' ' A' ' 74' ' ' PHE . 64.5 t80 -70.04 -37.49 75.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.188 -1.824 . . . . 0.0 111.096 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 86' ' ' SER . 1.0 OUTLIER -72.72 -32.53 65.79 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.397 -178.004 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 55.0 ptt85 -77.31 41.84 0.32 Allowed 'General case' 0 C--N 1.348 0.506 0 C-N-CA 117.276 -1.769 . . . . 0.0 110.396 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 84' ' ' HIS . 42.6 t -150.01 -44.93 0.13 Allowed 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.344 -1.753 . . . . 0.0 109.656 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 88' ' ' SER . 9.5 t -103.91 -137.6 0.35 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.192 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' A' ' 95' ' ' ILE . 70.1 p -143.03 175.54 9.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 118.166 -1.414 . . . . 0.0 109.853 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 90' ' ' SER . 1.9 m -95.94 -41.4 11.65 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-N 113.054 -1.884 . . . . 0.0 110.427 176.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.523 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 16.6 t -120.52 119.36 32.71 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.938 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -54.82 -38.69 67.68 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.698 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -50.73 -39.37 51.66 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.848 -1.524 . . . . 0.0 110.711 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 90' ' ' SER . 19.4 pt20 -150.68 128.62 11.76 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.247 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.418 ' O ' ' HG3' ' A' ' 94' ' ' GLN . 12.1 pt20 -68.89 123.1 20.06 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.868 -178.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.587 ' H ' ' HB2' ' A' ' 88' ' ' SER . 14.9 mt -119.97 126.79 75.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.205 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 97' ' ' LEU . 67.4 t80 -103.46 155.45 18.5 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.062 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.45 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 91.2 mt -89.89 120.36 31.05 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 117.27 -1.772 . . . . 0.0 109.707 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -127.96 143.52 51.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.285 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -47.92 127.07 11.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.462 -2.154 . . . . 0.0 109.719 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.746 HG23 ' H ' ' A' ' 101' ' ' GLU . 17.8 tt -62.82 -121.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.707 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.746 ' H ' HG23 ' A' ' 100' ' ' ILE . 6.6 tp10 -89.9 -177.91 5.34 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.153 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.514 ' H ' ' HG3' ' A' ' 101' ' ' GLU . 26.7 tt0 57.01 118.48 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.709 176.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.402 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 9.0 p -142.79 135.46 13.64 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.046 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -43.88 124.01 4.36 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.085 1.857 . . . . 0.0 113.815 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 21.0 pt20 -172.29 122.88 0.47 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 111.944 -2.389 . . . . 0.0 109.758 -172.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 1' ' ' GLY . 29.1 mm100 -127.05 154.68 76.59 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.03 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.595 ' O ' ' CB ' ' A' ' 108' ' ' THR . 52.1 Cg_exo -46.65 124.29 8.08 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.784 2.323 . . . . 0.0 113.482 176.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.595 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 18.7 m 132.0 122.6 0.0 OUTLIER 'General case' 0 C--N 1.35 0.613 0 CA-C-N 112.411 -2.177 . . . . 0.0 109.489 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -153.58 116.45 4.5 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 112.518 -2.128 . . . . 0.0 109.353 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 110' ' ' VAL . 34.1 m -86.61 124.78 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 113.143 -1.844 . . . . 0.0 109.915 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 29.4 pt20 -100.51 122.8 43.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.888 -1.96 . . . . 0.0 109.681 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.448 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.725 -179.676 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.036 0 CA-C-O 121.803 0.668 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.3 tt -46.37 128.52 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 113.061 -1.569 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 71.5 mt-10 -45.61 121.17 2.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.017 -1.902 . . . . 0.0 110.161 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.601 ' HE2' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -42.88 137.97 2.16 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 112.497 -2.138 . . . . 0.0 109.514 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.601 ' H ' ' HE2' ' A' ' 4' ' ' MET . 19.9 pttm 49.79 156.17 0.04 OUTLIER Pre-proline 0 C--N 1.349 0.576 0 CA-C-N 112.864 -1.971 . . . . 0.0 110.488 -174.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 5' ' ' LYS . 80.1 Cg_exo -44.19 -120.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.506 2.137 . . . . 0.0 114.534 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.701 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 76.9 m80 -151.52 -46.77 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 116.813 -1.955 . . . . 0.0 113.264 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.701 ' HD2' ' H ' ' A' ' 7' ' ' HIS . 50.3 Cg_exo -49.61 -121.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 121.717 1.612 . . . . 0.0 114.54 -174.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.402 ' H ' ' HB2' ' A' ' 8' ' ' PRO . 1.6 p-90 -146.43 27.69 1.11 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.93 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -102.29 116.91 33.62 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.334 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 12' ' ' GLY . 7.5 m-85 -105.65 104.28 13.97 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 113.233 -1.803 . . . . 0.0 108.497 174.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -22.41 -108.23 0.0 OUTLIER Glycine 0 C--N 1.348 1.21 0 CA-C-N 111.63 -2.532 . . . . 0.0 112.883 -173.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.623 ' HZ2' ' HA ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -115.99 50.01 1.06 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 112.727 -1.736 . . . . 0.0 108.885 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.554 HG22 ' CB ' ' A' ' 35' ' ' ARG . 7.6 tp -69.27 132.03 90.07 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.721 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' ARG . 21.1 Cg_endo -66.11 125.03 13.42 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.263 1.976 . . . . 0.0 112.122 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.473 HH11 HH21 ' A' ' 35' ' ' ARG . 60.0 ttt85 -31.9 -40.68 0.04 OUTLIER 'General case' 0 C--N 1.349 0.544 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.083 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -55.54 -76.35 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.281 -1.781 . . . . 0.0 109.405 177.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 17' ' ' ALA . 56.8 tptt -38.92 -39.81 0.57 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 112.993 -1.912 . . . . 0.0 110.915 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.576 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -54.61 -70.76 0.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 117.071 -1.852 . . . . 0.0 108.705 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 24' ' ' SER . 47.6 mt-10 -39.36 -43.25 1.16 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.504 -2.135 . . . . 0.0 110.753 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' O ' ' OG ' ' A' ' 24' ' ' SER . 34.6 mt-10 -61.8 -91.78 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.4 -175.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.0 ptm -45.02 -39.65 5.83 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 117.524 -1.67 . . . . 0.0 110.687 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 23.5 tp -59.93 -41.11 91.05 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.748 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 26' ' ' GLN . 81.1 p -67.4 -37.35 82.97 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.471 176.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -70.66 35.16 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.613 -1.631 . . . . 0.0 111.053 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.621 HE21 ' HA ' ' A' ' 26' ' ' GLN . 2.3 mm-40 -107.95 145.67 33.5 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 118.082 -1.447 . . . . 0.0 109.397 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 1.9 mpt_? -91.21 -69.79 0.72 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.876 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -61.72 105.11 0.5 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.956 -1.929 . . . . 0.0 109.709 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -45.99 121.03 2.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.623 -2.08 . . . . 0.0 109.537 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.2 -22.11 4.03 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 117.98 -2.057 . . . . 0.0 112.674 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -46.98 114.14 0.79 Allowed 'General case' 0 C--N 1.35 0.605 0 C-N-CA 118.245 -1.382 . . . . 0.0 108.995 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.51 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 17.4 p90 -132.29 160.69 35.49 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 116.675 -2.01 . . . . 0.0 110.753 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.431 ' HG ' ' OG ' ' A' ' 47' ' ' SER . 4.5 pp -150.73 149.67 30.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 116.401 -2.12 . . . . 0.0 109.74 169.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.8 mt -108.44 106.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.62 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.554 ' CB ' HG22 ' A' ' 14' ' ' ILE . 31.8 ptt-85 -94.95 126.78 40.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 112.623 -2.08 . . . . 0.0 110.077 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' GLY . 63.7 tt0 -69.06 120.48 14.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.874 -1.967 . . . . 0.0 109.121 177.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.466 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 43.0 t -45.81 120.31 2.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.817 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.623 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 61.3 tt0 -45.3 -40.1 7.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 112.743 -2.026 . . . . 0.0 110.81 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.8 m -89.93 -95.15 0.11 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.168 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.66 130.37 55.17 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 113.699 -1.591 . . . . 0.0 109.621 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.35 -6.16 15.41 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.833 1.689 . . . . 0.0 114.968 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.61 40.37 2.35 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 118.506 -1.807 . . . . 0.0 111.065 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.466 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 1.0 OUTLIER -133.0 120.83 21.89 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 117.747 -1.581 . . . . 0.0 109.836 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.412 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 86.7 m-85 -125.61 130.39 51.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.558 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.7 p -127.72 132.92 49.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.162 -1.836 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 tt -94.8 115.26 27.28 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.806 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.493 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 91.4 p -102.58 130.96 49.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.85 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.77 149.38 30.51 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 117.768 -1.573 . . . . 0.0 110.281 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 41.7 tptt -82.28 101.94 10.86 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.888 -1.96 . . . . 0.0 108.842 172.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 53' ' ' ASP . 10.4 t80 -110.04 144.75 38.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 113.321 -1.763 . . . . 0.0 108.871 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 52' ' ' ASN . . . -45.47 135.56 7.86 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 117.225 -2.417 . . . . 0.0 110.912 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 58.4 t30 76.72 -34.57 0.22 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 111.536 -2.332 . . . . 0.0 111.075 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 50' ' ' PHE . 11.0 m-20 -157.35 153.35 27.18 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 114.955 -2.698 . . . . 0.0 111.592 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 24' ' ' SER . 66.5 t -69.95 125.23 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 112.325 -2.216 . . . . 0.0 108.991 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.649 HE22 ' HB2' ' A' ' 90' ' ' SER . 58.4 tt0 -90.04 164.0 14.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.542 -177.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.509 ' CE1' ' CG ' ' A' ' 58' ' ' LYS . 16.6 t-160 -140.86 129.58 22.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 112.959 -1.928 . . . . 0.0 111.124 -168.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 92.2 m-85 -138.31 103.15 4.83 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.263 175.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.509 ' CG ' ' CE1' ' A' ' 56' ' ' HIS . 53.6 mtmt -74.39 120.64 20.23 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 117.381 -1.728 . . . . 0.0 110.323 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 77' ' ' LEU . 56.6 t -75.32 87.37 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 112.688 -2.051 . . . . 0.0 108.69 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 71.3 mt -80.47 158.2 25.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.023 -1.899 . . . . 0.0 110.182 -174.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -131.04 157.19 43.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.663 -178.296 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -153.31 153.73 33.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 112.215 -2.266 . . . . 0.0 109.797 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -48.6 -40.61 25.0 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.126 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.11 -42.21 3.08 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 118.026 -1.47 . . . . 0.0 110.373 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.31 -24.96 24.78 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 118.293 -1.908 . . . . 0.0 112.613 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.563 ' HA ' ' HZ3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 58.71 -156.14 0.34 Allowed 'General case' 0 C--N 1.349 0.548 0 C-N-CA 117.956 -1.498 . . . . 0.0 108.959 -177.666 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 88.8 m-85 -76.67 125.23 28.89 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 116.886 -1.926 . . . . 0.0 109.303 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.451 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -159.29 145.9 16.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.942 -1.935 . . . . 0.0 110.968 -177.015 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.556 HD22 ' H ' ' A' ' 69' ' ' LEU . 1.7 mm? -74.09 -66.9 0.66 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.94 -1.936 . . . . 0.0 108.88 175.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 19.0 m0 -136.15 -44.48 0.63 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 112.395 -2.184 . . . . 0.0 110.137 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.2 t -125.75 -80.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 112.99 -1.914 . . . . 0.0 110.445 -173.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.0 m -48.74 134.36 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.421 -172.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -101.51 155.05 18.31 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.829 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 80' ' ' LEU . 5.6 p90 -170.05 138.62 1.73 Allowed 'General case' 0 C--N 1.342 0.275 0 CA-C-N 111.153 -2.748 . . . . 0.0 109.156 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -98.2 24.13 7.51 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 112.711 -2.041 . . . . 0.0 111.724 176.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 40.3 t -144.94 132.16 20.54 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 116.814 -1.955 . . . . 0.0 110.345 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.504 ' CD2' HG11 ' A' ' 59' ' ' VAL . 96.1 mt -56.88 -44.58 82.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 113.178 -1.828 . . . . 0.0 109.57 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -51.43 -45.63 62.69 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.756 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 76' ' ' SER . 31.7 tp10 -58.67 -38.2 77.69 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.62 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' A' ' 59' ' ' VAL . 7.9 tt -60.19 -46.27 90.29 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.331 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 77' ' ' LEU . 86.4 t -65.49 -35.53 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 112.78 -2.009 . . . . 0.0 111.337 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 24.6 t0 -58.7 -43.01 89.94 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.373 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.404 ' C ' ' H ' ' A' ' 85' ' ' ARG . 33.2 m-85 -64.55 -42.76 95.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.112 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.47 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 38.2 m170 -80.03 30.28 0.27 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 113.599 -1.637 . . . . 0.0 111.378 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 83' ' ' TYR . 79.7 ttt-85 -112.98 -38.58 4.46 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 117.973 -1.491 . . . . 0.0 110.762 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.5 p -99.6 -39.82 8.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 117.974 -1.49 . . . . 0.0 110.677 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 88' ' ' SER . 8.8 t -106.17 39.13 1.86 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 117.731 -1.588 . . . . 0.0 110.863 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 87' ' ' THR . 44.2 t 44.93 -169.35 0.01 OUTLIER 'General case' 0 C--N 1.347 0.473 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.842 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.403 ' N ' ' OG ' ' A' ' 88' ' ' SER . 10.9 p -117.81 -39.88 2.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.359 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.649 ' HB2' HE22 ' A' ' 55' ' ' GLN . 32.8 t -109.38 -23.94 11.3 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 113.796 -1.547 . . . . 0.0 112.164 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 90' ' ' SER . 59.0 mtp85 66.61 -5.98 0.57 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.213 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.422 ' HA ' HD22 ' A' ' 92' ' ' ASN . 15.9 m120 -48.21 -68.22 0.2 Allowed 'General case' 0 C--N 1.348 0.53 0 C-N-CA 117.481 -1.688 . . . . 0.0 109.323 177.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 94' ' ' GLN . 54.6 mt-30 -123.46 40.74 3.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.41 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 93' ' ' GLN . 23.2 tt0 57.32 111.44 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.485 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 90' ' ' SER . 55.2 mt -116.57 137.33 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 113.064 -1.88 . . . . 0.0 110.258 -178.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -121.47 133.37 55.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.735 -2.03 . . . . 0.0 109.112 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.47 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 80.8 mt -89.93 105.88 18.1 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.749 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.802 ' CD ' ' H ' ' A' ' 99' ' ' ASP . 0.7 OUTLIER 177.98 -141.94 0.01 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 112.35 -2.204 . . . . 0.0 107.678 -178.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.802 ' H ' ' CD ' ' A' ' 98' ' ' ARG . 27.0 m-20 69.61 -27.44 0.16 Allowed 'General case' 0 C--N 1.347 0.461 0 O-C-N 125.383 1.677 . . . . 0.0 113.104 166.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 13.3 tt -75.04 30.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 116.653 -2.019 . . . . 0.0 112.119 -172.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.518 ' H ' ' C ' ' A' ' 99' ' ' ASP . 43.2 tt0 -150.06 111.96 4.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.596 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 48.7 tt0 -140.15 47.61 1.8 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.191 -1.822 . . . . 0.0 109.565 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.683 HG13 ' HD3' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -147.22 -61.97 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 112.613 -2.085 . . . . 0.0 110.245 -178.659 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.683 ' HD3' HG13 ' A' ' 103' ' ' VAL . 32.8 Cg_exo -50.23 131.36 31.12 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.347 2.031 . . . . 0.0 113.24 172.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 104' ' ' PRO . 19.1 mm100 88.65 12.88 0.08 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 112.168 -2.287 . . . . 0.0 113.299 175.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.441 ' CD ' ' O ' ' A' ' 106' ' ' GLN . 0.5 OUTLIER -170.06 74.38 0.64 Allowed Pre-proline 0 C--N 1.349 0.557 0 C-N-CA 117.829 -1.548 . . . . 0.0 109.493 175.455 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 108' ' ' THR . 58.7 Cg_endo -81.26 117.72 3.19 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.841 2.36 . . . . 0.0 111.214 -178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 107' ' ' PRO . 6.1 t 45.74 117.06 0.0 OUTLIER 'General case' 0 C--N 1.347 0.471 0 CA-C-N 112.699 -2.046 . . . . 0.0 112.263 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.45 ' CD2' ' O ' ' A' ' 109' ' ' TYR . 52.3 p90 -65.99 118.35 9.65 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.669 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 108' ' ' THR . 34.3 m -115.83 127.23 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.768 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 20.7 pt20 -45.8 122.26 3.63 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 112.996 -1.911 . . . . 0.0 109.734 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.438 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.666 -179.843 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 9' ' ' TRP 0.252 60.9 Cg_endo . . . . . 0 N--CA 1.452 -0.912 0 N-CA-C 110.883 -0.468 . . . . 0.0 110.883 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 1.3 m-90 -135.22 60.68 1.69 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 -15.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CE1' ' CA ' ' A' ' 12' ' ' GLY . 50.9 t80 -90.58 124.0 34.68 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 110.928 -2.851 . . . . 0.0 112.379 -155.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.7 m-85 -127.78 92.01 3.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 112.105 -2.316 . . . . 0.0 107.862 167.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.517 ' CA ' ' CE1' ' A' ' 10' ' ' PHE . . . -54.91 116.33 6.6 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.958 -170.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' CD ' ' OE2' ' A' ' 38' ' ' GLU . 25.4 pttm 31.1 42.28 0.01 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 111.685 -2.257 . . . . 0.0 111.109 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.518 ' CG1' ' HD2' ' A' ' 18' ' ' LYS . 10.3 tp -62.79 129.2 92.85 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 112.971 -1.922 . . . . 0.0 108.843 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.4 Cg_exo -45.86 123.29 5.92 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.834 1.689 . . . . 0.0 113.194 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 15' ' ' PRO . 41.5 ttm180 -37.06 -41.86 0.38 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.707 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -56.32 -81.19 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.246 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.604 ' CE ' ' SD ' ' A' ' 22' ' ' MET . 8.1 tmtm? -31.48 -42.66 0.05 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 112.646 -2.07 . . . . 0.0 111.029 -176.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -58.05 -69.55 0.17 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.717 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' SER . 53.5 mt-10 -48.03 -52.9 18.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.592 -2.095 . . . . 0.0 110.255 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 24' ' ' SER . 77.4 mm-40 -40.4 -87.46 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.753 -2.021 . . . . 0.0 110.621 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.604 ' SD ' ' CE ' ' A' ' 18' ' ' LYS . 16.9 ptm -50.77 -53.08 34.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.088 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.543 HD13 ' CD1' ' A' ' 100' ' ' ILE . 48.3 tp -48.38 -21.93 0.62 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 117.223 -1.791 . . . . 0.0 112.681 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 37.0 t -83.18 -35.97 25.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.78 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HD3' ' CA ' ' A' ' 22' ' ' MET . 5.2 pttp -42.75 -25.18 0.08 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.028 172.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.473 ' HG3' ' CB ' ' A' ' 31' ' ' ALA . 38.6 mm-40 -53.9 141.96 25.9 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.481 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -81.71 -69.49 0.61 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 111.936 -2.393 . . . . 0.0 110.455 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -76.1 -156.97 0.07 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.749 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -122.5 130.38 52.99 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 112.75 -2.023 . . . . 0.0 110.068 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.37 34.47 1.01 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 118.236 -1.935 . . . . 0.0 111.901 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.473 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -99.9 131.93 45.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 118.114 -1.434 . . . . 0.0 108.101 173.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' SER . 40.2 p90 -143.08 157.55 44.42 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 115.231 -2.588 . . . . 0.0 111.835 -173.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -148.43 151.83 35.9 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 112.003 -2.362 . . . . 0.0 109.451 171.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.85 110.71 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 112.492 -2.14 . . . . 0.0 108.976 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 34.4 ptt180 -96.7 128.11 43.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.373 -2.194 . . . . 0.0 110.051 -174.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.439 ' O ' ' CA ' ' A' ' 13' ' ' LYS . 45.1 tt0 -79.05 126.06 30.21 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.062 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.464 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 49.9 m -58.57 138.58 56.74 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 112.781 -2.009 . . . . 0.0 109.955 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' OE2' ' CD ' ' A' ' 13' ' ' LYS . 9.7 tp10 -38.6 -90.65 0.0 OUTLIER 'General case' 0 C--N 1.345 0.375 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.624 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 40' ' ' ALA . 49.0 m -89.9 -36.55 14.97 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 113.601 -1.636 . . . . 0.0 111.259 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HB3' ' CB ' ' A' ' 37' ' ' SER . . . -42.58 150.23 0.43 Allowed Pre-proline 0 C--N 1.348 0.508 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.158 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.67 -116.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.995 2.463 . . . . 0.0 110.784 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.02 57.83 4.83 Favored Glycine 0 C--N 1.346 1.089 0 C-N-CA 118.145 -1.979 . . . . 0.0 110.869 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 3.4 m-20 -102.9 117.1 33.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 117.903 -1.519 . . . . 0.0 109.32 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.403 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 95.3 m-85 -134.24 130.28 36.92 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 112.904 -1.953 . . . . 0.0 109.839 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 77.7 p -119.0 126.38 51.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.48 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.436 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.0 tt -93.51 115.07 27.57 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.354 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.434 ' OG ' ' HG ' ' A' ' 33' ' ' LEU . 90.3 p -94.04 144.64 25.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.789 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 60.7 t -146.44 137.4 18.51 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.726 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 66.3 tttp -73.36 93.66 1.95 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 116.83 -1.948 . . . . 0.0 108.824 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.477 ' O ' ' O ' ' A' ' 51' ' ' GLY . 4.6 t80 -92.6 40.6 1.06 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.615 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . 58.6 145.37 0.01 OUTLIER Glycine 0 C--N 1.346 1.131 0 C-N-CA 118.148 -1.977 . . . . 0.0 110.54 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 8.1 t-20 72.07 -35.04 0.32 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 112.475 -1.863 . . . . 0.0 110.854 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 51' ' ' GLY . 56.2 p30 -171.45 -163.63 0.29 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 117.264 -1.775 . . . . 0.0 110.295 176.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.474 ' CG1' HD23 ' A' ' 23' ' ' LEU . 88.4 t -108.76 123.87 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 112.369 -2.196 . . . . 0.0 110.009 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -100.44 157.97 16.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.716 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.474 ' H ' ' HD2' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -136.61 133.85 36.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 112.515 -2.129 . . . . 0.0 110.304 -176.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.499 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 92.6 m-85 -113.19 111.12 21.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.927 -1.942 . . . . 0.0 109.897 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 29.6 mmmt -72.25 100.36 2.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.089 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 98.9 t -72.09 88.47 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 113.041 -1.891 . . . . 0.0 108.553 173.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 82.0 mt -74.04 160.41 31.32 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.733 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 . . . . . 0 N--CA 1.447 -0.586 0 CA-C-N 112.032 -2.349 . . . . 0.0 108.628 177.19 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 122.291 1.044 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 17.3 m-85 -86.82 142.37 28.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.244 -2.253 . . . . 0.0 109.503 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -160.22 124.71 3.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.989 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.499 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 1.7 mt -61.59 -83.49 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.155 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -110.16 -42.76 4.09 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.222 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.0 t -137.93 -82.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.599 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.4 HG11 ' CZ ' ' A' ' 83' ' ' TYR . 24.4 m -47.03 134.2 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 112.649 -2.069 . . . . 0.0 110.544 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.56 165.98 12.26 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.563 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.783 ' CZ ' HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -170.04 140.13 1.94 Allowed 'General case' 0 C--N 1.343 0.31 0 CA-C-N 111.505 -2.589 . . . . 0.0 109.631 -175.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -91.88 -13.43 31.31 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 111.692 -2.504 . . . . 0.0 112.558 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 79' ' ' GLU . 41.1 t -140.56 129.93 23.85 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 117.573 -1.651 . . . . 0.0 109.908 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 80' ' ' LEU . 99.3 mt -47.12 -39.81 14.18 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.455 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -52.0 -45.43 64.53 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.149 -1.82 . . . . 0.0 109.594 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 83' ' ' TYR . 47.4 tp10 -57.0 -32.68 66.37 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 113.16 -1.836 . . . . 0.0 111.284 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.783 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 7.1 tt -72.1 -70.83 0.31 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.333 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.6 t -37.98 -35.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 112.685 -2.052 . . . . 0.0 111.187 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -80.3 -42.07 23.72 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.563 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 65.5 t80 -58.72 -43.08 90.05 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.2 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.421 ' NE2' ' CD1' ' A' ' 69' ' ' LEU . 87.7 m-70 -89.5 39.13 0.93 Allowed 'General case' 0 C--N 1.345 0.406 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.689 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.66 HH12 HH21 ' A' ' 98' ' ' ARG . 60.7 ttm-85 -107.33 -40.63 5.33 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.368 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -89.97 -40.89 12.07 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.476 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 87' ' ' THR . 23.6 m -110.97 41.29 1.85 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 117.831 -1.547 . . . . 0.0 110.903 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.606 ' HB3' ' H ' ' A' ' 95' ' ' ILE . 41.8 m 43.14 -153.59 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.527 169.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 89' ' ' VAL . 15.0 p -153.99 44.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-N 113.058 -1.883 . . . . 0.0 109.788 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' A' ' 95' ' ' ILE . 43.0 t . . . . . 0 C--N 1.347 0.482 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.731 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 21.4 pt20 . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 122.103 0.954 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.606 ' H ' ' HB3' ' A' ' 88' ' ' SER . 64.2 mt -115.96 151.63 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 112.622 -2.081 . . . . 0.0 109.433 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -143.71 138.78 29.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.35 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.4 mt -89.92 118.54 29.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.995 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.66 HH21 HH12 ' A' ' 85' ' ' ARG . 2.0 mmp_? -126.17 149.36 49.05 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.521 -2.127 . . . . 0.0 109.875 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 101' ' ' GLU . 7.1 m-20 -54.01 124.19 14.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 112.163 -2.29 . . . . 0.0 109.83 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.543 ' CD1' HD13 ' A' ' 23' ' ' LEU . 10.6 tt -71.95 31.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 112.533 -2.121 . . . . 0.0 111.578 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 99' ' ' ASP . 47.3 mm-40 . . . . . 0 N--CA 1.448 -0.569 0 C-N-CA 118.001 -1.479 . . . . 0.0 109.651 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' O ' ' CD2' ' A' ' 9' ' ' TRP . 75.2 Cg_exo . . . . . 0 N--CA 1.459 -0.538 0 N-CA-C 116.93 1.858 . . . . 0.0 116.93 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.458 ' CD2' ' O ' ' A' ' 8' ' ' PRO . 32.5 p-90 49.25 16.65 0.16 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 111.872 -2.422 . . . . 0.0 113.502 170.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -97.77 119.13 35.82 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 116.229 -2.188 . . . . 0.0 109.653 175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 8.6 m-85 -121.92 109.14 14.26 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 113.076 -1.875 . . . . 0.0 109.164 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -69.22 129.18 23.04 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 112.56 -2.109 . . . . 0.0 111.557 -174.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.467 ' CE ' ' HB2' ' A' ' 38' ' ' GLU . 83.7 tttt 25.89 47.66 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 111.713 -2.243 . . . . 0.0 111.899 176.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.427 HG22 ' CB ' ' A' ' 35' ' ' ARG . 8.7 tp -75.21 134.0 74.45 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 117.268 -1.773 . . . . 0.0 108.8 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' ARG . 20.8 Cg_endo -65.67 124.54 12.93 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.178 1.919 . . . . 0.0 111.332 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' CZ ' ' NH2' ' A' ' 35' ' ' ARG . 94.9 mtt-85 -34.22 -41.6 0.11 Allowed 'General case' 0 C--N 1.349 0.558 0 CA-C-N 112.779 -2.009 . . . . 0.0 110.983 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -54.72 -72.13 0.07 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.243 -1.798 . . . . 0.0 109.537 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 22' ' ' MET . 4.8 tppp? -41.74 -49.52 4.3 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.492 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -47.36 -58.53 4.04 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.479 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 89.4 mt-10 -49.96 -52.06 36.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.733 -2.03 . . . . 0.0 109.989 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 70.9 mt-10 -55.53 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.891 -1.958 . . . . 0.0 110.852 -173.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 3.0 ptm -45.46 -39.99 7.81 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.773 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.532 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 45.7 tp -68.56 -32.03 71.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 117.644 -1.623 . . . . 0.0 111.755 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.534 ' C ' ' H ' ' A' ' 26' ' ' GLN . 59.3 m -68.58 -35.9 78.0 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 117.503 -1.679 . . . . 0.0 111.044 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -72.07 33.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.241 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.575 HE21 HG13 ' A' ' 100' ' ' ILE . 13.6 mm-40 -101.69 132.37 47.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 117.818 -1.553 . . . . 0.0 110.022 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -81.26 -41.93 21.45 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 111.707 -2.497 . . . . 0.0 110.599 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.49 106.88 18.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.583 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -53.74 123.94 13.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.705 -2.043 . . . . 0.0 109.419 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 136.55 -31.77 2.54 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 117.585 -2.245 . . . . 0.0 112.037 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.571 ' HB1' HE21 ' A' ' 26' ' ' GLN . . . -46.32 136.61 7.04 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 118.078 -1.449 . . . . 0.0 109.358 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 47' ' ' SER . 28.2 p90 -145.3 162.76 36.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 116.384 -2.126 . . . . 0.0 110.982 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 33' ' ' LEU . 4.5 pp -147.95 150.17 33.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.343 -2.208 . . . . 0.0 109.577 172.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.7 mt -116.92 111.98 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 112.666 -2.061 . . . . 0.0 108.662 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 40.7 ptt85 -95.59 129.09 42.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 112.634 -2.076 . . . . 0.0 110.259 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -96.96 128.36 43.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 112.45 -2.159 . . . . 0.0 109.869 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 43.2 t -60.54 155.63 18.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.845 -1.979 . . . . 0.0 109.613 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.467 ' HB2' ' CE ' ' A' ' 13' ' ' LYS . 45.3 tt0 -41.08 -91.52 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 112.563 -2.108 . . . . 0.0 110.252 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 40' ' ' ALA . 50.5 m -90.0 -44.25 9.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.1 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -41.44 102.58 0.27 Allowed Pre-proline 0 C--N 1.347 0.488 0 CA-C-N 113.218 -1.81 . . . . 0.0 110.059 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.62 -4.45 14.6 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.88 1.72 . . . . 0.0 115.079 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.45 39.63 2.69 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 118.422 -1.846 . . . . 0.0 111.108 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 54.9 m-20 -130.32 112.17 13.05 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 117.736 -1.586 . . . . 0.0 109.933 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 96.9 m-85 -147.64 117.54 7.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.867 -1.969 . . . . 0.0 109.389 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 79.0 p -122.98 128.04 49.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.486 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.487 ' CD2' ' CG2' ' A' ' 48' ' ' VAL . 6.2 tt -93.59 119.7 32.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.81 -1.995 . . . . 0.0 109.673 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 50.1 m -99.44 145.02 27.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.534 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.487 ' CG2' ' CD2' ' A' ' 46' ' ' LEU . 88.6 t -145.36 138.67 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 113.378 -1.737 . . . . 0.0 110.452 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.604 ' HZ2' ' C ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -80.35 106.56 12.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 112.869 -1.969 . . . . 0.0 108.721 173.046 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 95' ' ' ILE . 72.8 t80 -79.76 -104.33 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 116.847 -1.941 . . . . 0.0 108.928 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.91 -69.08 1.35 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 118.718 -1.706 . . . . 0.0 109.633 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.604 ' C ' ' HZ2' ' A' ' 49' ' ' LYS . 29.1 t-20 -130.4 -24.31 2.55 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 111.978 -2.111 . . . . 0.0 112.088 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -99.9 157.37 16.57 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 118.661 -1.216 . . . . 0.0 110.473 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG2' ' OG ' ' A' ' 24' ' ' SER . 88.6 t -85.25 114.59 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.693 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.415 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 9.8 tt0 -90.27 158.74 17.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.933 -1.94 . . . . 0.0 109.399 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -130.66 131.62 44.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.779 -2.01 . . . . 0.0 110.746 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 45' ' ' SER . 96.3 m-85 -123.81 133.34 53.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.432 -2.167 . . . . 0.0 109.137 175.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.6 ' HB2' ' HZ2' ' A' ' 58' ' ' LYS . 10.6 mtmp? -104.06 107.97 19.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.321 -1.752 . . . . 0.0 110.242 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 72.1 t -76.57 85.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 112.683 -2.053 . . . . 0.0 108.565 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.597 HD21 ' HZ3' ' A' ' 58' ' ' LYS . 71.9 mt -70.33 161.0 31.22 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 112.68 -2.055 . . . . 0.0 110.679 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HG3' ' CE1' ' A' ' 67' ' ' TYR . 1.9 tmt_? . . . . . 0 N--CA 1.449 -0.501 0 CA-C-N 112.392 -2.186 . . . . 0.0 109.884 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HD3' HD22 ' A' ' 75' ' ' ASN . 7.6 mtpm? . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.129 0.49 . . . . 0.0 110.004 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 55.0 m-85 -88.05 129.53 35.25 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 115.848 -2.341 . . . . 0.0 109.899 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -159.27 134.57 8.36 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 112.344 -2.207 . . . . 0.0 109.171 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.678 ' H ' HD12 ' A' ' 69' ' ' LEU . 4.2 mp -68.77 -52.95 24.9 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 116.682 -2.007 . . . . 0.0 109.247 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 18.2 m0 -135.53 -41.41 0.7 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.53 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.5 t -138.33 -83.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.546 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -47.19 133.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 112.552 -2.113 . . . . 0.0 110.782 -171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -94.21 158.38 15.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.491 -2.141 . . . . 0.0 110.592 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.878 ' CZ ' HD12 ' A' ' 80' ' ' LEU . 6.6 p90 -159.13 140.14 12.78 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 111.156 -2.747 . . . . 0.0 109.213 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.446 HD22 ' HD3' ' A' ' 66' ' ' LYS . 6.0 m120 -81.41 -16.91 50.7 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 111.247 -2.706 . . . . 0.0 112.352 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 79' ' ' GLU . 40.3 t -147.28 134.89 20.99 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 117.681 -1.608 . . . . 0.0 109.97 -175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 80' ' ' LEU . 82.6 mt -46.61 -42.89 16.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 112.724 -2.035 . . . . 0.0 110.288 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 38.5 m-80 -49.53 -46.82 49.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.545 -1.661 . . . . 0.0 109.572 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 76' ' ' SER . 41.9 tt0 -57.92 -34.72 70.16 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 112.922 -1.944 . . . . 0.0 111.098 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.878 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 5.4 tt -61.93 -65.54 0.67 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.783 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.5 t -43.83 -35.8 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 112.07 -2.332 . . . . 0.0 111.076 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 72.6 m-20 -59.87 -38.57 82.54 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.833 -178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.406 ' N ' ' O ' ' A' ' 80' ' ' LEU . 23.0 m-85 -66.24 -51.96 52.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.836 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.05 36.59 0.51 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.971 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 6.1 tpm_? -101.12 7.7 43.13 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.389 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 87' ' ' THR . 79.4 p -89.93 -78.2 0.37 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 118.656 -1.218 . . . . 0.0 109.896 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.418 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 9.2 t -170.02 39.48 0.02 OUTLIER 'General case' 0 C--N 1.346 0.451 0 C-N-CA 116.7 -2.0 . . . . 0.0 110.997 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 87' ' ' THR . 77.6 p -177.22 140.98 0.31 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 116.887 -1.925 . . . . 0.0 110.537 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.4 ' CG2' HG22 ' A' ' 95' ' ' ILE . 38.4 t -114.3 -38.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 111.985 -2.371 . . . . 0.0 110.778 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 C--N 1.346 0.446 0 C-N-CA 117.989 -1.484 . . . . 0.0 110.127 -175.372 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 50' ' ' PHE . 25.0 mt -149.29 121.39 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 117.314 -1.754 . . . . 0.0 109.963 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.582 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 67.3 m-85 -120.62 140.6 51.32 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.76 -2.018 . . . . 0.0 109.499 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.97 106.67 18.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 117.311 -1.756 . . . . 0.0 108.825 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -121.5 152.81 38.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.4 -173.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -45.08 126.82 6.31 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 112.441 -2.163 . . . . 0.0 109.52 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.575 HG13 HE21 ' A' ' 26' ' ' GLN . 15.4 tt -84.63 2.64 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 112.766 -2.016 . . . . 0.0 113.656 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 . . . . . 0 N--CA 1.447 -0.61 0 C-N-CA 117.774 -1.571 . . . . 0.0 110.303 -176.539 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.453 -0.853 0 CA-C-O 122.076 0.782 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.467 ' CB ' ' CE2' ' A' ' 32' ' ' PHE . 59.2 p-90 38.57 47.37 1.1 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-N 112.538 -2.119 . . . . 0.0 110.545 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -142.67 108.4 5.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.438 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 12' ' ' GLY . 9.8 m-85 -125.03 97.23 5.17 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.195 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -27.79 -105.7 0.0 OUTLIER Glycine 0 C--N 1.347 1.167 0 CA-C-N 112.184 -2.28 . . . . 0.0 112.77 -174.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 63.9 tttp -110.19 53.52 0.69 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 112.77 -1.715 . . . . 0.0 109.035 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.43 HG22 ' CB ' ' A' ' 35' ' ' ARG . 8.5 tp -71.08 133.74 85.68 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.977 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' ARG . 23.1 Cg_endo -66.24 124.05 12.02 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.184 1.923 . . . . 0.0 111.268 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 15' ' ' PRO . 68.1 ttt180 -33.74 -39.38 0.06 Allowed 'General case' 0 C--N 1.347 0.495 0 CA-C-N 112.766 -2.016 . . . . 0.0 111.124 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -53.55 -81.17 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.049 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 17' ' ' ALA . 16.8 tppt? -36.45 -36.54 0.1 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 112.977 -1.919 . . . . 0.0 111.374 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.549 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -59.23 -72.29 0.1 Allowed 'General case' 0 C--N 1.347 0.487 0 C-N-CA 117.375 -1.73 . . . . 0.0 109.061 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 21' ' ' GLU . 94.3 mt-10 -43.97 -56.13 4.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 112.541 -2.118 . . . . 0.0 109.801 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 11.9 mm-40 -37.05 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.317 -2.22 . . . . 0.0 110.887 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 17.7 ptm -56.84 -40.69 76.56 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 117.536 -1.666 . . . . 0.0 110.79 -172.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 39.5 tp -50.82 -32.78 21.17 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 116.922 -1.911 . . . . 0.0 111.433 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.555 ' C ' ' H ' ' A' ' 26' ' ' GLN . 41.6 t -75.51 -39.78 57.96 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.201 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -71.55 36.19 0.06 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.305 -1.77 . . . . 0.0 110.923 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.572 HE21 HG13 ' A' ' 100' ' ' ILE . 12.9 mm100 -102.28 -172.96 2.23 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 117.926 -1.509 . . . . 0.0 109.697 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.439 ' O ' ' C ' ' A' ' 28' ' ' HIS . 3.0 mpt_? -75.63 37.34 0.14 Allowed 'General case' 0 C--N 1.346 0.428 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.947 -176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 26' ' ' GLN . 78.9 m80 38.09 36.25 0.11 Allowed 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.258 176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 74.8 m-20 -141.49 76.33 1.54 Allowed 'General case' 0 C--N 1.347 0.498 0 C-N-CA 116.748 -1.981 . . . . 0.0 110.975 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.547 ' HA2' ' CG1' ' A' ' 48' ' ' VAL . . . 46.72 20.89 0.72 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 113.013 -1.903 . . . . 0.0 113.373 170.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.412 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -52.29 135.81 31.94 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 116.765 -1.974 . . . . 0.0 108.043 172.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.467 ' CE2' ' CB ' ' A' ' 9' ' ' TRP . 30.5 p90 -139.48 148.62 42.95 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 115.656 -2.418 . . . . 0.0 111.926 -169.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -139.58 150.89 45.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 112.082 -2.326 . . . . 0.0 109.333 171.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.403 HD12 ' CE3' ' A' ' 9' ' ' TRP . 60.5 mt -117.69 107.93 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.622 175.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 31.4 ptt-85 -98.38 140.21 32.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 112.904 -1.953 . . . . 0.0 110.556 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' GLY . 23.9 pt-20 -105.36 137.46 43.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.307 -2.224 . . . . 0.0 109.451 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 36' ' ' GLU . 49.9 m -57.88 -153.87 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.692 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -71.63 -95.35 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.558 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 40' ' ' ALA . 87.1 p -89.99 -41.9 11.47 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.223 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -38.83 100.68 0.21 Allowed Pre-proline 0 C--N 1.348 0.519 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.248 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' SER . 57.9 Cg_endo -77.37 -4.36 14.63 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.855 1.703 . . . . 0.0 115.034 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.49 37.37 3.63 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 118.579 -1.772 . . . . 0.0 111.378 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 49.9 m-20 -129.74 100.83 5.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 117.732 -1.587 . . . . 0.0 109.647 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 21.6 m-85 -132.32 121.33 23.37 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.662 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.439 ' OG ' ' CZ ' ' A' ' 35' ' ' ARG . 78.8 p -119.04 126.56 51.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.096 -1.866 . . . . 0.0 109.37 178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.465 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.3 tt -90.36 114.34 26.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.765 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 33.8 m -97.34 149.51 22.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.314 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.547 ' CG1' ' HA2' ' A' ' 30' ' ' GLY . 75.5 t -140.64 141.56 32.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 113.397 -1.729 . . . . 0.0 110.29 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.509 ' CG ' ' HA ' ' A' ' 28' ' ' HIS . 22.2 tptp -73.78 97.29 2.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.792 -2.004 . . . . 0.0 108.847 173.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.479 ' O ' ' O ' ' A' ' 53' ' ' ASP . 5.7 t80 -116.46 110.43 18.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.031 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 50' ' ' PHE . . . -30.97 143.8 0.01 OUTLIER Glycine 0 C--N 1.347 1.193 0 CA-C-N 112.734 -2.03 . . . . 0.0 111.826 -176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 14.0 t30 82.99 -28.69 0.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 111.848 -2.176 . . . . 0.0 111.39 -175.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.557 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 30.7 t0 -172.53 -148.01 0.04 OUTLIER 'General case' 0 C--N 1.35 0.62 0 C-N-CA 116.33 -2.148 . . . . 0.0 110.381 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.557 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 93.3 t -129.22 119.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.506 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.499 HE22 ' HB2' ' A' ' 90' ' ' SER . 10.2 tt0 -90.01 159.95 16.61 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.052 -1.885 . . . . 0.0 109.655 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -146.73 145.17 29.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.66 -175.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.419 ' CE2' HG13 ' A' ' 89' ' ' VAL . 41.0 m-85 -134.02 110.48 9.68 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.304 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 56.1 mtmt -65.83 115.28 5.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 116.299 -2.16 . . . . 0.0 109.415 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 46.7 t -78.81 102.01 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 113.244 -1.798 . . . . 0.0 108.426 174.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 78.7 mt -93.96 -167.93 1.78 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.183 -169.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 66' ' ' LYS . 34.9 tpt85 . . . . . 0 CA--C 1.539 0.528 0 CA-C-N 111.954 -2.385 . . . . 0.0 110.387 172.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.517 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 5.3 mtpm? . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 121.318 0.58 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 28.1 m-85 -94.93 139.03 31.9 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 117.512 -1.675 . . . . 0.0 110.617 -168.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.527 ' CB ' ' HA ' ' A' ' 73' ' ' LYS . 4.0 p90 -141.22 152.38 44.54 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 116.251 -2.18 . . . . 0.0 110.366 172.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.458 HD11 ' CG ' ' A' ' 80' ' ' LEU . 15.3 mt -90.49 -85.82 0.21 Allowed 'General case' 0 C--N 1.346 0.447 0 CA-C-N 112.744 -2.025 . . . . 0.0 109.633 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.403 ' CZ2' HG22 ' A' ' 89' ' ' VAL . 34.7 m0 -91.13 -44.8 9.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.887 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.7 t -145.34 -87.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 113.196 -1.82 . . . . 0.0 109.85 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.0 m -53.58 132.37 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.838 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.527 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 23.2 pttp -82.42 -162.37 0.56 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 112.818 -1.992 . . . . 0.0 109.988 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 67' ' ' TYR . 20.9 m-85 -154.8 137.38 15.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.73 -2.032 . . . . 0.0 108.726 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.517 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 54.4 p30 -65.45 -0.91 2.14 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 112.981 -1.918 . . . . 0.0 113.042 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 80.3 p 178.21 146.57 0.14 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.15 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 80' ' ' LEU . 92.6 mt -47.28 -40.29 16.44 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 116.897 -1.921 . . . . 0.0 110.176 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.437 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 25.8 m-80 -55.59 -38.15 69.03 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.809 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 76' ' ' SER . 36.5 tt0 -70.18 -23.91 63.05 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 117.49 -1.684 . . . . 0.0 111.868 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.477 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.0 tt -71.95 -49.33 38.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.046 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.79 -37.11 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 112.434 -2.166 . . . . 0.0 110.827 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 66.1 m-20 -74.66 -37.82 62.63 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 113.943 -1.481 . . . . 0.0 111.01 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 44.8 t80 -64.45 -52.34 58.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.743 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -86.27 40.55 0.88 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.564 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -73.28 -36.84 66.4 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.806 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.542 ' C ' ' H ' ' A' ' 88' ' ' SER . 46.3 m -136.87 -27.0 1.02 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 118.16 -1.416 . . . . 0.0 112.079 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' SER . 10.3 t -70.51 26.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 118.099 -1.44 . . . . 0.0 112.23 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 86' ' ' SER . 80.2 p 43.21 -166.66 0.01 OUTLIER 'General case' 0 C--N 1.348 0.521 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.235 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 89' ' ' VAL . 13.8 p -178.58 43.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 112.59 -2.096 . . . . 0.0 109.794 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.499 ' HB2' HE22 ' A' ' 55' ' ' GLN . 33.0 t . . . . . 0 N--CA 1.449 -0.476 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.406 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.466 ' O ' ' OE1' ' A' ' 94' ' ' GLN . 5.9 tm0? . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.842 0.83 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.415 HD13 ' O ' ' A' ' 94' ' ' GLN . 12.7 mm -149.38 120.93 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.139 173.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.425 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 76.3 m-85 -138.8 139.45 38.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 113.118 -1.855 . . . . 0.0 108.879 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 86.2 mt -89.66 94.05 9.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.04 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.414 ' HD3' ' CB ' ' A' ' 29' ' ' ASP . 68.7 mtp85 -92.79 137.32 32.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 111.749 -2.478 . . . . 0.0 109.913 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 101' ' ' GLU . 16.1 m-20 -48.58 118.75 2.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 112.412 -2.176 . . . . 0.0 109.377 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.572 HG13 HE21 ' A' ' 26' ' ' GLN . 11.0 tt -71.22 27.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 112.76 -2.018 . . . . 0.0 112.193 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 99' ' ' ASP . 55.2 mm-40 . . . . . 0 N--CA 1.446 -0.642 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.083 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 CA--C 1.543 0.946 0 N-CA-C 114.163 0.793 . . . . 0.0 114.163 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.69 35.04 3.15 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.265 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -110.97 109.14 19.14 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.894 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 15.7 m-85 -105.82 99.18 8.79 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 117.709 -1.596 . . . . 0.0 109.332 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -66.27 124.59 25.43 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 112.102 -2.317 . . . . 0.0 111.485 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' CA ' ' O ' ' A' ' 36' ' ' GLU . 26.0 pttm 32.39 40.31 0.02 OUTLIER 'General case' 0 C--N 1.344 0.341 0 CA-C-N 111.857 -2.171 . . . . 0.0 111.145 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.501 ' CG1' ' HD2' ' A' ' 18' ' ' LYS . 10.8 tp -68.5 127.31 93.24 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.6 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' ARG . 53.5 Cg_exo -44.98 121.89 3.88 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.753 1.635 . . . . 0.0 113.103 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 15' ' ' PRO . 43.8 ttp180 -36.68 -37.53 0.14 Allowed 'General case' 0 C--N 1.345 0.4 0 CA-C-N 112.811 -1.995 . . . . 0.0 111.178 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' GLU . . . -70.43 -59.06 3.08 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.748 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.54 ' HE3' ' SD ' ' A' ' 22' ' ' MET . 7.2 tmtm? -44.69 -49.76 10.27 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.863 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -41.58 -54.3 3.24 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.835 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' SER . 66.0 mt-10 -60.35 -34.69 74.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.214 -2.267 . . . . 0.0 111.548 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' OG ' ' A' ' 24' ' ' SER . 61.7 mt-10 -64.41 -70.76 0.21 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 117.182 -1.807 . . . . 0.0 111.05 -171.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.54 ' SD ' ' HE3' ' A' ' 18' ' ' LYS . 26.6 ptm -61.44 -39.17 89.84 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 116.836 -1.945 . . . . 0.0 110.644 -175.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.464 HD23 ' CG1' ' A' ' 54' ' ' VAL . 32.1 tp -61.28 -41.4 96.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 117.805 -1.558 . . . . 0.0 110.5 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.547 ' C ' ' H ' ' A' ' 26' ' ' GLN . 75.6 p -64.87 -37.77 88.76 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.593 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 53.9 mttt -70.98 35.9 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.001 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.547 ' H ' ' C ' ' A' ' 24' ' ' SER . 43.0 mm-40 -108.96 135.77 49.6 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 117.981 -1.488 . . . . 0.0 110.003 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' A' ' 28' ' ' HIS . 10.0 mpt_? -91.21 89.96 7.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 111.813 -2.449 . . . . 0.0 109.407 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.496 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER 117.38 121.51 0.0 OUTLIER 'General case' 0 C--N 1.349 0.547 0 CA-C-N 111.561 -2.563 . . . . 0.0 109.277 177.392 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 49' ' ' LYS . 66.7 m-20 -61.01 132.03 52.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.686 -2.052 . . . . 0.0 109.876 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 146.45 -35.14 1.34 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 118.091 -2.004 . . . . 0.0 111.732 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -43.08 150.85 0.16 Allowed 'General case' 0 C--N 1.349 0.56 0 C-N-CA 118.581 -1.248 . . . . 0.0 109.717 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 47' ' ' SER . 44.0 p90 -154.8 160.45 41.28 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 115.157 -2.617 . . . . 0.0 111.84 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.495 HD23 ' CD1' ' A' ' 100' ' ' ILE . 0.4 OUTLIER -116.91 -174.42 2.58 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.534 169.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.6 mt -147.36 103.33 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 111.103 -2.772 . . . . 0.0 107.382 153.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 50.1 ptt85 -97.47 149.34 22.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.054 -169.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 37' ' ' SER . 39.4 tt0 -114.45 142.96 45.7 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 112.021 -2.354 . . . . 0.0 110.024 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' GLU . 35.8 t -53.84 -167.52 0.0 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.783 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' ' OG ' ' A' ' 37' ' ' SER . 39.9 tt0 -98.58 -70.04 0.74 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.109 -1.859 . . . . 0.0 110.37 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 89.3 p -89.97 30.67 1.04 Allowed 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.948 -173.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -179.46 136.44 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.637 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.574 ' C ' ' H ' ' A' ' 43' ' ' ASP . 57.0 Cg_endo -72.29 -143.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.981 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 172.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 -31.76 0.39 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 118.438 -1.839 . . . . 0.0 112.517 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 41' ' ' PRO . 17.5 t70 -90.05 108.74 19.91 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.945 -175.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 23.8 m-85 -133.41 123.08 24.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.544 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 57' ' ' PHE . 79.6 p -133.82 128.67 35.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 112.952 -1.931 . . . . 0.0 109.348 177.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.463 HD22 ' CG2' ' A' ' 48' ' ' VAL . 5.5 tt -84.14 116.21 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.693 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.8 m -93.2 143.17 26.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.965 -1.925 . . . . 0.0 108.932 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.463 ' CG2' HD22 ' A' ' 46' ' ' LEU . 58.2 t -135.05 141.54 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 117.041 -1.864 . . . . 0.0 110.43 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.821 ' HA ' ' HZ3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -82.55 97.33 8.4 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.439 -2.164 . . . . 0.0 109.086 176.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.482 ' N ' ' HZ2' ' A' ' 49' ' ' LYS . 9.3 t80 -110.07 139.92 44.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 117.527 -1.669 . . . . 0.0 109.145 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 52' ' ' ASN . . . -46.33 143.01 4.77 Favored Glycine 0 C--N 1.343 0.958 0 C-N-CA 117.322 -2.37 . . . . 0.0 110.399 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 57.0 t30 77.65 -31.17 0.17 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 111.859 -2.17 . . . . 0.0 111.365 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 50' ' ' PHE . 2.8 p30 -174.93 154.31 1.84 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 115.346 -2.542 . . . . 0.0 111.829 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.464 ' CG1' HD23 ' A' ' 23' ' ' LEU . 92.2 t -72.92 125.84 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.459 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.0 tt0 -90.04 163.13 15.02 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.775 -177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -133.37 123.61 25.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 112.622 -2.081 . . . . 0.0 110.6 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.41 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 22.9 m-85 -123.19 144.99 49.0 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 112.816 -1.993 . . . . 0.0 109.403 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -105.89 116.62 32.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.232 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 80' ' ' LEU . 33.4 t -89.36 101.21 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 112.667 -2.061 . . . . 0.0 108.171 173.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' ARG . 69.4 mt -82.61 152.58 25.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 112.933 -1.94 . . . . 0.0 111.743 -166.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.507 HH12 ' HZ ' ' A' ' 68' ' ' PHE . 22.6 ptt-85 . . . . . 0 CA--C 1.538 0.484 0 CA-C-N 110.272 -3.149 . . . . 0.0 113.298 -172.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.711 ' HZ2' ' HB3' ' A' ' 73' ' ' LYS . 10.3 mtmp? . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.454 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 76.5 m-85 -97.2 127.49 43.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 117.509 -1.676 . . . . 0.0 108.987 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' HZ ' HH12 ' A' ' 61' ' ' ARG . 31.1 p90 -157.87 153.6 26.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 116.124 -2.23 . . . . 0.0 110.366 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 80' ' ' LEU . 4.7 mp -95.07 -43.02 8.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.215 -1.812 . . . . 0.0 110.031 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -138.73 -78.12 0.35 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.163 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.9 t -105.46 -85.25 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.584 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.31 131.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 112.823 -1.99 . . . . 0.0 109.874 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.711 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 64.0 mttm -102.79 179.91 4.15 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.853 -1.976 . . . . 0.0 110.304 -176.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 67' ' ' TYR . 14.1 m-85 -150.17 133.42 16.35 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 112.693 -2.049 . . . . 0.0 109.28 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.591 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -69.44 -5.46 23.94 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.119 -1.855 . . . . 0.0 113.449 -178.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 49.4 m -167.93 149.21 5.26 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 117.724 -1.591 . . . . 0.0 109.784 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.507 ' CD2' HG11 ' A' ' 59' ' ' VAL . 87.2 mt -45.71 -45.68 14.45 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.202 -1.817 . . . . 0.0 109.831 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -54.07 -41.59 68.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 112.821 -1.991 . . . . 0.0 110.512 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.459 ' HB2' HD21 ' A' ' 75' ' ' ASN . 48.5 tp10 -63.86 -31.87 73.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 116.627 -2.029 . . . . 0.0 110.941 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 69' ' ' LEU . 5.9 tt -63.16 -50.88 68.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 118.522 -1.271 . . . . 0.0 108.4 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 82' ' ' ASP . 87.4 t -54.72 -75.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.673 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.464 ' HA ' ' CD ' ' A' ' 85' ' ' ARG . 33.2 t0 -34.22 -47.49 0.29 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.617 -2.083 . . . . 0.0 111.273 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -71.7 -32.62 68.01 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.863 -172.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.421 ' C ' ' H ' ' A' ' 86' ' ' SER . 35.8 m170 -98.68 -6.73 29.1 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 117.688 -1.605 . . . . 0.0 113.18 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.464 ' CD ' ' HA ' ' A' ' 82' ' ' ASP . 9.0 ptm180 -82.42 39.11 0.58 Allowed 'General case' 0 C--N 1.348 0.533 0 C-N-CA 116.889 -1.924 . . . . 0.0 110.557 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 84' ' ' HIS . 79.9 p -150.0 -73.81 0.17 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.741 -1.572 . . . . 0.0 109.566 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.408 ' N ' ' OG ' ' A' ' 86' ' ' SER . 60.0 p -84.08 38.31 0.65 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 112.966 -1.925 . . . . 0.0 110.961 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 95' ' ' ILE . 48.4 t 48.54 -168.97 0.02 OUTLIER 'General case' 0 C--N 1.346 0.425 0 C-N-CA 117.919 -1.512 . . . . 0.0 109.888 177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.506 ' H ' ' HB ' ' A' ' 95' ' ' ILE . 13.6 p -152.51 43.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.439 0 CA-C-N 113.199 -1.818 . . . . 0.0 110.201 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.483 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 19.2 t . . . . . 0 N--CA 1.45 -0.426 0 CA-C-N 113.145 -1.843 . . . . 0.0 108.793 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' OE1' ' CZ ' ' A' ' 50' ' ' PHE . 42.8 tt0 . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 111.644 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.506 ' O ' ' CB ' ' A' ' 88' ' ' SER . 13.0 mm -102.04 147.49 8.72 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 C-N-CA 117.367 -1.733 . . . . 0.0 110.499 -175.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.577 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 90.5 m-85 -149.99 135.55 18.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.631 -2.077 . . . . 0.0 109.101 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.3 mt -89.89 118.55 29.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 116.958 -1.897 . . . . 0.0 109.553 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 17.4 tpt180 -121.33 147.85 45.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.71 -2.041 . . . . 0.0 110.258 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 101' ' ' GLU . 67.6 m-20 -61.0 116.21 4.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.431 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.495 ' CD1' HD23 ' A' ' 33' ' ' LEU . 12.0 tt -72.19 32.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.644 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' A' ' 99' ' ' ASP . 17.8 mm-40 . . . . . 0 N--CA 1.447 -0.598 0 C-N-CA 117.884 -1.526 . . . . 0.0 109.787 -174.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 CA--C 1.54 0.821 0 N-CA-C 113.872 0.682 . . . . 0.0 113.872 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.41 ' CZ3' HD12 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -133.15 32.94 3.67 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.473 -177.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -89.63 121.09 31.49 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 117.594 -1.642 . . . . 0.0 109.961 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.9 m-85 -105.28 92.38 4.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 112.962 -1.926 . . . . 0.0 108.598 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -55.82 120.46 19.03 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 112.447 -2.161 . . . . 0.0 111.584 -172.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.481 ' CA ' ' O ' ' A' ' 36' ' ' GLU . 17.4 ptpt 28.77 44.71 0.01 OUTLIER 'General case' 0 C--N 1.346 0.433 0 CA-C-N 111.591 -2.305 . . . . 0.0 111.384 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.8 tp -63.17 131.23 94.68 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.611 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.5 Cg_exo -45.25 121.43 3.75 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.719 1.612 . . . . 0.0 112.886 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.496 ' CB ' ' NH1' ' A' ' 16' ' ' ARG . 22.4 ttm105 -38.78 -40.53 0.63 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.818 -177.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -63.8 -59.92 3.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 113.47 -1.695 . . . . 0.0 109.627 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -44.65 -51.09 9.46 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 112.917 -1.947 . . . . 0.0 110.182 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -45.49 -47.02 14.11 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 113.456 -1.702 . . . . 0.0 109.842 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 88.8 mt-10 -62.65 -46.38 88.47 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.116 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 24' ' ' SER . 40.5 mt-10 -60.82 -77.93 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.693 -2.049 . . . . 0.0 110.644 -173.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 21' ' ' GLU . 2.9 ptm -43.87 -38.78 3.53 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.884 -176.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.505 HD23 ' CG1' ' A' ' 54' ' ' VAL . 28.4 tp -71.55 -33.17 68.89 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.62 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.474 ' C ' ' H ' ' A' ' 26' ' ' GLN . 53.5 m -70.41 -28.01 64.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 117.888 -1.525 . . . . 0.0 111.897 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -76.98 42.36 0.31 Allowed 'General case' 0 C--N 1.349 0.55 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.314 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.609 HE21 HG13 ' A' ' 100' ' ' ILE . 22.6 mm-40 -112.28 136.11 52.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.224 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.463 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 74.9 mtp85 -38.64 -85.26 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 111.646 -2.525 . . . . 0.0 110.37 -177.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 1.2 m-70 163.27 117.33 0.0 OUTLIER 'General case' 0 C--N 1.348 0.505 0 CA-C-N 112.506 -2.134 . . . . 0.0 107.995 -175.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -166.75 135.68 2.87 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.956 1.703 . . . . 0.0 108.462 -0.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 138.71 -9.98 3.41 Favored Glycine 0 CA--C 1.544 1.896 0 C-N-CA 117.301 -2.38 . . . . 0.0 113.41 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -46.19 144.58 1.93 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 118.372 -1.331 . . . . 0.0 109.142 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 47' ' ' SER . 53.4 p90 -147.76 160.13 43.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 115.868 -2.333 . . . . 0.0 111.424 -174.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.4 pp -149.07 153.07 37.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.001 -2.363 . . . . 0.0 109.29 173.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 45' ' ' SER . 23.0 mt -115.91 112.52 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.785 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 30.4 ptt-85 -96.71 128.52 43.74 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 112.153 -2.294 . . . . 0.0 110.394 -172.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' O ' ' CA ' ' A' ' 13' ' ' LYS . 2.9 mp0 -79.05 112.32 16.13 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.281 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.477 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 50.5 m -58.52 144.61 41.91 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 112.921 -1.945 . . . . 0.0 110.413 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.8 tp10 -46.28 -96.76 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 112.359 -2.2 . . . . 0.0 110.024 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.1 t -113.58 43.1 1.84 Allowed 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.403 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.477 ' HB3' ' CB ' ' A' ' 37' ' ' SER . . . -99.05 154.65 37.21 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 113.134 -1.848 . . . . 0.0 108.983 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' ALA . 74.7 Cg_exo -34.82 -110.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.917 2.411 . . . . 0.0 114.54 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . -47.7 -59.78 5.82 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 117.333 -2.365 . . . . 0.0 108.352 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -111.47 107.27 16.41 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 113.772 -1.214 . . . . 0.0 108.103 -45.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -90.36 137.36 32.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.128 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 27.4 t -133.39 132.35 41.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.621 -2.081 . . . . 0.0 109.335 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.501 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.7 tt -103.05 115.93 31.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.953 -1.931 . . . . 0.0 109.319 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 49.8 m -97.41 149.17 22.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.948 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 85.6 t -143.51 140.95 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 113.048 -1.887 . . . . 0.0 109.731 176.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 66.3 tttp -73.06 102.59 3.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 116.64 -2.024 . . . . 0.0 108.931 173.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 50' ' ' PHE . 62.7 t80 -88.29 -8.99 54.31 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.256 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . 88.54 134.74 4.96 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 118.875 -1.631 . . . . 0.0 109.431 -174.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 7.3 t30 71.91 -33.36 0.27 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 112.307 -1.947 . . . . 0.0 110.826 -174.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 51' ' ' GLY . 18.5 t70 -159.13 -175.57 5.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 117.416 -1.714 . . . . 0.0 109.436 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.539 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 85.5 t -114.42 121.8 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.701 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.451 ' OE1' ' CZ ' ' A' ' 57' ' ' PHE . 7.3 tt0 -90.69 159.29 16.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.769 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -141.76 143.7 33.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.024 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.524 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 83.5 m-85 -122.3 105.08 9.89 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.697 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.1 mmmp? -65.58 105.0 1.11 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.942 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 64.9 t -75.05 96.92 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.274 172.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 88.7 mt -79.41 -161.52 0.33 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.165 -170.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.578 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 111.799 -2.455 . . . . 0.0 108.378 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.539 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 3.4 mtpm? . . . . . 0 CA--C 1.543 0.7 0 CA-C-O 121.927 0.87 . . . . 0.0 113.29 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 94.0 m-85 -144.02 140.76 29.75 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.539 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -163.75 134.95 4.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 114.768 -2.773 . . . . 0.0 111.884 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -124.81 162.97 23.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 112.204 -2.271 . . . . 0.0 107.713 163.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 38.5 m0 64.86 -84.66 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 111.986 -2.37 . . . . 0.0 110.188 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 69' ' ' LEU . 51.6 t -139.16 -92.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 116.902 -1.919 . . . . 0.0 110.428 -173.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -55.28 141.29 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.677 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.419 ' C ' ' CG ' ' A' ' 74' ' ' PHE . 67.7 mttm -76.98 -165.88 0.62 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 112.821 -1.991 . . . . 0.0 109.438 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.419 ' CG ' ' C ' ' A' ' 73' ' ' LYS . 15.3 m-85 -157.06 136.45 12.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.059 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.539 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 2.6 p-10 -65.48 -5.14 7.02 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.076 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 80.2 p 178.22 153.72 0.33 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.988 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.441 ' CD2' HG11 ' A' ' 59' ' ' VAL . 94.1 mt -45.35 -42.52 10.08 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 117.386 -1.726 . . . . 0.0 110.21 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 14.0 t-20 -58.4 -40.49 82.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.239 -1.8 . . . . 0.0 110.816 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 76' ' ' SER . 43.1 tp10 -63.18 -30.11 71.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 116.644 -2.022 . . . . 0.0 111.237 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 80' ' ' LEU . 5.8 tt -71.42 -59.96 2.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.531 176.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 97.5 t -46.15 -31.99 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 112.618 -2.083 . . . . 0.0 111.501 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 90.2 m-20 -80.06 -42.08 24.41 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.362 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -59.63 -41.08 89.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.591 -1.641 . . . . 0.0 110.449 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.436 ' CG ' HG23 ' A' ' 89' ' ' VAL . 33.1 m170 -90.41 39.69 0.98 Allowed 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.54 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 85' ' ' ARG . 62.0 ttt180 -124.45 0.8 8.3 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.876 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -89.91 -45.84 8.95 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.795 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 87' ' ' THR . 9.3 t -170.05 119.21 0.6 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 117.02 -1.872 . . . . 0.0 110.597 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.561 ' HA ' ' H ' ' A' ' 95' ' ' ILE . 43.0 t 66.14 143.89 0.03 OUTLIER 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.689 -2.05 . . . . 0.0 110.963 172.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 89' ' ' VAL . 14.0 p -147.74 42.98 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.879 172.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.53 ' CB ' HD12 ' A' ' 95' ' ' ILE . 48.1 t . . . . . 0 C--N 1.347 0.469 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.39 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.418 ' HA ' ' OG ' ' A' ' 88' ' ' SER . 26.6 mt-30 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.93 0.871 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.561 ' H ' ' HA ' ' A' ' 88' ' ' SER . 40.6 mt -143.13 140.88 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.811 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.45 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 16.8 m-30 -111.67 146.45 37.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.524 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.6 mt -90.04 118.93 29.97 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 117.079 -1.848 . . . . 0.0 109.284 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 90.0 mtt-85 -122.23 146.79 46.94 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.905 -1.952 . . . . 0.0 109.97 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 100' ' ' ILE . 33.5 m-20 -57.12 122.63 12.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.759 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.621 HG12 ' H ' ' A' ' 101' ' ' GLU . 14.9 tt -59.74 -136.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 112.739 -2.028 . . . . 0.0 109.391 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.621 ' H ' HG12 ' A' ' 100' ' ' ILE . 81.0 mt-10 . . . . . 0 N--CA 1.447 -0.593 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.777 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 CA--C 1.543 0.946 0 N-CA-C 114.166 0.794 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.438 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 4.6 p-90 -161.34 31.19 0.14 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.653 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.438 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 96.5 m-85 -103.11 120.23 40.31 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.013 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 12' ' ' GLY . 8.1 m-85 -108.51 108.58 19.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.746 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -16.7 -111.57 0.0 OUTLIER Glycine 0 C--N 1.349 1.259 0 CA-C-N 111.67 -2.514 . . . . 0.0 113.016 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -116.12 43.07 2.23 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 112.978 -1.611 . . . . 0.0 109.88 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.9 tp -53.12 114.46 6.01 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.315 -178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' ARG . 47.2 Cg_exo -50.15 125.84 15.83 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.581 1.52 . . . . 0.0 111.869 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.734 ' HB3' HH12 ' A' ' 35' ' ' ARG . 18.3 ptp180 -34.7 -38.14 0.07 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.481 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -69.52 -62.44 1.38 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.455 -1.702 . . . . 0.0 109.74 178.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.521 ' CD ' HD11 ' A' ' 14' ' ' ILE . 0.1 OUTLIER -38.22 -44.43 0.86 Allowed 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.219 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -54.38 -59.88 4.09 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 112.735 -2.029 . . . . 0.0 109.459 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' ALA . 89.3 mt-10 -43.26 -43.65 4.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 112.795 -2.002 . . . . 0.0 110.263 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 24' ' ' SER . 38.5 mt-10 -60.6 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.443 -175.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.519 ' HB3' ' HZ3' ' A' ' 18' ' ' LYS . 17.3 ptm -43.28 -40.31 3.44 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.794 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 25' ' ' LYS . 31.8 tp -64.71 -36.74 85.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.132 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.51 ' OG ' ' CG2' ' A' ' 54' ' ' VAL . 63.2 m -73.23 28.71 0.06 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 117.368 -1.733 . . . . 0.0 111.656 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.551 ' H ' ' C ' ' A' ' 23' ' ' LEU . 53.1 mtpt -135.03 46.21 2.45 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.198 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.548 HE21 HG13 ' A' ' 100' ' ' ILE . 17.6 mm-40 -119.77 117.56 28.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 112.877 -1.965 . . . . 0.0 109.926 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 31.8 tpt85 -98.56 30.95 3.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 111.453 -2.612 . . . . 0.0 112.327 -169.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 29' ' ' ASP . 73.4 m80 -149.39 11.84 0.8 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 116.019 -2.273 . . . . 0.0 113.593 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' HIS . 7.6 t70 58.77 141.9 0.01 OUTLIER 'General case' 0 C--N 1.347 0.474 0 CA-C-O 122.155 0.979 . . . . 0.0 110.79 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.25 -21.82 43.76 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 117.749 -2.167 . . . . 0.0 112.932 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.514 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -42.58 117.46 1.03 Allowed 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.774 -1.17 . . . . 0.0 109.748 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.461 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 29.6 p90 -130.9 158.87 39.06 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 116.399 -2.121 . . . . 0.0 111.632 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 33' ' ' LEU . 4.5 pp -151.87 153.53 34.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 112.618 -2.083 . . . . 0.0 109.753 172.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.717 ' CD1' HD12 ' A' ' 77' ' ' LEU . 15.6 mt -121.46 113.39 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.639 -2.073 . . . . 0.0 108.793 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.734 HH12 ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -84.57 131.16 34.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 115.423 -2.511 . . . . 0.0 110.156 -175.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.9 tp10 -72.27 69.53 0.8 Allowed 'General case' 0 C--N 1.346 0.42 0 CA-C-N 112.744 -2.025 . . . . 0.0 109.401 176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' GLU . 60.0 p 24.7 -147.61 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 112.158 -2.292 . . . . 0.0 111.791 -177.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -130.58 -70.56 0.61 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 112.999 -1.909 . . . . 0.0 109.021 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.1 t -134.87 43.85 2.68 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 112.435 -2.166 . . . . 0.0 109.677 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.596 ' HB3' ' CA ' ' A' ' 41' ' ' PRO . . . -80.18 -65.14 0.29 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.471 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.596 ' CA ' ' HB3' ' A' ' 40' ' ' ALA . 84.2 Cg_endo -93.02 -2.11 49.82 Favored 'Cis proline' 0 C--N 1.357 0.978 0 N-CA-C 114.903 1.078 . . . . 0.0 114.903 -4.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.5 55.35 4.41 Favored Glycine 0 C--N 1.346 1.111 0 C-N-CA 119.052 -1.546 . . . . 0.0 111.493 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' A' ' 37' ' ' SER . 49.3 m-20 -130.35 94.63 3.71 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 117.675 -1.61 . . . . 0.0 109.676 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -110.64 127.29 55.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 112.931 -1.94 . . . . 0.0 109.698 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 20.4 p -125.17 132.34 53.06 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.25 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.4 tt -91.68 113.95 26.35 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.099 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.9 m -95.33 153.0 17.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.159 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.4 t -153.12 135.92 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 117.167 -1.813 . . . . 0.0 110.11 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 89.0 tttt -83.32 106.94 15.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 112.946 -1.933 . . . . 0.0 108.645 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -75.22 -79.44 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.57 -176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.3 -75.94 0.44 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-N 111.796 -2.456 . . . . 0.0 109.871 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.64 -24.35 9.26 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 112.107 -2.046 . . . . 0.0 111.99 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -111.6 156.78 21.26 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 118.464 -1.294 . . . . 0.0 110.115 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' CG2' ' OG ' ' A' ' 24' ' ' SER . 99.1 t -83.44 105.27 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 112.683 -2.053 . . . . 0.0 109.952 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 56' ' ' HIS . 1.0 OUTLIER -96.98 145.71 25.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.081 176.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.471 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 44.4 p-80 -134.0 168.62 18.47 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.044 -171.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.455 ' CZ ' ' OE1' ' A' ' 55' ' ' GLN . 85.3 m-85 -139.02 112.13 7.99 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 112.142 -2.299 . . . . 0.0 109.208 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.41 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 37.4 mtmm -77.74 108.93 11.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 116.203 -2.199 . . . . 0.0 109.771 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.512 HG21 ' CD1' ' A' ' 77' ' ' LEU . 89.6 t -74.68 89.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.71 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 55.2 mt -81.39 152.35 27.5 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 112.61 -2.086 . . . . 0.0 109.664 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 10.7 ttt180 . . . . . 0 N--CA 1.445 -0.69 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.76 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 4.6 mtpm? . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.236 0.541 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 87.8 m-85 -106.33 134.23 49.79 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.335 -177.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -151.79 172.04 16.77 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 116.616 -2.034 . . . . 0.0 110.983 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 80' ' ' LEU . 5.0 mp -112.17 -91.67 0.48 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 111.833 -2.44 . . . . 0.0 109.498 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -90.15 -40.59 12.13 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.789 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 82.4 t -149.44 -85.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 117.428 -1.709 . . . . 0.0 110.203 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.404 HG23 ' CE1' ' A' ' 74' ' ' PHE . 32.6 m -49.42 132.45 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.367 -174.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -87.5 151.0 23.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 112.238 -2.255 . . . . 0.0 109.963 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.404 ' CE1' HG23 ' A' ' 72' ' ' VAL . 7.2 m-85 -125.71 141.72 51.87 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 112.557 -2.11 . . . . 0.0 108.603 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.443 ' O ' ' OG ' ' A' ' 76' ' ' SER . 1.7 p-10 -56.78 -33.64 66.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 116.856 -1.937 . . . . 0.0 111.126 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 69.0 m -170.67 170.47 6.67 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 118.465 -1.294 . . . . 0.0 109.451 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.717 HD12 ' CD1' ' A' ' 34' ' ' ILE . 3.7 mm? -39.8 -46.93 2.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.355 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 76' ' ' SER . 6.0 p-10 -52.35 -50.55 62.13 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 114.798 -2.761 . . . . 0.0 110.284 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 6.6 tp10 -64.08 -15.85 60.47 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 116.502 -2.079 . . . . 0.0 112.392 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 69' ' ' LEU . 5.0 tt -83.04 -70.55 0.55 Allowed 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.42 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 81' ' ' VAL . 92.0 t -35.87 -37.7 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 112.051 -2.34 . . . . 0.0 111.146 174.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 84' ' ' HIS . 25.1 t0 -70.81 -50.83 31.31 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.898 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 84' ' ' HIS . 16.3 m-30 -78.32 42.07 0.41 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.602 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.553 ' C ' ' H ' ' A' ' 86' ' ' SER . 58.8 m80 -152.44 -21.26 0.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.275 -1.784 . . . . 0.0 112.362 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 85' ' ' ARG . 11.7 ptp85 -75.08 38.84 0.13 Allowed 'General case' 0 C--N 1.348 0.543 0 C-N-CA 117.232 -1.787 . . . . 0.0 110.701 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.553 ' H ' ' C ' ' A' ' 84' ' ' HIS . 50.4 m -110.84 -45.73 3.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.566 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' SER . 8.9 t -169.95 105.9 0.34 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.173 -1.83 . . . . 0.0 109.991 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.588 ' HA ' ' H ' ' A' ' 95' ' ' ILE . 39.2 t 54.28 164.33 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.749 -2.023 . . . . 0.0 110.491 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 89' ' ' VAL . 14.7 p -143.93 42.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.381 0 CA-C-N 112.607 -2.088 . . . . 0.0 110.039 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 37.4 t . . . . . 0 C--N 1.348 0.504 0 CA-C-N 113.607 -1.633 . . . . 0.0 109.979 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 121.952 0.882 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.588 ' H ' ' HA ' ' A' ' 88' ' ' SER . 58.5 mt -132.75 125.81 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 112.896 -1.956 . . . . 0.0 109.717 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.81 145.84 47.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.844 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.9 mt -89.95 106.7 18.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.488 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HG2' ' H ' ' A' ' 99' ' ' ASP . 47.6 ttt180 -177.16 -159.63 0.05 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.413 -2.176 . . . . 0.0 107.567 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.586 ' H ' ' HG2' ' A' ' 98' ' ' ARG . 53.4 t0 80.35 -34.23 0.13 Allowed 'General case' 0 C--N 1.346 0.424 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.638 161.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.548 HG13 HE21 ' A' ' 26' ' ' GLN . 9.4 tt -69.84 20.61 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 115.886 -2.325 . . . . 0.0 112.92 -171.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 99' ' ' ASP . 75.5 tt0 . . . . . 0 N--CA 1.444 -0.768 0 C-N-CA 117.712 -1.595 . . . . 0.0 109.592 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo . . . . . 0 CA--C 1.543 0.927 0 N-CA-C 114.708 1.003 . . . . 0.0 114.708 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.401 ' CZ2' HG21 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -165.1 36.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.731 -175.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -101.34 125.33 47.96 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.279 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 6.2 m-85 -120.91 114.67 21.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 113.199 -1.818 . . . . 0.0 108.577 175.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -75.91 124.54 7.46 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 112.447 -2.16 . . . . 0.0 111.554 -174.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.497 ' CG ' ' HA ' ' A' ' 38' ' ' GLU . 43.6 mtmt 32.3 45.42 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 111.739 -2.23 . . . . 0.0 111.243 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 14' ' ' ILE . 10.4 tp -74.45 130.84 81.23 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 113.319 -1.764 . . . . 0.0 108.836 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' ARG . 50.9 Cg_exo -46.04 121.26 4.21 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.618 1.545 . . . . 0.0 112.717 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 15' ' ' PRO . 53.3 ttp180 -40.59 -41.01 1.38 Allowed 'General case' 0 C--N 1.345 0.393 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.627 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -61.46 -68.65 0.3 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.61 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 17' ' ' ALA . 17.1 tppt? -38.5 -47.05 1.24 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.735 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.715 ' HB3' HH21 ' A' ' 35' ' ' ARG . . . -50.41 -65.97 0.47 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.226 -1.806 . . . . 0.0 109.072 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -42.65 -43.97 4.07 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.492 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 24' ' ' SER . 44.9 mt-10 -64.66 -82.3 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.602 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.409 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 27.0 ptm -47.19 -35.93 8.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.224 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.584 ' O ' ' CG ' ' A' ' 26' ' ' GLN . 49.3 tp -67.92 -32.25 72.57 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.571 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 26' ' ' GLN . 38.7 t -74.46 -34.18 63.08 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 117.915 -1.514 . . . . 0.0 111.219 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -77.86 43.89 0.44 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.928 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.584 ' CG ' ' O ' ' A' ' 23' ' ' LEU . 23.1 mm-40 -114.35 -4.25 13.01 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.266 -1.788 . . . . 0.0 114.068 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 26' ' ' GLN . 10.6 tpp180 34.33 38.74 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.564 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 26' ' ' GLN . 1.7 t-80 -158.43 107.45 1.99 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.657 -1.611 . . . . 0.0 109.856 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.6 114.58 3.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.199 -1.818 . . . . 0.0 109.683 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 137.2 -31.96 2.47 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 117.611 -2.233 . . . . 0.0 112.101 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 30' ' ' GLY . . . -40.94 127.85 2.66 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.265 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.525 ' CD1' HD23 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -136.36 136.53 39.72 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.931 -1.94 . . . . 0.0 110.097 -177.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 33' ' ' LEU . 4.2 pp -128.03 147.97 50.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 111.289 -2.687 . . . . 0.0 108.195 160.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -107.7 104.46 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 113.568 -1.651 . . . . 0.0 108.708 178.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.715 HH21 ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -84.35 127.26 33.88 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.849 -175.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 37' ' ' SER . 39.6 tt0 -90.37 130.41 36.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 112.577 -2.101 . . . . 0.0 109.781 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 40' ' ' ALA . 1.6 p -39.95 122.11 1.41 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.414 -1.721 . . . . 0.0 110.257 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HA ' ' CG ' ' A' ' 13' ' ' LYS . 61.1 tt0 -49.55 -54.45 18.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.401 -2.181 . . . . 0.0 110.56 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 p -90.03 -94.59 0.11 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.065 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' O ' ' OG ' ' A' ' 37' ' ' SER . . . -53.76 139.64 50.85 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.04 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 43' ' ' ASP . 66.5 Cg_endo -77.44 -146.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 N-CA-C 106.879 -2.008 . . . . 0.0 106.879 171.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . 63.76 -18.45 0.09 OUTLIER Glycine 0 CA--C 1.542 1.726 0 O-C-N 124.84 1.338 . . . . 0.0 113.794 172.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 41' ' ' PRO . 70.2 m-20 -126.62 135.16 50.84 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 117.746 -1.582 . . . . 0.0 110.643 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.73 -169.82 2.37 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.285 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.456 ' OG ' ' HD3' ' A' ' 35' ' ' ARG . 74.7 p -170.05 137.86 1.63 Allowed 'General case' 0 C--N 1.345 0.408 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.465 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 32' ' ' PHE . 2.6 tt -98.22 113.91 25.99 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 112.936 -1.938 . . . . 0.0 110.413 -172.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.492 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 88.8 p -95.24 133.48 39.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.385 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' CG2' HD22 ' A' ' 46' ' ' LEU . 46.9 t -135.28 147.93 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 117.496 -1.682 . . . . 0.0 109.299 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HD3' ' H ' ' A' ' 28' ' ' HIS . 63.9 tttp -83.79 100.69 11.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 115.914 -2.314 . . . . 0.0 108.955 172.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 53' ' ' ASP . 6.6 t80 -119.46 103.07 9.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.79 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -26.56 141.3 0.01 OUTLIER Glycine 0 C--N 1.348 1.227 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.942 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.576 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 87.6 m-20 104.68 -52.89 0.0 OUTLIER 'General case' 0 C--N 1.345 0.403 0 CA-C-N 111.356 -2.422 . . . . 0.0 108.111 -165.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 16.9 t70 -177.75 -173.23 0.39 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 111.584 -2.553 . . . . 0.0 109.799 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.532 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 77.9 t -88.9 119.54 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 113.112 -1.858 . . . . 0.0 109.442 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.421 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.1 tt0 -92.08 159.51 15.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.204 -1.816 . . . . 0.0 109.827 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 28.9 p80 -147.62 134.85 20.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.955 -174.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.421 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 83.3 m-85 -127.21 111.26 13.75 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 112.629 -2.078 . . . . 0.0 109.229 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -58.52 122.16 12.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 116.811 -1.955 . . . . 0.0 109.549 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' A' ' 80' ' ' LEU . 67.1 t -94.2 87.43 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 112.797 -2.002 . . . . 0.0 108.624 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.6 mt -89.17 159.34 17.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.393 -2.185 . . . . 0.0 110.855 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 . . . . . 0 N--CA 1.444 -0.733 0 CA-C-N 112.55 -2.114 . . . . 0.0 109.484 173.721 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.687 ' HZ3' ' N ' ' A' ' 66' ' ' LYS . 1.2 mmpm? . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 122.289 1.042 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -101.97 143.23 32.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 112.195 -2.275 . . . . 0.0 108.513 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 71' ' ' VAL . 52.6 p90 -149.23 -161.64 1.39 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 116.204 -2.198 . . . . 0.0 111.099 -174.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.416 ' CG ' HD11 ' A' ' 80' ' ' LEU . 11.4 mt -137.28 -37.89 0.62 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 111.677 -2.51 . . . . 0.0 110.545 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -112.15 -41.09 4.02 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.508 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 92.6 t -150.01 -79.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 117.183 -1.807 . . . . 0.0 109.689 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 71' ' ' VAL . 20.1 m -162.75 134.96 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.777 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.5 ' CD ' ' CZ ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -170.04 -33.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 114.206 -2.998 . . . . 0.0 112.977 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.5 ' CZ ' ' CD ' ' A' ' 73' ' ' LYS . 2.6 m-85 -112.29 149.07 32.89 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 116.439 -2.104 . . . . 0.0 109.758 -174.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.577 ' HA ' ' HZ2' ' A' ' 66' ' ' LYS . 27.8 p30 -103.65 19.57 19.61 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.431 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.5 t -179.24 143.8 0.21 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.644 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 34' ' ' ILE . 82.6 mt -43.02 -46.12 5.41 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.011 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 12.1 m120 -59.17 -38.1 78.93 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.924 -177.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 76' ' ' SER . 61.5 tt0 -70.38 -26.08 63.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 117.111 -1.836 . . . . 0.0 111.689 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.566 ' CD1' HG13 ' A' ' 59' ' ' VAL . 9.1 tt -66.81 -50.36 62.88 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.908 174.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.401 HG21 ' CZ2' ' A' ' 9' ' ' TRP . 95.0 t -68.1 -30.54 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.026 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 84.7 m-20 -70.59 -44.46 67.29 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 118.341 -1.344 . . . . 0.0 110.307 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 2.0 t80 -83.57 29.2 0.53 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 116.366 -2.133 . . . . 0.0 111.989 -177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.558 ' C ' ' H ' ' A' ' 86' ' ' SER . 5.8 m-70 -130.21 -25.7 2.43 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.727 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 16.7 ptm180 -72.92 35.16 0.07 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 118.447 -1.301 . . . . 0.0 111.354 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 84' ' ' HIS . 50.3 m -150.02 -43.6 0.13 Allowed 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.939 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.412 ' O ' ' OG ' ' A' ' 88' ' ' SER . 8.7 t -118.13 45.47 1.98 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.871 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 87' ' ' THR . 87.9 p 51.44 -163.59 0.06 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.811 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.31 -39.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 112.832 -1.986 . . . . 0.0 110.461 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.511 ' H ' HD12 ' A' ' 95' ' ' ILE . 43.3 t . . . . . 0 N--CA 1.45 -0.446 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.487 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.668 0.747 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 90' ' ' SER . 56.6 mt -131.93 121.23 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.215 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.461 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 83.3 m-85 -114.09 121.94 45.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.186 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 70.6 mt -90.09 104.32 16.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.122 -1.853 . . . . 0.0 110.054 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' ASP . 67.5 ttt-85 -170.53 -116.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 116.601 -2.04 . . . . 0.0 110.546 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' ARG . 10.0 t70 -30.0 112.94 0.09 Allowed 'General case' 0 C--N 1.35 0.59 0 CA-C-N 113.681 -1.6 . . . . 0.0 111.667 -172.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.443 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 15.1 tt -120.41 -39.93 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 112.389 -2.187 . . . . 0.0 111.359 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 . . . . . 0 N--CA 1.447 -0.591 0 CA-C-N 112.724 -2.034 . . . . 0.0 109.642 -176.5 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 CA--C 1.544 0.986 0 N-CA-C 114.087 0.764 . . . . 0.0 114.087 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.431 ' CZ3' ' CE1' ' A' ' 10' ' ' PHE . 1.6 p-90 -147.15 26.5 1.08 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.125 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.431 ' CE1' ' CZ3' ' A' ' 9' ' ' TRP . 92.8 m-85 -90.6 110.66 21.81 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 118.319 -1.353 . . . . 0.0 109.582 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.0 m-85 -94.96 99.38 11.41 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.184 -1.825 . . . . 0.0 108.446 174.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -70.09 140.47 32.72 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 112.202 -2.272 . . . . 0.0 111.618 -173.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' GLY . 60.4 tttp 27.73 48.24 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.007 -2.097 . . . . 0.0 111.447 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 14' ' ' ILE . 11.0 tp -80.02 124.62 82.91 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 113.227 -1.806 . . . . 0.0 108.961 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' ARG . 50.5 Cg_exo -47.24 122.19 6.18 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.622 1.548 . . . . 0.0 112.815 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.528 ' NH1' ' CG ' ' A' ' 20' ' ' GLU . 1.6 tmt_? -38.28 -42.45 0.7 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 112.922 -1.945 . . . . 0.0 110.401 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -64.62 -58.5 6.16 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.105 -1.862 . . . . 0.0 109.956 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 15' ' ' PRO . 59.1 tptt -42.93 -51.37 5.59 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 113.033 -1.894 . . . . 0.0 110.125 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.765 ' CB ' HH21 ' A' ' 35' ' ' ARG . . . -43.03 -49.31 6.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.829 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.528 ' CG ' ' NH1' ' A' ' 16' ' ' ARG . 57.0 mt-10 -63.89 -44.72 92.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.581 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 34.8 mt-10 -63.3 -78.75 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.811 -1.995 . . . . 0.0 110.759 -171.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.528 ' CE ' ' CD2' ' A' ' 33' ' ' LEU . 22.9 ptt? -46.41 -38.29 8.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.994 -175.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 31.7 tp -69.6 -35.88 75.72 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 117.558 -1.657 . . . . 0.0 111.232 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 26' ' ' GLN . 92.5 p -62.87 -27.65 69.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 117.674 -1.61 . . . . 0.0 111.73 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 25.1 mtpp -74.23 36.5 0.1 Allowed 'General case' 0 C--N 1.349 0.549 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.972 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.592 HE21 HG13 ' A' ' 100' ' ' ILE . 21.7 mm-40 -112.55 142.43 45.14 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.423 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' HIS . 10.5 mpt_? -92.6 -62.85 1.31 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 112.408 -2.178 . . . . 0.0 109.995 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 27' ' ' ARG . 36.5 m170 -58.42 -154.41 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.61 -177.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -139.59 120.08 14.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.424 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.71 -17.47 3.47 Favored Glycine 0 CA--C 1.542 1.769 0 C-N-CA 117.985 -2.055 . . . . 0.0 113.0 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -46.54 118.22 1.91 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.22 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.489 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 10.3 p90 -132.11 158.67 41.03 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 116.516 -2.074 . . . . 0.0 111.384 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.528 ' CD2' ' CE ' ' A' ' 22' ' ' MET . 4.3 pp -155.61 155.89 34.09 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 111.925 -2.398 . . . . 0.0 108.76 168.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.19 114.34 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 117.254 -1.778 . . . . 0.0 109.247 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.765 HH21 ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -80.5 125.06 29.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.072 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 37' ' ' SER . 21.5 pt-20 -116.03 133.35 56.12 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.064 -172.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.585 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 38.3 t 70.77 -14.11 0.45 Allowed 'General case' 0 C--N 1.346 0.442 0 CA-C-N 111.903 -2.408 . . . . 0.0 113.344 172.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 37' ' ' SER . 56.1 tt0 -40.32 -35.74 0.46 Allowed 'General case' 0 C--N 1.35 0.623 0 C-N-CA 117.209 -1.797 . . . . 0.0 111.224 174.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 80.4 p -148.75 72.89 1.2 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.083 -1.871 . . . . 0.0 107.976 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.93 ' HB1' ' HA ' ' A' ' 41' ' ' PRO . . . -70.57 -165.22 0.04 OUTLIER Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 112.797 -2.001 . . . . 0.0 106.275 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.93 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . 25.4 Cg_endo -63.1 -108.73 0.0 OUTLIER 'Cis proline' 0 C--N 1.353 0.769 0 O-C-N 122.299 0.631 . . . . 0.0 112.472 -0.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . -72.42 74.56 0.87 Allowed Glycine 0 C--N 1.345 1.077 0 C-N-CA 118.952 -1.594 . . . . 0.0 109.906 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.457 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 0.9 OUTLIER -131.54 105.17 7.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.047 -2.077 . . . . 0.0 109.591 -178.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 22.0 m-85 -132.83 134.19 44.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.753 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.434 ' OG ' ' HD3' ' A' ' 35' ' ' ARG . 72.0 p -127.62 138.9 52.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 112.981 -1.918 . . . . 0.0 109.389 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.494 ' CD2' HG23 ' A' ' 48' ' ' VAL . 5.4 tt -97.22 117.28 31.06 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.507 -2.133 . . . . 0.0 109.969 -174.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.6 m -96.57 141.65 29.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.242 -1.799 . . . . 0.0 109.839 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.494 HG23 ' CD2' ' A' ' 46' ' ' LEU . 92.4 t -150.8 138.4 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.039 -1.891 . . . . 0.0 110.03 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.579 ' HE3' ' H ' ' A' ' 26' ' ' GLN . 23.5 ttmm -78.53 109.32 12.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 116.503 -2.079 . . . . 0.0 108.979 171.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -77.39 -90.9 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.446 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.61 -77.98 1.39 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 112.502 -2.136 . . . . 0.0 109.974 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 52' ' ' ASN . 4.6 t-20 -117.17 -24.63 7.42 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 112.288 -1.956 . . . . 0.0 112.13 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 34.4 t0 -108.34 -178.49 3.62 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 118.029 -1.468 . . . . 0.0 109.868 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 95.1 t -98.21 117.83 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.899 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -98.27 157.81 15.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 112.874 -1.966 . . . . 0.0 109.428 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -146.02 136.88 24.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.421 -175.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HB3' HD22 ' A' ' 69' ' ' LEU . 26.5 m-85 -118.59 110.9 17.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.55 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.5 mtmm -62.62 109.48 1.41 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 117.059 -1.856 . . . . 0.0 109.405 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 77' ' ' LEU . 40.6 t -77.86 92.17 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 116.896 -1.922 . . . . 0.0 107.86 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 61' ' ' ARG . 96.9 mt -73.35 179.73 3.83 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 112.216 -2.265 . . . . 0.0 112.342 -165.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 60' ' ' LEU . 14.7 ptm180 . . . . . 0 C--N 1.349 0.545 0 CA-C-N 110.04 -3.255 . . . . 0.0 112.409 -172.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HZ2' ' HA ' ' A' ' 75' ' ' ASN . 7.6 mtpm? . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.36 0.6 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.518 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 57.0 m-85 -78.37 143.08 37.17 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 113.974 -1.467 . . . . 0.0 109.303 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' O ' ' A' ' 70' ' ' TRP . 2.7 t80 -156.05 135.53 12.38 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 116.075 -2.25 . . . . 0.0 111.016 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.536 ' CG ' HD11 ' A' ' 80' ' ' LEU . 40.2 mt -100.98 -78.54 0.52 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.13 -1.85 . . . . 0.0 109.882 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.456 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 25.7 m0 -123.24 -69.03 0.84 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.116 -1.856 . . . . 0.0 111.607 -169.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.82 -41.96 5.31 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 C-N-CA 117.6 -1.64 . . . . 0.0 111.217 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.459 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 34.4 m -115.24 142.18 29.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.648 -1.615 . . . . 0.0 109.935 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.419 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 10.0 ptpp? -82.21 -169.53 2.45 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.557 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 10.2 m-85 -150.51 136.64 18.55 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.384 -1.726 . . . . 0.0 108.911 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 76' ' ' SER . 23.4 t-20 -91.76 47.55 1.37 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 116.47 -2.092 . . . . 0.0 109.904 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 23.1 p 141.02 143.42 0.0 OUTLIER 'General case' 0 C--N 1.349 0.563 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.041 175.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.52 ' CD2' HG11 ' A' ' 59' ' ' VAL . 98.6 mt -47.75 -44.11 27.79 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 117.171 -1.812 . . . . 0.0 109.647 175.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 23.5 t-20 -57.96 -34.8 70.32 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 113.341 -1.754 . . . . 0.0 111.315 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 46.3 tp10 -62.81 -26.11 68.58 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 116.219 -2.192 . . . . 0.0 111.664 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.536 HD11 ' CG ' ' A' ' 69' ' ' LEU . 8.3 tt -85.66 -57.62 2.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.239 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 85' ' ' ARG . 97.5 t -49.43 -34.31 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 112.397 -2.183 . . . . 0.0 111.117 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 37.6 t70 -70.87 -41.0 71.97 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.627 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 79' ' ' GLU . 10.3 m-30 -62.33 -54.83 34.84 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 117.32 -1.752 . . . . 0.0 109.43 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 25.0 m170 -62.52 -30.14 71.07 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 113.074 -1.876 . . . . 0.0 111.639 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 84' ' ' HIS . 53.2 tpt85 -37.73 -36.03 0.16 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.304 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.5 p -148.82 42.77 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 117.73 -1.588 . . . . 0.0 110.394 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.588 ' O ' ' CB ' ' A' ' 88' ' ' SER . 93.4 m -132.33 -41.86 0.97 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.507 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.588 ' CB ' ' O ' ' A' ' 87' ' ' THR . 27.9 t 110.43 145.08 0.0 OUTLIER 'General case' 0 C--N 1.35 0.63 0 O-C-N 125.835 1.959 . . . . 0.0 109.693 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 90' ' ' SER . 3.6 m -92.0 21.91 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.218 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 9.2 t . . . . . 0 N--CA 1.445 -0.704 0 C-N-CA 117.315 -1.754 . . . . 0.0 109.321 -164.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 4.1 pm0 . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 121.962 0.887 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.5 mt -122.3 117.6 52.68 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.921 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -92.69 142.51 27.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.532 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 95.4 mt -89.95 105.18 17.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.816 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 99' ' ' ASP . 62.2 ttt-85 -175.6 -119.36 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 112.581 -2.1 . . . . 0.0 108.344 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 29.2 t70 25.79 48.33 0.01 OUTLIER 'General case' 0 C--N 1.348 0.508 0 O-C-N 125.234 1.584 . . . . 0.0 112.699 172.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.62 HG12 ' H ' ' A' ' 101' ' ' GLU . 7.5 tt -135.07 -146.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 117.503 -1.679 . . . . 0.0 108.991 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.62 ' H ' HG12 ' A' ' 100' ' ' ILE . 40.6 mm-40 . . . . . 0 N--CA 1.446 -0.659 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.473 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.54 0.791 0 N-CA-C 110.972 -0.434 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.429 ' CB ' ' CZ ' ' A' ' 32' ' ' PHE . 36.8 p-90 -86.56 7.27 26.91 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.501 -174.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -89.37 111.07 21.83 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 117.322 -1.751 . . . . 0.0 109.879 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 12' ' ' GLY . 33.5 m-85 -112.08 121.73 45.8 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.25 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -56.33 -151.38 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.928 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.633 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -72.8 77.96 1.13 Allowed 'General case' 0 C--N 1.346 0.445 0 C-N-CA 117.153 -1.819 . . . . 0.0 109.618 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.0 tp -79.1 130.76 68.51 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.247 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.2 Cg_exo -47.4 124.54 9.44 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.984 1.789 . . . . 0.0 113.133 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.843 ' CG ' HH22 ' A' ' 35' ' ' ARG . 69.0 mtp180 -37.33 -42.73 0.5 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.67 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -58.89 -75.46 0.05 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.212 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 17' ' ' ALA . 56.9 tptt -36.64 -36.81 0.12 Allowed 'General case' 0 C--N 1.345 0.379 0 CA-C-N 112.979 -1.919 . . . . 0.0 111.457 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -63.21 -66.5 0.53 Allowed 'General case' 0 C--N 1.347 0.469 0 C-N-CA 117.387 -1.725 . . . . 0.0 109.567 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.409 ' HA ' HG21 ' A' ' 54' ' ' VAL . 63.2 mt-10 -47.98 -54.69 12.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.864 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 24' ' ' SER . 11.4 mm-40 -52.8 -84.41 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.791 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.575 ' C ' ' SD ' ' A' ' 22' ' ' MET . 2.9 ppp? -43.18 -43.78 4.82 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.609 -172.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' N ' ' SD ' ' A' ' 22' ' ' MET . 37.2 tp -66.78 -35.32 79.8 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.998 -1.91 . . . . 0.0 111.475 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 26' ' ' GLN . 37.4 t -70.47 -40.03 73.89 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 117.796 -1.562 . . . . 0.0 110.484 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -73.11 35.42 0.08 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.859 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.516 ' HG3' ' CB ' ' A' ' 31' ' ' ALA . 29.5 mm-40 -101.53 153.43 19.73 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 117.108 -1.837 . . . . 0.0 110.837 -174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -72.07 87.73 1.07 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 111.819 -2.446 . . . . 0.0 109.55 -177.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER 69.04 145.9 0.05 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 111.942 -2.39 . . . . 0.0 111.049 170.031 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 22.7 t70 -31.94 133.99 0.09 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 111.5 -2.591 . . . . 0.0 111.462 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 96' ' ' PHE . . . 142.02 -41.62 1.2 Allowed Glycine 0 C--N 1.348 1.237 0 C-N-CA 117.665 -2.207 . . . . 0.0 112.198 169.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HB2' ' H ' ' A' ' 100' ' ' ILE . . . -47.49 136.17 10.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 117.533 -1.667 . . . . 0.0 109.512 -176.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' CB ' HG22 ' A' ' 48' ' ' VAL . 12.6 p90 -143.8 158.08 43.93 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 115.636 -2.426 . . . . 0.0 111.503 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 33' ' ' LEU . 4.6 pp -153.58 146.64 24.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 112.399 -2.182 . . . . 0.0 109.812 170.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 45' ' ' SER . 45.6 mt -108.05 115.56 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 112.562 -2.108 . . . . 0.0 108.549 172.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.843 HH22 ' CG ' ' A' ' 16' ' ' ARG . 10.0 ptm180 -101.74 128.91 47.86 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.57 -2.104 . . . . 0.0 110.865 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 37.8 mt-10 -76.76 144.86 38.95 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.317 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 40' ' ' ALA . 96.5 p -59.31 -168.2 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 117.292 -1.763 . . . . 0.0 109.029 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 29.5 tp10 -100.47 -49.13 4.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.433 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 44.8 t -132.47 64.01 1.61 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.342 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' O ' ' OG ' ' A' ' 37' ' ' SER . . . 178.49 68.47 0.11 Allowed Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.462 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -64.37 -3.46 6.39 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.137 1.891 . . . . 0.0 115.302 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.86 34.23 5.34 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 118.575 -1.774 . . . . 0.0 111.364 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -150.08 121.96 8.16 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 118.464 -1.295 . . . . 0.0 109.45 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 59' ' ' VAL . 79.2 m-85 -130.75 156.15 45.44 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 113.052 -1.886 . . . . 0.0 109.796 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 77.5 p -141.51 154.07 45.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.231 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' A' ' 48' ' ' VAL . 4.9 tt -119.23 114.95 23.21 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 113.504 -1.68 . . . . 0.0 109.595 -177.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 49.8 m -108.62 133.59 52.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.671 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' A' ' 46' ' ' LEU . 91.1 t -134.16 133.9 55.52 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.548 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 29' ' ' ASP . 42.3 tptt -55.56 97.11 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 112.785 -2.007 . . . . 0.0 107.719 168.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 48' ' ' VAL . 5.7 t80 -107.97 118.19 36.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 117.74 -1.584 . . . . 0.0 109.858 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.57 -94.65 0.06 OUTLIER Glycine 0 C--N 1.344 1.028 0 C-N-CA 117.971 -2.061 . . . . 0.0 110.323 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -123.06 -26.74 4.31 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.862 -1.669 . . . . 0.0 112.175 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 29.0 t0 -110.04 -174.65 2.54 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 118.022 -1.471 . . . . 0.0 109.663 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.543 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 93.0 t -103.85 122.24 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 113.079 -1.873 . . . . 0.0 109.685 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.419 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.0 tt0 -98.89 162.78 12.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 112.913 -1.949 . . . . 0.0 109.779 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.41 ' CD2' ' C ' ' A' ' 56' ' ' HIS . 6.7 t60 -141.02 133.73 28.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 112.799 -2.0 . . . . 0.0 110.546 -171.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.419 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 85.7 m-85 -137.1 104.06 5.32 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.094 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -63.2 111.74 2.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.159 -1.837 . . . . 0.0 110.088 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.514 HG11 ' CD2' ' A' ' 77' ' ' LEU . 97.6 t -77.33 72.12 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 112.934 -1.939 . . . . 0.0 108.437 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 99.1 mt -76.74 168.36 20.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.521 -2.127 . . . . 0.0 110.335 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.3 ptm180 . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 116.868 -1.933 . . . . 0.0 109.56 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.495 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 6.0 mtpm? . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.506 0.669 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 89.7 m-85 -85.31 157.62 20.51 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.259 -168.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -174.99 155.05 1.93 Allowed 'General case' 0 C--N 1.348 0.543 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.34 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.448 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 4.7 mp -92.12 -44.08 9.02 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 116.896 -1.922 . . . . 0.0 109.928 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 13.7 m0 -136.97 -43.09 0.57 Allowed 'General case' 0 C--N 1.346 0.427 0 CA-C-N 113.381 -1.736 . . . . 0.0 110.466 -177.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.3 t -139.62 -84.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.34 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.1 m -49.11 130.75 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 112.904 -1.953 . . . . 0.0 110.106 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 56.2 mttp -101.38 148.12 25.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.119 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.411 ' CE2' HD12 ' A' ' 69' ' ' LEU . 4.3 m-85 -117.03 150.13 39.13 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.634 -173.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.495 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 32.7 p-10 -75.37 -19.35 59.62 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.291 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 79' ' ' GLU . 83.3 p -167.37 154.06 8.28 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 118.666 -1.214 . . . . 0.0 109.342 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.514 ' CD2' HG11 ' A' ' 59' ' ' VAL . 90.4 mt -47.26 -43.69 22.35 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.042 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -50.05 -40.15 44.27 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 113.248 -1.796 . . . . 0.0 110.536 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 76' ' ' SER . 36.6 tp10 -70.05 -24.01 63.18 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.924 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.489 ' C ' HD23 ' A' ' 80' ' ' LEU . 7.8 tt -69.38 -58.29 4.19 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 117.905 -1.518 . . . . 0.0 108.351 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.6 t -48.8 -19.22 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 112.572 -2.104 . . . . 0.0 112.294 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 64.8 m-20 -90.03 -37.11 14.52 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.453 174.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -50.15 -50.55 48.5 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 116.952 -1.899 . . . . 0.0 108.689 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.459 ' CE1' HD21 ' A' ' 80' ' ' LEU . 57.7 m170 -61.98 -64.3 0.98 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 111.986 -2.37 . . . . 0.0 108.2 168.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 45.0 tpt85 67.79 -65.54 0.24 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 125.804 1.94 . . . . 0.0 108.657 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 87' ' ' THR . 48.2 t -89.85 -113.27 0.07 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 112.002 -2.363 . . . . 0.0 105.16 156.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 88' ' ' SER . 9.7 t -170.36 -133.97 0.02 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 117.841 -1.543 . . . . 0.0 110.724 169.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 87' ' ' THR . 3.2 m 143.19 -58.98 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.117 -1.856 . . . . 0.0 107.872 -168.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.553 ' CG2' HG13 ' A' ' 95' ' ' ILE . 0.8 OUTLIER 51.44 4.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 112.661 -2.063 . . . . 0.0 113.537 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 117.552 -1.659 . . . . 0.0 112.198 -164.028 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 94' ' ' GLN . 21.5 mm100 . . . . . 0 N--CA 1.445 -0.686 0 CA-C-O 121.973 0.892 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.617 HG22 ' H ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -91.47 -156.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 112.788 -2.006 . . . . 0.0 108.97 -177.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.617 ' H ' HG22 ' A' ' 95' ' ' ILE . 90.6 m-85 -150.07 145.19 26.23 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 113.406 -1.725 . . . . 0.0 109.289 170.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.455 ' O ' ' CG ' ' A' ' 98' ' ' ARG . 83.2 mt -113.94 77.93 1.1 Allowed 'General case' 0 C--N 1.346 0.436 0 C-N-CA 117.376 -1.729 . . . . 0.0 109.317 173.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 42.6 mtp180 -154.73 -123.21 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 112.951 -1.931 . . . . 0.0 108.864 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.6 t0 39.13 -117.08 0.21 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.812 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.604 HG12 ' H ' ' A' ' 101' ' ' GLU . 6.8 tt 38.08 -149.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.545 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.99 -171.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.604 ' H ' HG12 ' A' ' 100' ' ' ILE . 79.1 mm-40 . . . . . 0 N--CA 1.445 -0.676 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.955 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 64.6 Cg_endo . . . . . 0 CA--C 1.541 0.861 0 N-CA-C 110.468 -0.628 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.417 ' CG ' ' CE2' ' A' ' 32' ' ' PHE . 39.9 p-90 -62.85 1.17 0.43 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.557 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -84.0 119.75 25.3 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 117.097 -1.841 . . . . 0.0 109.952 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 12' ' ' GLY . 7.3 m-85 -115.69 121.92 43.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.167 -1.833 . . . . 0.0 107.838 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -57.39 -146.49 0.01 OUTLIER Glycine 0 CA--C 1.531 1.09 0 CA-C-N 112.685 -2.052 . . . . 0.0 110.85 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 59.2 pttt -74.04 75.45 1.72 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 117.069 -1.853 . . . . 0.0 109.755 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.0 tp -85.12 129.33 56.36 Favored Pre-proline 0 N--CA 1.447 -0.591 0 CA-C-N 112.734 -2.03 . . . . 0.0 108.674 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.1 Cg_exo -45.55 120.83 3.52 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.542 1.495 . . . . 0.0 112.465 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 15' ' ' PRO . 61.2 ttt85 -39.49 -39.46 0.7 Allowed 'General case' 0 C--N 1.345 0.37 0 CA-C-N 112.976 -1.92 . . . . 0.0 110.806 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -65.35 -66.54 0.53 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.411 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 17' ' ' ALA . 24.4 tptm -37.12 -38.65 0.21 Allowed 'General case' 0 C--N 1.347 0.475 0 CA-C-N 112.95 -1.932 . . . . 0.0 111.118 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -54.79 -65.98 0.48 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.059 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 24' ' ' SER . 93.6 mt-10 -45.86 -44.02 14.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 112.396 -2.184 . . . . 0.0 110.313 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.465 ' O ' ' OG ' ' A' ' 24' ' ' SER . 66.2 mt-10 -61.81 -78.7 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.719 -172.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.573 ' SD ' HD11 ' A' ' 100' ' ' ILE . 3.8 ppp? -54.39 -37.23 64.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 117.47 -1.692 . . . . 0.0 110.968 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.548 ' N ' ' SD ' ' A' ' 22' ' ' MET . 40.0 tp -69.22 -30.35 68.48 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.89 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.549 ' C ' ' H ' ' A' ' 26' ' ' GLN . 78.2 p -69.67 -29.13 66.51 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 117.326 -1.75 . . . . 0.0 111.407 176.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 5.4 mtpm? -72.38 33.3 0.06 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.133 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.732 HE21 ' CB ' ' A' ' 31' ' ' ALA . 15.0 mm100 -107.52 145.15 33.5 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 117.829 -1.549 . . . . 0.0 109.498 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 28' ' ' HIS . 95.8 mtt180 -75.5 38.23 0.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 112.388 -2.187 . . . . 0.0 110.798 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.528 ' H ' ' C ' ' A' ' 26' ' ' GLN . 0.8 OUTLIER 44.62 89.79 0.01 OUTLIER 'General case' 0 C--N 1.348 0.527 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.541 -178.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 41.9 m-20 -158.06 37.21 0.25 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.092 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.581 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 81.75 -4.62 73.5 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 115.947 -3.025 . . . . 0.0 113.205 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.732 ' CB ' HE21 ' A' ' 26' ' ' GLN . . . -40.55 117.69 0.85 Allowed 'General case' 0 C--N 1.352 0.7 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.705 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 47' ' ' SER . 23.8 p90 -137.78 154.79 49.53 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 116.5 -2.08 . . . . 0.0 110.943 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 33' ' ' LEU . 4.5 pp -152.92 149.02 27.81 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 112.379 -2.191 . . . . 0.0 109.276 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 45' ' ' SER . 46.4 mt -109.51 115.89 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 112.418 -2.174 . . . . 0.0 108.569 174.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.427 ' CB ' HG22 ' A' ' 14' ' ' ILE . 8.5 ptm180 -99.22 125.48 44.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.678 -2.055 . . . . 0.0 110.422 -174.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 72.7 tt0 -89.62 120.64 31.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.354 -2.203 . . . . 0.0 109.748 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 46.5 t -46.05 138.36 5.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.887 -1.961 . . . . 0.0 110.026 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.413 ' HA ' ' CB ' ' A' ' 13' ' ' LYS . 64.8 mt-10 -41.1 -76.53 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.569 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 t -102.09 51.02 0.83 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 112.514 -2.13 . . . . 0.0 110.367 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 37' ' ' SER . . . -171.35 97.84 0.41 Allowed Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.579 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.445 ' O ' ' CE1' ' A' ' 44' ' ' PHE . 54.2 Cg_endo -75.46 -4.27 15.05 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.744 1.629 . . . . 0.0 115.014 -177.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.67 40.06 2.6 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 118.697 -1.716 . . . . 0.0 110.876 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -145.99 118.4 8.46 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 118.227 -1.389 . . . . 0.0 109.604 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 84.9 m-85 -139.91 157.82 45.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 112.993 -1.912 . . . . 0.0 109.56 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.8 p -156.01 129.22 8.13 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.515 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 46' ' ' LEU . 4.5 tt -89.1 113.43 24.57 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 113.105 -1.861 . . . . 0.0 109.711 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.458 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 79.1 p -94.88 149.48 21.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.766 -2.015 . . . . 0.0 109.577 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 73.7 t -146.82 138.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.027 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.482 ' HG2' ' H ' ' A' ' 28' ' ' HIS . 42.2 tptt -69.12 98.17 0.97 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 112.964 -1.925 . . . . 0.0 109.242 176.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 53' ' ' ASP . 7.2 t80 -115.21 108.98 17.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.934 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.526 ' H ' ' CD2' ' A' ' 28' ' ' HIS . . . -25.97 144.44 0.01 OUTLIER Glycine 0 C--N 1.348 1.207 0 CA-C-N 112.325 -2.216 . . . . 0.0 112.294 -175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 59.6 t30 86.99 -30.53 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 111.66 -2.27 . . . . 0.0 111.226 -175.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 22.1 t70 -174.68 -170.84 0.51 Allowed 'General case' 0 C--N 1.35 0.622 0 C-N-CA 116.232 -2.187 . . . . 0.0 110.388 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.551 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 86.4 t -102.15 118.68 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.338 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.418 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 10.9 tt0 -90.08 158.49 17.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 113.111 -1.859 . . . . 0.0 109.613 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.63 142.9 27.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.658 -2.065 . . . . 0.0 110.514 -175.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 88.3 m-85 -126.77 101.94 6.83 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.53 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.0 mtmm -60.08 122.68 14.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.908 -1.951 . . . . 0.0 109.594 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.525 HG11 ' CD2' ' A' ' 77' ' ' LEU . 37.1 t -79.89 97.57 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 112.845 -1.979 . . . . 0.0 108.047 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 94.6 mt -91.42 178.79 5.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.183 -165.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 9.9 tpt180 . . . . . 0 C--N 1.347 0.466 0 CA-C-N 111.207 -2.724 . . . . 0.0 109.519 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 6.0 mtpm? . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 121.428 0.632 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.516 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 76.4 m-85 -97.52 134.34 40.89 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 117.881 -1.527 . . . . 0.0 110.342 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -152.17 148.69 27.91 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 116.606 -2.038 . . . . 0.0 110.679 176.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.454 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 5.4 mt -86.06 -49.01 8.12 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 112.773 -2.012 . . . . 0.0 109.456 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 20.7 m0 -133.15 -77.48 0.49 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.852 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.1 t -107.15 -83.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.901 -1.954 . . . . 0.0 109.611 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.3 m -50.8 131.27 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 112.648 -2.069 . . . . 0.0 110.023 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 66.7 mttm -88.93 -169.94 2.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.721 -2.036 . . . . 0.0 109.951 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 73' ' ' LYS . 37.7 m-85 -152.88 135.06 14.91 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.127 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.425 ' O ' ' OG ' ' A' ' 76' ' ' SER . 1.7 m120 -64.12 -16.87 62.74 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.561 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 46.9 m -168.69 160.54 10.71 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.83 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' CD2' HG11 ' A' ' 59' ' ' VAL . 89.4 mt -45.51 -41.98 10.25 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 117.268 -1.773 . . . . 0.0 110.362 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 52.8 t30 -55.8 -39.34 71.18 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.382 -1.735 . . . . 0.0 110.893 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.4 OUTLIER -67.89 -28.64 67.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 117.347 -1.741 . . . . 0.0 111.452 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.6 tt -65.68 -47.37 75.7 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 118.708 -1.197 . . . . 0.0 109.088 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 85' ' ' ARG . 70.6 t -64.57 -31.25 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 112.756 -2.02 . . . . 0.0 111.594 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 57.0 m-20 -74.57 -42.95 57.84 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.116 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -58.82 -46.05 88.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 117.104 -1.839 . . . . 0.0 109.096 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 85' ' ' ARG . 60.1 m-70 -92.76 32.39 1.25 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.143 -1.844 . . . . 0.0 110.965 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 84' ' ' HIS . 35.2 ptt-85 -40.24 -35.09 0.37 Allowed 'General case' 0 C--N 1.349 0.568 0 C-N-CA 118.309 -1.356 . . . . 0.0 110.935 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.8 p -89.93 -80.61 0.31 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 117.803 -1.559 . . . . 0.0 108.206 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 95' ' ' ILE . 14.8 t -170.16 -169.97 0.92 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.51 -1.677 . . . . 0.0 109.925 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.659 ' H ' ' CG1' ' A' ' 89' ' ' VAL . 29.3 t -121.25 -96.02 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 112.116 -2.311 . . . . 0.0 107.622 160.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.659 ' CG1' ' H ' ' A' ' 88' ' ' SER . 4.0 m -142.18 41.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.953 1 C-N-CA 133.737 4.815 . . . . 0.0 108.684 -8.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 12.0 t . . . . . 0 N--CA 1.448 -0.531 0 CA-C-N 112.821 -1.99 . . . . 0.0 109.06 -154.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.417 ' C ' HG12 ' A' ' 95' ' ' ILE . 23.1 mm100 . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.279 0.561 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.602 HG13 ' H ' ' A' ' 89' ' ' VAL . 5.8 mm -142.97 165.39 15.8 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 117.779 -1.568 . . . . 0.0 109.298 -176.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.581 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 86.1 m-85 -150.07 155.16 39.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.657 -1.611 . . . . 0.0 109.894 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.412 ' C ' ' CE1' ' A' ' 32' ' ' PHE . 58.0 mt -116.2 90.92 3.44 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 113.659 -1.61 . . . . 0.0 109.083 169.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 99' ' ' ASP . 71.4 mtp180 -156.47 -147.79 0.2 Allowed 'General case' 0 C--N 1.346 0.446 0 CA-C-N 112.951 -1.932 . . . . 0.0 108.803 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 100' ' ' ILE . 33.7 t0 48.1 -177.87 0.01 OUTLIER 'General case' 0 C--N 1.348 0.506 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.674 172.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.573 HD11 ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER 84.29 6.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 112.93 -1.941 . . . . 0.0 113.967 177.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 . . . . . 0 N--CA 1.445 -0.685 0 C-N-CA 118.415 -1.314 . . . . 0.0 109.581 -178.052 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 69.6 Cg_endo . . . . . 0 N--CA 1.454 -0.808 0 N-CA-C 108.867 -1.244 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.413 ' H ' ' HB2' ' A' ' 8' ' ' PRO . 5.9 p-90 -83.72 16.34 2.77 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 118.386 -1.326 . . . . 0.0 112.782 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -93.36 125.06 37.77 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.419 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.453 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 83.5 m-85 -130.02 118.33 21.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 117.301 -1.76 . . . . 0.0 110.088 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.535 ' CA ' ' C ' ' A' ' 13' ' ' LYS . . . 137.83 -161.35 25.46 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 115.823 -3.084 . . . . 0.0 112.488 166.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' C ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -57.4 115.8 2.94 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 112.648 -1.776 . . . . 0.0 111.081 0.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.469 ' N ' ' CA ' ' A' ' 12' ' ' GLY . 9.8 tp -106.02 133.77 20.06 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.253 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.3 Cg_exo -46.24 121.75 4.83 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.788 1.659 . . . . 0.0 112.933 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 15' ' ' PRO . 95.0 mtt180 -42.94 -41.18 3.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.479 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -62.8 -61.61 2.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.795 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 17' ' ' ALA . 58.5 tptt -43.02 -44.24 4.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.051 -1.886 . . . . 0.0 110.275 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -48.4 -62.57 1.42 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.148 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 21' ' ' GLU . 46.8 mt-10 -44.95 -65.0 0.59 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.346 -2.206 . . . . 0.0 109.901 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 20' ' ' GLU . 69.1 mt-10 -37.51 -85.7 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.039 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.505 ' CA ' ' HD3' ' A' ' 25' ' ' LYS . 26.5 ptt? -48.62 -52.39 23.32 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 117.495 -1.682 . . . . 0.0 110.233 -176.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.517 HD13 ' CD1' ' A' ' 100' ' ' ILE . 42.0 tp -50.62 -22.92 2.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 117.145 -1.822 . . . . 0.0 112.708 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 21' ' ' GLU . 90.3 p -83.82 -33.13 24.99 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.115 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.505 ' HD3' ' CA ' ' A' ' 22' ' ' MET . 8.2 pttm -42.29 -25.88 0.09 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 113.538 -1.664 . . . . 0.0 112.018 172.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 35.5 mm-40 -55.58 161.37 2.07 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.282 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 6.5 mpt_? -119.0 -41.95 2.73 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.057 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.19 107.78 19.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.691 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -47.76 125.51 8.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.505 -2.134 . . . . 0.0 109.728 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 138.5 -29.47 2.59 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 117.35 -2.357 . . . . 0.0 112.485 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.73 138.59 8.24 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 117.829 -1.549 . . . . 0.0 109.181 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' SER . 37.5 p90 -142.94 156.11 44.83 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 116.09 -2.244 . . . . 0.0 111.515 -174.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -146.93 150.94 36.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.448 -2.16 . . . . 0.0 109.334 169.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.7 mt -111.08 108.16 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 113.025 -1.898 . . . . 0.0 108.577 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 37.0 ptt180 -92.72 135.8 33.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.67 -2.059 . . . . 0.0 110.805 -172.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.8 pt-20 -91.71 128.38 37.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.694 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 36' ' ' GLU . 49.8 m -54.51 -165.27 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.182 -1.826 . . . . 0.0 109.822 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -81.61 -98.41 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.423 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.4 t -94.24 43.64 1.11 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.015 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.26 94.75 7.6 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 113.227 -1.806 . . . . 0.0 109.448 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.39 -4.79 15.48 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.954 1.769 . . . . 0.0 114.943 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.95 39.45 2.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 118.864 -1.636 . . . . 0.0 110.932 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 57.0 t0 -143.38 106.84 4.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 118.264 -1.375 . . . . 0.0 109.652 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 23.4 m-85 -133.85 120.22 20.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.533 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.3 p -113.6 125.95 54.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.643 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' A' ' 48' ' ' VAL . 5.4 tt -85.44 117.2 24.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 112.817 -1.992 . . . . 0.0 109.562 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.484 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 49.9 m -94.83 144.52 25.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.533 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' A' ' 46' ' ' LEU . 78.6 t -151.57 131.41 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.735 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 66.2 tttp -76.32 106.13 7.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 116.754 -1.979 . . . . 0.0 108.427 174.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -104.37 37.53 2.08 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 113.212 -1.813 . . . . 0.0 111.524 -172.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.82 -95.34 0.26 Allowed Glycine 0 C--N 1.346 1.109 0 C-N-CA 117.249 -2.405 . . . . 0.0 110.811 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 52.2 t-20 -107.19 -31.42 8.24 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 112.675 -1.763 . . . . 0.0 111.411 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 34.2 t70 -120.85 -176.81 3.33 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.499 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.549 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 94.6 t -100.23 122.79 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.2 -175.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.42 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.1 tt0 -97.36 159.53 14.86 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.778 -2.01 . . . . 0.0 109.486 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -139.69 134.98 32.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.748 -2.023 . . . . 0.0 110.522 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.447 ' CZ ' ' O ' ' A' ' 89' ' ' VAL . 97.4 m-85 -123.88 101.56 7.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.409 176.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 55.1 mtmt -58.85 100.25 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 116.59 -2.044 . . . . 0.0 109.612 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.528 HG13 ' CD1' ' A' ' 80' ' ' LEU . 93.6 t -70.33 86.22 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 112.984 -1.917 . . . . 0.0 108.563 174.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 77.2 mt -78.76 163.04 25.71 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.752 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.2 ptm180 . . . . . 0 N--CA 1.448 -0.556 0 CA-C-N 113.075 -1.875 . . . . 0.0 109.205 173.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.502 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 21.8 mtpp . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.415 0.626 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 90.1 m-85 -71.13 147.68 48.16 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.476 -173.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 17.1 p90 -166.01 167.53 16.45 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.418 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 80' ' ' LEU . 4.7 mp -124.94 97.76 5.4 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.06 173.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.44 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 34.4 m0 73.63 -39.2 0.43 Allowed 'General case' 0 C--N 1.346 0.414 0 CA-C-N 112.774 -2.012 . . . . 0.0 110.786 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' A' ' 69' ' ' LEU . 84.5 t -150.04 -85.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 117.56 -1.656 . . . . 0.0 110.549 -174.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 31.0 m -49.33 135.8 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.591 -173.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 74' ' ' PHE . 2.5 mptp? -99.21 -179.25 4.18 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.797 -2.001 . . . . 0.0 111.04 -176.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.435 ' CG ' ' O ' ' A' ' 73' ' ' LYS . 19.4 m-85 -158.63 137.17 10.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 111.74 -2.482 . . . . 0.0 108.842 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.502 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 56.6 p30 -62.18 -9.3 7.28 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 113.227 -1.806 . . . . 0.0 112.963 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 42.8 t -179.05 152.57 0.57 Allowed 'General case' 0 C--N 1.349 0.555 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.697 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.518 ' CD2' HG11 ' A' ' 59' ' ' VAL . 77.1 mt -43.14 -43.96 4.8 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 113.184 -1.826 . . . . 0.0 110.212 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.636 ' H ' HD22 ' A' ' 78' ' ' ASN . 5.3 m-80 -55.3 -39.52 69.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.918 -1.946 . . . . 0.0 110.791 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 36.0 tt0 -69.36 -35.12 75.55 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 116.882 -1.927 . . . . 0.0 110.812 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 69' ' ' LEU . 6.5 tt -57.7 -49.09 77.66 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.949 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.6 t -63.58 -40.46 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 112.505 -2.134 . . . . 0.0 110.647 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.43 -44.57 96.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.204 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 87' ' ' THR . 4.1 m-85 -63.84 -42.84 97.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.854 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.422 ' O ' HD12 ' A' ' 97' ' ' LEU . 9.0 m-70 -93.48 41.69 1.09 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 117.684 -1.607 . . . . 0.0 110.294 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -94.54 -41.02 9.56 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.466 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.4 t -101.61 -42.58 6.17 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.279 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 83' ' ' TYR . 12.2 t -70.01 -147.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.441 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 83.6 p -123.81 -151.53 0.48 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.437 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.447 ' O ' ' CZ ' ' A' ' 57' ' ' PHE . 14.9 p -176.18 45.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 113.478 -1.692 . . . . 0.0 109.77 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 113.129 -1.85 . . . . 0.0 109.149 179.706 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.429 ' O ' HD13 ' A' ' 95' ' ' ILE . 56.6 tp60 . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.821 0.82 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 94' ' ' GLN . 14.2 mm -146.28 128.23 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.082 -1.872 . . . . 0.0 109.428 177.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.575 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 88.7 m-85 -149.98 139.58 21.61 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.532 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 84' ' ' HIS . 91.8 mt -89.93 94.87 9.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 117.114 -1.835 . . . . 0.0 109.249 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.492 ' NH1' ' CB ' ' A' ' 98' ' ' ARG . 4.4 ptm85 -105.46 149.07 26.5 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.614 -2.085 . . . . 0.0 109.997 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -47.26 119.55 2.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.309 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CD1' HD23 ' A' ' 33' ' ' LEU . 12.1 tt -70.06 -41.78 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.846 -1.979 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.435 ' N ' HG23 ' A' ' 100' ' ' ILE . 2.5 tm-20 . . . . . 0 N--CA 1.442 -0.834 0 CA-C-N 112.407 -2.178 . . . . 0.0 110.259 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 CA--C 1.542 0.88 0 N-CA-C 114.571 0.95 . . . . 0.0 114.571 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.436 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 3.2 p-90 -152.76 21.63 0.6 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.788 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 71.2 m-85 -90.45 115.3 27.51 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 118.452 -1.299 . . . . 0.0 109.115 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 60.6 m-85 -118.03 103.7 10.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.395 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.64 162.9 31.87 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 114.773 -3.584 . . . . 0.0 112.069 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -88.65 110.25 20.8 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 113.155 -1.522 . . . . 0.0 109.059 -6.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.46 HG12 ' CE ' ' A' ' 22' ' ' MET . 10.2 tp -97.96 126.02 41.96 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.523 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.4 Cg_exo -48.36 121.67 6.57 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.661 1.574 . . . . 0.0 112.811 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 15' ' ' PRO . 71.3 ttt180 -38.53 -37.65 0.33 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 113.02 -1.9 . . . . 0.0 111.075 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -68.45 -59.79 2.91 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.635 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 22' ' ' MET . 58.5 tptt -42.01 -42.97 3.01 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.353 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -51.1 -63.46 1.12 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.186 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 24' ' ' SER . 90.3 mt-10 -43.05 -44.77 4.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.576 -2.102 . . . . 0.0 110.236 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 34.1 mt-10 -63.65 -80.59 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 112.907 -1.952 . . . . 0.0 110.588 -173.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.499 ' HE3' ' CD2' ' A' ' 33' ' ' LEU . 25.9 ptt? -48.92 -39.93 28.07 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 113.456 -1.702 . . . . 0.0 110.662 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.503 HD23 ' CG1' ' A' ' 54' ' ' VAL . 38.8 tp -63.97 -32.61 74.21 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 117.726 -1.59 . . . . 0.0 111.474 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 26' ' ' GLN . 44.2 t -68.0 -32.3 72.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 117.662 -1.615 . . . . 0.0 111.267 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -73.15 35.61 0.08 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.111 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.563 HE21 ' HB1' ' A' ' 31' ' ' ALA . 12.8 mm100 -105.08 135.46 46.39 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.814 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.445 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 1.6 mpp_? -98.52 33.11 2.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 112.312 -2.222 . . . . 0.0 111.242 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 74.7 m80 -155.47 103.57 2.32 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.219 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.38 103.6 0.11 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.268 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 152.28 -31.45 0.87 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 117.419 -2.324 . . . . 0.0 112.134 -178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.563 ' HB1' HE21 ' A' ' 26' ' ' GLN . . . -46.86 141.39 4.03 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.539 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 98' ' ' ARG . 49.1 p90 -141.89 169.96 16.61 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 116.641 -2.023 . . . . 0.0 110.888 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -161.31 150.04 16.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.164 -2.289 . . . . 0.0 109.001 167.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 45' ' ' SER . 49.3 mt -110.11 114.57 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 113.133 -1.849 . . . . 0.0 108.349 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 33.7 ptt85 -90.07 130.48 36.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.041 -170.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -59.9 135.88 57.83 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 111.99 -2.368 . . . . 0.0 109.879 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 43' ' ' ASP . 50.0 m -52.35 119.65 4.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.855 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -50.54 -78.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.109 -1.859 . . . . 0.0 109.434 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -127.46 62.32 1.37 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.547 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -152.34 156.82 33.83 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 113.048 -1.887 . . . . 0.0 109.517 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ALA . 64.3 Cg_exo -44.29 -120.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.769 2.313 . . . . 0.0 114.157 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . -103.51 66.26 0.34 Allowed Glycine 0 C--N 1.346 1.128 0 C-N-CA 118.226 -1.94 . . . . 0.0 110.498 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' O ' ' OG ' ' A' ' 37' ' ' SER . 1.0 OUTLIER -99.43 114.18 26.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.914 -1.643 . . . . 0.0 109.501 178.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.415 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 22.1 m-85 -128.39 124.2 35.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.025 -1.898 . . . . 0.0 109.745 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.2 p -117.99 133.24 56.11 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.007 -1.906 . . . . 0.0 109.662 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.453 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.3 tt -94.39 113.92 25.88 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 112.697 -2.047 . . . . 0.0 109.173 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 88.3 p -95.01 148.8 21.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.73 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 73.8 t -146.4 136.06 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.625 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.447 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 60.6 tttp -80.1 106.79 12.38 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 116.482 -2.087 . . . . 0.0 109.756 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 53' ' ' ASP . 49.1 t80 -126.51 114.91 18.75 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 112.553 -2.112 . . . . 0.0 108.863 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -27.43 144.51 0.01 OUTLIER Glycine 0 C--N 1.349 1.287 0 CA-C-N 112.648 -2.069 . . . . 0.0 111.884 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 74.9 m-20 102.53 -52.86 0.0 OUTLIER 'General case' 0 C--N 1.346 0.439 0 CA-C-N 111.52 -2.34 . . . . 0.0 108.189 -166.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 50' ' ' PHE . 56.3 p30 -179.64 -161.08 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 111.396 -2.638 . . . . 0.0 110.194 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.503 ' CG1' HD23 ' A' ' 23' ' ' LEU . 91.4 t -96.93 124.63 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.703 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -95.86 160.63 14.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.797 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -141.42 143.74 34.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.708 -2.042 . . . . 0.0 110.129 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -128.65 102.39 6.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.744 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -58.4 108.47 0.63 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.99 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' CD2' ' A' ' 77' ' ' LEU . 60.7 t -81.38 78.28 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 112.981 -1.918 . . . . 0.0 108.423 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 91.2 mt -83.66 172.49 12.24 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 112.417 -2.174 . . . . 0.0 109.845 -174.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.1 ptm180 . . . . . 0 N--CA 1.447 -0.614 0 C-N-CA 116.463 -2.095 . . . . 0.0 109.476 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HZ3' ' C ' ' A' ' 74' ' ' PHE . 8.4 mtmp? . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 88.5 m-85 -71.93 158.12 36.6 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.723 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 72' ' ' VAL . 55.1 t80 -152.62 156.85 40.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.62 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.607 HD13 HD11 ' A' ' 80' ' ' LEU . 33.3 tp -124.49 -66.84 0.95 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.449 -2.159 . . . . 0.0 109.826 -169.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.459 ' CD2' ' O ' ' A' ' 69' ' ' LEU . 27.7 m95 -147.09 -37.13 0.22 Allowed 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.101 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.416 ' C ' ' CE2' ' A' ' 68' ' ' PHE . 59.7 t -125.89 -37.59 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.471 0 C-N-CA 117.208 -1.797 . . . . 0.0 111.299 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 33.8 m -130.6 171.81 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 117.463 -1.695 . . . . 0.0 110.155 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.697 ' CD ' ' H ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -98.49 173.9 6.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.026 179.11 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.594 ' C ' ' HZ3' ' A' ' 66' ' ' LYS . 1.3 m-85 -145.6 132.27 19.93 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 117.063 -1.855 . . . . 0.0 109.551 -175.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' SER . 7.0 p30 -86.66 25.67 1.22 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.617 -2.083 . . . . 0.0 112.214 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.2 t 175.69 130.85 0.04 OUTLIER 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.971 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.511 ' CD2' HG11 ' A' ' 59' ' ' VAL . 85.1 mt -47.71 -41.12 22.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 116.879 -1.929 . . . . 0.0 109.998 174.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 82' ' ' ASP . 39.7 m-80 -60.67 -30.98 70.24 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 113.533 -1.667 . . . . 0.0 111.659 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 83' ' ' TYR . 10.2 tp10 -66.45 -26.39 67.18 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 117.114 -1.835 . . . . 0.0 111.694 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 69' ' ' LEU . 10.4 tt -83.71 -53.12 5.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.384 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.59 -44.76 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 112.644 -2.071 . . . . 0.0 109.711 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 78' ' ' ASN . 25.1 t0 -63.62 -63.67 1.11 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.076 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.434 ' CB ' ' O ' ' A' ' 79' ' ' GLU . 38.7 t80 -48.76 -42.04 34.22 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.445 -176.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.457 ' HE2' ' HZ ' ' A' ' 74' ' ' PHE . 92.4 m-70 -100.15 44.14 1.03 Allowed 'General case' 0 C--N 1.345 0.393 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.088 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -86.08 -40.46 15.71 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.491 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 88' ' ' SER . 39.1 t -112.59 -36.6 5.17 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.73 -1.577 . . . . 0.0 111.048 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -77.47 42.79 0.37 Allowed 'General case' 0 C--N 1.346 0.453 0 C-N-CA 118.044 -1.463 . . . . 0.0 110.797 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 86' ' ' SER . 45.0 m 49.93 -149.77 0.24 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.912 170.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 90' ' ' SER . 6.4 p -176.9 -41.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.434 0 CA-C-N 113.393 -1.731 . . . . 0.0 110.337 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.404 ' N ' HG13 ' A' ' 89' ' ' VAL . 41.5 t . . . . . 0 N--CA 1.45 -0.453 0 CA-C-N 113.648 -1.614 . . . . 0.0 109.503 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.685 0.755 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 34.5 mm -114.75 145.68 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.858 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.54 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 65.3 t80 -135.11 132.16 37.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.865 -1.97 . . . . 0.0 109.338 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.01 101.87 14.58 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 117.304 -1.758 . . . . 0.0 109.406 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.729 ' HE ' ' H ' ' A' ' 99' ' ' ASP . 5.1 tpm_? -97.3 151.76 19.57 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 112.602 -2.09 . . . . 0.0 109.976 -176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.729 ' H ' ' HE ' ' A' ' 98' ' ' ARG . 51.8 p-10 -72.59 33.66 0.07 Allowed 'General case' 0 C--N 1.346 0.428 0 CA-C-N 113.073 -1.876 . . . . 0.0 112.196 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.601 HG12 ' H ' ' A' ' 101' ' ' GLU . 10.8 tt 40.9 -143.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.133 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 100' ' ' ILE . 85.5 mt-10 . . . . . 0 N--CA 1.447 -0.614 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.369 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo . . . . . 0 CA--C 1.542 0.904 0 N-CA-C 114.403 0.886 . . . . 0.0 114.403 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.44 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 2.6 p-90 -154.54 22.6 0.47 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.487 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.44 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 91.2 m-85 -90.48 119.48 30.79 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.843 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.54 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 32.7 m-85 -115.98 89.72 3.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.341 -1.754 . . . . 0.0 108.953 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -36.62 -106.67 0.01 OUTLIER Glycine 0 C--N 1.346 1.108 0 CA-C-N 111.979 -2.373 . . . . 0.0 112.918 -171.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 14.7 ptmm? -95.3 67.38 2.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.415 -173.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.428 HG22 ' CB ' ' A' ' 35' ' ' ARG . 6.3 tp -95.87 128.51 37.24 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 116.996 -1.882 . . . . 0.0 107.603 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.414 ' HG2' ' CB ' ' A' ' 18' ' ' LYS . 20.7 Cg_endo -66.54 -157.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 O-C-N 123.614 1.323 . . . . 0.0 111.496 -172.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 25.7 ttm180 -94.94 -49.94 5.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.629 -1.623 . . . . 0.0 108.884 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -48.42 -71.68 0.06 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 112.59 -2.096 . . . . 0.0 108.946 174.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.417 ' HG2' HD11 ' A' ' 14' ' ' ILE . 54.4 tptt -43.51 -56.23 3.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.588 -2.097 . . . . 0.0 110.725 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.39 -44.3 24.24 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 116.701 -2.0 . . . . 0.0 110.093 -178.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.579 ' O ' ' CB ' ' A' ' 24' ' ' SER . 95.1 mt-10 -66.98 -37.39 84.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.042 -1.89 . . . . 0.0 111.264 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 47.6 mt-10 -67.8 -80.27 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 117.365 -1.734 . . . . 0.0 110.478 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.616 ' HE3' ' CD2' ' A' ' 33' ' ' LEU . 23.6 ptt? -44.34 -39.76 4.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.7 -175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' A' ' 25' ' ' LYS . 39.4 tp -72.73 -36.64 67.8 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 116.618 -2.033 . . . . 0.0 111.178 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 48.3 t -73.59 29.51 0.07 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 116.971 -1.892 . . . . 0.0 111.735 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 23' ' ' LEU . 55.4 mtpt -134.88 44.05 2.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.59 177.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 26.5 mm-40 -112.16 144.25 41.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.291 -1.777 . . . . 0.0 110.142 -174.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 28' ' ' HIS . 87.2 mtt180 -83.97 85.06 7.38 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 112.085 -2.325 . . . . 0.0 110.715 -172.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.424 ' HB3' ' O ' ' A' ' 27' ' ' ARG . 1.8 t-80 80.62 -45.64 0.26 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.199 -2.273 . . . . 0.0 110.904 173.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' LYS . 35.6 m-20 -47.42 166.08 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 111.905 -2.407 . . . . 0.0 108.199 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 96' ' ' PHE . . . 107.73 -39.51 2.86 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.552 1.072 . . . . 0.0 110.582 7.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -68.73 149.03 49.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 118.475 -1.29 . . . . 0.0 109.182 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' SER . 41.6 p90 -146.26 162.34 38.31 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 116.475 -2.09 . . . . 0.0 111.033 -172.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.616 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 4.5 pp -149.61 148.85 29.82 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.49 -2.141 . . . . 0.0 109.335 170.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 44' ' ' PHE . 58.2 mt -113.74 111.6 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.651 -2.068 . . . . 0.0 108.444 174.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 11.6 ptm180 -95.85 136.12 36.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.446 -2.161 . . . . 0.0 110.934 -170.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 12' ' ' GLY . 68.6 tt0 -82.6 125.74 31.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.126 -2.306 . . . . 0.0 109.449 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 47.7 t -59.22 132.66 54.68 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.762 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -42.27 -42.91 3.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.616 -2.084 . . . . 0.0 110.356 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 49.1 m -144.98 71.22 1.29 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 113.44 -1.709 . . . . 0.0 110.26 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 179.05 101.35 0.16 Allowed Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 112.898 -1.956 . . . . 0.0 109.113 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.3 -4.07 14.77 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.719 1.613 . . . . 0.0 115.185 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.29 40.2 2.61 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 118.731 -1.7 . . . . 0.0 110.895 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.458 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 9.5 t0 -143.23 106.55 4.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.959 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.521 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 23.2 m-85 -133.96 107.01 7.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.433 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 80.3 p -104.73 126.55 51.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.906 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.3 tt -90.76 114.9 27.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.318 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 98.2 p -96.97 147.18 24.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.081 -1.872 . . . . 0.0 110.017 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 60.2 t -145.12 134.49 18.12 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.284 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' ASP . 13.7 tptp -76.31 96.62 4.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 112.654 -2.066 . . . . 0.0 108.417 174.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.51 -44.03 65.41 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 117.17 -1.812 . . . . 0.0 110.703 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.92 -69.89 0.03 OUTLIER Glycine 0 CA--C 1.527 0.83 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.265 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -116.28 -25.86 7.39 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 111.927 -2.137 . . . . 0.0 111.816 176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.05 153.63 29.09 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 118.397 -1.321 . . . . 0.0 110.291 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 20' ' ' GLU . 74.8 t -79.59 131.28 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 112.41 -2.177 . . . . 0.0 109.569 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.453 ' OE1' ' CZ ' ' A' ' 57' ' ' PHE . 31.8 tt0 -101.51 164.47 11.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.674 -2.057 . . . . 0.0 109.868 -176.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 55' ' ' GLN . 42.1 m80 -150.06 140.54 22.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.007 -1.906 . . . . 0.0 110.723 -176.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 23.3 m-85 -135.88 111.98 9.66 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.381 173.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 37.9 mtmm -74.5 116.06 14.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 116.886 -1.925 . . . . 0.0 109.837 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.522 HG11 ' CD2' ' A' ' 77' ' ' LEU . 48.2 t -81.47 107.83 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 112.829 -1.987 . . . . 0.0 108.036 173.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 84.9 mt -96.68 162.2 13.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.162 -164.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 34.9 tpt85 . . . . . 0 N--CA 1.449 -0.5 0 CA-C-N 111.129 -2.759 . . . . 0.0 109.829 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.518 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 5.8 mtpm? . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.328 0.585 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.517 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 26.7 m-85 -95.0 130.52 41.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.975 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 11.9 p90 -149.13 138.14 21.36 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 116.048 -2.261 . . . . 0.0 110.726 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 9.9 mt -81.33 -45.64 15.88 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 112.425 -2.17 . . . . 0.0 109.563 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -129.13 -86.19 0.55 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.188 -1.823 . . . . 0.0 109.934 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -106.87 -84.48 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.188 -1.824 . . . . 0.0 109.555 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.7 m -50.32 130.27 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.915 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -81.67 -169.48 2.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 112.819 -1.991 . . . . 0.0 109.93 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -148.13 134.49 19.56 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.421 -2.172 . . . . 0.0 108.7 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' O ' ' OG ' ' A' ' 76' ' ' SER . 17.9 m-20 -58.16 -22.26 50.59 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.153 -1.839 . . . . 0.0 112.336 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 50.3 m -168.04 161.33 12.61 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.953 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.522 ' CD2' HG11 ' A' ' 59' ' ' VAL . 86.3 mt -45.6 -40.88 9.41 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 117.34 -1.744 . . . . 0.0 110.318 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -54.07 -38.25 65.07 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.068 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.4 OUTLIER -69.91 -28.17 65.39 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.51 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.48 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.0 tt -67.59 -49.86 61.1 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.819 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.3 -37.03 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 112.538 -2.119 . . . . 0.0 110.86 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.31 -35.97 71.46 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.145 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -55.29 -46.05 76.22 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 117.845 -1.542 . . . . 0.0 109.746 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.486 ' C ' ' H ' ' A' ' 86' ' ' SER . 52.1 t60 -63.79 -9.38 14.31 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.646 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 4.1 tpm_? -78.98 46.82 0.72 Allowed 'General case' 0 C--N 1.349 0.567 0 C-N-CA 117.799 -1.56 . . . . 0.0 109.402 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 84' ' ' HIS . 40.4 t -147.15 -41.44 0.18 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.787 -2.006 . . . . 0.0 110.248 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 t -149.16 -146.61 0.2 Allowed 'General case' 0 C--N 1.347 0.488 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.604 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.7 p -92.42 167.55 11.89 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 113.897 -1.501 . . . . 0.0 109.636 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.49 HG23 ' CB ' ' A' ' 90' ' ' SER . 11.8 m -73.32 -33.12 39.97 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 C-N-CA 117.103 -1.839 . . . . 0.0 111.587 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.49 ' CB ' HG23 ' A' ' 89' ' ' VAL . 13.4 t . . . . . 0 N--CA 1.445 -0.71 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.924 -165.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 53.7 tp60 . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.974 0.892 . . . . 0.0 109.176 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.442 HD12 HG22 ' A' ' 89' ' ' VAL . 68.9 mt -133.0 128.02 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.979 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.461 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 45.2 t80 -127.17 139.83 52.67 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.922 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.7 mt -91.58 105.1 17.49 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.797 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.452 ' CZ ' ' H ' ' A' ' 99' ' ' ASP . 4.1 tpm_? -108.63 158.32 17.7 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.178 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.452 ' H ' ' CZ ' ' A' ' 98' ' ' ARG . 57.8 p30 -60.3 145.38 47.8 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 117.535 -1.666 . . . . 0.0 109.447 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.54 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 7.1 tt -99.45 29.27 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 113.076 -1.874 . . . . 0.0 111.937 -175.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 . . . . . 0 N--CA 1.447 -0.577 0 C-N-CA 117.616 -1.633 . . . . 0.0 110.065 -176.631 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.429 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 58.4 Cg_endo . . . . . 0 CA--C 1.541 0.828 0 N-CA-C 110.857 -0.478 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.502 ' CB ' ' CE2' ' A' ' 32' ' ' PHE . 37.7 p-90 -139.08 38.55 2.13 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.709 -174.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -121.91 115.09 21.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 117.812 -1.555 . . . . 0.0 110.162 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.434 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 18.7 m-85 -124.05 108.19 12.1 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.057 176.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -61.33 112.03 4.38 Favored Glycine 0 C--N 1.345 1.075 0 C-N-CA 118.127 -1.987 . . . . 0.0 111.127 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 36' ' ' GLU . 23.3 pttp 25.57 47.29 0.01 OUTLIER 'General case' 0 C--N 1.346 0.414 0 CA-C-N 111.481 -2.359 . . . . 0.0 111.472 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.7 tp -60.21 131.64 89.97 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.928 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.9 Cg_exo -45.52 122.54 4.87 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.742 1.628 . . . . 0.0 112.983 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.573 ' CB ' HH12 ' A' ' 35' ' ' ARG . 53.2 ttp180 -38.86 -41.24 0.72 Allowed 'General case' 0 C--N 1.345 0.388 0 CA-C-N 112.885 -1.961 . . . . 0.0 110.626 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -54.21 -79.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 113.345 -1.752 . . . . 0.0 109.442 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HG3' ' HE2' ' A' ' 22' ' ' MET . 28.1 tptp -37.91 -39.88 0.41 Allowed 'General case' 0 C--N 1.346 0.442 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.969 -177.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.94 -65.76 0.54 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 117.595 -1.642 . . . . 0.0 109.209 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 24' ' ' SER . 46.7 mt-10 -42.77 -41.01 3.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.696 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 22' ' ' MET . 65.5 mt-10 -62.58 -90.56 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 113.567 -1.652 . . . . 0.0 110.758 -173.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.564 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 5.6 ptp -42.6 -38.32 1.96 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.995 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.543 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 45.6 tp -68.03 -41.92 81.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 117.654 -1.619 . . . . 0.0 110.801 -176.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 26' ' ' GLN . 77.3 p -62.72 -36.91 84.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 117.402 -1.719 . . . . 0.0 110.706 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -69.38 30.73 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.534 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.553 ' H ' ' C ' ' A' ' 24' ' ' SER . 35.2 mm-40 -104.14 142.46 34.45 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 117.786 -1.565 . . . . 0.0 109.247 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 28' ' ' HIS . 2.0 mpt_? -79.05 44.28 0.56 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.883 -177.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.484 ' H ' ' HG2' ' A' ' 49' ' ' LYS . 0.9 OUTLIER 47.05 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.708 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -162.39 33.32 0.11 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.092 -1.867 . . . . 0.0 111.493 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.567 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 70.0 -1.98 15.17 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 116.576 -2.726 . . . . 0.0 113.241 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.401 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -46.23 134.56 8.56 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 118.297 -1.361 . . . . 0.0 108.899 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.502 ' CE2' ' CB ' ' A' ' 9' ' ' TRP . 15.3 p90 -150.77 163.23 39.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 115.897 -2.321 . . . . 0.0 111.087 -173.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.487 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.6 pp -149.92 146.66 27.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.172 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.44 109.87 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.844 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.573 HH12 ' CB ' ' A' ' 16' ' ' ARG . 27.7 ptt180 -92.1 126.31 37.13 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 112.022 -2.354 . . . . 0.0 110.167 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 67.4 tt0 -67.98 129.61 40.44 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.445 -2.161 . . . . 0.0 109.781 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 43' ' ' ASP . 73.5 m -67.12 129.88 41.32 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.501 178.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.649 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 2.3 mp0 -38.41 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 112.423 -2.171 . . . . 0.0 110.644 -176.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 40' ' ' ALA . 37.1 t -89.94 -29.54 18.43 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.086 -172.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -44.06 148.95 0.73 Allowed Pre-proline 0 C--N 1.348 0.538 0 C-N-CA 117.921 -1.512 . . . . 0.0 110.09 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -74.65 -8.62 20.63 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.934 2.423 . . . . 0.0 116.081 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.22 33.34 0.02 OUTLIER Glycine 0 CA--C 1.537 1.415 0 C-N-CA 118.611 -1.757 . . . . 0.0 111.68 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.474 ' O ' ' OG ' ' A' ' 37' ' ' SER . 1.3 m-20 -89.91 132.5 35.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 118.284 -1.366 . . . . 0.0 109.568 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.411 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 91.8 m-85 -143.62 132.34 22.54 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.59 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 99.7 p -119.15 138.17 53.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.492 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.4 tt -101.04 116.3 32.52 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 113.083 -1.871 . . . . 0.0 110.008 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.543 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 40.6 m -98.38 139.21 34.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.148 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -138.55 148.47 24.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.128 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.573 ' HZ3' ' C ' ' A' ' 52' ' ' ASN . 24.2 tptp -79.0 106.11 10.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.98 -1.918 . . . . 0.0 108.775 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' O ' ' CE1' ' A' ' 28' ' ' HIS . 7.4 t80 -76.28 -102.73 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 116.784 -1.966 . . . . 0.0 109.071 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -99.1 -69.39 0.92 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.751 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.573 ' C ' ' HZ3' ' A' ' 49' ' ' LYS . 25.6 t-20 -121.46 -23.26 5.69 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 111.917 -2.141 . . . . 0.0 112.174 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.27 158.54 18.28 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 118.404 -1.319 . . . . 0.0 110.32 -174.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 24' ' ' SER . 95.2 t -80.69 118.85 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.4 -2.182 . . . . 0.0 109.678 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -102.78 158.2 16.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.718 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.3 143.18 47.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.57 -2.104 . . . . 0.0 110.598 -175.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -129.57 100.64 5.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.494 -2.139 . . . . 0.0 108.795 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 51.2 mtmt -67.56 113.06 5.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 112.984 -1.916 . . . . 0.0 110.345 -174.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.523 HG11 ' CD2' ' A' ' 77' ' ' LEU . 58.8 t -74.04 83.59 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 112.522 -2.126 . . . . 0.0 108.633 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 79.0 mt -72.88 161.02 31.22 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 112.799 -2.001 . . . . 0.0 110.703 -173.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.702 ' HG3' HH11 ' A' ' 61' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.523 0 CA-C-N 112.006 -2.361 . . . . 0.0 109.227 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HA ' ' HZ3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.97 0.891 . . . . 0.0 109.545 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 87.5 m-85 -117.55 150.32 39.16 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.939 -1.937 . . . . 0.0 109.301 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -166.01 144.37 5.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.573 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.634 HD22 ' H ' ' A' ' 69' ' ' LEU . 2.5 mm? -65.05 -52.79 53.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 116.714 -1.994 . . . . 0.0 109.043 176.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 10.7 m0 -139.75 -45.0 0.44 Allowed 'General case' 0 C--N 1.345 0.413 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.013 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 77.8 t -129.23 -81.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 112.965 -1.925 . . . . 0.0 110.175 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -50.17 133.75 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 112.614 -2.085 . . . . 0.0 110.275 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 94.0 mttt -93.36 160.9 14.61 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.464 -176.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -133.88 137.8 45.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 111.936 -2.393 . . . . 0.0 109.444 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -62.61 -34.57 77.3 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 112.712 -2.04 . . . . 0.0 110.989 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 77' ' ' LEU . 42.1 t -153.29 152.79 31.55 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 118.278 -1.369 . . . . 0.0 109.888 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.523 ' CD2' HG11 ' A' ' 59' ' ' VAL . 76.0 mt -39.28 -40.42 0.76 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.823 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -48.67 -42.47 34.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.316 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -73.42 -34.1 65.29 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 115.729 -2.388 . . . . 0.0 110.893 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 80' ' ' LEU . 6.9 tt -56.78 -46.38 81.53 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.234 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' LEU . 96.0 t -63.16 -40.56 89.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 112.801 -1.999 . . . . 0.0 110.904 -177.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -71.33 -40.02 71.01 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.895 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -56.53 -41.07 76.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.449 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -93.15 40.07 1.06 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.677 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -107.45 -13.18 15.15 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.663 -1.608 . . . . 0.0 112.693 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.4 t -132.25 -42.15 0.98 Allowed 'General case' 0 C--N 1.351 0.635 0 C-N-CA 117.982 -1.487 . . . . 0.0 110.296 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 88' ' ' SER . 62.0 p -89.76 37.43 0.88 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.618 -1.628 . . . . 0.0 111.082 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' THR . 34.1 t 41.97 -165.71 0.01 OUTLIER 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.136 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 89' ' ' VAL . 12.8 p -147.71 47.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.582 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 45.5 t . . . . . 0 C--N 1.345 0.382 0 CA-C-N 112.805 -1.998 . . . . 0.0 109.512 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 31.1 tt0 . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.939 0.876 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 88' ' ' SER . 44.7 mt -138.9 153.87 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 113.115 -1.857 . . . . 0.0 109.579 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.567 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 88.2 m-85 -149.99 179.86 7.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.684 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.3 mt -125.03 108.46 11.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 112.854 -1.975 . . . . 0.0 109.182 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 17.4 mmm180 -125.0 154.37 41.35 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.872 -1.967 . . . . 0.0 109.88 -177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 101' ' ' GLU . 58.6 t0 -52.72 118.76 3.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.62 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.487 ' CD1' HD23 ' A' ' 33' ' ' LEU . 11.6 tt -71.99 29.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.774 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 99' ' ' ASP . 12.3 mm-40 . . . . . 0 N--CA 1.448 -0.572 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.681 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo . . . . . 0 CA--C 1.544 1.022 0 N-CA-C 114.283 0.84 . . . . 0.0 114.283 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' CZ ' ' A' ' 10' ' ' PHE . 5.2 p-90 -159.2 17.59 0.18 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.511 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.439 ' CZ ' ' CH2' ' A' ' 9' ' ' TRP . 96.8 m-85 -85.82 109.21 18.52 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.676 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 56.0 m-85 -97.53 95.8 7.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.866 -1.97 . . . . 0.0 108.853 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -49.65 105.62 0.17 Allowed Glycine 0 C--N 1.345 1.077 0 CA-C-N 112.797 -2.002 . . . . 0.0 111.254 -173.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 12' ' ' GLY . 63.4 pttt 30.51 42.07 0.01 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 111.459 -2.37 . . . . 0.0 111.193 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.437 HG12 ' CE ' ' A' ' 22' ' ' MET . 9.3 tp -56.51 134.85 77.12 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 113.373 -1.74 . . . . 0.0 108.727 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.8 Cg_exo -44.74 121.23 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.807 1.671 . . . . 0.0 112.911 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' PRO . 74.6 ttt180 -37.28 -37.12 0.17 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.268 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -69.79 -63.24 1.11 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.766 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.461 ' HG3' ' CE ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -42.78 -42.19 3.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.458 -177.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -48.07 -58.63 4.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.1 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 91.2 mt-10 -49.1 -45.06 42.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 112.392 -2.185 . . . . 0.0 110.068 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 35.5 mt-10 -59.08 -81.17 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.799 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.461 ' CE ' ' HG3' ' A' ' 18' ' ' LYS . 9.8 ptp -50.82 -41.17 57.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 116.491 -2.084 . . . . 0.0 110.422 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.459 ' O ' ' CG ' ' A' ' 26' ' ' GLN . 39.3 tp -62.27 -26.96 68.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 117.725 -1.59 . . . . 0.0 112.531 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.545 ' C ' ' H ' ' A' ' 26' ' ' GLN . 93.3 p -71.84 -29.06 64.0 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 117.803 -1.559 . . . . 0.0 111.733 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -72.28 37.19 0.07 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.819 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 24' ' ' SER . 29.1 mm-40 -119.27 19.52 12.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 117.86 -1.536 . . . . 0.0 113.095 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 28' ' ' HIS . 58.2 mmm-85 20.37 58.25 0.02 OUTLIER 'General case' 0 C--N 1.349 0.555 0 O-C-N 125.215 1.572 . . . . 0.0 111.952 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 27' ' ' ARG . 72.5 t60 43.53 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.015 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 55.0 m-20 -157.71 29.06 0.27 Allowed 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.858 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 78.16 -9.34 33.5 Favored Glycine 0 CA--C 1.542 1.777 0 C-N-CA 115.969 -3.015 . . . . 0.0 113.147 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.409 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -44.98 120.74 2.48 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.055 177.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.492 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 14.0 p90 -126.14 151.2 47.6 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 116.638 -2.025 . . . . 0.0 111.716 -173.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.583 ' HB3' ' H ' ' A' ' 47' ' ' SER . 0.6 OUTLIER -114.53 146.75 40.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 110.892 -2.867 . . . . 0.0 109.013 -169.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 33' ' ' LEU . 18.4 mt -147.16 121.83 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 114.935 -2.706 . . . . 0.0 109.42 154.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 27.9 ptt180 -108.81 128.31 54.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.411 -2.177 . . . . 0.0 110.369 -174.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 31.2 tp10 -68.92 136.36 52.46 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 112.459 -2.155 . . . . 0.0 109.853 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.61 ' HB3' ' H ' ' A' ' 43' ' ' ASP . 88.9 p -42.07 118.55 1.16 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.299 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.32 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.141 -1.845 . . . . 0.0 109.271 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.6 p -112.01 44.36 1.42 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.318 -1.764 . . . . 0.0 109.809 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -135.11 156.88 77.92 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.507 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ALA . 74.0 Cg_exo -43.56 -119.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.873 2.382 . . . . 0.0 114.099 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.29 68.31 0.51 Allowed Glycine 0 C--N 1.346 1.119 0 C-N-CA 118.154 -1.974 . . . . 0.0 110.187 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.61 ' H ' ' HB3' ' A' ' 37' ' ' SER . 61.9 t0 -90.05 117.87 29.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 112.82 -1.69 . . . . 0.0 109.799 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 21.4 m-85 -130.18 115.85 17.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.491 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.2 p -124.51 137.71 54.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.476 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.483 ' CD2' HG23 ' A' ' 48' ' ' VAL . 6.0 tt -110.24 119.07 38.06 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.7 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.583 ' H ' ' HB3' ' A' ' 33' ' ' LEU . 49.4 m -112.85 122.45 47.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.216 -1.811 . . . . 0.0 109.795 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.483 HG23 ' CD2' ' A' ' 46' ' ' LEU . 86.8 t -113.65 146.73 17.87 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.379 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 26' ' ' GLN . 41.7 tptt -69.35 89.54 0.49 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 116.693 -2.003 . . . . 0.0 108.915 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 53' ' ' ASP . 63.3 t80 -91.31 134.33 34.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 117.27 -1.772 . . . . 0.0 108.549 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -43.37 129.14 5.87 Favored Glycine 0 C--N 1.342 0.886 0 C-N-CA 117.286 -2.388 . . . . 0.0 111.299 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.533 HD22 ' CG ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 83.33 -31.19 0.08 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 111.471 -2.364 . . . . 0.0 111.222 176.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.533 ' CG ' HD22 ' A' ' 52' ' ' ASN . 33.6 m-20 -155.24 150.63 27.17 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 114.441 -2.903 . . . . 0.0 112.37 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.2 t -70.46 119.22 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 111.742 -2.481 . . . . 0.0 108.927 171.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 47' ' ' SER . 10.3 tt0 -101.75 159.61 15.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.884 -177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -128.51 134.7 48.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.493 -2.14 . . . . 0.0 110.63 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 93.7 m-85 -129.37 102.84 6.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 112.258 -2.247 . . . . 0.0 108.803 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 54.5 mtmt -70.49 114.12 8.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 116.97 -1.892 . . . . 0.0 109.718 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' CD2' ' A' ' 77' ' ' LEU . 94.3 t -74.88 86.77 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.537 174.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 81.6 mt -78.24 159.13 28.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 112.741 -2.027 . . . . 0.0 110.955 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 CA-C-N 111.948 -2.387 . . . . 0.0 108.583 175.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.729 ' HZ2' ' CG ' ' A' ' 73' ' ' LYS . 8.5 mtmp? . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 121.52 0.676 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 20.5 m-85 -105.95 144.08 33.19 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 113.571 -1.649 . . . . 0.0 110.085 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.409 ' C ' HD12 ' A' ' 69' ' ' LEU . 11.3 p90 -151.82 -165.89 2.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 117.262 -1.775 . . . . 0.0 109.381 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.516 HD11 HD11 ' A' ' 80' ' ' LEU . 5.6 mp -125.87 -46.34 1.7 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.36 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 21.5 m0 -132.54 -42.92 0.93 Allowed 'General case' 0 C--N 1.346 0.437 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.125 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.6 t -141.7 -84.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.011 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.403 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 32.9 m -51.74 136.23 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.211 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.729 ' CG ' ' HZ2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -104.4 176.09 5.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.899 -177.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.455 ' C ' ' HZ3' ' A' ' 66' ' ' LYS . 21.5 m-85 -146.59 138.31 24.6 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.131 -1.849 . . . . 0.0 108.915 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.468 ' O ' ' OG ' ' A' ' 76' ' ' SER . 41.8 p30 -66.5 -8.98 30.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 113.253 -1.794 . . . . 0.0 113.266 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 49.2 m -167.96 150.16 5.52 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 117.791 -1.564 . . . . 0.0 109.422 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.511 ' CD2' HG11 ' A' ' 59' ' ' VAL . 97.7 mt -46.01 -42.51 13.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.114 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -55.87 -42.86 76.53 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.349 -1.751 . . . . 0.0 110.442 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 76' ' ' SER . 32.3 tp10 -63.68 -35.44 80.57 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 113.335 -1.757 . . . . 0.0 110.665 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 80' ' ' LEU . 6.1 tt -58.43 -50.84 72.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.073 -1.422 . . . . 0.0 108.375 173.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.453 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 81.3 t -63.85 -14.25 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 112.393 -2.185 . . . . 0.0 112.834 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -84.61 -26.44 27.89 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.715 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.433 ' O ' ' C ' ' A' ' 84' ' ' HIS . 68.8 t80 -73.12 -40.85 64.6 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.104 -174.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.546 ' C ' ' H ' ' A' ' 86' ' ' SER . 7.1 p-80 -45.52 -36.84 4.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.299 -2.16 . . . . 0.0 110.842 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 85' ' ' ARG . 67.4 ttt-85 -73.4 37.35 0.09 Allowed 'General case' 0 C--N 1.348 0.516 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.877 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 84' ' ' HIS . 42.4 t -136.74 -41.63 0.61 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.141 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 88' ' ' SER . 9.0 t -165.52 55.63 0.11 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.092 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.567 ' HB2' ' H ' ' A' ' 95' ' ' ILE . 69.7 p 50.56 -179.0 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.261 -1.791 . . . . 0.0 110.101 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 89' ' ' VAL . 13.8 p -128.69 37.03 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.711 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.588 ' OG ' ' CD1' ' A' ' 95' ' ' ILE . 86.7 p . . . . . 0 N--CA 1.447 -0.613 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.505 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.54 ' HA ' ' CB ' ' A' ' 88' ' ' SER . 77.3 mt-30 . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 121.919 0.866 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.588 ' CD1' ' OG ' ' A' ' 90' ' ' SER . 35.9 mt -150.04 140.6 16.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.904 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.45 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 88.5 m-85 -118.81 133.04 56.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.618 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.406 ' O ' ' HD3' ' A' ' 98' ' ' ARG . 28.6 mt -90.0 102.02 14.73 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.451 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 97' ' ' LEU . 27.7 mmt180 -150.29 -159.83 1.09 Allowed 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.144 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.44 ' O ' HG22 ' A' ' 100' ' ' ILE . 55.4 t0 48.73 -120.67 1.37 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.136 170.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 5.0 tt 40.16 22.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 113.843 -1.526 . . . . 0.0 113.371 -174.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 . . . . . 0 N--CA 1.442 -0.875 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.0 -177.512 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.436 ' C ' ' CG ' ' A' ' 9' ' ' TRP . 38.2 Cg_exo . . . . . 0 N--CA 1.455 -0.773 0 N-CA-C 115.565 1.333 . . . . 0.0 115.565 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.436 ' CG ' ' C ' ' A' ' 8' ' ' PRO . 41.4 p-90 43.7 30.64 0.38 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 116.965 -1.894 . . . . 0.0 111.583 177.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -105.37 118.97 37.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.478 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 29.1 m-85 -121.58 83.93 2.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.113 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -49.81 111.37 1.07 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-N 112.641 -2.072 . . . . 0.0 110.778 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.497 ' H ' ' HB2' ' A' ' 36' ' ' GLU . 26.2 pttm 26.44 46.16 0.01 OUTLIER 'General case' 0 C--N 1.344 0.357 0 CA-C-N 111.529 -2.335 . . . . 0.0 111.387 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.4 tp -61.61 135.61 94.2 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 112.96 -1.927 . . . . 0.0 108.912 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' ARG . 54.3 Cg_exo -44.08 121.74 3.16 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.855 1.703 . . . . 0.0 113.029 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.689 ' HB3' HH22 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -40.74 -41.81 1.62 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.702 -177.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.557 ' H ' ' HD3' ' A' ' 16' ' ' ARG . . . -59.16 -63.09 1.43 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.483 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -43.39 -52.0 6.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 112.766 -2.016 . . . . 0.0 110.421 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.75 -49.47 14.82 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.759 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.29 -44.65 96.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.775 -2.011 . . . . 0.0 110.114 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' SER . 44.2 mt-10 -67.09 -70.4 0.25 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.872 -173.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.57 ' C ' ' SD ' ' A' ' 22' ' ' MET . 3.5 ppp? -46.48 -42.48 15.57 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 117.088 -1.845 . . . . 0.0 110.474 -173.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.562 ' N ' ' SD ' ' A' ' 22' ' ' MET . 60.8 tp -75.89 -25.11 55.77 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 113.357 -1.747 . . . . 0.0 112.569 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 26' ' ' GLN . 78.4 p -74.18 -33.31 63.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 117.186 -1.806 . . . . 0.0 111.151 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 50.1 mtpt -75.54 38.78 0.15 Allowed 'General case' 0 C--N 1.347 0.467 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.605 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.76 HE21 ' CB ' ' A' ' 31' ' ' ALA . 12.9 mm100 -102.25 136.05 42.77 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 117.687 -1.605 . . . . 0.0 110.225 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HA ' ' CB ' ' A' ' 28' ' ' HIS . 9.9 mpt_? -116.54 84.33 2.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 110.688 -2.96 . . . . 0.0 106.374 171.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 27' ' ' ARG . 1.3 t-80 -171.24 12.07 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.702 13.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 7.0 m-20 -163.09 128.69 3.19 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.753 -1.579 . . . . 0.0 110.619 -173.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 103.26 -27.03 21.77 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 117.835 -2.126 . . . . 0.0 112.875 170.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.76 ' CB ' HE21 ' A' ' 26' ' ' GLN . . . -46.95 135.76 9.04 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 117.762 -1.575 . . . . 0.0 109.147 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.512 ' CB ' HD22 ' A' ' 97' ' ' LEU . 17.3 p90 -139.94 164.51 29.82 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 115.077 -2.649 . . . . 0.0 112.427 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.608 ' HB3' ' H ' ' A' ' 47' ' ' SER . 0.4 OUTLIER -129.03 145.96 51.12 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 110.31 -3.132 . . . . 0.0 108.658 -165.364 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.519 ' CG1' ' O ' ' A' ' 33' ' ' LEU . 16.5 mt -145.85 119.94 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 114.886 -2.726 . . . . 0.0 109.504 153.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.689 HH22 ' HB3' ' A' ' 16' ' ' ARG . 10.1 ptm180 -113.11 147.79 36.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 111.852 -2.431 . . . . 0.0 110.223 -172.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.497 ' HB2' ' H ' ' A' ' 13' ' ' LYS . 40.7 mt-10 -86.97 167.38 14.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.69 -2.05 . . . . 0.0 109.719 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 38.9 t -71.83 -134.41 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.255 -1.793 . . . . 0.0 108.679 175.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -101.26 -70.92 0.73 Allowed 'General case' 0 C--N 1.347 0.473 0 C-N-CA 118.097 -1.441 . . . . 0.0 109.114 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.4 t -128.81 45.52 2.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.666 -2.061 . . . . 0.0 109.566 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -156.44 110.21 2.04 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.841 -176.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' A' ' 43' ' ' ASP . 23.6 Cg_exo -57.48 -144.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.132 0 N-CA-C 107.798 -1.655 . . . . 0.0 107.798 171.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.78 -28.33 0.14 Allowed Glycine 0 CA--C 1.541 1.679 0 CA-C-N 114.091 -1.413 . . . . 0.0 113.376 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 41' ' ' PRO . 11.2 m-20 -112.8 116.52 30.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.967 0.889 . . . . 0.0 109.253 -173.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.433 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 91.7 m-85 -149.19 91.14 1.81 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.986 -1.916 . . . . 0.0 109.791 -175.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.473 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 28.4 p -89.99 137.41 32.36 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 115.947 -2.301 . . . . 0.0 109.93 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.499 ' CD2' HG23 ' A' ' 48' ' ' VAL . 6.5 tt -100.01 121.02 40.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 111.965 -2.38 . . . . 0.0 109.562 -173.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.608 ' H ' ' HB3' ' A' ' 33' ' ' LEU . 49.2 m -114.38 130.29 56.69 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.25 -176.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.517 ' CA ' HD21 ' A' ' 23' ' ' LEU . 84.3 t -128.13 145.4 35.33 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 CA-C-N 113.287 -1.778 . . . . 0.0 110.317 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 24' ' ' SER . 22.0 tptp -72.39 96.69 1.92 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 113.332 -1.758 . . . . 0.0 108.034 172.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CD2' ' O ' ' A' ' 53' ' ' ASP . 24.4 p90 -89.12 -1.31 58.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 116.546 -2.061 . . . . 0.0 113.801 -170.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.41 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 153.8 -80.48 0.18 Allowed Glycine 0 C--N 1.346 1.124 0 C-N-CA 117.024 -2.512 . . . . 0.0 110.77 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -109.28 -29.3 8.55 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 112.4 -1.9 . . . . 0.0 111.642 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 32.2 t70 -133.36 -174.92 3.64 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 117.434 -1.706 . . . . 0.0 110.159 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.561 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 73.9 t -100.08 122.19 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 112.857 -1.974 . . . . 0.0 110.377 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' SER . 11.5 tt0 -94.48 166.52 12.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.583 -2.099 . . . . 0.0 108.491 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 43.6 p-80 -150.08 144.52 25.8 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.495 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.491 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 98.6 m-85 -138.59 89.93 2.41 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.931 177.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.473 ' HA ' ' CB ' ' A' ' 45' ' ' SER . 9.1 ptmm? -45.06 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 112.535 -2.121 . . . . 0.0 109.912 169.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 22.9 t -79.09 71.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-N 113.237 -1.801 . . . . 0.0 108.912 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.434 ' CD1' ' NZ ' ' A' ' 58' ' ' LYS . 16.6 mt -73.06 -151.89 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.227 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 8.7 ptm180 . . . . . 0 N--CA 1.446 -0.663 0 C-N-CA 116.982 -1.887 . . . . 0.0 109.885 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.511 ' HZ2' ' HA ' ' A' ' 75' ' ' ASN . 5.1 mtpm? . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 8.1 m-30 -71.09 140.79 50.79 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 118.196 -1.402 . . . . 0.0 109.91 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -156.58 151.23 25.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 117.094 -1.842 . . . . 0.0 110.745 174.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.491 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 4.9 mt -87.77 -43.44 11.87 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 112.441 -2.163 . . . . 0.0 109.956 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -147.4 -44.61 0.17 Allowed 'General case' 0 C--N 1.346 0.435 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.929 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.2 t -135.75 -83.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.903 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.6 m -53.92 131.64 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 112.814 -1.994 . . . . 0.0 110.09 -176.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.454 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 47.7 mtmt -88.04 176.24 7.39 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.693 -2.049 . . . . 0.0 110.053 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.454 ' CD1' ' O ' ' A' ' 73' ' ' LYS . 18.0 m-85 -147.25 132.76 18.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 112.507 -2.133 . . . . 0.0 108.725 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 76' ' ' SER . 1.7 t-20 -83.67 49.34 1.58 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.949 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 29.2 t 138.94 142.7 0.0 OUTLIER 'General case' 0 C--N 1.349 0.562 0 CA-C-N 112.249 -2.25 . . . . 0.0 109.344 173.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 80' ' ' LEU . 95.7 mt -49.09 -49.42 41.81 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.238 -1.801 . . . . 0.0 108.851 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -47.45 -39.46 15.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 112.624 -2.08 . . . . 0.0 110.621 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 79' ' ' GLU . 4.7 tm-20 -64.1 -35.76 81.8 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 116.772 -1.971 . . . . 0.0 110.5 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.464 HD11 ' CG ' ' A' ' 69' ' ' LEU . 6.8 tt -64.88 -66.67 0.51 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.692 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.6 t -39.69 -38.84 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 112.321 -2.218 . . . . 0.0 110.893 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 12.6 t70 -77.64 -36.25 51.72 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.209 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' LEU . 60.8 t80 -68.76 -28.29 66.66 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 117.942 -1.503 . . . . 0.0 111.948 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -107.45 35.2 3.15 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 117.953 -1.499 . . . . 0.0 111.328 -175.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 12.7 ptm180 -97.38 30.55 2.8 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 117.426 -1.71 . . . . 0.0 111.656 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 88' ' ' SER . 80.5 p -149.98 -74.06 0.17 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 117.651 -1.62 . . . . 0.0 110.259 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.417 ' N ' ' OG ' ' A' ' 86' ' ' SER . 9.0 t -76.23 39.68 0.2 Allowed 'General case' 0 C--N 1.345 0.41 0 CA-C-N 112.966 -1.924 . . . . 0.0 110.862 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 86' ' ' SER . 32.7 t 50.93 -146.22 0.46 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 117.825 -1.55 . . . . 0.0 109.398 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 89' ' ' VAL . 15.0 p -160.12 45.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.678 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.2 t . . . . . 0 C--N 1.346 0.425 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.592 -179.347 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.428 ' CG2' HG11 ' A' ' 48' ' ' VAL . 37.0 mt -149.96 127.18 2.42 Favored 'Isoleucine or valine' 0 C--N 1.349 0.55 0 C-N-CA 117.831 -1.548 . . . . 0.0 110.054 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.577 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 29.9 t80 -123.74 135.76 54.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.965 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.512 HD22 ' CB ' ' A' ' 32' ' ' PHE . 95.5 mt -89.94 96.11 10.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 117.045 -1.862 . . . . 0.0 110.228 -174.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' A' ' 99' ' ' ASP . 53.4 ttm-85 -153.8 -137.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.808 175.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.584 ' H ' ' HG2' ' A' ' 98' ' ' ARG . 35.9 t0 43.85 -170.84 0.01 OUTLIER 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.286 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.531 ' H ' ' CG ' ' A' ' 99' ' ' ASP . 0.5 OUTLIER 86.78 -38.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.361 173.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.418 ' HG2' HG23 ' A' ' 100' ' ' ILE . 24.2 mm-40 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-N 112.988 -1.914 . . . . 0.0 109.98 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 N--CA 1.453 -0.898 0 CA-C-O 121.089 0.37 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.456 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 5.0 m-90 -126.31 -29.88 2.94 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 117.779 -1.569 . . . . 0.0 111.856 -167.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 92.3 m-85 -67.59 116.99 8.93 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.159 -171.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 9' ' ' TRP . 97.4 m-85 -123.94 95.56 4.61 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.682 171.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.56 163.76 30.44 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 114.861 -3.542 . . . . 0.0 112.242 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.658 ' HD3' ' H ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -88.65 109.04 19.78 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 113.26 -1.47 . . . . 0.0 109.296 -6.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.2 tp -87.71 123.26 69.59 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 113.198 -1.819 . . . . 0.0 109.341 -177.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 16' ' ' ARG . 49.2 Cg_exo -49.88 122.38 8.95 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.493 1.462 . . . . 0.0 112.199 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 15' ' ' PRO . 71.2 ttt180 -38.83 -40.17 0.6 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-N 113.33 -1.759 . . . . 0.0 110.73 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -57.84 -70.89 0.12 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.494 -1.684 . . . . 0.0 108.961 173.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.56 ' NZ ' ' SD ' ' A' ' 22' ' ' MET . 28.6 tptp -35.9 -48.52 0.58 Allowed 'General case' 0 C--N 1.346 0.414 0 CA-C-N 112.833 -1.985 . . . . 0.0 111.051 -176.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.14 -69.32 0.15 Allowed 'General case' 0 C--N 1.346 0.421 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.423 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 80.3 mt-10 -49.72 -23.42 1.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 112.388 -2.187 . . . . 0.0 112.245 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 81.6 mm-40 -81.34 -81.71 0.13 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 118.486 -1.286 . . . . 0.0 110.11 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.56 ' SD ' ' NZ ' ' A' ' 18' ' ' LYS . 18.4 ptm -47.05 -41.72 17.29 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 117.045 -1.862 . . . . 0.0 110.28 -176.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.495 HD13 ' CD1' ' A' ' 100' ' ' ILE . 41.8 tp -63.42 -34.49 77.85 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.422 -178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.55 ' C ' ' H ' ' A' ' 26' ' ' GLN . 71.7 p -69.24 -33.67 73.63 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 116.616 -2.034 . . . . 0.0 110.954 176.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -72.35 34.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.108 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.55 ' H ' ' C ' ' A' ' 24' ' ' SER . 28.6 mm-40 -100.75 149.95 23.28 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.454 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 28' ' ' HIS . 24.7 tpt180 -73.57 36.41 0.09 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.107 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.678 ' CE1' ' H ' ' A' ' 51' ' ' GLY . 77.7 t60 44.13 93.13 0.01 OUTLIER 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.631 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -164.03 37.36 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 116.83 -1.948 . . . . 0.0 111.258 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 68.02 1.45 19.31 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 116.785 -2.626 . . . . 0.0 113.44 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.3 132.62 16.29 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 117.775 -1.57 . . . . 0.0 108.761 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' SER . 26.7 p90 -144.87 160.99 40.41 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 115.787 -2.365 . . . . 0.0 111.427 -173.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.532 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.6 pp -145.81 146.12 31.05 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.397 170.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 45' ' ' SER . 71.3 mt -110.25 105.19 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 112.57 -2.105 . . . . 0.0 108.096 173.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 11.1 ptm180 -92.0 152.45 20.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 116.751 -1.98 . . . . 0.0 111.219 -170.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' SER . 47.4 mt-10 -113.59 129.25 56.6 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 111.73 -2.486 . . . . 0.0 109.315 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 39.9 t -50.57 -179.46 0.01 OUTLIER 'General case' 0 C--N 1.346 0.415 0 C-N-CA 116.821 -1.952 . . . . 0.0 109.878 -178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -42.79 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.345 0.392 0 CA-C-N 112.978 -1.919 . . . . 0.0 109.692 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 46.6 t -89.93 -49.18 6.75 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.497 174.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' A' ' 37' ' ' SER . . . 70.95 119.49 0.03 OUTLIER Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 112.462 -2.154 . . . . 0.0 111.246 165.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.95 -112.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 170.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.49 58.57 0.39 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 117.346 -2.359 . . . . 0.0 109.99 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -101.46 107.63 19.0 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 117.481 -1.688 . . . . 0.0 109.587 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 19.8 m-85 -129.64 127.59 40.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.494 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.7 p -134.06 127.31 31.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.717 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.423 ' CD2' ' HB2' ' A' ' 32' ' ' PHE . 4.8 tt -90.79 115.51 27.91 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.786 -2.006 . . . . 0.0 109.55 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.435 ' OG ' ' HG ' ' A' ' 33' ' ' LEU . 90.1 p -100.54 146.73 26.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.898 -1.956 . . . . 0.0 109.735 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.8 t -140.6 149.24 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 117.553 -1.659 . . . . 0.0 110.515 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.48 ' CE ' ' O ' ' A' ' 24' ' ' SER . 20.7 tptm -75.44 102.73 5.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.747 -2.024 . . . . 0.0 108.795 174.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' ASN . 38.5 t80 -98.82 108.4 21.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.472 -1.695 . . . . 0.0 109.607 -178.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.678 ' H ' ' CE1' ' A' ' 28' ' ' HIS . . . 54.79 -97.37 0.04 OUTLIER Glycine 0 CA--C 1.53 1.02 0 C-N-CA 118.021 -2.038 . . . . 0.0 110.161 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 50' ' ' PHE . 51.7 t30 -112.16 -26.34 8.86 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 112.659 -1.771 . . . . 0.0 112.043 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.544 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 30.3 t0 -101.43 -173.23 2.31 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.223 -1.391 . . . . 0.0 109.528 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.544 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 96.0 t -111.47 120.5 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 113.259 -1.791 . . . . 0.0 109.742 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 10.2 tt0 -90.01 159.38 16.9 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 112.881 -1.963 . . . . 0.0 109.357 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -136.31 121.55 19.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.733 -2.031 . . . . 0.0 110.47 -173.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 46' ' ' LEU . 24.2 m-85 -112.71 126.28 55.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.79 -2.005 . . . . 0.0 109.191 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.0 mtmm -95.87 118.12 31.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 116.733 -1.987 . . . . 0.0 109.538 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.534 HG11 ' CD2' ' A' ' 77' ' ' LEU . 68.0 t -75.97 92.76 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 113.031 -1.895 . . . . 0.0 108.734 176.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 54.0 mt -89.94 151.51 21.67 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 113.03 -1.895 . . . . 0.0 110.871 -174.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 64.8 ttp85 . . . . . 0 N--CA 1.445 -0.713 0 CA-C-N 111.858 -2.428 . . . . 0.0 109.431 174.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.659 ' HZ2' ' HA ' ' A' ' 75' ' ' ASN . 1.9 mmpm? . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 122.167 0.984 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.521 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 86.6 m-85 -96.8 134.49 40.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.42 -2.173 . . . . 0.0 109.04 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 71' ' ' VAL . 50.7 p90 -152.75 -162.37 1.48 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 117.188 -1.805 . . . . 0.0 109.999 -176.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 69' ' ' LEU . 5.6 mp -133.27 -39.4 0.93 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 112.31 -2.223 . . . . 0.0 110.767 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -110.32 -38.67 5.18 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.84 -173.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 98.5 t -150.02 -83.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 117.148 -1.821 . . . . 0.0 109.365 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 71' ' ' VAL . 18.4 m -162.1 136.89 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.202 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.565 ' CD ' ' CZ ' ' A' ' 74' ' ' PHE . 17.3 ptpt -170.07 -24.26 0.02 OUTLIER 'General case' 0 C--N 1.347 0.483 0 C-N-CA 114.684 -2.806 . . . . 0.0 112.829 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.565 ' CZ ' ' CD ' ' A' ' 73' ' ' LYS . 10.8 m-85 -120.24 146.58 45.92 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 116.671 -2.011 . . . . 0.0 109.986 -174.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.659 ' HA ' ' HZ2' ' A' ' 66' ' ' LYS . 53.1 p-10 -86.77 -22.6 25.83 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 113.087 -1.87 . . . . 0.0 112.065 175.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.416 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 41.0 t -155.6 162.34 40.65 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 118.201 -1.399 . . . . 0.0 109.703 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.534 ' CD2' HG11 ' A' ' 59' ' ' VAL . 95.9 mt -46.32 -45.48 17.51 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.932 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.406 ' OD1' ' CZ3' ' A' ' 9' ' ' TRP . 1.8 m-20 -48.49 -38.59 20.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.871 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' CB ' ' HB3' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -77.34 -19.98 55.53 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 113.994 -1.457 . . . . 0.0 112.17 -178.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.467 ' C ' HD23 ' A' ' 80' ' ' LEU . 6.8 tt -72.62 -57.68 3.94 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 118.154 -1.418 . . . . 0.0 108.227 172.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 58.2 t -51.75 -41.72 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 111.911 -2.404 . . . . 0.0 110.573 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 11.2 t70 -63.43 -44.48 94.42 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.35 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CB ' ' CE1' ' A' ' 74' ' ' PHE . 64.5 t80 -70.04 -37.49 75.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.188 -1.824 . . . . 0.0 111.096 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 86' ' ' SER . 1.0 OUTLIER -72.72 -32.53 65.79 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.397 -178.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 55.0 ptt85 -77.31 41.84 0.32 Allowed 'General case' 0 C--N 1.348 0.506 0 C-N-CA 117.276 -1.769 . . . . 0.0 110.396 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 84' ' ' HIS . 42.6 t -150.01 -44.93 0.13 Allowed 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.344 -1.753 . . . . 0.0 109.656 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 88' ' ' SER . 9.5 t -103.91 -137.6 0.35 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.192 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' A' ' 95' ' ' ILE . 70.1 p -143.03 175.54 9.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 118.166 -1.414 . . . . 0.0 109.853 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 90' ' ' SER . 1.9 m -95.94 -41.4 11.65 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-N 113.054 -1.884 . . . . 0.0 110.427 176.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.523 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 16.6 t . . . . . 0 N--CA 1.446 -0.646 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.938 -172.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 12.1 pt20 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.808 0.813 . . . . 0.0 109.868 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.587 ' H ' ' HB2' ' A' ' 88' ' ' SER . 14.9 mt -119.97 126.79 75.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.205 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 97' ' ' LEU . 67.4 t80 -103.46 155.45 18.5 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.062 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.45 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 91.2 mt -89.89 120.36 31.05 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 117.27 -1.772 . . . . 0.0 109.707 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -127.96 143.52 51.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.285 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -47.92 127.07 11.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.462 -2.154 . . . . 0.0 109.719 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.746 HG23 ' H ' ' A' ' 101' ' ' GLU . 17.8 tt -62.82 -121.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.707 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.746 ' H ' HG23 ' A' ' 100' ' ' ILE . 6.6 tp10 . . . . . 0 N--CA 1.442 -0.869 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.153 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 50.3 Cg_exo . . . . . 0 CA--C 1.542 0.882 0 N-CA-C 114.54 0.939 . . . . 0.0 114.54 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.402 ' H ' ' HB2' ' A' ' 8' ' ' PRO . 1.6 p-90 -146.43 27.69 1.11 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.93 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -102.29 116.91 33.62 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.334 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 12' ' ' GLY . 7.5 m-85 -105.65 104.28 13.97 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 113.233 -1.803 . . . . 0.0 108.497 174.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -22.41 -108.23 0.0 OUTLIER Glycine 0 C--N 1.348 1.21 0 CA-C-N 111.63 -2.532 . . . . 0.0 112.883 -173.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.623 ' HZ2' ' HA ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -115.99 50.01 1.06 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 112.727 -1.736 . . . . 0.0 108.885 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.554 HG22 ' CB ' ' A' ' 35' ' ' ARG . 7.6 tp -69.27 132.03 90.07 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.721 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' ARG . 21.1 Cg_endo -66.11 125.03 13.42 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.263 1.976 . . . . 0.0 112.122 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.473 HH11 HH21 ' A' ' 35' ' ' ARG . 60.0 ttt85 -31.9 -40.68 0.04 OUTLIER 'General case' 0 C--N 1.349 0.544 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.083 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -55.54 -76.35 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.281 -1.781 . . . . 0.0 109.405 177.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 17' ' ' ALA . 56.8 tptt -38.92 -39.81 0.57 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 112.993 -1.912 . . . . 0.0 110.915 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.576 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -54.61 -70.76 0.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 117.071 -1.852 . . . . 0.0 108.705 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 24' ' ' SER . 47.6 mt-10 -39.36 -43.25 1.16 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.504 -2.135 . . . . 0.0 110.753 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.464 ' O ' ' OG ' ' A' ' 24' ' ' SER . 34.6 mt-10 -61.8 -91.78 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.4 -175.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.0 ptm -45.02 -39.65 5.83 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 117.524 -1.67 . . . . 0.0 110.687 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 23.5 tp -59.93 -41.11 91.05 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.748 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 26' ' ' GLN . 81.1 p -67.4 -37.35 82.97 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.471 176.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -70.66 35.16 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.613 -1.631 . . . . 0.0 111.053 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.568 HE21 ' HB1' ' A' ' 31' ' ' ALA . 13.6 mm100 -107.95 145.67 33.5 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 118.082 -1.447 . . . . 0.0 109.397 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 1.9 mpt_? -91.21 -69.79 0.72 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.876 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -61.72 105.11 0.5 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.956 -1.929 . . . . 0.0 109.709 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -45.99 121.03 2.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.623 -2.08 . . . . 0.0 109.537 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.2 -22.11 4.03 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 117.98 -2.057 . . . . 0.0 112.674 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HB1' HE21 ' A' ' 26' ' ' GLN . . . -46.98 114.14 0.79 Allowed 'General case' 0 C--N 1.35 0.605 0 C-N-CA 118.245 -1.382 . . . . 0.0 108.995 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.51 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 17.4 p90 -132.29 160.69 35.49 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 116.675 -2.01 . . . . 0.0 110.753 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 33' ' ' LEU . 4.5 pp -150.73 149.67 30.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 116.401 -2.12 . . . . 0.0 109.74 169.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.8 mt -108.44 106.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.62 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.554 ' CB ' HG22 ' A' ' 14' ' ' ILE . 31.8 ptt-85 -94.95 126.78 40.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 112.623 -2.08 . . . . 0.0 110.077 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' GLY . 63.7 tt0 -69.06 120.48 14.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.874 -1.967 . . . . 0.0 109.121 177.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.466 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 43.0 t -45.81 120.31 2.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.817 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.623 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 61.3 tt0 -45.3 -40.1 7.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 112.743 -2.026 . . . . 0.0 110.81 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.8 m -89.93 -95.15 0.11 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.168 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.66 130.37 55.17 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 113.699 -1.591 . . . . 0.0 109.621 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.35 -6.16 15.41 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.833 1.689 . . . . 0.0 114.968 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.61 40.37 2.35 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 118.506 -1.807 . . . . 0.0 111.065 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.466 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 1.0 OUTLIER -133.0 120.83 21.89 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 117.747 -1.581 . . . . 0.0 109.836 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.412 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 86.7 m-85 -125.61 130.39 51.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.558 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.7 p -127.72 132.92 49.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.162 -1.836 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 tt -94.8 115.26 27.28 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.806 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.493 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 91.4 p -102.58 130.96 49.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.85 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.77 149.38 30.51 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 117.768 -1.573 . . . . 0.0 110.281 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 41.7 tptt -82.28 101.94 10.86 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.888 -1.96 . . . . 0.0 108.842 172.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 53' ' ' ASP . 10.4 t80 -110.04 144.75 38.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 113.321 -1.763 . . . . 0.0 108.871 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 52' ' ' ASN . . . -45.47 135.56 7.86 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 117.225 -2.417 . . . . 0.0 110.912 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 58.4 t30 76.72 -34.57 0.22 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 111.536 -2.332 . . . . 0.0 111.075 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 50' ' ' PHE . 11.0 m-20 -157.35 153.35 27.18 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 114.955 -2.698 . . . . 0.0 111.592 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 24' ' ' SER . 66.5 t -69.95 125.23 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 112.325 -2.216 . . . . 0.0 108.991 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.562 HE22 ' CD1' ' A' ' 95' ' ' ILE . 11.2 tt0 -90.04 164.0 14.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.542 -177.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.509 ' CE1' ' CG ' ' A' ' 58' ' ' LYS . 16.6 t-160 -140.86 129.58 22.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 112.959 -1.928 . . . . 0.0 111.124 -168.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 92.2 m-85 -138.31 103.15 4.83 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.263 175.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.509 ' CG ' ' CE1' ' A' ' 56' ' ' HIS . 53.6 mtmt -74.39 120.64 20.23 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 117.381 -1.728 . . . . 0.0 110.323 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 77' ' ' LEU . 56.6 t -75.32 87.37 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 112.688 -2.051 . . . . 0.0 108.69 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 71.3 mt -80.47 158.2 25.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.023 -1.899 . . . . 0.0 110.182 -174.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.547 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.663 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.563 ' HA ' ' HZ3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 88.8 m-85 -76.67 125.23 28.89 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 116.886 -1.926 . . . . 0.0 109.303 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -159.29 145.9 16.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.942 -1.935 . . . . 0.0 110.968 -177.015 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.556 HD22 ' H ' ' A' ' 69' ' ' LEU . 1.7 mm? -74.09 -66.9 0.66 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.94 -1.936 . . . . 0.0 108.88 175.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 19.0 m0 -136.15 -44.48 0.63 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 112.395 -2.184 . . . . 0.0 110.137 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.2 t -125.75 -80.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 112.99 -1.914 . . . . 0.0 110.445 -173.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.0 m -48.74 134.36 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.421 -172.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -101.51 155.05 18.31 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.829 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 80' ' ' LEU . 5.6 p90 -170.05 138.62 1.73 Allowed 'General case' 0 C--N 1.342 0.275 0 CA-C-N 111.153 -2.748 . . . . 0.0 109.156 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -98.2 24.13 7.51 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 112.711 -2.041 . . . . 0.0 111.724 176.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 40.3 t -144.94 132.16 20.54 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 116.814 -1.955 . . . . 0.0 110.345 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.504 ' CD2' HG11 ' A' ' 59' ' ' VAL . 96.1 mt -56.88 -44.58 82.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 113.178 -1.828 . . . . 0.0 109.57 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -51.43 -45.63 62.69 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.756 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 76' ' ' SER . 31.7 tp10 -58.67 -38.2 77.69 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.62 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' A' ' 59' ' ' VAL . 7.9 tt -60.19 -46.27 90.29 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.331 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 77' ' ' LEU . 86.4 t -65.49 -35.53 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 112.78 -2.009 . . . . 0.0 111.337 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 24.6 t0 -58.7 -43.01 89.94 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.373 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.404 ' C ' ' H ' ' A' ' 85' ' ' ARG . 33.2 m-85 -64.55 -42.76 95.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.112 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.47 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 38.2 m170 -80.03 30.28 0.27 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 113.599 -1.637 . . . . 0.0 111.378 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 83' ' ' TYR . 79.7 ttt-85 -112.98 -38.58 4.46 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 117.973 -1.491 . . . . 0.0 110.762 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.5 p -99.6 -39.82 8.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 117.974 -1.49 . . . . 0.0 110.677 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 88' ' ' SER . 8.8 t -106.17 39.13 1.86 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 117.731 -1.588 . . . . 0.0 110.863 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 87' ' ' THR . 44.2 t 44.93 -169.35 0.01 OUTLIER 'General case' 0 C--N 1.347 0.473 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.842 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.403 ' N ' ' OG ' ' A' ' 88' ' ' SER . 10.9 p -117.81 -39.88 2.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.359 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.454 ' HB3' ' CD1' ' A' ' 95' ' ' ILE . 32.8 t . . . . . 0 CA--C 1.545 0.756 0 CA-C-N 113.796 -1.547 . . . . 0.0 112.164 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 N--CA 1.45 -0.433 0 CA-C-O 121.852 0.834 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.562 ' CD1' HE22 ' A' ' 55' ' ' GLN . 55.2 mt -116.57 137.33 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 113.064 -1.88 . . . . 0.0 110.258 -178.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -121.47 133.37 55.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.735 -2.03 . . . . 0.0 109.112 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.47 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 80.8 mt -89.93 105.88 18.1 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.749 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.802 ' CD ' ' H ' ' A' ' 99' ' ' ASP . 0.7 OUTLIER 177.98 -141.94 0.01 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 112.35 -2.204 . . . . 0.0 107.678 -178.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.802 ' H ' ' CD ' ' A' ' 98' ' ' ARG . 27.0 m-20 69.61 -27.44 0.16 Allowed 'General case' 0 C--N 1.347 0.461 0 O-C-N 125.383 1.677 . . . . 0.0 113.104 166.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 13.3 tt -75.04 30.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 116.653 -2.019 . . . . 0.0 112.119 -172.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.518 ' H ' ' C ' ' A' ' 99' ' ' ASP . 43.2 tt0 . . . . . 0 N--CA 1.444 -0.74 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.596 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' HA2' ' CD ' ' A' ' 107' ' ' PRO . . . . . . . . 0 CA--C 1.53 0.976 0 CA-C-O 121.844 0.691 . . . . 0.0 111.993 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 2' ' ' ILE . 19.5 tt -134.96 44.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 113.112 -1.544 . . . . 0.0 109.951 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' C ' ' CD ' ' A' ' 3' ' ' GLU . 2.2 tm-20 -100.57 107.54 19.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 113.195 -1.821 . . . . 0.0 108.979 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' LYS . 71.3 mtp -95.22 117.94 31.12 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 112.981 -1.918 . . . . 0.0 110.401 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' MET . 86.9 tttt 39.08 94.11 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 112.643 -2.071 . . . . 0.0 110.928 174.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.1 Cg_exo -49.78 121.69 7.75 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.356 2.037 . . . . 0.0 112.185 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -90.68 115.39 64.1 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.964 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 9' ' ' TRP 0.252 60.9 Cg_endo -88.83 118.02 0.92 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.312 2.008 . . . . 0.0 110.883 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 1.3 m-90 -135.22 60.68 1.69 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 -15.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CE1' ' CA ' ' A' ' 12' ' ' GLY . 50.9 t80 -90.58 124.0 34.68 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 110.928 -2.851 . . . . 0.0 112.379 -155.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.7 m-85 -127.78 92.01 3.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 112.105 -2.316 . . . . 0.0 107.862 167.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.517 ' CA ' ' CE1' ' A' ' 10' ' ' PHE . . . -54.91 116.33 6.6 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.958 -170.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' CD ' ' OE2' ' A' ' 38' ' ' GLU . 25.4 pttm 31.1 42.28 0.01 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 111.685 -2.257 . . . . 0.0 111.109 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.518 ' CG1' ' HD2' ' A' ' 18' ' ' LYS . 10.3 tp -62.79 129.2 92.85 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 112.971 -1.922 . . . . 0.0 108.843 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.4 Cg_exo -45.86 123.29 5.92 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.834 1.689 . . . . 0.0 113.194 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 15' ' ' PRO . 41.5 ttm180 -37.06 -41.86 0.38 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.707 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -56.32 -81.19 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.246 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.604 ' CE ' ' SD ' ' A' ' 22' ' ' MET . 8.1 tmtm? -31.48 -42.66 0.05 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 112.646 -2.07 . . . . 0.0 111.029 -176.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -58.05 -69.55 0.17 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.717 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' SER . 53.5 mt-10 -48.03 -52.9 18.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.592 -2.095 . . . . 0.0 110.255 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 24' ' ' SER . 77.4 mm-40 -40.4 -87.46 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.753 -2.021 . . . . 0.0 110.621 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.604 ' SD ' ' CE ' ' A' ' 18' ' ' LYS . 16.9 ptm -50.77 -53.08 34.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.088 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.543 HD13 ' CD1' ' A' ' 100' ' ' ILE . 48.3 tp -48.38 -21.93 0.62 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 117.223 -1.791 . . . . 0.0 112.681 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 37.0 t -83.18 -35.97 25.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.78 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HD3' ' CA ' ' A' ' 22' ' ' MET . 5.2 pttp -42.75 -25.18 0.08 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.028 172.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.473 ' HG3' ' CB ' ' A' ' 31' ' ' ALA . 38.6 mm-40 -53.9 141.96 25.9 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.481 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -81.71 -69.49 0.61 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 111.936 -2.393 . . . . 0.0 110.455 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -76.1 -156.97 0.07 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.749 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -122.5 130.38 52.99 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 112.75 -2.023 . . . . 0.0 110.068 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.37 34.47 1.01 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 118.236 -1.935 . . . . 0.0 111.901 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.473 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -99.9 131.93 45.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 118.114 -1.434 . . . . 0.0 108.101 173.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' SER . 40.2 p90 -143.08 157.55 44.42 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 115.231 -2.588 . . . . 0.0 111.835 -173.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -148.43 151.83 35.9 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 112.003 -2.362 . . . . 0.0 109.451 171.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.85 110.71 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 112.492 -2.14 . . . . 0.0 108.976 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 34.4 ptt180 -96.7 128.11 43.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.373 -2.194 . . . . 0.0 110.051 -174.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' O ' ' CA ' ' A' ' 13' ' ' LYS . 45.1 tt0 -79.05 126.06 30.21 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.062 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.464 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 49.9 m -58.57 138.58 56.74 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 112.781 -2.009 . . . . 0.0 109.955 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' OE2' ' CD ' ' A' ' 13' ' ' LYS . 9.7 tp10 -38.6 -90.65 0.0 OUTLIER 'General case' 0 C--N 1.345 0.375 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.624 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 40' ' ' ALA . 49.0 m -89.9 -36.55 14.97 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 113.601 -1.636 . . . . 0.0 111.259 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HB3' ' CB ' ' A' ' 37' ' ' SER . . . -42.58 150.23 0.43 Allowed Pre-proline 0 C--N 1.348 0.508 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.158 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.67 -116.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.995 2.463 . . . . 0.0 110.784 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.02 57.83 4.83 Favored Glycine 0 C--N 1.346 1.089 0 C-N-CA 118.145 -1.979 . . . . 0.0 110.869 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 3.4 m-20 -102.9 117.1 33.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 117.903 -1.519 . . . . 0.0 109.32 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.403 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 95.3 m-85 -134.24 130.28 36.92 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 112.904 -1.953 . . . . 0.0 109.839 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 77.7 p -119.0 126.38 51.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.48 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.436 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.0 tt -93.51 115.07 27.57 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.354 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.434 ' OG ' ' HG ' ' A' ' 33' ' ' LEU . 90.3 p -94.04 144.64 25.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.184 -1.826 . . . . 0.0 109.789 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 60.7 t -146.44 137.4 18.51 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.726 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 66.3 tttp -73.36 93.66 1.95 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 116.83 -1.948 . . . . 0.0 108.824 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.477 ' O ' ' O ' ' A' ' 51' ' ' GLY . 4.6 t80 -92.6 40.6 1.06 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.615 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . 58.6 145.37 0.01 OUTLIER Glycine 0 C--N 1.346 1.131 0 C-N-CA 118.148 -1.977 . . . . 0.0 110.54 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 8.1 t-20 72.07 -35.04 0.32 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 112.475 -1.863 . . . . 0.0 110.854 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 51' ' ' GLY . 56.2 p30 -171.45 -163.63 0.29 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 117.264 -1.775 . . . . 0.0 110.295 176.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.474 ' CG1' HD23 ' A' ' 23' ' ' LEU . 88.4 t -108.76 123.87 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 112.369 -2.196 . . . . 0.0 110.009 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -100.44 157.97 16.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.716 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.474 ' H ' ' HD2' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -136.61 133.85 36.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 112.515 -2.129 . . . . 0.0 110.304 -176.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.499 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 92.6 m-85 -113.19 111.12 21.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.927 -1.942 . . . . 0.0 109.897 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 29.6 mmmt -72.25 100.36 2.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.231 -1.804 . . . . 0.0 110.089 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 98.9 t -72.09 88.47 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 113.041 -1.891 . . . . 0.0 108.553 173.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 82.0 mt -74.04 160.41 31.32 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.733 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.757 HH12 ' C ' ' A' ' 65' ' ' GLY . 23.2 tpt85 -99.43 178.58 4.83 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.032 -2.349 . . . . 0.0 108.628 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.589 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 34.1 t0 74.79 -129.74 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.661 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 62' ' ' ASP . . . 74.05 -70.14 1.54 Allowed Glycine 0 C--N 1.347 1.169 0 C-N-CA 117.774 -2.155 . . . . 0.0 109.317 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.83 36.01 1.28 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.487 -1.856 . . . . 0.0 110.062 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.757 ' C ' HH12 ' A' ' 61' ' ' ARG . . . 86.73 11.8 70.24 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 118.318 -1.896 . . . . 0.0 113.341 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.78 178.41 7.17 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 118.463 -1.295 . . . . 0.0 110.579 -175.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 17.3 m-85 -86.82 142.37 28.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.244 -2.253 . . . . 0.0 109.503 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -160.22 124.71 3.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.989 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.499 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 1.7 mt -61.59 -83.49 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.155 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -110.16 -42.76 4.09 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.222 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.0 t -137.93 -82.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.599 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.4 HG11 ' CZ ' ' A' ' 83' ' ' TYR . 24.4 m -47.03 134.2 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 112.649 -2.069 . . . . 0.0 110.544 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.56 165.98 12.26 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.563 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.783 ' CZ ' HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -170.04 140.13 1.94 Allowed 'General case' 0 C--N 1.343 0.31 0 CA-C-N 111.505 -2.589 . . . . 0.0 109.631 -175.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -91.88 -13.43 31.31 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 111.692 -2.504 . . . . 0.0 112.558 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 79' ' ' GLU . 41.1 t -140.56 129.93 23.85 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 117.573 -1.651 . . . . 0.0 109.908 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 80' ' ' LEU . 99.3 mt -47.12 -39.81 14.18 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.455 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -52.0 -45.43 64.53 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.149 -1.82 . . . . 0.0 109.594 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 83' ' ' TYR . 47.4 tp10 -57.0 -32.68 66.37 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 113.16 -1.836 . . . . 0.0 111.284 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.783 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 7.1 tt -72.1 -70.83 0.31 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.333 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.6 t -37.98 -35.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 112.685 -2.052 . . . . 0.0 111.187 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -80.3 -42.07 23.72 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.563 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 65.5 t80 -58.72 -43.08 90.05 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.2 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.421 ' NE2' ' CD1' ' A' ' 69' ' ' LEU . 87.7 m-70 -89.5 39.13 0.93 Allowed 'General case' 0 C--N 1.345 0.406 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.689 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.66 HH12 HH21 ' A' ' 98' ' ' ARG . 60.7 ttm-85 -107.33 -40.63 5.33 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.368 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -89.97 -40.89 12.07 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.476 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 87' ' ' THR . 23.6 m -110.97 41.29 1.85 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 117.831 -1.547 . . . . 0.0 110.903 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.606 ' HB3' ' H ' ' A' ' 95' ' ' ILE . 41.8 m 43.14 -153.59 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.527 169.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 89' ' ' VAL . 15.0 p -153.99 44.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-N 113.058 -1.883 . . . . 0.0 109.788 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' A' ' 95' ' ' ILE . 43.0 t 179.55 124.48 0.06 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.731 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 92' ' ' ASN . 48.0 mtp180 -69.68 -32.86 71.72 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 112.949 -1.932 . . . . 0.0 111.381 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 91' ' ' ARG . 63.1 m-80 -40.63 -39.9 1.16 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.772 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -160.67 -148.69 0.17 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.993 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 21.4 pt20 -116.16 120.16 38.12 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.019 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.606 ' H ' ' HB3' ' A' ' 88' ' ' SER . 64.2 mt -115.96 151.63 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 112.622 -2.081 . . . . 0.0 109.433 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -143.71 138.78 29.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.35 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.4 mt -89.92 118.54 29.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.995 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.66 HH21 HH12 ' A' ' 85' ' ' ARG . 2.0 mmp_? -126.17 149.36 49.05 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 112.521 -2.127 . . . . 0.0 109.875 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 101' ' ' GLU . 7.1 m-20 -54.01 124.19 14.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 112.163 -2.29 . . . . 0.0 109.83 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.543 ' CD1' HD13 ' A' ' 23' ' ' LEU . 10.6 tt -71.95 31.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 112.533 -2.121 . . . . 0.0 111.578 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 99' ' ' ASP . 47.3 mm-40 -150.15 119.49 6.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 118.001 -1.479 . . . . 0.0 109.651 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.463 ' OE1' ' O ' ' A' ' 103' ' ' VAL . 6.3 tm0? -74.62 132.66 41.93 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.65 -2.068 . . . . 0.0 109.64 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.708 ' CG1' ' H ' ' A' ' 105' ' ' GLN . 0.9 OUTLIER -33.98 149.0 0.08 OUTLIER Pre-proline 0 C--N 1.347 0.496 0 CA-C-N 112.623 -2.081 . . . . 0.0 110.85 -177.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 105' ' ' GLN . 19.3 Cg_endo -63.69 -7.73 13.6 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.069 2.513 . . . . 0.0 115.3 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.708 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 27.8 mt-30 36.59 -156.54 0.0 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.806 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -119.86 87.08 37.4 Favored Pre-proline 0 C--N 1.346 0.454 0 CA-C-N 113.01 -1.905 . . . . 0.0 109.466 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' THR . 45.6 Cg_exo -52.14 119.98 6.57 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.873 2.382 . . . . 0.0 113.685 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 107' ' ' PRO . 60.1 m 60.22 143.87 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.024 -1.898 . . . . 0.0 110.163 176.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 108' ' ' THR . 21.3 m-85 65.27 124.29 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.99 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 111' ' ' GLN . 7.4 p -113.09 122.96 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 112.803 -1.999 . . . . 0.0 109.6 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 110' ' ' VAL . 1.1 tm0? 57.9 114.31 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.469 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.409 0 CA-C-N 112.938 -1.937 . . . . 0.0 109.657 -179.518 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 CA-C-O 121.958 0.755 . . . . 0.0 112.027 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 2' ' ' ILE . 15.7 tt -46.75 121.87 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 112.999 -1.6 . . . . 0.0 109.634 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -107.96 123.17 48.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 112.957 -1.929 . . . . 0.0 109.658 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.576 ' SD ' ' C ' ' A' ' 4' ' ' MET . 0.2 OUTLIER -110.05 120.33 42.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.012 -1.903 . . . . 0.0 109.565 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.569 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 48.8 pttt -152.1 -174.64 0.42 Allowed Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.211 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 5' ' ' LYS . 44.0 Cg_exo -54.17 121.5 9.78 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.825 1.683 . . . . 0.0 112.606 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.431 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 5.8 p-80 -37.35 153.12 0.12 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.64 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' O ' ' CD2' ' A' ' 9' ' ' TRP . 75.2 Cg_exo -43.11 131.49 6.2 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.331 2.687 . . . . 0.0 116.93 -174.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.458 ' CD2' ' O ' ' A' ' 8' ' ' PRO . 32.5 p-90 49.25 16.65 0.16 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 111.872 -2.422 . . . . 0.0 113.502 170.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.431 ' CG ' ' CE1' ' A' ' 7' ' ' HIS . 49.2 t80 -97.77 119.13 35.82 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 116.229 -2.188 . . . . 0.0 109.653 175.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 8.6 m-85 -121.92 109.14 14.26 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 113.076 -1.875 . . . . 0.0 109.164 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -69.22 129.18 23.04 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 112.56 -2.109 . . . . 0.0 111.557 -174.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' CE ' ' HB2' ' A' ' 38' ' ' GLU . 83.7 tttt 25.89 47.66 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 111.713 -2.243 . . . . 0.0 111.899 176.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.427 HG22 ' CB ' ' A' ' 35' ' ' ARG . 8.7 tp -75.21 134.0 74.45 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 117.268 -1.773 . . . . 0.0 108.8 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' ARG . 20.8 Cg_endo -65.67 124.54 12.93 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.178 1.919 . . . . 0.0 111.332 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' CZ ' ' NH2' ' A' ' 35' ' ' ARG . 94.9 mtt-85 -34.22 -41.6 0.11 Allowed 'General case' 0 C--N 1.349 0.558 0 CA-C-N 112.779 -2.009 . . . . 0.0 110.983 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -54.72 -72.13 0.07 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.243 -1.798 . . . . 0.0 109.537 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 22' ' ' MET . 4.8 tppp? -41.74 -49.52 4.3 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.492 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -47.36 -58.53 4.04 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.479 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 89.4 mt-10 -49.96 -52.06 36.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.733 -2.03 . . . . 0.0 109.989 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 70.9 mt-10 -55.53 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.891 -1.958 . . . . 0.0 110.852 -173.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 3.0 ptm -45.46 -39.99 7.81 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.773 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.532 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 45.7 tp -68.56 -32.03 71.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 117.644 -1.623 . . . . 0.0 111.755 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.534 ' C ' ' H ' ' A' ' 26' ' ' GLN . 59.3 m -68.58 -35.9 78.0 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 117.503 -1.679 . . . . 0.0 111.044 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -72.07 33.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.241 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.575 HE21 HG13 ' A' ' 100' ' ' ILE . 13.6 mm-40 -101.69 132.37 47.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 117.818 -1.553 . . . . 0.0 110.022 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -81.26 -41.93 21.45 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 111.707 -2.497 . . . . 0.0 110.599 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.49 106.88 18.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.583 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -53.74 123.94 13.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.705 -2.043 . . . . 0.0 109.419 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 136.55 -31.77 2.54 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 117.585 -2.245 . . . . 0.0 112.037 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.571 ' HB1' HE21 ' A' ' 26' ' ' GLN . . . -46.32 136.61 7.04 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 118.078 -1.449 . . . . 0.0 109.358 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 47' ' ' SER . 28.2 p90 -145.3 162.76 36.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 116.384 -2.126 . . . . 0.0 110.982 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 33' ' ' LEU . 4.5 pp -147.95 150.17 33.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.343 -2.208 . . . . 0.0 109.577 172.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.7 mt -116.92 111.98 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 112.666 -2.061 . . . . 0.0 108.662 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 40.7 ptt85 -95.59 129.09 42.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 112.634 -2.076 . . . . 0.0 110.259 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -96.96 128.36 43.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 112.45 -2.159 . . . . 0.0 109.869 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 43.2 t -60.54 155.63 18.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.845 -1.979 . . . . 0.0 109.613 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.467 ' HB2' ' CE ' ' A' ' 13' ' ' LYS . 45.3 tt0 -41.08 -91.52 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 112.563 -2.108 . . . . 0.0 110.252 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 40' ' ' ALA . 50.5 m -90.0 -44.25 9.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.1 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -41.44 102.58 0.27 Allowed Pre-proline 0 C--N 1.347 0.488 0 CA-C-N 113.218 -1.81 . . . . 0.0 110.059 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.62 -4.45 14.6 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.88 1.72 . . . . 0.0 115.079 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.45 39.63 2.69 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 118.422 -1.846 . . . . 0.0 111.108 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 54.9 m-20 -130.32 112.17 13.05 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 117.736 -1.586 . . . . 0.0 109.933 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 96.9 m-85 -147.64 117.54 7.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.867 -1.969 . . . . 0.0 109.389 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 79.0 p -122.98 128.04 49.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.486 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.487 ' CD2' ' CG2' ' A' ' 48' ' ' VAL . 6.2 tt -93.59 119.7 32.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.81 -1.995 . . . . 0.0 109.673 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 50.1 m -99.44 145.02 27.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.534 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.487 ' CG2' ' CD2' ' A' ' 46' ' ' LEU . 88.6 t -145.36 138.67 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 113.378 -1.737 . . . . 0.0 110.452 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.604 ' HZ2' ' C ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -80.35 106.56 12.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 112.869 -1.969 . . . . 0.0 108.721 173.046 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 95' ' ' ILE . 72.8 t80 -79.76 -104.33 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 116.847 -1.941 . . . . 0.0 108.928 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.91 -69.08 1.35 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 118.718 -1.706 . . . . 0.0 109.633 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.604 ' C ' ' HZ2' ' A' ' 49' ' ' LYS . 29.1 t-20 -130.4 -24.31 2.55 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 111.978 -2.111 . . . . 0.0 112.088 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -99.9 157.37 16.57 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 118.661 -1.216 . . . . 0.0 110.473 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' CG2' ' OG ' ' A' ' 24' ' ' SER . 88.6 t -85.25 114.59 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.693 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.415 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 9.8 tt0 -90.27 158.74 17.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.933 -1.94 . . . . 0.0 109.399 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -130.66 131.62 44.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.779 -2.01 . . . . 0.0 110.746 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 45' ' ' SER . 96.3 m-85 -123.81 133.34 53.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.432 -2.167 . . . . 0.0 109.137 175.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.6 ' HB2' ' HZ2' ' A' ' 58' ' ' LYS . 10.6 mtmp? -104.06 107.97 19.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.321 -1.752 . . . . 0.0 110.242 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 72.1 t -76.57 85.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 112.683 -2.053 . . . . 0.0 108.565 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.597 HD21 ' HZ3' ' A' ' 58' ' ' LYS . 71.9 mt -70.33 161.0 31.22 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 112.68 -2.055 . . . . 0.0 110.679 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 1.9 tmt_? -128.68 156.99 42.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.392 -2.186 . . . . 0.0 109.884 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.557 ' C ' ' H ' ' A' ' 64' ' ' ALA . 43.4 t0 179.15 140.11 0.11 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 111.939 -2.391 . . . . 0.0 109.448 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.21 35.1 0.78 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 117.831 -2.128 . . . . 0.0 111.688 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 62' ' ' ASP . . . -142.98 45.0 1.58 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.879 -1.161 . . . . 0.0 109.707 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.467 ' HA2' ' CD ' ' A' ' 73' ' ' LYS . . . 140.5 -12.33 2.97 Favored Glycine 0 CA--C 1.544 1.87 0 C-N-CA 118.41 -1.853 . . . . 0.0 113.154 -175.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HD3' HD22 ' A' ' 75' ' ' ASN . 7.6 mtpm? 71.53 -140.69 0.05 OUTLIER 'General case' 0 C--N 1.351 0.637 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.004 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 55.0 m-85 -88.05 129.53 35.25 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 115.848 -2.341 . . . . 0.0 109.899 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -159.27 134.57 8.36 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 112.344 -2.207 . . . . 0.0 109.171 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.678 ' H ' HD12 ' A' ' 69' ' ' LEU . 4.2 mp -68.77 -52.95 24.9 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 116.682 -2.007 . . . . 0.0 109.247 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 18.2 m0 -135.53 -41.41 0.7 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.53 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.5 t -138.33 -83.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.546 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -47.19 133.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 112.552 -2.113 . . . . 0.0 110.782 -171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.467 ' CD ' ' HA2' ' A' ' 65' ' ' GLY . 9.7 mtmp? -94.21 158.38 15.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.491 -2.141 . . . . 0.0 110.592 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.878 ' CZ ' HD12 ' A' ' 80' ' ' LEU . 6.6 p90 -159.13 140.14 12.78 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 111.156 -2.747 . . . . 0.0 109.213 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.446 HD22 ' HD3' ' A' ' 66' ' ' LYS . 6.0 m120 -81.41 -16.91 50.7 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 111.247 -2.706 . . . . 0.0 112.352 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 79' ' ' GLU . 40.3 t -147.28 134.89 20.99 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 117.681 -1.608 . . . . 0.0 109.97 -175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 80' ' ' LEU . 82.6 mt -46.61 -42.89 16.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 112.724 -2.035 . . . . 0.0 110.288 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 38.5 m-80 -49.53 -46.82 49.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.545 -1.661 . . . . 0.0 109.572 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 76' ' ' SER . 41.9 tt0 -57.92 -34.72 70.16 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 112.922 -1.944 . . . . 0.0 111.098 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.878 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 5.4 tt -61.93 -65.54 0.67 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.783 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.5 t -43.83 -35.8 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 112.07 -2.332 . . . . 0.0 111.076 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 72.6 m-20 -59.87 -38.57 82.54 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.833 -178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.406 ' N ' ' O ' ' A' ' 80' ' ' LEU . 23.0 m-85 -66.24 -51.96 52.46 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.836 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.05 36.59 0.51 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.971 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 6.1 tpm_? -101.12 7.7 43.13 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.389 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 87' ' ' THR . 79.4 p -89.93 -78.2 0.37 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 118.656 -1.218 . . . . 0.0 109.896 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.418 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 9.2 t -170.02 39.48 0.02 OUTLIER 'General case' 0 C--N 1.346 0.451 0 C-N-CA 116.7 -2.0 . . . . 0.0 110.997 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.435 ' CB ' ' C ' ' A' ' 92' ' ' ASN . 77.6 p -177.22 140.98 0.31 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 116.887 -1.925 . . . . 0.0 110.537 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.4 ' CG2' HG22 ' A' ' 95' ' ' ILE . 38.4 t -114.3 -38.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 111.985 -2.371 . . . . 0.0 110.778 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.502 ' C ' ' H ' ' A' ' 92' ' ' ASN . 34.8 t -138.94 -69.4 0.43 Allowed 'General case' 0 C--N 1.346 0.446 0 C-N-CA 117.989 -1.484 . . . . 0.0 110.127 -175.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 52.6 mmm-85 -60.99 6.9 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 112.45 -2.159 . . . . 0.0 113.322 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.502 ' H ' ' C ' ' A' ' 90' ' ' SER . 70.7 m-20 70.86 -11.97 0.6 Allowed 'General case' 0 CA--C 1.545 0.756 0 O-C-N 124.054 0.846 . . . . 0.0 112.8 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.524 ' O ' ' CB ' ' A' ' 94' ' ' GLN . 4.0 pt20 -168.18 129.34 1.36 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 118.337 -1.345 . . . . 0.0 108.983 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 93' ' ' GLN . 18.3 mm100 102.22 26.85 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.504 -2.135 . . . . 0.0 112.053 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 50' ' ' PHE . 25.0 mt -149.29 121.39 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 117.314 -1.754 . . . . 0.0 109.963 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.582 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 67.3 m-85 -120.62 140.6 51.32 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.76 -2.018 . . . . 0.0 109.499 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.97 106.67 18.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 117.311 -1.756 . . . . 0.0 108.825 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -121.5 152.81 38.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.4 -173.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -45.08 126.82 6.31 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 112.441 -2.163 . . . . 0.0 109.52 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.575 HG13 HE21 ' A' ' 26' ' ' GLN . 15.4 tt -84.63 2.64 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 112.766 -2.016 . . . . 0.0 113.656 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -150.21 117.79 6.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 117.774 -1.571 . . . . 0.0 110.303 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -75.24 127.86 34.13 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 112.922 -1.945 . . . . 0.0 109.27 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.579 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -139.01 -66.88 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.573 -176.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.579 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 19.4 Cg_endo -65.81 2.33 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.674 1.582 . . . . 0.0 115.303 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -44.32 111.35 0.29 Allowed 'General case' 0 C--N 1.346 0.439 0 C-N-CA 118.526 -1.27 . . . . 0.0 109.62 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.408 ' CD ' ' C ' ' A' ' 106' ' ' GLN . 3.6 pp0? -158.75 155.46 24.95 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.665 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.405 ' O ' ' HA ' ' A' ' 106' ' ' GLN . 72.8 Cg_endo -78.2 -140.03 0.17 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.625 0 O-C-N 124.393 1.733 . . . . 0.0 109.734 -5.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.457 ' O ' ' CD1' ' A' ' 109' ' ' TYR . 5.2 t -144.76 42.33 1.33 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.05 -1.886 . . . . 0.0 110.216 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.457 ' CD1' ' O ' ' A' ' 108' ' ' THR . 66.0 m-85 -151.75 118.89 5.89 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.501 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 111' ' ' GLN . 36.0 m -91.96 118.5 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 113.098 -1.864 . . . . 0.0 109.557 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 110' ' ' VAL . 95.1 mt-30 25.73 101.52 0.0 OUTLIER 'General case' 0 C--N 1.349 0.572 0 CA-C-N 112.354 -2.203 . . . . 0.0 111.543 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 0.425 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.724 179.805 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 CA-C-O 121.875 0.708 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.412 ' O ' HG13 ' A' ' 2' ' ' ILE . 41.4 pt -148.54 129.13 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 113.031 -1.585 . . . . 0.0 109.624 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -129.65 121.08 26.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.503 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.583 ' SD ' ' C ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -70.17 116.13 10.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.469 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 6' ' ' PRO . 62.7 pttt -178.9 157.14 0.92 Allowed Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 112.987 -1.915 . . . . 0.0 108.888 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 5' ' ' LYS . 79.9 Cg_exo -42.02 -120.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.013 2.475 . . . . 0.0 114.29 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -147.3 147.29 28.03 Favored Pre-proline 0 N--CA 1.451 -0.418 0 C-N-CA 117.673 -1.611 . . . . 0.0 109.658 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -73.4 124.48 9.44 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.923 2.415 . . . . 0.0 111.621 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.467 ' CB ' ' CE2' ' A' ' 32' ' ' PHE . 59.2 p-90 38.57 47.37 1.1 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-N 112.538 -2.119 . . . . 0.0 110.545 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -142.67 108.4 5.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.438 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 12' ' ' GLY . 9.8 m-85 -125.03 97.23 5.17 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.195 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -27.79 -105.7 0.0 OUTLIER Glycine 0 C--N 1.347 1.167 0 CA-C-N 112.184 -2.28 . . . . 0.0 112.77 -174.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 63.9 tttp -110.19 53.52 0.69 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 112.77 -1.715 . . . . 0.0 109.035 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.43 HG22 ' CB ' ' A' ' 35' ' ' ARG . 8.5 tp -71.08 133.74 85.68 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.977 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' ARG . 23.1 Cg_endo -66.24 124.05 12.02 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.184 1.923 . . . . 0.0 111.268 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 15' ' ' PRO . 68.1 ttt180 -33.74 -39.38 0.06 Allowed 'General case' 0 C--N 1.347 0.495 0 CA-C-N 112.766 -2.016 . . . . 0.0 111.124 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -53.55 -81.17 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 113.422 -1.717 . . . . 0.0 109.049 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 17' ' ' ALA . 16.8 tppt? -36.45 -36.54 0.1 Allowed 'General case' 0 C--N 1.347 0.462 0 CA-C-N 112.977 -1.919 . . . . 0.0 111.374 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.549 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -59.23 -72.29 0.1 Allowed 'General case' 0 C--N 1.347 0.487 0 C-N-CA 117.375 -1.73 . . . . 0.0 109.061 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 21' ' ' GLU . 94.3 mt-10 -43.97 -56.13 4.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 112.541 -2.118 . . . . 0.0 109.801 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 11.9 mm-40 -37.05 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.317 -2.22 . . . . 0.0 110.887 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 17.7 ptm -56.84 -40.69 76.56 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 117.536 -1.666 . . . . 0.0 110.79 -172.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 39.5 tp -50.82 -32.78 21.17 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 116.922 -1.911 . . . . 0.0 111.433 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.555 ' C ' ' H ' ' A' ' 26' ' ' GLN . 41.6 t -75.51 -39.78 57.96 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.201 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -71.55 36.19 0.06 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.305 -1.77 . . . . 0.0 110.923 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.572 HE21 HG13 ' A' ' 100' ' ' ILE . 12.9 mm100 -102.28 -172.96 2.23 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 117.926 -1.509 . . . . 0.0 109.697 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HE ' ' NE2' ' A' ' 102' ' ' GLN . 3.0 mpt_? -75.63 37.34 0.14 Allowed 'General case' 0 C--N 1.346 0.428 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.947 -176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 26' ' ' GLN . 78.9 m80 38.09 36.25 0.11 Allowed 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.258 176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 74.8 m-20 -141.49 76.33 1.54 Allowed 'General case' 0 C--N 1.347 0.498 0 C-N-CA 116.748 -1.981 . . . . 0.0 110.975 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.547 ' HA2' ' CG1' ' A' ' 48' ' ' VAL . . . 46.72 20.89 0.72 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 113.013 -1.903 . . . . 0.0 113.373 170.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.412 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -52.29 135.81 31.94 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 116.765 -1.974 . . . . 0.0 108.043 172.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.467 ' CE2' ' CB ' ' A' ' 9' ' ' TRP . 30.5 p90 -139.48 148.62 42.95 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 115.656 -2.418 . . . . 0.0 111.926 -169.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -139.58 150.89 45.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 112.082 -2.326 . . . . 0.0 109.333 171.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.403 HD12 ' CE3' ' A' ' 9' ' ' TRP . 60.5 mt -117.69 107.93 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.622 175.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 31.4 ptt-85 -98.38 140.21 32.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 112.904 -1.953 . . . . 0.0 110.556 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 12' ' ' GLY . 23.9 pt-20 -105.36 137.46 43.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.307 -2.224 . . . . 0.0 109.451 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 36' ' ' GLU . 49.9 m -57.88 -153.87 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.692 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -71.63 -95.35 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.558 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 40' ' ' ALA . 87.1 p -89.99 -41.9 11.47 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.223 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -38.83 100.68 0.21 Allowed Pre-proline 0 C--N 1.348 0.519 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.248 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' SER . 57.9 Cg_endo -77.37 -4.36 14.63 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.855 1.703 . . . . 0.0 115.034 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.49 37.37 3.63 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 118.579 -1.772 . . . . 0.0 111.378 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 49.9 m-20 -129.74 100.83 5.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 117.732 -1.587 . . . . 0.0 109.647 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 21.6 m-85 -132.32 121.33 23.37 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.662 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.439 ' OG ' ' CZ ' ' A' ' 35' ' ' ARG . 78.8 p -119.04 126.56 51.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.096 -1.866 . . . . 0.0 109.37 178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.465 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.3 tt -90.36 114.34 26.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.765 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 33.8 m -97.34 149.51 22.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.314 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.547 ' CG1' ' HA2' ' A' ' 30' ' ' GLY . 75.5 t -140.64 141.56 32.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 113.397 -1.729 . . . . 0.0 110.29 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.509 ' CG ' ' HA ' ' A' ' 28' ' ' HIS . 22.2 tptp -73.78 97.29 2.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.792 -2.004 . . . . 0.0 108.847 173.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.479 ' O ' ' O ' ' A' ' 53' ' ' ASP . 5.7 t80 -116.46 110.43 18.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.031 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 50' ' ' PHE . . . -30.97 143.8 0.01 OUTLIER Glycine 0 C--N 1.347 1.193 0 CA-C-N 112.734 -2.03 . . . . 0.0 111.826 -176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 14.0 t30 82.99 -28.69 0.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 111.848 -2.176 . . . . 0.0 111.39 -175.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.557 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 30.7 t0 -172.53 -148.01 0.04 OUTLIER 'General case' 0 C--N 1.35 0.62 0 C-N-CA 116.33 -2.148 . . . . 0.0 110.381 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.557 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 93.3 t -129.22 119.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.506 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.499 HE22 ' HB2' ' A' ' 90' ' ' SER . 10.2 tt0 -90.01 159.95 16.61 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.052 -1.885 . . . . 0.0 109.655 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -146.73 145.17 29.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.66 -175.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.419 ' CE2' HG13 ' A' ' 89' ' ' VAL . 41.0 m-85 -134.02 110.48 9.68 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.304 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 56.1 mtmt -65.83 115.28 5.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 116.299 -2.16 . . . . 0.0 109.415 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 46.7 t -78.81 102.01 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 113.244 -1.798 . . . . 0.0 108.426 174.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 78.7 mt -93.96 -167.93 1.78 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 112.743 -2.026 . . . . 0.0 111.183 -169.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.619 HH22 ' HB3' ' A' ' 64' ' ' ALA . 34.9 tpt85 75.0 -121.32 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 111.954 -2.385 . . . . 0.0 110.387 172.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 61' ' ' ARG . 2.3 p30 53.27 118.39 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.552 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.0 -44.15 1.02 Allowed Glycine 0 CA--C 1.532 1.109 0 CA-C-N 112.144 -2.298 . . . . 0.0 110.081 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.619 ' HB3' HH22 ' A' ' 61' ' ' ARG . . . -138.69 -39.82 0.5 Allowed 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.025 -1.588 . . . . 0.0 110.484 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.512 ' H ' ' CZ ' ' A' ' 61' ' ' ARG . . . -111.02 22.07 21.65 Favored Glycine 0 CA--C 1.542 1.742 0 C-N-CA 118.129 -1.986 . . . . 0.0 112.975 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.517 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 5.3 mtpm? 57.71 -166.51 0.15 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.829 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 28.1 m-85 -94.93 139.03 31.9 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 117.512 -1.675 . . . . 0.0 110.617 -168.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.527 ' CB ' ' HA ' ' A' ' 73' ' ' LYS . 4.0 p90 -141.22 152.38 44.54 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 116.251 -2.18 . . . . 0.0 110.366 172.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.458 HD11 ' CG ' ' A' ' 80' ' ' LEU . 15.3 mt -90.49 -85.82 0.21 Allowed 'General case' 0 C--N 1.346 0.447 0 CA-C-N 112.744 -2.025 . . . . 0.0 109.633 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.403 ' CZ2' HG22 ' A' ' 89' ' ' VAL . 34.7 m0 -91.13 -44.8 9.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.887 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.7 t -145.34 -87.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 113.196 -1.82 . . . . 0.0 109.85 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.0 m -53.58 132.37 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.838 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.527 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 23.2 pttp -82.42 -162.37 0.56 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 112.818 -1.992 . . . . 0.0 109.988 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 67' ' ' TYR . 20.9 m-85 -154.8 137.38 15.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.73 -2.032 . . . . 0.0 108.726 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.517 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 54.4 p30 -65.45 -0.91 2.14 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 112.981 -1.918 . . . . 0.0 113.042 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 80.3 p 178.21 146.57 0.14 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.15 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 80' ' ' LEU . 92.6 mt -47.28 -40.29 16.44 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 116.897 -1.921 . . . . 0.0 110.176 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.437 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 25.8 m-80 -55.59 -38.15 69.03 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.809 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 76' ' ' SER . 36.5 tt0 -70.18 -23.91 63.05 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 117.49 -1.684 . . . . 0.0 111.868 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.477 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.0 tt -71.95 -49.33 38.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.046 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.79 -37.11 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 112.434 -2.166 . . . . 0.0 110.827 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 66.1 m-20 -74.66 -37.82 62.63 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 113.943 -1.481 . . . . 0.0 111.01 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 44.8 t80 -64.45 -52.34 58.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.743 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -86.27 40.55 0.88 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.564 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -73.28 -36.84 66.4 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.806 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.542 ' C ' ' H ' ' A' ' 88' ' ' SER . 46.3 m -136.87 -27.0 1.02 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 118.16 -1.416 . . . . 0.0 112.079 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' SER . 10.3 t -70.51 26.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 118.099 -1.44 . . . . 0.0 112.23 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 86' ' ' SER . 80.2 p 43.21 -166.66 0.01 OUTLIER 'General case' 0 C--N 1.348 0.521 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.235 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 89' ' ' VAL . 13.8 p -178.58 43.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 112.59 -2.096 . . . . 0.0 109.794 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.499 ' HB2' HE22 ' A' ' 55' ' ' GLN . 33.0 t -175.21 96.91 0.08 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.406 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 68.0 mtt85 55.8 3.56 0.09 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 113.249 -1.796 . . . . 0.0 113.633 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 90' ' ' SER . 27.0 m120 63.96 28.9 14.51 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.797 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 24.8 pt20 -113.38 103.64 11.5 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.011 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.466 ' O ' ' OE1' ' A' ' 94' ' ' GLN . 5.9 tm0? 37.54 91.87 0.01 OUTLIER 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.427 -2.169 . . . . 0.0 110.793 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.415 HD13 ' O ' ' A' ' 94' ' ' GLN . 12.7 mm -149.38 120.93 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.139 173.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.425 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 76.3 m-85 -138.8 139.45 38.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 113.118 -1.855 . . . . 0.0 108.879 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 86.2 mt -89.66 94.05 9.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.04 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.414 ' HD3' ' CB ' ' A' ' 29' ' ' ASP . 68.7 mtp85 -92.79 137.32 32.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 111.749 -2.478 . . . . 0.0 109.913 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 101' ' ' GLU . 16.1 m-20 -48.58 118.75 2.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 112.412 -2.176 . . . . 0.0 109.377 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.572 HG13 HE21 ' A' ' 26' ' ' GLN . 11.0 tt -71.22 27.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 112.76 -2.018 . . . . 0.0 112.193 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 99' ' ' ASP . 55.2 mm-40 -150.18 114.1 5.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.083 -176.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.46 ' NE2' ' HE ' ' A' ' 27' ' ' ARG . 10.7 mm100 -65.73 -177.97 0.51 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.971 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 104' ' ' PRO . 11.1 p -44.49 138.54 3.75 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.457 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 103' ' ' VAL . 72.5 Cg_exo -41.92 -119.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.728 2.286 . . . . 0.0 114.381 176.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -146.87 74.34 1.34 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 117.609 -1.636 . . . . 0.0 109.968 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -170.02 51.36 0.18 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.461 177.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 40.0 Cg_endo -68.85 124.66 11.69 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.259 1.973 . . . . 0.0 111.407 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.46 ' C ' ' O ' ' A' ' 107' ' ' PRO . 6.2 t -6.21 125.36 0.0 OUTLIER 'General case' 0 C--N 1.348 0.538 0 O-C-N 126.481 2.363 . . . . 0.0 112.394 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -128.27 123.64 34.63 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.87 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.2 p -105.92 121.5 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.913 -1.948 . . . . 0.0 109.624 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.652 ' CD ' ' H ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -81.95 -157.97 0.22 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.761 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.43 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.695 179.769 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 CA-C-O 121.91 0.728 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.409 ' O ' HG13 ' A' ' 2' ' ' ILE . 42.6 pt -147.61 129.14 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 112.981 -1.609 . . . . 0.0 109.75 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 3' ' ' GLU . 12.0 pt-20 -79.28 119.74 22.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.909 -1.95 . . . . 0.0 109.703 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.429 ' O ' ' C ' ' A' ' 5' ' ' LYS . 62.8 mtt -75.54 107.9 7.99 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.268 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' PRO . 87.9 tttt -37.38 99.06 0.18 Allowed Pre-proline 0 C--N 1.346 0.445 0 CA-C-N 112.86 -1.973 . . . . 0.0 110.726 -176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 5' ' ' LYS . 58.8 Cg_exo -48.36 -123.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.526 2.151 . . . . 0.0 113.487 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 8' ' ' PRO . 48.9 t60 -147.82 137.4 12.14 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.092 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 7' ' ' HIS . 63.8 Cg_exo -44.79 -121.66 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.522 2.148 . . . . 0.0 114.163 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.69 35.04 3.15 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.265 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -110.97 109.14 19.14 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.894 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 15.7 m-85 -105.82 99.18 8.79 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 117.709 -1.596 . . . . 0.0 109.332 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -66.27 124.59 25.43 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 112.102 -2.317 . . . . 0.0 111.485 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' CA ' ' O ' ' A' ' 36' ' ' GLU . 26.0 pttm 32.39 40.31 0.02 OUTLIER 'General case' 0 C--N 1.344 0.341 0 CA-C-N 111.857 -2.171 . . . . 0.0 111.145 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.501 ' CG1' ' HD2' ' A' ' 18' ' ' LYS . 10.8 tp -68.5 127.31 93.24 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.6 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' ARG . 53.5 Cg_exo -44.98 121.89 3.88 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.753 1.635 . . . . 0.0 113.103 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 15' ' ' PRO . 43.8 ttp180 -36.68 -37.53 0.14 Allowed 'General case' 0 C--N 1.345 0.4 0 CA-C-N 112.811 -1.995 . . . . 0.0 111.178 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' GLU . . . -70.43 -59.06 3.08 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.748 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' HE3' ' SD ' ' A' ' 22' ' ' MET . 7.2 tmtm? -44.69 -49.76 10.27 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.863 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -41.58 -54.3 3.24 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.835 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' SER . 66.0 mt-10 -60.35 -34.69 74.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.214 -2.267 . . . . 0.0 111.548 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' OG ' ' A' ' 24' ' ' SER . 61.7 mt-10 -64.41 -70.76 0.21 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 117.182 -1.807 . . . . 0.0 111.05 -171.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.54 ' SD ' ' HE3' ' A' ' 18' ' ' LYS . 26.6 ptm -61.44 -39.17 89.84 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 116.836 -1.945 . . . . 0.0 110.644 -175.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.464 HD23 ' CG1' ' A' ' 54' ' ' VAL . 32.1 tp -61.28 -41.4 96.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 117.805 -1.558 . . . . 0.0 110.5 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.547 ' C ' ' H ' ' A' ' 26' ' ' GLN . 75.6 p -64.87 -37.77 88.76 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.593 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 53.9 mttt -70.98 35.9 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.001 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.547 ' H ' ' C ' ' A' ' 24' ' ' SER . 43.0 mm-40 -108.96 135.77 49.6 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 117.981 -1.488 . . . . 0.0 110.003 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' A' ' 28' ' ' HIS . 10.0 mpt_? -91.21 89.96 7.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 111.813 -2.449 . . . . 0.0 109.407 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.496 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER 117.38 121.51 0.0 OUTLIER 'General case' 0 C--N 1.349 0.547 0 CA-C-N 111.561 -2.563 . . . . 0.0 109.277 177.392 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 49' ' ' LYS . 66.7 m-20 -61.01 132.03 52.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.686 -2.052 . . . . 0.0 109.876 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 146.45 -35.14 1.34 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 118.091 -2.004 . . . . 0.0 111.732 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -43.08 150.85 0.16 Allowed 'General case' 0 C--N 1.349 0.56 0 C-N-CA 118.581 -1.248 . . . . 0.0 109.717 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 47' ' ' SER . 44.0 p90 -154.8 160.45 41.28 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 115.157 -2.617 . . . . 0.0 111.84 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.495 HD23 ' CD1' ' A' ' 100' ' ' ILE . 0.4 OUTLIER -116.91 -174.42 2.58 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 112.276 -2.238 . . . . 0.0 108.534 169.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.6 mt -147.36 103.33 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 111.103 -2.772 . . . . 0.0 107.382 153.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 50.1 ptt85 -97.47 149.34 22.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.054 -169.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 37' ' ' SER . 39.4 tt0 -114.45 142.96 45.7 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 112.021 -2.354 . . . . 0.0 110.024 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' GLU . 35.8 t -53.84 -167.52 0.0 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 113.29 -1.777 . . . . 0.0 109.783 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' ' OG ' ' A' ' 37' ' ' SER . 39.9 tt0 -98.58 -70.04 0.74 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.109 -1.859 . . . . 0.0 110.37 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 89.3 p -89.97 30.67 1.04 Allowed 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.996 -1.911 . . . . 0.0 111.948 -173.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -179.46 136.44 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.637 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.574 ' C ' ' H ' ' A' ' 43' ' ' ASP . 57.0 Cg_endo -72.29 -143.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.981 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 172.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 -31.76 0.39 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 118.438 -1.839 . . . . 0.0 112.517 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 41' ' ' PRO . 17.5 t70 -90.05 108.74 19.91 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.945 -175.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 23.8 m-85 -133.41 123.08 24.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.544 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 57' ' ' PHE . 79.6 p -133.82 128.67 35.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 112.952 -1.931 . . . . 0.0 109.348 177.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.463 HD22 ' CG2' ' A' ' 48' ' ' VAL . 5.5 tt -84.14 116.21 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.693 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.8 m -93.2 143.17 26.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.965 -1.925 . . . . 0.0 108.932 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.463 ' CG2' HD22 ' A' ' 46' ' ' LEU . 58.2 t -135.05 141.54 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 117.041 -1.864 . . . . 0.0 110.43 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.821 ' HA ' ' HZ3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -82.55 97.33 8.4 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.439 -2.164 . . . . 0.0 109.086 176.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.482 ' N ' ' HZ2' ' A' ' 49' ' ' LYS . 9.3 t80 -110.07 139.92 44.68 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 117.527 -1.669 . . . . 0.0 109.145 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 52' ' ' ASN . . . -46.33 143.01 4.77 Favored Glycine 0 C--N 1.343 0.958 0 C-N-CA 117.322 -2.37 . . . . 0.0 110.399 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 57.0 t30 77.65 -31.17 0.17 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 111.859 -2.17 . . . . 0.0 111.365 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 50' ' ' PHE . 2.8 p30 -174.93 154.31 1.84 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 115.346 -2.542 . . . . 0.0 111.829 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.464 ' CG1' HD23 ' A' ' 23' ' ' LEU . 92.2 t -72.92 125.84 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.459 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.0 tt0 -90.04 163.13 15.02 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.775 -177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -133.37 123.61 25.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 112.622 -2.081 . . . . 0.0 110.6 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.41 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 22.9 m-85 -123.19 144.99 49.0 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 112.816 -1.993 . . . . 0.0 109.403 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -105.89 116.62 32.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.232 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 80' ' ' LEU . 33.4 t -89.36 101.21 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 112.667 -2.061 . . . . 0.0 108.171 173.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' ARG . 69.4 mt -82.61 152.58 25.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 112.933 -1.94 . . . . 0.0 111.743 -166.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.571 ' HG3' ' H ' ' A' ' 62' ' ' ASP . 22.6 ptt-85 5.9 -127.65 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 110.272 -3.149 . . . . 0.0 113.298 -172.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.571 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 23.2 t0 170.51 -37.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.759 -160.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 62' ' ' ASP . . . -37.68 -95.68 0.01 OUTLIER Glycine 0 C--N 1.348 1.213 0 CA-C-N 113.855 -1.52 . . . . 0.0 111.163 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.92 -47.11 5.96 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.056 -1.572 . . . . 0.0 109.373 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 73' ' ' LYS . . . -59.78 -6.17 4.77 Favored Glycine 0 CA--C 1.545 1.95 0 CA-C-N 112.746 -2.025 . . . . 0.0 113.375 175.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.711 ' HZ2' ' HB3' ' A' ' 73' ' ' LYS . 10.3 mtmp? 53.16 -153.73 0.24 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 118.131 -1.428 . . . . 0.0 108.999 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.454 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 76.5 m-85 -97.2 127.49 43.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 117.509 -1.676 . . . . 0.0 108.987 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' HZ ' HH12 ' A' ' 61' ' ' ARG . 31.1 p90 -157.87 153.6 26.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 116.124 -2.23 . . . . 0.0 110.366 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 80' ' ' LEU . 4.7 mp -95.07 -43.02 8.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.215 -1.812 . . . . 0.0 110.031 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -138.73 -78.12 0.35 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.163 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.9 t -105.46 -85.25 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.584 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.31 131.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 112.823 -1.99 . . . . 0.0 109.874 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.711 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 64.0 mttm -102.79 179.91 4.15 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.853 -1.976 . . . . 0.0 110.304 -176.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 67' ' ' TYR . 14.1 m-85 -150.17 133.42 16.35 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 112.693 -2.049 . . . . 0.0 109.28 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.591 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -69.44 -5.46 23.94 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.119 -1.855 . . . . 0.0 113.449 -178.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 49.4 m -167.93 149.21 5.26 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 117.724 -1.591 . . . . 0.0 109.784 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.507 ' CD2' HG11 ' A' ' 59' ' ' VAL . 87.2 mt -45.71 -45.68 14.45 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.202 -1.817 . . . . 0.0 109.831 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -54.07 -41.59 68.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 112.821 -1.991 . . . . 0.0 110.512 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.459 ' HB2' HD21 ' A' ' 75' ' ' ASN . 48.5 tp10 -63.86 -31.87 73.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 116.627 -2.029 . . . . 0.0 110.941 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 69' ' ' LEU . 5.9 tt -63.16 -50.88 68.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 118.522 -1.271 . . . . 0.0 108.4 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 82' ' ' ASP . 87.4 t -54.72 -75.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.673 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.464 ' HA ' ' CD ' ' A' ' 85' ' ' ARG . 33.2 t0 -34.22 -47.49 0.29 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.617 -2.083 . . . . 0.0 111.273 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -71.7 -32.62 68.01 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.863 -172.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.421 ' C ' ' H ' ' A' ' 86' ' ' SER . 35.8 m170 -98.68 -6.73 29.1 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 117.688 -1.605 . . . . 0.0 113.18 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.464 ' CD ' ' HA ' ' A' ' 82' ' ' ASP . 9.0 ptm180 -82.42 39.11 0.58 Allowed 'General case' 0 C--N 1.348 0.533 0 C-N-CA 116.889 -1.924 . . . . 0.0 110.557 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 84' ' ' HIS . 79.9 p -150.0 -73.81 0.17 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.741 -1.572 . . . . 0.0 109.566 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.408 ' N ' ' OG ' ' A' ' 86' ' ' SER . 60.0 p -84.08 38.31 0.65 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 112.966 -1.925 . . . . 0.0 110.961 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 95' ' ' ILE . 48.4 t 48.54 -168.97 0.02 OUTLIER 'General case' 0 C--N 1.346 0.425 0 C-N-CA 117.919 -1.512 . . . . 0.0 109.888 177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.506 ' H ' ' HB ' ' A' ' 95' ' ' ILE . 13.6 p -152.51 43.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.439 0 CA-C-N 113.199 -1.818 . . . . 0.0 110.201 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.483 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 19.2 t 178.59 112.02 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.145 -1.843 . . . . 0.0 108.793 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.428 ' O ' ' CG ' ' A' ' 92' ' ' ASN . 65.8 mtp180 59.8 0.75 0.26 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 117.01 -1.876 . . . . 0.0 112.999 -172.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 90' ' ' SER . 11.0 p30 50.92 35.36 12.31 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 124.079 0.862 . . . . 0.0 111.796 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 21.3 pt20 -169.95 57.63 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 117.771 -1.571 . . . . 0.0 110.604 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.421 ' OE1' ' CZ ' ' A' ' 50' ' ' PHE . 42.8 tt0 -174.03 -34.35 0.01 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 116.458 -2.097 . . . . 0.0 111.644 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.506 ' O ' ' CB ' ' A' ' 88' ' ' SER . 13.0 mm -102.04 147.49 8.72 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 C-N-CA 117.367 -1.733 . . . . 0.0 110.499 -175.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.577 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 90.5 m-85 -149.99 135.55 18.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.631 -2.077 . . . . 0.0 109.101 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.3 mt -89.89 118.55 29.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 116.958 -1.897 . . . . 0.0 109.553 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 17.4 tpt180 -121.33 147.85 45.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.71 -2.041 . . . . 0.0 110.258 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 101' ' ' GLU . 67.6 m-20 -61.0 116.21 4.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.431 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.495 ' CD1' HD23 ' A' ' 33' ' ' LEU . 12.0 tt -72.19 32.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.644 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' A' ' 99' ' ' ASP . 17.8 mm-40 -150.1 126.86 11.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 117.884 -1.526 . . . . 0.0 109.787 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -64.39 129.32 39.45 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 112.603 -2.089 . . . . 0.0 109.919 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.472 ' C ' ' H ' ' A' ' 105' ' ' GLN . 9.7 p -48.11 137.53 10.99 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 112.87 -1.968 . . . . 0.0 109.418 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 105' ' ' GLN . 51.2 Cg_exo -48.52 -4.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.283 1.989 . . . . 0.0 115.989 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.472 ' H ' ' C ' ' A' ' 103' ' ' VAL . 47.9 mt-30 57.8 151.57 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 118.106 -1.438 . . . . 0.0 109.864 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.637 ' H ' ' HD2' ' A' ' 107' ' ' PRO . 2.3 mt-30 -154.02 -57.2 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.983 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.637 ' HD2' ' H ' ' A' ' 106' ' ' GLN . 52.9 Cg_exo -47.11 120.89 4.62 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.665 1.577 . . . . 0.0 113.777 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 107' ' ' PRO . 72.7 m 64.49 113.61 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.214 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 108' ' ' THR . 8.6 t80 179.45 106.06 0.03 OUTLIER 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.436 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 110' ' ' VAL . 11.9 p -170.01 51.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.737 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 111' ' ' GLN . 29.8 pt20 -97.83 121.7 40.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.004 -1.907 . . . . 0.0 109.702 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.445 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.705 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 2' ' ' ILE . . . . . . . . 0 CA--C 1.531 1.047 0 CA-C-O 121.796 0.665 . . . . 0.0 111.977 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.521 HG12 ' SD ' ' A' ' 4' ' ' MET . 14.6 tt 38.69 96.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 112.819 -1.69 . . . . 0.0 110.538 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 104' ' ' PRO . 60.0 mt-10 -66.87 93.4 0.26 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 112.763 -2.017 . . . . 0.0 109.862 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.521 ' SD ' HG12 ' A' ' 2' ' ' ILE . 70.1 mmm -93.11 113.2 25.38 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.841 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' O ' ' CD2' ' A' ' 7' ' ' HIS . 24.9 pttm -177.84 154.58 1.0 Allowed Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 113.134 -1.848 . . . . 0.0 109.419 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 7' ' ' HIS . 53.9 Cg_exo -47.02 118.65 2.88 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.42 2.08 . . . . 0.0 113.895 176.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER 175.97 76.78 0.08 OUTLIER Pre-proline 0 C--N 1.346 0.456 0 CA-C-N 112.915 -1.948 . . . . 0.0 110.269 175.045 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 7' ' ' HIS . 53.3 Cg_exo -44.92 -122.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.524 2.816 . . . . 0.0 113.872 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.41 ' CZ3' HD12 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -133.15 32.94 3.67 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.473 -177.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -89.63 121.09 31.49 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 117.594 -1.642 . . . . 0.0 109.961 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.9 m-85 -105.28 92.38 4.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 112.962 -1.926 . . . . 0.0 108.598 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -55.82 120.46 19.03 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 112.447 -2.161 . . . . 0.0 111.584 -172.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.481 ' CA ' ' O ' ' A' ' 36' ' ' GLU . 17.4 ptpt 28.77 44.71 0.01 OUTLIER 'General case' 0 C--N 1.346 0.433 0 CA-C-N 111.591 -2.305 . . . . 0.0 111.384 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.8 tp -63.17 131.23 94.68 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.611 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.5 Cg_exo -45.25 121.43 3.75 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.719 1.612 . . . . 0.0 112.886 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.496 ' CB ' ' NH1' ' A' ' 16' ' ' ARG . 22.4 ttm105 -38.78 -40.53 0.63 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.818 -177.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -63.8 -59.92 3.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 113.47 -1.695 . . . . 0.0 109.627 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -44.65 -51.09 9.46 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 112.917 -1.947 . . . . 0.0 110.182 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -45.49 -47.02 14.11 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 113.456 -1.702 . . . . 0.0 109.842 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 88.8 mt-10 -62.65 -46.38 88.47 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.116 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 24' ' ' SER . 40.5 mt-10 -60.82 -77.93 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.693 -2.049 . . . . 0.0 110.644 -173.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 21' ' ' GLU . 2.9 ptm -43.87 -38.78 3.53 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.884 -176.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.505 HD23 ' CG1' ' A' ' 54' ' ' VAL . 28.4 tp -71.55 -33.17 68.89 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.62 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.474 ' C ' ' H ' ' A' ' 26' ' ' GLN . 53.5 m -70.41 -28.01 64.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 117.888 -1.525 . . . . 0.0 111.897 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -76.98 42.36 0.31 Allowed 'General case' 0 C--N 1.349 0.55 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.314 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.609 HE21 HG13 ' A' ' 100' ' ' ILE . 22.6 mm-40 -112.28 136.11 52.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.224 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.463 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 74.9 mtp85 -38.64 -85.26 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 111.646 -2.525 . . . . 0.0 110.37 -177.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 1.2 m-70 163.27 117.33 0.0 OUTLIER 'General case' 0 C--N 1.348 0.505 0 CA-C-N 112.506 -2.134 . . . . 0.0 107.995 -175.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -166.75 135.68 2.87 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.956 1.703 . . . . 0.0 108.462 -0.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 138.71 -9.98 3.41 Favored Glycine 0 CA--C 1.544 1.896 0 C-N-CA 117.301 -2.38 . . . . 0.0 113.41 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -46.19 144.58 1.93 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 118.372 -1.331 . . . . 0.0 109.142 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 47' ' ' SER . 53.4 p90 -147.76 160.13 43.06 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 115.868 -2.333 . . . . 0.0 111.424 -174.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.4 pp -149.07 153.07 37.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.001 -2.363 . . . . 0.0 109.29 173.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 45' ' ' SER . 23.0 mt -115.91 112.52 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.785 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 30.4 ptt-85 -96.71 128.52 43.74 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 112.153 -2.294 . . . . 0.0 110.394 -172.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' O ' ' CA ' ' A' ' 13' ' ' LYS . 2.9 mp0 -79.05 112.32 16.13 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.281 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.477 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 50.5 m -58.52 144.61 41.91 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 112.921 -1.945 . . . . 0.0 110.413 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.8 tp10 -46.28 -96.76 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 112.359 -2.2 . . . . 0.0 110.024 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.1 t -113.58 43.1 1.84 Allowed 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.403 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.477 ' HB3' ' CB ' ' A' ' 37' ' ' SER . . . -99.05 154.65 37.21 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 113.134 -1.848 . . . . 0.0 108.983 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' ALA . 74.7 Cg_exo -34.82 -110.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.917 2.411 . . . . 0.0 114.54 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . -47.7 -59.78 5.82 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 117.333 -2.365 . . . . 0.0 108.352 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -111.47 107.27 16.41 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 113.772 -1.214 . . . . 0.0 108.103 -45.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -90.36 137.36 32.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.128 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 27.4 t -133.39 132.35 41.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.621 -2.081 . . . . 0.0 109.335 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.501 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.7 tt -103.05 115.93 31.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.953 -1.931 . . . . 0.0 109.319 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 49.8 m -97.41 149.17 22.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.948 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 85.6 t -143.51 140.95 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 113.048 -1.887 . . . . 0.0 109.731 176.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 66.3 tttp -73.06 102.59 3.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 116.64 -2.024 . . . . 0.0 108.931 173.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 50' ' ' PHE . 62.7 t80 -88.29 -8.99 54.31 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.256 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 53' ' ' ASP . . . 88.54 134.74 4.96 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 118.875 -1.631 . . . . 0.0 109.431 -174.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 7.3 t30 71.91 -33.36 0.27 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 112.307 -1.947 . . . . 0.0 110.826 -174.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 51' ' ' GLY . 18.5 t70 -159.13 -175.57 5.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 117.416 -1.714 . . . . 0.0 109.436 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.539 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 85.5 t -114.42 121.8 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 113.044 -1.889 . . . . 0.0 109.701 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.451 ' OE1' ' CZ ' ' A' ' 57' ' ' PHE . 7.3 tt0 -90.69 159.29 16.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.769 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -141.76 143.7 33.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.024 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.524 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 83.5 m-85 -122.3 105.08 9.89 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.697 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.1 mmmp? -65.58 105.0 1.11 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.942 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' A' ' 67' ' ' TYR . 64.9 t -75.05 96.92 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.274 172.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 88.7 mt -79.41 -161.52 0.33 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.165 -170.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.877 HH11 ' H ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER 93.55 -137.66 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 111.799 -2.455 . . . . 0.0 108.378 -175.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.877 ' H ' HH11 ' A' ' 61' ' ' ARG . 17.7 t70 110.88 -32.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 O-C-N 125.647 1.842 . . . . 0.0 111.252 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.523 ' H ' ' HD2' ' A' ' 61' ' ' ARG . . . -158.99 110.94 0.46 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 116.467 -2.778 . . . . 0.0 112.664 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.616 ' HB3' ' HE ' ' A' ' 61' ' ' ARG . . . 151.81 -71.66 0.0 OUTLIER 'General case' 0 C--N 1.351 0.674 0 CA-C-N 112.238 -1.981 . . . . 0.0 106.467 -174.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.507 ' H ' ' NE ' ' A' ' 61' ' ' ARG . . . -176.8 85.01 0.07 OUTLIER Glycine 0 CA--C 1.54 1.624 0 CA-C-N 112.216 -2.265 . . . . 0.0 112.661 166.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.772 ' H ' ' CZ ' ' A' ' 61' ' ' ARG . 3.4 mtpm? 110.02 -126.98 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.247 -1.476 . . . . 0.0 113.29 153.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 94.0 m-85 -144.02 140.76 29.75 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.539 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -163.75 134.95 4.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 114.768 -2.773 . . . . 0.0 111.884 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -124.81 162.97 23.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 112.204 -2.271 . . . . 0.0 107.713 163.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 38.5 m0 64.86 -84.66 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 111.986 -2.37 . . . . 0.0 110.188 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 69' ' ' LEU . 51.6 t -139.16 -92.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 116.902 -1.919 . . . . 0.0 110.428 -173.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -55.28 141.29 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 113.273 -1.785 . . . . 0.0 110.677 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.419 ' C ' ' CG ' ' A' ' 74' ' ' PHE . 67.7 mttm -76.98 -165.88 0.62 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 112.821 -1.991 . . . . 0.0 109.438 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.419 ' CG ' ' C ' ' A' ' 73' ' ' LYS . 15.3 m-85 -157.06 136.45 12.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.059 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.539 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 2.6 p-10 -65.48 -5.14 7.02 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.076 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 80.2 p 178.22 153.72 0.33 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.988 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.441 ' CD2' HG11 ' A' ' 59' ' ' VAL . 94.1 mt -45.35 -42.52 10.08 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 117.386 -1.726 . . . . 0.0 110.21 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 14.0 t-20 -58.4 -40.49 82.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.239 -1.8 . . . . 0.0 110.816 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 76' ' ' SER . 43.1 tp10 -63.18 -30.11 71.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 116.644 -2.022 . . . . 0.0 111.237 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 80' ' ' LEU . 5.8 tt -71.42 -59.96 2.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.531 176.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 97.5 t -46.15 -31.99 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 112.618 -2.083 . . . . 0.0 111.501 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 90.2 m-20 -80.06 -42.08 24.41 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.362 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -59.63 -41.08 89.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.591 -1.641 . . . . 0.0 110.449 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.436 ' CG ' HG23 ' A' ' 89' ' ' VAL . 33.1 m170 -90.41 39.69 0.98 Allowed 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.54 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 85' ' ' ARG . 62.0 ttt180 -124.45 0.8 8.3 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.876 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -89.91 -45.84 8.95 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.795 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 87' ' ' THR . 9.3 t -170.05 119.21 0.6 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 117.02 -1.872 . . . . 0.0 110.597 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.561 ' HA ' ' H ' ' A' ' 95' ' ' ILE . 43.0 t 66.14 143.89 0.03 OUTLIER 'General case' 0 C--N 1.346 0.426 0 CA-C-N 112.689 -2.05 . . . . 0.0 110.963 172.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 89' ' ' VAL . 14.0 p -147.74 42.98 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.879 172.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.53 ' CB ' HD12 ' A' ' 95' ' ' ILE . 48.1 t 176.38 113.65 0.02 OUTLIER 'General case' 0 C--N 1.347 0.469 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.39 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -59.21 -1.36 0.19 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 113.121 -1.854 . . . . 0.0 113.101 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 90' ' ' SER . 75.7 m-20 -65.04 -58.15 6.83 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 118.354 -1.338 . . . . 0.0 110.078 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 94' ' ' GLN . 12.2 pt20 -163.53 39.8 0.09 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.658 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 93' ' ' GLN . 26.6 mt-30 62.52 126.84 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.115 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.561 ' H ' ' HA ' ' A' ' 88' ' ' SER . 40.6 mt -143.13 140.88 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.811 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.45 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 16.8 m-30 -111.67 146.45 37.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.524 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.6 mt -90.04 118.93 29.97 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 117.079 -1.848 . . . . 0.0 109.284 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 90.0 mtt-85 -122.23 146.79 46.94 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.905 -1.952 . . . . 0.0 109.97 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 100' ' ' ILE . 33.5 m-20 -57.12 122.63 12.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.759 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.621 HG12 ' H ' ' A' ' 101' ' ' GLU . 14.9 tt -59.74 -136.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 112.739 -2.028 . . . . 0.0 109.391 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.621 ' H ' HG12 ' A' ' 100' ' ' ILE . 81.0 mt-10 -90.02 108.63 19.84 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.777 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.612 HE22 ' C ' ' A' ' 100' ' ' ILE . 9.1 mp0 -108.32 107.98 18.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.049 -1.887 . . . . 0.0 109.517 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.496 HG23 ' HD3' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -49.29 -62.78 2.09 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.362 176.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 105' ' ' GLN . 52.4 Cg_exo -44.31 128.65 8.04 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.032 1.821 . . . . 0.0 113.625 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 104' ' ' PRO . 29.2 mt-30 108.65 115.53 0.0 OUTLIER 'General case' 0 C--N 1.345 0.41 0 CA-C-N 112.114 -2.312 . . . . 0.0 109.961 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.414 ' NE2' ' O ' ' A' ' 105' ' ' GLN . 92.4 mm-40 -128.0 151.57 76.08 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 112.519 -2.128 . . . . 0.0 109.302 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.499 ' HB2' ' H ' ' A' ' 108' ' ' THR . 53.4 Cg_endo -69.25 -138.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.629 2.219 . . . . 0.0 109.9 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.499 ' H ' ' HB2' ' A' ' 107' ' ' PRO . 90.5 m -167.78 125.12 1.16 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 113.391 -1.731 . . . . 0.0 109.769 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 109' ' ' TYR . 8.5 t80 -166.76 44.7 0.06 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 112.902 -1.954 . . . . 0.0 109.955 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.4 p -88.36 122.01 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.783 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -48.14 120.6 3.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 112.922 -1.945 . . . . 0.0 109.705 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.444 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.689 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.972 0 CA-C-O 121.954 0.752 . . . . 0.0 111.995 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 2' ' ' ILE . 2.4 mp -62.9 92.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 112.974 -1.613 . . . . 0.0 109.209 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 2' ' ' ILE . 25.0 pt-20 34.59 56.13 0.69 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.835 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' A' ' 4' ' ' MET . 14.9 tpt -116.17 54.25 0.84 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.917 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HB3' ' CD ' ' A' ' 6' ' ' PRO . 41.3 tttm 174.02 -69.99 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.229 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' CD ' ' HB3' ' A' ' 5' ' ' LYS . 35.7 Cg_endo -66.85 118.66 5.72 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.818 1.679 . . . . 0.0 111.301 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.613 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 59.0 t-80 -177.08 -44.19 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 113.077 -1.874 . . . . 0.0 112.073 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 7' ' ' HIS . 50.9 Cg_exo -50.33 -122.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 121.519 1.479 . . . . 0.0 114.166 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.438 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 4.6 p-90 -161.34 31.19 0.14 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.653 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.438 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 96.5 m-85 -103.11 120.23 40.31 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.013 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 12' ' ' GLY . 8.1 m-85 -108.51 108.58 19.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.746 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -16.7 -111.57 0.0 OUTLIER Glycine 0 C--N 1.349 1.259 0 CA-C-N 111.67 -2.514 . . . . 0.0 113.016 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -116.12 43.07 2.23 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 112.978 -1.611 . . . . 0.0 109.88 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.9 tp -53.12 114.46 6.01 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.315 -178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' ARG . 47.2 Cg_exo -50.15 125.84 15.83 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.581 1.52 . . . . 0.0 111.869 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.734 ' HB3' HH12 ' A' ' 35' ' ' ARG . 18.3 ptp180 -34.7 -38.14 0.07 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.481 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -69.52 -62.44 1.38 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.455 -1.702 . . . . 0.0 109.74 178.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.521 ' CD ' HD11 ' A' ' 14' ' ' ILE . 0.1 OUTLIER -38.22 -44.43 0.86 Allowed 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.219 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -54.38 -59.88 4.09 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 112.735 -2.029 . . . . 0.0 109.459 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 17' ' ' ALA . 89.3 mt-10 -43.26 -43.65 4.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 112.795 -2.002 . . . . 0.0 110.263 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 24' ' ' SER . 38.5 mt-10 -60.6 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.443 -175.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.519 ' HB3' ' HZ3' ' A' ' 18' ' ' LYS . 17.3 ptm -43.28 -40.31 3.44 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 113.613 -1.63 . . . . 0.0 110.794 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 25' ' ' LYS . 31.8 tp -64.71 -36.74 85.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.132 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.51 ' OG ' ' CG2' ' A' ' 54' ' ' VAL . 63.2 m -73.23 28.71 0.06 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 117.368 -1.733 . . . . 0.0 111.656 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.551 ' H ' ' C ' ' A' ' 23' ' ' LEU . 53.1 mtpt -135.03 46.21 2.45 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.198 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.548 HE21 HG13 ' A' ' 100' ' ' ILE . 17.6 mm-40 -119.77 117.56 28.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 112.877 -1.965 . . . . 0.0 109.926 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 31.8 tpt85 -98.56 30.95 3.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 111.453 -2.612 . . . . 0.0 112.327 -169.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 29' ' ' ASP . 73.4 m80 -149.39 11.84 0.8 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 116.019 -2.273 . . . . 0.0 113.593 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' HIS . 7.6 t70 58.77 141.9 0.01 OUTLIER 'General case' 0 C--N 1.347 0.474 0 CA-C-O 122.155 0.979 . . . . 0.0 110.79 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.25 -21.82 43.76 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 117.749 -2.167 . . . . 0.0 112.932 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.514 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -42.58 117.46 1.03 Allowed 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.774 -1.17 . . . . 0.0 109.748 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.461 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 29.6 p90 -130.9 158.87 39.06 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 116.399 -2.121 . . . . 0.0 111.632 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 33' ' ' LEU . 4.5 pp -151.87 153.53 34.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 112.618 -2.083 . . . . 0.0 109.753 172.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.717 ' CD1' HD12 ' A' ' 77' ' ' LEU . 15.6 mt -121.46 113.39 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.639 -2.073 . . . . 0.0 108.793 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.734 HH12 ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -84.57 131.16 34.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 115.423 -2.511 . . . . 0.0 110.156 -175.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.9 tp10 -72.27 69.53 0.8 Allowed 'General case' 0 C--N 1.346 0.42 0 CA-C-N 112.744 -2.025 . . . . 0.0 109.401 176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' GLU . 60.0 p 24.7 -147.61 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 112.158 -2.292 . . . . 0.0 111.791 -177.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -130.58 -70.56 0.61 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 112.999 -1.909 . . . . 0.0 109.021 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.1 t -134.87 43.85 2.68 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 112.435 -2.166 . . . . 0.0 109.677 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.596 ' HB3' ' CA ' ' A' ' 41' ' ' PRO . . . -80.18 -65.14 0.29 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.471 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.596 ' CA ' ' HB3' ' A' ' 40' ' ' ALA . 84.2 Cg_endo -93.02 -2.11 49.82 Favored 'Cis proline' 0 C--N 1.357 0.978 0 N-CA-C 114.903 1.078 . . . . 0.0 114.903 -4.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.5 55.35 4.41 Favored Glycine 0 C--N 1.346 1.111 0 C-N-CA 119.052 -1.546 . . . . 0.0 111.493 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' A' ' 37' ' ' SER . 49.3 m-20 -130.35 94.63 3.71 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 117.675 -1.61 . . . . 0.0 109.676 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -110.64 127.29 55.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 112.931 -1.94 . . . . 0.0 109.698 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 20.4 p -125.17 132.34 53.06 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.25 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.4 tt -91.68 113.95 26.35 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.099 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.9 m -95.33 153.0 17.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.159 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.4 t -153.12 135.92 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 117.167 -1.813 . . . . 0.0 110.11 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 89.0 tttt -83.32 106.94 15.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 112.946 -1.933 . . . . 0.0 108.645 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -75.22 -79.44 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.57 -176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.3 -75.94 0.44 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-N 111.796 -2.456 . . . . 0.0 109.871 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.64 -24.35 9.26 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 112.107 -2.046 . . . . 0.0 111.99 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -111.6 156.78 21.26 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 118.464 -1.294 . . . . 0.0 110.115 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' CG2' ' OG ' ' A' ' 24' ' ' SER . 99.1 t -83.44 105.27 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 112.683 -2.053 . . . . 0.0 109.952 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 56' ' ' HIS . 1.0 OUTLIER -96.98 145.71 25.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.081 176.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.471 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 44.4 p-80 -134.0 168.62 18.47 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.044 -171.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.455 ' CZ ' ' OE1' ' A' ' 55' ' ' GLN . 85.3 m-85 -139.02 112.13 7.99 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 112.142 -2.299 . . . . 0.0 109.208 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.41 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 37.4 mtmm -77.74 108.93 11.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 116.203 -2.199 . . . . 0.0 109.771 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.512 HG21 ' CD1' ' A' ' 77' ' ' LEU . 89.6 t -74.68 89.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.71 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 55.2 mt -81.39 152.35 27.5 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 112.61 -2.086 . . . . 0.0 109.664 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.507 ' HG2' ' H ' ' A' ' 62' ' ' ASP . 10.7 ttt180 -90.06 -142.25 0.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.76 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.507 ' H ' ' HG2' ' A' ' 61' ' ' ARG . 9.7 t70 -168.55 -30.18 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 117.408 -1.717 . . . . 0.0 111.763 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 61' ' ' ARG . . . 106.63 -47.22 1.07 Allowed Glycine 0 C--N 1.346 1.129 0 C-N-CA 118.334 -1.889 . . . . 0.0 109.563 -174.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.98 -40.76 1.67 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.421 -1.889 . . . . 0.0 110.16 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.502 ' CA ' ' HD2' ' A' ' 73' ' ' LYS . . . -66.78 -12.74 60.11 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 118.639 -1.743 . . . . 0.0 113.545 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 4.6 mtpm? 79.41 -140.22 0.02 OUTLIER 'General case' 0 C--N 1.35 0.594 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.911 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 87.8 m-85 -106.33 134.23 49.79 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.335 -177.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -151.79 172.04 16.77 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 116.616 -2.034 . . . . 0.0 110.983 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 80' ' ' LEU . 5.0 mp -112.17 -91.67 0.48 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 111.833 -2.44 . . . . 0.0 109.498 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -90.15 -40.59 12.13 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.789 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 82.4 t -149.44 -85.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 117.428 -1.709 . . . . 0.0 110.203 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.404 HG23 ' CE1' ' A' ' 74' ' ' PHE . 32.6 m -49.42 132.45 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 112.926 -1.943 . . . . 0.0 110.367 -174.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.502 ' HD2' ' CA ' ' A' ' 65' ' ' GLY . 41.0 mtmt -87.5 151.0 23.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 112.238 -2.255 . . . . 0.0 109.963 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.404 ' CE1' HG23 ' A' ' 72' ' ' VAL . 7.2 m-85 -125.71 141.72 51.87 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 112.557 -2.11 . . . . 0.0 108.603 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.443 ' O ' ' OG ' ' A' ' 76' ' ' SER . 1.7 p-10 -56.78 -33.64 66.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 116.856 -1.937 . . . . 0.0 111.126 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 69.0 m -170.67 170.47 6.67 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 118.465 -1.294 . . . . 0.0 109.451 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.717 HD12 ' CD1' ' A' ' 34' ' ' ILE . 3.7 mm? -39.8 -46.93 2.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.355 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 76' ' ' SER . 6.0 p-10 -52.35 -50.55 62.13 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 114.798 -2.761 . . . . 0.0 110.284 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 6.6 tp10 -64.08 -15.85 60.47 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 116.502 -2.079 . . . . 0.0 112.392 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 69' ' ' LEU . 5.0 tt -83.04 -70.55 0.55 Allowed 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.42 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 81' ' ' VAL . 92.0 t -35.87 -37.7 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 112.051 -2.34 . . . . 0.0 111.146 174.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 84' ' ' HIS . 25.1 t0 -70.81 -50.83 31.31 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.898 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 84' ' ' HIS . 16.3 m-30 -78.32 42.07 0.41 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.602 -176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.553 ' C ' ' H ' ' A' ' 86' ' ' SER . 58.8 m80 -152.44 -21.26 0.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.275 -1.784 . . . . 0.0 112.362 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 85' ' ' ARG . 11.7 ptp85 -75.08 38.84 0.13 Allowed 'General case' 0 C--N 1.348 0.543 0 C-N-CA 117.232 -1.787 . . . . 0.0 110.701 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.553 ' H ' ' C ' ' A' ' 84' ' ' HIS . 50.4 m -110.84 -45.73 3.44 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.566 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' SER . 8.9 t -169.95 105.9 0.34 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.173 -1.83 . . . . 0.0 109.991 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.588 ' HA ' ' H ' ' A' ' 95' ' ' ILE . 39.2 t 54.28 164.33 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.749 -2.023 . . . . 0.0 110.491 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 89' ' ' VAL . 14.7 p -143.93 42.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.381 0 CA-C-N 112.607 -2.088 . . . . 0.0 110.039 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 37.4 t -176.65 -101.03 0.0 OUTLIER 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.607 -1.633 . . . . 0.0 109.979 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 56.8 mmm-85 -88.59 13.04 13.0 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 113.907 -1.497 . . . . 0.0 113.238 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.512 ' HA ' ' CB ' ' A' ' 88' ' ' SER . 22.1 m120 66.27 27.61 10.15 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.01 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -92.45 40.08 1.04 Allowed 'General case' 0 C--N 1.347 0.48 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.695 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 52.64 86.82 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.905 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.588 ' H ' ' HA ' ' A' ' 88' ' ' SER . 58.5 mt -132.75 125.81 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 112.896 -1.956 . . . . 0.0 109.717 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.81 145.84 47.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.844 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.9 mt -89.95 106.7 18.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.488 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HG2' ' H ' ' A' ' 99' ' ' ASP . 47.6 ttt180 -177.16 -159.63 0.05 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.413 -2.176 . . . . 0.0 107.567 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.586 ' H ' ' HG2' ' A' ' 98' ' ' ARG . 53.4 t0 80.35 -34.23 0.13 Allowed 'General case' 0 C--N 1.346 0.424 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.638 161.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.548 HG13 HE21 ' A' ' 26' ' ' GLN . 9.4 tt -69.84 20.61 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 115.886 -2.325 . . . . 0.0 112.92 -171.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 99' ' ' ASP . 75.5 tt0 -139.14 -101.95 0.17 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 117.712 -1.595 . . . . 0.0 109.592 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 40.53 71.58 0.19 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.068 -1.878 . . . . 0.0 110.111 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.75 HG23 ' CG ' ' A' ' 106' ' ' GLN . 0.3 OUTLIER -135.51 -63.72 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 112.92 -1.946 . . . . 0.0 110.687 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.661 ' HD3' HG22 ' A' ' 103' ' ' VAL . 57.7 Cg_endo -80.91 126.53 5.82 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.412 2.074 . . . . 0.0 110.412 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 103' ' ' VAL . 80.3 mt-30 -73.81 141.65 46.19 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-O 121.776 0.798 . . . . 0.0 110.05 3.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.75 ' CG ' HG23 ' A' ' 103' ' ' VAL . 16.5 mt-30 -81.59 -77.35 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 113.258 -1.792 . . . . 0.0 110.291 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.639 ' CD ' ' CB ' ' A' ' 106' ' ' GLN . 38.2 Cg_endo -70.53 121.95 8.44 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.633 1.555 . . . . 0.0 111.648 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.1 m -41.32 122.48 1.87 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.415 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -105.52 119.41 39.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.129 -1.85 . . . . 0.0 109.235 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.9 p -169.24 122.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.821 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.414 ' OE1' ' HB3' ' A' ' 112' ' ' ALA . 13.2 tm0? -71.66 118.71 14.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.949 -1.932 . . . . 0.0 109.309 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB3' ' OE1' ' A' ' 111' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.706 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.407 ' C ' HD12 ' A' ' 2' ' ' ILE . . . . . . . . 0 CA--C 1.53 1.009 0 CA-C-O 121.908 0.727 . . . . 0.0 112.051 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 2' ' ' ILE . 3.7 mp -121.86 -85.37 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 112.999 -1.601 . . . . 0.0 109.114 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 4' ' ' MET . 67.6 mm-40 -69.48 -168.0 0.15 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.054 -1.884 . . . . 0.0 109.988 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.488 ' CA ' ' HG2' ' A' ' 104' ' ' PRO . 33.4 tpp -34.44 118.98 0.42 Allowed 'General case' 0 C--N 1.344 0.339 0 CA-C-N 111.877 -2.42 . . . . 0.0 111.149 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.618 ' HB2' ' CD ' ' A' ' 6' ' ' PRO . 62.5 pttt -56.28 -166.22 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 112.433 -2.167 . . . . 0.0 107.471 173.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.618 ' CD ' ' HB2' ' A' ' 5' ' ' LYS . 73.8 Cg_exo -44.78 119.18 2.19 Favored 'Trans proline' 0 C--N 1.357 0.98 0 CA-C-O 122.338 0.891 . . . . 0.0 112.935 -175.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.522 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 13.2 m170 -49.88 -46.03 80.71 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 111.988 -2.369 . . . . 0.0 113.291 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 7' ' ' HIS . 66.4 Cg_exo -46.1 -118.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.849 1.699 . . . . 0.0 114.708 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.401 ' CZ2' HG21 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -165.1 36.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.731 -175.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -101.34 125.33 47.96 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.279 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 6.2 m-85 -120.91 114.67 21.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 113.199 -1.818 . . . . 0.0 108.577 175.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -75.91 124.54 7.46 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 112.447 -2.16 . . . . 0.0 111.554 -174.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' CG ' ' HA ' ' A' ' 38' ' ' GLU . 43.6 mtmt 32.3 45.42 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 111.739 -2.23 . . . . 0.0 111.243 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 14' ' ' ILE . 10.4 tp -74.45 130.84 81.23 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 113.319 -1.764 . . . . 0.0 108.836 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' ARG . 50.9 Cg_exo -46.04 121.26 4.21 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.618 1.545 . . . . 0.0 112.717 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 15' ' ' PRO . 53.3 ttp180 -40.59 -41.01 1.38 Allowed 'General case' 0 C--N 1.345 0.393 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.627 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -61.46 -68.65 0.3 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.61 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 17' ' ' ALA . 17.1 tppt? -38.5 -47.05 1.24 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.735 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.715 ' HB3' HH21 ' A' ' 35' ' ' ARG . . . -50.41 -65.97 0.47 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.226 -1.806 . . . . 0.0 109.072 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -42.65 -43.97 4.07 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.492 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 24' ' ' SER . 44.9 mt-10 -64.66 -82.3 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.602 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.409 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 27.0 ptm -47.19 -35.93 8.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.224 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' O ' ' CG ' ' A' ' 26' ' ' GLN . 49.3 tp -67.92 -32.25 72.57 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.571 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 26' ' ' GLN . 38.7 t -74.46 -34.18 63.08 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 117.915 -1.514 . . . . 0.0 111.219 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -77.86 43.89 0.44 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.928 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.584 ' CG ' ' O ' ' A' ' 23' ' ' LEU . 23.1 mm-40 -114.35 -4.25 13.01 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.266 -1.788 . . . . 0.0 114.068 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 26' ' ' GLN . 10.6 tpp180 34.33 38.74 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.564 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 26' ' ' GLN . 1.7 t-80 -158.43 107.45 1.99 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.657 -1.611 . . . . 0.0 109.856 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.6 114.58 3.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.199 -1.818 . . . . 0.0 109.683 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 137.2 -31.96 2.47 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 117.611 -2.233 . . . . 0.0 112.101 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 30' ' ' GLY . . . -40.94 127.85 2.66 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.265 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' CD1' HD23 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -136.36 136.53 39.72 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.931 -1.94 . . . . 0.0 110.097 -177.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 33' ' ' LEU . 4.2 pp -128.03 147.97 50.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 111.289 -2.687 . . . . 0.0 108.195 160.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -107.7 104.46 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 113.568 -1.651 . . . . 0.0 108.708 178.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.715 HH21 ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -84.35 127.26 33.88 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.849 -175.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 37' ' ' SER . 39.6 tt0 -90.37 130.41 36.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 112.577 -2.101 . . . . 0.0 109.781 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 40' ' ' ALA . 1.6 p -39.95 122.11 1.41 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.414 -1.721 . . . . 0.0 110.257 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HA ' ' CG ' ' A' ' 13' ' ' LYS . 61.1 tt0 -49.55 -54.45 18.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.401 -2.181 . . . . 0.0 110.56 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 p -90.03 -94.59 0.11 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.065 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' O ' ' OG ' ' A' ' 37' ' ' SER . . . -53.76 139.64 50.85 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.04 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 43' ' ' ASP . 66.5 Cg_endo -77.44 -146.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 N-CA-C 106.879 -2.008 . . . . 0.0 106.879 171.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . 63.76 -18.45 0.09 OUTLIER Glycine 0 CA--C 1.542 1.726 0 O-C-N 124.84 1.338 . . . . 0.0 113.794 172.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 41' ' ' PRO . 70.2 m-20 -126.62 135.16 50.84 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 117.746 -1.582 . . . . 0.0 110.643 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.73 -169.82 2.37 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 112.584 -2.098 . . . . 0.0 109.285 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.456 ' OG ' ' HD3' ' A' ' 35' ' ' ARG . 74.7 p -170.05 137.86 1.63 Allowed 'General case' 0 C--N 1.345 0.408 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.465 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 32' ' ' PHE . 2.6 tt -98.22 113.91 25.99 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 112.936 -1.938 . . . . 0.0 110.413 -172.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.492 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 88.8 p -95.24 133.48 39.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.385 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' CG2' HD22 ' A' ' 46' ' ' LEU . 46.9 t -135.28 147.93 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 117.496 -1.682 . . . . 0.0 109.299 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HD3' ' H ' ' A' ' 28' ' ' HIS . 63.9 tttp -83.79 100.69 11.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 115.914 -2.314 . . . . 0.0 108.955 172.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 53' ' ' ASP . 6.6 t80 -119.46 103.07 9.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.79 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -26.56 141.3 0.01 OUTLIER Glycine 0 C--N 1.348 1.227 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.942 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.576 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 87.6 m-20 104.68 -52.89 0.0 OUTLIER 'General case' 0 C--N 1.345 0.403 0 CA-C-N 111.356 -2.422 . . . . 0.0 108.111 -165.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 16.9 t70 -177.75 -173.23 0.39 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 111.584 -2.553 . . . . 0.0 109.799 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.532 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 77.9 t -88.9 119.54 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 113.112 -1.858 . . . . 0.0 109.442 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.421 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.1 tt0 -92.08 159.51 15.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.204 -1.816 . . . . 0.0 109.827 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 28.9 p80 -147.62 134.85 20.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.955 -174.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.421 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 83.3 m-85 -127.21 111.26 13.75 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 112.629 -2.078 . . . . 0.0 109.229 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -58.52 122.16 12.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 116.811 -1.955 . . . . 0.0 109.549 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' A' ' 80' ' ' LEU . 67.1 t -94.2 87.43 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 112.797 -2.002 . . . . 0.0 108.624 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.6 mt -89.17 159.34 17.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.393 -2.185 . . . . 0.0 110.855 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -86.79 167.7 14.16 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 112.55 -2.114 . . . . 0.0 109.484 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 63' ' ' GLY . 36.3 t70 -110.78 42.39 1.61 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.294 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 62' ' ' ASP . . . 38.77 34.75 0.29 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 118.192 -1.956 . . . . 0.0 111.725 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.85 -42.94 0.13 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.865 -1.167 . . . . 0.0 109.664 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.4 ' C ' ' HZ3' ' A' ' 66' ' ' LYS . . . 157.27 -30.68 0.53 Allowed Glycine 0 CA--C 1.537 1.445 0 C-N-CA 118.044 -2.027 . . . . 0.0 112.065 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.797 ' HZ2' ' HA ' ' A' ' 66' ' ' LYS . 1.2 mmpm? -79.29 136.62 37.08 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 117.667 -1.613 . . . . 0.0 110.172 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -101.97 143.23 32.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 112.195 -2.275 . . . . 0.0 108.513 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 71' ' ' VAL . 52.6 p90 -149.23 -161.64 1.39 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 116.204 -2.198 . . . . 0.0 111.099 -174.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.416 ' CG ' HD11 ' A' ' 80' ' ' LEU . 11.4 mt -137.28 -37.89 0.62 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 111.677 -2.51 . . . . 0.0 110.545 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -112.15 -41.09 4.02 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.508 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 92.6 t -150.01 -79.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 117.183 -1.807 . . . . 0.0 109.689 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 71' ' ' VAL . 20.1 m -162.75 134.96 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.777 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.5 ' CD ' ' CZ ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -170.04 -33.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 114.206 -2.998 . . . . 0.0 112.977 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.5 ' CZ ' ' CD ' ' A' ' 73' ' ' LYS . 2.6 m-85 -112.29 149.07 32.89 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 116.439 -2.104 . . . . 0.0 109.758 -174.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 76' ' ' SER . 27.8 p30 -103.65 19.57 19.61 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.431 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.5 t -179.24 143.8 0.21 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.644 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 34' ' ' ILE . 82.6 mt -43.02 -46.12 5.41 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.011 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 12.1 m120 -59.17 -38.1 78.93 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.924 -177.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 76' ' ' SER . 61.5 tt0 -70.38 -26.08 63.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 117.111 -1.836 . . . . 0.0 111.689 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.566 ' CD1' HG13 ' A' ' 59' ' ' VAL . 9.1 tt -66.81 -50.36 62.88 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.908 174.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.401 HG21 ' CZ2' ' A' ' 9' ' ' TRP . 95.0 t -68.1 -30.54 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.026 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 84.7 m-20 -70.59 -44.46 67.29 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 118.341 -1.344 . . . . 0.0 110.307 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 2.0 t80 -83.57 29.2 0.53 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 116.366 -2.133 . . . . 0.0 111.989 -177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.558 ' C ' ' H ' ' A' ' 86' ' ' SER . 5.8 m-70 -130.21 -25.7 2.43 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.727 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 16.7 ptm180 -72.92 35.16 0.07 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 118.447 -1.301 . . . . 0.0 111.354 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 84' ' ' HIS . 50.3 m -150.02 -43.6 0.13 Allowed 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.939 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 88' ' ' SER . 8.7 t -118.13 45.47 1.98 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.871 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.517 ' CB ' ' HA ' ' A' ' 93' ' ' GLN . 87.9 p 51.44 -163.59 0.06 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.811 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.31 -39.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 112.832 -1.986 . . . . 0.0 110.461 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.511 ' H ' HD12 ' A' ' 95' ' ' ILE . 43.3 t -99.4 155.51 17.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.487 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 90' ' ' SER . 9.5 ptp85 -40.15 -42.09 1.4 Allowed 'General case' 0 C--N 1.348 0.5 0 CA-C-N 113.21 -1.813 . . . . 0.0 110.624 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -70.76 93.36 0.94 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.796 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.517 ' HA ' ' CB ' ' A' ' 88' ' ' SER . 6.1 pt20 -69.91 104.98 2.66 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.091 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' A' ' 93' ' ' GLN . 5.9 pt20 175.49 43.41 0.0 OUTLIER 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.627 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 90' ' ' SER . 56.6 mt -131.93 121.23 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.215 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.461 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 83.3 m-85 -114.09 121.94 45.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.186 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 70.6 mt -90.09 104.32 16.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.122 -1.853 . . . . 0.0 110.054 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' ASP . 67.5 ttt-85 -170.53 -116.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 116.601 -2.04 . . . . 0.0 110.546 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' ARG . 10.0 t70 -30.0 112.94 0.09 Allowed 'General case' 0 C--N 1.35 0.59 0 CA-C-N 113.681 -1.6 . . . . 0.0 111.667 -172.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.443 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 15.1 tt -120.41 -39.93 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 112.389 -2.187 . . . . 0.0 111.359 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -150.05 125.84 10.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 112.724 -2.034 . . . . 0.0 109.642 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -127.46 116.7 20.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 113.072 -1.876 . . . . 0.0 109.714 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.687 HG13 ' HD3' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -138.72 -62.28 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 113.075 -1.875 . . . . 0.0 110.335 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.687 ' HD3' HG13 ' A' ' 103' ' ' VAL . 35.6 Cg_exo -50.18 126.83 18.2 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.317 2.011 . . . . 0.0 113.212 173.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 104' ' ' PRO . 88.3 mt-30 104.79 34.46 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 112.071 -2.331 . . . . 0.0 111.101 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.66 ' H ' ' HD2' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -142.92 -57.68 0.02 OUTLIER Pre-proline 0 C--N 1.347 0.499 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.406 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.66 ' HD2' ' H ' ' A' ' 106' ' ' GLN . 50.5 Cg_exo -51.49 118.74 4.67 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.555 1.503 . . . . 0.0 113.427 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.457 ' O ' ' CG ' ' A' ' 109' ' ' TYR . 82.3 m 41.2 91.15 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.857 -1.974 . . . . 0.0 110.531 178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.457 ' CD2' ' O ' ' A' ' 107' ' ' PRO . 47.0 m-85 -158.66 45.78 0.3 Allowed 'General case' 0 C--N 1.345 0.388 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.382 175.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 111' ' ' GLN . 11.1 p -145.53 52.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 113.207 -1.815 . . . . 0.0 109.643 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 110' ' ' VAL . 77.4 mt-30 30.63 99.0 0.0 OUTLIER 'General case' 0 C--N 1.348 0.519 0 CA-C-N 112.516 -2.129 . . . . 0.0 111.367 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.727 179.606 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 111.869 -0.493 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.26 131.33 34.55 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.821 -0.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -48.83 122.73 6.0 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.588 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' LYS . 9.2 tpt -93.06 95.75 9.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.983 -1.917 . . . . 0.0 109.778 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 4' ' ' MET . 87.4 tttt 60.16 134.2 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.688 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -74.32 120.58 6.32 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.219 1.946 . . . . 0.0 110.58 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 8' ' ' PRO . 58.3 t60 -65.63 131.38 94.76 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 117.045 -1.862 . . . . 0.0 109.498 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 7' ' ' HIS . 53.4 Cg_exo -45.45 -122.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.581 2.187 . . . . 0.0 114.087 176.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.431 ' CZ3' ' CE1' ' A' ' 10' ' ' PHE . 1.6 p-90 -147.15 26.5 1.08 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.125 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.431 ' CE1' ' CZ3' ' A' ' 9' ' ' TRP . 92.8 m-85 -90.6 110.66 21.81 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 118.319 -1.353 . . . . 0.0 109.582 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 9.0 m-85 -94.96 99.38 11.41 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.184 -1.825 . . . . 0.0 108.446 174.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -70.09 140.47 32.72 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 112.202 -2.272 . . . . 0.0 111.618 -173.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' GLY . 60.4 tttp 27.73 48.24 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 112.007 -2.097 . . . . 0.0 111.447 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 14' ' ' ILE . 11.0 tp -80.02 124.62 82.91 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 113.227 -1.806 . . . . 0.0 108.961 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 16' ' ' ARG . 50.5 Cg_exo -47.24 122.19 6.18 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.622 1.548 . . . . 0.0 112.815 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.528 ' NH1' ' CG ' ' A' ' 20' ' ' GLU . 1.6 tmt_? -38.28 -42.45 0.7 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 112.922 -1.945 . . . . 0.0 110.401 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -64.62 -58.5 6.16 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.105 -1.862 . . . . 0.0 109.956 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 15' ' ' PRO . 59.1 tptt -42.93 -51.37 5.59 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 113.033 -1.894 . . . . 0.0 110.125 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.765 ' CB ' HH21 ' A' ' 35' ' ' ARG . . . -43.03 -49.31 6.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.062 -1.881 . . . . 0.0 109.829 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.528 ' CG ' ' NH1' ' A' ' 16' ' ' ARG . 57.0 mt-10 -63.89 -44.72 92.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.581 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 34.8 mt-10 -63.3 -78.75 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.811 -1.995 . . . . 0.0 110.759 -171.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.528 ' CE ' ' CD2' ' A' ' 33' ' ' LEU . 22.9 ptt? -46.41 -38.29 8.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.994 -175.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 31.7 tp -69.6 -35.88 75.72 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 117.558 -1.657 . . . . 0.0 111.232 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 26' ' ' GLN . 92.5 p -62.87 -27.65 69.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 117.674 -1.61 . . . . 0.0 111.73 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 25.1 mtpp -74.23 36.5 0.1 Allowed 'General case' 0 C--N 1.349 0.549 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.972 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.592 HE21 HG13 ' A' ' 100' ' ' ILE . 21.7 mm-40 -112.55 142.43 45.14 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.423 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' HIS . 10.5 mpt_? -92.6 -62.85 1.31 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 112.408 -2.178 . . . . 0.0 109.995 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 27' ' ' ARG . 36.5 m170 -58.42 -154.41 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.61 -177.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -139.59 120.08 14.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.424 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.71 -17.47 3.47 Favored Glycine 0 CA--C 1.542 1.769 0 C-N-CA 117.985 -2.055 . . . . 0.0 113.0 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' CB ' ' HG3' ' A' ' 26' ' ' GLN . . . -46.54 118.22 1.91 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.22 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.489 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 10.3 p90 -132.11 158.67 41.03 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 116.516 -2.074 . . . . 0.0 111.384 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.528 ' CD2' ' CE ' ' A' ' 22' ' ' MET . 4.3 pp -155.61 155.89 34.09 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 111.925 -2.398 . . . . 0.0 108.76 168.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.19 114.34 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 117.254 -1.778 . . . . 0.0 109.247 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.765 HH21 ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -80.5 125.06 29.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.072 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 37' ' ' SER . 21.5 pt-20 -116.03 133.35 56.12 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.064 -172.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.585 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 38.3 t 70.77 -14.11 0.45 Allowed 'General case' 0 C--N 1.346 0.442 0 CA-C-N 111.903 -2.408 . . . . 0.0 113.344 172.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 37' ' ' SER . 56.1 tt0 -40.32 -35.74 0.46 Allowed 'General case' 0 C--N 1.35 0.623 0 C-N-CA 117.209 -1.797 . . . . 0.0 111.224 174.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 80.4 p -148.75 72.89 1.2 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.083 -1.871 . . . . 0.0 107.976 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.93 ' HB1' ' HA ' ' A' ' 41' ' ' PRO . . . -70.57 -165.22 0.04 OUTLIER Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 112.797 -2.001 . . . . 0.0 106.275 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.93 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . 25.4 Cg_endo -63.1 -108.73 0.0 OUTLIER 'Cis proline' 0 C--N 1.353 0.769 0 O-C-N 122.299 0.631 . . . . 0.0 112.472 -0.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . -72.42 74.56 0.87 Allowed Glycine 0 C--N 1.345 1.077 0 C-N-CA 118.952 -1.594 . . . . 0.0 109.906 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.457 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 0.9 OUTLIER -131.54 105.17 7.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.047 -2.077 . . . . 0.0 109.591 -178.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 22.0 m-85 -132.83 134.19 44.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.753 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.434 ' OG ' ' HD3' ' A' ' 35' ' ' ARG . 72.0 p -127.62 138.9 52.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 112.981 -1.918 . . . . 0.0 109.389 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.494 ' CD2' HG23 ' A' ' 48' ' ' VAL . 5.4 tt -97.22 117.28 31.06 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.507 -2.133 . . . . 0.0 109.969 -174.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 50.6 m -96.57 141.65 29.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.242 -1.799 . . . . 0.0 109.839 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.494 HG23 ' CD2' ' A' ' 46' ' ' LEU . 92.4 t -150.8 138.4 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.039 -1.891 . . . . 0.0 110.03 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.579 ' HE3' ' H ' ' A' ' 26' ' ' GLN . 23.5 ttmm -78.53 109.32 12.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 116.503 -2.079 . . . . 0.0 108.979 171.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CE1' ' OE1' ' A' ' 93' ' ' GLN . 6.6 t80 -77.39 -90.9 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.446 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.61 -77.98 1.39 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 112.502 -2.136 . . . . 0.0 109.974 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 52' ' ' ASN . 4.6 t-20 -117.17 -24.63 7.42 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 112.288 -1.956 . . . . 0.0 112.13 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 34.4 t0 -108.34 -178.49 3.62 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 118.029 -1.468 . . . . 0.0 109.868 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 95.1 t -98.21 117.83 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.899 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -98.27 157.81 15.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 112.874 -1.966 . . . . 0.0 109.428 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -146.02 136.88 24.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.421 -175.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HB3' HD22 ' A' ' 69' ' ' LEU . 26.5 m-85 -118.59 110.9 17.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.55 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.5 mtmm -62.62 109.48 1.41 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 117.059 -1.856 . . . . 0.0 109.405 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 77' ' ' LEU . 40.6 t -77.86 92.17 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 116.896 -1.922 . . . . 0.0 107.86 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 61' ' ' ARG . 96.9 mt -73.35 179.73 3.83 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 112.216 -2.265 . . . . 0.0 112.342 -165.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.606 HH21 ' H ' ' A' ' 65' ' ' GLY . 14.7 ptm180 15.16 -144.6 0.0 OUTLIER 'General case' 0 C--N 1.349 0.545 0 CA-C-N 110.04 -3.255 . . . . 0.0 112.409 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 63' ' ' GLY . 16.4 t0 165.36 -33.93 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.829 -167.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 62' ' ' ASP . . . -37.86 -97.62 0.01 OUTLIER Glycine 0 C--N 1.348 1.232 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.529 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' H ' HH21 ' A' ' 61' ' ' ARG . . . -97.77 -44.35 6.77 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 113.045 -1.578 . . . . 0.0 109.791 -177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.606 ' H ' HH21 ' A' ' 61' ' ' ARG . . . -60.52 -18.79 52.38 Favored Glycine 0 CA--C 1.544 1.846 0 C-N-CA 118.446 -1.835 . . . . 0.0 112.833 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HZ2' ' HA ' ' A' ' 75' ' ' ASN . 7.6 mtpm? 66.82 -141.74 0.14 Allowed 'General case' 0 C--N 1.348 0.541 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.411 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.518 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 57.0 m-85 -78.37 143.08 37.17 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 113.974 -1.467 . . . . 0.0 109.303 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' O ' ' A' ' 70' ' ' TRP . 2.7 t80 -156.05 135.53 12.38 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 116.075 -2.25 . . . . 0.0 111.016 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.536 ' CG ' HD11 ' A' ' 80' ' ' LEU . 40.2 mt -100.98 -78.54 0.52 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.13 -1.85 . . . . 0.0 109.882 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.456 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 25.7 m0 -123.24 -69.03 0.84 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 113.116 -1.856 . . . . 0.0 111.607 -169.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.82 -41.96 5.31 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 C-N-CA 117.6 -1.64 . . . . 0.0 111.217 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.459 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 34.4 m -115.24 142.18 29.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 113.648 -1.615 . . . . 0.0 109.935 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.419 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 10.0 ptpp? -82.21 -169.53 2.45 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.557 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 10.2 m-85 -150.51 136.64 18.55 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.384 -1.726 . . . . 0.0 108.911 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 76' ' ' SER . 23.4 t-20 -91.76 47.55 1.37 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 116.47 -2.092 . . . . 0.0 109.904 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 23.1 p 141.02 143.42 0.0 OUTLIER 'General case' 0 C--N 1.349 0.563 0 CA-C-N 112.056 -2.338 . . . . 0.0 109.041 175.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.52 ' CD2' HG11 ' A' ' 59' ' ' VAL . 98.6 mt -47.75 -44.11 27.79 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 117.171 -1.812 . . . . 0.0 109.647 175.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 23.5 t-20 -57.96 -34.8 70.32 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 113.341 -1.754 . . . . 0.0 111.315 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 46.3 tp10 -62.81 -26.11 68.58 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 116.219 -2.192 . . . . 0.0 111.664 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.536 HD11 ' CG ' ' A' ' 69' ' ' LEU . 8.3 tt -85.66 -57.62 2.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.239 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 85' ' ' ARG . 97.5 t -49.43 -34.31 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 112.397 -2.183 . . . . 0.0 111.117 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 37.6 t70 -70.87 -41.0 71.97 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.627 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 79' ' ' GLU . 10.3 m-30 -62.33 -54.83 34.84 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 117.32 -1.752 . . . . 0.0 109.43 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 25.0 m170 -62.52 -30.14 71.07 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 113.074 -1.876 . . . . 0.0 111.639 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 84' ' ' HIS . 53.2 tpt85 -37.73 -36.03 0.16 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.304 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.5 p -148.82 42.77 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 117.73 -1.588 . . . . 0.0 110.394 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.588 ' O ' ' CB ' ' A' ' 88' ' ' SER . 93.4 m -132.33 -41.86 0.97 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.507 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.588 ' CB ' ' O ' ' A' ' 87' ' ' THR . 27.9 t 110.43 145.08 0.0 OUTLIER 'General case' 0 C--N 1.35 0.63 0 O-C-N 125.835 1.959 . . . . 0.0 109.693 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 90' ' ' SER . 3.6 m -92.0 21.91 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.218 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.533 ' HG ' ' CG ' ' A' ' 92' ' ' ASN . 9.2 t 170.18 126.49 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 117.315 -1.754 . . . . 0.0 109.321 -164.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -66.38 -30.76 71.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.836 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.533 ' CG ' ' HG ' ' A' ' 90' ' ' SER . 30.1 p30 -50.87 -29.02 10.77 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 117.676 -1.61 . . . . 0.0 111.827 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.43 ' OE1' ' CE1' ' A' ' 50' ' ' PHE . 6.5 pt20 -170.08 146.91 3.12 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.982 177.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.562 ' CD ' ' H ' ' A' ' 94' ' ' GLN . 4.1 pm0 -70.13 121.57 17.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.282 -1.781 . . . . 0.0 110.005 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 93' ' ' GLN . 61.5 mt -122.3 117.6 52.68 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.921 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -92.69 142.51 27.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.532 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 95.4 mt -89.95 105.18 17.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.132 -1.849 . . . . 0.0 109.816 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 99' ' ' ASP . 62.2 ttt-85 -175.6 -119.36 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 112.581 -2.1 . . . . 0.0 108.344 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 29.2 t70 25.79 48.33 0.01 OUTLIER 'General case' 0 C--N 1.348 0.508 0 O-C-N 125.234 1.584 . . . . 0.0 112.699 172.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.62 HG12 ' H ' ' A' ' 101' ' ' GLU . 7.5 tt -135.07 -146.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 117.503 -1.679 . . . . 0.0 108.991 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.62 ' H ' HG12 ' A' ' 100' ' ' ILE . 40.6 mm-40 -89.96 94.84 9.96 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.473 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.424 ' O ' ' HB ' ' A' ' 103' ' ' VAL . 13.4 tt0 -148.76 161.01 42.65 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 113.055 -1.884 . . . . 0.0 109.602 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 104' ' ' PRO . 1.1 t 70.41 151.05 0.13 Allowed Pre-proline 0 C--N 1.346 0.432 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.365 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 103' ' ' VAL . 88.6 Cg_exo -34.55 -119.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.89 3.06 . . . . 0.0 115.018 174.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 104' ' ' PRO . 30.2 pt20 -175.78 137.8 0.35 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 114.76 -2.776 . . . . 0.0 110.738 -169.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.547 ' HB2' ' CD ' ' A' ' 107' ' ' PRO . 36.1 mt-30 -69.95 -65.39 1.14 Allowed Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 112.585 -2.098 . . . . 0.0 111.008 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.574 ' O ' ' CB ' ' A' ' 108' ' ' THR . 12.4 Cg_endo -55.96 123.86 14.86 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 120.964 1.109 . . . . 0.0 111.925 176.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.574 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 1.3 m 146.99 -40.77 0.01 OUTLIER 'General case' 0 C--N 1.347 0.489 0 CA-C-N 112.342 -2.208 . . . . 0.0 109.852 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -58.56 120.86 9.62 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.281 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.54 127.01 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 113.276 -1.783 . . . . 0.0 110.079 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -126.54 122.34 34.85 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 112.857 -1.974 . . . . 0.0 109.342 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.435 0 CA-C-N 113.047 -1.888 . . . . 0.0 109.707 -179.883 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . . . . . . 0 CA--C 1.53 0.973 0 CA-C-O 121.83 0.683 . . . . 0.0 112.019 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 16.1 tt -177.87 136.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 113.037 -1.582 . . . . 0.0 109.736 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.441 ' OE1' ' CG2' ' A' ' 103' ' ' VAL . 11.8 pt-20 -41.1 128.05 2.78 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 112.957 -1.929 . . . . 0.0 110.298 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 42.6 tpp -94.09 115.36 27.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.041 -1.89 . . . . 0.0 109.385 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' O ' ' CD2' ' A' ' 7' ' ' HIS . 87.6 tttt 60.59 95.47 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.707 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 58.6 Cg_exo -46.34 122.98 6.12 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.501 2.134 . . . . 0.0 113.892 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.456 ' CD2' ' O ' ' A' ' 5' ' ' LYS . 95.1 m-70 -108.58 96.68 20.15 Favored Pre-proline 0 C--N 1.346 0.432 0 CA-C-N 112.834 -1.985 . . . . 0.0 109.209 177.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 6' ' ' PRO . 57.2 Cg_endo -73.4 -118.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.159 1.906 . . . . 0.0 110.972 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.429 ' CB ' ' CZ ' ' A' ' 32' ' ' PHE . 36.8 p-90 -86.56 7.27 26.91 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.501 -174.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -89.37 111.07 21.83 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 117.322 -1.751 . . . . 0.0 109.879 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 12' ' ' GLY . 33.5 m-85 -112.08 121.73 45.8 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.25 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -56.33 -151.38 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.928 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.633 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -72.8 77.96 1.13 Allowed 'General case' 0 C--N 1.346 0.445 0 C-N-CA 117.153 -1.819 . . . . 0.0 109.618 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.0 tp -79.1 130.76 68.51 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.247 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.2 Cg_exo -47.4 124.54 9.44 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.984 1.789 . . . . 0.0 113.133 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.843 ' CG ' HH22 ' A' ' 35' ' ' ARG . 69.0 mtp180 -37.33 -42.73 0.5 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.67 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -58.89 -75.46 0.05 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.212 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 17' ' ' ALA . 56.9 tptt -36.64 -36.81 0.12 Allowed 'General case' 0 C--N 1.345 0.379 0 CA-C-N 112.979 -1.919 . . . . 0.0 111.457 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -63.21 -66.5 0.53 Allowed 'General case' 0 C--N 1.347 0.469 0 C-N-CA 117.387 -1.725 . . . . 0.0 109.567 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.409 ' HA ' HG21 ' A' ' 54' ' ' VAL . 63.2 mt-10 -47.98 -54.69 12.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.864 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 24' ' ' SER . 11.4 mm-40 -52.8 -84.41 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 112.461 -2.154 . . . . 0.0 110.791 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.575 ' C ' ' SD ' ' A' ' 22' ' ' MET . 2.9 ppp? -43.18 -43.78 4.82 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.609 -172.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' N ' ' SD ' ' A' ' 22' ' ' MET . 37.2 tp -66.78 -35.32 79.8 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 112.998 -1.91 . . . . 0.0 111.475 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 26' ' ' GLN . 37.4 t -70.47 -40.03 73.89 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 117.796 -1.562 . . . . 0.0 110.484 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -73.11 35.42 0.08 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.859 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.516 ' HG3' ' CB ' ' A' ' 31' ' ' ALA . 29.5 mm-40 -101.53 153.43 19.73 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 117.108 -1.837 . . . . 0.0 110.837 -174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -72.07 87.73 1.07 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 111.819 -2.446 . . . . 0.0 109.55 -177.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER 69.04 145.9 0.05 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 111.942 -2.39 . . . . 0.0 111.049 170.031 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 22.7 t70 -31.94 133.99 0.09 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 111.5 -2.591 . . . . 0.0 111.462 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 96' ' ' PHE . . . 142.02 -41.62 1.2 Allowed Glycine 0 C--N 1.348 1.237 0 C-N-CA 117.665 -2.207 . . . . 0.0 112.198 169.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HB2' ' H ' ' A' ' 100' ' ' ILE . . . -47.49 136.17 10.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 117.533 -1.667 . . . . 0.0 109.512 -176.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' CB ' HG22 ' A' ' 48' ' ' VAL . 12.6 p90 -143.8 158.08 43.93 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 115.636 -2.426 . . . . 0.0 111.503 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 33' ' ' LEU . 4.6 pp -153.58 146.64 24.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 112.399 -2.182 . . . . 0.0 109.812 170.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 45' ' ' SER . 45.6 mt -108.05 115.56 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 112.562 -2.108 . . . . 0.0 108.549 172.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.843 HH22 ' CG ' ' A' ' 16' ' ' ARG . 10.0 ptm180 -101.74 128.91 47.86 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.57 -2.104 . . . . 0.0 110.865 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 37.8 mt-10 -76.76 144.86 38.95 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.317 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 40' ' ' ALA . 96.5 p -59.31 -168.2 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 117.292 -1.763 . . . . 0.0 109.029 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 29.5 tp10 -100.47 -49.13 4.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.433 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 44.8 t -132.47 64.01 1.61 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.342 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' O ' ' OG ' ' A' ' 37' ' ' SER . . . 178.49 68.47 0.11 Allowed Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.462 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -64.37 -3.46 6.39 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.137 1.891 . . . . 0.0 115.302 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.86 34.23 5.34 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 118.575 -1.774 . . . . 0.0 111.364 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -150.08 121.96 8.16 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 118.464 -1.295 . . . . 0.0 109.45 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 59' ' ' VAL . 79.2 m-85 -130.75 156.15 45.44 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 113.052 -1.886 . . . . 0.0 109.796 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 77.5 p -141.51 154.07 45.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.231 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' A' ' 48' ' ' VAL . 4.9 tt -119.23 114.95 23.21 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 113.504 -1.68 . . . . 0.0 109.595 -177.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 49.8 m -108.62 133.59 52.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.671 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' A' ' 46' ' ' LEU . 91.1 t -134.16 133.9 55.52 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.548 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 29' ' ' ASP . 42.3 tptt -55.56 97.11 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 112.785 -2.007 . . . . 0.0 107.719 168.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 48' ' ' VAL . 5.7 t80 -107.97 118.19 36.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 117.74 -1.584 . . . . 0.0 109.858 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.57 -94.65 0.06 OUTLIER Glycine 0 C--N 1.344 1.028 0 C-N-CA 117.971 -2.061 . . . . 0.0 110.323 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -123.06 -26.74 4.31 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.862 -1.669 . . . . 0.0 112.175 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 29.0 t0 -110.04 -174.65 2.54 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 118.022 -1.471 . . . . 0.0 109.663 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.543 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 93.0 t -103.85 122.24 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 113.079 -1.873 . . . . 0.0 109.685 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.419 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.0 tt0 -98.89 162.78 12.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 112.913 -1.949 . . . . 0.0 109.779 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.41 ' CD2' ' C ' ' A' ' 56' ' ' HIS . 6.7 t60 -141.02 133.73 28.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 112.799 -2.0 . . . . 0.0 110.546 -171.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.419 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 85.7 m-85 -137.1 104.06 5.32 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.094 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -63.2 111.74 2.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.159 -1.837 . . . . 0.0 110.088 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.514 HG11 ' CD2' ' A' ' 77' ' ' LEU . 97.6 t -77.33 72.12 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 112.934 -1.939 . . . . 0.0 108.437 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 99.1 mt -76.74 168.36 20.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.521 -2.127 . . . . 0.0 110.335 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 63' ' ' GLY . 9.3 ptm180 -139.91 -145.3 0.18 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 116.868 -1.933 . . . . 0.0 109.56 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 61' ' ' ARG . 38.2 t70 69.72 -23.47 0.15 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.71 -1.586 . . . . 0.0 112.329 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 61' ' ' ARG . . . -39.25 -56.77 2.25 Favored Glycine 0 C--N 1.35 1.306 0 C-N-CA 118.946 -1.597 . . . . 0.0 110.812 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.536 ' CB ' ' HE2' ' A' ' 73' ' ' LYS . . . -142.38 -2.51 1.1 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 113.096 -1.552 . . . . 0.0 112.754 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.406 ' C ' ' CG ' ' A' ' 66' ' ' LYS . . . 158.98 -25.47 0.35 Allowed Glycine 0 CA--C 1.538 1.476 0 C-N-CA 116.85 -2.595 . . . . 0.0 112.767 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.495 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 6.0 mtpm? -151.44 -157.68 0.83 Allowed 'General case' 0 C--N 1.347 0.486 0 C-N-CA 116.543 -2.063 . . . . 0.0 110.828 -175.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 89.7 m-85 -85.31 157.62 20.51 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.259 -168.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.473 ' HE1' ' H ' ' A' ' 63' ' ' GLY . 36.6 p90 -174.99 155.05 1.93 Allowed 'General case' 0 C--N 1.348 0.543 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.34 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.448 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 4.7 mp -92.12 -44.08 9.02 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 116.896 -1.922 . . . . 0.0 109.928 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 13.7 m0 -136.97 -43.09 0.57 Allowed 'General case' 0 C--N 1.346 0.427 0 CA-C-N 113.381 -1.736 . . . . 0.0 110.466 -177.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.3 t -139.62 -84.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.34 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.1 m -49.11 130.75 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 112.904 -1.953 . . . . 0.0 110.106 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.536 ' HE2' ' CB ' ' A' ' 64' ' ' ALA . 56.2 mttp -101.38 148.12 25.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.119 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.411 ' CE2' HD12 ' A' ' 69' ' ' LEU . 4.3 m-85 -117.03 150.13 39.13 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.634 -173.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.495 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 32.7 p-10 -75.37 -19.35 59.62 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.291 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 79' ' ' GLU . 83.3 p -167.37 154.06 8.28 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 118.666 -1.214 . . . . 0.0 109.342 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.514 ' CD2' HG11 ' A' ' 59' ' ' VAL . 90.4 mt -47.26 -43.69 22.35 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.042 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -50.05 -40.15 44.27 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 113.248 -1.796 . . . . 0.0 110.536 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 76' ' ' SER . 36.6 tp10 -70.05 -24.01 63.18 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.924 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.489 ' C ' HD23 ' A' ' 80' ' ' LEU . 7.8 tt -69.38 -58.29 4.19 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 117.905 -1.518 . . . . 0.0 108.351 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.6 t -48.8 -19.22 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 112.572 -2.104 . . . . 0.0 112.294 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 64.8 m-20 -90.03 -37.11 14.52 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.453 174.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -50.15 -50.55 48.5 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 116.952 -1.899 . . . . 0.0 108.689 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.459 ' CE1' HD21 ' A' ' 80' ' ' LEU . 57.7 m170 -61.98 -64.3 0.98 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 111.986 -2.37 . . . . 0.0 108.2 168.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 45.0 tpt85 67.79 -65.54 0.24 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 125.804 1.94 . . . . 0.0 108.657 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 87' ' ' THR . 48.2 t -89.85 -113.27 0.07 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 112.002 -2.363 . . . . 0.0 105.16 156.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 88' ' ' SER . 9.7 t -170.36 -133.97 0.02 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 117.841 -1.543 . . . . 0.0 110.724 169.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 87' ' ' THR . 3.2 m 143.19 -58.98 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.117 -1.856 . . . . 0.0 107.872 -168.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.553 ' CG2' HG13 ' A' ' 95' ' ' ILE . 0.8 OUTLIER 51.44 4.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 112.661 -2.063 . . . . 0.0 113.537 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.549 ' C ' ' H ' ' A' ' 92' ' ' ASN . 22.6 t -159.73 -26.0 0.07 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 117.552 -1.659 . . . . 0.0 112.198 -164.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 90' ' ' SER . 1.2 mpp_? 70.52 -31.33 0.22 Allowed 'General case' 0 C--N 1.351 0.67 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.492 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.549 ' H ' ' C ' ' A' ' 90' ' ' SER . 78.7 m-20 -74.88 -24.64 58.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 118.31 -1.356 . . . . 0.0 112.105 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' O ' ' OE1' ' A' ' 94' ' ' GLN . 17.8 mp0 -141.35 -150.93 0.34 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.474 ' OE1' ' O ' ' A' ' 93' ' ' GLN . 21.5 mm100 -149.5 120.76 7.83 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 116.348 -2.141 . . . . 0.0 109.849 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.617 HG22 ' H ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -91.47 -156.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 112.788 -2.006 . . . . 0.0 108.97 -177.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.617 ' H ' HG22 ' A' ' 95' ' ' ILE . 90.6 m-85 -150.07 145.19 26.23 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 113.406 -1.725 . . . . 0.0 109.289 170.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.455 ' O ' ' CG ' ' A' ' 98' ' ' ARG . 83.2 mt -113.94 77.93 1.1 Allowed 'General case' 0 C--N 1.346 0.436 0 C-N-CA 117.376 -1.729 . . . . 0.0 109.317 173.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 42.6 mtp180 -154.73 -123.21 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 112.951 -1.931 . . . . 0.0 108.864 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.6 t0 39.13 -117.08 0.21 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.812 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.604 HG12 ' H ' ' A' ' 101' ' ' GLU . 6.8 tt 38.08 -149.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.545 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.99 -171.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.604 ' H ' HG12 ' A' ' 100' ' ' ILE . 79.1 mm-40 -89.94 121.08 31.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.955 -177.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.542 ' CD ' ' H ' ' A' ' 102' ' ' GLN . 0.0 OUTLIER -66.58 143.75 56.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 112.822 -1.99 . . . . 0.0 109.906 178.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.51 ' CG2' ' HD2' ' A' ' 104' ' ' PRO . 12.3 p -45.4 147.29 1.42 Allowed Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.05 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.51 ' HD2' ' CG2' ' A' ' 103' ' ' VAL . 22.9 Cg_exo -61.26 128.65 25.7 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.333 1.355 . . . . 0.0 113.547 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 104' ' ' PRO . 29.3 mm100 68.66 126.76 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.673 -2.058 . . . . 0.0 110.287 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.476 ' OE1' ' O ' ' A' ' 108' ' ' THR . 11.0 tm0? -77.69 135.64 64.02 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.779 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.419 ' O ' ' HB ' ' A' ' 108' ' ' THR . 36.6 Cg_endo -70.56 120.73 7.33 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.321 2.014 . . . . 0.0 112.215 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.476 ' O ' ' OE1' ' A' ' 106' ' ' GLN . 81.2 m 64.16 129.49 0.02 OUTLIER 'General case' 0 C--N 1.346 0.43 0 CA-C-N 112.821 -1.991 . . . . 0.0 110.158 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 108' ' ' THR . 63.1 t80 64.54 122.34 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 112.835 -1.984 . . . . 0.0 109.926 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 110' ' ' VAL . 12.1 p -165.04 50.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.834 -1.984 . . . . 0.0 109.512 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -122.41 43.04 3.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 112.801 -2.0 . . . . 0.0 110.152 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.424 0 CA-C-N 113.418 -1.719 . . . . 0.0 109.703 -179.859 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.059 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 2' ' ' ILE . 2.6 mp -82.79 132.51 31.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 114.37 -0.915 . . . . 0.0 109.548 0.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 3' ' ' GLU . 40.1 tt0 -175.27 77.67 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.723 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.442 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 26.3 ttt -133.53 45.5 2.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.946 177.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.561 ' H ' ' CD ' ' A' ' 6' ' ' PRO . 61.0 pttt 174.82 -35.2 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 112.654 -2.067 . . . . 0.0 113.724 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.561 ' CD ' ' H ' ' A' ' 5' ' ' LYS . 50.6 Cg_exo -52.38 -122.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 120.847 1.031 . . . . 0.0 114.6 -174.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.445 ' CD2' ' O ' ' A' ' 7' ' ' HIS . 47.0 p-80 -142.74 118.91 6.76 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 118.111 -1.436 . . . . 0.0 109.593 -178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 64.6 Cg_endo -75.81 -118.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.986 1.791 . . . . 0.0 110.468 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.417 ' CG ' ' CE2' ' A' ' 32' ' ' PHE . 39.9 p-90 -62.85 1.17 0.43 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.557 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -84.0 119.75 25.3 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 117.097 -1.841 . . . . 0.0 109.952 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 12' ' ' GLY . 7.3 m-85 -115.69 121.92 43.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.167 -1.833 . . . . 0.0 107.838 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -57.39 -146.49 0.01 OUTLIER Glycine 0 CA--C 1.531 1.09 0 CA-C-N 112.685 -2.052 . . . . 0.0 110.85 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 59.2 pttt -74.04 75.45 1.72 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 117.069 -1.853 . . . . 0.0 109.755 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.0 tp -85.12 129.33 56.36 Favored Pre-proline 0 N--CA 1.447 -0.591 0 CA-C-N 112.734 -2.03 . . . . 0.0 108.674 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.1 Cg_exo -45.55 120.83 3.52 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.542 1.495 . . . . 0.0 112.465 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 15' ' ' PRO . 61.2 ttt85 -39.49 -39.46 0.7 Allowed 'General case' 0 C--N 1.345 0.37 0 CA-C-N 112.976 -1.92 . . . . 0.0 110.806 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -65.35 -66.54 0.53 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.411 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 17' ' ' ALA . 24.4 tptm -37.12 -38.65 0.21 Allowed 'General case' 0 C--N 1.347 0.475 0 CA-C-N 112.95 -1.932 . . . . 0.0 111.118 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 23' ' ' LEU . . . -54.79 -65.98 0.48 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.059 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 24' ' ' SER . 93.6 mt-10 -45.86 -44.02 14.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 112.396 -2.184 . . . . 0.0 110.313 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.465 ' O ' ' OG ' ' A' ' 24' ' ' SER . 66.2 mt-10 -61.81 -78.7 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.719 -172.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.573 ' SD ' HD11 ' A' ' 100' ' ' ILE . 3.8 ppp? -54.39 -37.23 64.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 117.47 -1.692 . . . . 0.0 110.968 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.548 ' N ' ' SD ' ' A' ' 22' ' ' MET . 40.0 tp -69.22 -30.35 68.48 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.89 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.549 ' C ' ' H ' ' A' ' 26' ' ' GLN . 78.2 p -69.67 -29.13 66.51 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 117.326 -1.75 . . . . 0.0 111.407 176.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 5.4 mtpm? -72.38 33.3 0.06 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.133 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.732 HE21 ' CB ' ' A' ' 31' ' ' ALA . 15.0 mm100 -107.52 145.15 33.5 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 117.829 -1.549 . . . . 0.0 109.498 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 28' ' ' HIS . 95.8 mtt180 -75.5 38.23 0.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 112.388 -2.187 . . . . 0.0 110.798 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.528 ' H ' ' C ' ' A' ' 26' ' ' GLN . 0.8 OUTLIER 44.62 89.79 0.01 OUTLIER 'General case' 0 C--N 1.348 0.527 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.541 -178.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 41.9 m-20 -158.06 37.21 0.25 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.092 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.581 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 81.75 -4.62 73.5 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 115.947 -3.025 . . . . 0.0 113.205 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.732 ' CB ' HE21 ' A' ' 26' ' ' GLN . . . -40.55 117.69 0.85 Allowed 'General case' 0 C--N 1.352 0.7 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.705 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 47' ' ' SER . 23.8 p90 -137.78 154.79 49.53 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 116.5 -2.08 . . . . 0.0 110.943 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 33' ' ' LEU . 4.5 pp -152.92 149.02 27.81 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 112.379 -2.191 . . . . 0.0 109.276 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 45' ' ' SER . 46.4 mt -109.51 115.89 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 112.418 -2.174 . . . . 0.0 108.569 174.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.427 ' CB ' HG22 ' A' ' 14' ' ' ILE . 8.5 ptm180 -99.22 125.48 44.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.678 -2.055 . . . . 0.0 110.422 -174.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 72.7 tt0 -89.62 120.64 31.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.354 -2.203 . . . . 0.0 109.748 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 46.5 t -46.05 138.36 5.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.887 -1.961 . . . . 0.0 110.026 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.413 ' HA ' ' CB ' ' A' ' 13' ' ' LYS . 64.8 mt-10 -41.1 -76.53 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.569 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 t -102.09 51.02 0.83 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 112.514 -2.13 . . . . 0.0 110.367 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 37' ' ' SER . . . -171.35 97.84 0.41 Allowed Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.579 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.445 ' O ' ' CE1' ' A' ' 44' ' ' PHE . 54.2 Cg_endo -75.46 -4.27 15.05 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.744 1.629 . . . . 0.0 115.014 -177.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.67 40.06 2.6 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 118.697 -1.716 . . . . 0.0 110.876 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -145.99 118.4 8.46 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 118.227 -1.389 . . . . 0.0 109.604 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 84.9 m-85 -139.91 157.82 45.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 112.993 -1.912 . . . . 0.0 109.56 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.8 p -156.01 129.22 8.13 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.515 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 46' ' ' LEU . 4.5 tt -89.1 113.43 24.57 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 113.105 -1.861 . . . . 0.0 109.711 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.458 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 79.1 p -94.88 149.48 21.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.766 -2.015 . . . . 0.0 109.577 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 73.7 t -146.82 138.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.027 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.482 ' HG2' ' H ' ' A' ' 28' ' ' HIS . 42.2 tptt -69.12 98.17 0.97 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 112.964 -1.925 . . . . 0.0 109.242 176.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 53' ' ' ASP . 7.2 t80 -115.21 108.98 17.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.303 -1.771 . . . . 0.0 108.934 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.526 ' H ' ' CD2' ' A' ' 28' ' ' HIS . . . -25.97 144.44 0.01 OUTLIER Glycine 0 C--N 1.348 1.207 0 CA-C-N 112.325 -2.216 . . . . 0.0 112.294 -175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 59.6 t30 86.99 -30.53 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 111.66 -2.27 . . . . 0.0 111.226 -175.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 22.1 t70 -174.68 -170.84 0.51 Allowed 'General case' 0 C--N 1.35 0.622 0 C-N-CA 116.232 -2.187 . . . . 0.0 110.388 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.551 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 86.4 t -102.15 118.68 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.338 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 10.9 tt0 -90.08 158.49 17.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 113.111 -1.859 . . . . 0.0 109.613 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.63 142.9 27.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.658 -2.065 . . . . 0.0 110.514 -175.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 88.3 m-85 -126.77 101.94 6.83 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 112.807 -1.997 . . . . 0.0 109.53 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.0 mtmm -60.08 122.68 14.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.908 -1.951 . . . . 0.0 109.594 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.525 HG11 ' CD2' ' A' ' 77' ' ' LEU . 37.1 t -79.89 97.57 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 112.845 -1.979 . . . . 0.0 108.047 173.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 94.6 mt -91.42 178.79 5.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.183 -165.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 62' ' ' ASP . 9.9 tpt180 66.64 -136.12 0.15 Allowed 'General case' 0 C--N 1.347 0.466 0 CA-C-N 111.207 -2.724 . . . . 0.0 109.519 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 25.5 t70 90.83 113.63 0.03 OUTLIER 'General case' 0 C--N 1.347 0.471 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.567 -178.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.92 -41.57 1.52 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 118.216 -1.945 . . . . 0.0 110.698 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.15 -45.13 1.71 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.34 -1.43 . . . . 0.0 109.509 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 66' ' ' LYS . . . -113.29 33.9 5.32 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 113.083 -1.871 . . . . 0.0 111.573 177.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 6.0 mtpm? 37.3 -147.56 0.01 OUTLIER 'General case' 0 C--N 1.347 0.458 0 CA-C-N 113.992 -1.104 . . . . 0.0 110.313 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.516 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 76.4 m-85 -97.52 134.34 40.89 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 117.881 -1.527 . . . . 0.0 110.342 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -152.17 148.69 27.91 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 116.606 -2.038 . . . . 0.0 110.679 176.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.454 ' O ' ' CD1' ' A' ' 70' ' ' TRP . 5.4 mt -86.06 -49.01 8.12 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 112.773 -2.012 . . . . 0.0 109.456 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 20.7 m0 -133.15 -77.48 0.49 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.852 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.1 t -107.15 -83.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.901 -1.954 . . . . 0.0 109.611 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.3 m -50.8 131.27 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 112.648 -2.069 . . . . 0.0 110.023 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 66.7 mttm -88.93 -169.94 2.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.721 -2.036 . . . . 0.0 109.951 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 73' ' ' LYS . 37.7 m-85 -152.88 135.06 14.91 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.127 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.425 ' O ' ' OG ' ' A' ' 76' ' ' SER . 1.7 m120 -64.12 -16.87 62.74 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.561 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 46.9 m -168.69 160.54 10.71 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.83 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' CD2' HG11 ' A' ' 59' ' ' VAL . 89.4 mt -45.51 -41.98 10.25 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 117.268 -1.773 . . . . 0.0 110.362 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 82' ' ' ASP . 52.8 t30 -55.8 -39.34 71.18 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.382 -1.735 . . . . 0.0 110.893 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.4 OUTLIER -67.89 -28.64 67.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 117.347 -1.741 . . . . 0.0 111.452 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.6 tt -65.68 -47.37 75.7 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 118.708 -1.197 . . . . 0.0 109.088 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 85' ' ' ARG . 70.6 t -64.57 -31.25 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 112.756 -2.02 . . . . 0.0 111.594 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 57.0 m-20 -74.57 -42.95 57.84 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.116 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -58.82 -46.05 88.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 117.104 -1.839 . . . . 0.0 109.096 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 85' ' ' ARG . 60.1 m-70 -92.76 32.39 1.25 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.143 -1.844 . . . . 0.0 110.965 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 84' ' ' HIS . 35.2 ptt-85 -40.24 -35.09 0.37 Allowed 'General case' 0 C--N 1.349 0.568 0 C-N-CA 118.309 -1.356 . . . . 0.0 110.935 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.8 p -89.93 -80.61 0.31 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 117.803 -1.559 . . . . 0.0 108.206 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 95' ' ' ILE . 14.8 t -170.16 -169.97 0.92 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.51 -1.677 . . . . 0.0 109.925 176.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.659 ' H ' ' CG1' ' A' ' 89' ' ' VAL . 29.3 t -121.25 -96.02 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 112.116 -2.311 . . . . 0.0 107.622 160.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.659 ' CG1' ' H ' ' A' ' 88' ' ' SER . 4.0 m -142.18 41.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.953 1 C-N-CA 133.737 4.815 . . . . 0.0 108.684 -8.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 12.0 t 162.67 -86.04 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 112.821 -1.99 . . . . 0.0 109.06 -154.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.438 ' O ' ' CG ' ' A' ' 92' ' ' ASN . 85.9 mtt180 -99.94 5.63 45.23 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.171 -1.832 . . . . 0.0 113.352 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER 47.91 27.26 1.11 Allowed 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.02 0.825 . . . . 0.0 112.569 177.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' O ' ' CD ' ' A' ' 94' ' ' GLN . 8.4 pt20 -170.04 31.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 117.296 -1.762 . . . . 0.0 112.009 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' CD ' ' O ' ' A' ' 93' ' ' GLN . 23.1 mm100 -158.44 37.75 0.24 Allowed 'General case' 0 C--N 1.347 0.498 0 C-N-CA 118.218 -1.393 . . . . 0.0 110.661 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.602 HG13 ' H ' ' A' ' 89' ' ' VAL . 5.8 mm -142.97 165.39 15.8 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 117.779 -1.568 . . . . 0.0 109.298 -176.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.581 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 86.1 m-85 -150.07 155.16 39.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.657 -1.611 . . . . 0.0 109.894 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' C ' ' CE1' ' A' ' 32' ' ' PHE . 58.0 mt -116.2 90.92 3.44 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 113.659 -1.61 . . . . 0.0 109.083 169.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 99' ' ' ASP . 71.4 mtp180 -156.47 -147.79 0.2 Allowed 'General case' 0 C--N 1.346 0.446 0 CA-C-N 112.951 -1.932 . . . . 0.0 108.803 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 100' ' ' ILE . 33.7 t0 48.1 -177.87 0.01 OUTLIER 'General case' 0 C--N 1.348 0.506 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.674 172.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.573 HD11 ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER 84.29 6.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 112.93 -1.941 . . . . 0.0 113.967 177.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -150.17 83.29 1.38 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 118.415 -1.314 . . . . 0.0 109.581 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.493 ' C ' HG22 ' A' ' 103' ' ' VAL . 37.7 mt-30 -115.08 99.94 7.8 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.055 -1.884 . . . . 0.0 109.691 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.553 HG23 ' CD ' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -163.64 -65.57 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 113.077 -1.874 . . . . 0.0 110.86 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.553 ' CD ' HG23 ' A' ' 103' ' ' VAL . 20.0 Cg_endo -69.13 122.94 9.79 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.931 1.754 . . . . 0.0 111.921 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 104' ' ' PRO . 70.8 mt-30 95.75 86.95 0.01 OUTLIER 'General case' 0 C--N 1.347 0.477 0 CA-C-N 112.038 -2.346 . . . . 0.0 109.848 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.519 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.7 OUTLIER -170.02 53.84 0.22 Allowed Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 112.81 -1.995 . . . . 0.0 110.991 179.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 44.7 Cg_endo -64.21 -139.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.218 1.946 . . . . 0.0 110.067 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.423 ' H ' ' HB2' ' A' ' 107' ' ' PRO . 4.4 t -144.24 136.96 26.96 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.271 -1.786 . . . . 0.0 109.441 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' A' ' 109' ' ' TYR . 54.9 p90 -93.09 121.49 34.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.001 -1.909 . . . . 0.0 109.638 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.7 p -140.95 122.64 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.788 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -73.66 120.49 19.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.034 -1.893 . . . . 0.0 109.664 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.422 0 CA-C-N 113.004 -1.907 . . . . 0.0 109.719 179.955 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 CA-C-O 122.006 0.781 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 2' ' ' ILE . 8.3 tp -46.37 122.38 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-N 112.911 -1.645 . . . . 0.0 109.641 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 104' ' ' PRO . 23.2 mm-40 -103.6 50.03 0.81 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.828 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 50.5 ttp -122.18 114.93 21.54 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 112.624 -2.08 . . . . 0.0 109.517 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.429 ' O ' ' HE2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -177.86 153.24 0.92 Allowed Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.3 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' HA ' ' C ' ' A' ' 7' ' ' HIS . 77.2 Cg_exo -42.66 136.8 4.3 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.828 2.352 . . . . 0.0 112.586 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.431 ' C ' ' HA ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -87.46 141.64 32.52 Favored Pre-proline 0 C--N 1.351 0.663 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.988 11.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 69.6 Cg_endo -76.55 -119.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.53 2.153 . . . . 0.0 108.867 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.413 ' H ' ' HB2' ' A' ' 8' ' ' PRO . 5.9 p-90 -83.72 16.34 2.77 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 118.386 -1.326 . . . . 0.0 112.782 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -93.36 125.06 37.77 Favored 'General case' 0 C--N 1.349 0.547 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.419 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.453 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 83.5 m-85 -130.02 118.33 21.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 117.301 -1.76 . . . . 0.0 110.088 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.535 ' CA ' ' C ' ' A' ' 13' ' ' LYS . . . 137.83 -161.35 25.46 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 115.823 -3.084 . . . . 0.0 112.488 166.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' C ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -57.4 115.8 2.94 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 112.648 -1.776 . . . . 0.0 111.081 0.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.469 ' N ' ' CA ' ' A' ' 12' ' ' GLY . 9.8 tp -106.02 133.77 20.06 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.253 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.3 Cg_exo -46.24 121.75 4.83 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.788 1.659 . . . . 0.0 112.933 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 15' ' ' PRO . 95.0 mtt180 -42.94 -41.18 3.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.479 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -62.8 -61.61 2.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.795 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 17' ' ' ALA . 58.5 tptt -43.02 -44.24 4.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 113.051 -1.886 . . . . 0.0 110.275 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -48.4 -62.57 1.42 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.148 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 21' ' ' GLU . 46.8 mt-10 -44.95 -65.0 0.59 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.346 -2.206 . . . . 0.0 109.901 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 20' ' ' GLU . 69.1 mt-10 -37.51 -85.7 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.039 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.505 ' CA ' ' HD3' ' A' ' 25' ' ' LYS . 26.5 ptt? -48.62 -52.39 23.32 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 117.495 -1.682 . . . . 0.0 110.233 -176.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.517 HD13 ' CD1' ' A' ' 100' ' ' ILE . 42.0 tp -50.62 -22.92 2.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 117.145 -1.822 . . . . 0.0 112.708 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 21' ' ' GLU . 90.3 p -83.82 -33.13 24.99 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.115 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.505 ' HD3' ' CA ' ' A' ' 22' ' ' MET . 8.2 pttm -42.29 -25.88 0.09 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 113.538 -1.664 . . . . 0.0 112.018 172.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 35.5 mm-40 -55.58 161.37 2.07 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.282 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 6.5 mpt_? -119.0 -41.95 2.73 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.057 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.19 107.78 19.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.691 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -47.76 125.51 8.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 112.505 -2.134 . . . . 0.0 109.728 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 138.5 -29.47 2.59 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 117.35 -2.357 . . . . 0.0 112.485 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.73 138.59 8.24 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 117.829 -1.549 . . . . 0.0 109.181 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' SER . 37.5 p90 -142.94 156.11 44.83 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 116.09 -2.244 . . . . 0.0 111.515 -174.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -146.93 150.94 36.19 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.448 -2.16 . . . . 0.0 109.334 169.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.7 mt -111.08 108.16 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 113.025 -1.898 . . . . 0.0 108.577 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 37.0 ptt180 -92.72 135.8 33.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.67 -2.059 . . . . 0.0 110.805 -172.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 37' ' ' SER . 16.8 pt-20 -91.71 128.38 37.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.694 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 36' ' ' GLU . 49.8 m -54.51 -165.27 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.182 -1.826 . . . . 0.0 109.822 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -81.61 -98.41 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.423 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.4 t -94.24 43.64 1.11 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.015 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.26 94.75 7.6 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 113.227 -1.806 . . . . 0.0 109.448 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.39 -4.79 15.48 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.954 1.769 . . . . 0.0 114.943 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.95 39.45 2.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 118.864 -1.636 . . . . 0.0 110.932 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 57.0 t0 -143.38 106.84 4.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 118.264 -1.375 . . . . 0.0 109.652 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 23.4 m-85 -133.85 120.22 20.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.533 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.3 p -113.6 125.95 54.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.643 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' A' ' 48' ' ' VAL . 5.4 tt -85.44 117.2 24.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 112.817 -1.992 . . . . 0.0 109.562 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.484 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 49.9 m -94.83 144.52 25.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.533 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' A' ' 46' ' ' LEU . 78.6 t -151.57 131.41 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.735 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 66.2 tttp -76.32 106.13 7.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 116.754 -1.979 . . . . 0.0 108.427 174.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -104.37 37.53 2.08 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 113.212 -1.813 . . . . 0.0 111.524 -172.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.82 -95.34 0.26 Allowed Glycine 0 C--N 1.346 1.109 0 C-N-CA 117.249 -2.405 . . . . 0.0 110.811 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 52.2 t-20 -107.19 -31.42 8.24 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 112.675 -1.763 . . . . 0.0 111.411 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 34.2 t70 -120.85 -176.81 3.33 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.499 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.549 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 94.6 t -100.23 122.79 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 112.956 -1.929 . . . . 0.0 110.2 -175.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.42 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 11.1 tt0 -97.36 159.53 14.86 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.778 -2.01 . . . . 0.0 109.486 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -139.69 134.98 32.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.748 -2.023 . . . . 0.0 110.522 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.447 ' CZ ' ' O ' ' A' ' 89' ' ' VAL . 97.4 m-85 -123.88 101.56 7.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.409 176.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 55.1 mtmt -58.85 100.25 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 116.59 -2.044 . . . . 0.0 109.612 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.528 HG13 ' CD1' ' A' ' 80' ' ' LEU . 93.6 t -70.33 86.22 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 112.984 -1.917 . . . . 0.0 108.563 174.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 77.2 mt -78.76 163.04 25.71 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.752 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.2 ptm180 -132.42 -154.76 0.64 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.075 -1.875 . . . . 0.0 109.205 173.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -172.97 -37.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.063 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.76 -41.61 2.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 117.79 -2.148 . . . . 0.0 110.599 -176.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.85 53.25 1.1 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.141 -1.53 . . . . 0.0 108.089 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 66' ' ' LYS . . . 150.83 -31.52 1.0 Allowed Glycine 0 CA--C 1.54 1.636 0 CA-C-N 111.82 -2.445 . . . . 0.0 111.351 -168.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.502 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 21.8 mtpp 70.93 -151.38 0.09 Allowed 'General case' 0 C--N 1.349 0.573 0 CA-C-N 114.172 -1.014 . . . . 0.0 110.253 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 90.1 m-85 -71.13 147.68 48.16 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.476 -173.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 17.1 p90 -166.01 167.53 16.45 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.418 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 80' ' ' LEU . 4.7 mp -124.94 97.76 5.4 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.06 173.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.44 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 34.4 m0 73.63 -39.2 0.43 Allowed 'General case' 0 C--N 1.346 0.414 0 CA-C-N 112.774 -2.012 . . . . 0.0 110.786 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' A' ' 69' ' ' LEU . 84.5 t -150.04 -85.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 117.56 -1.656 . . . . 0.0 110.549 -174.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 31.0 m -49.33 135.8 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.591 -173.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 74' ' ' PHE . 2.5 mptp? -99.21 -179.25 4.18 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 112.797 -2.001 . . . . 0.0 111.04 -176.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.435 ' CG ' ' O ' ' A' ' 73' ' ' LYS . 19.4 m-85 -158.63 137.17 10.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 111.74 -2.482 . . . . 0.0 108.842 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.502 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 56.6 p30 -62.18 -9.3 7.28 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 113.227 -1.806 . . . . 0.0 112.963 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 42.8 t -179.05 152.57 0.57 Allowed 'General case' 0 C--N 1.349 0.555 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.697 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.518 ' CD2' HG11 ' A' ' 59' ' ' VAL . 77.1 mt -43.14 -43.96 4.8 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 113.184 -1.826 . . . . 0.0 110.212 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.636 ' H ' HD22 ' A' ' 78' ' ' ASN . 5.3 m-80 -55.3 -39.52 69.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.918 -1.946 . . . . 0.0 110.791 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HB2' ' OD1' ' A' ' 75' ' ' ASN . 36.0 tt0 -69.36 -35.12 75.55 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 116.882 -1.927 . . . . 0.0 110.812 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 69' ' ' LEU . 6.5 tt -57.7 -49.09 77.66 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.949 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.6 t -63.58 -40.46 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 112.505 -2.134 . . . . 0.0 110.647 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.43 -44.57 96.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.204 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 87' ' ' THR . 4.1 m-85 -63.84 -42.84 97.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.854 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.422 ' O ' HD12 ' A' ' 97' ' ' LEU . 9.0 m-70 -93.48 41.69 1.09 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 117.684 -1.607 . . . . 0.0 110.294 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -94.54 -41.02 9.56 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.466 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.4 t -101.61 -42.58 6.17 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.279 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 83' ' ' TYR . 12.2 t -70.01 -147.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.441 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 83.6 p -123.81 -151.53 0.48 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.437 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.447 ' O ' ' CZ ' ' A' ' 57' ' ' PHE . 14.9 p -176.18 45.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 113.478 -1.692 . . . . 0.0 109.77 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 92' ' ' ASN . 32.2 t -171.25 -145.74 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.129 -1.85 . . . . 0.0 109.149 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 86.7 mtt180 -63.36 7.81 0.09 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 117.971 -1.492 . . . . 0.0 113.133 177.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 90' ' ' SER . 11.1 m120 64.3 28.33 13.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.824 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -112.3 97.11 6.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.378 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.429 ' O ' HD13 ' A' ' 95' ' ' ILE . 56.6 tp60 43.85 89.66 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 112.925 -1.943 . . . . 0.0 110.031 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 94' ' ' GLN . 14.2 mm -146.28 128.23 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.082 -1.872 . . . . 0.0 109.428 177.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.575 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 88.7 m-85 -149.98 139.58 21.61 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.532 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 84' ' ' HIS . 91.8 mt -89.93 94.87 9.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 117.114 -1.835 . . . . 0.0 109.249 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.492 ' NH1' ' CB ' ' A' ' 98' ' ' ARG . 4.4 ptm85 -105.46 149.07 26.5 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.614 -2.085 . . . . 0.0 109.997 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -47.26 119.55 2.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.309 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.523 ' CD1' HD23 ' A' ' 33' ' ' LEU . 12.1 tt -70.06 -41.78 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.846 -1.979 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.435 ' N ' HG23 ' A' ' 100' ' ' ILE . 2.5 tm-20 -120.77 125.21 47.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 112.407 -2.178 . . . . 0.0 110.259 -174.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -134.2 117.95 17.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.068 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.634 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -109.25 -62.72 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 112.909 -1.951 . . . . 0.0 110.25 177.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.634 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 34.2 Cg_exo -48.52 130.55 22.05 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.902 1.735 . . . . 0.0 113.07 174.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 104' ' ' PRO . 8.3 mm100 79.67 55.57 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.407 -2.179 . . . . 0.0 110.23 175.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -69.97 152.58 95.87 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 112.836 -1.984 . . . . 0.0 109.254 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.58 ' O ' ' CB ' ' A' ' 108' ' ' THR . 38.0 Cg_endo -73.58 119.78 6.11 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.286 1.99 . . . . 0.0 111.143 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.58 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 15.1 m 103.96 114.88 0.01 OUTLIER 'General case' 0 C--N 1.348 0.536 0 CA-C-N 112.273 -2.24 . . . . 0.0 109.465 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -48.9 117.11 1.91 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.095 -1.866 . . . . 0.0 109.688 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.6 p -100.81 122.14 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 112.942 -1.935 . . . . 0.0 109.757 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -94.73 95.81 8.97 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.606 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 0.398 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.185 179.709 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.01 0 CA-C-O 121.919 0.733 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 3' ' ' GLU . 8.3 tp -72.7 -39.64 60.54 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-N 113.009 -1.596 . . . . 0.0 110.649 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 4' ' ' MET . 0.9 OUTLIER -95.8 118.87 33.28 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.205 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' GLU . 22.4 ttt -42.85 165.64 0.01 OUTLIER 'General case' 0 C--N 1.346 0.416 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.86 -176.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 7.5 ttpm? -43.82 -49.03 21.06 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.519 -176.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 60.5 Cg_endo -81.19 120.14 3.63 Favored 'Trans proline' 0 C--N 1.358 1.059 0 O-C-N 122.624 0.802 . . . . 0.0 111.262 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.617 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 14.4 t-160 -110.98 -43.72 0.09 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 113.01 -1.905 . . . . 0.0 112.162 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.617 ' CD ' ' H ' ' A' ' 7' ' ' HIS . 53.4 Cg_exo -48.99 -121.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.533 1.489 . . . . 0.0 114.571 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.436 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 3.2 p-90 -152.76 21.63 0.6 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.788 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 71.2 m-85 -90.45 115.3 27.51 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 118.452 -1.299 . . . . 0.0 109.115 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 60.6 m-85 -118.03 103.7 10.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.395 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.64 162.9 31.87 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 114.773 -3.584 . . . . 0.0 112.069 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -88.65 110.25 20.8 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 113.155 -1.522 . . . . 0.0 109.059 -6.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.46 HG12 ' CE ' ' A' ' 22' ' ' MET . 10.2 tp -97.96 126.02 41.96 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.523 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.4 Cg_exo -48.36 121.67 6.57 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.661 1.574 . . . . 0.0 112.811 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 15' ' ' PRO . 71.3 ttt180 -38.53 -37.65 0.33 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 113.02 -1.9 . . . . 0.0 111.075 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -68.45 -59.79 2.91 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.635 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 22' ' ' MET . 58.5 tptt -42.01 -42.97 3.01 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.353 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -51.1 -63.46 1.12 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.186 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 24' ' ' SER . 90.3 mt-10 -43.05 -44.77 4.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.576 -2.102 . . . . 0.0 110.236 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 34.1 mt-10 -63.65 -80.59 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 112.907 -1.952 . . . . 0.0 110.588 -173.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.499 ' HE3' ' CD2' ' A' ' 33' ' ' LEU . 25.9 ptt? -48.92 -39.93 28.07 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 113.456 -1.702 . . . . 0.0 110.662 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.503 HD23 ' CG1' ' A' ' 54' ' ' VAL . 38.8 tp -63.97 -32.61 74.21 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 117.726 -1.59 . . . . 0.0 111.474 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 26' ' ' GLN . 44.2 t -68.0 -32.3 72.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 117.662 -1.615 . . . . 0.0 111.267 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -73.15 35.61 0.08 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.111 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.563 HE21 ' HB1' ' A' ' 31' ' ' ALA . 12.8 mm100 -105.08 135.46 46.39 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.814 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.445 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 1.6 mpp_? -98.52 33.11 2.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 112.312 -2.222 . . . . 0.0 111.242 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 27' ' ' ARG . 74.7 m80 -155.47 103.57 2.32 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.219 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -56.38 103.6 0.11 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.268 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 152.28 -31.45 0.87 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 117.419 -2.324 . . . . 0.0 112.134 -178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.563 ' HB1' HE21 ' A' ' 26' ' ' GLN . . . -46.86 141.39 4.03 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.539 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 98' ' ' ARG . 49.1 p90 -141.89 169.96 16.61 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 116.641 -2.023 . . . . 0.0 110.888 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.5 pp -161.31 150.04 16.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.164 -2.289 . . . . 0.0 109.001 167.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 45' ' ' SER . 49.3 mt -110.11 114.57 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 113.133 -1.849 . . . . 0.0 108.349 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 33.7 ptt85 -90.07 130.48 36.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.041 -170.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -59.9 135.88 57.83 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 111.99 -2.368 . . . . 0.0 109.879 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 43' ' ' ASP . 50.0 m -52.35 119.65 4.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.855 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -50.54 -78.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.109 -1.859 . . . . 0.0 109.434 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -127.46 62.32 1.37 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.547 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -152.34 156.82 33.83 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 113.048 -1.887 . . . . 0.0 109.517 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ALA . 64.3 Cg_exo -44.29 -120.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.769 2.313 . . . . 0.0 114.157 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' H ' ' HB2' ' A' ' 41' ' ' PRO . . . -103.51 66.26 0.34 Allowed Glycine 0 C--N 1.346 1.128 0 C-N-CA 118.226 -1.94 . . . . 0.0 110.498 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' O ' ' OG ' ' A' ' 37' ' ' SER . 1.0 OUTLIER -99.43 114.18 26.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.914 -1.643 . . . . 0.0 109.501 178.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.415 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 22.1 m-85 -128.39 124.2 35.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.025 -1.898 . . . . 0.0 109.745 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.2 p -117.99 133.24 56.11 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.007 -1.906 . . . . 0.0 109.662 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.453 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.3 tt -94.39 113.92 25.88 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 112.697 -2.047 . . . . 0.0 109.173 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 88.3 p -95.01 148.8 21.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.73 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 73.8 t -146.4 136.06 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.625 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.447 ' CD ' ' HB2' ' A' ' 26' ' ' GLN . 60.6 tttp -80.1 106.79 12.38 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 116.482 -2.087 . . . . 0.0 109.756 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 53' ' ' ASP . 49.1 t80 -126.51 114.91 18.75 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 112.553 -2.112 . . . . 0.0 108.863 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -27.43 144.51 0.01 OUTLIER Glycine 0 C--N 1.349 1.287 0 CA-C-N 112.648 -2.069 . . . . 0.0 111.884 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 74.9 m-20 102.53 -52.86 0.0 OUTLIER 'General case' 0 C--N 1.346 0.439 0 CA-C-N 111.52 -2.34 . . . . 0.0 108.189 -166.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 50' ' ' PHE . 56.3 p30 -179.64 -161.08 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 111.396 -2.638 . . . . 0.0 110.194 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.503 ' CG1' HD23 ' A' ' 23' ' ' LEU . 91.4 t -96.93 124.63 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.703 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -95.86 160.63 14.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.797 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -141.42 143.74 34.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.708 -2.042 . . . . 0.0 110.129 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -128.65 102.39 6.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.744 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -58.4 108.47 0.63 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.99 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' CD2' ' A' ' 77' ' ' LEU . 60.7 t -81.38 78.28 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 112.981 -1.918 . . . . 0.0 108.423 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 91.2 mt -83.66 172.49 12.24 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 112.417 -2.174 . . . . 0.0 109.845 -174.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 9.1 ptm180 -145.95 -148.74 0.25 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 116.463 -2.095 . . . . 0.0 109.476 172.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 61' ' ' ARG . 24.4 t0 58.72 150.78 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.35 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 39.26 35.16 0.42 Allowed Glycine 0 CA--C 1.534 1.268 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.712 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.17 -42.18 0.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.045 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 66' ' ' LYS . . . 118.62 62.41 0.29 Allowed Glycine 0 C--N 1.347 1.149 0 C-N-CA 118.548 -1.787 . . . . 0.0 109.54 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HZ3' ' C ' ' A' ' 74' ' ' PHE . 8.4 mtmp? 82.82 -150.89 0.01 OUTLIER 'General case' 0 C--N 1.347 0.489 0 CA-C-N 112.307 -1.946 . . . . 0.0 109.272 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 88.5 m-85 -71.93 158.12 36.6 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.723 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 72' ' ' VAL . 55.1 t80 -152.62 156.85 40.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.62 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.607 HD13 HD11 ' A' ' 80' ' ' LEU . 33.3 tp -124.49 -66.84 0.95 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 112.449 -2.159 . . . . 0.0 109.826 -169.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.459 ' CD2' ' O ' ' A' ' 69' ' ' LEU . 27.7 m95 -147.09 -37.13 0.22 Allowed 'General case' 0 C--N 1.346 0.432 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.101 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.416 ' C ' ' CE2' ' A' ' 68' ' ' PHE . 59.7 t -125.89 -37.59 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.471 0 C-N-CA 117.208 -1.797 . . . . 0.0 111.299 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 33.8 m -130.6 171.81 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 117.463 -1.695 . . . . 0.0 110.155 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.697 ' CD ' ' H ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -98.49 173.9 6.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.026 179.11 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.594 ' C ' ' HZ3' ' A' ' 66' ' ' LYS . 1.3 m-85 -145.6 132.27 19.93 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 117.063 -1.855 . . . . 0.0 109.551 -175.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' SER . 7.0 p30 -86.66 25.67 1.22 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.617 -2.083 . . . . 0.0 112.214 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.2 t 175.69 130.85 0.04 OUTLIER 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.971 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.511 ' CD2' HG11 ' A' ' 59' ' ' VAL . 85.1 mt -47.71 -41.12 22.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 116.879 -1.929 . . . . 0.0 109.998 174.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 82' ' ' ASP . 39.7 m-80 -60.67 -30.98 70.24 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 113.533 -1.667 . . . . 0.0 111.659 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 83' ' ' TYR . 10.2 tp10 -66.45 -26.39 67.18 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 117.114 -1.835 . . . . 0.0 111.694 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 69' ' ' LEU . 10.4 tt -83.71 -53.12 5.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.384 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.59 -44.76 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 112.644 -2.071 . . . . 0.0 109.711 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 78' ' ' ASN . 25.1 t0 -63.62 -63.67 1.11 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.076 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.434 ' CB ' ' O ' ' A' ' 79' ' ' GLU . 38.7 t80 -48.76 -42.04 34.22 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.445 -176.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.457 ' HE2' ' HZ ' ' A' ' 74' ' ' PHE . 92.4 m-70 -100.15 44.14 1.03 Allowed 'General case' 0 C--N 1.345 0.393 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.088 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -86.08 -40.46 15.71 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.491 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 88' ' ' SER . 39.1 t -112.59 -36.6 5.17 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.73 -1.577 . . . . 0.0 111.048 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -77.47 42.79 0.37 Allowed 'General case' 0 C--N 1.346 0.453 0 C-N-CA 118.044 -1.463 . . . . 0.0 110.797 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 86' ' ' SER . 45.0 m 49.93 -149.77 0.24 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.912 170.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 90' ' ' SER . 6.4 p -176.9 -41.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.434 0 CA-C-N 113.393 -1.731 . . . . 0.0 110.337 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.404 ' N ' HG13 ' A' ' 89' ' ' VAL . 41.5 t -83.32 147.97 27.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.648 -1.614 . . . . 0.0 109.503 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.646 ' H ' ' HD2' ' A' ' 91' ' ' ARG . 2.2 mpt_? -41.26 -42.25 2.09 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.402 -1.726 . . . . 0.0 110.192 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -67.22 96.47 0.47 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 117.097 -1.841 . . . . 0.0 108.369 172.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 86.1 mm-40 -69.88 93.37 0.76 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.746 -175.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 93' ' ' GLN . 21.1 pt20 176.81 43.35 0.0 OUTLIER 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.135 -2.302 . . . . 0.0 109.685 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 34.5 mm -114.75 145.68 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.858 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.54 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 65.3 t80 -135.11 132.16 37.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.865 -1.97 . . . . 0.0 109.338 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.01 101.87 14.58 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 117.304 -1.758 . . . . 0.0 109.406 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.729 ' HE ' ' H ' ' A' ' 99' ' ' ASP . 5.1 tpm_? -97.3 151.76 19.57 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 112.602 -2.09 . . . . 0.0 109.976 -176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.729 ' H ' ' HE ' ' A' ' 98' ' ' ARG . 51.8 p-10 -72.59 33.66 0.07 Allowed 'General case' 0 C--N 1.346 0.428 0 CA-C-N 113.073 -1.876 . . . . 0.0 112.196 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.601 HG12 ' H ' ' A' ' 101' ' ' GLU . 10.8 tt 40.9 -143.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.133 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 100' ' ' ILE . 85.5 mt-10 -92.13 42.64 1.11 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.369 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 7' ' ' HIS . 36.6 tp60 -133.19 108.6 8.89 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 117.579 -1.648 . . . . 0.0 109.765 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.508 ' CG1' ' HG2' ' A' ' 105' ' ' GLN . 7.1 p -179.05 136.64 0.31 Allowed Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 113.127 -1.851 . . . . 0.0 109.775 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 105' ' ' GLN . 42.3 Cg_exo -51.05 1.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.293 1.996 . . . . 0.0 116.296 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.508 ' HG2' ' CG1' ' A' ' 103' ' ' VAL . 30.0 mm100 -37.02 121.96 0.82 Allowed 'General case' 0 C--N 1.348 0.501 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.749 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -104.61 152.61 39.45 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 112.583 -2.099 . . . . 0.0 109.689 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 108' ' ' THR . 32.1 Cg_endo -68.26 123.72 10.89 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.827 2.351 . . . . 0.0 111.222 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 107' ' ' PRO . 91.5 m -32.59 121.48 0.34 Allowed 'General case' 0 C--N 1.348 0.501 0 CA-C-N 112.623 -2.08 . . . . 0.0 111.12 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.416 ' HB3' ' OE1' ' A' ' 111' ' ' GLN . 83.9 m-85 -56.5 123.9 16.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.784 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.3 p -109.55 120.7 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.706 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.592 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 4.1 mp0 -125.01 -157.24 0.77 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.304 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.592 ' CB ' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.349 0.554 0 CA-C-N 112.509 -2.132 . . . . 0.0 109.171 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.007 0 CA-C-O 121.887 0.715 . . . . 0.0 112.046 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 2' ' ' ILE . 15.8 tt -165.63 122.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.004 -1.598 . . . . 0.0 109.645 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 3' ' ' GLU . 23.7 pt-20 -105.38 58.78 0.67 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.743 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 5' ' ' LYS . 39.5 ttm -46.08 152.22 0.41 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 112.83 -1.987 . . . . 0.0 109.583 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 4' ' ' MET . 87.7 tttt -40.99 135.22 1.68 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.951 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -44.76 119.98 2.59 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.001 1.801 . . . . 0.0 113.187 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.481 ' O ' ' O ' ' A' ' 8' ' ' PRO . 57.8 t60 -66.14 137.09 95.59 Favored Pre-proline 0 C--N 1.346 0.451 0 CA-C-N 112.959 -1.928 . . . . 0.0 109.159 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 7' ' ' HIS . 77.8 Cg_exo -43.07 -120.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.603 2.202 . . . . 0.0 114.403 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.44 ' CZ3' ' CE2' ' A' ' 10' ' ' PHE . 2.6 p-90 -154.54 22.6 0.47 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.487 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.44 ' CE2' ' CZ3' ' A' ' 9' ' ' TRP . 91.2 m-85 -90.48 119.48 30.79 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.843 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.54 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 32.7 m-85 -115.98 89.72 3.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.341 -1.754 . . . . 0.0 108.953 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -36.62 -106.67 0.01 OUTLIER Glycine 0 C--N 1.346 1.108 0 CA-C-N 111.979 -2.373 . . . . 0.0 112.918 -171.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 14.7 ptmm? -95.3 67.38 2.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.415 -173.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.428 HG22 ' CB ' ' A' ' 35' ' ' ARG . 6.3 tp -95.87 128.51 37.24 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 116.996 -1.882 . . . . 0.0 107.603 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.414 ' HG2' ' CB ' ' A' ' 18' ' ' LYS . 20.7 Cg_endo -66.54 -157.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 O-C-N 123.614 1.323 . . . . 0.0 111.496 -172.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 25.7 ttm180 -94.94 -49.94 5.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.629 -1.623 . . . . 0.0 108.884 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -48.42 -71.68 0.06 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 112.59 -2.096 . . . . 0.0 108.946 174.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.417 ' HG2' HD11 ' A' ' 14' ' ' ILE . 54.4 tptt -43.51 -56.23 3.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.588 -2.097 . . . . 0.0 110.725 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.39 -44.3 24.24 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 116.701 -2.0 . . . . 0.0 110.093 -178.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.579 ' O ' ' CB ' ' A' ' 24' ' ' SER . 95.1 mt-10 -66.98 -37.39 84.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.042 -1.89 . . . . 0.0 111.264 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 47.6 mt-10 -67.8 -80.27 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 117.365 -1.734 . . . . 0.0 110.478 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.616 ' HE3' ' CD2' ' A' ' 33' ' ' LEU . 23.6 ptt? -44.34 -39.76 4.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.7 -175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' A' ' 25' ' ' LYS . 39.4 tp -72.73 -36.64 67.8 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 116.618 -2.033 . . . . 0.0 111.178 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 48.3 t -73.59 29.51 0.07 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 116.971 -1.892 . . . . 0.0 111.735 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 23' ' ' LEU . 55.4 mtpt -134.88 44.05 2.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.59 177.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 26.5 mm-40 -112.16 144.25 41.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.291 -1.777 . . . . 0.0 110.142 -174.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 28' ' ' HIS . 87.2 mtt180 -83.97 85.06 7.38 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 112.085 -2.325 . . . . 0.0 110.715 -172.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.424 ' HB3' ' O ' ' A' ' 27' ' ' ARG . 1.8 t-80 80.62 -45.64 0.26 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.199 -2.273 . . . . 0.0 110.904 173.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' LYS . 35.6 m-20 -47.42 166.08 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 111.905 -2.407 . . . . 0.0 108.199 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 96' ' ' PHE . . . 107.73 -39.51 2.86 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.552 1.072 . . . . 0.0 110.582 7.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -68.73 149.03 49.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 118.475 -1.29 . . . . 0.0 109.182 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' SER . 41.6 p90 -146.26 162.34 38.31 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 116.475 -2.09 . . . . 0.0 111.033 -172.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.616 ' CD2' ' HE3' ' A' ' 22' ' ' MET . 4.5 pp -149.61 148.85 29.82 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.49 -2.141 . . . . 0.0 109.335 170.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 44' ' ' PHE . 58.2 mt -113.74 111.6 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 112.651 -2.068 . . . . 0.0 108.444 174.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 11.6 ptm180 -95.85 136.12 36.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.446 -2.161 . . . . 0.0 110.934 -170.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 12' ' ' GLY . 68.6 tt0 -82.6 125.74 31.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.126 -2.306 . . . . 0.0 109.449 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 47.7 t -59.22 132.66 54.68 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 112.891 -1.959 . . . . 0.0 109.762 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -42.27 -42.91 3.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.616 -2.084 . . . . 0.0 110.356 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 49.1 m -144.98 71.22 1.29 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 113.44 -1.709 . . . . 0.0 110.26 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 179.05 101.35 0.16 Allowed Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 112.898 -1.956 . . . . 0.0 109.113 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.3 -4.07 14.77 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.719 1.613 . . . . 0.0 115.185 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.29 40.2 2.61 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 118.731 -1.7 . . . . 0.0 110.895 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.458 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 9.5 t0 -143.23 106.55 4.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.959 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.521 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 23.2 m-85 -133.96 107.01 7.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.433 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 80.3 p -104.73 126.55 51.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.906 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.3 tt -90.76 114.9 27.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.318 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 98.2 p -96.97 147.18 24.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.081 -1.872 . . . . 0.0 110.017 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 60.2 t -145.12 134.49 18.12 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.284 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' ASP . 13.7 tptp -76.31 96.62 4.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 112.654 -2.066 . . . . 0.0 108.417 174.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CZ ' ' CG ' ' A' ' 92' ' ' ASN . 14.4 t80 -71.51 -44.03 65.41 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 117.17 -1.812 . . . . 0.0 110.703 -173.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.92 -69.89 0.03 OUTLIER Glycine 0 CA--C 1.527 0.83 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.265 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -116.28 -25.86 7.39 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 111.927 -2.137 . . . . 0.0 111.816 176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.05 153.63 29.09 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 118.397 -1.321 . . . . 0.0 110.291 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 20' ' ' GLU . 74.8 t -79.59 131.28 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 112.41 -2.177 . . . . 0.0 109.569 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.453 ' OE1' ' CZ ' ' A' ' 57' ' ' PHE . 31.8 tt0 -101.51 164.47 11.74 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.674 -2.057 . . . . 0.0 109.868 -176.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 55' ' ' GLN . 42.1 m80 -150.06 140.54 22.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.007 -1.906 . . . . 0.0 110.723 -176.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 23.3 m-85 -135.88 111.98 9.66 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.381 173.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 37.9 mtmm -74.5 116.06 14.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 116.886 -1.925 . . . . 0.0 109.837 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.522 HG11 ' CD2' ' A' ' 77' ' ' LEU . 48.2 t -81.47 107.83 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 112.829 -1.987 . . . . 0.0 108.036 173.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 84.9 mt -96.68 162.2 13.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.162 -164.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.588 ' O ' ' CB ' ' A' ' 62' ' ' ASP . 34.9 tpt85 74.46 -132.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 111.129 -2.759 . . . . 0.0 109.829 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 40.2 t0 100.01 88.14 0.01 OUTLIER 'General case' 0 C--N 1.347 0.487 0 O-C-N 125.405 1.69 . . . . 0.0 109.433 -175.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.66 -41.22 0.56 Allowed Glycine 0 CA--C 1.533 1.162 0 C-N-CA 117.905 -2.093 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.415 ' CB ' ' NH2' ' A' ' 61' ' ' ARG . . . -125.84 -48.16 1.65 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.2 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' LYS . . . -104.96 28.21 15.66 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.112 175.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.518 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 5.8 mtpm? 35.93 -140.29 0.02 OUTLIER 'General case' 0 C--N 1.351 0.655 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.41 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.517 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 26.7 m-85 -95.0 130.52 41.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.975 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 11.9 p90 -149.13 138.14 21.36 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 116.048 -2.261 . . . . 0.0 110.726 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 9.9 mt -81.33 -45.64 15.88 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 112.425 -2.17 . . . . 0.0 109.563 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -129.13 -86.19 0.55 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.188 -1.823 . . . . 0.0 109.934 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -106.87 -84.48 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.188 -1.824 . . . . 0.0 109.555 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.7 m -50.32 130.27 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.915 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 65' ' ' GLY . 11.4 mptt -81.67 -169.48 2.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 112.819 -1.991 . . . . 0.0 109.93 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -148.13 134.49 19.56 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.421 -2.172 . . . . 0.0 108.7 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' O ' ' OG ' ' A' ' 76' ' ' SER . 17.9 m-20 -58.16 -22.26 50.59 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.153 -1.839 . . . . 0.0 112.336 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 50.3 m -168.04 161.33 12.61 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.953 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.522 ' CD2' HG11 ' A' ' 59' ' ' VAL . 86.3 mt -45.6 -40.88 9.41 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 117.34 -1.744 . . . . 0.0 110.318 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -54.07 -38.25 65.07 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.068 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.4 OUTLIER -69.91 -28.17 65.39 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.51 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.48 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.0 tt -67.59 -49.86 61.1 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.819 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.3 -37.03 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 112.538 -2.119 . . . . 0.0 110.86 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.31 -35.97 71.46 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.145 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -55.29 -46.05 76.22 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 117.845 -1.542 . . . . 0.0 109.746 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.486 ' C ' ' H ' ' A' ' 86' ' ' SER . 52.1 t60 -63.79 -9.38 14.31 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.646 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 4.1 tpm_? -78.98 46.82 0.72 Allowed 'General case' 0 C--N 1.349 0.567 0 C-N-CA 117.799 -1.56 . . . . 0.0 109.402 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 84' ' ' HIS . 40.4 t -147.15 -41.44 0.18 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.787 -2.006 . . . . 0.0 110.248 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 t -149.16 -146.61 0.2 Allowed 'General case' 0 C--N 1.347 0.488 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.604 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.7 p -92.42 167.55 11.89 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 113.897 -1.501 . . . . 0.0 109.636 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.49 HG23 ' CB ' ' A' ' 90' ' ' SER . 11.8 m -73.32 -33.12 39.97 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 C-N-CA 117.103 -1.839 . . . . 0.0 111.587 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.49 ' CB ' HG23 ' A' ' 89' ' ' VAL . 13.4 t -149.12 178.87 8.34 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.924 -165.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 90' ' ' SER . 16.5 mmm180 -37.66 -40.82 0.44 Allowed 'General case' 0 C--N 1.346 0.451 0 CA-C-N 112.767 -2.015 . . . . 0.0 110.935 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.453 ' HB2' HD11 ' A' ' 95' ' ' ILE . 16.3 m-80 -67.88 92.83 0.37 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 117.354 -1.738 . . . . 0.0 109.47 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 94' ' ' GLN . 80.7 mt-30 -71.06 75.15 0.66 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.968 -1.923 . . . . 0.0 109.757 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 53.7 tp60 -179.71 47.13 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 112.872 -1.967 . . . . 0.0 109.176 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' A' ' 92' ' ' ASN . 68.9 mt -133.0 128.02 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.979 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.461 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 45.2 t80 -127.17 139.83 52.67 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.922 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.7 mt -91.58 105.1 17.49 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.797 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.452 ' CZ ' ' H ' ' A' ' 99' ' ' ASP . 4.1 tpm_? -108.63 158.32 17.7 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.178 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.452 ' H ' ' CZ ' ' A' ' 98' ' ' ARG . 57.8 p30 -60.3 145.38 47.8 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 117.535 -1.666 . . . . 0.0 109.447 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.54 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 7.1 tt -99.45 29.27 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 113.076 -1.874 . . . . 0.0 111.937 -175.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -150.1 115.88 5.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 117.616 -1.633 . . . . 0.0 110.065 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -144.72 117.83 8.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.163 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.513 HG23 ' HD3' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -155.24 -63.01 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.787 -178.511 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.513 ' HD3' HG23 ' A' ' 103' ' ' VAL . 58.6 Cg_exo -43.68 117.18 1.07 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 121.901 1.734 . . . . 0.0 113.686 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 104' ' ' PRO . 88.5 mt-30 -158.91 77.26 0.74 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 112.818 -1.992 . . . . 0.0 109.304 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.725 ' H ' ' CD ' ' A' ' 107' ' ' PRO . 21.0 mt-30 -126.4 -44.48 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 113.066 -1.879 . . . . 0.0 112.339 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.725 ' CD ' ' H ' ' A' ' 106' ' ' GLN . 51.5 Cg_exo -50.56 119.69 5.46 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 120.975 1.117 . . . . 0.0 113.495 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 107' ' ' PRO . 91.3 m 53.95 106.92 0.01 OUTLIER 'General case' 0 C--N 1.346 0.435 0 CA-C-N 112.74 -2.027 . . . . 0.0 109.934 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 108' ' ' THR . 70.3 t80 -179.07 114.76 0.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.99 -1.913 . . . . 0.0 109.57 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 110' ' ' VAL . 8.0 p -74.39 123.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 113.146 -1.843 . . . . 0.0 109.971 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -167.12 121.23 1.01 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 113.014 -1.903 . . . . 0.0 109.714 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.423 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.649 179.791 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.997 0 CA-C-O 121.937 0.743 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 3' ' ' GLU . 48.6 mm -52.0 -41.43 31.6 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 112.926 -1.637 . . . . 0.0 110.357 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 2' ' ' ILE . 40.9 tp10 61.07 121.95 0.01 OUTLIER 'General case' 0 C--N 1.347 0.483 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.604 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.586 ' SD ' ' C ' ' A' ' 4' ' ' MET . 0.2 OUTLIER -80.98 102.15 9.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.066 -1.879 . . . . 0.0 109.604 -178.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 4' ' ' MET . 6.2 pttp 53.27 152.74 0.05 OUTLIER Pre-proline 0 C--N 1.346 0.436 0 CA-C-N 112.428 -2.169 . . . . 0.0 110.959 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.471 ' HB3' ' CD ' ' A' ' 104' ' ' PRO . 39.1 Cg_endo -72.93 122.43 8.13 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.935 2.423 . . . . 0.0 111.605 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -46.21 133.68 7.34 Favored Pre-proline 0 C--N 1.346 0.443 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.092 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.429 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 58.4 Cg_endo -74.83 -117.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.99 1.793 . . . . 0.0 110.857 -174.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.502 ' CB ' ' CE2' ' A' ' 32' ' ' PHE . 37.7 p-90 -139.08 38.55 2.13 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.709 -174.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -121.91 115.09 21.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 117.812 -1.555 . . . . 0.0 110.162 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.434 ' CZ ' ' CG2' ' A' ' 100' ' ' ILE . 18.7 m-85 -124.05 108.19 12.1 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 113.081 -1.872 . . . . 0.0 109.057 176.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -61.33 112.03 4.38 Favored Glycine 0 C--N 1.345 1.075 0 C-N-CA 118.127 -1.987 . . . . 0.0 111.127 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 36' ' ' GLU . 23.3 pttp 25.57 47.29 0.01 OUTLIER 'General case' 0 C--N 1.346 0.414 0 CA-C-N 111.481 -2.359 . . . . 0.0 111.472 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.7 tp -60.21 131.64 89.97 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.928 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 16' ' ' ARG . 51.9 Cg_exo -45.52 122.54 4.87 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.742 1.628 . . . . 0.0 112.983 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.573 ' CB ' HH12 ' A' ' 35' ' ' ARG . 53.2 ttp180 -38.86 -41.24 0.72 Allowed 'General case' 0 C--N 1.345 0.388 0 CA-C-N 112.885 -1.961 . . . . 0.0 110.626 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -54.21 -79.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 113.345 -1.752 . . . . 0.0 109.442 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HG3' ' HE2' ' A' ' 22' ' ' MET . 28.1 tptp -37.91 -39.88 0.41 Allowed 'General case' 0 C--N 1.346 0.442 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.969 -177.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.94 -65.76 0.54 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 117.595 -1.642 . . . . 0.0 109.209 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 24' ' ' SER . 46.7 mt-10 -42.77 -41.01 3.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.696 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 22' ' ' MET . 65.5 mt-10 -62.58 -90.56 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 113.567 -1.652 . . . . 0.0 110.758 -173.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.564 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 5.6 ptp -42.6 -38.32 1.96 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.995 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.543 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 45.6 tp -68.03 -41.92 81.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 117.654 -1.619 . . . . 0.0 110.801 -176.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 26' ' ' GLN . 77.3 p -62.72 -36.91 84.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 117.402 -1.719 . . . . 0.0 110.706 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -69.38 30.73 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.534 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.553 ' H ' ' C ' ' A' ' 24' ' ' SER . 35.2 mm-40 -104.14 142.46 34.45 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 117.786 -1.565 . . . . 0.0 109.247 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 28' ' ' HIS . 2.0 mpt_? -79.05 44.28 0.56 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.883 -177.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.484 ' H ' ' HG2' ' A' ' 49' ' ' LYS . 0.9 OUTLIER 47.05 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.708 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -162.39 33.32 0.11 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 113.092 -1.867 . . . . 0.0 111.493 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.567 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 70.0 -1.98 15.17 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 116.576 -2.726 . . . . 0.0 113.241 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.401 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -46.23 134.56 8.56 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 118.297 -1.361 . . . . 0.0 108.899 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.502 ' CE2' ' CB ' ' A' ' 9' ' ' TRP . 15.3 p90 -150.77 163.23 39.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 115.897 -2.321 . . . . 0.0 111.087 -173.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.487 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.6 pp -149.92 146.66 27.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.172 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.44 109.87 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.844 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.573 HH12 ' CB ' ' A' ' 16' ' ' ARG . 27.7 ptt180 -92.1 126.31 37.13 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 112.022 -2.354 . . . . 0.0 110.167 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 67.4 tt0 -67.98 129.61 40.44 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.445 -2.161 . . . . 0.0 109.781 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 43' ' ' ASP . 73.5 m -67.12 129.88 41.32 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.099 -1.864 . . . . 0.0 109.501 178.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.649 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 2.3 mp0 -38.41 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 112.423 -2.171 . . . . 0.0 110.644 -176.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 40' ' ' ALA . 37.1 t -89.94 -29.54 18.43 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.086 -172.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' SER . . . -44.06 148.95 0.73 Allowed Pre-proline 0 C--N 1.348 0.538 0 C-N-CA 117.921 -1.512 . . . . 0.0 110.09 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -74.65 -8.62 20.63 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.934 2.423 . . . . 0.0 116.081 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.22 33.34 0.02 OUTLIER Glycine 0 CA--C 1.537 1.415 0 C-N-CA 118.611 -1.757 . . . . 0.0 111.68 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.474 ' O ' ' OG ' ' A' ' 37' ' ' SER . 1.3 m-20 -89.91 132.5 35.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 118.284 -1.366 . . . . 0.0 109.568 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.411 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 91.8 m-85 -143.62 132.34 22.54 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.59 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 99.7 p -119.15 138.17 53.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.492 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.4 tt -101.04 116.3 32.52 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 113.083 -1.871 . . . . 0.0 110.008 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.543 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . 40.6 m -98.38 139.21 34.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.148 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -138.55 148.47 24.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.128 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.573 ' HZ3' ' C ' ' A' ' 52' ' ' ASN . 24.2 tptp -79.0 106.11 10.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.98 -1.918 . . . . 0.0 108.775 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' O ' ' CE1' ' A' ' 28' ' ' HIS . 7.4 t80 -76.28 -102.73 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 116.784 -1.966 . . . . 0.0 109.071 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -99.1 -69.39 0.92 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.751 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.573 ' C ' ' HZ3' ' A' ' 49' ' ' LYS . 25.6 t-20 -121.46 -23.26 5.69 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 111.917 -2.141 . . . . 0.0 112.174 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.27 158.54 18.28 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 118.404 -1.319 . . . . 0.0 110.32 -174.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 24' ' ' SER . 95.2 t -80.69 118.85 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.4 -2.182 . . . . 0.0 109.678 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -102.78 158.2 16.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.718 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.3 143.18 47.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.57 -2.104 . . . . 0.0 110.598 -175.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -129.57 100.64 5.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.494 -2.139 . . . . 0.0 108.795 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 51.2 mtmt -67.56 113.06 5.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 112.984 -1.916 . . . . 0.0 110.345 -174.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.523 HG11 ' CD2' ' A' ' 77' ' ' LEU . 58.8 t -74.04 83.59 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 112.522 -2.126 . . . . 0.0 108.633 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 79.0 mt -72.88 161.02 31.22 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 112.799 -2.001 . . . . 0.0 110.703 -173.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.702 ' HG3' HH11 ' A' ' 61' ' ' ARG . 0.0 OUTLIER -143.65 164.92 29.07 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.006 -2.361 . . . . 0.0 109.227 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.567 ' H ' ' HG2' ' A' ' 61' ' ' ARG . 52.3 m-20 102.28 -151.69 0.0 OUTLIER 'General case' 0 C--N 1.348 0.517 0 CA-C-N 112.218 -2.265 . . . . 0.0 108.949 -173.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 -54.64 4.57 Favored Glycine 0 C--N 1.346 1.116 0 C-N-CA 118.157 -1.973 . . . . 0.0 110.436 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.494 ' CB ' ' NZ ' ' A' ' 73' ' ' LYS . . . -141.98 -45.73 0.35 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 112.839 -1.681 . . . . 0.0 109.296 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' O ' ' HE2' ' A' ' 66' ' ' LYS . . . 151.67 27.5 0.05 OUTLIER Glycine 0 CA--C 1.538 1.523 0 C-N-CA 117.655 -2.212 . . . . 0.0 112.679 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HA ' ' HZ3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -137.21 -161.36 1.16 Allowed 'General case' 0 C--N 1.348 0.538 0 C-N-CA 117.952 -1.499 . . . . 0.0 109.545 178.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 87.5 m-85 -117.55 150.32 39.16 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 112.939 -1.937 . . . . 0.0 109.301 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -166.01 144.37 5.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.573 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.634 HD22 ' H ' ' A' ' 69' ' ' LEU . 2.5 mm? -65.05 -52.79 53.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 116.714 -1.994 . . . . 0.0 109.043 176.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 10.7 m0 -139.75 -45.0 0.44 Allowed 'General case' 0 C--N 1.345 0.413 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.013 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 77.8 t -129.23 -81.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 112.965 -1.925 . . . . 0.0 110.175 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -50.17 133.75 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 112.614 -2.085 . . . . 0.0 110.275 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.494 ' NZ ' ' CB ' ' A' ' 64' ' ' ALA . 94.0 mttt -93.36 160.9 14.61 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.464 -176.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -133.88 137.8 45.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 111.936 -2.393 . . . . 0.0 109.444 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -62.61 -34.57 77.3 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 112.712 -2.04 . . . . 0.0 110.989 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 77' ' ' LEU . 42.1 t -153.29 152.79 31.55 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 118.278 -1.369 . . . . 0.0 109.888 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.523 ' CD2' HG11 ' A' ' 59' ' ' VAL . 76.0 mt -39.28 -40.42 0.76 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.823 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -48.67 -42.47 34.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.316 -175.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -73.42 -34.1 65.29 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 115.729 -2.388 . . . . 0.0 110.893 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 80' ' ' LEU . 6.9 tt -56.78 -46.38 81.53 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.234 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' LEU . 96.0 t -63.16 -40.56 89.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 112.801 -1.999 . . . . 0.0 110.904 -177.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -71.33 -40.02 71.01 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.895 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -56.53 -41.07 76.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.449 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -93.15 40.07 1.06 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.677 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -107.45 -13.18 15.15 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.663 -1.608 . . . . 0.0 112.693 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.4 t -132.25 -42.15 0.98 Allowed 'General case' 0 C--N 1.351 0.635 0 C-N-CA 117.982 -1.487 . . . . 0.0 110.296 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 88' ' ' SER . 62.0 p -89.76 37.43 0.88 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.618 -1.628 . . . . 0.0 111.082 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' THR . 34.1 t 41.97 -165.71 0.01 OUTLIER 'General case' 0 C--N 1.346 0.414 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.136 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 89' ' ' VAL . 12.8 p -147.71 47.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.582 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 45.5 t 179.1 142.84 0.12 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-N 112.805 -1.998 . . . . 0.0 109.512 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 90' ' ' SER . 8.7 ptm180 -41.51 -42.48 2.39 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.371 -1.74 . . . . 0.0 110.372 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.24 94.33 1.98 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.629 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 94' ' ' GLN . 48.9 mt-30 -69.86 100.06 1.49 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.949 -1.932 . . . . 0.0 109.893 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 31.1 tt0 -178.89 45.41 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 112.34 -2.209 . . . . 0.0 109.429 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 88' ' ' SER . 44.7 mt -138.9 153.87 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 113.115 -1.857 . . . . 0.0 109.579 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.567 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 88.2 m-85 -149.99 179.86 7.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.684 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.3 mt -125.03 108.46 11.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 112.854 -1.975 . . . . 0.0 109.182 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 17.4 mmm180 -125.0 154.37 41.35 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 112.872 -1.967 . . . . 0.0 109.88 -177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 101' ' ' GLU . 58.6 t0 -52.72 118.76 3.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.62 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.487 ' CD1' HD23 ' A' ' 33' ' ' LEU . 11.6 tt -71.99 29.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.774 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 99' ' ' ASP . 12.3 mm-40 -150.17 129.19 12.63 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.681 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -43.15 129.64 4.63 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 112.831 -1.986 . . . . 0.0 110.017 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.3 p -68.44 135.37 90.83 Favored Pre-proline 0 C--N 1.346 0.421 0 CA-C-N 112.812 -1.994 . . . . 0.0 109.329 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.471 ' CD ' ' HB3' ' A' ' 6' ' ' PRO . 37.1 Cg_endo -70.5 125.08 11.38 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.367 2.045 . . . . 0.0 111.653 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 104' ' ' PRO . 18.2 mt-30 88.54 121.51 0.03 OUTLIER 'General case' 0 C--N 1.346 0.428 0 CA-C-N 112.357 -2.201 . . . . 0.0 109.959 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.408 HE21 ' C ' ' A' ' 105' ' ' GLN . 20.1 mm-40 -101.99 155.33 36.57 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 112.899 -1.955 . . . . 0.0 109.499 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' O ' ' HB ' ' A' ' 108' ' ' THR . 50.3 Cg_exo -46.94 121.16 4.75 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.373 2.049 . . . . 0.0 113.43 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 107' ' ' PRO . 78.4 m 63.51 123.24 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.895 -1.957 . . . . 0.0 109.989 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -127.3 119.9 27.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 112.856 -1.975 . . . . 0.0 109.574 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.539 ' O ' ' CG ' ' A' ' 111' ' ' GLN . 7.8 p -147.88 123.47 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.728 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 110' ' ' VAL . 11.7 pt20 52.65 144.84 0.0 OUTLIER 'General case' 0 C--N 1.348 0.508 0 CA-C-N 112.41 -2.177 . . . . 0.0 111.633 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.553 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.739 4.378 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 2' ' ' ILE . . . . . . . . 0 CA--C 1.531 1.04 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.518 ' C ' HD12 ' A' ' 2' ' ' ILE . 2.5 pp -79.0 -159.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-N 114.177 -1.012 . . . . 0.0 109.872 -0.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.571 ' HG3' HE22 ' A' ' 105' ' ' GLN . 24.4 pt-20 -119.54 121.53 39.58 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.722 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.0 mtm -73.29 149.83 42.4 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 112.882 -1.963 . . . . 0.0 109.455 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.85 154.34 0.44 Allowed Pre-proline 0 C--N 1.346 0.43 0 CA-C-N 113.193 -1.821 . . . . 0.0 109.499 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.25 119.99 6.97 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.213 1.942 . . . . 0.0 111.354 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' PRO . 57.8 t60 -84.16 135.55 41.79 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 113.155 -1.839 . . . . 0.0 109.194 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 7' ' ' HIS . 64.5 Cg_exo -44.39 -121.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.436 2.091 . . . . 0.0 114.283 177.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.439 ' CH2' ' CZ ' ' A' ' 10' ' ' PHE . 5.2 p-90 -159.2 17.59 0.18 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.511 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.439 ' CZ ' ' CH2' ' A' ' 9' ' ' TRP . 96.8 m-85 -85.82 109.21 18.52 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.676 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 56.0 m-85 -97.53 95.8 7.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 112.866 -1.97 . . . . 0.0 108.853 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -49.65 105.62 0.17 Allowed Glycine 0 C--N 1.345 1.077 0 CA-C-N 112.797 -2.002 . . . . 0.0 111.254 -173.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 12' ' ' GLY . 63.4 pttt 30.51 42.07 0.01 OUTLIER 'General case' 0 C--N 1.345 0.401 0 CA-C-N 111.459 -2.37 . . . . 0.0 111.193 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.437 HG12 ' CE ' ' A' ' 22' ' ' MET . 9.3 tp -56.51 134.85 77.12 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 113.373 -1.74 . . . . 0.0 108.727 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' ARG . 52.8 Cg_exo -44.74 121.23 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.807 1.671 . . . . 0.0 112.911 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' PRO . 74.6 ttt180 -37.28 -37.12 0.17 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.268 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 20' ' ' GLU . . . -69.79 -63.24 1.11 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.766 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.461 ' HG3' ' CE ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -42.78 -42.19 3.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.458 -177.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -48.07 -58.63 4.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.1 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 91.2 mt-10 -49.1 -45.06 42.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 112.392 -2.185 . . . . 0.0 110.068 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 35.5 mt-10 -59.08 -81.17 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.799 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.461 ' CE ' ' HG3' ' A' ' 18' ' ' LYS . 9.8 ptp -50.82 -41.17 57.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 116.491 -2.084 . . . . 0.0 110.422 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.459 ' O ' ' CG ' ' A' ' 26' ' ' GLN . 39.3 tp -62.27 -26.96 68.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 117.725 -1.59 . . . . 0.0 112.531 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.545 ' C ' ' H ' ' A' ' 26' ' ' GLN . 93.3 p -71.84 -29.06 64.0 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 117.803 -1.559 . . . . 0.0 111.733 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -72.28 37.19 0.07 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.819 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 24' ' ' SER . 29.1 mm-40 -119.27 19.52 12.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 117.86 -1.536 . . . . 0.0 113.095 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 28' ' ' HIS . 58.2 mmm-85 20.37 58.25 0.02 OUTLIER 'General case' 0 C--N 1.349 0.555 0 O-C-N 125.215 1.572 . . . . 0.0 111.952 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 27' ' ' ARG . 72.5 t60 43.53 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.015 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 55.0 m-20 -157.71 29.06 0.27 Allowed 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.858 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 78.16 -9.34 33.5 Favored Glycine 0 CA--C 1.542 1.777 0 C-N-CA 115.969 -3.015 . . . . 0.0 113.147 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.409 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -44.98 120.74 2.48 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.055 177.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.492 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 14.0 p90 -126.14 151.2 47.6 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 116.638 -2.025 . . . . 0.0 111.716 -173.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.583 ' HB3' ' H ' ' A' ' 47' ' ' SER . 0.6 OUTLIER -114.53 146.75 40.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 110.892 -2.867 . . . . 0.0 109.013 -169.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 33' ' ' LEU . 18.4 mt -147.16 121.83 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 114.935 -2.706 . . . . 0.0 109.42 154.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 27.9 ptt180 -108.81 128.31 54.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 112.411 -2.177 . . . . 0.0 110.369 -174.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 31.2 tp10 -68.92 136.36 52.46 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 112.459 -2.155 . . . . 0.0 109.853 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.61 ' HB3' ' H ' ' A' ' 43' ' ' ASP . 88.9 p -42.07 118.55 1.16 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.299 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.32 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.141 -1.845 . . . . 0.0 109.271 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.6 p -112.01 44.36 1.42 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-N 113.318 -1.764 . . . . 0.0 109.809 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -135.11 156.88 77.92 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.507 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ALA . 74.0 Cg_exo -43.56 -119.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.873 2.382 . . . . 0.0 114.099 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.29 68.31 0.51 Allowed Glycine 0 C--N 1.346 1.119 0 C-N-CA 118.154 -1.974 . . . . 0.0 110.187 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.61 ' H ' ' HB3' ' A' ' 37' ' ' SER . 61.9 t0 -90.05 117.87 29.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 112.82 -1.69 . . . . 0.0 109.799 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 43' ' ' ASP . 21.4 m-85 -130.18 115.85 17.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.491 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.2 p -124.51 137.71 54.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.476 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.483 ' CD2' HG23 ' A' ' 48' ' ' VAL . 6.0 tt -110.24 119.07 38.06 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.7 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.583 ' H ' ' HB3' ' A' ' 33' ' ' LEU . 49.4 m -112.85 122.45 47.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.216 -1.811 . . . . 0.0 109.795 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.483 HG23 ' CD2' ' A' ' 46' ' ' LEU . 86.8 t -113.65 146.73 17.87 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.379 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 26' ' ' GLN . 41.7 tptt -69.35 89.54 0.49 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 116.693 -2.003 . . . . 0.0 108.915 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 53' ' ' ASP . 63.3 t80 -91.31 134.33 34.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 117.27 -1.772 . . . . 0.0 108.549 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 52' ' ' ASN . . . -43.37 129.14 5.87 Favored Glycine 0 C--N 1.342 0.886 0 C-N-CA 117.286 -2.388 . . . . 0.0 111.299 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.533 HD22 ' CG ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 83.33 -31.19 0.08 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 111.471 -2.364 . . . . 0.0 111.222 176.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.533 ' CG ' HD22 ' A' ' 52' ' ' ASN . 33.6 m-20 -155.24 150.63 27.17 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 114.441 -2.903 . . . . 0.0 112.37 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.2 t -70.46 119.22 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 111.742 -2.481 . . . . 0.0 108.927 171.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 47' ' ' SER . 10.3 tt0 -101.75 159.61 15.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 112.722 -2.036 . . . . 0.0 109.884 -177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -128.51 134.7 48.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 112.493 -2.14 . . . . 0.0 110.63 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 93.7 m-85 -129.37 102.84 6.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 112.258 -2.247 . . . . 0.0 108.803 174.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 54.5 mtmt -70.49 114.12 8.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 116.97 -1.892 . . . . 0.0 109.718 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' CD2' ' A' ' 77' ' ' LEU . 94.3 t -74.88 86.77 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.537 174.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 81.6 mt -78.24 159.13 28.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 112.741 -2.027 . . . . 0.0 110.955 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.602 ' HE ' ' C ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -122.31 164.78 17.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 111.948 -2.387 . . . . 0.0 108.583 175.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.602 ' C ' ' HE ' ' A' ' 61' ' ' ARG . 69.0 m-20 -128.68 -96.85 0.39 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 117.112 -1.835 . . . . 0.0 110.354 -176.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.545 ' HA2' HH21 ' A' ' 61' ' ' ARG . . . 156.12 72.96 0.01 OUTLIER Glycine 0 C--N 1.345 1.055 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -140.95 51.78 1.61 Allowed 'General case' 0 C--N 1.351 0.664 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 7.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 73' ' ' LYS . . . -64.09 10.4 0.26 Allowed Glycine 0 CA--C 1.55 2.251 0 CA-C-N 112.507 -2.133 . . . . 0.0 112.969 171.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.729 ' HZ2' ' CG ' ' A' ' 73' ' ' LYS . 8.5 mtmp? 76.56 -146.34 0.03 OUTLIER 'General case' 0 C--N 1.351 0.631 0 CA-C-O 121.52 0.676 . . . . 0.0 110.632 171.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 20.5 m-85 -105.95 144.08 33.19 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 113.571 -1.649 . . . . 0.0 110.085 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.409 ' C ' HD12 ' A' ' 69' ' ' LEU . 11.3 p90 -151.82 -165.89 2.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 117.262 -1.775 . . . . 0.0 109.381 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.516 HD11 HD11 ' A' ' 80' ' ' LEU . 5.6 mp -125.87 -46.34 1.7 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.36 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 21.5 m0 -132.54 -42.92 0.93 Allowed 'General case' 0 C--N 1.346 0.437 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.125 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.6 t -141.7 -84.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.011 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.403 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 32.9 m -51.74 136.23 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.211 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.729 ' CG ' ' HZ2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -104.4 176.09 5.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.899 -177.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' C ' ' HZ3' ' A' ' 66' ' ' LYS . 21.5 m-85 -146.59 138.31 24.6 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 113.131 -1.849 . . . . 0.0 108.915 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.468 ' O ' ' OG ' ' A' ' 76' ' ' SER . 41.8 p30 -66.5 -8.98 30.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 113.253 -1.794 . . . . 0.0 113.266 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 75' ' ' ASN . 49.2 m -167.96 150.16 5.52 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 117.791 -1.564 . . . . 0.0 109.422 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.511 ' CD2' HG11 ' A' ' 59' ' ' VAL . 97.7 mt -46.01 -42.51 13.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.114 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -55.87 -42.86 76.53 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.349 -1.751 . . . . 0.0 110.442 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 76' ' ' SER . 32.3 tp10 -63.68 -35.44 80.57 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 113.335 -1.757 . . . . 0.0 110.665 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 80' ' ' LEU . 6.1 tt -58.43 -50.84 72.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.073 -1.422 . . . . 0.0 108.375 173.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 81.3 t -63.85 -14.25 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 112.393 -2.185 . . . . 0.0 112.834 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -84.61 -26.44 27.89 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.715 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.433 ' O ' ' C ' ' A' ' 84' ' ' HIS . 68.8 t80 -73.12 -40.85 64.6 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.104 -174.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.546 ' C ' ' H ' ' A' ' 86' ' ' SER . 7.1 p-80 -45.52 -36.84 4.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 116.299 -2.16 . . . . 0.0 110.842 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 85' ' ' ARG . 67.4 ttt-85 -73.4 37.35 0.09 Allowed 'General case' 0 C--N 1.348 0.516 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.877 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 84' ' ' HIS . 42.4 t -136.74 -41.63 0.61 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.141 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 88' ' ' SER . 9.0 t -165.52 55.63 0.11 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.092 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.567 ' HB2' ' H ' ' A' ' 95' ' ' ILE . 69.7 p 50.56 -179.0 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.261 -1.791 . . . . 0.0 110.101 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 89' ' ' VAL . 13.8 p -128.69 37.03 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.711 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.588 ' OG ' ' CD1' ' A' ' 95' ' ' ILE . 86.7 p 179.99 121.82 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.505 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.473 ' CB ' ' NH1' ' A' ' 91' ' ' ARG . 15.0 mtp-105 -67.97 2.42 2.07 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 113.356 -1.747 . . . . 0.0 113.209 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.571 HD22 ' HB2' ' A' ' 90' ' ' SER . 17.5 m-80 -68.16 -57.2 6.43 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 118.348 -1.341 . . . . 0.0 110.548 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 94' ' ' GLN . 8.3 pt20 -163.33 37.67 0.09 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 116.962 -1.895 . . . . 0.0 111.164 -176.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.54 ' HA ' ' CB ' ' A' ' 88' ' ' SER . 77.3 mt-30 62.54 137.73 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 117.841 -1.543 . . . . 0.0 110.255 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.588 ' CD1' ' OG ' ' A' ' 90' ' ' SER . 35.9 mt -150.04 140.6 16.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.904 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.45 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 88.5 m-85 -118.81 133.04 56.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.618 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.406 ' O ' ' HD3' ' A' ' 98' ' ' ARG . 28.6 mt -90.0 102.02 14.73 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.451 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 97' ' ' LEU . 27.7 mmt180 -150.29 -159.83 1.09 Allowed 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.144 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.44 ' O ' HG22 ' A' ' 100' ' ' ILE . 55.4 t0 48.73 -120.67 1.37 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.136 170.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 5.0 tt 40.16 22.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 113.843 -1.526 . . . . 0.0 113.371 -174.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 102' ' ' GLN . 6.1 tm-20 -145.94 93.49 2.34 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.0 -177.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 101' ' ' GLU . 61.7 mt-30 30.17 -151.67 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.911 -1.949 . . . . 0.0 111.465 177.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.548 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -102.16 -66.04 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 112.53 -2.123 . . . . 0.0 109.922 175.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.548 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 62.0 Cg_exo -40.24 132.15 2.24 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.679 1.586 . . . . 0.0 111.445 174.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.571 HE22 ' HG3' ' A' ' 3' ' ' GLU . 8.3 mm100 -93.03 36.56 1.03 Allowed 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.609 0.764 . . . . 0.0 111.065 12.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.633 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 21.9 mt-30 -69.91 -84.91 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 116.034 -2.266 . . . . 0.0 111.045 -172.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.633 ' CD ' ' CB ' ' A' ' 106' ' ' GLN . 44.0 Cg_endo -72.34 122.58 8.46 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.255 1.303 . . . . 0.0 112.281 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 109' ' ' TYR . 99.1 m -46.17 -83.81 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.711 -2.04 . . . . 0.0 109.298 172.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 108' ' ' THR . 9.4 t80 61.27 125.29 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.181 177.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.1 p -157.67 117.78 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.681 -2.054 . . . . 0.0 109.413 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -79.67 121.99 26.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.041 -1.89 . . . . 0.0 109.815 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.504 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.737 179.96 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.984 0 CA-C-O 121.88 0.711 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 2' ' ' ILE . 8.1 tp -110.79 120.67 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 113.01 -1.595 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.54 ' CB ' ' HB2' ' A' ' 104' ' ' PRO . 43.2 tt0 -98.63 124.84 43.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 112.928 -1.942 . . . . 0.0 109.632 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.582 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 44.2 ttp -103.95 124.91 49.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.933 -1.939 . . . . 0.0 109.878 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 4' ' ' MET . 38.3 ttpt 110.11 133.84 0.0 OUTLIER Pre-proline 0 C--N 1.35 0.599 0 CA-C-N 112.26 -2.245 . . . . 0.0 109.304 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' HA ' ' CD ' ' A' ' 102' ' ' GLN . 61.5 Cg_endo -74.05 -119.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.148 1.899 . . . . 0.0 109.85 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.468 ' C ' ' H ' ' A' ' 9' ' ' TRP . 1.9 p80 -140.83 84.55 13.31 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 118.714 -1.195 . . . . 0.0 109.71 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' C ' ' CG ' ' A' ' 9' ' ' TRP . 38.2 Cg_exo -51.4 1.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.159 2.573 . . . . 0.0 115.565 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.468 ' H ' ' C ' ' A' ' 7' ' ' HIS . 41.4 p-90 43.7 30.64 0.38 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 116.965 -1.894 . . . . 0.0 111.583 177.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -105.37 118.97 37.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.478 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 29.1 m-85 -121.58 83.93 2.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.113 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 13' ' ' LYS . . . -49.81 111.37 1.07 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-N 112.641 -2.072 . . . . 0.0 110.778 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' H ' ' HB2' ' A' ' 36' ' ' GLU . 26.2 pttm 26.44 46.16 0.01 OUTLIER 'General case' 0 C--N 1.344 0.357 0 CA-C-N 111.529 -2.335 . . . . 0.0 111.387 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' GLY . 9.4 tp -61.61 135.61 94.2 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 112.96 -1.927 . . . . 0.0 108.912 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' ARG . 54.3 Cg_exo -44.08 121.74 3.16 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.855 1.703 . . . . 0.0 113.029 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.689 ' HB3' HH22 ' A' ' 35' ' ' ARG . 0.0 OUTLIER -40.74 -41.81 1.62 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.702 -177.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.557 ' H ' ' HD3' ' A' ' 16' ' ' ARG . . . -59.16 -63.09 1.43 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 113.244 -1.798 . . . . 0.0 109.483 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -43.39 -52.0 6.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 112.766 -2.016 . . . . 0.0 110.421 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.75 -49.47 14.82 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.759 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.29 -44.65 96.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.775 -2.011 . . . . 0.0 110.114 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' SER . 44.2 mt-10 -67.09 -70.4 0.25 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.872 -173.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.57 ' C ' ' SD ' ' A' ' 22' ' ' MET . 3.5 ppp? -46.48 -42.48 15.57 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 117.088 -1.845 . . . . 0.0 110.474 -173.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.562 ' N ' ' SD ' ' A' ' 22' ' ' MET . 60.8 tp -75.89 -25.11 55.77 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 113.357 -1.747 . . . . 0.0 112.569 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 26' ' ' GLN . 78.4 p -74.18 -33.31 63.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 117.186 -1.806 . . . . 0.0 111.151 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' NH1' ' A' ' 27' ' ' ARG . 50.1 mtpt -75.54 38.78 0.15 Allowed 'General case' 0 C--N 1.347 0.467 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.605 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.76 HE21 ' CB ' ' A' ' 31' ' ' ALA . 12.9 mm100 -102.25 136.05 42.77 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 117.687 -1.605 . . . . 0.0 110.225 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HA ' ' CB ' ' A' ' 28' ' ' HIS . 9.9 mpt_? -116.54 84.33 2.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 110.688 -2.96 . . . . 0.0 106.374 171.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 27' ' ' ARG . 1.3 t-80 -171.24 12.07 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.702 13.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 7.0 m-20 -163.09 128.69 3.19 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 117.753 -1.579 . . . . 0.0 110.619 -173.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 96' ' ' PHE . . . 103.26 -27.03 21.77 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 117.835 -2.126 . . . . 0.0 112.875 170.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.76 ' CB ' HE21 ' A' ' 26' ' ' GLN . . . -46.95 135.76 9.04 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 117.762 -1.575 . . . . 0.0 109.147 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.512 ' CB ' HD22 ' A' ' 97' ' ' LEU . 17.3 p90 -139.94 164.51 29.82 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 115.077 -2.649 . . . . 0.0 112.427 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.608 ' HB3' ' H ' ' A' ' 47' ' ' SER . 0.4 OUTLIER -129.03 145.96 51.12 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 110.31 -3.132 . . . . 0.0 108.658 -165.364 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.519 ' CG1' ' O ' ' A' ' 33' ' ' LEU . 16.5 mt -145.85 119.94 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 114.886 -2.726 . . . . 0.0 109.504 153.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.689 HH22 ' HB3' ' A' ' 16' ' ' ARG . 10.1 ptm180 -113.11 147.79 36.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 111.852 -2.431 . . . . 0.0 110.223 -172.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.497 ' HB2' ' H ' ' A' ' 13' ' ' LYS . 40.7 mt-10 -86.97 167.38 14.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.69 -2.05 . . . . 0.0 109.719 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 38.9 t -71.83 -134.41 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.255 -1.793 . . . . 0.0 108.679 175.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -101.26 -70.92 0.73 Allowed 'General case' 0 C--N 1.347 0.473 0 C-N-CA 118.097 -1.441 . . . . 0.0 109.114 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.4 t -128.81 45.52 2.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 112.666 -2.061 . . . . 0.0 109.566 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 41' ' ' PRO . . . -156.44 110.21 2.04 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.841 -176.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' A' ' 43' ' ' ASP . 23.6 Cg_exo -57.48 -144.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.132 0 N-CA-C 107.798 -1.655 . . . . 0.0 107.798 171.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.78 -28.33 0.14 Allowed Glycine 0 CA--C 1.541 1.679 0 CA-C-N 114.091 -1.413 . . . . 0.0 113.376 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 41' ' ' PRO . 11.2 m-20 -112.8 116.52 30.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.967 0.889 . . . . 0.0 109.253 -173.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.433 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 91.7 m-85 -149.19 91.14 1.81 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.986 -1.916 . . . . 0.0 109.791 -175.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.473 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 28.4 p -89.99 137.41 32.36 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 115.947 -2.301 . . . . 0.0 109.93 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.499 ' CD2' HG23 ' A' ' 48' ' ' VAL . 6.5 tt -100.01 121.02 40.73 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 111.965 -2.38 . . . . 0.0 109.562 -173.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.608 ' H ' ' HB3' ' A' ' 33' ' ' LEU . 49.2 m -114.38 130.29 56.69 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.25 -176.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.517 ' CA ' HD21 ' A' ' 23' ' ' LEU . 84.3 t -128.13 145.4 35.33 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 CA-C-N 113.287 -1.778 . . . . 0.0 110.317 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 24' ' ' SER . 22.0 tptp -72.39 96.69 1.92 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 113.332 -1.758 . . . . 0.0 108.034 172.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CD2' ' O ' ' A' ' 53' ' ' ASP . 24.4 p90 -89.12 -1.31 58.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 116.546 -2.061 . . . . 0.0 113.801 -170.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.41 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 153.8 -80.48 0.18 Allowed Glycine 0 C--N 1.346 1.124 0 C-N-CA 117.024 -2.512 . . . . 0.0 110.77 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -109.28 -29.3 8.55 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 112.4 -1.9 . . . . 0.0 111.642 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 32.2 t70 -133.36 -174.92 3.64 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 117.434 -1.706 . . . . 0.0 110.159 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.561 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 73.9 t -100.08 122.19 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 112.857 -1.974 . . . . 0.0 110.377 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' SER . 11.5 tt0 -94.48 166.52 12.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.583 -2.099 . . . . 0.0 108.491 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 46' ' ' LEU . 43.6 p-80 -150.08 144.52 25.8 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.495 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.491 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 98.6 m-85 -138.59 89.93 2.41 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.931 177.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.473 ' HA ' ' CB ' ' A' ' 45' ' ' SER . 9.1 ptmm? -45.06 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 112.535 -2.121 . . . . 0.0 109.912 169.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 22.9 t -79.09 71.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-N 113.237 -1.801 . . . . 0.0 108.912 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.434 ' CD1' ' NZ ' ' A' ' 58' ' ' LYS . 16.6 mt -73.06 -151.89 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 112.598 -2.092 . . . . 0.0 109.227 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 8.7 ptm180 -157.23 -136.82 0.05 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 116.982 -1.887 . . . . 0.0 109.885 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 61' ' ' ARG . 36.9 m-20 -24.49 147.46 0.0 OUTLIER 'General case' 0 C--N 1.349 0.566 0 O-C-N 125.284 1.615 . . . . 0.0 111.502 174.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.44 110.62 4.07 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 122.417 1.009 . . . . 0.0 111.875 7.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.412 ' CB ' ' HD3' ' A' ' 73' ' ' LYS . . . -161.02 -46.68 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 112.085 -2.057 . . . . 0.0 108.396 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . 171.29 -44.56 0.19 Allowed Glycine 0 C--N 1.348 1.229 0 CA-C-N 112.832 -1.985 . . . . 0.0 110.353 174.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.511 ' HZ2' ' HA ' ' A' ' 75' ' ' ASN . 5.1 mtpm? -160.94 -147.91 0.15 Allowed 'General case' 0 C--N 1.349 0.559 0 CA-C-N 112.855 -1.673 . . . . 0.0 108.715 -173.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 8.1 m-30 -71.09 140.79 50.79 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 118.196 -1.402 . . . . 0.0 109.91 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -156.58 151.23 25.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 117.094 -1.842 . . . . 0.0 110.745 174.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.491 ' CD2' ' HB3' ' A' ' 57' ' ' PHE . 4.9 mt -87.77 -43.44 11.87 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 112.441 -2.163 . . . . 0.0 109.956 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -147.4 -44.61 0.17 Allowed 'General case' 0 C--N 1.346 0.435 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.929 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.2 t -135.75 -83.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.903 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.6 m -53.92 131.64 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 112.814 -1.994 . . . . 0.0 110.09 -176.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 47.7 mtmt -88.04 176.24 7.39 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.693 -2.049 . . . . 0.0 110.053 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.454 ' CD1' ' O ' ' A' ' 73' ' ' LYS . 18.0 m-85 -147.25 132.76 18.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 112.507 -2.133 . . . . 0.0 108.725 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 76' ' ' SER . 1.7 t-20 -83.67 49.34 1.58 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.949 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 29.2 t 138.94 142.7 0.0 OUTLIER 'General case' 0 C--N 1.349 0.562 0 CA-C-N 112.249 -2.25 . . . . 0.0 109.344 173.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 80' ' ' LEU . 95.7 mt -49.09 -49.42 41.81 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.238 -1.801 . . . . 0.0 108.851 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -47.45 -39.46 15.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 112.624 -2.08 . . . . 0.0 110.621 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 79' ' ' GLU . 4.7 tm-20 -64.1 -35.76 81.8 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 116.772 -1.971 . . . . 0.0 110.5 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.464 HD11 ' CG ' ' A' ' 69' ' ' LEU . 6.8 tt -64.88 -66.67 0.51 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.692 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.6 t -39.69 -38.84 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 112.321 -2.218 . . . . 0.0 110.893 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 12.6 t70 -77.64 -36.25 51.72 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.209 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' LEU . 60.8 t80 -68.76 -28.29 66.66 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 117.942 -1.503 . . . . 0.0 111.948 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -107.45 35.2 3.15 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 117.953 -1.499 . . . . 0.0 111.328 -175.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 82' ' ' ASP . 12.7 ptm180 -97.38 30.55 2.8 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 117.426 -1.71 . . . . 0.0 111.656 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 88' ' ' SER . 80.5 p -149.98 -74.06 0.17 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 117.651 -1.62 . . . . 0.0 110.259 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 92' ' ' ASN . 9.0 t -76.23 39.68 0.2 Allowed 'General case' 0 C--N 1.345 0.41 0 CA-C-N 112.966 -1.924 . . . . 0.0 110.862 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.543 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 32.7 t 50.93 -146.22 0.46 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 117.825 -1.55 . . . . 0.0 109.398 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 89' ' ' VAL . 15.0 p -160.12 45.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.678 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.2 t -170.78 -96.94 0.01 OUTLIER 'General case' 0 C--N 1.346 0.425 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.592 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.562 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 87.9 mtt180 -72.18 4.64 3.4 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 113.859 -1.518 . . . . 0.0 113.421 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 91' ' ' ARG . 11.6 m120 101.91 -37.87 0.01 OUTLIER 'General case' 0 C--N 1.352 0.702 0 O-C-N 124.455 1.097 . . . . 0.0 110.904 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 22.0 pt20 -153.87 114.23 3.95 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 117.052 -1.859 . . . . 0.0 110.371 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.543 ' H ' ' HB2' ' A' ' 88' ' ' SER . 11.3 pt20 158.39 21.55 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 112.314 -2.221 . . . . 0.0 111.908 176.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.428 ' CG2' HG11 ' A' ' 48' ' ' VAL . 37.0 mt -149.96 127.18 2.42 Favored 'Isoleucine or valine' 0 C--N 1.349 0.55 0 C-N-CA 117.831 -1.548 . . . . 0.0 110.054 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.577 ' O ' ' CA ' ' A' ' 30' ' ' GLY . 29.9 t80 -123.74 135.76 54.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.965 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.512 HD22 ' CB ' ' A' ' 32' ' ' PHE . 95.5 mt -89.94 96.11 10.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 117.045 -1.862 . . . . 0.0 110.228 -174.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' A' ' 99' ' ' ASP . 53.4 ttm-85 -153.8 -137.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.808 175.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.584 ' H ' ' HG2' ' A' ' 98' ' ' ARG . 35.9 t0 43.85 -170.84 0.01 OUTLIER 'General case' 0 C--N 1.347 0.495 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.286 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.531 ' H ' ' CG ' ' A' ' 99' ' ' ASP . 0.5 OUTLIER 86.78 -38.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.361 173.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.418 ' HG2' HG23 ' A' ' 100' ' ' ILE . 24.2 mm-40 -150.12 -163.99 1.91 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 112.988 -1.914 . . . . 0.0 109.98 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.44 ' CD ' ' HA ' ' A' ' 6' ' ' PRO . 61.8 tt0 39.55 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 112.802 -1.999 . . . . 0.0 110.588 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.627 ' H ' ' HD2' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -107.7 -53.38 0.07 OUTLIER Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.607 173.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.627 ' HD2' ' H ' ' A' ' 103' ' ' VAL . 31.3 Cg_exo -58.14 115.86 2.83 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.545 2.163 . . . . 0.0 112.683 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 104' ' ' PRO . 53.9 mt-30 -159.63 -89.16 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.969 -1.923 . . . . 0.0 109.185 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.667 ' H ' ' CD ' ' A' ' 107' ' ' PRO . 21.4 mt-30 -116.92 -44.32 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.616 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.667 ' CD ' ' H ' ' A' ' 106' ' ' GLN . 49.3 Cg_exo -52.25 119.63 6.09 Favored 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 120.826 1.017 . . . . 0.0 112.817 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 6.7 m 95.79 72.26 0.0 OUTLIER 'General case' 0 C--N 1.346 0.446 0 CA-C-N 112.394 -2.184 . . . . 0.0 109.475 -178.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -74.32 117.68 16.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 112.887 -1.96 . . . . 0.0 109.688 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 110' ' ' VAL . 34.1 m -76.09 124.08 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.63 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -49.91 119.0 3.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 113.0 -1.909 . . . . 0.0 109.741 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.595 -179.765 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 106' ' ' GLN . . . . . . . . 0 CA--C 1.533 1.163 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 2' ' ' ILE . 4.1 mp -94.84 45.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.693 0 CA-C-O 122.234 1.016 . . . . 0.0 109.739 -0.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.406 ' H ' ' HA2' ' A' ' 1' ' ' GLY . 78.7 mm-40 -69.64 118.53 12.62 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.56 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' LYS . 13.4 tpp -108.76 116.4 31.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.828 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' MET . 87.6 tttt 60.77 134.25 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 112.891 -1.958 . . . . 0.0 109.397 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.26 -119.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.159 1.906 . . . . 0.0 109.838 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.57 136.72 2.14 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 118.526 -1.27 . . . . 0.0 109.342 178.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.08 -113.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.317 2.011 . . . . 0.0 111.415 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.456 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 5.0 m-90 -126.31 -29.88 2.94 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 117.779 -1.569 . . . . 0.0 111.856 -167.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 92.3 m-85 -67.59 116.99 8.93 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.159 -171.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 9' ' ' TRP . 97.4 m-85 -123.94 95.56 4.61 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.682 171.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.56 163.76 30.44 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 114.861 -3.542 . . . . 0.0 112.242 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.658 ' HD3' ' H ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -88.65 109.04 19.78 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 113.26 -1.47 . . . . 0.0 109.296 -6.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 14' ' ' ILE . 10.2 tp -87.71 123.26 69.59 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 113.198 -1.819 . . . . 0.0 109.341 -177.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 16' ' ' ARG . 49.2 Cg_exo -49.88 122.38 8.95 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.493 1.462 . . . . 0.0 112.199 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 15' ' ' PRO . 71.2 ttt180 -38.83 -40.17 0.6 Allowed 'General case' 0 C--N 1.346 0.45 0 CA-C-N 113.33 -1.759 . . . . 0.0 110.73 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -57.84 -70.89 0.12 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.494 -1.684 . . . . 0.0 108.961 173.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.56 ' NZ ' ' SD ' ' A' ' 22' ' ' MET . 28.6 tptp -35.9 -48.52 0.58 Allowed 'General case' 0 C--N 1.346 0.414 0 CA-C-N 112.833 -1.985 . . . . 0.0 111.051 -176.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.14 -69.32 0.15 Allowed 'General case' 0 C--N 1.346 0.421 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.423 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 80.3 mt-10 -49.72 -23.42 1.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 112.388 -2.187 . . . . 0.0 112.245 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 81.6 mm-40 -81.34 -81.71 0.13 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 118.486 -1.286 . . . . 0.0 110.11 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.56 ' SD ' ' NZ ' ' A' ' 18' ' ' LYS . 18.4 ptm -47.05 -41.72 17.29 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 117.045 -1.862 . . . . 0.0 110.28 -176.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.495 HD13 ' CD1' ' A' ' 100' ' ' ILE . 41.8 tp -63.42 -34.49 77.85 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.422 -178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.55 ' C ' ' H ' ' A' ' 26' ' ' GLN . 71.7 p -69.24 -33.67 73.63 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 116.616 -2.034 . . . . 0.0 110.954 176.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -72.35 34.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.108 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.55 ' H ' ' C ' ' A' ' 24' ' ' SER . 28.6 mm-40 -100.75 149.95 23.28 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.454 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 28' ' ' HIS . 24.7 tpt180 -73.57 36.41 0.09 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.107 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.678 ' CE1' ' H ' ' A' ' 51' ' ' GLY . 77.7 t60 44.13 93.13 0.01 OUTLIER 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.631 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -164.03 37.36 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 116.83 -1.948 . . . . 0.0 111.258 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 96' ' ' PHE . . . 68.02 1.45 19.31 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 116.785 -2.626 . . . . 0.0 113.44 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.3 132.62 16.29 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 117.775 -1.57 . . . . 0.0 108.761 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' SER . 26.7 p90 -144.87 160.99 40.41 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 115.787 -2.365 . . . . 0.0 111.427 -173.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.532 HD23 ' CD1' ' A' ' 100' ' ' ILE . 4.6 pp -145.81 146.12 31.05 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.397 170.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 45' ' ' SER . 71.3 mt -110.25 105.19 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 112.57 -2.105 . . . . 0.0 108.096 173.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 11' ' ' PHE . 11.1 ptm180 -92.0 152.45 20.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 116.751 -1.98 . . . . 0.0 111.219 -170.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' SER . 47.4 mt-10 -113.59 129.25 56.6 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 111.73 -2.486 . . . . 0.0 109.315 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 39.9 t -50.57 -179.46 0.01 OUTLIER 'General case' 0 C--N 1.346 0.415 0 C-N-CA 116.821 -1.952 . . . . 0.0 109.878 -178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -42.79 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.345 0.392 0 CA-C-N 112.978 -1.919 . . . . 0.0 109.692 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 46.6 t -89.93 -49.18 6.75 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.497 174.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' A' ' 37' ' ' SER . . . 70.95 119.49 0.03 OUTLIER Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 112.462 -2.154 . . . . 0.0 111.246 165.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.95 -112.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 170.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.49 58.57 0.39 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 117.346 -2.359 . . . . 0.0 109.99 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -101.46 107.63 19.0 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 117.481 -1.688 . . . . 0.0 109.587 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 19.8 m-85 -129.64 127.59 40.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.494 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 80.7 p -134.06 127.31 31.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.717 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' CD2' ' HB2' ' A' ' 32' ' ' PHE . 4.8 tt -90.79 115.51 27.91 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.786 -2.006 . . . . 0.0 109.55 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.435 ' OG ' ' HG ' ' A' ' 33' ' ' LEU . 90.1 p -100.54 146.73 26.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.898 -1.956 . . . . 0.0 109.735 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.8 t -140.6 149.24 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 117.553 -1.659 . . . . 0.0 110.515 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.48 ' CE ' ' O ' ' A' ' 24' ' ' SER . 20.7 tptm -75.44 102.73 5.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 112.747 -2.024 . . . . 0.0 108.795 174.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' ASN . 38.5 t80 -98.82 108.4 21.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.472 -1.695 . . . . 0.0 109.607 -178.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.678 ' H ' ' CE1' ' A' ' 28' ' ' HIS . . . 54.79 -97.37 0.04 OUTLIER Glycine 0 CA--C 1.53 1.02 0 C-N-CA 118.021 -2.038 . . . . 0.0 110.161 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 50' ' ' PHE . 51.7 t30 -112.16 -26.34 8.86 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 112.659 -1.771 . . . . 0.0 112.043 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.544 ' CG ' ' H ' ' A' ' 54' ' ' VAL . 30.3 t0 -101.43 -173.23 2.31 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.223 -1.391 . . . . 0.0 109.528 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.544 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 96.0 t -111.47 120.5 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 113.259 -1.791 . . . . 0.0 109.742 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 57' ' ' PHE . 10.2 tt0 -90.01 159.38 16.9 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 112.881 -1.963 . . . . 0.0 109.357 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -136.31 121.55 19.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 112.733 -2.031 . . . . 0.0 110.47 -173.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 46' ' ' LEU . 24.2 m-85 -112.71 126.28 55.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.79 -2.005 . . . . 0.0 109.191 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 38.0 mtmm -95.87 118.12 31.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 116.733 -1.987 . . . . 0.0 109.538 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.534 HG11 ' CD2' ' A' ' 77' ' ' LEU . 68.0 t -75.97 92.76 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 113.031 -1.895 . . . . 0.0 108.734 176.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 54.0 mt -89.94 151.51 21.67 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 113.03 -1.895 . . . . 0.0 110.871 -174.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 64.8 ttp85 -103.24 168.89 8.88 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 111.858 -2.428 . . . . 0.0 109.431 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -119.64 -148.52 0.42 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.376 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -102.39 36.89 3.97 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 117.909 -2.091 . . . . 0.0 111.446 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -146.4 -45.16 0.19 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.717 -1.242 . . . . 0.0 109.618 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.412 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 134.27 19.6 0.86 Allowed Glycine 0 CA--C 1.542 1.741 0 CA-C-N 112.955 -1.93 . . . . 0.0 112.936 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.797 ' HZ2' ' HA ' ' A' ' 66' ' ' LYS . 1.9 mmpm? -92.41 138.7 31.3 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 118.237 -1.385 . . . . 0.0 109.532 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' HB3' ' CG1' ' A' ' 59' ' ' VAL . 86.6 m-85 -96.8 134.49 40.03 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.42 -2.173 . . . . 0.0 109.04 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 71' ' ' VAL . 50.7 p90 -152.75 -162.37 1.48 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 117.188 -1.805 . . . . 0.0 109.999 -176.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 69' ' ' LEU . 5.6 mp -133.27 -39.4 0.93 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 112.31 -2.223 . . . . 0.0 110.767 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -110.32 -38.67 5.18 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.84 -173.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 98.5 t -150.02 -83.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 117.148 -1.821 . . . . 0.0 109.365 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 71' ' ' VAL . 18.4 m -162.1 136.89 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.202 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.565 ' CD ' ' CZ ' ' A' ' 74' ' ' PHE . 17.3 ptpt -170.07 -24.26 0.02 OUTLIER 'General case' 0 C--N 1.347 0.483 0 C-N-CA 114.684 -2.806 . . . . 0.0 112.829 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.565 ' CZ ' ' CD ' ' A' ' 73' ' ' LYS . 10.8 m-85 -120.24 146.58 45.92 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 116.671 -2.011 . . . . 0.0 109.986 -174.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 76' ' ' SER . 53.1 p-10 -86.77 -22.6 25.83 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 113.087 -1.87 . . . . 0.0 112.065 175.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.416 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 41.0 t -155.6 162.34 40.65 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 118.201 -1.399 . . . . 0.0 109.703 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.534 ' CD2' HG11 ' A' ' 59' ' ' VAL . 95.9 mt -46.32 -45.48 17.51 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.932 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.406 ' OD1' ' CZ3' ' A' ' 9' ' ' TRP . 1.8 m-20 -48.49 -38.59 20.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.871 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' CB ' ' HB3' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -77.34 -19.98 55.53 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 113.994 -1.457 . . . . 0.0 112.17 -178.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.467 ' C ' HD23 ' A' ' 80' ' ' LEU . 6.8 tt -72.62 -57.68 3.94 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 118.154 -1.418 . . . . 0.0 108.227 172.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 58.2 t -51.75 -41.72 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 111.911 -2.404 . . . . 0.0 110.573 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 11.2 t70 -63.43 -44.48 94.42 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.35 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CB ' ' CE1' ' A' ' 74' ' ' PHE . 64.5 t80 -70.04 -37.49 75.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.188 -1.824 . . . . 0.0 111.096 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 86' ' ' SER . 1.0 OUTLIER -72.72 -32.53 65.79 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.397 -178.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 55.0 ptt85 -77.31 41.84 0.32 Allowed 'General case' 0 C--N 1.348 0.506 0 C-N-CA 117.276 -1.769 . . . . 0.0 110.396 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 84' ' ' HIS . 42.6 t -150.01 -44.93 0.13 Allowed 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.344 -1.753 . . . . 0.0 109.656 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 88' ' ' SER . 9.5 t -103.91 -137.6 0.35 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.192 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' A' ' 95' ' ' ILE . 70.1 p -143.03 175.54 9.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 118.166 -1.414 . . . . 0.0 109.853 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.523 ' CG2' ' N ' ' A' ' 90' ' ' SER . 1.9 m -95.94 -41.4 11.65 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-N 113.054 -1.884 . . . . 0.0 110.427 176.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.523 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 16.6 t -120.52 119.36 32.71 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.938 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -54.82 -38.69 67.68 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.698 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -50.73 -39.37 51.66 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 113.848 -1.524 . . . . 0.0 110.711 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 90' ' ' SER . 5.1 pt20 -150.68 128.62 11.76 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.247 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 12.1 pt20 -68.89 123.1 20.06 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.868 -178.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.587 ' H ' ' HB2' ' A' ' 88' ' ' SER . 14.9 mt -119.97 126.79 75.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.205 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 97' ' ' LEU . 67.4 t80 -103.46 155.45 18.5 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.062 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.45 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 91.2 mt -89.89 120.36 31.05 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 117.27 -1.772 . . . . 0.0 109.707 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -127.96 143.52 51.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.285 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -47.92 127.07 11.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.462 -2.154 . . . . 0.0 109.719 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.746 HG23 ' H ' ' A' ' 101' ' ' GLU . 17.8 tt -62.82 -121.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 112.719 -2.037 . . . . 0.0 109.707 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.746 ' H ' HG23 ' A' ' 100' ' ' ILE . 6.6 tp10 -89.9 -177.91 5.34 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.153 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.514 ' H ' ' HG3' ' A' ' 101' ' ' GLU . 26.7 tt0 57.01 118.48 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.709 176.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.402 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 9.0 p -142.79 135.46 13.64 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.046 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -43.88 124.01 4.36 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.085 1.857 . . . . 0.0 113.815 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 105' ' ' GLN . 21.0 pt20 -172.29 122.88 0.47 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 111.944 -2.389 . . . . 0.0 109.758 -172.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 105' ' ' GLN . 89.0 mm-40 -127.05 154.68 76.59 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.03 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.595 ' O ' ' CB ' ' A' ' 108' ' ' THR . 52.1 Cg_exo -46.65 124.29 8.08 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.784 2.323 . . . . 0.0 113.482 176.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.595 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 18.7 m 132.0 122.6 0.0 OUTLIER 'General case' 0 C--N 1.35 0.613 0 CA-C-N 112.411 -2.177 . . . . 0.0 109.489 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -153.58 116.45 4.5 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 112.518 -2.128 . . . . 0.0 109.353 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 110' ' ' VAL . 34.1 m -86.61 124.78 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 113.143 -1.844 . . . . 0.0 109.915 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 9.1 pt20 -100.51 122.8 43.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 112.888 -1.96 . . . . 0.0 109.681 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.448 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.725 -179.676 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.036 0 CA-C-O 121.803 0.668 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.3 tt -46.37 128.52 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 113.061 -1.569 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 71.5 mt-10 -45.61 121.17 2.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.017 -1.902 . . . . 0.0 110.161 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.601 ' HE2' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -42.88 137.97 2.16 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 112.497 -2.138 . . . . 0.0 109.514 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.601 ' H ' ' HE2' ' A' ' 4' ' ' MET . 19.9 pttm 49.79 156.17 0.04 OUTLIER Pre-proline 0 C--N 1.349 0.576 0 CA-C-N 112.864 -1.971 . . . . 0.0 110.488 -174.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 5' ' ' LYS . 80.1 Cg_exo -44.19 -120.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.506 2.137 . . . . 0.0 114.534 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.701 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 87.1 m-70 -151.52 -46.77 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 116.813 -1.955 . . . . 0.0 113.264 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.701 ' HD2' ' H ' ' A' ' 7' ' ' HIS . 50.3 Cg_exo -49.61 -121.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 121.717 1.612 . . . . 0.0 114.54 -174.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.402 ' H ' ' HB2' ' A' ' 8' ' ' PRO . 1.6 p-90 -146.43 27.69 1.11 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.93 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -102.29 116.91 33.62 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.334 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 12' ' ' GLY . 7.5 m-85 -105.65 104.28 13.97 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 113.233 -1.803 . . . . 0.0 108.497 174.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 11' ' ' PHE . . . -22.41 -108.23 0.0 OUTLIER Glycine 0 C--N 1.348 1.21 0 CA-C-N 111.63 -2.532 . . . . 0.0 112.883 -173.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.623 ' HZ2' ' HA ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -115.99 50.01 1.06 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 112.727 -1.736 . . . . 0.0 108.885 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.554 HG22 ' CB ' ' A' ' 35' ' ' ARG . 7.6 tp -69.27 132.03 90.07 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.721 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' ARG . 21.1 Cg_endo -66.11 125.03 13.42 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.263 1.976 . . . . 0.0 112.122 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.473 HH11 HH21 ' A' ' 35' ' ' ARG . 60.0 ttt85 -31.9 -40.68 0.04 OUTLIER 'General case' 0 C--N 1.349 0.544 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.083 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' LYS . . . -55.54 -76.35 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.281 -1.781 . . . . 0.0 109.405 177.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 17' ' ' ALA . 56.8 tptt -38.92 -39.81 0.57 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 112.993 -1.912 . . . . 0.0 110.915 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.576 ' O ' ' CB ' ' A' ' 23' ' ' LEU . . . -54.61 -70.76 0.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 117.071 -1.852 . . . . 0.0 108.705 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 24' ' ' SER . 47.6 mt-10 -39.36 -43.25 1.16 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.504 -2.135 . . . . 0.0 110.753 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' O ' ' OG ' ' A' ' 24' ' ' SER . 34.6 mt-10 -61.8 -91.78 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.4 -175.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.0 ptm -45.02 -39.65 5.83 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 117.524 -1.67 . . . . 0.0 110.687 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 23.5 tp -59.93 -41.11 91.05 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 113.842 -1.526 . . . . 0.0 110.748 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 26' ' ' GLN . 81.1 p -67.4 -37.35 82.97 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.471 176.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -70.66 35.16 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.613 -1.631 . . . . 0.0 111.053 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.568 HE21 ' HB1' ' A' ' 31' ' ' ALA . 13.6 mm100 -107.95 145.67 33.5 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 118.082 -1.447 . . . . 0.0 109.397 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 1.9 mpt_? -91.21 -69.79 0.72 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.876 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -61.72 105.11 0.5 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 112.956 -1.929 . . . . 0.0 109.709 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -45.99 121.03 2.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 112.623 -2.08 . . . . 0.0 109.537 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.2 -22.11 4.03 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 117.98 -2.057 . . . . 0.0 112.674 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HB1' HE21 ' A' ' 26' ' ' GLN . . . -46.98 114.14 0.79 Allowed 'General case' 0 C--N 1.35 0.605 0 C-N-CA 118.245 -1.382 . . . . 0.0 108.995 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.51 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 17.4 p90 -132.29 160.69 35.49 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 116.675 -2.01 . . . . 0.0 110.753 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 33' ' ' LEU . 4.5 pp -150.73 149.67 30.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 116.401 -2.12 . . . . 0.0 109.74 169.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.8 mt -108.44 106.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.62 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.554 ' CB ' HG22 ' A' ' 14' ' ' ILE . 31.8 ptt-85 -94.95 126.78 40.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 112.623 -2.08 . . . . 0.0 110.077 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' GLY . 63.7 tt0 -69.06 120.48 14.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.874 -1.967 . . . . 0.0 109.121 177.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.466 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 43.0 t -45.81 120.31 2.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.817 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.623 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 61.3 tt0 -45.3 -40.1 7.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 112.743 -2.026 . . . . 0.0 110.81 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.8 m -89.93 -95.15 0.11 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.168 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.66 130.37 55.17 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 113.699 -1.591 . . . . 0.0 109.621 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.35 -6.16 15.41 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.833 1.689 . . . . 0.0 114.968 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.61 40.37 2.35 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 118.506 -1.807 . . . . 0.0 111.065 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.466 ' HB2' ' CB ' ' A' ' 37' ' ' SER . 1.0 OUTLIER -133.0 120.83 21.89 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 117.747 -1.581 . . . . 0.0 109.836 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.412 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 86.7 m-85 -125.61 130.39 51.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.558 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.7 p -127.72 132.92 49.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.162 -1.836 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 tt -94.8 115.26 27.28 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.806 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.493 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 91.4 p -102.58 130.96 49.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.85 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.77 149.38 30.51 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 117.768 -1.573 . . . . 0.0 110.281 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HE2' ' O ' ' A' ' 26' ' ' GLN . 41.7 tptt -82.28 101.94 10.86 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.888 -1.96 . . . . 0.0 108.842 172.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 53' ' ' ASP . 10.4 t80 -110.04 144.75 38.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 113.321 -1.763 . . . . 0.0 108.871 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 52' ' ' ASN . . . -45.47 135.56 7.86 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 117.225 -2.417 . . . . 0.0 110.912 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 51' ' ' GLY . 58.4 t30 76.72 -34.57 0.22 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 111.536 -2.332 . . . . 0.0 111.075 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 50' ' ' PHE . 11.0 m-20 -157.35 153.35 27.18 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 114.955 -2.698 . . . . 0.0 111.592 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 24' ' ' SER . 66.5 t -69.95 125.23 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 112.325 -2.216 . . . . 0.0 108.991 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.562 HE22 ' CD1' ' A' ' 95' ' ' ILE . 11.2 tt0 -90.04 164.0 14.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.542 -177.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.509 ' CE1' ' CG ' ' A' ' 58' ' ' LYS . 16.6 t-160 -140.86 129.58 22.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 112.959 -1.928 . . . . 0.0 111.124 -168.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 92.2 m-85 -138.31 103.15 4.83 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.263 175.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.509 ' CG ' ' CE1' ' A' ' 56' ' ' HIS . 53.6 mtmt -74.39 120.64 20.23 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 117.381 -1.728 . . . . 0.0 110.323 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 77' ' ' LEU . 56.6 t -75.32 87.37 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 112.688 -2.051 . . . . 0.0 108.69 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' TYR . 71.3 mt -80.47 158.2 25.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.023 -1.899 . . . . 0.0 110.182 -174.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -131.04 157.19 43.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.663 -178.296 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -153.31 153.73 33.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 112.215 -2.266 . . . . 0.0 109.797 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -48.6 -40.61 25.0 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.126 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.11 -42.21 3.08 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 118.026 -1.47 . . . . 0.0 110.373 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.31 -24.96 24.78 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 118.293 -1.908 . . . . 0.0 112.613 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.563 ' HA ' ' HZ3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 58.71 -156.14 0.34 Allowed 'General case' 0 C--N 1.349 0.548 0 C-N-CA 117.956 -1.498 . . . . 0.0 108.959 -177.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 88.8 m-85 -76.67 125.23 28.89 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 116.886 -1.926 . . . . 0.0 109.303 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -159.29 145.9 16.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.942 -1.935 . . . . 0.0 110.968 -177.015 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.556 HD22 ' H ' ' A' ' 69' ' ' LEU . 1.7 mm? -74.09 -66.9 0.66 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.94 -1.936 . . . . 0.0 108.88 175.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 19.0 m0 -136.15 -44.48 0.63 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 112.395 -2.184 . . . . 0.0 110.137 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.2 t -125.75 -80.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 112.99 -1.914 . . . . 0.0 110.445 -173.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.0 m -48.74 134.36 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.421 -172.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -101.51 155.05 18.31 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.829 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 80' ' ' LEU . 5.6 p90 -170.05 138.62 1.73 Allowed 'General case' 0 C--N 1.342 0.275 0 CA-C-N 111.153 -2.748 . . . . 0.0 109.156 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -98.2 24.13 7.51 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 112.711 -2.041 . . . . 0.0 111.724 176.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 40.3 t -144.94 132.16 20.54 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 116.814 -1.955 . . . . 0.0 110.345 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.504 ' CD2' HG11 ' A' ' 59' ' ' VAL . 96.1 mt -56.88 -44.58 82.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 113.178 -1.828 . . . . 0.0 109.57 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -51.43 -45.63 62.69 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.756 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 76' ' ' SER . 31.7 tp10 -58.67 -38.2 77.69 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 112.997 -1.91 . . . . 0.0 110.62 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' A' ' 59' ' ' VAL . 7.9 tt -60.19 -46.27 90.29 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.331 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 77' ' ' LEU . 86.4 t -65.49 -35.53 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 112.78 -2.009 . . . . 0.0 111.337 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 24.6 t0 -58.7 -43.01 89.94 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.373 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.404 ' C ' ' H ' ' A' ' 85' ' ' ARG . 33.2 m-85 -64.55 -42.76 95.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.112 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.47 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 38.2 m170 -80.03 30.28 0.27 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 113.599 -1.637 . . . . 0.0 111.378 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 83' ' ' TYR . 79.7 ttt-85 -112.98 -38.58 4.46 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 117.973 -1.491 . . . . 0.0 110.762 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.5 p -99.6 -39.82 8.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 117.974 -1.49 . . . . 0.0 110.677 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 88' ' ' SER . 8.8 t -106.17 39.13 1.86 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 117.731 -1.588 . . . . 0.0 110.863 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 87' ' ' THR . 44.2 t 44.93 -169.35 0.01 OUTLIER 'General case' 0 C--N 1.347 0.473 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.842 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.403 ' N ' ' OG ' ' A' ' 88' ' ' SER . 10.9 p -117.81 -39.88 2.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.359 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.454 ' HB3' ' CD1' ' A' ' 95' ' ' ILE . 32.8 t -109.38 -23.94 11.3 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 113.796 -1.547 . . . . 0.0 112.164 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 90' ' ' SER . 59.0 mtp85 66.61 -5.98 0.57 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.213 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.422 ' HA ' HD22 ' A' ' 92' ' ' ASN . 15.9 m120 -48.21 -68.22 0.2 Allowed 'General case' 0 C--N 1.348 0.53 0 C-N-CA 117.481 -1.688 . . . . 0.0 109.323 177.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 94' ' ' GLN . 54.6 mt-30 -123.46 40.74 3.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.41 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 93' ' ' GLN . 23.2 tt0 57.32 111.44 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.485 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.562 ' CD1' HE22 ' A' ' 55' ' ' GLN . 55.2 mt -116.57 137.33 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 113.064 -1.88 . . . . 0.0 110.258 -178.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -121.47 133.37 55.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 112.735 -2.03 . . . . 0.0 109.112 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.47 ' CD1' ' HB2' ' A' ' 84' ' ' HIS . 80.8 mt -89.93 105.88 18.1 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.303 -1.771 . . . . 0.0 109.749 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.802 ' CD ' ' H ' ' A' ' 99' ' ' ASP . 0.7 OUTLIER 177.98 -141.94 0.01 OUTLIER 'General case' 0 C--N 1.345 0.398 0 CA-C-N 112.35 -2.204 . . . . 0.0 107.678 -178.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.802 ' H ' ' CD ' ' A' ' 98' ' ' ARG . 27.0 m-20 69.61 -27.44 0.16 Allowed 'General case' 0 C--N 1.347 0.461 0 O-C-N 125.383 1.677 . . . . 0.0 113.104 166.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 13.3 tt -75.04 30.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 116.653 -2.019 . . . . 0.0 112.119 -172.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.518 ' H ' ' C ' ' A' ' 99' ' ' ASP . 43.2 tt0 -150.06 111.96 4.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.596 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 48.7 tt0 -140.15 47.61 1.8 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.191 -1.822 . . . . 0.0 109.565 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.683 HG13 ' HD3' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -147.22 -61.97 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 112.613 -2.085 . . . . 0.0 110.245 -178.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.683 ' HD3' HG13 ' A' ' 103' ' ' VAL . 32.8 Cg_exo -50.23 131.36 31.12 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.347 2.031 . . . . 0.0 113.24 172.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 104' ' ' PRO . 19.1 mm100 88.65 12.88 0.08 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 112.168 -2.287 . . . . 0.0 113.299 175.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.441 ' CD ' ' O ' ' A' ' 106' ' ' GLN . 0.1 OUTLIER -170.06 74.38 0.64 Allowed Pre-proline 0 C--N 1.349 0.557 0 C-N-CA 117.829 -1.548 . . . . 0.0 109.493 175.455 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 108' ' ' THR . 58.7 Cg_endo -81.26 117.72 3.19 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.841 2.36 . . . . 0.0 111.214 -178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 107' ' ' PRO . 6.1 t 45.74 117.06 0.0 OUTLIER 'General case' 0 C--N 1.347 0.471 0 CA-C-N 112.699 -2.046 . . . . 0.0 112.263 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.45 ' O ' ' CD2' ' A' ' 109' ' ' TYR . 52.3 p90 -65.99 118.35 9.65 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.669 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 108' ' ' THR . 34.3 m -115.83 127.23 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.768 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 111' ' ' GLN . 20.7 pt20 -45.8 122.26 3.63 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 112.996 -1.911 . . . . 0.0 109.734 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.438 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.666 -179.843 . . . . . . . . 0 0 . 1 stop_ save_